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ABSTRACT 
 
Biologically active and structurally complex natural products provide a powerful 
driving force for the development of novel reaction methodology.  Major advances can 
reshape the way chemists approach the construction of challenging chemical bonds.   
In this work, we begin by describing the development of a catalytic asymmetric 
synthesis of five and seven-membered rings containing all-carbon quaternary 
stereocenters.  Enantioselective Pd-catalyzed decarboxylative allylic alkylation reactions 
of β-ketoester substrates afforded a variety of chiral seven-membered α-quaternary 
vinylogous esters.  Initial attempts to convert these compounds to γ-quaternary 
cycloheptenones led to the discovery of a two-carbon ring contraction reaction, which 
provided isomeric γ-quaternary acylcyclopentenes.  Subsequent adjustment of reaction 
parameters provided divergent access to the originally targeted cycloheptenones.  
Numerous synthetic applications of the two versatile product types are demonstrated.  
The methodology expands on our previous investigations of six-membered ring scaffolds 
and provides additional chiral building blocks for asymmetric total synthesis.   
The ring contraction approach to acylcyclopentenes was further developed in the total 
synthesis of the presilphiperfolanols, which are important intermediates in sesquiterpene 
biosynthesis.  Key to our synthetic route to the tricyclic core was the application of 
intramolecular Diels–Alder and Ni-catalyzed 1,4-hydroboration reactions.  From these 
efforts, the enantioselective total synthesis of presilphiperfolan-1β-ol was achieved.  
Future research efforts seek to extend the synthetic route to presilphiperfolan-9α-ol and 
study the synthetic compounds in biomimetic carbocation rearrangement processes. 
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CHAPTER 1 
The Construction of All-Carbon Quaternary Stereocenters Using Pd-
Catalyzed Asymmetric Allylic Alkylation Reactions in Total Synthesis† 
 
1.1 INTRODUCTION AND BACKGROUND  
Complex natural products serve a vital role in chemistry as a driving force for the 
invention of novel chemical transformations.1  The fundamental synthetic challenges 
posed by all-carbon quaternary stereocenters2 contained in many natural products have 
inspired the development of novel synthetic methods for the enantioselective construction 
these important motifs.  In particular, the research area of Pd-catalyzed asymmetric 
allylic alkylation3,4 has significantly advanced in response to synthetic limitations 
identified during efforts toward complex molecules (Figure 1.1).  Modern catalytic 
enantioselective methods of this type have led to the development of novel strategies for 
the efficient and direct assembly of challenging cyclic core structures in many natural 
products and additionally provided powerful, broadly applicable tools for the 
                                                
† A similar version has been published.  See: Hong, A. Y.; Stoltz, B. M. Eur. J. Org. Chem. 2013, Early 
View, DOI: 10.1002/ejoc.201201761. 
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functionalization of highly substituted ketone-derived enolates.  In this short review, the 
direct construction of all-carbon quaternary stereocenters at nucleophilic enolates via Pd-
catalyzed allylic alkylation reactions will be discussed within the broader context of 
challenges derived from total synthesis.  An all-carbon quaternary stereocenter, which is 
composed of a central carbon atom bound to four carbon substituents, should be 
distinguished from a heteroatom-substituted tertiary center, which bears one heteroatom 
and three carbon substituents (Figure 1.1).  In the following discussions, particular 
attention will be given to reported syntheses that have appeared since the most recent 
reviews.5  Total syntheses featuring enantioselective tertiary stereocenter formation6 or 
catalyst-controlled diastereoselective transformations7 will not be discussed in detail. 
 
Figure 1.1.  Natural Products as an Inspiration for The Development of Asymmetric Catalysis 
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1.2 REACTION DESIGN AND MECHANISTIC CONSIDERATIONS  
Pd-catalyzed allylic alkylation reactions have found increasingly wide synthetic 
applications due to the continued evolution of the methodology.  The invention of highly 
enantioselective transformations for the assembly of all-carbon quaternary stereocenters 
has facilitated the efficient asymmetric synthesis of numerous complex natural products.  
While a number of factors have been instrumental to the success of these Pd-catalyzed 
reactions in complex settings, advances in substrate scope and identification of suitable 
chiral ligands for these substrate types have had a direct impact on the general utility of 
these reactions.  
 
1.2.1 GENERAL ASPECTS OF Pd-CATALYZED ALLYLIC ALKYLATION  
In a typical allylic alkylation reaction, a Pd(0) complex undergoes initial olefin 
coordination and subsequent oxidative addition to an allyl electrophile (Scheme 1.1).  
Expulsion of the leaving group leads to a cationic Pd(II) π-allyl complex.  Upon 
combination with an enolate in the reaction mixture, subsequent C–C bond formation can 
lead to the α-quaternary ketone product and regenerate the initial Pd(0) complex.  The 
precise reaction mechanism can vary based on the choice of ligand, palladium precursor, 
substrate, allyl source, additive, and solvent. 
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Scheme 1.1.  General Mechanism for Pd-Catalyzed Allylic Alkylation Reactions 
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1.2.2 DEVELOPMENT OF METHODS FOR ENOLATE GENERATION 
Various methods have been employed for the generation of ketone enolates for Pd-
catalyzed asymmetric allylic alkylation reactions, but important advances in the past 
decade have rendered these transformations more practical and useful for the preparation 
of complex molecules.  An unavoidable and general problem in the allylation of 
differentially substituted ketones with multiple acidic sites is the formation of isomeric 
enolates, which can proceed to different products in the presence of a palladium π-allyl 
complex (Scheme 1.2A). 
In order to circumvent this problem, many groups have employed substrates that 
contain either α'-blocking groups to shield undesired sites of deprotonation or α-electron 
withdrawing groups to greatly reduce the pKa of the desired site of deprotonation 
(Scheme 1.2B).  While both of these strategies have afforded control of regioselective 
deprotonations in asymmetric alkylation reactions and enantioselective transformations 
on these types of substrates have been documented,8,9,10,11 this approach can introduce 
unwanted functional groups into cyclic ketone scaffolds.  The modification or removal of 
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this vestigial functionality from the α-quaternary ketone products can greatly diminish 
the general application of these compounds in total synthesis. 
 
Scheme 1.2.  The Enolate Alkylation Problem and Approaches to Selective Enolate Formation 
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The general synthesis of chiral α-quaternary ketone building blocks using Pd-
catalyzed asymmetric allylic alkylation reactions of non-biased unstabilized enolates 
constituted a major synthetic challenge until the past decade.  The lack of established 
methods for the preparation of relatively simple compounds such as ketone 4 (Figure 1.1) 
in high ee presented a significant obstacle to the synthesis of complex natural products 
with all-carbon quaternary stereocenters.  
Alternative methods for selective enolate generation could be found in the work of 
Tsuji and co-workers from the 1980s (Scheme 1.3).  Using either enol acetate12 or silyl 
enol ether13 substrates in the presence of appropriate additives, it was possible to unmask 
the latent enolates as a single isomer.  Subsequent allylic alkylation provided α-
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quaternary ketone product without ancillary group incorporation.  Additionally, Tsuji’s 
work showed that it was possible to incorporate allyl fragments into the substrate by 
using allyl enol carbonates14 or allyl β-ketoesters.15,16 The in situ formation of both an 
allyl electrophile and an enolate nucleophile could be conveniently initiated by a Pd(0) 
catalyst with both of these substrate types.  With all of these methods explored by Tsuji, 
the enolates formed under the reaction conditions maintain high regiochemical fidelity 
and smoothly proceed to the corresponding allylation products.  While these methods 
provided promising strategies for generating enolates in a widely applicable manner, 
asymmetric variants of these transformations did not surface until over 20 years later.  
 
Scheme 1.3.  Tsuji Reactions for the Allylation of Non-Shielded, Non-Stabilized Enolates 
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1.2.3 DEVELOPMENT OF ASYMMETRIC ALLYLATION REACTIONS 
In the past decade, contributions from predominantly the Stoltz and Trost groups have 
helped address the difficulty of performing Pd-catalyzed asymmetric allylic alkylations 
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on non-stabilized unbiased enolates to give α-quaternary ketones.  In the earliest report 
by Stoltz in 2004, numerous chiral bidentate ligands were screened for their ability to 
promote high asymmetric induction in reactions with allyl enol carbonate and silyl enol 
ether substrates (Scheme 1.4).17a  Ultimately, it was found that treatment of these 
substrates with the combination of (S)-t-Bu-PHOX (13) and Pd2(dba)3 provided the 
highest degree of enantioenrichment in the α-quaternary ketone products.  Other P,N- 
and P,P-chelating ligands were investigated, but they proved to be less effective under 
the optimized conditions.  Carbocyclic substrates with various ring sizes could undergo 
the transformation to give products in high ee.  Examples of benzannulated and non-
benzannulated substrates were reported. 
Shortly afterward, a study from the Trost group in 2005 described the development of 
a different catalyst system for the decarboxylative allylic alkylation of allyl enol 
carbonates (Scheme 1.4).18  A screen of various Trost bis-phosphine ligands with 
modified diamine backbones and arylphosphines revealed that ligand (R,R)-17 was most 
effective for this transformation.  Complexation of this ligand with Pd2(dba)3·CHCl3 
provided an effective catalyst for the synthesis of chiral α-quaternary ketone products 
with various ring sizes.  While most of the examples consist of benzannulated substrates, 
two examples of non-benzannulated ketones were presented.  Notably, several cyclic 
ketones with incorporated heterocycles could also be prepared.  The catalyst system was 
additionally shown to be applicable for the formation of α-tertiary ketones. 
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Scheme 1.4.  Pd-Catalyzed Asymmetric Allylic Alkylation Reactions with Allyl Enol Carbonate, Silyl 
Enol Ether, and β-Ketoester Substrate Classes 
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Figure 1.2.  Selected Chiral Ligands for Pd-Catalyzed Asymmetric Allylic Alkylation Reactions 
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Subsequent work by the Stoltz group extended the asymmetric alkylation 
methodology with the PHOX ligand system to β-ketoester substrates (Scheme 1.4).17b,c  
Since the starting materials are racemates, the destruction and reconstruction of 
stereochemical information through the intermediacy of a prochiral enolate must take 
place in order for these compounds to form asymmetric alkylation products in what has 
been termed a stereoablative process.19  Despite this key mechanistic difference, these 
substrates demonstrated similar yields and levels of asymmetric induction compared to 
the silyl enol ethers and enol carbonates.  The development of reactions for this class of 
substrates had practical advantages since various α-substituents could be introduced 
under relatively mild conditions, and β-ketoester substrates typically have higher thermal 
and chemical stablility than silyl enol ether and enol carbonate substrates.  
The bis-phosphine and phosphinooxazoline-type ligands described in the examples 
above have enjoyed notable success in the construction of challenging all-carbon 
quaternary stereocenters to prepare key intermediates for natural product synthesis 
(Figure 1.2).  Trost ligands20 possess C2 symmetry and equivalent donor atoms as well as 
amide functionality capable of hydrogen bonding.  To date, numerous ligands with 
modified backbone scaffolds and arylphosphine substitution have been reported.  
Structural modification of these ligands has led to changes in reactivity in cases with 
multiple possible asymmetric alkylation pathways.  PHOX ligands,21 which were 
pioneered by Pfaltz, Helmchen, and Williams, have also proven to be useful ligands for 
asymmetric allylic alkylation reactions.  These ligands possess C1 symmetry and non-
equivalent donor atoms.  This lack of symmetry has important ligand design implications 
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since the oxazoline and arylphosphine regions of the ligand can be tuned somewhat 
independently.  Overall, the ligand classes have unique and complementary steric and 
electronic features that make them particularly useful and adaptable for Pd-catalyzed 
asymmetric allylic alkylation reactions in total synthesis. 
 
1.3 CATALYTIC ASYMMETRIC SYNTHESIS OF NATURAL PRODUCTS 
The development of Pd-catalyzed asymmetric allylic alkylation reactions of non-
biased unstabilized enolates for the synthesis of α-quaternary ketone products has 
provided a powerful tool for total synthesis.  The following case studies not only 
illustrate important advances in synthetic chemistry, but also provide examples of how 
broader, long-standing problems in the field have been identified and overcome in the 
process of constructing complex molecules.   
 
1.3.1 TOTAL SYNTHESES OF HAMIGERAN B AND ALLOCYATHIN B2 
The synthetic potential of Pd-catalyzed allylic alkylation reactions for the assembly of 
all-carbon quaternary stereocenters was illustrated by the early enantioselective syntheses 
of hamigeran B (27)22 and allocyathin B2 (37)23 by the Trost group (Scheme 1.5 and 
Scheme 1.6).  The common component for both of these syntheses was enantioenriched 
exocyclic vinylogous ester 19.  In order to form the requisite quaternary stereocenter, the 
development of an effective asymmetric allylic alkylation reaction for exocyclic 
vinylogous ester 18 was needed.  The treatment of this compound with allyl acetate as the 
allyl source, LDA as base, trimethyltin chloride as Lewis acid, and [(η3-C3H5)PdCl]2 and 
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chiral ligand (S,S)-15 as catalyst precursors in DME at 0 °C provided α-quaternary 
ketone (R)-19 in 93% yield but only 12% ee.  Extensive reaction optimization revealed 
that the use of t-BuOH as an additive greatly improved asymmetric induction and 
provided optimized reaction conditions leading to the formation of product 19 in 87% 
yield and 91% ee.  Additionally, it was found that reduced catalyst loadings could also be 
employed to obtain similar results.  The exocyclic vinylogous ester functionality not only 
served an important purpose as an α'-blocking group to prevent the formation of isomeric 
enolates, but also enabled subsequent transformations later in the synthetic sequence. 
The convergent synthetic approach to hamigeran B (27)22 sought to unite an aryl 
fragment with a cyclopentenyl fragment containing an all-carbon quaternary stereocenter 
(Scheme 1.5).  Subsequent formation of the central six-membered ring would provide the 
core of the target.  In order to proceed toward hamigeran B (27), it was necessary to 
obtain the (S)-enantiomer of 19 generated from the optimization studies.  By application 
of Trost ligand (R,R)-15 under otherwise identical reaction conditions, vinylogous ester 
(S)-19 was obtained in 77% yield and 93% ee.  Subsequent treatment with lithium 
dimethylcuprate in Et2O led to the formation of cyclopentanone 20 bearing an all-carbon 
quaternary stereoenter.  Triflate formation and oxidative cleavage of the allyl group 
provided aldehyde 21.  Nucleophilic addition of the aryllithium of 22 followed by 
oxidation of the intermediate alcohol with Dess–Martin periodinane and selective 
monodemethylation with BCl3 gave ketone 23.  Enol triflate reduction under palladium 
catalysis, formation of the aryl triflate 24, and application of Heck cyclization conditions 
using Pd(OAc)2, dppb, and K2CO3 in toluene afforded a mixture of isomeric 
disubstituted, trisubstituted, and tetrasubstituted olefinic tricycles.  Following BBr3-
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induced demethylation, phenolic trisubstituted olefin 25 could be isolated from the 
mixture in 51% yield over 2 steps.  The selection of appropriate hydrogenation conditions 
proved crucial to the formation of the remaining stereocenter.  Treatment of alkene 25 
with Pd/C in ethanol with 1500 psi H2 led to the undesired C(6)-epimer, while 
hydrogenation with Ir black in ethanol directly provided desired tricycle 26.  Late stage 
diketone formation with SeO2 and acetic acid in p-dioxane followed by regioselective 
arene bromination led to hamigeran B (27). 
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Scheme 1.5.  Total Synthesis of Hamigeran B 
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Reaction Conditions:  (a) (CH3)2CuLi, Et2O, –20 °C (89% yield).  (b) LDA, THF, –78→0 °C;  then 
PhN(Tf)2 (87% yield).  (c) OsO4 (3.77 mol %), NMO, THF, H2O;  then NaIO4.  (d) iodoarene 22,  
DME, –55 °C;  then aldehyde 21.  (e) Dess–Martin periodinane, NaHCO3, CH2Cl2, 75% yield (3 
steps).  (f) BCl3, CH2Cl2, –20 °C (85% yield).  (g) Pd(OAc)2 (10 mol %), dppf (20 mol %), 
HCO2H, Et3N, DMF, 70 °C (94% yield).  (h) Tf2O, CH2Cl2, pyridine, 0 °C (94% yield).   
(i) Pd(OAc)2, dppb, K2CO3, PhCH3.  (j) BBr3, CH2Cl2, –78 °C (51% yield, 2 steps).  (k) Ir black, H2 
(1500 psi), EtOH (>99% yield).  (l) SeO2, cat. AcOH, p-dioxane (90% yield).  (m) NBS, i-Pr2NH (5 
mol %), CH2Cl2 (85% yield).  
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By employing the enantiomeric chiral intermediate (R)-19, the Trost group completed 
the synthesis of allocyathin B2 (37) shortly after their investigations of hamigeran B (27) 
(Scheme 1.6).  The challenging central cyclohexane ring bearing two all-carbon 
quaternary stereocenters presented an opportunity to test the group’s methods for Ru-
catalyzed enyne cycloisomerizations.  Exocyclic vinylogous ester 19 underwent a double 
organocuprate addition to give ketone 20 as in the earlier synthesis of hamigeran B (27).  
Triflation and Sonagashira coupling provided alkyne 28.  Oxidative olefin cleavage, 
aldehyde reduction, and terminal alcohol substitution provided iodide 29.  Lithium-
halogen exchange and zincation enabled a Negishi coupling with iodide 30.  
Esterification of the alkyne and alcohol deprotection provided enyne 32.  Treatment of 
this compound with the group’s previously developed conditions for Ru-catalyzed 
cycloisomerization24 provided a mixture of E and Z olefin isomers.  An investigation of 
various ester groups found that the tert-butyl ester provided the best ratio of E:Z olefin 
isomers.  Ultimately, the E isomer could be isolated and advanced to unsaturated lactone 
35 by a hydroxylative Knoevenagel reaction with phenylsulfinyl acetonitrile.25  
Hydrogenation of the least hindered disubstituted double bond, hydride reduction, and 
aldol cyclization completed the total synthesis of allocyathin B2 (37).  The preparation of 
this compound also constituted a formal synthesis of erinacine A (38) based on the prior 
work of Snider.26  By applying their asymmetric alkylation methodology, the Trost group 
achieved the divergent total syntheses of hamigeran B (27) and allocyathin B2 (37) with 
exocyclic vinylogous ester 19 as the common precursor. 
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Scheme 1.6.  Total Synthesis of Allocyathin B2 and Formal Synthesis of Erinacine A 
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Reaction Conditions:  (a) (CH3)2CuLi, Et2O, –20 °C (89% yield).  (b) LDA, THF, –78→0 °C;  then 
PhN(Tf)2 (96% yield).  (c) Pd2(dba)3·CHCl3 (2.5 mol %), PPh3 (20 mol %), CuI (5 mol %), TMS-
acetylene, n-BuNH2, 50 °C (85% yield).  (d) OsO4 (1 mol %), NMO;  then NaIO4 (87% yield).  
(e) NaBH4, MeOH (94% yield).  (f) PPh3, I2, imidazole, (97% yield).  (g) t-BuLi, ZnCl2, THF,  
–78 °C→rt;  then Pd(PPh3)4 (5 mol %), vinyl iodide 30.  (h) K2CO3, MeOH (74% yield, 2 steps).   
(i) n-BuLi, THF, –78 °C; then Boc2O, –78→rt (99% yield).  (j) TBAF, THF, (52–55% yield).   
(k) CpRu(CH3CN)3PF6 (20 mol %), DMF (1 equiv), 2-butanone, rt (48% yield of 35, or 55% 
combined yield, 6.7:1 E:Z ratio).  (l) PhS(O)CH2CN, piperidine, PhH (75% yield).  (m) 10% Pd/C, 
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EtOAc, H2 (1 atm) (83% yield).  (n) DIBAL, CH2Cl2, –78 °C.  (o) KOH, MeOH, 60 °C (51% yield, 
2 steps). 
   
1.3.2 TOTAL SYNTHESES OF DICHROANONE AND LIPHAGAL 
Following the development of a Pd·PHOX catalyst system for the catalytic 
construction of α-quaternary cyclic ketones,17a the Stoltz group sought to prepare the 
unique and highly substituted carbocyclic structures of dichroanone (46)27 and liphagal 
(56)28 (Scheme 1.7 and Scheme 1.8). Central to their divergent synthetic approach to 
these natural products was the preparation of bicyclic enone 41, which contains two 
quaternary carbons in close proximity in the cyclohexane ring (Scheme 1.7).  The 
synthetic routes toward both of these natural products began with the Pd-catalyzed 
asymmetric decarboxylative allylic alkylation of cyclic enol carbonate 39.  The addition 
of this compound to a solution of Pd2(dba)3 and (S)-t-Bu-PHOX (13) in THF (or TBME) 
led to enantioenriched ketone 40 in 83% yield and 92% ee.  The presence of the α'-
methyl groups in the substrate did not appear to impede catalysis.  By performing Wacker 
oxidation and intramolecular aldol cyclization according to previously developed 
protocols,17a bicyclic ketone 41 could be obtained in 74% yield over 2 steps.  The key 
enone possesses a prevalent substitution pattern found in not only dichroanone (46) and 
liphagal (56), but also many other terpenoid natural products.   
The (S)-enantiomer of bicyclic enone 41 was advanced toward dichroanone (46) by 
the de novo construction of the fully substituted quinone nucleus.  A Robinson annulation 
sequence followed by vinyl triflate formation and Pd-catalyzed Kumada coupling with 
isopropenyl magnesium bromide led to isopropyl arene 44.  The reaction likely proceeds 
CHAPTER 1 – Pd-Catalyzed Asymmetric Allylic Alkylation Reactions in Total Synthesis 17 
through coupling product 43, which can undergo facile aromatization to give the 
benzannulated ring system.  Titanium-mediated formylation of the aromatic ring 
proceeded smoothly to give an intermediate aldehyde, which was converted to the 
corresponding phenol 45 by means of a Baeyer–Villiger oxidation.  Careful generation of 
a reactive intermediate o-quinone could be achieved by the treatment of the tricycle with 
IBX.  Subsequent trapping of the reactive intermediate with pentafluorothiophenol, 
reoxidation with NaOH/MeOH/O2, and hydrolysis with aqueous HCl completed the 
synthesis of dichroanone (46).  Notably, the total synthesis proceeded without the use of 
protecting groups and provided an asymmetric route to this family of quinone 
norditerpenoids.  
 
Scheme 1.7.  Total Synthesis of Dichroanone 
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Reaction Conditions:  (a) PdCl2 (5 mol %), Cu(OAc)2·H2O (25 mol %), O2 (1 atm), DMA/H2O 
(7:1), 23 °C, Parr-shaker (77% yield).  (b) KOH (0.45 equiv), xylenes, 110 °C, Dean–Stark (96% 
yield).  (c) LiHMDS, THF, 0→23 °C;  then methyl vinyl ketone, –78 °C;  then aq NH4Cl, –78→23 
°C (72% yield).  (d) powdered KOH (2 equiv), xylenes, 110 °C, Dean–Stark (80% yield).  (e) LDA, 
THF, –78 °C;  then PhN(Tf)2, –78→23 °C.  (f) isopropenylmagnesium bromide (2 equiv), Pd(PPh3)4 
(5 mol %), THF, 23 °C;  then 6 M aq HCl, 23 °C (65% yield, 2 steps).  (g) Cl2HCOCH3. TiCl4, 
CH2Cl2, –78→23 °C (79% yield).  (h) aq H2O2, aq H2SO4, THF/MeOH/H2O (2:5:1), 23 °C (74% 
yield).  (i)  IBX (1.2 equiv), CHCl3, 23 °C;  then C6F5SH (4 equiv), 23 °C;  then O2 (1 atm), NaOH 
(10 equiv), MeOH, 23→75 °C; then 6 M aq HCl, 23 °C (35% yield). 
 
While the route toward dichroanone demonstrated the utility of bicyclic enone 41 in 
α-functionalization reactions, the synthesis of liphagal28 (56) demonstrated further 
synthetic applications for this bicyclic scaffold.  With enone (R)-41 available by allylic 
alklation of substrate 39 with (R)-t-Bu-PHOX (13), a photoinduced [2+2] cycloaddition 
with TMS-acetylene was performed (Scheme 1.8).  Treatment of the crude cycloadduct 
with BF3·OEt2, followed by TBAF, led to cyclobutene 47.  The strained ketone underwent 
α-arylation with 4-bromoveratrole (48) under microwave irradiation to give highly 
functionalized tricycle 49.  Arene bromination of this compound proved to be remarkably 
chemoselective as the strained cyclobutene remained intact during the transformation.  
Subsequent microwave-assisted thermal ring expansion provided conjugated 
cycloheptadienone 50.  Selective hydrogenation of the less substituted double bond 
followed by base-mediated epimerization led to bicycle 52 after two equilibration cycles.  
LDA-mediated methylation of the non-conjugated cycloheptenone and DIBAL reduction 
provided alcohol 53.  Treatment of this compound with LDA led to a reactive aryne 
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intermediate, which could react intramolecularly with the adjacent lithium alkoxide to 
provide dihydrobenzofuran 55.  Hydrogenation of the remaining olefin provided the 
necessary stereochemistry at the junction of the six- and seven-membered rings.  
Dihydrobenzofuran oxidation followed by arene formylation and phenol demethylation 
provided liphagal (56).  Taken together, the two syntheses demonstrate the unique 
synthetic utility of bicyclic enone 41, which is formed from the decarboxylative 
asymmetric allylic alkylation of enol carbonate 39.  
 
Scheme 1.8.  Total Synthesis of Liphagal 
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Reaction Conditions:  (a) TMS-acetylene, UV-B lamps, acetone.  (b) BF3·OEt2, CH2Cl2.  (c) TBAF, 
THF (68% yield, 3 steps).  (d) Pd(P(t-Bu)3)2 (5 mol %), 4-bromoveratrole, NaOt-Bu, THF, µwaves, 
120 °C (67% yield).  (e) Br2 (1.8 equiv), CHCl3 (65% yield).  (f) µwaves, o-dichlorobenzene, 250 
°C (68% yield).  (g) PtO2 (20 mol %), H2 (1 atm), EtOAc (69% yield).  (h) NaOMe, MeOH, 65 °C 
(78% yield, 3 cycles).  (i) LDA, THF, –78→0 °C;  then CH3I, –78→0 °C (68% yield).  (j) DIBAL, 
PhCH3 (91% yield).  (k) LDA (3 equiv), THF, –20 °C (83% yield).  (l) Pd/C (19 mol %), H2 (1 
atm), EtOH, 21 °C (97% yield).  (m) NO+BF4
–, CH3CN, 0 °C (70% yield).  (n) n-BuLi, TMEDA, 
THF, 0 °C;  then DMF, 0→21 °C (70 % yield).  (o) BI3, CH2Cl2 (45% yield). 
 
1.3.3 TOTAL SYNTHESES OF ELATOL,  α-CHAMIGRENE, 
LAURENCENONE C 
After successfully demonstrating the utility of the allyl enol carbonate approach17a for 
enolate generation in the asymmetric construction of quaternary stereocenters, the Stoltz 
group sought to extend the scope of the asymmetric decarboxylative allylic alkylation 
reactions in order to gain access to the chamigrene family of natural products29 (Scheme 
1.9).  These compounds are distinguished by the central all-carbon quaternary 
stereocenter connecting two highly substituted six-membered rings, as evidenced by the 
structures of laurencenone C (63) and α-chamigrene (64).  The halogenation patterns for 
members such as elatol (66) presented additional synthetic challenges.  In order to arrive 
at these natural products, a flexible synthetic route was needed. 
The gem-dimethyl group adjacent to the desired site of alkylation in substrates 57 and 
58 presented a formidable challenge for the decarboxylative allylic alkylation 
methodology with the Pd·PHOX catalyst system.  The investigation of enol carbonate and 
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β-ketoester substrates with (S)-t-Bu-PHOX (13) led to product in 81% ee, but 
conversions were consistently poor in both cases.  Faced with these synthetic difficulties, 
ligand modifications were explored to promote the desired C–C bond forming step in the 
catalytic cycle.  By employing the electron-deficient PHOX derivative 14, it was 
reasoned that the increased electrophilicity of the derived Pd π-allyl complex could 
override the steric constraints imposed by the substrate.  The combination of electron-
deficient PHOX ligand 14 with Pd(dmdba)2 in toluene or benzene ultimately provided the 
most effective conditions.  Vinylogous ester 59 could be obtained in 87% yield and 87% 
ee while the analogous chlorinated vinylogous ester 60 could be obtained in 82% yield 
and 87% ee.  In the presence of catalyst, these substrates could be converted to product 
below ambient temperature.  In addition to these two substrates, the reaction conditions 
could be applied to numerous α-substituted analogs as well.   
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Scheme 1.9. Total Syntheses of Laurencenone C, α-Chamigrene, the Proposed Structure of 
Laurencenone B, and Elatol  
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Reaction Conditions:  (a) substrate 59, Grubbs–Hoveyda 3rd generation catalyst (69) (5 mol %), 
PhH, 60 °C (97% yield).  (b) substrate 60, Grubbs–Hoveyda 3rd generation catalyst (69) (5 mol 
%), PhH, 60 °C (97% yield).  (c) MeLi, CeCl3, THF, –78→0 °C;  then 10% aq HCl, 0→23 °C (80% 
yield).  (d) BF3·OEt2, HSCH2CH2SH, MeOH, 23 °C (92% yield).  (e) Na(0), Et2O/NH3(l),  
–60→reflux (44% yield).  (f) MeLi, CeCl3, THF, –78→0 °C;  then 10% aq HCl, 0→23 °C (89% 
yield).  (g) Br2, 48% aq HBr, AcOH, 23 °C.  (h) DIBAL, THF, –78→60 °C (32% yield, 2 steps).  
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From enantioenriched vinylogous esters 59 and 60, it was envisioned that a ring-
closing metathesis to a trisubstituted or tetrasubstituted olefin would provide the 
spirobicylic core of the chamigrene natural products (Scheme 1.9).  Unfortunately, the 
application of commonly used ruthenium metathesis catalysts 67 and 68 (Figure 1.3) 
provided unsatisfactory results.  The use of the metathesis catalyst 69,30 which was 
concurrently developed by the Grubbs laboratory, proved to be an effective solution.  
Trisubstituted olefin 61 and chlorinated tetrasubstituted olefin 62 were both formed in 
excellent yields.  Notably, the advances enabled by ruthenium complex 69 provided one 
of the first examples of the effective ring-closing metathesis to form highly substituted 
halogenated olefins. 
 
Figure 1.3.  Ruthenium Olefin Metathesis Catalysts 
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With the spirocyclic core of the target natural products secured, short sequences 
enabled the synthesis of various chamigrene natural products. The addition of 
methyllithium to spirocycle 61 in the presence of CeCl3 activator followed by acid 
workup provided laurencenone C (63).  Formation of the corresponding thioketal 
followed by dissolving metal reduction provided α-chamigrene (64) in only two 
additional steps.  The application of the same methyllithium addition and acidic workup 
CHAPTER 1 – Pd-Catalyzed Asymmetric Allylic Alkylation Reactions in Total Synthesis 24 
conditions to vinylogous ester 62 enabled the formation of enone 65, which represents a 
chlorinated analog of 63.  Although this structure was reported as laurencenone B, the 
spectra did not match those of the published compound.  Nevertheless, the compound 
was brominated and reduced with DIBAL to obtain elatol (66).  Overall, three spirocyclic 
natural products in the family were prepared using this unified asymmetric 
alkylation/ring-closing metathesis strategy.   
 
1.3.4 FORMAL SYNTHESIS OF PLATENCIN 
Maier completed a formal synthesis of platencin (82)31 by employing a 
decarboxylative allylic alkylation reaction to build the substitution around a central 
quaternary carbon atom that joins three different rings (Scheme 1.10).  Beginning from 
vinylogous ester 70, formylation and allyl enol carbonate construction provided rapid 
access to allylic alkylation substrate 71 as a mixture of E and Z isomers.  Treatment with 
catalytic Pd(OAc)2 and PPh3 provided allylation product (±)-72.  Subsequent Luche 
reduction and rearrangement under acidic conditions provided enone 73.  Esterification of 
the primary alcohol and silylation provided silyl dienol ether 74.  Aerobic oxidative 
cyclization according to Toyota’s conditions32 afforded [3.2.1] bicycle 75.  The addition 
of silyl ketene acetal 76 provided conjugate adduct 77.  Subsequent tosylhydrazone 
formation and skeletal rearrangement led to [2.2.2] bicycle 78.  Weinreb amide formation 
and treatment with methyllithium gave hemiacetal 79 as an inconsequential mixture of 
diastereomers.  Reduction and oxidation of this compound provided the ring-opened 
ketoaldehyde 80.  A straightforward aldol cyclization completed the advanced 
intermediate 81 employed in numerous syntheses of platencin (82).33  
CHAPTER 1 – Pd-Catalyzed Asymmetric Allylic Alkylation Reactions in Total Synthesis 25 
In order to provide asymmetric entry into this route, Maier returned to the allylic 
alkylation step with a focus on the development of an enantioselective variant.  Treatment 
of (Z)-71 with catalytic Pd2(dba)3·CHCl3 and ligand (S,S)-17 in THF at 0 °C provided 
access to α-quaternary product 72 in 78% ee.  Further optimization revealed that 
decreasing the reaction temperature to –20 °C provided improved results with the desired 
compound isolable in 95% yield and 87% ee.  As observed in Trost’s initial studies on 
decarboxylative alkylations of allyl enol carbonates,18 the chiral diamine scaffold of 
ligand 17 proved effective for quaternary stereocenter formation.  As a demonstration of 
the essentially neutral conditions of the decarboxylative alkylation reaction, the 
potentially sensitive aldehyde functionality underwent minimal side reactions following 
quaternary stereocenter formation.  
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Scheme 1.10.  Formal Synthesis of Platencin 
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Reaction Conditions:  (a) NaH, HCO2i-Bu, 0 °C;  then ClCO2allyl, cat. KH, THF, 0 °C.   
(b) Pd(OAc)2 (1.3 mol %), PPh3, THF, 20 °C (92% yield, 2 steps).  (c) NaBH4, CeCl3·7H2O, 
MeOH, 0 °C;  then p-TsOH, H2O/Et2O, rt.  (d) PivCl (2 equiv), pyridine (4 equiv), DMAP (0.05 
equiv), CH2Cl2, rt (94% yield, 2 steps).  (e) LDA (1.5 equiv), TBSCl (2 equiv), HMPA (1 equiv), 
THF, –80 °C→rt (88% yield).  (f) O2, Pd(OAc)2 (5.8 mol %), DMSO (85% yield).   
(g) H2C=C(OMe)OTBS (76) (1.5 equiv), TiCl4 (1.2 equiv), CH2Cl2, –80 °C, (88% yield).   
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(h) TsNHNH2 (1.3 equiv), MeOH, 60 °C (95% yield).  (i) NaCNBH3, ZnCl2, MeOH, 60 °C (60% 
yield).  (j) HCl·NH(OMe)Me (6 equiv), Me3Al (5 equiv), CH2Cl2, 0 °C.  (k) MeLi (6 equiv), Et2O,  
–80→–30 °C.  (l) LiAlH4 (1 equiv), Et2O, –80→0 °C (85% yield, 2 steps).  (m) (COCl)2 (5.8 equiv), 
DMSO (9 equiv), –80 °C, Et3N (73% yield).  (n) NaOH (6.5 equiv), EtOH, 20 °C, 20 h, 87% 
yield). 
 
1.3.5 FORMAL SYNTHESIS OF HAMIGERAN B 
A report from the Stoltz group outlined an intramolecular aldol strategy for the 
construction of the tricyclic framework of hamigeran B (27).34  The synthetic plan 
targeted the early construction of an α-quaternary tetralone fragment through a Pd-
catalyzed decarboxylative allylic alkylation reaction17a (Scheme 1.11).  Facile access to 
enol carbonate 83 enabled rapid evaluation of reaction conditions for the construction of 
the key quaternary stereocenter.  The initial evaluation of (S)-t-Bu-PHOX (13) and 
Pd2(dba)3 as catalyst precursors in THF provided functionalized tetralone 84 in 71% yield 
and 88% ee.  The application of the electron-deficient ligand 14 provided greater levels 
of asymmetric induction with the product isolable in 83% yield and 94% ee.  Subsequent 
olefin cross-metathesis with methyl vinyl ketone provided enone 85 for the evaluation of 
the planned tandem conjugate reduction and aldol cyclization.  Treatment of the 
compound with Stryker’s reagent ([Ph3PCuH]6) gave desired β-hydroxyketone 86 along 
with the uncyclized reduction product.  Dehydration of compound 86 led to a tricyclic 
enone 87, which was previously reported by Miesch,35 and completed an asymmetric 
formal synthesis of hamigeran B (27).  The synthesis provides another example of the 
beneficial effect of electron-deficient PHOX ligand 14 in enantioselective allylic 
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alkylation reactions.  When taken together with Trost’s earlier total synthesis,22 the value 
of asymmetric allylic alkylation reactions can be seen in the different chiral ketone 
synthons available for the construction a common natural product target.   
 
Scheme 1.11.  Formal Synthesis of Hamigeran B 
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Reaction Conditions:  (a) methyl vinyl ketone (10 equiv), Grubbs–Hoveyda 2nd generation catalyst 
(68) (10 mol %), PhH, 35 °C (66% yield).  (b) [Ph3PCuH]6 (0.5 equiv), PhCH3, –40 °C.  (c) SOCl2 
(15 equiv), DMAP (30 mol %), pyridine, 0 °C (62% yield). 
 
1.3.6 TOTAL SYNTHESES OF CARISSONE AND CASSIOL 
The dual syntheses of carissone (99)36 and cassiol (105)37 by the Stoltz group were 
enabled by the unique synthetic potential of vinylogous thioester-derived β-ketoester 
substrates (Scheme 1.13 and Scheme 1.14).  While Stoltz developed the first asymmetric 
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allylic alkylation reactions for cycloalkanone-derived β-ketoester substrates17b (Scheme 
1.4), Trost succeeded in extending the substrate scope to vinylogous thioester-derived β-
ketoester substrates (Scheme 1.12).38  Under the influence of chiral ligand 17, α-
quaternary vinylogous thioesters such as 89 were prepared in high ee.  These products 
could be readily converted to γ-quaternary enone derivatives through Stork–Danheiser-
type transformations.  While vinylogous ester derived β-ketoester substrates were also 
evaluated, conversion was typically sluggish due to the greater orbital overlap of oxygen 
relative to sulfur. 
 
Scheme 1.12.  Extension of β-Ketoester Substrate Scope to Vinylogous Thioester Scaffolds 
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Concurrent work in the Stoltz group sought to develop a PHOX-based catalyst system 
for the preparation of these useful compounds and their further application in the total 
synthesis of natural products.  While the investigation of β-ketoester and enol carbonate 
derivatives of α'-substituted isobutyl vinylogous esters provided low conversions and 
unsatisfactory ee values, the asymmetric allylic alkylation of vinylogous thioester-derived 
β-ketoester substrate 91 with Pd2(pmdba)3 and (S)-t-Bu-PHOX (13) in toluene led to 
enantioenriched product 92 in 85% yield and 92% ee.  
Further manipulations provided a novel asymmetric synthetic route toward 
eudesmane sesquiterpenoids such as carissone and α-eudesmol36 (Scheme 1.13).  The 
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addition of Grignard reagent of bromide 93 followed by acid-promoted ketone 
transposition led to enone 94.  Ring-closing metathesis with Grubbs 2nd generation 
catalyst (67) led to fused bicycle 95.  Selective hydrogenation of the less-substituted 
double bond and desilylation provided hydroxy enone 96.  Oxidation of the alcohol 
followed by carboxylate methylation led to enone 97.  Subsequent Luche reduction of the 
enone and dimethylation of the ester led to diol 98.  Allylic alcohol oxidation provided 
carissone (99).  Notably, the assembly of diol 98 also completed a formal synthesis of  
(–)-α-eudesmol (100) by interception of Aoyama’s route.39 
 
Scheme 1.13.  Total Synthesis of Carissone and Formal Synthesis of α-Eudesmol 
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Reaction Conditions:  (a) allylic bromide 93, Mg(0), I2, 0→23 °C (94% yield).  (b) Grubbs 2nd 
generation catalyst (67) (3 mol %), PhH, 40 °C (99% yield).  (c) Rh/Al2O3 (5 mol %), H2 (1 atm), 
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MeOH.  (d) HCl, THF (56% yield, 2 steps).  (e) Dess–Martin periodinane, CH2Cl2, 0→23 °C.   
(f) NaClO2, NaH2PO4, 2-methyl-2-butene, t-BuOH/H2O;  then CH2N2 (87% yield, 2 steps).   
(g) CeCl3·7H2O, NaBH4, MeOH, –45 °C.  (h) MeMgBr, THF, 0→26 °C (73% yield, 2 steps).   
(i) MnO2, 4Å MS, CH2Cl2, (100% yield).  
 
The concise synthesis of cassiol (105)37 also illustrated the utility of α-quaternary 
vinylogous thioesters formed from decarboxylative asymmetric allylic alkylation 
reactions (Scheme 1.14).  The key enantioenriched vinylogous thioester 92 was subjected 
to palladium-catalyzed olefin isomerization, oxidative olefin cleavage, and aldehyde 
reduction steps to provide alcohol 103.  Treatment of this compound with the 
vinyllithium of 104 followed by aqueous acid workup led to cassiol (105) in a concise 
sequence.  Both of the syntheses completed by the Stoltz group illustrate the conversion 
of α-quaternary vinylogous thioesters to γ-quaternary cyclohexenones in a unified 
catalytic asymmetric strategy toward natural products. 
 
Scheme 1.14.  Total Synthesis of Cassiol  
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Reaction Conditions:  (a) PdCl2(CH3CN)2 (10 mol %), PhH, 60 °C (99% yield, 13:1 ratio 101:92).  
(b) OsO4 (10 mol %), DABCO, K3Fe(CN)6, K2CO3, t-BuOH/H2O (1:1), 35 °C.  (c) Pb(OAc)4, PhH, 
30 °C (70 % yield).  (d) Li(Ot-Bu)3AlH, THF, 0 °C (85% yield).  (e) vinyl iodide 104, t-BuLi, Et2O,  
–78 °C;  then vinylogous thioester 103;  then aq HCl, TBME (36% yield).   
 
1.3.7 TOTAL SYNTHESES OF FLUSTRAMIDES A AND B, FLUSTRAMINES 
A AND B 
Trost devised a novel and concise strategy for the synthesis of highly substituted 
pyrroloindoline and pyrroloindolone-type alkaloids such as flustramines A and B and 
flustramides A and B (111–114) (Scheme 1.15).40  His group sought to develop reactions 
based on chiral Pd π-prenyl complex 108, which can undergo regioselective  asymmetric 
alkylation by an oxindole enolate to forge either the linear prenylated product or the 
branched reverse prenylated product.  Past work has shown that C–C bond formation 
predominantly occurs at the less substituted allyl terminus,41 favoring linear product 109, 
but the successful modification of reaction conditions would provide branched isomer 
110, which would be difficult to form by alternative means given the proximity of two 
quaternary carbons. 
With this overall problem in mind, a variety of reaction conditions were evaluated to 
provide potential access to the linear or branched prenylated products.  Carbonate 107 
was identified as an excellent prenyl source and masked alkoxide base, generating one 
equivalent of each following oxidative addition and decarboxylation of the substrate by 
Pd(0).  With carbonate 107, chiral phenyl bis-phosphine ligand 15, and Pd2(dba)3·CHCl3 
in toluene, a 1:2 ratio of branched:linear products was observed, and the linear product 
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109 could be isolated in 66% yield and 94% ee.  Conversely, combination of the napthyl 
bis-phosphine ligand 16, Pd2(dba)3·CHCl3, and catalytic TBAT in CH2Cl2 led to a 5.7:1 
ratio of branched:linear products with the branched product 110 isolable in 58% yield and 
greater than 99% ee.  These results show that the careful choice and modification of the 
chiral ligand can greatly influence the regioselectivity of the asymmetric alkylation event 
leading to all-carbon quaternary stereocenters.  Additionally, the general method could be 
extended to geranylation reactions,40 providing impressive access to vicinal all-carbon 
quaternary stereocenters.  The studies performed by Trost show that it is possible to exert 
control over the regioselectivity, enantioselectivity, and diastereoselectivity of 
asymmetric alkylation reactions with their chiral ligand systems.  
The adoption of Kawasaki’s reductive amide cyclization route42 provided access to 
the highly substituted flustramine and flustramide alkaloids.  Oxindole reduction of linear 
alkylation product 109 and branched alkylation product 110 with alane-
dimethylethylamine complex at low temperature provided (+)-flustramide A (111) and 
(+)-flustramide B (113).  Treatment of these compounds with additional reductant 
ambient temperature effected lactam reduction to give (+)-flustramine A (112) and (+)-
flustramine B (114).  The synthetic route powerfully enables divergent access to C(3)-
quaternary prenylated and reverse prenylated oxindole scaffolds by appropriate choice of 
chiral ligand.  In general, examples of the catalytic, asymmetric synthesis of vicinal 
quaternary stereocenters are quite rare. 
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Scheme 1.15.  Total Syntheses of Flustramides A and B, Flustramines A and B 
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Reaction Conditions:  (a) AlH3·NMe2Et, THF, –15 °C (95% yield).  (b) AlH3·NMe2Et, THF, rt (97% 
yield).  (c) AlH3·NMe2Et, THF, –15 °C (92% yield).  (d) AlH3·NMe2Et, THF, rt (90% yield). 
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1.3.8 TOTAL SYNTHESES OF CYANTHIWIGINS B, F, AND G 
The previously described investigations of Pd-catalyzed allylic alkylations in total 
synthesis sought to establish one quaternary stereocenter at a time.  The highly 
substituted cyclohexane core of the cyathane diterpenoids motivated the Stoltz group to 
develop novel double asymmetric decarboxylative allylic alkylationreactions for efficient 
construction of multiple all-carbon quaternary stereocenters on a single molecule of 
substrate.  These efforts culminated in the efficient total syntheses of cyanthiwigins B, F, 
and G (124, 126, and 127) (Scheme 1.17).43 
The Stoltz group investigated reactions of substrate 115 in a mixture of catalytic 
Pd(dmdba)2 and (S)-t-Bu-PHOX (13) in Et2O (Scheme 1.16).17b  After two sequential 
asymmetric alkylation events, diketone 116 could be obtained in 76% yield, 92% ee, and 
4:1 dr.  Studies on the related bis-β-ketoester double alkylation substrate 117 provided 
product 118 in 78% yield, 99% ee, and 4.4:1 dr.43  These impressive levels of asymmetric 
induction can be explained by statistical amplification resulting from multiple 
asymmetric transformations occurring in sequence.44,45  The efficiency of these 
transformations for the assembly of two all-carbon quaternary stereocenters within the 
same ring system provided an excellent foundation for further synthetic efforts toward the 
cyathane diterpenoids. 
With double alkylation product 118 in hand, the synthesis of numerous members of 
the cyanthiwigin family could be completed (Scheme 1.17).  Desymmetrization of the 
diketone was achieved by triflation and Negishi coupling to give enone 120.  Subsequent 
ring-closing metathesis and cross-metathesis with Grubbs–Hoveyda 3rd generation 
catalyst (69) in the presence of vinylboronate 121 provided aldehyde 122.  Radical 
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cyclization completed the remaining cyclopentane ring.  Subsequent triflation and 
Kumada coupling afforded cyanthiwigin F (124).  
 
Scheme 1.16.  Double Enantioselective Decarboxylative Allylic Alkylation Reactions 
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Diketone 123 was further functionalized to related natural products cyanthiwigin B 
(126) and cyanthiwigin G (127) in a short, concise sequence (Scheme 1.17).  By 
performing a Tsuji oxidation46 and treating the intermediate enone with isopropyllithium 
in the presence of a CeCl3 activator, adduct 125 could be formed as an inconsequential 
mixture of diastereomers.  Oxidative transposition of the tertiary allylic alcohol enabled 
the completion of cyanthiwigin B (126).  Reduction of the ketone and enone moieties 
with NaBH4 followed by reoxidation of the allylic alcohol afforded an intermediate 
alcohol, which could be eliminated using Martin’s sulfurane to give cyanthiwigin G 
(127).  The unified approach to these natural products was enabled by the development of 
a doubly enantioselective and diastereoselective allylic alkylation of a single molecule of 
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substrate.  The efficient synthetic route provided unique access to the highly substituted 
cyclohexanoid core of the cyathane diterpenoids. 
 
Scheme 1.17.  Total Syntheses of Cyanthiwigins B, F, and G 
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Reaction Conditions:  (a) KHMDS, PhN(Tf)2, THF, –78 °C (73% yield).  (b) Zn(0), TMSCl, 1,2-
dibromoethane, alkyl iodide 119, THF, 65 °C;  then Pd(PPh3)4 (5 mol %) (78% yield).   
(c) vinylboronic ester 121, Grubbs–Hoveyda 3rd generation catalyst (69) (10 mol %), PhH, 60 °C;  
then NaBO3, THF/H2O (51% yield).  (d) t-BuSH, AIBN, PhH, 80 °C.  (e) KHMDS, PhN(Tf)2, THF, 
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–78 °C (60% yield).  (f) i-PrMgCl, CuCN, THF;  Pd(dppf)Cl2 (10 mol %) (41% yield).  (g) KHMDS, 
THF –78 °C;  then allyl chloroformate.  (h) Pd2(pmdba)3 (5 mol %), CH3CN, 80 °C (57% yield, 2 
steps).  (i) CeCl3, i-PrLi, THF, –78 °C (76% yield, mixture of diastereomers).  (j) PCC, CH2Cl2 (86% 
yield).  (k) NaBH4, MeOH/CH2Cl2, 25 °C.  (l) MnO2, CH2Cl2 (15% yield, 2 steps).  (m) Martin’s 
sulfurane, CDCl3 (48% yield). 
 
1.4 CONCLUSION AND OUTLOOK 
The pursuit of complex targets has provided inspiration for the development of Pd-
catalyzed asymmetric allylic alkylation reactions for the construction of challenging all-
carbon quaternary stereocenters.  The synthetic methods developed in the past ten years 
have provided chemists with useful tools for the assembly of densely substituted ring 
systems, and consequently, the total synthesis of complex natural products.  While major 
advances have been made, broader examination of reaction scope, development of novel 
catalyst systems, and coupling of palladium enolate chemistry to other powerful bond-
forming processes can reshape the future of the field.   
CHAPTER 1 – Pd-Catalyzed Asymmetric Allylic Alkylation Reactions in Total Synthesis 39 
1.5 NOTES AND REFERENCES 
 
(1) For a review discussing our strategy of using natural-product structures to drive 
the development of enantioselective catalysis, see:  Mohr, J. T.; Krout, M. R.; 
Stoltz, B. M. Nature 2008, 455, 323–332.  
(2) For excellent general reviews on the catalytic enantioselective generation of 
quaternary stereocenters, see:  (a) Martin, S. F. Tetrahedron 1980, 36, 419–460.  
(b) Fuji, K. Chem. Rev. 1993, 93, 2037–2066.  (c) Corey, E. J.; Guzman-Perez, A. 
Angew. Chem. Int. Ed. 1998, 37, 388–401.  (d) Christoffers, J.; Mann, A. Angew. 
Chem. Int. Ed. 2001, 40, 4591–4597.  (e) Denissova, I.; Barriault, L. Tetrahedron 
2003, 59, 10105–10146.  (f) Douglas, C. J.; Overman, L. E. Proc. Natl. Acad. Sci. 
U.S.A. 2004, 101, 5363–5367.  (g) Christoffers, J.; Baro, A. Adv. Synth. Catal. 
2005, 347, 1473–1482.  (h) Quaternary Stereocenters: Challenges and Solutions 
for Organic Synthesis, Christoffers, J., Baro, A., Eds.; Wiley: Weinheim, 2005.  
(i) Trost, B. M.; Jiang, C. Synthesis 2006, 369–396.  (j) Cozzi, P. G.; Hilgraf, R.; 
Zimmermann, N. Eur. J. Org. Chem. 2007, 5969–5994.  (k) Das, J. P.; Marek, I. 
Chem. Commun. 2011, 47, 4593–4623. 
(3) For general reviews discussing palladium-catalyzed asymmetric allylic alkylation, 
see: (a) Trost, B. M. Acc. Chem. Res. 1996, 29, 355–364.  (b) Trost, B. M.; Van 
Vranken, D. L. Chem. Rev. 1996, 96, 395−422.  (c) Helmchen, G. J. Organomet. 
Chem. 1999, 576, 203–214.  (d) Pfaltz, A.; Lautens, M. In Comprehensive 
Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer: 
New York, 1999; Vol. 2, pp 833–884.  (e) Trost, B. M.; Lee, C. In Catalytic 
Asymmetric Synthesis, 2nd ed.; Ojima, I., Ed.; Wiley-VCH: New York, 2000; pp 
593–649.  (f) Trost, B. M. Chem. Pharm. Bull. 2002, 50, 1–14.  (g) Trost, B. M. J. 
CHAPTER 1 – Pd-Catalyzed Asymmetric Allylic Alkylation Reactions in Total Synthesis 40 
 
Org. Chem. 2004, 69, 5813–5837.  (h) Lu, Z.; Ma, S. Angew. Chem. Int. Ed. 
2008, 47, 258–297.  (i) Trost, B. M. Org. Process Res. Dev. 2012, 16, 185−194. 
(4) For reviews discussing Pd-catalyzed decarboxylative allylic alkylation reactions, 
see:  (a) Tunge, J. A.; Burger, E. C. Eur. J. Org. Chem. 2005, 1715–1726.   
(b) Mohr, J. T.; Stoltz, B. M. Chem. Asian J. 2007, 2, 1476–1491.  (c) Weaver, J. 
D.; Recio, III, A.; Grenning, A. J.; Tunge, J. A. Chem. Rev. 2011, 111, 1846–
1913. 
(5) For an earlier review discussing the application of Pd-catalyzed allylic alkylation 
reactions in total synthesis, see:  Trost, B. M.; Crawley, M. L. Chem. Rev. 2003, 
103, 2921–2944. 
(6) For some recent examples of Pd-catalyzed enantioselective allylic alkylation 
reactions of ketone enolates leading to the formation of chiral tertiary centers at 
the nucleophile in the context of total synthesis, see:  (a) Nigellamine A2:  Bian, 
J.; Van Wingerden, M.; Ready, J. M. J. Am. Chem. Soc. 2006, 128, 7428–7429.  
(b) Hyperolactone C and Biyouyanagin A:  Du, C.; Li, L.; Li, Y.; Xie, Z. Angew. 
Chem. Int. Ed. 2009, 48, 7853–7856.  (c) Tekturna (Aliskiren):  Hanessian, S.; 
Chénard, E. Org. Lett. 2012, 14, 3222–3225.  
(7) For some recent examples of catalyst-controlled Pd-catalyzed diastereoselective 
allylic alkylation reactions in the context of total synthesis, see:   
(a) Spirotryprostatin B:  Trost, B. M.; Stiles, D. T. Org. Lett. 2007, 9, 2763–2766.  
(b) Epothilone D:  Prantz, K.; Mulzer, J. Chem. Eur. J. 2010, 16, 485–506.   
(c) Drechslerines A and B:  Hagiwara, H.; Fukushima, M.; Kinugawa, K.; Matsui, 
T.; Hoshi, T.; Suzuki, T. Tetrahedron 2011, 67, 4061–4068. 
CHAPTER 1 – Pd-Catalyzed Asymmetric Allylic Alkylation Reactions in Total Synthesis 41 
 
(8) Hayashi, T.; Kanehira, K.; Hagihara, T.; Kumada, M. J. Org. Chem. 1988, 53, 
113–120. 
(9) (a) Sawamura, M.; Nagata, H.; Sakamoto, H.; Ito, Y. J. Am. Chem. Soc. 1992, 
114, 2586–2592.  (b) Sawamura, M.; Sudoh, M.; Ito, Y. J. Am. Chem. Soc. 1996, 
118, 3309–3310.  (c) Kuwano, R.; Ito, Y. J. Am. Chem. Soc. 1999, 121, 3236–
3237.  (d) Kuwano, R.; Uchida, K.; Ito, Y. Org. Lett. 2003, 5, 2177–2179. 
(10) (a) Trost, B. M.; Ariza, X. Angew. Chem. Int. Ed. Engl. 1997, 36, 2635–2637.   
(b) Trost, B. M.; Radinov, R.; Grenzer, E. M. J. Am. Chem. Soc. 1997, 119, 7879–
7880.  (c) Trost, B. M.; Schroeder, G. M. J. Am. Chem. Soc. 1999, 121, 6759–
6760.  (d) Trost, B. M.; Schroeder, G. M.; Kristensen, J. Angew. Chem. Int. Ed. 
2002, 41, 3492–3495.  (e) Trost, B. M.; Schroeder, G. M. Chem. Eur. J. 2005, 11, 
174–184. 
(11) (a) You, S.-L.; Hou, X.-L.; Dai, L.-X.; Cao, B.-X.; Sun, J. Chem. Commun. 2000, 
1933–1934.  (b) You, S.-L.; Hou, X.-L.; Dai, L.-X.; Zhu, X.-Z. Org. Lett. 2001, 3, 
149–151. 
(12) Tsuji, J.; Minami, I.; Shimizu, I. Tetrahedron Lett. 1983, 24, 4713–4714. 
(13) Tsuji, J.; Minami, I.; Shimizu, I. Chem. Lett. 1983, 1325–1326. 
(14) Tsuji, J.; Minami, I.; Shimizu, I. Tetrahedron Lett. 1983, 24, 1793–1796. 
(15) Shimizu, I.; Yamada, T.; Tsuji, J. Tetrahedron Lett. 1980, 21, 3199–3202. 
CHAPTER 1 – Pd-Catalyzed Asymmetric Allylic Alkylation Reactions in Total Synthesis 42 
 
(16) Saegusa published very similar work with β-ketoesters simultaneous to Tsuji’s 
work, see:  Tsuda, T.; Chujo, Y.; Nishi, S.; Tawara, K.; Saegusa, T. J. Am. Chem. 
Soc. 1980, 102, 6381–6384. 
(17) (a) Behenna, D. C.; Stoltz, B. M. J. Am. Chem. Soc. 2004, 126, 15044–15045.   
(b) Mohr, J. T.; Behenna, D. C.; Harned, A. M.; Stoltz, B. M. Angew. Chem. Int. 
Ed. 2005, 44, 6924–6927.  (c) Behenna, D. C.; Mohr, J. T.; Sherden, N. H.; 
Marinescu, S. C.; Harned, A. M.; Tani, K.; Seto, M.; Ma, S.; Novák, Z.; Krout, 
M. R.; McFadden, R. M.; Roizen, J. L.; Enquist, Jr., J. A.; White, D. E.; Levine, 
S. R.; Petrova, K. V.; Iwashita, A.; Virgil, S. C.; Stoltz, B. M. Chem. Eur. J. 2011, 
17, 14199–14223. 
(18) (a) Trost, B. M.; Xu, J. J. Am. Chem. Soc. 2005, 127, 2846–2847.  (b) Trost, B. 
M.; Xu, J.; Schmidt, T. J. Am. Chem. Soc. 2009, 131, 18343−18357. 
(19) For a review discussing catalytic enantioselective stereoablative processes, see:  
Mohr, J. T.; Ebner, D. C.; Stoltz, B. M. Org. Biomol. Chem. 2007, 5, 3571–3576. 
(20) For an early report of Trost ligands in Pd-catalyzed asymmetric alkylation 
reactions, see:  Trost, B. M.; Van Vranken. D. L.; Bingel, C. J. Am. Chem. Soc. 
1992, 114, 9327–9343. 
(21) For early reports of PHOX ligands, see:  (a) von Matt, P.; Pfaltz, A. Angew. 
Chem. Int. Ed. Engl. 1993, 32, 566–568.  (b) Sprinz, J.; Helmchen, G. 
Tetrahedron Lett. 1993, 34, 1769–1772.  (c) Dawson, G. J.; Frost, C. G.; 
Williams, J. M. J.; Coote, S. J. Tetrahedron Lett. 1993, 34, 3149–3150. 
CHAPTER 1 – Pd-Catalyzed Asymmetric Allylic Alkylation Reactions in Total Synthesis 43 
 
(22) (a) Trost, B. M.; Pissot-Soldermann, C.; Chen, I.; Schroeder, G. M. J. Am. Chem. 
Soc. 2004, 126, 4480–4481.  (b) Trost, B. M.; Pissot-Soldermann, C.; Chen, I. 
Chem. Eur. J. 2005, 11, 951–959. 
(23) (a) Trost, B. M.; Dong, L.; Schroeder, G. M. J. Am. Chem. Soc. 2005, 127, 2844–
2845.  (b) Trost, B. M.; Dong, L.; Schroeder, G. M. J. Am. Chem. Soc. 2005, 127, 
10259–10268. 
(24) (a) Trost, B. M.; Toste, F. D. J. Am. Chem. Soc. 1999, 121, 9728–9729.  (b) Trost, 
B. M.; Toste, F. D. J. Am. Chem. Soc. 2000, 122, 714–715.  (c) Trost, B. M.; 
Toste, F. D. J. Am. Chem. Soc. 2002, 124, 5025–5036. 
(25) (a) Nokami, J.; Mandai, T.; Imakura, Y.; Nishiuchi, K.; Kawada, M.; 
Wakabayashi, S. Tetrahedron Lett. 1981, 22, 4489–4490.  (b) Ono, T.; Tamaoka, 
T.; Yuasa, Y.; Matsuda, T.; Nokami, J.; Wakabayashi, S. J. Am. Chem. Soc. 1984, 
106, 7890–7893.  (c) Trost, B. M.; Mallart, S. Tetrahedron Lett. 1993, 34, 8025–
8028. 
(26) Snider, B. B.; Vo, N. H.; O’Neil, S. V.; Foxman, B. M. J. Am. Chem. Soc. 1996, 
118, 7644–7645. 
(27) McFadden, R. M.; Stoltz, B. M. J. Am. Chem. Soc. 2006, 128, 7738–7739. 
(28) Day, J. J.; McFadden, R. M.; Virgil, S. C.; Kolding, H.; Alleva, J. L.; Stoltz, B. 
M. Angew. Chem. Int. Ed. 2011, 50, 6814–6818. 
(29) (a) White, D. E.; Stewart, I. C.; Grubbs, R. H.; Stoltz, B. M. J. Am. Chem. Soc. 
2008, 130, 810–811.  (b) White, D. E.; Stewart, I. C.; Seashore-Ludlow, B. A.; 
Grubbs, R. H.; Stoltz, B. M. Tetrahedron 2010, 66, 4668–4686.  
CHAPTER 1 – Pd-Catalyzed Asymmetric Allylic Alkylation Reactions in Total Synthesis 44 
 
(30) Stewart, I. C.; Ung, T.; Pletnev, A. A.; Berlin, J. M.; Grubbs, R. H.; Schrodi, Y. 
Org. Lett. 2007, 9, 1589–1592. 
(31) Varseev, G. N.; Maier, M. E. Angew. Chem. Int. Ed. 2009, 48, 3685–3688. 
(32) Toyota, M.; Wada, T.; Fukumoto, K.; Ihara, M. J. Am. Chem. Soc. 1998, 120, 
4916–4925. 
(33) (a) Nicolaou, K. C.; Tria, G. S.; Edmonds, D. J. Angew. Chem. Int. Ed. 2008, 47, 
1780–1783.  (b) Hayashida, J.; Rawal, V. H. Angew. Chem. Int. Ed. 2008, 47, 
4373–4376.  (c) Yun, S. Y.; Zheng, J.-C.; Lee, D. Angew. Chem. Int. Ed. 2008, 
47, 6201–6203.  (d) Tiefenbacher, K.; Mulzer, J. Angew. Chem. Int. Ed. 2008, 47, 
6199–6200.  (e) Waalboer, D. C. J.; Schaapman, M. C.; van Delft, F. L.; Rutjes, 
F. P. J. T. Angew. Chem. Int. Ed. 2008, 47, 6576–6578.  (f) Nicolaou, K. C.; Toh, 
Q.-Y.; Chen, D. Y.-K. J. Am. Chem. Soc. 2008, 130, 11292–11293; Nicolaou, K. 
C.; Toh, Q.-Y.; Chen, D. Y.-K. J. Am. Chem. Soc. 2008, 130, 14016.  (g) Austin, 
K. A. B.; Banwell, M. G.; Willis, A. C. Org. Lett. 2008, 10, 4465–4468. 
(34) Mukherjee, H.; McDougal, N. T.; Virgil, S. C.; Stoltz, B. M. Org. Lett. 2011, 13, 
825–827. 
(35) Miesch, L.; Welsch, T.; Rietsch, V.; Miesch, M. Chem. Eur. J. 2009, 15, 4394–
4401. 
(36) Levine, S. R.; Krout, M. R.; Stoltz, B. M. Org. Lett. 2009, 11, 289–292. 
(37) Petrova, K. V.; Mohr, J. T.; Stoltz, B. M. Org. Lett. 2009, 11, 293–295. 
(38) Trost, B. M.; Bream, R. N.; Xu, J. Angew. Chem. Int. Ed. 2006, 45, 3109–3112. 
CHAPTER 1 – Pd-Catalyzed Asymmetric Allylic Alkylation Reactions in Total Synthesis 45 
 
(39) Aoyama, Y.; Araki, Y.; Konoike, T. Synlett 2001, 9, 1452–1454. 
(40) Trost, B. M.; Malhotra, S.; Chan, W. H. J. Am. Chem. Soc. 2011, 133, 7328–
7331. 
(41) Kazmaier, U.; Stolz, D.; Krämer, K.; Zumpe, F. L. Chem. Eur. J. 2008, 14, 1322–
1329. 
(42) Kawasaki, T.; Shinada, M.; Kamimura, D.; Ohzono, M.; Ogawa, A. Chem. 
Commun. 2006, 420–422. 
(43) (a) Enquist, Jr., J. A.; Stoltz, B. M. Nature 2008, 453, 1228–1231.  (b) Enquist, 
Jr., J. A.; Virgil, S. C.; Stoltz, B. M. Chem. Eur. J. 2011, 17, 9957–9969. 
(44) Langenbeck, W.; Triem, G. Z. Phys. Chem. Abt. A 1936, 117, 401–409. 
(45) (a) Vigneron, J. P.; Dhaenens, M.; Horeau, A. Tetrahedron 1973, 29, 1055–1059.  
(b) Rautentrauch, V. Bull. Soc. Chim. Fr. 1994, 131, 515–524.  (c) Baba, S. E.; 
Sartor, K.; Poulin, J.; Kagan, H. Bull. Soc. Chim. Fr. 1994, 131, 525–533. 
(46) (a) Shimizu, I.; Tsuji, J. J. Am. Chem. Soc. 1982, 104, 5844–5846.  (b) Shimizu, 
I.; Minami, I.; Tsuji, J. Tetrahedron Lett. 1983, 24, 1797–1800.  (c) Minami, I.; 
Takahashi, K.; Shimizu, I.; Kimura, T.; Tsuji, J. Tetrahedron 1986, 42, 2971–
2977. 
CHAPTER 2 – Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures  
 
46 
 
 
 
 
CHAPTER 2 
Catalytic Asymmetric Synthesis of Cyclopentanoid and Cycloheptanoid 
Core Structures Using Pd-Catalyzed Asymmetric Alkylation† 
 
2.1 INTRODUCTION AND BACKGROUND 
The stereoselective total synthesis of polycyclic natural products depends greatly on 
the available tools for the efficient preparation of small and medium sized rings in 
enantioenriched form.1  Facile means to elaborate these monocyclic intermediates to 
fused, bridged, and spirocyclic architectures found within many natural ring systems 
would significantly contribute to modern synthetic methods.  While many strategies have 
been developed for the preparation of six-membered rings and their corresponding 
polycyclic derivatives, approaches toward the synthesis of five- and seven-membered 
rings would benefit from further development. 
                                                
† This work was performed in collaboration with Dr. Michael R. Krout, Dr. Thomas Jensen, Nathan B. 
Bennett, and Dr. Andrew M. Harned.  These works have been published.  See:  (a) Hong, A. Y.; Krout, M. 
R.; Jensen, T.; Bennett, N. B.; Harned, A. M.; Stoltz, B. M. Angew. Chem. Int. Ed. 2011, 50, 2756–2760.  
(b) Bennett, N. B.; Hong, A. Y.; Harned, A. M.; Stoltz, B. M. Org. Biomol. Chem. 2012, 10, 56–59.   
(c) Hong, A. Y.; Bennett, N. B.; Krout, M. R.; Jensen, T.; Harned, A. M.; Stoltz, B. M. Tetrahedron 2011, 
67, 10234–10248. 
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Guided by our continuing interest in the preparation of polycyclic systems bearing 
all-carbon quaternary stereocenters using Pd-catalyzed asymmetric alkylation 
chemistry,2,3,4,5,6 we sought to prepare various chiral cyclic ketone building blocks for 
total synthesis (Figure 2.1).  Our investigation of six-membered ring substrates has 
allowed us to achieve the enantioselective total syntheses of a number of complex natural 
products.7  Given our earlier success, we aimed to generalize our approach and gain 
access to natural products containing chiral cyclopentanoid and cycloheptanoid ring 
systems as a part of a broader synthetic strategy. 
 
Figure 2.1.  Application of Cyclopentanoid, Cyclohexanoid, and Cycloheptanoid Cores Toward 
Stereoselective Natural Product Synthesis 
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Our efforts led to the development of general strategies for the preparation of α-
quaternary vinylogous esters and their conversion to γ-quaternary cycloheptenones using 
Stork–Danheiser transformations (Figure 2.2).8  During the course of this work, we 
observed the unusual reactivity of β-hydroxycycloheptanones and exploited a two-carbon 
ring contraction to provide a general synthesis of γ-quaternary acylcyclopentenes.9  With 
access to the isomeric five- and seven-membered enones, we prepared diverse synthetic 
derivatives and polycyclic systems that can potentially provide different entry points for 
synthetic routes toward complex natural products. 
 
Figure 2.2.  General Access to Enantioenriched Cyclopentanoid and Cyclohexanoid Cores  
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2.2 β-KETOESTER SYNTHESIS AND Pd-CATALYZED ASYMMETRIC 
ALKYLATION REACTIONS 
Much of our past research on the asymmetric alkylation of cyclic ketones2,3,7a,c,g–i,10d 
and vinylogous esters7b,d–f,10a–c,e focused on six-membered rings, while transformations of 
larger rings were less thoroughly investigated.  We hoped to extend our work by 
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exploring asymmetric alkylations of seven-membered vinylogous esters.  The feasibility 
of various types of substrates for our asymmetric alkylation chemistry suggested that 
vinylogous ester 147 could be transformed into silyl enol ether, enol carbonate, or β-
ketoester substrates, but we chose to prepare β-ketoesters due to their relative stability 
and ease of further functionalization.  To access a variety of racemic α-quaternary β-
ketoester substrates for Pd-catalyzed asymmetric alkylation reactions, we required multi-
gram quantities of 1,3-cycloheptanedione (146).  Dione 146 is commercially available,11 
but we typically prepare it from cyclopentanone by the route of Ragan and co-workers to 
facilitate large scale synthesis.12  Treatment of 146 with i-BuOH and catalytic PPTS 
under Dean–Stark conditions produced vinylogous ester 147 (Scheme 2.1).11  Acylation 
of 5 with allyl cyanoformate following deprotonation with LDA enabled facile 
installation of the requisite allyl ester functionality.  Subsequent enolate trapping with a 
variety of electrophiles under basic conditions provided substrates containing alkyl, 
alkyne, alkene, 1,3-diene, vinyl chloride, nitrile, heteroarene, aldehyde, fluoride, silyl 
ether, and ester functionalities in 61–88% yield over two to four steps (148a–n).  With 
these quaternary β-ketoesters in hand, we evaluated the scope of Pd-catalyzed 
asymmetric alkylation reactions on seven-membered ring vinylogous ester substrates, 
focusing on methyl/allyl substituted 148a for our optimization efforts. 
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Scheme 2.1.  Synthesis of Parent Vinylogous Ester 147 and β-Ketoester Substrates 148 
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A survey of several electronically differentiated PHOX ligands combined with 
Pd2(pmdba)313,14 in a number of different solvents using methyl-substituted β-ketoester 
148a identified the optimal parameters for this transformation (Table 2.1).  Initial 
conditions employed (S)-t-Bu-PHOX2,15 (13, 6.25 mol %) and Pd2(pmdba)3 (2.5 mol %) 
in THF and gave vinylogous ester 149a in 94% yield and 84% ee (entry 1).16  Application 
of the same catalyst system in other ethereal solvents, such as p-dioxane, 2-methyl THF, 
TBME, and Et2O led to only slight improvements in the enantioselectivity of the reaction 
to give the desired product in up to 86% ee (entries 2–5).  Switching to aromatic solvents 
provided modest increases in asymmetric induction, furnishing 149a in 91% yield and 
88% ee in the case of toluene (entries 6 and 7). 
We next examined the impact of other PHOX ligands (14 and 150) in this medium.  
Electron-deficient ligand 147b,f,17 improved enantioselectivity at the cost of higher catalyst 
loading and lower yield (entry 8).  Structural modification of the aryl phosphine 
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backbone was evaluated with ligand 150, but this proved to be less effective, giving 
reduced yield and ee (entry 9).  Of the three ligands, 13 furnished the best overall results. 
 
Table 2.1.  Solvent and Ligand Effects on Enantioselective Decarboxylative Allylationa 
entry solvent yield (%)b ee (%)c
1 94 84THFe
4 88 85
5 93 86
6 84 86
7 91 88
TBMEe
Et2O
PhH
PhCH3
2 86 84p-dioxane
3 75 852-methyl THFe
8d 57 90PhCH3
9 77 72PhCH3
ligand
13
13
13
13
13
13
13
14
150
a Conditions: !-ketoester 148a (1.0 equiv), Pd2(pmdba)3 (2.5 mol %), ligand
(6.25 mol %) in solvent (0.1 M) at 30 °C; pmdba = 4,4ʼ-
methoxydibenzylideneacetone. b Isolated yield. c Determined by chiral
HPLC.  d Increased catalyst loadings were required to achieve full conversion: 
Pd2(pmdba)3 (5 mol %), 14 (12.5 mol %). e THF = tetrahydrofuran, 2-methyl
THF = 2-methyl tetrahydrofuran, TBME = tert-butyl methyl ether.
O
i-BuO
149a
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With optimal ligand and solvent conditions in hand, we explored asymmetric 
alkylation reactions of a variety of α-substituted β-ketoesters (Table 2.2).  Simple alkyl 
substitution performed well under our standard conditions (entries 1 and 2).  A variety of 
aromatic and heteroaromatic functionality was well tolerated by the reaction (entries 3, 
9–10).  Additionally, unsaturated functionality such as alkynes, alkenes, and 1,3-dienes 
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did not suffer from competitive reaction pathways (entries 4–6).  In the case of vinyl 
chloride 148g, no products derived from oxidative addition into the C–Cl bond were 
observed (entry 7).  Gratifyingly, N-basic functionality such as nitriles and pyridines 
could be carried through the reaction without noticeable catalyst poisoning (entries 8 and 
9).  Perhaps the most intriguing result was the observation that substrate 148k with an 
unprotected aldehyde could be converted to the enantioenriched product 149k in 90% 
yield and 80% ee, highlighting the essentially neutral character of the reaction conditions 
(entry 11).  Tertiary fluoride products could also be obtained efficiently in 94% yield and 
91% ee (entry 12).  Although most substrates underwent smooth asymmetric alkylation, 
several substrates such as silyl ether 148m18 and benzoate ester 148n19 were not formed 
as efficiently due to unproductive side reactions (entries 13–14). 
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Table 2.2.  Scope of the Pd-Catalyzed Enantioselective Alkylation of Cyclic Vinylogous Estersa 
entry yield (%)b ee (%)c
1 91 88–CH3
4 88 89
5 95 87
6 90 90
7 99 86
–CH2C
–CH2CH2CH
2 89 92–CH2CH3
3 98 86–CH2Ph
96 87–CH2CH2CN
9 97 85
substrate 148
148a
148d
148e
148f
148g
148b
148c
148h
148i
a Conditions: !-ketoester 148 (1.0 equiv), Pd2(pmdba)3 (2.5 mol %), (S)-t-Bu-PHOX (13) (6.25 
mol %) in PhCH3 (0.1 M) at 30 °C; pmdba = 4,4ʼ-methoxydibenzylideneacetone. b Isolated
yield. c Determined by chiral HPLC or SFC. d Ts = 4-toluenesulfonyl, TBDPS = tert-
butyldiphenylsilyl.
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2.3 OBSERVATION OF THE UNUSUAL REACTIVITY OF β-
HYDROXYCYCLOHEPTANONES 
With an assortment of asymmetric alkylation products in hand, we next sought to 
perform a carbonyl transposition using methods developed by Stork and Danheiser.20  
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Earlier experiments on the hydride reduction of six-membered vinylogous ester 151 with 
subsequent acid treatment gave enone 152 as expected (Scheme 2.2A).  To our surprise, 
application of identical reaction conditions to the seven-membered analog (149a) gave 
poor yields of cycloheptenone 137a (Scheme 2.2B).  Only minor quantities of elimination 
product were observed even after prolonged stirring with 10% aqueous HCl.  Closer 
inspection of the reaction mixture revealed β-hydroxyketone 154a as the major product, 
suggesting that these seven-membered ring compounds display unique and unusual 
reactivity compared to their six-membered ring counterparts.21,22,23 
 
Scheme 2.2.  Observation of the Unusual Reactivity of β-Hydroxycycloheptanone 154a 
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Without initial success using acidic conditions, we reasoned that β-hydroxyketone 
154a24 could potentially provide cycloheptenone 137a under basic conditions through a 
β-elimination pathway (Scheme 2.2B).  However, attempts in this regard did not produce 
enone 137a, but instead gave isomeric enone 135a that appeared to be formed through an 
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unexpected ring contraction pathway.  Notably, this transformation serves as a rare 
example of a two-carbon ring contraction.22,25,26 
Upon consideration of the reaction mechanism, we believed that this process occurred 
through an initial deprotonation of the hydroxy moiety, followed by retro-aldol ring 
fragmentation to a ketoaldehyde enolate  (Scheme 2.3).  Subsequent isomerization to the 
more substituted enolate and aldol cyclization could lead to the observed two-carbon ring 
contraction product 135a.  Attempts to isolate the intermediate ketoaldehyde 156a were 
unsuccessful, but aldehyde peaks could be observed by 1H NMR in reactions that did not 
proceed to full conversion.  Subsequent experiments on more substituted β-
hydroxyketones enabled isolation of linear uncyclized intermediates and provided 
additional support for this reaction mechanism (Scheme 2.6). 
 
Scheme 2.3.  Proposed Ring Contraction Mechanism 
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To explore the general stability and reactivity of β-hydroxycycloheptanones, we 
briefly examined simplified analogs that do not possess the α-quaternary stereocenter 
(Scheme 2.4).  Following hydride reduction, elimination to cyclohexenone 157 was 
observed for the six-membered vinylogous ester 70, while β-hydroxycycloheptanone 160 
and volatile cycloheptenone 159 were observed for seven-membered analog 147.  In the 
seven-membered ring case, a higher proportion of elimination product was observed 
when compared to the substituted analog 149a.  A milder aqueous acid work-up may 
suffice to hydrolyze the isobutyl enol ether and enable isolation of the β-hydroxyketone 
in higher yield in this case.  The ring contraction of β-hydroxycycloheptanone 160 under 
basic conditions proceeded smoothly to give volatile acylcyclopentene 161.  These 
observations suggest that the unusual two-carbon ring contraction appears to be a 
reactivity trend associated seven-membered rings and motivated the development of the 
ring contraction chemistry as a general approach to obtaining chiral acylcyclopentenes. 
 
Scheme 2.4.  Attempted Stork–Danheiser Manipulations on Unsubstituted Rings 
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2.4 RING CONTRACTION STRATEGY FOR PREPARING γ-
QUATERNARY ACYLCYCLOPENTENES 
Intrigued by our findings, we sought to develop a robust route to γ-quaternary 
acylcyclopentenes with many substitution patterns.  Exploring a number of bases, 
additives, solvents, and temperatures for the ring contraction of β-hydroxyketone 154a 
provided insight into the optimal parameters for the transformation (Table 2.3).  Given 
our early result using LiOt-Bu, we examined numerous aldol cyclization conditions with 
a variety of non-nucleophilic bases.  We observed that several tert-butoxides in t-BuOH 
and THF gave conversion to the desired product (135a) in good yields (entries 1–4), but 
noted that the rate of product formation was comparatively slower with LiOt-Bu than 
with NaOt-Bu or KOt-Bu.  The use of various hydroxides revealed a similar trend, where 
NaOH and KOH generated acylcyclopentene 135a in 4 hours with improved yields over 
their respective tert-butoxides (entries 5 and 6).  The relatively sluggish reactivity of 
LiOH may be due to the lower solubility of this base in THF, providing 135a in low yield 
with the formation of various intermediates (entry 7). 
To improve the yield of the reaction with LiOH as base, we investigated the effect of 
alcohol additives to facilitate the production of mild, organic-soluble bases under the 
reaction conditions to increase the efficiency of the transformation.  The combination of 
t-BuOH and LiOH in THF increased the yield of 135a to a similar level as that observed 
with LiOt-Bu, although the reaction still proceeded slowly (entry 8).  Application of more 
acidic, non-nucleophilic alcohols such as hexafluoroisopropanol (HFIP) and 
trifluoroethanol (TFE) demonstrated exceptional reactivity in combination with LiOH 
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and efficiently afforded 135a in high yields (entries 9 and 10).27  In particular, TFE 
enabled the production of 135a in 96% yield.  Comparable results with preformed 
LiOCH2CF328 suggest that this alkoxide could be the active base under the LiOH/TFE 
ring contraction conditions (entry 11). 
Concurrent investigation of cesium bases reinforced the importance of alcohol 
additives for the in situ formation of organic-soluble bases in ring contraction reactions.  
With CsOH·H2O and Cs2CO3, product formation was inefficient due to low yield or 
sluggish reactions (entries 12 and 13).  The addition of TFE afforded acylcyclopentene 
135a in yields comparable to those of the LiOH/TFE conditions (entry 14).  Notably, ring 
contraction with Cs2CO3/TFE can also be performed in acetonitrile as an alternative, non-
ethereal solvent with high efficiency (entry 15).  Additional combinations of bases, 
additives, solvents, and temperatures were evaluated, but these conditions were generally 
less effective (entries 16–21).29 
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Table 2.3.  Ring Contraction Reaction Optimizationa 
HO
O
conditions
154a 135a
O
entry base additive solvent T (°C) yield (%)b
–– 40 60
–– 40 81
–– 40 85
–– 60 89
–– 60 87
KOt-Bu THF
–– 60 19d
60 78
60 87
LiOH THF
TFEc 60 96
–– 60 90e
LiOt-Bu
NaOt-Bu
NaOH
KOH
LiOH
LiOH
LiOH
LiOCH2CF3
t-BuOH
HFIPc
THF
THF
THF
THF
THF
THF
THF
THF
8
9
10
2
11
7
3
4
5
6
time (h)
8
5
5
4
4
24
24
12.5
12.5
10
–– 40 71LiOt-Bu t-BuOH1 9
conversion (%)
100
100
100
100
100
78
98
99
99
––
100
40 52
40 57
40 77
NaOt-Bu THF
TFEc 40 73
HFIPc 40 81
KOt-Bu
LiOH
LiOH
LiOH
t-BuOH
t-BuOH
THF
THF
THF
THF
17
18
19
20
16 8
8
24
24
24
100
100
87
73
84
t-BuOH
–– 60 10CsF CH3CN21 2486
a Conditions: !-hydroxyketone 154a (1.0 equiv), additive (1.5 equiv), base (1.5 equiv), solvent (0.1 M) at
indicated temperature for 9–24 h. b GC yield using an internal standard at ≥ 98% conversion unless otherwise
stated. c HFIP = 1,1,1,3,3,3-hexafluoro-2-propanol; TFE = 2,2,2-trifluoroethanol. d Several reaction
intermediates observed by TLC and GC analysis; proceeded to 78% conversion.  e Isolated yield.  f Reaction did 
not reach completion at 24 h; proceeded to 67% conversion.
60 48
60 61f
TFEc 60 86
TFEc 60 100
CsOH•H2O
Cs2CO3
Cs2CO3
Cs2CO3
––
––
THF
THF
THF
CH3CN
12
13
14
15
4
24
12.5
12.5
100
67
100
100
O
not observed
137a
+
 
 
While a number of bases are effective for the production of 135a in excellent yields, 
we selected the combination of LiOH/TFE as our standard conditions for reaction scope 
investigation due to the lower cost and greater availability of base.  The data from our 
study further recognize the unique properties of these mild bases and suggest their 
application may be examined in a broader context.30,31  Importantly, none of the 
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conditions surveyed for the ring contraction studies generated the β-elimination product, 
cycloheptenone 137a. 
With the optimal base-promoted conditions in hand, we investigated the scope of the 
ring contraction chemistry with a variety of substitution patterns23 (Table 2.4).  Simple 
alkyl, aromatic, heteroaromatic substitution performed well under our standard conditions 
(Method A) in 84–95% yield (entries 1–6, 10).  Additionally, vinyl chlorides, nitriles, and 
indoles could be incorporated into the target acylcyclopentenes in 85–92% yield (entries 
7 and 8).  Further studies revealed that alternative aluminum hydrides such as DIBAL 
could be employed in the generation of the intermediate β-hydroxyketone by enabling 
more precise control of hydride stoichiometry.  The use of these modified conditions 
followed by oxalic acid work-up in methanol (Method B) facilitated the preparation of 
pyridine-containing acylcyclopentene 135i in higher yield compared to Method A (entry 
9). 
While various compounds could undergo the ring contraction sequence with high 
efficiency, other substrates with more sensitive functionality required slight modification 
of the reaction conditions.  To this end, we investigated the use of milder reduction 
conditions developed by Luche32 to further increase the reaction scope.  Silyl ether 
substrate 149m33 could be converted to the corresponding acylcyclopentene 135m in 86% 
yield using the LiAlH4 protocol (Method A), but application of Luche reaction conditions 
using (Method C) enabled an improvement to 91% yield (entry 11).  The same conditions 
provided the related silyl ether-containing acylcyclopentene 135o with a longer carbon 
chain in 85% yield (entry 12). 
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Table 2.4.  Ring Contraction Reaction Substrate Scopea–e 
reduction
conditions
A, B, C, or D
HO
O
R1
149 154
R2
O
i-BuO
R1
R2 LiOHCF3CH2OH
THF, 60 °C
135
R2
R1
O
entry product 135e yield (%)f
1 84
4 95
5 87
6 91
7 92
2 90
3 86
85
9 80
substrate 149
149a
149d
149e
149f
149g
149b
149c
149h
149i
a Reduction Conditions A: vinylogous ester 149 (1.0 equiv), LiAlH4 (0.55 equiv) in Et2O (0.2 M) at 0 °C, then 10% aqueous HCl
quench.  b Reduction Conditions B: (1) vinylogous ester 149 (1.0 equiv), DIBAL (1.2 equiv) in PhCH3 (0.03 M) at –78 °C; (2) oxalic 
acid·2H2O in MeOH (0.02 M). c Reduction Conditions C: vinylogous ester 149 (1.0 equiv), CeCl3·7H2O (1.0 equiv), NaBH4 (3.0
equiv) in MeOH (0.02 M) at 0 °C, then 10% aqueous HCl in Et2O at 0 °C. d Reduction Conditions D: (1) vinylogous ester 149 (1.0
equiv), DIBAL (3.3 equiv) in PhCH3 (0.03 M) at –78 °C; (2) 10% aqueous HCl in Et2O at 0 °C. e Ring Contraction Conditions E: !-
hydroxyketone 154 (1.0 equiv), CF3CH2OH (1.5 equiv), LiOH (1.5 equiv) in THF (0.1 M) at 60 °C. f Isolated yield over 2–3 steps.
g Prepared from 149k. See Experimental Section. h Prepared from 149a. See Experimental Section. i Ts = 4-toluenesulfonyl,
TBDPS = tert-butyldiphenylsilyl, DIBAL = diisobutylaluminum hydride.
reduction conditions
10 87149j
11 91149m
12 85149og
13 81149ph
14 87149qg
8
Cl
N
N
Ts
R1
–CH2Ph
–CH2CH3
–CH3
–CH2CH2CN
–(CH2)3OTBDPSi
A
A
A
A
A
A
A
A
B
A
C
C
A
A
15 25149n D
16 0149l A
–OH
–F
–CH2OTBDPSi
–CH2CH
R2
CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2CH CH2
–CH2C
–CH2CH2CH
CH
CH2
135a
135d
135e
135f
135g
135b
135c
135h
135i
135j
135m
135o
135p
135q
135n
135l
O
O
O
i-BuO
O
i-BuO
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Our success in performing ring contractions with a variety of substituents at the 
quaternary stereocenter encouraged studies aimed at determining whether additional 
substitution patterns could be introduced into the acylcyclopentene products.  While most 
substrates involved a variable group and an allyl fragment positioned on the quaternary 
center, we were intrigued by the possibility of performing the ring contraction chemistry 
with other groups.  Investigation of methyl and trans-propenyl substituted vinylogous 
ester 149p using the standard LiOH/TFE conditions showed that the chemistry was 
unaffected by modification of the allyl fragment, giving product in 81% yield (entry 13).  
Additionally, the reaction of spirocycle 149q also proceeded without complications and 
afforded the desired product in 87% yield (entry 14). 
Although many compounds performed well in the ring contraction sequence, certain 
substrates posed significant challenges.  Application of DIBAL reduction conditions with 
10% aqueous HCl work-up (Method D) and ring contraction of α-benzoate ester 149n 
enabled access to tertiary hydroxyl acylcyclopentene 135n, but the yield was relatively 
low compared to other substrates (entry 15).  Attempts to prepare the corresponding 
tertiary fluoride 149l were unsuccessful as no desired product was observed (entry 16).  
Under the reaction conditions, both vinylogous esters led to more complex product 
mixtures from unproductive side reactions in contrast to the typically high yielding 
transformations observed for other substrates. 
To obtain more functionalized acylcyclopentene products and extend our 
methodology, we sought access to β-substituted acylcyclopentenes by replacing the 
hydride reduction step with the addition of an organometallic reagent and applying the 
ring contraction chemistry on the resulting tertiary β-hydroxyketones.  We selected a 
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simple system for our initial investigations and evaluated the reaction of n-butyl 
nucleophiles with vinylogous ester 149a.  Unfortunately, the addition of n-BuMgCl or n-
BuLi afforded a complex mixture of products and proceeded slowly without reaching 
completion, consequently converting unreacted starting material to dione 162 upon work-
up with strong acid (Scheme 2.5A).34  This low reactivity could be understood from the 
electron-rich and sterically-crowded nature of the carbonyl electrophile.  Gratifyingly, 
excellent reactivity was achieved by introducing CeCl3 to the reaction with the Grignard 
reagent,35 although a fair amount of the corresponding enone was produced in the 
transformation (Scheme 2.5B).36  Nevertheless, the CeCl3-supplemented addition 
furnished a significantly improved overall yield of addition products with good 
selectivity for β-hydroxyketone 154r. 
 
Scheme 2.5.  Organometallic Addition to Vinylogous Ester 149a 
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O
n-BuMgCl, THF, 23 °C
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O
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+
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65% yield28% yield
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We next examined the ring contraction sequence with β-hydroxyketone 154r 
(Scheme 2.6).  Treatment of alcohol 154r with the optimized ring contraction conditions 
using LiOH/TFE yielded linear dione 156r without any of the β-substituted 
acylcyclopentene.  Even though the conditions did not afford the desired product, the 
isolation of stable uncyclized intermediate 156r supports our proposed retro-aldol 
fragmentation/aldol cyclization mechanism (Scheme 2.3).  By employing a stronger base 
such as KOt-Bu, both steps of the rearrangement could be achieved to give 
acylcyclopentene 135r.  Furthermore, significantly higher yields and reduced reaction 
times were achieved with microwave irradiation. 
 
Scheme 2.6.  Ring Contraction Screen on β-Hydroxyketone 154r 
n-Bu
O
O
n-Bu
O
O
OHn-Bu
154r 156r 135r
+
71% yield not observed
not observed 65% yield
not observed 73% yield
LiOH, CF3CH2OH, THF, 60 °C, 3 h
KOt-Bu, THF, 60 °C, 22 h
KOt-Bu, THF, 85 °C, µwaves, 5 min
conditions
 
 
With a route to form a variety of acylcyclopentenes that possess different substitution 
patterns, we were interested in increasing the enantiopurity of these potentially useful 
intermediates.  Formation of the corresponding semicarbazone 163 enabled us to obtain 
material in 98% ee after two recrystallizations (Scheme 2.7A).  A high yielding 
hydrolysis afforded enantioenriched acylcyclopentene 135a.  Further functionalization of 
semicarbazone 163 with 4-iodobenzylamine provided crystals that allowed verification of 
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absolute stereochemistry by X-ray crystallography.37  To demonstrate the viability of our 
method for large-scale enantioselective synthesis, we performed the asymmetric 
alkylation and ring contraction transformations on multi-gram scale (Scheme 2.7B).  
Gratifyingly, our route proved to be robust and reliable.  Using 50 mmol of substrate (15 
g), we were able to achieve a 94% yield and 88% ee of our desired asymmetric alkylation 
product.  Notably, the increased reaction scale permitted reduced catalyst loadings (1.25 
mol % Pd2(pmdba)3 and 3.12 mol % (S)-t-Bu-PHOX, 13) and higher substrate 
concentrations (0.2 M).  β-Ketoester 148a underwent the asymmetric alkylation and ring 
contraction protocol to furnish the desired acylcyclopentene in 69% overall yield over the 
three step sequence. 
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Scheme 2.7.  Confirmation of Absolute Stereochemistry and Multi-Gram Scale Reactions 
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N
H
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2.5 SYNTHESIS OF ACYLCYCLOPENTENE DERIVATIVES USING SITE-
SELECTIVE TRANSFORMATIONS 
With the ultimate goal of applying our methodology toward the total synthesis of 
complex natural products, we set out to probe the synthetic utility of various 
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acylcyclopentenes prepared using our ring contraction strategy.  While acylcyclopentenes 
135 are chiral fragments with low molecular weights, they possess an array of useful 
functionality that can be exploited for synthetic applications through site-selective 
functionalizations (Figure 2.3).  Acylcyclopentenes 135 possess hard and soft 
electrophilic sites, a nucleophilic site, a functional group handle in the form of an allyl 
group, and a variable group which can be installed through asymmetric alkylation.  
Additionally, all of the acylcyclopentenes we have prepared bear an all-carbon quaternary 
stereocenter or a fully substituted tertiary center.   
We aimed to perform site-selective functionalizations to demonstrate that a variety of 
derivatives could be prepared by recognizing the rich functionality present in 
acylcyclopentene 135  (Figure 2.3).  Selective functionalization of site A enabled access 
to tertiary alcohols, oximes, and hydrazones in 74–92% yield (165–167).  Manipulation 
of site B through olefin metathesis reactions with methyl vinyl ketone or crotonaldehyde 
provided intermediate bis-enone or enone-enal compounds in 90–95% yield as trans 
olefin isomers.  Chemoselective hydrogenation with Wilkinson’s catalyst reduced the less 
substituted and less sterically hindered olefin in these systems to form mono-enones 168 
and 169 in 90–93% yield.  Using the insights gathered from these manipulations, we 
found it was possible to perform chemoselective Heck and hydrogenation reactions to 
provide acylcyclopentene 170 bearing a pendant phenol in 86% yield over two steps.  
Through modification of site C, access to Weinreb amides and divinyl ketones could be 
achieved (171–172).  Additionally, functionalization of site D gave rise to epoxide 173.  
Functionalization of this site was also demonstrated with β-substituted acylcyclopentene 
135r (Scheme 2.6).  Lastly, variations at site E were accomplished by installing the 
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appropriate groups at an early stage during the asymmetric alkylation step (Scheme 2.1 
and Table 2.2). 
 
Figure 2.3.  Selective Functionalizations on Sites A–E of Acylcyclopentenes 135 
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To further increase the potential of these chiral building blocks, we performed 
manipulations on a combination of reactive sites to arrive at more advanced synthetic 
intermediates (Scheme 2.8).  Hydroxydiene 175 was obtained from acylcyclopentene 
135a by performing a carbonyl epoxidation followed by fragmentation in 55% yield over 
two steps (Scheme 2.8A).  Spirocyclic systems such as enones 176 and 177 can be 
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obtained by performing an intramolecular Diels–Alder using 135f or a ring-closing 
metathesis of 135g using Grubbs–Hoveyda 3rd generation catalyst (Scheme 2.8B and 
Scheme 2.8C).  Additionally, phenolic indane 179 was generated in 57% yield over four 
steps by exploiting an intermolecular Diels–Alder reaction with DMAD (Scheme 2.8D).  
To arrive at synthetic intermediates that bear a stronger resemblance to natural products, 
we formed the triflate of Heck product 170 using Comins’ reagent38 and subjected the 
compound to a subsequent intramolecular Heck reaction using the Herrmann–Beller 
palladacycle 18239 to obtain tricycle 183 with the cis-ring fusion (Scheme 2.8E).  This 
key tricycle contains all of the carbocyclic core of hamigerans C and D with correct 
stereochemistry at the ring fusions.  
Overall, our general strategy has enabled the synthesis of valuable chiral building 
blocks by taking advantage of the rich functional group content embedded in 
acylcyclopentenes 135.  Site-selective manipulations at regions A–E can produce 
monocyclic and polycyclic compounds with a large degree of structural variation.  Our 
studies have provided valuable insight into the nature of these compounds and we aim to 
apply our knowledge of these promising synthetic intermediates in the total synthesis of 
complex natural products. 
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Scheme 2.8.  Functionalization of Multiple Acylcyclopentene Reactive Sites 
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2.6 CARBONYL TRANSPOSITION APPROACH TO γ-QUATERNARY 
CYCLOHEPTENONES 
While pleased to discover the unusual reactivity of vinylogous esters 149 that led to 
the synthesis of various acylcyclopentenes, we maintained our original interest in 
preparing enantioenriched γ-quaternary cycloheptenones 137 and began reexamining 
reaction parameters to this end.  Initially, we identified conditions to obtain 
cycloheptenone 137a in two steps by activation and elimination of the hydroxy group at 
elevated temperatures, but ultimately desired a more direct route from vinylogous ester 
149a (Scheme 2.9A).  After considerable experimentation, we fortuitously discovered 
that reduction and elimination using Luche conditions effectively furnished enone 137a 
with minimal β-hydroxyketone 154a (Scheme 2.9B).  A number of factors may 
contribute to the reversed product distribution, with methanol solvent likely playing a 
large role.40  With an effective route to enone 137a, we also sought to prepare β-
substituted cycloheptenones through the 1,2-addition of organometallic reagents. 
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Scheme 2.9.  Stepwise and One-Pot Formation of Cycloheptenone 137a 
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We again investigated the addition of n-BuMgCl to vinylogous ester 149a with CeCl3 
additive, focusing on the impact of various quenching parameters.  While our previous 
studies showed that the formation of β-hydroxyketone 154r was favored over 
cycloheptenone 137r (Scheme 2.10, and Scheme 2.11, path a vs path b), we reasoned that 
elevated temperatures would promote dehydration of β-hydroxyketone 154 to form 
cycloheptenone 137 as the major product and simplify the product mixture (Scheme 2.11, 
path c).  Subsequent heating of the reaction to 60 °C after acid quench led to complete 
consumption of β-hydroxyketone (Scheme 2.10).  However, the desired cycloheptenone 
137r was isolated as a minor product along with the non-conjugated enone 184 in 76% 
yield as a single olefin isomer.  The prevalence of non-conjugated enone 184 again 
emphasizes the unusual reactivity of these seven-membered ring systems.  To revise our 
approach, we extensively screened mild acidic work-up conditions to minimize the 
formation of side products such as isomer 184.  We ultimately discovered that a sodium 
CHAPTER 2 – Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures  
 
73 
phosphate buffer quench followed by treatment of the crude enol ether41 with dilute HCl 
in acetonitrile exclusively afforded desired cycloheptenone 137r (Scheme 2.10).  
Gratifyingly, a number of sp3-hybridized carbon nucleophiles can be employed under 
these conditions, permitting the preparation of allyl,42 homoallyl, and pentenyl substituted 
cycloheptenones (Table 2.5, entries 1–6, Method F). 
 
Scheme 2.10.  Synthesis of β-Substituted Cycloheptenones 
i-BuO
O
+
149a
O
+
137r 184
conditions
O
n-Bu
n-Pr
CeCl3, n-BuMgCl, THF, 23 °C
then 10% aq HCl 28% yield not observed
CeCl3, n-BuMgCl, THF, 23 °C
then 10% aq HCl, 23!60 °C 4% yield 76% yield
CeCl3, n-BuMgCl, THF, 23 °C
then Na3PO4 buffer (pH 6.5)
then aq HCl (6 mM), CH3CN
84% yield not observed
O
OHn-Bu
154r
65% yield
not observed
not observed
 
 
Scheme 2.11.  General Reaction Mechanism for Carbonyl Transposition 
i-BuO
R OH
O
R
CeCl3
RMgX or RLi
THF, 23 °C
O
i-BuO
137
path
a
149a pathb
O
R OH
154
H+
H+
b
a path
c
then
H+, H2O
155
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Table 2.5.  Scope of Organometallic Addition/Eliminationa 
i-BuO
O CeCl3, R–M
THF, 23 °C
then work-up
conditions O
R
149a 137
entry product 137 yield (%)c
1 84
4 90
5 82
6 92
7d G 84
2 73
3 93
97
9e 66
a Conditions: vinylogous ester 149a (1.0 equiv), CeCl3 (2.5 equiv), RMgX or RLi (3.0 equiv) in
THF, 23 °C then work-up by Method F, G, or H. b Method F: (1) pH 6.5 Na3PO4 buffer; (2) 6
mM HCl, CH3CN; Method G: 10% w/w aqueous HCl, 60 °C; Method H: 2 M H2SO4, 60 °C.
c Yield of isolated product.  d Performed without CeCl3 additive.  e Product was a 1.9:1 mixture 
of atropisomers.
M
137r
137u
137v
137w
137x
137s
137t
137y
137z
work-up conditionsb
10 G 72137aa
11 G 84137ab
8
R
–MgCl
–MgBr
–MgBr
–MgBr
–Li
–MgBr
–MgBr
–MgBr
–MgBr
–Li
–MgCl
Ph
O
S
F
F
F
F
F
F
H
H
 
 
We then turned our attention to sp- and sp2-hybridized carbon nucleophiles as part of 
our goal to prepare variably substituted cycloheptenones 137.  Attempts to apply the 
buffer and dilute acid quenching parameters provided poor selectivity and often led to 
complex mixtures of products.  A thorough evaluation of work-up conditions revealed 
that the desired unsaturated β-substituted cycloheptenones could be obtained by 
quenching the reactions with concentrated strong acid followed by stirring at elevated 
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temperatures.  Although investigated for sp3-hybridized carbon nucleophiles, the strong 
acid work-up conditions are more suitable for these reactions because the only possible 
elimination pathway leads to conjugated enone 137.  In this manner, the initial mixture of 
enone and β-hydroxyketone could be funneled to the desired product (Scheme 2.11, paths 
b and c).  By employing a HCl (Method G) or H2SO4 quench (Method H), the synthesis 
of vinyl,43 alkynyl,44 aryl, and heteroaryl substituted enones was achieved in moderate to 
excellent yield (Table 2.5, entries 7–11).  Particularly noteworthy was entry 9, where 
addition of an ortho-substituted Grignard reagent produced sterically congested 
cycloheptenone 137z.45 
These results demonstrate that application of the appropriate quenching parameters 
based on the type of carbon nucleophile employed is required for successful carbonyl 
transposition to β-substituted γ-quaternary cycloheptenones (Scheme 2.12).  For sp3-
hybridized carbon nucleophiles, reaction work-up with buffer and dilute acid maximizes 
enone yield and minimizes formation of non-conjugated enone isomers.  In contrast, 
reactions using sp- and sp2-hybridized carbon nucleophiles require strong acidic work-up 
with heating for best results.  Careful application of these general protocols (Methods F–
H) provides access to diverse β-substituted γ-quaternary cycloheptenones 137. 
 
CHAPTER 2 – Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures  
 
76 
Scheme 2.12.  Different Work-Up Conditions for Carbonyl Transposition Reactions Employing sp3 
versus sp/sp2 Carbon Nucleophiles 
O
RCeCl3, RMgX or RLi
THF, 23 °C
then Na3PO4 buffer (pH 6.5)
then aq HCl (6 mM), CH3CN
R = alkyl
O
i-BuO
CeCl3, RMgX or RLi
THF, 23 °C
then HCl or H2SO4
23!60 °C
O
i-BuO
R
O
149a 137
149a 137R = alkenyl, alkynyl, aryl
B
A Buffer and Dilute Acid Parameters: sp3 carbon nucleophiles
Strong Acid Conditions: sp and sp2 carbon nucleophiles
 
 
2.7 SYNTHESIS OF CYCLOHEPTENONE DERIVATIVES USING 
TRANSITION-METAL CATALYZED CYCLIZATIONS 
Having produced a variety of cycloheptenones, we next turned our attention to the 
preparation of a series of bi- and tricyclic structures that would be valuable for total 
synthesis applications.  The incorporation of alkene functionality at the β-position 
allowed rapid access to a series of [7–n] fused ring systems through ring-closing 
metathesis with the γ-allyl fragment (Table 2.6).  This transformation enables the 
formation of disubstituted bicycles (185x, 185s, 185u, and 185w) from terminal alkenes 
in excellent yields (entries 1, 3, 5, and 8).  Trisubstituted bicycles (185y, 185t, and 185v) 
are also accessible through enyne ring-forming metathesis (entry 2) and ring-closing 
metathesis with 1,1-disubstituted alkene β-substituents (entries 4 and 6).  Additionally, 
both atropisomers of cycloheptenone 137z converge to the [7–7–6] tricyclic enone (185z) 
under the reaction conditions (entry 7). 
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Table 2.6.  Formation of Bi- and Tricyclic Systems Through Ring-Closing Metathesisa 
entry product 185 yield (%)b
1c 93
4d 90
5 90
6 98
7e 96
2 99
3d 91
99
a Conditions: cycloheptenone 137 (1.0 equiv) and Grubbs–Hoveyda 2nd generation catalyst (68, 5.0
mol %) in PhH, 50 °C.  b Yield of isolated product.  c Conditions: cycloheptenone 137 (1.0 equiv) and 
Grubbs 2nd generation catalyst (68, 0.2 mol %) in CH2Cl2, reflux. d 1,4-benzoquinone (10 mol %)
added.  e Performed in PhCH3.
R1
185x
185t
185u
185v
185z
185y
185s
185w8
Ru
O
Cl
Cl
NN
185
(n = 0–3)
Grubbs–Hoveyda 2nd 
generation (68) (5 mol %)
PhH, 50 °C
137
nR
1
O O
R2
substrate 137
137t
137u
137v
137z
137y
137s
137w
137x
R2 = CH3
R2 = H
R2 = CH3
–––
R2 =
R2 = H
–––
R2
R2 = HPh
O
R2
O
R2
O
R2
O
O
 
 
With two [7–6] bicyclic structures in hand, we next investigated the preparation of 
other such bicycles with variable olefin positions.  Addition of 3-butenylmagnesium 
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bromide to trans-propenyl vinylogous ester 149p followed by ring-closing metathesis 
furnished bicycle 186 with the alkene adjacent to the quaternary stereocenter (Scheme 
2.13A).  Following the precedent of Fuchs,46 we envisioned accessing bicycle 188 
through a base-mediated migration from enone 185s.  However, treatment of skipped 
diene 185s with an amine base at ambient temperature unexpectedly afforded diene 187 
instead (Scheme 2.13B).  In the end, the alkene could be migrated in the desired direction 
to generate diene 188 by performing the reaction in the presence of microwave 
irradiation.  Overall, these methods allow for the preparation of [7–6] bicycles with 
variable olefin substitution. 
 
Scheme 2.13.  Synthesis of Additional [7–6] Bicycles and [7–5–5] Tricycles 
1. CeCl3, THF, 23 °C
    then Na3PO4 buffer (pH 6.5)
    then HCl (6 mM), CH3CN
2. Grubbs–Hoveyda 2nd 
    generation (68) (5 mol %)
    PhH, 50 °C
         70% yield, 2 steps
MgBr
73% yield
149p 186
185s 187 188
+
O O O
i-BuO
O
O
DBU, CH3CN, 23 °C
DBU, CH3CN, 180 °C, µwaves
not observed
16% yield 59% yield
conditions
137y
Co2(CO)8
THF, 23 °C
then DMSO, 60 °C
+
90% yield
3:1 dr
189a 189b
O
O
O
H
O
O
H
C
B
A
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Recognition of the proximal enyne functionality of cycloheptenone 137y prompted an 
investigation of a Pauson–Khand reaction to form more complex ring systems.  
Treatment of enone 137y with dicobalt octacarbonyl in the presence of 
dimethylsulfoxide47 generated the [7–5–5] tricycle in a 3:1 diastereomeric ratio of 189a to 
189b (Scheme 2.13C).  Overall, our organometallic addition and elimination strategy 
combined with the appropriate work-up conditions facilitated the preparation of 
numerous bi- and tricyclic systems with a wide array of substitution patterns that may 
prove useful in the context of natural product synthesis. 
 
2.8 UNIFIED STRATEGY FOR THE SYNTHESIS OF COMPLEX 
POLYCYCLIC NATURAL PRODUCTS 
Our divergent approaches to the synthesis of acylcyclopentenes 135 and 
cycloheptenones 137 from enantioenriched vinylogous esters 149 have provided the 
foundation for the preparation of complex polycyclic molecules based on cyclopentanoid 
and cycloheptanoid core structures (Figure 2.4).  Both [5–6] and [5–6–7] fused polycyclic 
structures could be obtained from acylcyclopentenes.  Synthetic elaboration of 
cycloheptenones provided access to [7–5], [7–6], [7–7], [7–8], [7–7–6], and [7–5–5] 
fused structures.  Additionally, [5–5], [5–6], and [7–6] spirocyclic structures could be 
obtained using our synthetic approaches.  These examples significantly add to the 
collection of polycyclic architectures accessible by elaboration of chiral six-membered 
ring carbocycles or heterocycles 136.2,3  We have applied previously developed 
methodology toward a number of polycyclic cyclohexanoid natural products7 (Figure 2.5) 
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and similarly plan to exploit the ring contraction and ketone transposition methodology in 
future efforts toward cyclopentanoid and cycloheptanoid natural products.  The work 
presented in this chapter will provide the foundation for future efforts and enable a 
broader synthetic approach to complex natural product targets. 
 
Figure 2.4.  Chiral Fused and Spirocyclic Structures Prepared by Asymmetric Allylic Alkylation 
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Figure 2.5. Pd-Catalyzed Asymmetric Allylic Alkylation in the Total Synthesis of Natural Products 
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2.9 CONCLUSION 
We have successfully developed general, enantioselective synthetic routes toward γ-
quaternary acylcyclopentenes (135) and γ-quaternary cycloheptenones (137).  The key 
stereoselective component unifying this chemistry is the Pd-catalyzed asymmetric 
alkylation of seven-membered vinylogous ester substrates to form α-quaternary 
vinylogous esters, for which we have demonstrated a broad substrate scope with a variety 
of all-carbon and heteroatom-containing functionality.  These enantioenriched products 
were transformed in a divergent manner to either facilitate a two-carbon ring contraction 
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to acylcyclopentenes or a carbonyl transposition to cycloheptenones.  Further synthetic 
elaboration of these products has enabled access to five- and seven-membered ring 
systems that are poised for further functionalization to bi- and tricyclic ring systems.  
Overall, the described strategies provide broader access to polycyclic ring systems and 
thus complement our previous work with six-membered ring building blocks.  Efforts to 
expand the scope of these reactions, understand the key reaction mechanisms, and apply 
the chiral products to the total synthesis of natural products are the subject of future 
studies. 
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2.10 EXPERIMENTAL SECTION 
2.10.1 MATERIALS AND METHODS 
Unless otherwise stated, reactions were performed in flame-dried glassware under an 
argon or nitrogen atmosphere using dry, deoxygenated solvents.  Reaction progress was 
monitored by thin-layer chromatography (TLC).  THF was distilled over 
sodium/fluorenone or dried by passage through an activated alumina column under 
argon48 prior to use.  p-Dioxane was distilled over sodium or dried by passage through an 
activated alumina column under argon prior to use.  Methanol was distilled over 
Mg(OMe)2 prior to use.  Other solvents were dried by passage through an activated 
alumina column under argon.  Diisopropylamine and triethylamine were distilled over 
CaH2 prior to use.  Iodomethane, iodoethane, acrylonitrile, methyl vinyl ketone, and 
acrolein were distilled prior to use.  Furan was distilled over KOH and hydroquinone 
prior to use.  Purified water was obtained using a Barnstead NANOpure Infinity UV/UF 
system.  Brine solutions are saturated aqueous solutions of sodium chloride.  MePh3PBr 
was purchased from Sigma-Aldrich and stored in a glove box prior to use.  NaH (60% wt. 
dispersion in mineral oil) was purchased from Sigma-Aldrich and purified by trituration 
with hexanes under a N2 atmosphere and removal of residual solvent under vacuum.  
Grignard and organolithium reagents were purchased from Sigma-Aldrich unless 
otherwise stated and titrated according to the method of Love.49  LiOCH2CF3 was 
prepared according to the method of Shreeve.50  Allyl cyanoformate was prepared 
according to the method of Mander51a or Rattigan.51b  Gramine methiodide was prepared 
according to the method of Armen.52  The procedure of Maruyama and Naruta was used 
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to prepare 1-chloro-2,4-pentadiene (92:8 E:Z).53  Phosphinooxazoline (PHOX) ligands 
(S)-t-Bu-PHOX (13)54 and (S)-p-(CF3)3-t-Bu-PHOX (14)55  were prepared by methods 
described in our previous work.  Tris(4,4’-methoxydibenzylideneacetone)dipalladium(0) 
(Pd2(pmdba)3) was prepared according to the method of Ibers56 or Fairlamb.56b  
Herrmann–Beller’s catalyst (182) was prepared according to a literature procedure.57  All 
other reagents were purchased from Sigma-Aldrich, Acros Organics, Strem, or Alfa 
Aesar and used as received unless otherwise stated.  Reaction temperatures were 
controlled by an IKAmag temperature modulator.  Microwave-assisted reactions were 
performed in a Biotage Initiator 2.5 microwave reactor.  Glove box manipulations were 
performed under a N2 atmosphere.  TLC was performed using E. Merck silica gel 60 
F254 precoated glass plates (0.25 mm) and visualized by UV fluorescence quenching, p-
anisaldehyde, or KMnO4 staining.  SiliaFlash P60 Academic Silica gel (particle size 
0.040–0.063 mm) or ICN silica gel (particle size 0.032–0.0653 mm) was used for flash 
column chromatography.  Automated flash column chromatography was performed on a 
Teledyne Isco CombiFlash Rf system.  1H NMR spectra were recorded on a Varian 
Mercury 300 MHz, a Varian 400 MR 400 MHz, or a Varian Inova 500 MHz 
spectrometer and are reported relative to residual CHCl3 (δ 7.26 ppm) or C6H6 (δ 7.16 
ppm).  Variable temperature 1H NMR experiments were performed on a Varian Inova 
500 MHz spectrometer and are reported relative to residual DMSO (δ 2.50 ppm).  13C 
NMR spectra were recorded on a Varian Mercury 300 MHz, a Varian 400 MR 400 MHz, 
or a Varian Inova 500 MHz spectrometer (at 75 MHz, 100 MHz, and 125 MHz 
respectively) and are reported relative to CHCl3 (δ 77.16 ppm) or C6H6 (δ 128.06 ppm).  
19F spectra were recorded on a Varian Mercury 300 MHz or a Varian Inova 500 MHz 
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spectrometer (at 282 MHz and 470 MHz respectively) and are reported without the use of 
a reference peak.  Data for 1H NMR are reported as follows:  chemical shift (δ ppm) 
(multiplicity, coupling constant (Hz), integration.  Multiplicities are reported as follows:  
s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, sept = septuplet, m = multiplet, 
dm = doublet of multiplets, br s = broad singlet, br d = broad doublet, app = apparent.  
Data for 13C and 19F NMR are reported in terms of chemical shifts (δ ppm).  IR spectra 
were obtained using a Perkin Elmer Paragon 1000 or Perkin Elmer Spectrum BXII 
spectrometer using thin films deposited on NaCl plates and reported in frequency of 
absorption (cm–1).  Optical rotations were measured with a Jasco P-1010 or Jasco P-2000 
polarimeter operating on the sodium D-line (589 nm) using a 100 mm path-length cell 
and are reported as follows:  [α]DT (concentration in g/100 mL, solvent, ee).  Melting 
points were measured using a Thomas-Hoover capillary melting point apparatus and the 
reported values are uncorrected.  Analytical chiral HPLC was performed with an Agilent 
1100 Series HPLC utilizing a Chiralcel AD or OD-H column (4.6 mm x 25 cm) obtained 
from Daicel Chemical Industries Ltd. with visualization at 254 nm.  Analytical chiral 
SFC was performed with a Mettler Toledo SFC supercritical CO2 analytical 
chromatography system with a Chiralcel AD-H column (4.6 mm x 25 cm) with 
visualization at 254 nm/210 nm.  Analytical chiral GC was performed with an Agilent 
6850 GC utilizing a G-TA (30 m x 0.25 mm) column (1.0 mL/min carrier gas flow).  
High-resolution mass spectra (HRMS) were obtained from the Caltech Mass Spectral 
Facility (EI+ or FAB+) or on an Agilent 6200 Series TOF with an Agilent G1978A 
Multimode source in electrospray ionization (ESI+), atmospheric pressure chemical 
ionization (APCI+), or mixed ionization mode (MM: ESI-APCI+). 
CHAPTER 2 – Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures  
 
86 
2.10.2 PREPARATIVE PROCEDURES 
2.10.2.1 PREPARATION PARENT VINYLOGOUS ESTER 147 
O
i-BuO
147
O 1. TMSCl, Et3N, NaI
    CH3CN, 23 °C
2. Cl2CHCOCl, Et3N
    hexanes, 23 °C H
TMSO
Cl
Cl
O
3. Zn, AcOH, H2O
    i-PrOH, –10!23 °C
4. PPTS (1.5 mol %)
    i-BuOH, PhCH3
    reflux, Dean–Stark
    66% yield, 4 steps
190
 
Vinylogous ester 147.  NaI (157 g, 1.05 mol, 1.25 equiv) was placed in a 3 L 3-neck 
round-bottom flask, dried under high vacuum at 90 °C for 12 h, and allowed to cool to 
ambient temperature under N2.  CH3CN (1.3 L) was added to dissolve the NaI.  To the 
solution was added cyclopentanone (74.3 mL, 0.84 mol, 1.00 equiv), followed by Et3N 
(146 mL, 1.05 mol, 1.25 equiv).  The flask was fitted with an addition funnel, and the 
funnel was charged with TMSCl (122 mL, 0.96 mmol, 1.14 equiv), which was added 
dropwise over 30 min.  The resulting suspension was stirred for an additional 1 h at 
ambient temperature.  Pentane (1.0 L) was added, and the biphasic system was stirred 
vigorously for 10 min.  The phases were separated and the CH3CN layer was extracted 
with pentane (3 x 400 mL).  The combined pentane phases were washed with H2O (2 x 
500 mL) and brine (500 mL), dried over Na2SO4, filtered, and concentrated under 
reduced pressure to afford the desired product (131 g, quantitative) as a colorless oil. 
A portion of the above trimethylsilyl ether (89.7 g, 0.57 mol, 1.00 equiv) was placed 
in a 3 L 3-neck round-bottom flask fitted with a stopper, an addition funnel, and an 
overhead stirrer.  Hexanes (900 mL) was added, followed by Et3N (111 mL, 0.80 mol, 
1.39 equiv).  Dichloroacetyl chloride (66.4 mL, 0.69 mol, 1.21 equiv) was dissolved in 
hexanes (400 mL) and added dropwise over 9.5 h.  After 18 h of stirring at ambient 
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temperature, the brown suspension was filtered, rinsing with EtOAc (3 x 500 mL).  The 
clear brown solution was concentrated under reduced pressure and then filtered through a 
pad of Al2O3 (7 x 18 cm, neutral) using EtOAc as eluent.  The solution was concentrated 
under reduced pressure to afford the desired product (125 g, 0.47 mol, 82% yield) as a 
brown oil that crystallized in the freezer (–20 °C). 
A portion of the above dichlorocyclobutanone (53.4 g, 0.20 mol, 1.00 equiv) was 
placed in a 3 L 3-neck round-bottom flask fitted with a thermometer, an addition funnel, 
and an overhead stirrer.  Isopropyl alcohol and purified water (170 mL each) were added 
and the suspension was cooled to –10 °C (internal temperature) using a MeOH/ice bath.  
Zn dust (58.8 g, 0.90 mol, 4.50 equiv) was added in four portions (5 min between each) 
and AcOH (63 mL, 1.10 mol, 5.50 equiv) dissolved in H2O (130 mL) was added 
dropwise while keeping the internal temperature below 0 °C  (usually added over 1.5 h).  
The reaction was stirred for an additional 30 min at –10 °C (internal temperature) before 
the cooling bath was removed and the reaction was allowed to warm to ambient 
temperature.  After 8.5 h, the reaction was filtered, rinsing with isopropyl alcohol (100 
mL).  The mixture was cooled to 0 °C and neutralized by portionwise addition of K2CO3 
(74.6 g, 0.54 mol, 5.50 equiv).  The viscous suspension was filtered, rinsing with H2O 
(100 mL) and EtOAc (300 mL).  The biphasic system was concentrated under reduced 
pressure to ca. 200 mL and extracted with CH2Cl2.  The combined organics were dried 
over MgSO4, filtered, and concentrated under reduced pressure to afford the desired 
product (24.2 g, 0.19 mol, 96% yield) as a pale orange oil. 
To a solution of 1,3-cycloheptanedione (35.8 g, 0.28 mol, 1.00 equiv) in toluene (280 
mL) in a 1 L flask fitted with a reflux condenser and Dean–Stark trap was added 
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isobutanol (208 mL, 2.27 mol, 8.11 equiv) and pyridinium p-toluenesulfonate (1.07 g, 
4.26 mmol, 1.50 mol %).  The solution was immersed in an oil bath at 130 °C and 
monitored by TLC.  When the starting material was consumed (typically within 4–6 h), 
the reaction was allowed to cool to ambient temperature.  The resulting dark orange 
solution was washed with sat. aqueous NaHCO3 (200 mL).  The aqueous phase was 
extracted with EtOAc (3 x 150 mL) and the combined organics were washed with brine, 
dried over MgSO4, filtered, and concentrated under reduced pressure to afford a thick 
dark orange oil.  The crude oil was flushed through a silica gel plug (SiO2, 7 x 9 cm, 
1:4→3:7→1:1 Et2O-hexanes) to afford vinylogous ester 147 (43.5 g, 0.24 mol, 84% 
yield, 66% yield over 4 steps) as a pale orange oil;  Rf  = 0.22 (2:1 hexanes:EtOAc);  1H 
NMR (500 MHz, CDCl3) δ 5.37 (s, 1H), 3.49 (d, J = 6.6 Hz, 2H), 2.60–2.56 (m, 4H), 
2.00 (sept, J = 6.6 Hz, 1H), 1.88–1.77 (m, 4H), 0.96 (d, J = 6.8 Hz, 6H);  13C NMR (125 
MHz, CDCl3) δ 202.5, 176.6, 106.0, 75.0, 41.9, 33.1, 27.9, 23.7, 21.5, 19.3;  IR (Neat 
Film NaCl) 2958, 2872, 1646, 1607, 1469, 1237, 1190, 1174 cm–1;  HRMS (EI+) m/z 
calc'd for C11H18O2 [M]+•: 182.1307; found 182.1310. 
 
2.10.2.2 PREPARATION OF β-KETOESTERS 148 
O
i-BuO
148a
O
O
O
i-BuO
147
1. LDA, THF, –78 °C 
     then
NC
O
O
2. CH3I, Cs2CO3
    CH3CN, 80 °C
    79% yield, 2 steps  
β-Ketoester 148a.  To a solution of diisopropylamine (6.46 mL, 46.1 mmol, 1.20 equiv) 
in THF (180 mL) in a 500 mL round-bottom flask at 0 °C was added n-BuLi (17.2 mL, 
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44.2 mmol, 2.57 M in hexanes, 1.15 equiv) dropwise over 15 min using a syringe pump.  
After 15 min of stirring at 0 °C, the mixture was cooled to –78 °C using an 
acetone/CO2(s) bath.  A solution of vinylogous ester 147 (7.01 g, 38.4 mmol, 1.00 equiv) 
in THF (20 mL) was added dropwise over 20 min using a syringe pump.  After an 
additional 1 h of stirring at –78 °C, allyl cyanoformate (4.60 mL, 42.2 mmol, 1.10 equiv) 
was added dropwise over 10 min.  The mixture was stirred at  –78 °C for 2.5 h, quenched 
by addition of sat. aqueous NH4Cl and H2O (30 mL each), and allowed to warm to 
ambient temperature.  The reaction was diluted with Et2O (100 mL) and the phases were 
separated.  The aqueous phase was extracted with Et2O (2 x 100 mL).  The combined 
organic phases were dried over MgSO4, filtered, and concentrated under reduced pressure 
to afford a pale orange oil. 
The crude oil was dissolved in CH3CN (130 mL) in a 500 mL round-bottom flask and 
treated with CH3I (7.2 mL, 115 mmol, 3.00 equiv) and Cs2CO3 (16.76 g, 49.9 mmol, 1.30 
equiv).  The flask was fitted with a condenser, immersed in an oil bath, and heated to 80 
°C with vigorous stirring.  After 12 h of stirring at 80 °C, the reaction was allowed to 
cool to ambient temperature, diluted with EtOAc (100 mL), dried over MgSO4, filtered, 
and concentrated under reduced pressure to afford an orange oil.  The crude product was 
purified by flash column chromatography (SiO2, 5 x 15 cm, 19:1→9:1 hexanes:EtOAc, 
dry-loaded using Celite) to afford β-ketoester 148a (8.51 g, 30.4 mmol, 79% yield over 2 
steps) as a pale yellow oil;  Rf = 0.43 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) 
δ 5.86 (dddd, J = 17.1, 10.7, 5.6, 5.6 Hz, 1H), 5.39 (s, 1H), 5.29 (app dq, J = 17.1, 1.5 
Hz, 1H), 5.20 (app dq, J = 10.5, 1.4 Hz, 1H), 4.62 (dddd, J = 13.3, 5.6, 1.2, 1.2 Hz, 1H), 
4.56 (dddd, J = 13.4, 5.6, 1.2, 1.2 Hz, 1H), 3.54–3.42 (m, 2H), 2.59 (ddd, J = 17.8, 9.8, 
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3.9 Hz, 1H), 2.45–2.38 (m, 2H), 2.02–1.94 (m, 2H), 1.84–1.75 (m, 1H), 1.70 (ddd, J = 
14.4, 7.3, 4.4 Hz, 1H), 1.43 (s, 3H), 0.94 (d, J = 6.6 Hz, 6H);  13C NMR (125 MHz, 
CDCl3) δ 199.1, 174.0, 173.5, 132.0, 118.4, 105.2, 74.8, 65.8, 59.1, 34.3, 33.9, 27.9, 24.2, 
21.4, 19.3;  IR (Neat Film NaCl) 2959, 2936, 2875, 1734, 1650, 1613, 1456, 1384, 1233, 
1170, 1115, 994 cm–1;  HRMS (EI+) m/z calc'd for C16H24O4 [M]+•: 280.1675; found 
280.1686. 
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i-BuO
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1. LDA, THF, –78 °C 
     then
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O
O
2. CH3CH2I, NaH
    THF, 0!55 °C
    81% yield, 2 steps
O
i-BuO
148b
O
O
 
β-Ketoester 148b.  To a solution of diisopropylamine (0.92 mL, 6.58 mmol, 1.20 equiv) 
in THF (27 mL) in a 100 mL round-bottom flask at 0 °C was added n-BuLi (2.56 mL, 
6.30 mmol, 2.46 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of 
stirring at 0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  A 
solution of vinylogous ester 147 (1.00 g, 5.48 mmol, 1.00 equiv) in THF (2 mL) was 
added dropwise using positive pressure cannulation.  After an additional 1 h of stirring at 
–78 °C, allyl cyanoformate (0.67 mL, 6.02 mmol, 1.10 equiv) was added dropwise over 
10 min.  The mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat. 
aqueous NH4Cl (8 mL), and allowed to warm to ambient temperature.  The reaction was 
diluted with Et2O (25 mL) and the phases were separated.  The aqueous phase was 
extracted with Et2O (3 x 25 mL).  The combined organic phases were dried over Na2SO4, 
filtered, and concentrated under reduced pressure to afford a pale orange oil.  
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The crude oil was dissolved in THF (8 mL) in a 100 mL round-bottom flask, cooled 
to 0 °C, and stirred vigorously as hexane-washed NaH (158 mg, 6.58 mmol, 1.20 equiv) 
was added in one portion.  Evolution of gas was observed and the reaction was stirred at 
0 °C for 30 min to give a yellow-orange solution.  CH3CH2I (1.31 mL, 16.4 mmol, 3.00 
equiv) was added dropwise.  The reaction was allowed to warm to ambient temperature 
and stirred for 4.5 h.  The mixture was heated to 45 °C and stirred for 1.5 h.  Additional 
CH3CH2I (0.65 mL, 8.22 mmol, 1.50 equiv) was added dropwise and the mixture was 
stirred at 45 °C for 6 h.  A third portion of CH3CH2I (0.33 mL, 4.11 mmol, 0.75 equiv) 
was added dropwise and the reaction was warmed to 55 °C and stirred for 1.5 h.  The 
flask was cooled to ambient temperature and quenched by addition of 50% sat. aqueous 
NH4Cl (10 mL).  The phases were separated and the aqueous layer was extracted with 
Et2O (3 x 15 mL).  The combined organic phases were washed with brine, dried over 
Na2SO4, filtered, and concentrated under reduced pressure.  The crude product was 
purified by flash column chromatography (SiO2, 5 x 20 cm, 9:1→6:1→3:1→2:1 
hexanes:EtOAc) to afford β-ketoester 148b (1.31 g, 4.44 mmol, 81% yield over 2 steps) 
as a yellow oil;  Rf = 0.53 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 5.85 
(dddd, J = 17.5, 10.2, 5.7, 5.7 Hz, 1H), 5.35 (s, 1H), 5.29 (app dq, J = 17.2, 1.5 Hz, 1H), 
5.19 (app dq, J = 10.4, 1.3 Hz, 1H), 4.62 (dddd, J = 13.2, 5.7, 1.4, 1.4 Hz, 1H), 4.54 
(dddd, J = 13.2, 5.7, 1.4, 1.4 Hz, 1H), 3.57–3.34 (m, 2H), 2.60 (dddd, J = 17.9, 9.9, 3.7, 
1.2 Hz, 1H), 2.49–2.26 (m, 2H), 2.12–1.85 (m, 4H), 1.85–1.57 (m, 2H), 0.93 (d, J = 6.7 
Hz, 6H), 0.84 (t, J = 7.5 Hz, 3H);  13C NMR (75 MHz, CDCl3) δ 198.7, 173.7, 173.2, 
132.0, 118.5, 105.5, 74.7, 65.7, 63.1, 34.1, 31.0, 30.6, 27.9, 22.0, 19.3, 9.0;  IR (Neat 
Film NaCl) 3085, 2960, 2937, 2876, 1731, 1663, 1613, 1471, 1461, 1453, 1424, 1383, 
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1369, 1328, 1304, 1278, 1229, 1199, 1170, 1121, 1006, 988, 931, 875, 858, 813 cm–1;  
HRMS (MM: ESI-APCI+) m/z calc'd for C17H27O4 [M+H]+: 295.1904; found 295.1918. 
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β-Ketoester 148c.  To a solution of diisopropylamine (0.92 mL, 6.58 mmol, 1.20 equiv) 
in THF (27 mL) in a 100 mL round-bottom flask at 0 °C was added n-BuLi (2.56 mL, 
6.30 mmol, 2.46 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of 
stirring at 0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  A 
solution of vinylogous ester 147 (1.00 g, 5.48 mmol, 1.00 equiv) in THF (2 mL) was 
added dropwise using positive pressure cannulation.  After an additional 1 h of stirring at 
–78 °C, allyl cyanoformate (0.67 mL, 6.02 mmol, 1.10 equiv) was added dropwise over 
10 min.  The mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat. 
aqueous NH4Cl (8 mL), and allowed to warm to ambient temperature.  The reaction was 
diluted with Et2O (25 mL) and the phases were separated.  The aqueous phase was 
extracted with Et2O (3 x 25 mL).  The combined organic phases were dried over Na2SO4, 
filtered, and concentrated under reduced pressure to afford a pale orange oil.   
The crude oil was dissolved in THF (8 mL) in a 100 mL round-bottom flask, cooled 
to 0 °C, and stirred vigorously as hexane-washed NaH (197 mg, 8.22 mmol, 1.50 equiv) 
was added in one portion.  Evolution of gas was observed and the reaction was stirred at 
0 °C for 30 min to give a yellow-orange solution.  Benzyl bromide (1.96 mL, 16.44 
mmol, 3.00 equiv) was added dropwise.  The reaction was allowed to warm to ambient 
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temperature and stirred for 3 h.  The reaction was quenched by addition of 50% sat. 
aqueous NH4Cl (10 mL).  The phases were separated and the aqueous layer was extracted 
with Et2O (3 x 15 mL).  The combined organic phases were washed with brine, dried 
over MgSO4, filtered, and concentrated under reduced pressure.  The crude product was 
purified by flash column chromatography (SiO2, 3 x 23 cm, hexanes→10:1 
hexanes:EtOAc) to afford β-ketoester 148c (1.72 g, 4.83 mmol, 88% yield over 2 steps) 
as a pale yellow oil;  Rf = 0.26 (10:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 
7.30–7.15 (m, 3H), 7.15–7.06 (m, 2H), 5.85 (dddd, J = 17.1, 10.4, 5.8, 5.8 Hz, 1H), 5.36 
(s, 1H), 5.30 (app dq, J = 17.2, 1.5 Hz, 1H), 5.21 (app dq, J = 10.4, 1.3 Hz, 1H), 4.63 
(dddd, J = 13.2, 5.7, 1.3, 1.3 Hz, 1H), 4.52 (dddd, J = 13.2, 5.8, 1.3, 1.3 Hz, 1H), 3.42 (d, 
J = 6.5 Hz, 2H), 3.30 (d, J = 13.5 Hz, 1H), 3.23 (d, J = 13.5 Hz, 1H), 2.54 (ddd, J = 12.1, 
10.0, 3.5 Hz, 1H), 2.38–2.18 (m, 2H), 2.04–1.83 (m, 2H), 1.81–1.64 (m, 2H), 0.92 (d, J = 
6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 198.0, 174.0, 172.7, 137.0, 131.8, 130.7, 
128.1, 126.8, 118.8, 105.7, 74.8, 66.0, 64.0, 43.1, 34.0, 31.3, 27.9, 22.0, 19.2;  IR (Neat 
Film NaCl) 3085, 3062, 3029, 2959, 2934, 2873, 1736, 1732, 1661, 1652, 1611, 1495, 
1471, 1454, 1423, 1383, 1368, 1270, 1235, 1173, 1088, 1007, 957, 992, 930, 862, 815, 
741 cm–1;  HRMS (APCI+) m/z calc'd for C22H29O4 [M+H]+: 357.2060; found 357.2051. 
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β-Ketoester 148d.  To a solution of diisopropylamine (0.92 mL, 6.58 mmol, 1.20 equiv) 
in THF (27 mL) in a 100 mL round-bottom flask at 0 °C was added n-BuLi (2.56 mL, 
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6.30 mmol, 2.46 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of 
stirring at 0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  A 
solution of vinylogous ester 147 (1.00 g, 5.48 mmol, 1.00 equiv) in THF (2 mL) was 
added dropwise using positive pressure cannulation.  After an additional 1 h of stirring at 
–78 °C, allyl cyanoformate (0.67 mL, 6.02 mmol, 1.10 equiv) was added dropwise over 
10 min.  The mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat. 
aqueous NH4Cl (8 mL), and then allowed to warm to ambient temperature.  The reaction 
was diluted with Et2O (25 mL) and the phases were separated.  The aqueous phase was 
extracted with Et2O (3 x 25 mL).  The combined organic phases were dried over Na2SO4, 
filtered, and concentrated under reduced pressure to afford a pale orange oil.  
The crude oil was dissolved in THF (8 mL) in a 100 mL round-bottom flask, cooled 
to 0 °C, and stirred vigorously as hexane-washed NaH (197 mg, 8.22 mmol, 1.5 equiv) 
was added in one portion.  Evolution of gas was observed and the reaction was stirred at 
0 °C for 30 min to give a yellow-orange solution.  Propargyl bromide (1.22 mL, 10.96 
mmol, 80% wt in toluene, 2.00 equiv) was added dropwise and the reaction was allowed 
to warm to ambient temperature and stirred for 5.5 h.  The reaction was quenched by 
addition of 50% sat. aqueous NH4Cl (10 mL).  The phases were separated and the 
aqueous layer was extracted with Et2O (3 x 15 mL).  The combined organic phases were 
washed with brine, dried over Na2SO4, filtered, and concentrated under reduced pressure.  
The crude product was purified by flash column chromatography (SiO2, 3 x 24 cm, 
hexanes→20:1→15:1→10:1 hexanes:EtOAc) to afford β-ketoester 148d (1.38 g, 4.53 
mmol, 83% yield over 2 steps) as a pale yellow oil;  Rf = 0.55 (4:1 hexanes:EtOAc);  1H 
NMR (300 MHz, CDCl3) δ 5.85 (dddd, J = 17.2, 10.4, 5.7, 5.7 Hz, 1H), 5.38 (s, 1H), 5.29 
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(app dq, J = 17.2, 1.5 Hz, 1H), 5.19 (app dq, J = 10.4, 1.3 Hz, 1H), 4.63 (dddd, J = 13.2, 
5.6, 1.4, 1.4 Hz, 1H), 4.56 (dddd, J = 13.2, 5.7, 1.4, 1.4 Hz, 1H), 3.56–3.38 (m, 2H), 2.79 
(dd, J = 2.7, 0.6 Hz, 1H), 2.72–2.32 (m, 4H), 2.15–1.89 (m, 4H), 1.89–1.71 (m, 1H), 0.93 
(d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 196.5, 174.8, 171.7, 131.7, 118.7, 
105.0, 80.2, 74.9, 71.4, 66.1, 62.0, 34.3, 31.2, 27.9, 27.5, 21.7, 19.2;  IR (Neat Film 
NaCl) 3289, 3085, 2959, 2933, 2874, 2120, 1740, 1735, 1654, 1649, 1470, 1452, 1424, 
1402, 1384, 1369, 1309, 1291, 1272, 1232, 1187, 1173, 1133, 1085, 1066, 1007, 968, 
930, 863, 820 cm–1;  HRMS (EI+) m/z calc'd for C18H25O4 [M+H]+: 305.1753; found 
305.1746. 
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β-Ketoester 148k.  To a solution of diisopropylamine (1.49 mL, 10.63 mmol, 1.20 
equiv) in THF (43 mL) in a 250 mL round-bottom flask at 0 °C was added n-BuLi (4.74 
mL, 10.19 mmol, 2.51 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of 
stirring at 0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  A 
solution of vinylogous ester 147 (1.61 g, 8.86 mmol, 1.00 equiv) in THF (3 mL) was 
added dropwise using positive pressure cannulation.  After an additional 1 h of stirring at 
–78 °C, allyl cyanoformate (1.06 mL, 9.74 mmol, 1.10 equiv) was added dropwise over 
10 min.  The mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat. 
aqueous NH4Cl (12.9 mL), and then allowed to warm to ambient temperature.  The 
reaction was diluted with Et2O (50 mL) and the phases were separated.  The aqueous 
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phase was extracted with Et2O (3 x 100 mL).  The combined organic phases were dried 
over Na2SO4, filtered, and concentrated under reduced pressure to afford a pale orange 
oil.  The crude oil was purified by automated flash column chromatography using a 
Teledyne Isco CombiFlash Rf (SiO2, 25 g loading cartridge, 330 g column, hold 0% [3 
min]→ramp to 20% [10 min]→hold 20% [10 min]→ramp to 50% [4 min]→hold 50% 
EtOAc in hexanes [5 min]) to afford the intermediate β-ketoester (2.02 g, 7.58 mmol, 
86% yield).  
A portion of the intermediate β-ketoester (990 mg, 3.72 mmol, 1.00 equiv) was 
dissolved in CH2Cl2 (10 mL) in a 100 mL round-bottom flask, cooled to 0 °C, and treated 
with Et3N (0.518 mL, 3.72 mmol, 1.00 equiv).  Acrolein (0.248 mL, 3.72 mmol, 1.00 
equiv) was added dropwise and the reaction was allowed to warm to ambient 
temperature.  After 51 h, the reaction was cooled to 0 °C and an additional portion of 
acrolein (0.125 mL, 1.86 mmol, 0.50 equiv) was added.  After 100 h, the reaction was 
concentrated under reduced pressure, dissolved in Et2O, and filtered through a cotton 
plug to remove salts.  The filtrate was concentrated under reduced pressure and the crude 
product was purified by flash column chromatography (SiO2, 3 x 25 cm, 10:1→6:1→4:1 
hexanes:EtOAc) to afford β-ketoester 148k (1.07 g, 3.34 mmol, 90% yield, 77% yield 
over 2 steps) as a clear oil;  Rf = 0.23, broad (4:1 hexanes:EtOAc);  1H NMR (300 MHz, 
CDCl3) δ 9.73 (t, J = 1.3 Hz, 1H), 5.86 (dddd, J = 17.1, 10.4, 5.8, 5.8 Hz, 1H), 5.36 (s, 
1H), 5.30 (app dq, J = 17.2, 1.5 Hz, 1H), 5.22 (app dq, J = 10.4, 1.2 Hz, 1H), 4.63 (dddd, 
J = 13.1, 5.7, 1.3, 1.3 Hz, 1H), 4.55 (dddd, J = 13.2, 5.8, 1.3, 1.3 Hz, 1H), 3.55–3.40 (m, 
2H), 2.66–2.29 (m, 5H), 2.29–2.08 (m, 2H), 2.08–1.89 (m, 2H), 1.89–1.59 (m, 2H), 0.94 
(d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 201.6, 197.9, 173.9, 172.7, 131.7, 
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119.0, 105.3, 74.9, 66.0, 61.8, 39.7, 34.2, 32.1, 29.6, 27.9, 21.5, 19.2;  IR (Neat Film 
NaCl) 3084, 2960, 2936, 2875, 2829, 2723, 1727, 1649, 1611, 1471, 1454, 1422, 1403, 
1385, 1369, 1306, 1270, 1234, 1191, 1173, 1104, 1004, 990, 931, 877, 862, 822 cm–1;  
HRMS (FAB+) m/z calc'd for C18H27O5 [M+H]+: 323.1858; found 323.1860. 
 
β-Ketoester 148e.  MePh3PBr (1.33 g, 3.72 mmol, 1.26 equiv) was suspended in toluene 
(20 mL) in 100 mL round-bottom flask and cooled to 0 °C.  KOt-Bu (0.348 g, 3.10 
mmol, 1.05 equiv) was added in one portion and the bright yellow mixture was stirred at 
0 °C for 30 min, warmed to ambient temperature, and stirred for an additional 2 h.  The 
mixture was cooled to 0 °C and a solution of aldehyde 148k (0.95 g, 2.94 mmol, 1.00 
equiv) in toluene (2 mL) was added to the reaction using positive pressure cannulation.  
The mixture turned brown.  The reaction was maintained at 0 °C for 1.5 h, warmed to 
ambient temperature, and stirred for 4 h.  The reaction was quenched by addition of 50% 
sat. aqueous NH4Cl (4 mL).  The phases were separated and the aqueous phase was 
extracted with Et2O (3 x 100 mL).  The combined organic phases were dried over 
Na2SO4, filtered, and concentrated under reduced pressure.  The crude product was 
purified by flash column chromatography (SiO2, 3 x 25 cm, 20:1→15:1 hexanes:EtOAc) 
to afford β-ketoester 148e (747 mg, 2.33 mmol, 79% yield) as a pale yellow oil;  Rf = 
0.66 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 5.85 (dddd, J = 17.2, 10.4, 5.7, 
5.7 Hz, 1H), 5.84–5.69 (m, 1H), 5.35 (s, 1H), 5.29 (app dq, J = 17.2, 1.5 Hz, 1H), 5.20 
(app dq, J = 10.4, 1.3 Hz, 1H), 5.08–4.96 (m, 1H), 4.96–4.87 (m, 1H), 4.62 (dddd, J = 
13.1, 5.7, 1.4, 1.4 Hz, 1H), 4.54 (dddd, J = 13.1, 5.7, 1.4, 1.4 Hz, 1H), 3.53–3.38 (m, 2H), 
2.59 (dddd, J = 17.9, 9.8, 3.7, 1.1 Hz, 1H), 2.51–2.29 (m, 2H), 2.09–1.87 (m, 6H), 1.87–
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1.66 (m, 2H), 0.94 (d, J = 6.7, 3H), 0.94 (d, J = 6.7, 3H);  13C NMR (75 MHz, CDCl3) δ 
198.4, 173.7, 173.0, 138.2, 131.9, 118.6, 114.9, 105.4, 74.8, 65.8, 62.6, 36.8, 34.1, 31.5, 
28.8, 27.9, 22.0, 19.3;  IR (Neat Film NaCl) 3078, 2959, 2935, 2874, 1732, 1662, 1612, 
1471, 1453, 1423, 1401, 1384, 1369, 1307, 1270, 1231, 1194, 1170, 1091, 993, 913, 874, 
817, 766 cm–1;  HRMS (EI+) m/z calc'd for C19H28O4 [M]+•: 320.1988; found 320.1977. 
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β-Ketoester 148f.  To a solution of diisopropylamine (0.406 mL, 2.90 mmol, 1.20 equiv) 
in THF (12 mL) in a 50 mL round-bottom flask at 0 °C was added n-BuLi (1.10 mL, 2.77 
mmol, 2.51 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of stirring at 
0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  A solution of 
vinylogous ester 147 (0.44 g, 2.41 mmol, 1.00 equiv) in THF (2 mL) was added dropwise 
using positive pressure cannulation.  After an additional 1 h of stirring at –78 °C, allyl 
cyanoformate (0.288 mL, 2.65 mmol, 1.10 equiv) was added dropwise over 10 min.  The 
mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat. aqueous NH4Cl 
(4 mL), and then allowed to warm to ambient temperature.  The reaction was diluted with 
Et2O (15 mL) and the phases were separated.  The aqueous phase was extracted with 
Et2O (3 x 15 mL).  The combined organic phases were dried over Na2SO4, filtered, and 
concentrated under reduced pressure to afford a pale orange oil.  The crude oil was 
purified by automated flash column chromatography using a Teledyne Isco CombiFlash 
Rf (SiO2, 5 g loading cartridge, 40 g column, hold 0% [1 min]→ramp to 20% [8 
CHAPTER 2 – Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures  
 
99 
min]→hold 20% [5 min]→ramp to 50% [4 min]→50% EtOAc in hexanes [6 min]) to 
afford the intermediate β-ketoester (590 mg, 2.21 mmol, 92% yield).  
A portion of the intermediate β-ketoester (250 mg, 0.94 mmol, 1.00 equiv) was 
dissolved in THF (5 mL) in a 50 mL round-bottom flask, cooled to 0 °C, and stirred 
vigorously as hexane-washed NaH (33.8 mg, 6.58 mmol, 1.50 equiv) was added in one 
portion.  Evolution of gas was observed and the reaction was stirred at 0 °C for 30 min to 
give a yellow-orange solution.  1-chloro-2,4-pentadiene53 (144 mg, 1.41 mmol, 1.50 
equiv) was added dropwise and the reaction was allowed to warm to ambient temperature 
and then heated to 40 °C.  After 10.5 h, an additional portion of 1-chloro-2,4-pentadiene 
(144 mg, 1.41 mmol, 1.50 equiv) was added and the reaction was heated at 50 °C for 11.5 
h.  The flask was cooled to ambient temperature and the reaction was quenched by 
addition of 50% sat. aqueous NH4Cl (2 mL).  The phases were separated and the aqueous 
layer was extracted with Et2O (3 x 10 mL).  The combined organic phases were washed 
with brine, dried over Na2SO4, filtered, and concentrated under reduced pressure.  The 
crude product was purified by flash column chromatography (SiO2, 3 x 25 cm, 
20:1→15:1→10:1 hexanes:EtOAc) to afford β-ketoester 148f (286 mg, 0.86 mmol, 91% 
yield, 84% yield over 2 steps) as a pale yellow oil;  Rf = 0.59 (4:1 hexanes:EtOAc);  1H 
NMR (300 MHz, CDCl3) δ 6.25 (ddd, J = 16.7, 10.3, 10.3 Hz, 1H), 6.11–5.98 (m, 1H), 
5.83 (dddd, J = 17.2, 10.4, 5.7, 5.7 Hz, 1H), 5.58 (ddd, J = 15.1, 7.7, 7.7 Hz, 1H), 5.36 (s, 
1H), 5.27 (app dq, J = 17.2, 1.5 Hz, 1H), 5.18 (app dq, J = 10.4, 1.2 Hz, 1H), 5.08 (dd, J 
= 16.9, 1.6 Hz, 1H), 4.96 (dd, J = 16.9, 1.6 Hz, 1H), 4.60 (dddd, J = 13.2, 5.8, 1.4, 1.4 
Hz, 1H), 4.52 (dddd, J = 13.2, 5.8, 1.4, 1.4 Hz, 1H), 3.57–3.35 (m, 2H), 2.65 (d, J = 7.7 
Hz, 2H), 2.56 (ddd, J = 12.7, 6.8, 2.3 Hz, 1H), 2.48–2.19 (m, 2H), 2.10–1.85 (m, 2H), 
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1.85–1.63 (m, 2H), 0.92 (d, J = 6.7, 3H), 0.92 (d, J = 6.7, 3H);  13C NMR (75 MHz, 
CDCl3) δ 197.9, 174.0, 172.7, 136.9, 134.6, 131.9, 129.7, 118.6, 116.1, 105.4, 74.8, 65.9, 
62.9, 41.0, 34.1, 31.4, 27.9, 21.8, 19.2;  IR (Neat Film NaCl) 3085, 2959, 2933, 2874, 
1733, 1650, 1612, 1471, 1453, 1434, 1402, 1384, 1369, 1307, 1272, 1234, 1194, 1171, 
1093, 1006, 968, 955, 929, 900, 864, 822, 761 cm–1;  HRMS (FAB+) m/z calc'd for 
C20H29O4 [M+H]+: 333.2066; found 333.2052. 
 
O
i-BuO
147
1. LDA, THF, –78 °C 
     then
NC
O
O
2. 2,3-dichloro-1-propene
    NaH, TBAI, THF, 0!40 °C
    84% yield, 2 steps
O
i-BuO
148g
O
O
Cl
 
β-Ketoester 148g.  To a solution of diisopropylamine (0.92 mL, 6.58 mmol, 1.20 equiv) 
in THF (27 mL) in a 100 mL round-bottom flask at 0 °C was added n-BuLi (2.56 mL, 
6.30 mmol, 2.46 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of 
stirring at 0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  A 
solution of vinylogous ester 147 (1.00 g, 5.48 mmol, 1.00 equiv) in THF (2 mL) was 
added dropwise using positive pressure cannulation.  After an additional 1 h of stirring at 
–78 °C, allyl cyanoformate (0.67 mL, 6.02 mmol, 1.10 equiv) was added dropwise over 
10 min.  The mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat. 
aqueous NH4Cl (8 mL), and allowed to warm to ambient temperature.  The reaction was 
diluted with Et2O (25 mL) and the phases were separated.  The aqueous phase was 
extracted with Et2O (3 x 25 mL).  The combined organic phases were dried over Na2SO4, 
filtered, and concentrated under reduced pressure to afford a pale orange oil.   
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The crude oil was dissolved in THF (8 mL) in a 100 mL round-bottom flask, cooled 
to 0 °C, and stirred vigorously as hexane-washed NaH (197 mg, 8.22 mmol, 1.50 equiv) 
was added in one portion.  Evolution of gas was observed and the reaction was stirred at 
0 °C for 30 min to give a yellow-orange solution.  2,3-dichloro-1-propene (1.00 mL, 
10.96 mmol, 2.0 equiv) was added dropwise and the reaction was allowed to warm to 
ambient temperature.  After 10 h, TBAI (202 mg, 0.548 mmol, 0.10 equiv) was added 
and the reaction was heated to 40 °C.  After 41 h, the reaction was cooled to ambient 
temperature and quenched by addition of 50% sat. aqueous NH4Cl (10 mL).  The phases 
were separated and the aqueous layer was extracted with Et2O (3 x 15 mL).  The 
combined organic phases were washed with brine, dried over Na2SO4, filtered, and 
concentrated under reduced pressure.  The crude product was purified by flash column 
chromatography (SiO2, 3 x 25 cm, 20:1→15:1 hexanes:EtOAc) to afford β-ketoester 
148g (1.57 g, 4.61 mmol, 84% yield over 2 steps) as a yellow oil;  Rf = 0.60 (4:1 
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 5.87 (dddd, J = 17.1, 10.4, 5.8, 5.8 Hz, 
1H), 5.38–5.25 (m, 3H), 5.25–5.16 (m, 2H), 4.65 (dddd, J = 13.2, 5.8, 1.3, 1.3 Hz, 1H), 
4.52 (dddd, J = 13.1, 5.8, 1.3, 1.3 Hz, 1H), 3.45 (ddd, J = 21.1, 9.3, 6.5 Hz, 2H), 3.04 (s, 
2H), 2.71 (dddd, J = 18.2, 10.2, 3.0, 1.3 Hz, 1H), 2.62–2.47 (m, 1H), 2.39 (ddd, J = 17.2, 
6.9, 2.6 Hz, 1H), 2.10–1.90 (m, 2H), 1.89–1.65 (m, 2H), 0.94 (d, J = 6.7 Hz, 3H), 0.94 (d, 
J = 6.7 Hz, 3H);  13C NMR (75 MHz, CDCl3) δ 196.6, 174.8, 172.1, 138.1, 131.7, 118.8, 
117.1, 104.9, 74.8, 66.2, 62.2, 46.1, 33.9, 30.7, 27.8, 22.6, 19.2;  IR (Neat Film NaCl) 
3085, 2960, 2935, 2875, 1737, 1662, 1610, 1471, 1452, 1427, 1384, 1369, 1298, 1272, 
1229, 1198, 1171, 1153, 1079, 1008, 967, 930, 890, 862, 813 cm–1;  HRMS (EI+) m/z 
calc'd for C18H25O4 [M–Cl]+: 305.1753; found 305.1742. 
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O
i-BuO
147
1. LDA, THF, –78 °C 
     then
NC
O
O
2. acrylonitrile
    NaH (25 mol %)
    THF, 0!23 °C
    65% yield, 2 steps
O
i-BuO
148h
O
O
NC
 
β-Ketoester 148h.  To a solution of diisopropylamine (1.53 mL, 10.93 mmol, 1.20 
equiv) in THF (45 mL) in a 250 mL round-bottom flask at 0 °C was added n-BuLi (4.17 
mL, 10.47 mmol, 2.51 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of 
stirring at 0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  A 
solution of vinylogous ester 147 (1.66 g, 9.11 mmol, 1.00 equiv) in THF (2 mL) was 
added dropwise over 10 min.  After an additional 1 h of stirring at –78 °C, allyl 
cyanoformate (1.09 mL, 10.0 mmol, 1.10 equiv) was added dropwise over 10 min.  The 
mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat. aqueous NH4Cl 
(13.5 mL), and then allowed to warm to ambient temperature.  The reaction was diluted 
with Et2O (50 mL) and the phases were separated.  The aqueous phase was extracted with 
Et2O (3 x 100 mL).  The combined organic phases were dried over Na2SO4, filtered, and 
concentrated under reduced pressure to afford a pale orange oil.  The crude oil was 
purified by automated flash column chromatography using a Teledyne Isco CombiFlash 
Rf (SiO2, 25 g loading cartridge, 80 g column, multi-step gradient, hold 0% [2 
min]→ramp to 20% [4 min]→hold 20% [15 min]→ramp to 50% [7 min]→hold 50% 
EtOAc in hexanes [5 min]) to afford the intermediate β-ketoester (2.08 g, 7.80 mmol, 
86% yield). 
One third of the intermediate β-ketoester (694 mg, 2.60 mmol, 1.00 equiv) was 
dissolved in THF (5 mL) in a 50 mL round-bottom flask, cooled to 0 °C, and stirred 
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vigorously as hexane-washed NaH (15.6 mg, 0.65 mmol, 0.25 equiv) was added in one 
portion.  Evolution of gas was observed and the reaction was stirred at 0 °C for 30 min to 
give a yellow-orange solution.  Acrylonitrile (0.256 mL, 3.90 mmol, 1.50 equiv) was 
added dropwise and the reaction was allowed to warm to ambient temperature.  After 40 
h, the reaction was diluted with Et2O (30 mL) and washed with H2O (5 mL) and brine (5 
mL).  The aqueous layer was extracted with Et2O (3 x 20 mL).  The combined organic 
phases were washed with brine, dried over Na2SO4, filtered, and concentrated under 
reduced pressure.  The crude product was purified by flash column chromatography 
(SiO2, 3 x 25 cm, 10:1→6:1→4:1 hexanes:EtOAc) to afford β-ketoester 148h (620 mg, 
1.94 mmol, 75% yield, 65% yield over 2 steps) as a clear, colorless oil;  Rf = 0.29 (4:1 
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 5.87 (dddd, J = 16.2, 10.4, 5.8, 5.8 Hz, 
1H), 5.38 (s, 1H), 5.32 (app dq, J = 17.2, 1.4 Hz, 1H), 5.25 (app dq, J = 10.4, 1.1 Hz, 
1H), 4.67 (dddd, J = 13.0, 5.8, 1.2, 1.2 Hz, 1H), 4.58 (dddd, J = 13.1, 5.9, 1.2, 1.2 Hz, 
1H), 3.57–3.39 (m, 2H), 2.58 (ddd, J = 13.1, 9.6, 3.9 Hz, 1H), 2.51–2.32 (m, 4H), 2.32–
2.11 (m, 2H), 2.11–1.90 (m, 2H), 1.90–1.64 (m, 2H), 0.95 (d, J = 6.7 Hz, 6H);  13C NMR 
(75 MHz, CDCl3) δ 196.9, 174.4, 172.0, 131.4, 119.7, 119.3, 105.1, 75.0, 66.3, 61.5, 
34.1, 33.1, 32.0, 27.9, 21.4, 19.2, 13.3;  IR (Neat Film NaCl) 3081, 2959, 2936, 2875, 
2247, 1733, 1648, 1609, 1471, 1454, 1423, 1403, 1385, 1369, 1297, 1269, 1235, 1192, 
1173, 1096, 996, 932, 874, 824, 764 cm–1;  HRMS (EI+) m/z calc'd for C18H25O4N [M]+•: 
319.1784; found 319.1777. 
 
CHAPTER 2 – Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures  
 
104 
N•HBr
Br
O
i-BuO
147
1. LDA, THF, –78 °C 
     then
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    71% yield, 2 steps
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β-Ketoester 148i.  To a solution of diisopropylamine (3.54 mL, 25.27 mmol, 1.20 equiv) 
in THF (108 mL) in a 250 mL round-bottom flask at 0 °C was added n-BuLi (10.26 mL, 
24.22 mmol, 2.36 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of 
stirring at 0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  A 
solution of vinylogous ester 147 (3.84 g, 21.06 mmol, 1.00 equiv) in THF (10 mL) was 
added dropwise using positive pressure cannulation.  After an additional 1 h of stirring at 
–78 °C, allyl cyanoformate (2.52 mL, 9.74 mmol, 1.10 equiv) was added dropwise over 
10 min.  The mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat. 
aqueous NH4Cl (30.7 mL), and then allowed to warm to ambient temperature.  The 
reaction was diluted with Et2O (100 mL) and the phases were separated.  The aqueous 
phase was extracted with Et2O (3 x 100 mL).  The combined organic phases were dried 
over Na2SO4, filtered, and concentrated under reduced pressure to afford a pale orange 
oil.  The crude oil was purified by automated flash column chromatography using a 
Teledyne Isco CombiFlash Rf (SiO2, 32 g loading cartridge, 330 g column, multi-step 
gradient, hold 0% [2 min]→ramp to 20% [10 min]→hold 20% [6 min]→ramp to 50% [3 
min]→hold 50% EtOAc in hexanes [11 min]) to afford the intermediate β-ketoester (4.66 
g, 17.50 mmol, 83% yield) as a pale orange oil.  
A portion of the intermediate β-ketoester (1.00 g, 3.75 mmol, 1.00 equiv) was 
dissolved in THF (25 mL) in a 100 mL round-bottom flask, cooled to 0 °C, and stirred 
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vigorously as hexane-washed NaH (90 mg, 3.75 mmol, 1.00 equiv) was added in one 
portion.  Evolution of gas was observed and the reaction was stirred at 0 °C for 30 min to 
give a yellow-orange solution.  Additional NaH (202 mg, 8.43 mmol, 2.25 equiv) was 
added, giving a thick yellow suspension.  After 5 min, 4-(bromomethyl)pyridine 
hydrogen bromide (996 mg, 3.94 mmol, 1.05 equiv) was added portionwise and the 
reaction was allowed to warm to ambient temperature.  After 14 h, the reaction was 
quenched by addition of 50% sat. aqueous NH4Cl (16 mL) to give a brown biphasic 
mixture.  The phases were separated and the aqueous layer was extracted with Et2O (3 x 
25 mL).  The combined organic phases were dried over Na2SO4, filtered, and 
concentrated under reduced pressure.  The crude product was purified by flash column 
chromatography (SiO2, 3 x 25 cm, 1:1→1:4 hexanes:EtOAc→EtOAc) to afford β-
ketoester 148i (1.16 g, 3.23 mmol, 86% yield, 71% yield over 2 steps) as a yellow oil;  Rf 
= 0.28, broad (1:2 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 8.44 (dd, J = 4.4, 1.6 
Hz, 2H), 7.06 (dd, J = 4.4, 1.6 Hz, 2H), 5.82 (dddd, J = 17.1, 10.4, 5.8, 5.8 Hz, 1H), 5.37 
(s, 1H), 5.28 (app dq, J = 17.2, 1.5 Hz, 1H), 5.21 (app dq, J = 10.4, 1.2 Hz, 1H), 4.61 
(dddd, J = 13.1, 5.9, 1.3, 1.3 Hz, 1H), 4.50 (dddd, J = 13.1, 5.9, 1.3, 1.3 Hz, 1H), 3.42 (d, 
J = 6.5 Hz, 2H), 3.27 (d, J = 13.3 Hz, 1H), 3.18 (d, J = 13.3 Hz, 1H), 2.54 (ddd, J = 17.2, 
9.3, 3.0 Hz, 1H), 2.38–2.21 (m, 2H), 2.03–1.86 (m, 2H), 1.83–1.59 (m, 2H), 0.91 (d, J = 
6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 197.0, 174.3, 172.3, 149.6, 146.1, 131.4, 
126.0, 119.2, 105.6, 74.9, 66.1, 63.5, 42.4, 33.9, 31.5, 27.8, 21.8, 19.2;  IR (Neat Film 
NaCl) 3072, 3026, 2959, 2935, 2874, 1733, 1660, 1608, 1557, 1496, 1470, 1452, 1415, 
1384, 1369, 1293, 1272, 1232, 1201, 1172, 1095, 1074, 1005, 994, 956, 935, 862, 823, 
773 cm–1;  HRMS (EI+) m/z calc'd for C21H27O4N [M]+•: 357.1940; found 357.1945. 
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Indolyl β-Ketoester 148ac.  To a solution of diisopropylamine (3.54 mL, 25.27 mmol, 
1.20 equiv) in THF (108 mL) in a 250 mL round-bottom flask at 0 °C was added n-BuLi 
(10.26 mL, 24.22 mmol, 2.36 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 
min of stirring at 0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  
A solution of vinylogous ester 147 (3.84 g, 21.06 mmol, 1.00 equiv) in THF (10 mL) was 
added dropwise using positive pressure cannulation.  After an additional 1 h of stirring at 
–78 °C, allyl cyanoformate (2.52 mL, 9.74 mmol, 1.10 equiv) was added dropwise over 
10 min.  The mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat. 
aqueous NH4Cl (30.7 mL), and then allowed to warm to ambient temperature.  The 
reaction was diluted with Et2O (100 mL) and the phases were separated.  The aqueous 
phase was extracted with Et2O (3 x 100 mL).  The combined organic phases were dried 
over Na2SO4, filtered, and concentrated under reduced pressure to afford a pale orange 
oil.  The crude oil was purified by automated flash column chromatography using a 
Teledyne Isco CombiFlash Rf (SiO2, 32 g loading cartridge, 330 g column, multi-step 
gradient, hold 0% [2 min]→ramp to 20% [10 min]→hold 20% [6 min]→ramp to 50% [3 
min]→hold 50% EtOAc in hexanes [11 min]) to afford the intermediate β-ketoester (4.66 
g, 17.50 mmol, 83% yield) as a pale orange oil.  
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A portion of the intermediate β-ketoester (0.85 g, 3.19 mmol, 1.00 equiv) was 
dissolved in THF (32 mL) in a 100 mL round-bottom flask, cooled to 0 °C, and stirred 
vigorously as hexane-washed NaH (84 mg, 3.51 mmol, 1.10 equiv) was added in one 
portion.  Evolution of gas was observed and the reaction was stirred at 0 °C for 30 min to 
give a yellow-orange solution.  Gramine methiodide52 (1.06 g, 3.35 mmol, 1.05 equiv) 
was added portionwise to give a suspension.  After 11.5 h, the reaction was a brown-
orange solution.  Additional gramine methiodide (212 mg, 0.67 mmol, 0.31 equiv) was 
added.  After 30 min, the reaction was quenched by addition of 50% sat. aqueous NH4Cl 
(4.3 mL) to give a brown biphasic mixture.  Volatiles were removed under reduced 
pressure.  The residue was extracted with EtOAc (3 x 40 mL), dried over Na2SO4, 
filtered, and concentrated under reduced pressure.  The residue was dissolved in a 
minimal amount of 1:1 hexanes:EtOAc and filtered through a silica gel pad (1.5 x 10 cm, 
1:1 hexanes:EtOAc).  The filtrate was concentrated under reduced pressure.  The crude 
product was purified by flash column chromatography (SiO2, 5 x 20 cm, 6:1→4:1→2:1 
hexanes:EtOAc) to afford β-ketoester 148ac (1.09 g, 2.75 mmol, 86% yield, 71% yield 
over 2 steps) as an orange-brown semi-solid;  Rf = 0.21 (4:1 hexanes:EtOAc);  1H NMR 
(300 MHz, CDCl3) δ 8.08 (s, 1H), 7.67–7.54 (m, 1H), 7.38–7.29 (m, 1H), 7.21–7.04 (m, 
2H), 7.00 (d, J = 2.4 Hz, 1H), 5.84 (dddd, J = 17.2, 10.4, 5.7, 5.7 Hz, 1H), 5.37 (s, 1H), 
5.29 (app dq, J = 17.2, 1.5 Hz, 1H), 5.20 (app dq, J = 10.4, 1.3 Hz, 1H), 4.60 (dddd, J = 
13.2, 5.6, 1.4, 1.4 Hz, 1H), 4.50 (dddd, J = 13.2, 5.8, 1.4, 1.4 Hz, 1H), 3.52 (dd, J = 14.3, 
0.5 Hz, 1H), 3.47–3.31 (m, 3H), 2.63–2.34 (m, 2H), 2.28 (ddd, J = 17.8, 7.7, 4.0 Hz, 1H), 
2.02–1.63 (m, 4H), 0.90 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 198.8, 173.7, 
173.2, 135.8, 131.9, 128.8, 124.3, 121.8, 119.5, 119.2, 118.6, 111.1, 111.0, 106.0, 74.7, 
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65.9, 64.3, 34.0, 32.8, 31.6, 27.8, 21.7, 19.2;  IR (Neat Film NaCl) 3785, 3584, 3392, 
3079, 3057, 2958, 2930, 2874, 1729, 1641, 1607, 1457, 1457, 1433, 1423, 1384, 1368, 
1341, 1233, 1191, 1174, 1127, 1085, 1010, 932, 879, 863, 822, 742 cm–1;  HRMS (EI+) 
m/z calc'd for C24H29O4N [M]+•: 395.2097; found 395.2097. 
 
Tosylindolyl β-Ketoester 148j.  To a solution of indole 148ac (250 mg, 0.63 mmol, 1.00 
equiv) in THF (9 mL) in a 100 mL round-bottom flask was added TsCl (241 mg, 1.26 
mmol, 2.00 equiv).  The mixture was cooled to 0 °C and stirred vigorously as hexane-
washed NaH (61 mg, 2.53 mmol, 4.00 equiv) was added in one portion.  The reaction 
was maintained at 0 °C for 5 min before warming to ambient temperature.  After 24 h, the 
white suspension was cooled to 0 °C and additional TsCl (241 mg, 1.26 mmol, 2.00 
equiv) was added, followed by hexane-washed NaH (121 mg, 5.06 mmol, 8.00 equiv) in 
one portion.  The reaction was allowed to warm to ambient temperature.  After 46 h, the 
reaction was quenched by addition of 50% sat. aqueous NH4Cl (3 mL).  The phases were 
separated and the aqueous phase was extracted with Et2O (3 x 15 mL).  The combined 
organic phases were dried over Na2SO4, filtered, and concentrated under reduced 
pressure.  The crude product was purified by flash column chromatography (SiO2, 3 x 25 
cm, 10:1→6:1→4:1 hexanes:EtOAc) to afford β-ketoester 148j (317 mg, 5.76 mmol, 
91% yield) as a yellow foam;  Rf = 0.40 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, 
CDCl3) δ 7.97–7.89 (m, 1H), 7.75–7.66 (m, 2H), 7.53–7.44 (m, 1H), 7.35 (s, 1H), 7.31–
7.13 (m, 4H), 5.77 (dddd, J = 17.1, 10.4, 5.8 Hz, 1H), 5.39 (s, 1H), 5.25 (app dq, J = 
17.2, 1.5 Hz, 1H), 5.18 (app dq, J = 10.4, 1.2 Hz, 1H), 4.52 (dddd, J = 13.1, 5.7, 1.3, 1.3 
Hz, 1H), 4.42 (dddd, J = 13.2, 5.9, 1.3, 1.3 Hz, 1H), 3.48–3.32 (m, 3H), 3.26 (d, J = 14.4 
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Hz, 1H), 2.52 (ddd, J = 17.7, 9.2, 3.3 Hz, 1H), 2.41–2.19 (m, 5H), 2.02–1.82 (m, 2H), 
1.78–1.58 (m, 2H), 0.92 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 197.8, 174.0, 
172.8, 144.8, 135.4, 134.9, 132.1, 131.6, 129.9, 127.0, 125.8, 124.6, 123.2, 119.9, 118.9, 
118.0, 113.7, 105.9, 74.8, 66.1, 63.6, 34.1, 32.2, 31.7, 27.9, 21.7, 21.6, 19.2;  IR (Neat 
Film NaCl) 3854, 3401, 2959, 2931, 2874, 1731, 1657, 1650, 1609, 1448, 1368, 1279, 
1233, 1188, 1173, 1121, 1098, 1087, 1019, 1007, 992, 976, 938, 864, 813, 748 cm–1;  
HRMS (FAB+) m/z calc'd for C31H36O6N [M+H]+: 550.2263; found 550.2250. 
 
O
i-BuO
147
1. LDA, THF, –78 °C 
     then
NC
O
O
2. TiCl4 (9.0 mol %)
    Selectfluor, CH3CN
    41% yield, 2 steps
O
i-BuO
F
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O
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β-Ketoester 148l.  To a solution of diisopropylamine (0.92 mL, 6.58 mmol, 1.20 equiv) 
in THF (27 mL) in a 100 mL round-bottomed flask at 0 °C in an ice/water bath was 
added n-BuLi (2.56 mL, 2.46 M in hexanes, 6.30 mmol, 1.15 equiv) dropwise over 10 
min.  After 15 min of stirring at 0 °C, the mixture was cooled to –78 °C using an 
acetone/CO2(s) bath.  A solution of vinylogous ester 147 (1.00 g, 5.48 mmol, 1.00 equiv) 
in THF (2 mL) was added dropwise using positive pressure cannulation.  After an 
additional 1 h of stirring at –78 °C, allyl cyanoformate (0.67 mL, 6.02 mmol, 1.10 equiv) 
was added dropwise over 10 min.  The mixture was stirred at –78 °C for 2.5 h, quenched 
by addition of 50% sat. aqueous NH4Cl (8 mL), and then allowed to warm to ambient 
temperature.  The reaction mixture was diluted with Et2O (25 mL) and the layers were 
separated.  The aqueous phase was extracted with Et2O (3 x 25 mL).  The combined 
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organic layers were dried over Na2SO4, filtered, and concentrated under reduced pressure 
to afford a pale orange oil.  
The crude oil was dissolved in CH3CN (55 mL) in a 100 mL round-bottomed flask 
under N2 and TiCl4 (53.7 µL, 0.49 mmol, 9.0 mol %) was added dropwise, giving a dark 
purple-brown mixture.  After 10 min, Selectfluor (2.33 g, 6.58 mmol, 1.20 equiv) was 
added in one portion.  After 3.5 h, the reaction mixture was an orange suspension.  The 
reaction was concentrated under reduced pressure and the orange residue was partitioned 
between water (25 mL) and Et2O (25 mL).  The layers were separated and the aqueous 
layer was extracted with Et2O (3 x 25 mL).  The combined organic layers were washed 
with brine, dried over Na2SO4, filtered, and concentrated under reduced pressure.  The 
crude product was purified by automated flash column chromatography using Teledyne 
Isco CombiFlash Rf (SiO2, 25 g loading cartridge, 120 g column, 10% EtOAc in hexanes) 
to afford β-ketoester 148l (639 mg, 2.25 mmol, 41% yield over 2 steps) as a pale yellow 
oil;  Rf = 0.44 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 5.86 (dddd, J = 17.1, 
10.7, 5.6, 5.6 Hz, 1H), 5.39 (s, 1H), 5.29 (ddd, J = 17.1, 2.9, 1.5 Hz, 1H), 5.20 (app d, J = 
10.5 Hz, 1H), 4.59 (dddd, J = 19.0, 13.2, 5.6, 1.2 Hz, 2H), 3.50 (dd, J = 9.3, 6.8 Hz, 1H), 
3.47 (dd, J = 9.3, 6.6 Hz, 1H), 2.59 (ddd, J = 17.8, 9.8, 3.9 Hz, 1H), 2.45–2.38 (m, 2H), 
2.02–1.94 (m, 1H), 1.84–1.75 (m, 1H), 1.70 (ddd, J = 14.4, 7.3, 4.4 Hz, 1H), 1.43 (s, 3H), 
0.94 (d, J = 6.6 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 192.1 (d, JCF = 24.1 Hz), 178.0, 
167.6 (d, JCF = 25.4 Hz), 131.3, 119.0, 102.0 (d, JCF = 1.1 Hz), 99.3 (d, JCF = 193.5 Hz), 
75.3, 66.6, 34.0 (d, JCF = 2.1 Hz), 31.9 (d, JCF = 22.5 Hz), 27.8, 20.7 (d, JCF = 1.7 Hz), 
19.1;  19F NMR (282 MHz, CDCl3) δ –148.54 (dd, J = 35.4, 20.7 Hz);  IR (Neat Film 
NaCl) 3086, 2960, 2938, 2876, 1752, 1654, 1649, 1603, 1471, 1453, 1422, 1403, 1385, 
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1369, 1282, 1249, 1229, 1204, 1176, 1137, 1095, 1045, 991, 953, 927, 874, 862, 843, 
829, 795, 758 cm–1;  HRMS (EI+) m/z calc'd for C15H21O4F [M]+•: 284.1425; found 
284.1424. 
 
O
i-BuO
O
i-BuO
imidazole
TBDPSCl
 
DMAP, DMF
97% yield
O
i-BuO
147 148ad 148m
OH OTBDPS
O
O
O
O
1. LDA, THF, –78 °C 
     then
NC
O
O
2. KHCO3, 37% aq CH2O
    THF, 0!23 °C
    83% yield, 2 steps  
Hydroxy β-Ketoester 148ad.  To a solution of diisopropylamine (1.84 mL, 13.15 mmol, 
1.20 equiv) in THF (54 mL) in a 250 mL round-bottom flask at 0 °C was added n-BuLi 
(5.12 mL, 12.60 mmol, 2.51 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 
min of stirring at 0 °C, the mixture was cooled to –78 °C using an acetone/CO2(s) bath.  
A solution of vinylogous ester 147 (2.00 g, 10.96 mmol, 1.00 equiv) in THF (4 mL) was 
added dropwise using positive pressure cannulation.  After an additional 1 h of stirring at 
–78 °C, allyl cyanoformate (1.34 mL, 12.06 mmol, 1.10 equiv) was added dropwise over 
10 min.  The mixture was stirred at –78 °C for 2.5 h, quenched by addition of 50% sat. 
aqueous NH4Cl (16 mL), and then allowed to warm to ambient temperature.  The reaction 
was diluted with Et2O (200 mL) and the phases were separated.  The aqueous phase was 
extracted with Et2O (3 x 100 mL).  The combined organic phases were dried over 
Na2SO4, filtered, and concentrated under reduced pressure to afford a pale orange oil 
(2.92 g).  
Half of the crude oil (1.46 g) was dissolved in THF (10 mL) in a 50 mL round-bottom 
flask and cooled to 0 °C.  KHCO3 (1.65 g, 16.44 mmol, 3.00 equiv) and 37% wt. aqueous 
formaldehyde (2.81 mL, 37.73 mmol, 6.9 equiv) were added.  The reaction was allowed 
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to warm to ambient temperature.  After 11 h, the reaction was diluted with H2O and 
CH2Cl2 (25 mL each).  The phases were separated and the aqueous layer was extracted 
with CH2Cl2 (4 x 12 mL).  The combined organic phases were dried over Na2SO4, 
filtered, and concentrated under reduced pressure.  The crude product was purified by 
flash column chromatography (SiO2, 3 x 25 cm, 4:1→2:1→1:1 hexanes:EtOAc) to afford 
β-ketoester 148ad (1.35 g, 4.55 mmol, 83% yield over 2 steps) as a pale yellow oil;  Rf = 
0.21 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 5.89 (dddd, J = 17.2, 10.4, 5.7, 
5.7 Hz, 1H), 5.43 (s, 1H), 5.32 (app dq, J = 17.2, 1.5 Hz, 1H), 5.23 (app dq, J = 10.4, 1.3 
Hz, 1H), 4.76–4.54 (m, 2H), 3.93–3.72 (m, 2H), 3.51 (d, J = 6.5 Hz, 2H), 3.59–3.45 (m, 
1H) 2.68–2.50 (m, 1H), 2.50–2.35 (m, 1H), 2.31–2.12 (m 1H), 2.10–1.91 (m, 2H), 1.91–
1.71 (m, 2H), 0.96 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 200.2, 175.1, 
171.9, 131.6, 118.9, 105.6, 75.1, 68.7, 66.1, 63.6, 33.7, 28.6, 27.9, 20.9, 19.2;  IR (Neat 
Film NaCl) 3448, 3083, 2959, 2937, 2875, 1733, 1646, 1608, 1471, 1457, 1420, 1404, 
1385, 1369, 1298, 1235, 1195, 1171, 1099, 1044, 998, 928, 869, 825 cm–1;  HRMS 
(FAB+) m/z calc'd for C16H25O5 [M+H]+: 297.1702; found 297.1715. 
 
Siloxy β-Ketoester 148m.  Alcohol 148ad (895 mg, 3.02 mmol, 1.00 equiv), DMAP 
(553 mg, 4.53 mmol, 1.50 equiv), and imidazole (308 mg, 4.53 mmol, 1.50 equiv) were 
dissolved in DMF (11 mL) in a 20 mL scintillation vial with magnetic stir bar and septum 
fitted screw cap.  TBDPSCl (0.942 mL, 3.62 mmol, 1.20 equiv) was added dropwise.  
The stirred mixture turned into a turbid white suspension within 5 min.  After 54 h, the 
reaction was poured into H2O (35 mL) and 2:1 CH2Cl2/hexanes (75 mL).  The phases 
were separated and the aqueous layer was further extracted with 2:1 CH2Cl2/hexanes (4 x 
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35 mL).  The combined organics were dried over Na2SO4, filtered, and concentrated 
under reduced pressure.  The crude product was purified by flash column 
chromatography (SiO2, 5 x 25 cm, 40:1→20:1 hexanes:EtOAc) to afford siloxy β-
ketoester 148m (1.567 g, 2.93 mmol, 97% yield) as a clear, colorless oil;  Rf = 0.58 (4:1 
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 7.70–7.61 (m, 4H), 7.47–7.32 (m, 6H), 
5.86 (dddd, J = 17.1, 10.5, 5.7, 5.7 Hz, 1H), 5.39 (s, 1H), 5.29 (app dq, J = 17.2, 1.5 Hz, 
1H), 5.19 (app dq, J = 10.4, 1.2 Hz, 1H), 4.65 (dddd, J = 13.2, 5.7, 1.3, 1.3 Hz, 1H), 4.52 
(dddd, J = 13.3, 5.7, 1.3, 1.3 Hz, 1H), 4.15 (d, J = 9.6 Hz, 1H), 4.05 (d, J = 9.6 Hz, 1H), 
3.47 (d, J = 6.5 Hz, 2H), 2.80–2.51 (m, 2H), 2.43 (ddd, J = 11.0, 7.4, 2.9 Hz, 1H), 2.17–
1.89 (m, 3H), 1.89–1.68 (m, 1H), 1.04 (s, 9H), 0.95 (d, J = 6.7 Hz, 6H);  13C NMR (75 
MHz, CDCl3) δ 197.5, 174.8, 171.6, 135.8, 135.7, 133.3, 133.2, 131.89, 129.8, 129.7, 
127.8, 127.7, 118.5, 105.8, 74.8, 69.0, 65.9, 65.1, 34.5, 30.0, 27.8, 26.8, 21.9, 19.4, 19.2;  
IR (Neat Film NaCl) 3460, 3071, 3049, 2958, 2931, 2890, 2857, 1738, 1650, 1609, 1472, 
1429, 1384, 1362, 1299, 1236, 1200, 1173, 1113, 1007, 998, 936, 864, 822, 740 cm–1;  
HRMS (FAB+) m/z calc'd for C32H43O5Si [M+H]+: 535.2880; found 535.2880. 
 
O
i-BuO
148n
O
O
O
O Ph
O
i-BuO
147
1. LDA, THF, –78 °C 
     then
NC
O
O
2. benzoyl peroxide, NaH
    PhCH3, 0!23 °C
      87% yield, 2 steps  
β-Ketoester 148n.  To a solution of diisopropylamine (1.84 mL, 13.15 mmol, 1.20 
equiv) in THF (54 mL) in a 250 mL round-bottomed flask at 0 °C in an ice/water bath 
was added n-BuLi (5.12 mL, 2.51 M in hexanes, 12.60 mmol, 1.15 equiv) dropwise over 
10 min.  After 15 min of stirring at 0 °C, the mixture was cooled to –78 °C using an 
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acetone/CO2(s) bath.  A solution of vinylogous ester 147 (2.00 g, 10.96 mmol, 1.00 
equiv) in THF (4 mL) was added dropwise using positive pressure cannulation.  After an 
additional 1 h of stirring at –78 °C, allyl cyanoformate (1.34 mL, 12.06 mmol, 1.10 
equiv) was added dropwise over 10 min.  The mixture was stirred at –78 °C for 2.5 h, 
quenched by addition of 50% sat. aqueous NH4Cl (16 mL), and then allowed to warm to 
ambient temperature.  The reaction mixture was diluted with Et2O (20 mL) and the layers 
were separated.  The aqueous phase was extracted with Et2O (3 x 10 mL).  The combined 
organic layers were dried over Na2SO4, filtered, and concentrated under reduced pressure 
to afford a pale orange oil (2.92 g). 
Half of the crude oil (1.46 g) was dissolved in toluene (30 mL) in a 100 mL round-
bottomed flask, cooled to 0 °C, and stirred vigorously as hexane-washed NaH (197 mg, 
8.22 mmol, 1.50 equiv) was added in one portion.  Evolution of gas was observed and the 
reaction mixture was stirred at 0 °C for 30 min.  Benzoyl peroxide (1.99 g, 8.22 mmol, 
1.50 equiv) was added slowly portionwise, giving a thick, pasty suspension.  The reaction 
was warmed to ambient temperature and diluted with toluene (20 mL) to give a more 
freely stirring turbid yellow mixture.  After 30 min, the reaction was diluted with toluene 
(50 mL) and washed with H2O (2 x 5 mL) and brine (2 x 5 mL).  The aqueous layers 
were combined and extracted with EtOAc (2 x 25 mL).  The combined organic layers 
were dried over Na2SO4, filtered, and concentrated under reduced pressure.  The crude 
product was purified by flash column chromatography (SiO2, 5 x 13 cm, 10:1 
hexanes:EtOAc) to afford β-ketoester 148n (1.85 g, 4.79 mmol, 87% yield over 2 steps) 
as a pale yellow oil;  Rf = 0.46 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 
8.09–7.99 (m, 2H), 7.64–7.53 (m, 1H), 7.50–7.38 (m, 2H), 5.89 (dddd, J = 17.2, 10.5, 
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5.7, 5.7 Hz, 1H), 5.42 (s, 1H), 5.31 (app dq, J = 17.2, 1.5 Hz, 1H), 5.20 (app dq, J = 10.4, 
1.3 Hz, 1H), 4.80–4.62 (m, 2H), 3.57 (d, J = 6.5 Hz, 2H), 2.87–2.46 (m, 4H), 2.12–1.85 
(m, 3H), 0.96 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 192.1, 175.9, 168.0, 
165.1, 133.6, 131.7, 130.0, 129.6, 128.6, 118.7, 102.2, 88.8, 75.2, 66.6, 33.8, 31.2, 27.9, 
21.2, 19.2, 19.2;  IR (Neat Film NaCl) 3070, 2960, 2937, 2875, 1753, 1727, 1661, 1605, 
1471, 1452, 1423, 1384, 1369, 1315, 1280, 1222, 1206, 1175, 1107, 1097, 1070, 1044, 
1026, 1002, 933, 849, 792 cm–1;  HRMS (EI+) m/z calc'd for C22H26O6 [M]+•: 386.1733; 
found 386.1729. 
 
2.10.2.3 SYNTHESIS OF PHOX LIGANDS 
Ligands (S)-t-Bu-PHOX (13)54 and (S)-p-(CF3)3-t-Bu-PHOX (14)55 were prepared 
according to previously reported procedures.  The preparation of ligands 192 and 150 are 
described below. 
 
Br O
Cl
1. H2N(CH2)2OH, Na2CO3
    CH2Cl2, H2O, 23 °C
2. MsCl, Et3N, CH2Cl2
    0!40 °C
    64% yield, 2 steps
Br N
O
191  
2-(2-Bromo-phenyl)-4,5-dihydrooxazole 191. 1To a solution of ethanolamine (1.32 mL, 
21.9 mmol, 1.20 equiv) in CH2Cl2 (60 mL) in a 250 mL round-bottom flask was added a 
solution of Na2CO3 (5.80 g, 54.7 mmol, 3.00 equiv) in H2O (45 mL).  Neat 2-
bromobenzoyl chloride (4.00 g, 2.38 mL, 18.2 mmol, 1.00 equiv) was added dropwise via 
syringe to the vigorously stirred biphasic system.  The reaction flask was capped with a 
yellow plastic stopper and stirred for 7.5 h at 23 °C.  The layers were separated and the 
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aqueous phase was extracted with CH2Cl2 (2 x 25 mL).  The combined organics were 
dried over Na2SO4, filtered, and concentrated under reduced pressure to afford a white 
solid.  The crude product was dissolved in CH2Cl2 (50 mL) and hexanes (10 mL) was 
added.  The solution was concentrated to ca. 25 mL under reduced pressure resulting in 
precipitation of the intermediate amide (4.02 g, 16.4 mmol, 90% yield) as a white solid. 
The intermediate amide (2.0 g, 8.2 mmol, 1.00 equiv) was dissolved in CH2Cl2 (62 
mL) in a 100 mL round-bottom flask equipped with a reflux condenser.  Et3N (3.43 mL, 
24.5 mmol, 3.00 equiv) was added and the solution was cooled to 0 °C by use of an 
ice/water bath.  Methanesulfonyl chloride (952 µL, 12.3 mmol, 1.50 equiv) was added 
dropwise.  The reaction mixture was stirred at 0 °C for 30 min and heated to 40 °C in an 
oil bath.  After 5 h of stirring, the resulting yellow solution was allowed to cool to 
ambient temperature, diluted with CH2Cl2 (25 mL), and washed with H2O (2 x 25 mL) 
and brine (25 mL).  The organic layer was dried over Na2SO4, filtered, and concentrated 
under reduced pressure to afford a thick, pale yellow oil.  The crude oil was purified by 
flash chromatography (SiO2, 5 x 10 cm, 6:2:2 hexanes:EtOAc:toluene) to afford 2-(2-
bromo-phenyl)-4,5-dihydrooxazole 191 (1.31 g, 5.79 mmol, 71% yield);  Rf = 0.45 (9:1 
CHCl3:MeOH);  1H NMR (500 MHz, CDCl3) δ 7.72 (dd, J = 7.8, 2.0 Hz, 1H), 7.65 (dd, J 
= 8.1, 1.0 Hz, 1H), 7.35 (app dt, J = 7.6, 1.2 Hz, 1H), 7.29 (app dt, J = 7.6, 1.7 Hz, 1H), 
4.46 (t, J = 9.6 Hz, 2H), 4.12 (t, J = 9.6 Hz, 2H);  13C NMR (125 MHz, CDCl3) δ 164.0, 
134.1, 131.8, 131.5, 129.8, 127.2, 122.0, 67.8, 55.5;  IR (Neat Film NaCl) 3390, 3070, 
2966, 2904, 2868, 1729, 1646, 1589, 1432, 1362, 1328, 1272, 1243, 1093, 1026, 938  
cm–1;  HRMS (EI+) m/z calc’d for C9H8BrNO [M]+•: 224.9789; found 224.9779. 
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Br Ph2P
CuI (2 mol %), Ph2PH
N,N'-dimethylethylenediamine (10 mol %)
Cs2CO3, PhCH3, 110 °C
86% yield
N
O
N
O
192191  
PHOX Ligand 192. 2A 250 mL Schlenk flask was charged with CuI (66.7 mg, 0.35 
mmol, 2 mol %), Ph2PH (3.85 mL, 22.1 mmol, 1.25 equiv), N,N’-
dimethylethylenediamine (191 mL, 1.77 mmol, 10 mol %), and toluene (18 mL).  The 
solution was stirred at 23 °C for 20 min.  2-(2-Bromo-phenyl)-4,5-dihydrooxazole 191 
(4.0 g, 17.7 mmol, 1.00 equiv) was azeotroped with toluene (2 x 5 mL) under reduced 
pressure, dissolved in toluene (18 mL), and transferred quantitatively to the Schlenk flask 
by use of positive pressure cannulation.  Cs2CO3 (8.65 g, 26.5 mmol, 1.50 equiv) was 
added in one portion and the flask was evacuated/backfilled with Ar (three cycles).  The 
teflon valve was sealed and the yellow heterogeneous reaction mixture was stirred 
vigorously, immersed in an oil bath, and heated to 110 °C.  After 20 h of stirring at 110 
°C, the mixture was allowed to cool to ambient temperature and filtered through a pad of 
Celite using CH2Cl2 (2 x 50 mL).  The filtrate was concentrated under reduced pressure to 
afford a clear orange oil.  The crude oil was flushed through a plug of silica gel (SiO2, 5 x 
10 cm, hexanes→9:1 CH2Cl2:Et2O) to afford PHOX ligand 192 (5.03 g, 15.2 mmol, 86% 
yield) as a colorless viscous oil that crystallized upon standing;  Rf = 0.50 (7:3 
hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 7.85 (dd, J = 7.6, 3.4 Hz, 1H), 7.37–
7.26 (comp. m, 12H), 6.89 (dd, J = 4.1, 7.6 Hz, 1H), 4.08 (t, J = 9.5 Hz, 2H), 3.78 (t, J = 
9.5 Hz, 2H);  13C NMR (125 MHz, CDCl3) δ 164.5 (d, JCP = 2.8 Hz), 139.1 (d, JCP = 24.9 
Hz), 138.0 (d, JCP = 11.5 Hz), 134.1 (d, JCP = 20.7 Hz), 133.7 (d, JCP = 1.8 Hz), 131.9 (d, 
JCP = 18.9 Hz), 130.5, 129.9 (d, JCP = 2.8 Hz), 128.7, 128.5 (d, JCP = 7.4 Hz), 128.1, 67.2, 
55.0;  31P NMR (121 MHz, CDCl3) δ –3.99 (s);  IR (Neat Film NaCl) 3053, 3000, 2971, 
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2901, 2876, 1650, 1585, 1562, 1478, 1434, 1354, 1326, 1248, 1133, 1089, 1070, 1041, 
974, 942, 898, 743 cm–1;  HRMS (FAB+) m/z calc'd for C21H19NOP [M+H]+: 332.1204; 
found 332.1218;  mp = 99–101 °C. 
 
H2N OH
1) Na2CO3
     CH2Cl2, H2O, 23 °C
2) MsCl, Et3N, CH2Cl2  
    0!40 °C
     82% yield, 2 steps
Br N
O
Br O
Cl
193  
Dihydrooxazole 193.  (S)-tert-Leucinol (1.02 g, 8.66 mmol, 1.00 equiv) was placed in a 
250 mL round-bottom flask and dissolved in CH2Cl2 (14 mL).  Na2CO3 (2.75 g, 26.0 
mmol, 3.00 equiv) in H2O (27.0 mL) was added dropwise via syringe to the vigorously 
stirred biphasic system.  To the biphasic mixture was added a solution of 1-
bromonaphthalene-2-carbonyl chloride (2.68 g, 9.96 mmol, 1.15 equiv) in CH2Cl2 (15 
mL).  The reaction was stirred vigorously at 23 °C for 9.5 h.  The phases were separated 
and the aqueous phase was extracted with CH2Cl2 (4 x 50 mL).  The combined organics 
were stirred with KOH (10 mL, 10 mmol, 1.0 N in MeOH) for 30 min then transferred to 
a separatory funnel.  H2O (10 mL) was added and the mixture was neutralized with HCl 
(6.0 M in H2O).  The phases were separated and the aqueous phase was extracted with 
CH2Cl2 (4 x 50 mL).  The combined organics were dried over MgSO4 and concentrated 
under reduced pressure to afford the intermediate amide (3.03 g) as a pale yellow solid. 
The intermediate amide (3.03 g) was dissolved in CH2Cl2 (43.3 mL) in a 100 mL 3-
neck round-bottom flask fitted with a reflux condenser.  The solution was cooled to 0 °C 
by use of an ice/water bath and Et3N (2.90 mL, 20.8 mmol, 2.40 equiv) was added.  
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Methanesulfonyl chloride (0.77 mL, 9.96 mmol, 1.15 equiv) was added dropwise.  The 
reaction mixture was stirred at 0 °C for 30 min and heated to 40 °C in a water bath.  After 
21 h of stirring, the mixture was allowed to cool to ambient temperature and saturated 
aqueous NaHCO3 was added.  The biphasic system was stirred vigorously for 5 min and 
the layers were separated.  The aqueous phase was extracted with CH2Cl2 (2 x 50 mL).  
The combined organics were washed with brine (50 mL), dried over MgSO4, and 
concentrated under reduced pressure to afford a pale yellow oil.  The crude oil was 
purified by flash chromatography (SiO2, 3 x 15 cm, 9:1 hexanes:EtOAc) to afford 193 
(2.36 g, 7.12 mmol, 82% yield over two steps) as a pale yellow oil that solidifies when 
placed in a –20 °C freezer;  Rf = 0.73 (9:1 CHCl3:MeOH);  1H NMR (300 MHz, CDCl3) δ 
8.41 (dd, J = 7.7, 0.5 Hz, 1H), 7.85–7.81 (m, 2H), 7.64 (d, J = 8.5 Hz, 1H), 7.60 (app dt, 
J = 8.2, 1.3 Hz, 1H), 7.56 (app dt, J = 6.9, 1.3 Hz, 1H), 4.46 (dd, J = 10.4, 8.5 Hz, 1H), 
4.33 (dd, J = 8.5, 8.0 Hz, 1H), 4.17 (dd, J = 10.4, 8.2 Hz, 1H), 1.05 (s, 9H);  13C NMR 
(125 MHz, CDCl3) δ 163.8, 134.9, 132.3, 128.8, 128.3, 128.3, 128.0, 127.8, 127.7, 126.9, 
123.2, 76.9, 69.2, 34.1, 26.1;  IR (Neat Film NaCl) 3065, 2956, 2899, 2863, 1667, 1620, 
1594, 1556, 1499, 1476, 1463, 1393, 1372, 1362, 1339, 1321, 1300, 1238, 1264, 1210, 
1161, 1104, 1024, 977, 956, 920, 817, 752 cm–1;  HRMS (EI+) m/z calc'd for C17H18ONBr 
[M]+•: 331.0572; found 331.0583;  [α]D20.0 –64.0 (c 0.92, CHCl3);  mp = 66–68 °C. 
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Br Ph2P
193 150
N
O
N
O
CuI (2 mol %), Ph2PH
N,N'-dimethylethylenediamine (10 mol %)
Cs2CO3, PhCH3, 110 °C
86% yield
 
PHOX Ligand 150.  Prepared by the typical method as described for 192 above by 
employing 193 (830.6 mg, 2.50 mmol).  After 24 h of stirring, the reaction mixture was 
filtered through a plug of Celite, eluted with CH2Cl2 (2 x 25 mL), and concentrated under 
reduced pressure.  The crude oil was passed through a short plug of silica (SiO2, 2.5 x 8 
cm, hexanes→9:1 CH2Cl2:Et2O) to afford a bright yellow oil.  The crude oil was purified 
by flash chromatography (SiO2, 2.5 x 25 cm, 19:1 hexanes:acetone and then 2.5 x 21 cm, 
9:1→6:1 hexanes:EtOAc) to afford PHOX ligand 150 (950.8 mg, 2.17 mmol, 87% yield) 
as a bright yellow foam;  Rf = 0.21 (9:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 
7.97 (d, J = 8.1 Hz, 1H), 7.96 (d, J = 8.0 Hz, 2H), 7.72 (dd, J = 8.3, 2.9 Hz, 1H), 7.45 
(app dt, J = 7.8, 1.7 Hz, 2H), 7.41–7.38 (m, 3H), 7.29–7.22 (m, 6H), 7.16 (ddd, J = 8.3, 
6.9, 1.0 Hz, 1H), 4.17–4.15 (m, 2H), 3.91 (dd, J = 9.8, 8.8 Hz, 1H), 0.97 (s, 9H);  13C 
NMR (125 MHz, CDCl3) δ 165.6 (d, JCP = 5.1 Hz), 137.5 (d, JCP = 33.1 Hz), 136.8, (d, JCP 
= 14.7 Hz), 136.5 (d, JCP = 14.7), 134.9, 134.7 (d, JCP = 33.6 Hz), 133.1 (d, JCP = 26.7 Hz), 
132.2 (d, JCP = 17.5 Hz), 132.1 (d, JCP = 17.5 Hz), 131.5 (d, JCP = 0.9 Hz), 129.1 (d, JCP = 
7.4 Hz), 129.0, 128.4 (d, JCP = 6.0 Hz), 127.8 (d, JCP = 8.3 Hz), 126.6 (d, JCP = 8.7 Hz), 
126.4 (d, JCP = 40.5 Hz), 76.8, 69.0, 34.1, 26.3;  31P NMR (121 MHz, CDCl3) δ –9.33 (s);  
IR (Neat Film NaCl) 3054, 2954, 2867, 1665, 1584, 1478, 1434, 1364, 1244, 1094, 1026, 
986, 962, 922, 824 cm–1;  HRMS (FAB+) m/z calc'd for C29H28NOP [M]+•: 437.1908; 
found 437.1908;  [α]D26.1 –38.2 (c 1.59, n-hexane). 
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2.10.2.4 ENANTIOSELECTIVE Pd-CATALYZED DECARBOXYLATIVE 
ALKYLATION SCREENING PROTOCOLa 
entry solvent yield (%)b ee (%)c
1 94 84THFe
4 88 85
5 93 86
6 84 86
7 91 88
TBMEe
Et2O
PhH
PhCH3
2 86 84p-dioxane
3 75 852-methyl THFe
8d 57 90PhCH3
9 77 72PhCH3
ligand
13
13
13
13
13
13
13
14
150
a Conditions: !-ketoester 148a (1.0 equiv), Pd2(pmdba)3 (2.5 mol %), ligand
(6.25 mol %) in solvent (0.1 M) at 30 °C; pmdba = 4,4ʼ-
methoxydibenzylideneacetone. b Isolated yield. c Determined by chiral
HPLC.  d Increased catalyst loadings were required to achieve full conversion: 
Pd2(pmdba)3 (5 mol %), 14 (12.5 mol %). e THF = tetrahydrofuran, 2-methyl
THF = 2-methyl tetrahydrofuran, TBME = tert-butyl methyl ether.
O
i-BuO
149a
ligand (6.25 mol %)
Pd2(pmdba)3  (2.5 mol %)
solvent, 30 °C
O
i-BuO
148a
O
O
Ph2P N
O
P N
O
CF3
F3C Ph2P N
O
13
(S)-t-Bu-PHOX CF3
14 150
 
Enantioselective Allylation Screen to Produce Vinylogous Ester 149a (0.20 mmol 
scale).  To a 25 mL flask was added Pd2(pmdba)3 (5.00 µmol, 2.5 mol %) and ligand 
(12.5 µmol, 6.25 mol %).  The flask was evacuated/backfilled with N2 (3 cycles, 5 min 
evacuation per cycle).  Solvent (most of total volume, 0.1 M final concentration) was 
added and the black suspension was stirred for 30 min at 30 °C using an oil bath.  A 
solution of β-ketoester 148a (0.20 mmol, 1.00 equiv) in solvent (remainder of total 
volume) was transferred to the catalyst solution using positive pressure cannulation.  
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When judged complete by TLC analysis, the reaction was filtered through a small plug of 
SiO2, eluted with Et2O, and concentrated under reduced pressure.  Purification by flash 
column chromatography (SiO2, 1.5 x 15 cm, 9:1→6:1 hexanes:EtOAc) or preparative 
TLC (SiO2, 2:1 hexanes:EtOAc) provided vinylogous ester 149a for analysis.  HPLC 
conditions: 1% IPA in hexanes, 1.0 mL/min, OD-H column, tR (min): major = 6.30, 
minor = 7.26.  (For characterization data, see p. 124) 
 
2.10.2.5 PREPARATION OF CHIRAL VINYLOGOUS ESTERS 149 
Non-enantioselective reactions were performed using Pd(PPh3)4 (5 mol %) or achiral 
PHOX ligand 192 (6.25 mol %) and Pd2(pmdba)3 (2.5 mol %) in toluene at 30 °C.  For 
the synthesis of ligand 192, see p. 115–117. 
 
O
i-BuO
149a
Pd2(pmdba)3 (2.5 mol %)
(S)-t-Bu-PHOX (13) (6.25 mol %)
PhCH3, 30 °C
91% yield, 88% ee
O
i-BuO
148a
O
O
 
Schlenk Manifold Method: Asymmetric Allylic Alkylation 
Vinylogous Ester 149a.  Pd2(pmdba)3 (5.0 mg, 4.5 µmol, 2.5 mol %) and (S)-t-Bu-PHOX 
(4.4 mg, 11 µmol, 6.25 mol %) were placed in a 1 dram vial.  The flask was 
evacuated/backfilled with N2 (3 cycles, 10 min evacuation per cycle).  Toluene (1.3 mL, 
sparged with N2 for 1 h immediately before use) was added and the black suspension was 
immersed in an oil bath preheated to 30 °C.  After 30 min of stirring, β-ketoester 148a 
(50.7 mg, 0.181 mmol, 1.00 equiv) was added as a solution in toluene (0.5 mL, sparged 
with N2 immediately before use) using positive pressure cannulation.  The dark orange 
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catalyst solution turned olive green immediately upon addition of β-ketoester 148a.  The 
reaction was stirred at 30 °C for 21 h, allowed to cool to ambient temperature, filtered 
through a silica gel plug (2 x 2 cm, Et2O), and concentrated under reduced pressure.  The 
crude oil was purified by preparative TLC (SiO2, 4:1 hexanes:EtOAc) to afford 
vinylogous ester 149a (38.8 mg, 0.164 mmol, 91% yield, 88% ee) as a pale yellow oil.  
(For characterization data, see p. 124). 
 
Pd2(pmdba)3 (2.5 mol %)
(S)-t-Bu-PHOX (13) (6.25 mol %)
PhCH3, 30 °C
98% yield, 83% ee
O
i-BuO
N Ts
149j
O
i-BuO
148j
O
O
N
Ts
 
Glove Box Method: Asymmetric Allylic Alkylation 
Vinylogous Ester 149j.  A 20 mL scintillation vial was loaded with β-ketoester 148j 
(447 mg, 0.81 mmol, 1.00 equiv).  A separate 20 mL scintillation vial was loaded with 
Pd2(pmdba)3 (19.7 mg, 0.051 mmol, 6.25 mol %), (S)-t-Bu-PHOX (22.3 mg, 0.020 mmol, 
2.5 mol %), and magnetic stir bar.  The two vials and a teflon-lined hard cap were 
evacuated/backfilled with N2 in a glove box antechamber (3 cycles, 5 min evacuation per 
cycle) before being trasnsferred into the glove box.  Toluene (5 mL) was added to the vial 
containing Pd2(pmdba)3 and (S)-t-Bu-PHOX.  The vial was capped and heated to 30 °C 
for 30 min.  During this time, the mixture developed a dark orange color.  β-Ketoester 
148j was dissolved in toluene (3 mL) and added to the catalyst solution dropwise, 
causing the solution to turn olive green.  The solution was stirred at 30 °C in a heating 
block.  The capped vial was removed from the glove box after 29 h of stirring.  The crude 
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product was concentrated under reduced pressure and purified by flash column 
chromatography (SiO2, 5 x 25 cm, 15:1→10:1→8:1→6:1 hexanes:EtOAc) to afford 
vinylogous ester 149j (403 mg, 0.796 mmol, 98% yield, 82.9% ee) as a thick, white semi-
solid.  (For characterization data, see p. 131). 
 
O
i-BuO
149a  
Vinylogous Ester 149a  (Table 2.1, entry 1). 3Prepared using Schlenk Manifold Method.  
38.8 mg, 0.164 mmol, 91% yield.  Preparative TLC (SiO2, 4:1 hexanes:EtOAc).  Rf  = 
0.31 (3:1 hexanes:Et2O);  1H NMR (500 MHz, CDCl3) δ 5.72 (dddd, J = 16.6, 10.5, 7.3, 
7.3 Hz, 1H), 5.31 (s, 1H), 5.05–5.00 (m, 2H), 3.50 (dd, J = 9.3, 6.6 Hz, 1H), 3.47 (dd, J = 
9.3, 6.6 Hz, 1H), 2.53–2.42 (m, 2H), 2.38 (dd, J = 13.7, 7.1 Hz, 1H), 2.20 (dd, J = 13.7, 
7.8 Hz, 1H), 1.98 (app sept, J = 6.6 Hz, 1H), 1.86–1.70 (m, 3H), 1.62–1.56 (m, 1H), 1.14 
(s, 3H), 0.95 (d, J = 6.6 Hz, 6H);  13C NMR (125 MHz, CDCl3) δ 206.7, 171.3, 134.6, 
117.9, 105.0, 74.5, 51.5, 45.4, 36.1, 35.2, 28.0, 25.2, 19.9, 19.3, 19.3;  IR (Neat Film 
NaCl) 2960, 2933, 2873, 1614, 1470, 1387, 1192, 1171, 998, 912 cm–1;  HRMS (EI+) m/z 
calc'd for C15H24O2 [M]+•: 236.1776; found 236.1767;  [α]D25.6 –69.04 (c 1.08, CHCl3, 
88.0% ee);  HPLC conditions: 1% IPA in hexanes, 1.0 mL/min, OD-H column, tR (min): 
major = 6.30, minor = 7.26. 
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O
i-BuO
149b  
Vinylogous Ester 149b  (Table 2.1, entry 2).  Prepared using Schlenk Manifold Method.  
226.3 mg, 0.90 mmol, 89% yield.  Flash column chromatography (SiO2, 3 x 24 cm, 
20:1→15:1→10:1 hexanes:EtOAc).  Rf = 0.43 (10:1 hexanes:EtOAc);  1H NMR (300 
MHz, CDCl3) δ 5.82–5.62 (m, 1H), 5.29 (s, 1H), 5.06–4.98 (m, 2H), 3.48 (dd, J = 11.1, 
6.6 Hz, 1H), 3.45 (dd, J = 11.2, 6.6 Hz, 1H), 2.49–2.42 (m, 2H), 2.40 (dddd, J = 13.8, 
7.1, 1.2 Hz, 1H), 2.23 (dddd, J = 13.8, 7.7, 1.1, 1.1 Hz, 1H), 1.97 (app sept, J = 6.7 Hz, 
1H), 1.84–1.44 (m, 6H), 0.98–0.91 (d, J = 6.7 Hz, 6H), 0.79 (t, J = 7.5 Hz, 3H);  13C 
NMR (75 MHz, CDCl3) δ 206.2, 171.0, 135.1, 117.6, 105.5, 74.4, 54.8, 41.9, 36.1, 32.3, 
31.3, 28.0, 20.0, 19.3, 8.6;  IR (Neat Film NaCl) 3073, 2960, 2933, 2876, 1617, 1613, 
1459, 1400, 1387, 1369, 1314, 1220, 1190, 1173, 996, 969, 954, 912, 883, 873, 856, 782 
cm–1;  HRMS (EI+) m/z calc'd for C16H26O2 [M]+•: 250.1933; found 250.1909;  [α]D25.0 
+25.83 (c 1.04, CHCl3, 91.6% ee);  HPLC conditions: 0.25% IPA in hexanes, 1.0 
mL/min, AD column, tR (min): minor = 16.23, major = 18.08. 
 
O
i-BuO
149c
Ph
 
Vinylogous Ester 149c  (Table 2.1, entry 3).  Prepared using Schlenk Manifold Method.  
172.5 mg, 0.552 mmol, 98% yield.  Flash column chromatography (SiO2, 3 x 24 cm, 
20:1→15:1→10:1 hexanes:EtOAc).  Rf = 0.50 (10:1 hexanes:EtOAc);  1H NMR (300 
MHz, CDCl3) δ 7.28–7.14 (m, 3H), 7.14–7.08 (m, 2H), 5.85–5.68 (m, 1H), 5.31 (s, 1H), 
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5.10–4.99 (m, 2H), 3.44 (dd, J = 14.7, 6.6 Hz, 1H), 3.41 (dd, J = 14.7, 6.6 Hz, 1H), 3.14 
(d, J = 13.3 Hz, 1H), 2.71 (d, J = 13.3 Hz, 1H), 2.51 (dddd, J = 13.7, 6.8, 1.2, 1.2 Hz, 
1H), 2.45–2.32 (m, 2H), 2.16 (dddd, J = 13.7, 7.9, 1.1, 1.1 Hz, 1H), 1.93 (app sept, J = 
6.7 Hz, 1H), 1.83–1.56 (m, 4H), 0.92 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 
205.5, 171.4, 138.3, 134.5, 130.8, 128.0, 126.3, 118.2, 106.3, 74.5, 56.2, 44.1, 43.9, 36.3, 
31.3, 27.9, 19.5, 19.3;  IR (Neat Film NaCl) 3072, 3061, 3027, 3002, 2957, 2931, 2871, 
1610, 1495, 1471, 1454, 1422, 1403, 1387, 1368, 1318, 1280, 1217, 1189, 1173, 1081, 
1031, 1007, 969, 957, 913, 875, 856, 831, 760, 746, 733 cm–1;  HRMS (EI+) m/z calc'd 
for C21H28O2 [M]+•: 312.2089; found 312.2083;  [α]D25.0 +2.91 (c 0.98, CHCl3, 86.3% ee);  
HPLC conditions: 0.5% IPA in hexanes, 1.0 mL/min, OD-H column, tR (min): minor = 
13.96, major = 15.70. 
 
O
i-BuO
149d  
Vinylogous Ester 149d  (Table 2.1, entry 4).  Prepared using Schlenk Manifold Method.  
224.7 mg, 0.86 mmol, 88% yield.  Flash column chromatography (SiO2, 3 x 25 cm, 
20:1→15:1 hexanes:EtOAc).  Rf = 0.44 (10:1 hexanes:EtOAc);  1H NMR (300 MHz, 
CDCl3) δ 5.74–5.59 (m, 1H), 5.32 (s, 1H), 5.12–5.02 (m, 2H), 3.50 (dd, J = 14.9, 6.5 Hz, 
1H), 3.47 (dd, J = 14.7, 6.6 Hz, 1H), 2.53–2.48 (m, 4H), 2.46 (dddd, J = 13.7, 7.3, 1.2, 
1.2 Hz, 1H), 2.35 (dddd, J = 13.7, 7.6, 1.1, 1.1 Hz, 1H), 2.09–1.67 (m, 5H), 1.57 (s, 1H), 
0.95 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 204.0, 171.7, 133.7, 118.5, 105.0, 
81.7, 74.6, 70.8, 54.2, 42.9, 36.1, 32.5, 28.0, 27.1, 20.0, 19.3;  IR (Neat Film NaCl) 3301, 
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3075, 2957, 2930, 2873, 2116, 1612, 1471, 1457, 1435, 1423, 1402, 1387, 1368, 1320, 
1221, 1191, 1175, 995,  969, 916, 874, 845 cm–1;  HRMS (EI+) m/z calc'd for C17H24O2 
[M]+•: 260.1776; found 260.1737;  [α]D25.0 –26.51 (c 1.03, CHCl3, 88.5% ee);  HPLC 
conditions: 0.5% IPA in hexanes, 1.0 mL/min, OD-H column, tR (min): major = 12.35, 
minor = 13.43. 
 
O
i-BuO
149e  
Vinylogous Ester 149e  (Table 2.1, entry 5). 4Prepared using Glove Box Method.  287.5 
mg, 1.04 mmol, 95% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 20:1 
hexanes:EtOAc).  Rf = 0.44 (10:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 5.84–
5.64 (m, 2H), 5.30 (s, 1H), 5.09–4.87 (m, 4H), 3.49 (dd, J = 11.2, 6.6 Hz, 1H), 3.46 (dd, J 
= 11.1, 6.6 Hz, 1H), 2.54–2.37 (m, 3H), 2.27 (dddd, J = 13.8, 7.7, 1.2, 1.2 Hz, 1H), 2.07–
1.89 (m, 3H), 1.86–1.45 (m, 6H), 0.95 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 
205.8, 171.1, 138.9, 134.8, 117.9, 114.5, 105.5, 74.8, 54.4, 42.3, 38.0, 36.1, 32.7, 28.6, 
28.0, 19.9, 19.3;  IR (Neat Film NaCl) 3076, 2958, 2932, 2874, 1639, 1614, 1471, 1455, 
1434, 1424, 1402, 1387, 1368, 1317, 1280, 1216, 1190, 1174, 1086, 996, 969, 955, 910, 
878, 853, 829, 771 cm–1;  HRMS (EI+) m/z calc'd for C18H28O2 [M]+•: 276.2089; found 
276.2060;  [α]D25.0 +15.28 (c 0.97, CHCl3, 86.9% ee);  HPLC conditions: 0.8% IPA in 
hexanes, 2.0 mL/min, AD column, tR (min): major = 5.03, minor = 6.06. 
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O
i-BuO
149f  
Vinylogous Ester 149f  (Table 2.1, entry 6).  Prepared using Schlenk Manifold Method.  
232.9 mg, 0.81 mmol, 90% yield.  Flash column chromatography (SiO2, 3 x 25 cm, 
20:1→15:1 hexanes:EtOAc).  Rf = 0.45 (10:1 hexanes:EtOAc);  1H NMR (300 MHz, 
CDCl3) δ 6.30 (dt, J = 16.9, 10.3 Hz, 1H), 6.04 (dd, J = 15.1, 10.4 Hz, 1H), 5.82–5.53 (m, 
2H), 5.31 (s, 1H), 5.15–4.92 (m, 4H), 3.48 (d, J = 6.5 Hz, 2H), 2.55–2.36 (m, 4H), 2.30–
2.16 (m, 2H), 1.98 (app sept, J = 6.7 Hz, 1H), 1.84–1.67 (m, 4H), 0.95 (d, J = 6.7 Hz, 
6H);  13C NMR (75 MHz, CDCl3) δ 205.3, 171.4, 137.2, 134.5, 134.1, 130.8, 118.0, 
115.5, 105.5, 74.5, 55.1, 43.1, 41.6, 36.1, 32.5, 28.0, 19.9, 19.3;  IR (Neat Film NaCl) 
3075, 3036, 3007, 2958, 2931, 2873, 1726, 1635, 1611, 1471, 1456, 1436, 1402, 1387, 
1368, 1312, 1277, 1219, 1190, 1173, 1085, 1005, 954, 911, 874, 831 cm–1;  HRMS 
(FAB+) m/z calc'd for C19H29O2 [M+H]+: 289.2168; found 289.2172;  [α]D25.0 –20.62 (c 
1.05, CHCl3, 89.6% ee);  SFC conditions: 5.0% IPA in hexanes, 2.5 mL/min, AD-H 
column, tR (min): minor = 6.31, major = 6.99. 
 
O
i-BuO
149g
Cl
 
Vinylogous Ester 149g  (Table 2.1, entry 7).  Prepared using Schlenk Manifold Method.  
259.5 mg, 0.87 mmol, 99% yield.  Flash column chromatography (SiO2, 3 x 25 cm, 
20:1→15:1 hexanes:EtOAc).  Rf = 0.36 (10:1 hexanes:EtOAc);  1H NMR (300 MHz, 
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CDCl3) δ 5.78–5.62 (m, 1H), 5.36 (s, 1H), 5.25 (s, 1H), 5.14 (s, 1H), 5.11–5.01 (m, 2H), 
3.54–3.43 (m, 2H), 2.95 (dd, J = 14.4, 0.7 Hz, 1H), 2.54–2.41 (m, 4H), 2.25 (dddd, J = 
13.9, 7.9, 1.1, 1.1 Hz, 1H), 2.07–1.89 (m, 2H), 1.88–1.70 (m, 3H), 0.95 (d, J = 6.7 Hz, 
6H);  13C NMR (75 MHz, CDCl3) δ 204.3, 171.6, 139.4, 133.9, 118.7, 116.6, 105.9, 74.6, 
54.7, 46.7, 43.7, 36.3, 31.5, 28.0, 19.6, 19.3;  IR (Neat Film NaCl) 3075, 2958, 2934, 
2874, 1612, 1471, 1458, 1424, 1403, 1388, 1368, 1339, 1321, 1297, 1222, 1192, 1175, 
1082, 1010, 995, 968, 956, 916, 875, 847, 746 cm–1;  HRMS (FAB+) m/z calc'd for 
C17H26O2Cl [M+H]+: 297.1621; found 297.1623;  [α]D25.0 +4.20 (c 1.02, CHCl3, 85.7% 
ee);  HPLC conditions: 0.1% IPA in hexanes, 1.0 mL/min, OD-H column, tR (min): minor 
= 24.19, major = 27.22. 
 
O
i-BuO
149h
CN
 
Vinylogous Ester 149h  (Table 2.1, entry 8).  Prepared using Schlenk Manifold Method.  
292.8 mg, 1.06 mmol, 96% yield.  Flash column chromatography (SiO2, 3 x 25 cm, 
20:1→10:1→8:1→6:1 hexanes:EtOAc).  Rf = 0.39 broad (4:1 hexanes:EtOAc);  1H NMR 
(300 MHz, CDCl3) δ 5.75–5.58 (m, 1H), 5.31 (s, 1H), 5.15–5.04 (m, 2H), 3.48 (d, J = 6.5 
Hz, 2H), 2.51 (t, J = 6.1 Hz, 2H), 2.40 (dddd, J = 14.0, 7.0, 1.2, 1.2 Hz, 1H), 2.35–2.22 
(m, 3H), 2.11–1.93 (m, 2H), 1.93–1.62 (m, 5H), 0.96 (d, J = 6.7 Hz, 6H);  13C NMR (75 
MHz, CDCl3) δ 203.9, 172.1, 133.1, 120.3, 119.2, 104.9, 74.7, 53.6, 41.8, 36.1, 33.9, 
32.8, 28.0, 19.8, 19.3, 12.8;  IR (Neat Film NaCl) 3076, 2958, 2933, 2874, 2246, 1635, 
1609, 1472, 1458, 1420, 1404, 1388, 1368, 1319, 1281, 1214, 1192, 1175, 1084, 1003, 
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917, 880, 854, 827, 766 cm–1;  HRMS (EI+) m/z calc'd for C17H25O2N [M]+•: 275.1885; 
found 275.1893;  [α]D25.0 –20.97 (c 1.06, CHCl3, 87.4% ee);  HPLC conditions: 5.0% IPA 
in hexanes, 1.0 mL/min, OD-H column, tR (min): major = 10.67, minor = 14.66.  
 
O
i-BuO
149i
N
 
Vinylogous Ester 149i  (Table 2.1, entry 9).  Prepared using Glove Box Method.  339.6 
mg, 1.08 mmol, 97% yield.  Flash column chromatography (SiO2, 3 x 20 cm, 1:1→1:4 
hexanes:EtOAc→EtOAc).  Rf = 0.28, broad (1:2 hexanes:EtOAc);  1H NMR (300 MHz, 
CDCl3) δ 8.45 (dd, J = 4.5, 1.5 Hz, 2H), 7.05 (dd, J = 4.5, 1.6 Hz, 2H), 5.84–5.66 (m, 
1H), 5.31 (s, 1H), 5.15–5.02 (m, 2H), 3.44 (dd, J = 15.1, 6.3 Hz, 1H), 3.41 (dd, J = 15.0, 
6.3 Hz, 1H), 3.20 (d, J = 12.9 Hz, 1H), 2.60 (d, J = 12.9 Hz, 1H), 2.48 (dddd, J = 13.8, 
6.9, 1.2, 1.2 Hz, 1H), 2.43–2.29 (m, 2H), 2.23 (dddd, J = 13.8, 7.8, 1.1, 1.1 Hz, 1H), 1.94 
(app sept, J = 6.7 Hz, 1H), 1.84–1.67 (m, 2H), 1.67–1.51 (m, 2H), 0.92 (d, J = 6.7 Hz, 
6H);  13C NMR (75 MHz, CDCl3) δ 204.4, 171.8, 149.5, 147.6, 133.7, 126.2, 118.9, 
106.0, 74.6, 55.8, 43.8, 43.5, 36.2, 31.5, 27.9, 19.4, 19.3;  IR (Neat Film NaCl) 3072, 
3024, 2957, 2931, 2873, 1608, 1558, 1496, 1471, 1458, 1438, 1415, 1388, 1368, 1320, 
1220, 1190, 1173, 1072, 994, 957, 916, 876, 844, 796 cm–1;  HRMS (EI+) m/z calc'd for 
C20H27O2N [M]+•: 313.2042; found 313.2045;  [α]D25.0 +22.44 (c 1.16, CHCl3, 84.6% ee);  
HPLC conditions: 5.0% EtOH in hexanes, 1.0 mL/min, AD column, tR (min): major = 
13.22, minor = 15.13.   
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O
i-BuO
149j
N Ts
 
Vinylogous Ester 149j  (Table 2.1, entry 10). 5Prepared using Glove Box Method.  403 
mg, 0.796 mmol, 98% yield.  Flash column chromatography (SiO2, 5 x 25 cm, 
15:1→10:1→8:1→6:1 hexanes:EtOAc).  Rf = 0.49 (4:1 hexanes:EtOAc);  1H NMR (300 
MHz, CDCl3) δ 7.96 (dm, J = 8.4 Hz, 1H), 7.70 (dm, J = 8.4 Hz, 2H), 7.48 (dm, J = 7.9 
Hz, 1H), 7.31–7.13 (m, 5H), 5.86–5.68 (m, 1H), 5.32 (s, 1H), 5.13–5.00 (m, 2H), 3.42 
(dd, J = 17.0, 7.7 Hz, 1H), 3.38 (dd, J = 17.0, 7.6 Hz, 1H), 3.20 (dd, J = 14.2, 0.7 Hz, 
1H), 2.73 (d, J = 14.1 Hz, 1H), 2.51 (dddd, J = 13.7, 6.9, 1.3, 1.3 Hz, 1H), 2.44–2.15 (m, 
6H), 1.92 (app sept, J = 6.7 Hz, 1H), 1.76–1.46 (m, 4H), 0.92 (d, J = 6.7 Hz, 6H);  13C 
NMR (75 MHz, CDCl3) δ 205.2, 171.7, 144.8, 135.4, 135.0, 134.1, 132.4, 129.8, 126.9, 
125.4, 124.5, 123.2, 120.1, 119.6, 118.6, 113.8, 106.4, 74.6, 55.9, 44.1, 36.3, 33.0, 31.9, 
27.9, 21.7, 19.5, 19.3;  IR (Neat Film NaCl) 3584, 3401, 2068, 2958, 2930, 2873, 1609, 
1494, 1470, 1448, 1422, 1402, 1368, 1306, 1279, 1215, 1188, 1174, 1120, 1097, 1020, 
975, 916, 876, 813, 782, 747 cm–1;  HRMS (FAB+) m/z calc'd for C30H36O4NS [M+H]+: 
506.2365; found 506.2358;  [α]D25.0 +9.10 (c 1.00, CHCl3, 82.9% ee);  HPLC conditions: 
5.0% EtOH in hexanes, 1.0 mL/min, AD column, tR (min): major = 11.11, minor = 16.64.  
 
CHAPTER 2 – Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures  
 
132 
O
i-BuO
149k
OH
 
Vinylogous Ester 149k  (Table 2.1, entry 11).  Prepared using Glove Box Method.  77.3 
mg, 0.278 mmol, 90% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 6:1→4:1 
hexanes:EtOAc).  Rf = 0.35, broad (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 
9.73 (t, J = 1.5 Hz, 1H), 5.78–5.61 (m, 1H), 5.29 (s, 1H), 5.11–5.02 (m, 2H), 3.47 (m, 
2H), 2.54–2.33 (m, 5H), 2.28 (dddd, J = 14.0, 7.6, 1.2, 1.2 Hz, 1H), 2.07–1.73 (m, 5H), 
1.73–1.56 (m, 2H), 0.95 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 205.0, 202.3, 
171.7, 134.0, 118.5, 105.2, 74.6, 53.6, 42.1, 39.4, 36.1, 33.1, 30.3, 28.0, 19.9, 19.3;  IR 
(Neat Film NaCl) 3075, 2958, 2931, 2719, 1724, 1611, 1471, 1458, 1421, 1403, 1388, 
1368, 1213, 1191, 1175, 998, 915, 878 cm–1;  HRMS (FAB+) m/z calc'd for C17H27O3 
[M+H]+: 279.1960; found 279.1969;  [α]D25.0 +15.37 (c 1.03, CHCl3, 79.5% ee);  
Compound 149k  was derivatized using procedure below to determine ee using the 
corresponding chiral HPLC assay for vinylogous ester 149e.  
 
MePPh3Br, KOt-Bu 
THF, 0 °C
81% yield
O
i-BuO
H O
O
i-BuO
149k 149e  
Vinylogous Ester 149e.  To a solution of MePh3PBr (323.2 mg, 0.905 mmol, 0.84 equiv) 
in THF (14.0 mL) in a 50 mL round-bottom flask at 0 °C was added KOt-Bu (84.6 mg, 
0.754 mmol, 0.699 equiv) to give a bright yellow suspension.  Aldehyde 149k (299.9 mg, 
1.078 mmol, 1.00 equiv) in THF (2 mL) was added to the suspension using positive 
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pressure cannulation and maintained at 0 °C.  The reaction faded to an off-white 
suspension.  After 1.5 h of stirring, an additional portion of Wittig reagent was prepared 
in a 20 mL scintillation vial.  MePPh3Br (323.2 mg, 0.905 mmol, 0.84 equiv) was added 
to the vial.  The vial was sealed with a septum, evacuated/backfilled with N2 (3 cycles, 5 
min evacuation per cycle).  Anhydrous THF (3 mL) was added and the vial was cooled to 
0 °C.  KOt-Bu (84.6 mg, 0.754 mmol, 0.699 equiv) was added in one portion, giving a 
bright yellow suspension which was added to the reaction flask using positive pressure 
cannulation.  The tan suspension was stirred at 0 °C for 1 h.  An additional portion of 
Wittig reagent using MePPh3Br (323.2 mg, 0.905 mmol, 0.84 equiv), KOt-Bu (84.6 mg, 
0.754 mmol, 0.699 equiv) and THF (3 mL) was prepared at 0 °C and added using 
positive pressure cannulation as previously described.  The reaction showed a persistent 
yellow color.  After 30 min of stirring at 0 °C, the reaction was quenched by addition of 
sat. aqueous NH4Cl (5 mL) and stirred for 30 min while the mixture was allowed to warm 
to ambient temperature.  The mixture was extracted with Et2O (3 x 20 mL), dried over 
Na2SO4, filtered, and concentrated under reduced pressure.  The residue was purified by 
flash column chromatography (SiO2, 3 x 25 cm, 1%→2%→3%→5% EtOAc in hexanes) 
to afford vinylogous ester 149e (243.7 mg, 0.882 mmol, 81% yield) as a yellow liquid;  
HPLC conditions: 0.8% IPA in hexanes, 2.0 mL/min, AD column, tR (min): major = 4.39, 
minor = 3.17.  (For characterization data, see p. 127). 
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i-BuO
F
149l  
Vinylogous Ester 149l  (Table 2.1, entry 12).  Prepared using Schlenk Manifold Method.  
172.5 mg, 0.552 mmol, 98% yield.  Flash column chromatography (SiO2, 3 x 24 cm, 
20:1→15:1→10:1 hexanes:EtOAc).  Rf = 0.59 (4:1 hexanes:EtOAc);  1H NMR (300 
MHz, CDCl3) δ 5.89–5.72 (m, 1H), 5.28 (s, 1H), 5.18–5.08 (m, 2H), 3.53 (dd, J = 10.6, 
6.5 Hz, 1H), 3.50 (dd, J = 10.6, 6.6 Hz, 1H), 2.80–2.46 (m, 3H), 2.46–2.33 (m, 1H), 
2.22–1.67 (m, 5H), 0.97 (d, J = 6.7 Hz, 3H), 0.96 (d, J = 6.7 Hz, 3H);  13C NMR (75 
MHz, CDCl3) δ 198.2 (d, JCF = 24.9 Hz), 176.9 (d, JCF = 1.8 Hz), 131.9 (d, JCF = 4.4 Hz), 
119.3, 101.7, 101.2 (d, JCF = 180.6 Hz), 75.0, 42.1 (d, JCF = 23.2 Hz), 34.4 (d, JCF = 23.2 
Hz), 34.1 (d, JCF = 2.4 Hz), 27.9, 21.7 (d, JCF = 2.1 Hz), 19.3, 19.2;  19F NMR (282 MHz, 
CDCl3) δ –145.81 (m);  IR (Neat Film NaCl) 3086, 2960, 1752, 1654, 1649, 1603, 1471, 
1453, 1422, 1403, 1385, 1369, 1282, 1249, 1229, 1204, 1176, 1137, 1095, 1066, 145, 
991, 927, 873, 843, 795, 758 cm–1;  HRMS (EI+) m/z calc'd for C14H21O2F [M]+•: 
240.1526; found 240.1524;  [α]D25.0 +0.61 (c 1.02, CHCl3, 91.2% ee);  HPLC conditions: 
1.0% IPA in hexanes, 1.0 mL/min, OD-H column, tR (min): minor = 8.05, major = 8.80. 
 
O
i-BuO
10m
OTBDPS
 
Vinylogous Ester 149m  (Table 2.1, entry 13).  Prepared using Glove Box Method.  
242.0 mg, 0.493 mmol, 66% yield.  Flash column chromatography (SiO2, 3 x 25 cm, 
2%→5%→10% EtOAc in hexanes).  Rf = 0.44 (10:1 hexanes:EtOAc);  1H NMR (300 
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MHz, CDCl3) δ 7.67–7.61 (m, 4H), 7.46–7.33 (m, 6H), 5.78–5.60 (m, 1H), 5.32 (s, 1H), 
5.08–4.96 (m, 2H), 3.78 (d, J = 9.7 Hz, 1H), 3.67 (d, J = 9.7 Hz, 1H), 3.46 (dd, J = 14.7, 
6.5 Hz, 1H), 3.43 (dd, J = 14.6, 6.5 Hz, 1H), 2.49 (dddd, J = 13.7, 6.6, 1.3, 1.3 Hz, 1H), 
2.48–2.41 (m, 2H), 2.33 (dddd, J = 13.8, 7.8, 1.2, 1.2 Hz, 1H), 2.09–1.88 (m, 2H), 1.82–
1.65 (m, 3H), 1.04 (s, 9H), 0.95 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 204.5, 
171.5, 135.9, 135.8, 134.7, 133.7, 133.5, 129.7, 127.8, 127.7, 117.8, 106.1, 74.5, 69.0, 
57.4, 41.0, 36.3, 30.3, 28.0, 27.0, 20.0, 19.5, 19.3;  IR (Neat Film NaCl) 3071, 3050, 
2957, 2930, 2857, 1731, 1614, 1472, 1428, 1402, 1388, 1368, 1315, 1261, 1222, 1190, 
1174, 1112, 1007, 998, 969, 955, 938, 914, 880, 824, 810, 740 cm–1;  HRMS (FAB+) m/z 
calc'd for C31H43O3Si [M+H]+: 491.2982; found 491.2993;  [α]D25.0 –6.72 (c 1.09, CHCl3, 
57.8% ee);  HPLC conditions: 0.2% IPA in hexanes, 1.0 mL/min, OD-H column, tR 
(min): major = 21.74, minor = 25.53. 
 
O
i-BuO
O
149n
Ph
O
 
Vinylogous Ester 149n  (Table 2.1, entry 14).  Prepared using Schlenk Manifold 
Method.  589.8 mg, 1.72 mmol, 75% yield.  Flash column chromatography (SiO2, 5 x 13 
cm, 20:1→15:1→10:1→6:1 hexanes:EtOAc).  Rf = 0.57 (4:1 hexanes:EtOAc);  1H NMR 
(300 MHz, CDCl3) δ 8.03–7.96 (m, 2H), 7.55 (t, J = 7.4 Hz, 1H), 7.42 (t, J = 7.5 Hz, 2H), 
5.96–5.78 (m, 1H), 5.27 (s, 1H), 5.19–5.08 (m, 2H), 3.42 (dd, J = 9.4, 6.6 Hz, 1H), 3.39 
(dd, J = 9.4, 6.5 Hz, 1H), 3.06 (dddd, J = 14.8, 6.7, 1.4, 1.4 Hz, 1H), 2.83–2.67 (m, 2H), 
2.55–2.34 (m, 2H), 2.10–1.74 (m, 4H), 0.80 (dd, J = 6.6, 4.7 Hz, 6H);  13C NMR (75 
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MHz, CDCl3) δ 198.1, 174.3, 165.5, 133.1, 132.5, 130.6, 129.7, 128.5, 119.2, 102.1, 
88.6, 74.9, 40.8, 34.0, 27.7, 21.9, 19.1, 19.0;  IR (Neat Film NaCl) 3073, 2959, 2934, 
2873, 1718, 1672, 1649, 1613, 1479, 1451, 1421, 1382, 1368, 1315, 1291, 1258, 1231, 
1199, 1174, 1108, 1070, 1026, 1004, 919, 866, 820, 801, 762, 715 cm–1;  HRMS (EI+) 
m/z calc'd for C21H26O4 [M]+•: 342.1815; found 342.1831;  [α]D25.0 +79.72 (c 1.02, CHCl3, 
57.1% ee);  HPLC conditions: 1.0% IPA in hexanes, 1.0 mL/min, OD-H column, tR 
(min): major = 18.28, minor = 22.01. 
 
O
i-BuO
H O
O
i-BuO
OTBDPS
1. NaBH4, MeOH
2. imidazole 
    TBDPSCl, DMF
85% yield, 2 steps149k 149o  
Vinylogous Ester 149o.  A round-bottom flask with magnetic stir bar was charged with 
aldehyde 149o (40.2 mg, 0.14 mmol, 1.00 equiv) and MeOH (3.0 mL).  The flask was 
cooled to 0 °C and NaBH4 (5.5 mg, 0.14 mmol, 1.00 equiv) was added slowly 
portionwise.  The mixture was stirred for 1 h at 0 °C.  Sat. aqueous NaHCO3 (3 mL) was 
added, followed by CH2Cl2 (10 mL).  The mixture was stirred vigorously for 5 min.  The 
phases were separated and the aqueous layer was extracted with CH2Cl2 (3 x 10 mL).  
Combined organic phases were dried over Na2SO4, filtered, and concentrated under 
reduced pressure.  The crude alcohol was used directly in the next step without further 
purification.  Rf = 0.29 (2:1 hexanes:EtOAc). 
To a 2 dram vial with a solution of crude alcohol and imidazole (11.8 mg, 0.17 mmol, 
1.20 equiv) in DMF (0.7 mL) at 0 °C was added TBDPSCl (39.6 µL, 0.14 mmol, 1.00 
equiv) dropwise.  After 2 h of stirring, the reaction was quenched by addition of H2O (0.3 
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mL) and extracted with Et2O (5 x 5 mL).  The combined organics were dried over 
MgSO4, filtered, and concentrated under reduced pressure.  The residue was purified by 
automated flash column chromatography using a Teledyne Isco CombiFlash Rf (SiO2, 12 
g loading cartridge, 80 g column, multi-step gradient, hold 2% [2 min]→ramp to 5% [10 
min]→hold 5% [10 min]→ramp to 10% [32 min]→hold 10% Et2O in hexanes [5 min]) to 
afford vinylogous ester 149o (63.3 mg, 0.12 mmol, 85% yield over 2 steps) as a pale, 
white oil;  Rf = 0.42 (10:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 7.69–7.62 (m, 
4H), 7.46–7.33 (m, 6H), 5.82–5.62 (m, 1H), 5.29 (s, 1H), 5.08–4.96 (m, 2H), 3.61 (t, J = 
6.1 Hz, 2H), 3.48 (dd, J = 13.7, 6.6 Hz, 1H), 3.45 (dd, J = 13.7, 6.6 Hz, 1H), 2.50–2.43 
(m, 2H), 2.40 (dddd, J = 13.8, 7.0, 1.2 Hz, 1H), 2.25 (dddd, J = 13.9, 7.8, 1.1 Hz, 1H), 
1.98 (app sept, J = 6.7 Hz, 1H), 1.86–1.38 (m, 8H), 1.04 (s, 9H), 0.95 (d, J = 6.7 Hz, 6H);  
13C NMR (75 MHz, CDCl3) δ 206.0, 171.0, 135.7, 134.9, 134.1, 129.6, 127.7, 117.7, 
105.2, 74.4, 64.4, 54.2, 42.1, 36.1, 34.8, 32.8, 28.0, 27.3, 27.0, 20.0, 19.3;  IR (Neat Film 
NaCl) 3071, 3051, 3013, 2998, 2956, 2930, 2858, 1614, 1471, 1428, 1401, 1387, 1368, 
1311, 1214, 1188, 1174, 1111, 1028, 1007, 998, 966, 913, 872, 823, 780, 740, 725 cm–1;  
HRMS (FAB+) m/z calc'd for C33H47O3Si [M+H]+: 519.3295; found 519.3275;  [α]D25.0 
+9.06 (c 0.95, CHCl3, 78.4% ee). 
 
Pd(CH3CN)2Cl2 (5 mol %)
 
CH3CN, PhH, 75 °C
92% yield
O
i-BuO
O
i-BuO
149a 149p  
Vinylogous Ester 149p.  Pd(CH3CN)2Cl2 (49.1 mg, 0.189 mmol, 5 mol %) was placed in 
a 50 mL round-bottom Schlenk flask and evacuated/backfilled with N2 (3 cycles, 5 min 
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per cycle).  Benzene (10 mL) was added, followed by acetonitrile (90 µL).  A solution of 
vinylogous ester 149a (895 mg, 3.79 mmol, 1.00 equiv) in benzene (5.0 mL) was added 
using positive pressure cannulation.  The resulting orange solution was heated to 75 °C in 
an oil bath.  After 11 h of stirring, the reaction was cooled to ambient temperature, 
filtered through a Celite plug (eluted with Et2O), and concentrated carefully under 
reduced pressure, allowing for a film of ice to form on the outside of the flask, to afford a 
pale yellow oil.  The crude oil was purified by automated flash column chromatography 
using a Teledyne Isco CombiFlash Rf (SiO2, 25 g loading cartridge, 80 g column, linear 
gradient, 0→10% EtOAc in hexanes [33 min]) to afford vinylogous ester 149p (823.6 
mg, 3.48 mmol, 92% yield) in a 20:1 ratio to isomeric starting material 149a.  
Analytically pure samples could be obtained using the above column conditions;  Rf = 
0.56 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 5.56 (dq, J = 15.7, 1.4 Hz, 
1H), 5.41 (dq, J = 15.7, 6.2, Hz, 1H), 5.34 (s, 1H), 3.48 (d, J = 6.5 Hz, 2H), 2.63–2.33 
(m, 2H), 2.04–1.91 (m, 1H), 1.90–1.70 (m, 4H), 1.67 (dd, J = 6.2, 1.4 Hz, 3H), 1.22 (s, 
3H), 0.95 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 205.3, 171.6, 136.5, 123.9, 
105.2, 74.5, 53.9, 36.2, 33.3, 28.0, 27.2, 20.2, 19.3, 18.4;  IR (Neat Film NaCl) 3022, 
2960, 2873, 1614, 1471, 1455, 1423, 1402, 1387, 1370, 1212, 1192, 1173, 1120, 967, 
883, 858, 827 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C15H25O2 [M+H]+: 
237.1849; found 237.1848;  [α]D25.0 +4.05 (c 1.39, CHCl3, 88.0 % ee). 
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Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (68) (5 mol %)
PhH, 50 °C
99% yield
O
i-BuO
O
i-BuO
149e 149q  
Vinylogous Ester 149q.  Vinylogous ester 149e (100 mg, 0.362 mmol, 1.00 equiv) was 
added to a 50 mL 2-neck flask fitted with a rubber septum and oven-dried reflux 
condenser.  The flask was evacuated/backfilled with Ar (3 cycles, 5 min evacuation per 
cycle).  Dry degassed benzene (36.2 mL, sparged with N2 for 1 h immediately before use) 
was added.  Grubbs–Hoveyda 2nd generation catalyst (11.3 mg, 18.1 µmol, 5 mol %) 
was added to the reaction, giving the solution an olive green color.  The mixture was kept 
under Ar, stirred until homogeneous, and heated to 50 °C using an oil bath.  After 30 min 
of stirring, the reaction was cooled to ambient temperature and several drops of ethyl 
vinyl ether were added.  After 30 min, the reaction developed a deep brown color.  The 
mixture was concentrated under reduced pressure and filtered through a silica gel plug (3 
x 5 cm, 1:1 hexanes:Et2O).  The solvents were removed under reduced pressure and the 
residue was purified by flash column chromatography (SiO2, 3 x 25 cm, 
20:1→15:1→10:1 hexanes:EtOAc) to afford vinylogous ester 149q (89.2 mg, 0.359 
mmol, 99% yield) as a white solid.  Rf = 0.39 (10:1 hexanes:EtOAc);  1H NMR (300 
MHz, CDCl3) δ 5.69–5.58 (m, 2H), 5.30 (s, 1H), 3.49 (dd, J = 14.4, 6.5 Hz, 1H), 3.46 
(dd, J = 14.3, 6.5 Hz, 1H), 2.70–2.57 (m, 1H), 2.54–2.44 (m, 2H), 2.08–1.91 (m, 3H), 
1.91–1.57 (m, 7H), 0.95 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, CDCl3) δ 207.2, 171.3, 
125.6, 125.4, 104.0, 74.4, 50.5, 35.9, 33.9, 32.3, 32.2, 28.0, 22.4, 20.6, 19.3;  IR (Neat 
Film NaCl) 3050, 3023, 2981, 2958, 2928, 2890, 2874, 2837, 1726, 1633, 1610, 1470, 
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1457, 1435, 1416, 1406, 1392, 1364, 1327, 1295, 1270, 1218, 1178, 1189, 1117, 1096, 
1045, 1028, 1003, 953, 935, 917, 888, 850, 837, 807, 758, 731 cm–1;  HRMS (EI+) m/z 
calc'd for C16H24O2 [M]+•: 248.1776; found 248.1774;  [α]D25.0 –32.18 (c 0.97, CHCl3, 
78.4% ee). 
 
2.10.2.6 SYNTHETIC STUDIES ON THE REDUCTION/REARRANGEMENT 
OF SIX- AND SEVEN-MEMBERED VINYLOGOUS ESTERS  
1. LDA, THF, –78 °C 
     then
NC
O
O
2. Cs2CO3, CH3I
    CH3CN, 80 °C
    84% yield, 2 steps
i-BuO
O
70
i-BuO
O
O
194
O
 
β-Ketoester 194.  To a solution of diisopropylamine (0.49 mL, 3.47 mmol, 1.17 equiv) 
in THF (10 mL) in a 50 mL round-bottom flask at 0 °C was added n-BuLi (1.70 mL, 3.40 
mmol, 2.1 M in hexanes, 1.15 equiv) dropwise over 10 min.  After 15 min of stirring at 0 
°C, the reaction was cooled to –78 °C using an acetone/CO2(s) bath.  A solution of 
vinylogous ester 7058 (0.50 g, 2.97 mmol, 1.00 equiv) in THF (5.0 mL) was added 
dropwise using positive pressure cannulation.  After an additional 1 h of stirring at –78 
°C, allyl cyanoformate (0.37 mL, 3.40 mmol, 1.15 equiv) was added dropwise.  The 
reaction was stirred at –78 °C for 2.5 h, quenched by addition of sat. aqueous NH4Cl and 
H2O (5 mL each), and then allowed to warm to ambient temperature.  The reaction was 
diluted with Et2O (25 mL) and the phases were separated.  The aqueous phase was 
extracted with Et2O (2 x 25 mL) and the combined organic phases were dried over 
MgSO4, filtered, and concentrated under reduced pressure to afford a pale red oil. 
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The crude oil was added to a 25 mL Schlenk flask and dissolved in CH3CN (10 mL). 
CH3I (0.56 mL, 8.90 mmol, 3.00 equiv) was added, followed by Cs2CO3 (1.26 g, 3.90 
mmol, 1.30 equiv).  The flask was sealed with a teflon valve, immersed in an oil bath, 
and heated to 80 °C.  After 14 h of vigorous stirring, the suspension was allowed to cool 
to ambient temperature, diluted with EtOAc (25 mL), dried over MgSO4, filtered, and 
concentrated under reduced pressure.  The crude product was purified by flash column 
chromatography (SiO2, 3 x 20 cm, 19:1→9:1→4:1, hexanes:EtOAc) to afford β-ketoester 
194 (0.67 g, 2.52 mmol, 84% yield over 2 steps) as a pale yellow oil;  Rf = 0.36 (4:1 
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 5.81 (dddd, J = 17.2, 10.7, 5.5, 5.5 Hz, 
1H), 5.30 (s, 1H), 5.22 (app dq, J = 17.2, 1.5 Hz, 1H), 5.14 (app dq, J = 10.5, 1.3 Hz, 
1H), 4.65–4.46 (m, 2H), 3.55 (d, J = 6.5 Hz, 2H), 2.60–2.23 (m, 3H), 1.97 (app sept, J = 
6.6 Hz, 1H), 1.89–1.70 (m, 1H), 1.35 (s, 3H), 0.91 (d, J = 6.7 Hz, 6H);  13C NMR (75 
MHz, CDCl3) δ 196.4, 176.7, 172.5, 131.9, 118.0, 101.7, 74.9, 65.5, 52.3, 31.7, 27.7, 
26.3, 20.6, 19.0;  IR (Neat Film NaCl) 2961, 2937, 2876, 1733, 1660, 1608, 1457, 1427, 
1406, 1385, 1369, 1346, 1319, 1248, 1199, 1176, 1113, 1039, 991, 928, 837, 818, 772, 
751 cm–1;  HRMS (EI+) m/z calc'd for C15H22O4 [M]+•: 266.1518; found 266.1510. 
 
i-BuO
O
151
(S)-t-Bu-PHOX (13) (6.25 mol %)
Pd2(pmdba)3 (2.5 mol %)
PhCH3, 50 °C
97% yield, 86% ee
NPh2P
O
t-Bu
i-BuO
O
O
194
O
 
Vinylogous Ester 151.  β-Ketoester 194 (180 mg, 0.68 mmol, 1.00 equiv) in a 20 mL 
scintillation vial and a septum-fitted screw cap were evacuated/backfilled with N2 (3 
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cycles, 5 min evacuation per cycle) in a glove box antechamber before being transferred 
into a glove box.  A separate 20 mL scintillation vial in the glove box was loaded with 
(S)-t-Bu-PHOX (16.4 mg, 0.042 mmol, 6.25 mol %), Pd2(pmdba)3 (18.5 mg, 0.017 mmol, 
2.5 mol %), and a magnetic stir bar.  Toluene (4 mL) was added and the black suspension 
was stirred at 30 °C in a heating block for 30 min.  β-Ketoester 194 was dissolved in 
toluene (2.8 mL) and added to the orange catalyst solution, causing an immediate color 
change to olive green.  The vial was capped with the septum-fitted screw cap and the 
edges were sealed with electrical tape.  The vial was removed from the glove box, 
connected to a N2-filled Schlenk manifold, and immersed in a 50 °C oil bath.  After 22 h, 
the reaction was an orange-brown solution.  The mixture was concentrated under reduced 
pressure and purified by flash column chromatography (SiO2, 2 x 25 cm, 20:1→10:1, 
hexanes:EtOAc) to afford vinylogous ester 151 (146 mg, 0.66 mmol, 97% yield) as a 
clear, colorless oil;  Rf = 0.57 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 5.81–
5.63 (m, 1H), 5.22 (s, 1H), 5.08–4.98 (m, 2H), 3.56 (d, J = 6.5 Hz, 2H), 2.40 (app t, J = 
6.4 Hz, 2H), 2.33 (dddd, J = 13.8, 7.6, 1.0, 1.0 Hz, 1H), 2.16 (dddd, J = 13.8, 7.6, 1.0, 1.0 
Hz, 1H), 2.00 (app sept, J = 6.7 Hz, 1H), 1.90 (ddd, J = 13.4, 6.6, 6.6 Hz, 1H), 1.68 (ddd, 
J = 13.6, 6.2, 6.2  Hz, 1H), 1.06 (s, 3H), 0.95 (d, J = 6.7 Hz, 6H);  13C NMR (75 MHz, 
CDCl3) δ 203.5, 176.1, 134.4, 117.9, 101.4, 74.8, 43.3, 41.6, 31.9, 27.9, 26.0, 22.3, 19.2;  
IR (Neat Film NaCl) 3074, 2962, 2932, 2875, 1655, 1611, 1470, 1464, 1429, 1404, 1384, 
1368, 1327, 1307, 1299, 1240, 1195, 1178, 1123, 1080, 1032, 996, 968, 951, 913, 862, 
840, 806, 786, 736 cm–1;  HRMS (EI+) m/z calc'd for C14H22O2 [M]+•: 222.1620; found 
222.1627;  [α]D25.0 –10.67 (c 0.98, CHCl3, 86.3% ee);  HPLC conditions: 5% IPA in 
hexanes, OD-H column, tR (min): major = 5.80, minor = 6.53. 
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LiAlH4, Et2O, 0 °C
then 10% aq HCl
92% yield151 152
O
i-BuO O
 
Cyclohexenone 152.  A 50 mL round-bottom flask was charged with Et2O (11.1 mL) and 
cooled to 0 °C in an ice/water bath.  LiAlH4 (13.6 mg, 0.36 mmol, 0.55 equiv) was added 
in one portion.  After 10 min, a solution of vinylogous ester 151 (146 mg, 0.66 mmol, 
1.00 equiv) in Et2O (2.0 mL) was added dropwise using positive pressure cannulation.  
After 30 min of stirring at 0 °C, an additional portion of LiAlH4 (2.5 mg, 0.066 mmol, 
0.10 equiv) was added.  After 60 min of stirring, the reaction was quenched by slow 
addition of aqueous HCl (1.0 mL, 10% w/w).  The resulting biphasic system was allowed 
to warm to ambient temperature and stirred vigorously for 8.5 h.  The phases were 
separated and the aqueous phase was extracted with Et2O (3 x 15 mL).  The combined 
organic phases were dried over Na2SO4, filtered, and concentrated under reduced 
pressure.  The crude product was purified using flash column chromatography (SiO2, 2 x 
25 cm, 10:1→4:1→1:1→1:2 hexanes:Et2O) to afford cyclohexenone 152 (90.5 mg, 0.60 
mmol, 92% yield) as a yellow oil;  Rf = 0.51 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, 
CDCl3) δ 6.67 (d, J = 10.2 Hz, 1H), 5.88 (d, J = 10.2 Hz, 1H), 5.79 (dddd, J = 16.8, 10.3, 
7.4, 7.4 Hz, 1H), 5.20–5.01 (m, 2H), 2.54–2.36 (m, 2H), 2.29–2.10 (m, 2H), 2.05–1.89 
(m, 1H), 1.85–1.69 (m, 1H), 1.14 (s, 3H);  13C NMR (75 MHz, CDCl3) δ 199.4, 158.4, 
133.4, 127.6, 118.6, 45.2, 35.7, 34.1, 33.6, 24.7;  IR (Neat Film NaCl) 3077, 3005, 2960, 
2917, 2868, 2849, 1682, 1639, 1616, 1459, 1419, 1390, 1373, 1332, 1250, 1223, 1193, 
1115, 996, 961, 918, 871, 803, 757 cm–1;  HRMS (EI+) m/z calc'd for C10H14O [M]+•: 
150.1045; found 150.1056;  [α]D25.0 +26.72 (c 1.02, CHCl3, 86.3% ee). 
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O O
+
O
i-BuO
LiAlH4, Et2O, 0 °C
then aq 10% HCl
6% yield 87% yield
149a 154a137a
HO
 
Cycloheptenone 137a and β-Hydroxyketone 154a.  For procedure and characterization 
data, see General Method A (Section 2.10.2.8, p. 155–155). 
 
HO
O
154a
LiOH, TFE
THF, 60 °C
96% yield 135a
O
 
Acylcyclopentene 135a.  For procedure and characterization data, see General Method E 
(Section 2.10.2.8, p. 156). 
 
i-BuO
O
LiAlH4
Et2O, 0 °C
then 
10% aq HCl
40% yield
O
15770  
Cyclohexenone 157.  A 25 mL round-bottom flask with magnetic stir bar and LiAlH4 
(22.8 mg, 0.60 mmol, 0.60 equiv) was charged with Et2O (4 mL) and cooled to 0 °C in an 
ice/water bath.  After 10 min, a solution of vinylogous ester 70 (168.23 mg, 1.00 mmol, 
1.00 equiv) in Et2O (1 mL) was added dropwise using positive pressure cannulation.  
After 30 min of stirring at 0 °C, the reaction was quenched by slow addition of aqueous 
HCl (2.60 mL, 10% w/w).  The resulting biphasic system was allowed to warm to 
ambient temperature.  The phases were separated and the aqueous phase was extracted 
with Et2O (3 x 10 mL).  The combined organic phases were dried over MgSO4, filtered, 
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and concentrated carefully under reduced pressure in an ice/water bath.  The crude 
product purified using flash column chromatography (SiO2, 2 x 25 cm, 5:1→4:1 
hexanes:EtOAc) to afford cyclohexenone 157 (39.4 mg, 0.41 mmol, 40% yield) as a 
volatile pale yellow oil.  Spectra for the compound match data for commercially available 
material. 
 
O O
+
O
i-BuO
LiAlH4, Et2O, 0 °C
then 10% aq HCl
24% yield 46% yield
147 160159
HO
 
Cycloheptenone 159 and β-Hydroxyketone 160.  A 50 mL round-bottom flask with 
magnetic stir bar and LiAlH4 (806 mg, 21.2 mmol, 0.60 equiv) was charged with Et2O (8 
mL) and cooled to 0 °C in an ice/water bath.  After 10 min, a solution of vinylogous ester 
147 (328.2 mg, 1.80 mmol, 1.00 equiv) in Et2O (2 mL) was added dropwise using 
positive pressure cannulation.  After 30 min of stirring at 0 °C, the reaction was quenched 
by slow addition of aqueous HCl (4.73 mL, 10% w/w).  The resulting biphasic system 
was allowed to warm to ambient temperature.  The phases were separated and the 
aqueous phase was extracted with EtOAc (3 x 10 mL).  The combined organic phases 
were dried over Na2SO4, filtered, and concentrated carefully under reduced pressure in an 
ice/water bath.  The crude product purified using flash column chromatography (SiO2, 2 x 
25 cm, 6:1→4:1→2:1→1:1→1:2→1:4 hexanes:EtOAc) to afford β-hydroxyketone 160 
(107.1 mg, 0.84 mmol, 46% yield) as a pale yellow oil and cycloheptenone 159 (47.9 mg, 
0.44 mmol, 24% yield) as a colorless oil. 
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Cycloheptenone 159:  Spectra for the compound match data for commercially available 
material. 
 
O
160
HO
 
β-Hydroxyketone 160:  Rf = 0.26 (1:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 
4.18–3.97 (m, 1H), 2.89–2.67 (m, 2H), 2.55–2.35 (m, 2H), 2.10 (br s, 1H), 1.95–1.69 (m, 
5H), 1.65–1.49 (m, 1H);  13C NMR (125 MHz, CDCl3) δ 212.6, 67.5, 51.8, 44.4, 38.8, 
24.4, 23.8;  IR (Neat Film NaCl) 3420, 2930, 2861, 1696, 1449, 1410, 1349, 1263, 1196, 
1157, 1109, 1043, 1016, 929, 878, 829, 752, 710 cm–1;  HRMS (EI+) m/z calc'd for 
C7H12O2 [M]+•: 128.0837; found 128.0828. 
 
HO
O
160
LiOH, TFE
THF, 60 °C
31% yield 161
O
 
Acylcyclopentene 161.  Alcohol 160 (101.3 mg, 0.79 mmol, 1.00 equiv) was dissolved 
in THF (7.9 mL) in a 20 mL scintillation vial with magnetic stir bar.  The solution was 
treated with 2,2,2-trifluoroethanol (86.4 µL, 1.19 mmol, 1.50 equiv) and anhydrous LiOH 
(28.4 mg, 1.19 mmol, 1.50 equiv).  The headspace of the vial was purged with N2 and the 
vial was capped with a teflon-lined hard cap and stirred at 60 °C in a heating block.  After 
16 h of stirring, the suspension was allowed to cool to ambient temperature, diluted with 
Et2O (150 mL), dried over Na2SO4 (30 min of stirring), filtered, and concentrated 
carefully under reduced pressure in an ice/water bath.  The crude product was purified 
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using flash column chromatography (SiO2, 2 x 20 cm, 15:1→10:1 hexanes:Et2O) to 
afford acylcyclopentene 161 (27 mg, 0.25 mmol, 31% yield) as a colorless fragrant oil.  
Spectra for the compound match data for commercially available material. 
 
2.10.2.7 RING CONTRACTION SCREENING PROTOCOLa 
HO
O
conditions
154a 135a
O
entry base additive solvent T (°C) yield (%)b
–– 40 60
–– 40 81
–– 40 85
–– 60 89
–– 60 87
KOt-Bu THF
–– 60 19d
60 78
60 87
LiOH THF
TFEc 60 96
–– 60 90e
LiOt-Bu
NaOt-Bu
NaOH
KOH
LiOH
LiOH
LiOH
LiOCH2CF3
t-BuOH
HFIPc
THF
THF
THF
THF
THF
THF
THF
THF
8
9
10
2
11
7
3
4
5
6
time (h)
8
5
5
4
4
24
24
12.5
12.5
10
–– 40 71LiOt-Bu t-BuOH1 9
conversion (%)
100
100
100
100
100
78
98
99
99
––
100
40 52
40 57
40 77
NaOt-Bu THF
TFEc 40 73
HFIPc 40 81
KOt-Bu
LiOH
LiOH
LiOH
t-BuOH
t-BuOH
THF
THF
THF
THF
17
18
19
20
16 8
8
24
24
24
100
100
87
73
84
t-BuOH
–– 60 10CsF CH3CN21 2486
a Conditions: !-hydroxyketone 154a (1.0 equiv), additive (1.5 equiv), base (1.5 equiv), solvent (0.1 M) at
indicated temperature for 9–24 h. b GC yield using an internal standard at ≥ 98% conversion unless otherwise
stated. c HFIP = 1,1,1,3,3,3-hexafluoro-2-propanol; TFE = 2,2,2-trifluoroethanol. d Several reaction
intermediates observed by TLC and GC analysis; proceeded to 78% conversion.  e Isolated yield.  f Reaction did 
not reach completion at 24 h; proceeded to 67% conversion.
60 48
60 61f
TFEc 60 86
TFEc 60 100
CsOH•H2O
Cs2CO3
Cs2CO3
Cs2CO3
––
––
THF
THF
THF
CH3CN
12
13
14
15
4
24
12.5
12.5
100
67
100
100
O
not observed
137a
+
 
Ring Contraction Screen to Produce Acylcyclopentene 135a (0.10 mmol scale, Table 
2.3, entries 1–15).  A benzene solution of β-hydroxyketone 154a was transferred to a dry 
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1 dram vial and concentrated under reduced pressure to obtain a starting mass.  To this 
vial was added a magnetic stir bar and 1,4-diisopropylbenzene (internal standard).  The 
contents were solvated in either t-BuOH or THF (0.1 M).  After complete solvation, an 
appropriate additive (t-BuOH, TFE, or HFIP; 1.50 equiv) was added, followed by base 
(1.50 equiv).  The head space of the vial was purged with N2 and the vial was capped 
with a teflon-lined hard cap and stirred at the appropriate temperature (40 or 60 °C) in a 
heating block.  Reaction progress was initially followed by TLC analysis and when 
necessary, aliquots were removed and flushed through a small SiO2 plug with EtOAc for 
GC analysis.  GC conditions: 90 °C isothermal for 5 min, then ramp 10 °C/min to 250 °C, 
DB-WAX column, tR (min): 1,4-diisopropylbenzene = 5.3, acylcyclopentene 135a = 9.3, 
β-hydroxyketone 154a = 17.1 and 17.2 (two diastereomers).  (For characterization data, 
see p. 155–156). 
 
HO
O
154a
LiOCH2CF3
THF, 60 °C
90% yield 135a
O
 
Ring Contraction using LiOCH2CF3 (Table 2.3, entry 11).  β-Hydroxyketone 154a 
(30.0 mg, 0.16 mmol, 1.00 equiv) was measured into a 1 dram vial with magnetic stir bar 
with a septum-fitted screw cap.  LiOCH2CF350 (26.0 mg, 0.25 mmol, 1.50 equiv) was 
measured into a separate 1 dram vial, capped with a septum, evacuated/backfilled with N2 
(3 cycles, 5 min evacuation per cycle), and dissolved in THF (0.5 mL).  The solution was 
cannulated into the vial containing β-hydroxyketone along with additional THF rinses (2 
x 0.5 mL).  The yellow solution was stirred at 60 °C in a heating block.  After 10 h, the 
reaction was cooled to ambient temperature.  The turbid brown solution was diluted with 
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Et2O and stirred with Na2SO4 for 30 min.  The reaction was filtered and concentrated 
under reduced pressure at 0 °C in an ice/water bath.  The residue was purified by flash 
column chromatography (SiO2, 1 x 20 cm, 15:1 hexanes:Et2O) to afford acylcyclopentene 
135a (24.4 mg, 0.149 mmol, 90% yield) as a clear, colorless oil.  (For characterization 
data, see p. 156). 
 
Additional Conditions.  Additional reaction conditions are listed in Table 2.3, entries 
16–21. 
 
Unsuccessful Conditions.  No reaction was observed using the following bases, with or 
without TFE additive: DBU, TMG, Na2CO3, K2CO3, BaCO3, CaH2.  DBU = 1,8-
diazabicyclo [5.4.0]undec-7-ene, TMG = 1,1,3,3-tetramethylguanidine. 
 
2.10.2.8 PREPARATION OF β-HYDROXYKETONES AND 
ACYLCYCLOPENTENES 
Full characterization data is reported for acylcyclopentenes 135, cycloheptenone 
137a, and β-hydroxyketone intermediate 154a (mixture of diastereomers).  For all other 
β-hydroxyketone intermediates (154b–j, l–o, mixtures of diastereomers), Rf, IR, and 
HRMS data are reported and 1H NMR and IR spectra are provided for reference in 
Figures A1.130–A1.160.  For acylcyclopentenes 135a, the ee value was unchanged from 
corresponding vinylogous ester 149a.  For all other acylcyclopentenes (135), ee values 
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are assumed to be unchanged from the corresponding vinylogous esters (149).  
Representative procedures for General Methods A–E are described below. 
 
O O
+
O
i-BuO
LiAlH4, Et2O, 0 °C
then 10% aq HCl
6% yield 87% yield
149a 154a137a
HO
 
General Method A:  LiAlH4 Hydride Reduction / 10% Aq. HCl Hydrolysis 
Cycloheptenone 137a and β-Hydroxyketone 154a.  A 500 mL round-bottom flask with 
magnetic stir bar was charged with Et2O (150 mL) and cooled to 0 °C in an ice/water 
bath.  LiAlH4 (806 mg, 21.2 mmol, 0.55 equiv) was added in one portion.  After 10 min, 
a solution of vinylogous ester 149a (9.13 g, 38.6 mmol, 1.00 equiv) in Et2O (43 mL) was 
added dropwise using positive pressure cannulation.  The grey suspension was stirred for 
40 min and additional LiAlH4 (148 mg, 3.9 mmol, 0.10 equiv) was added in one portion.  
After an additional 30 min of stirring at 0 °C, the reaction was quenched by slow addition 
of aqueous HCl (110 mL, 10% w/w).  The resulting biphasic system was allowed to 
warm to ambient temperature and stirred vigorously for 8.5 h.  The phases were separated 
and the aqueous phase was extracted with Et2O (3 x 100 mL).  The combined organic 
phases were dried over Na2SO4, filtered, and concentrated under reduced pressure.  The 
crude product was azeotroped with toluene (3 x 20 mL) and purified using flash column 
chromatography (SiO2, 5 x 15 cm, 9:1→3:1 hexanes:EtOAc, dry-loaded using Celite) to 
afford β-hydroxyketone 154a (6.09 g, 33.41 mmol, 87% yield, 1.3:1 dr) as a colorless 
semi-solid and cycloheptenone 137a (387 mg, 2.36 mmol, 6% yield) as a colorless oil.  
(For characterization data, see p. 155–155). 
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HO
O
O
i-BuO
1. DIBAL, PhCH3, –78 °C
2. oxalic acid·2H2O, MeOH
        89% yield, 2 steps149i 154i
N N
 
General Method B:  DIBAL Reduction / Oxalic Acid Hydrolysis 
β-Hydroxyketone 154i.  A 25 mL pear-shaped flask was charged with vinylogous ester 
149i (29.4 mg, 0.094 mmol, 1.00 equiv) and toluene (3.0 mL).  The solution was cooled 
to –78 °C using an acetone/CO2(s) bath.  A 1.0 M solution of DIBAL in toluene (112.6 
µL, 0.113 mmol, 1.00 equiv) was added dropwise and the solution was stirred for 10 min.  
MeOH (180 µL), Na2SO4·10H2O (1.08 g), and Celite (360 mg) were added.  The reaction 
was stirred vigorously and allowed to warm slowly to ambient temperature.  The mixture 
was filtered through a Celite plug (3 x 3 cm, EtOAc), and concentrated under reduced 
pressure.  Rf = 0.28, broad (1:2 hexanes:EtOAc). 
The crude hydroxy isobutyl enol ether was added to a 25 mL round-bottom flask and 
dissolved in MeOH (4.0 mL).  Oxalic acid dihydrate (354.9 mg, 2.82 mmol, 30.0 equiv) 
was added in one portion.  After 1 h of stirring, the reaction was neutralized to pH 7 with 
1 M aqueous pH 7 NaH2PO4/Na2HPO4 buffer (6 mL).  The biphasic mixture was stirred 
vigorously for 10 min and the phases were separated.  The aqueous layer was extracted 
with Et2O (4 x 15 mL).  The combined organic phases were dried over Na2SO4, filtered, 
and concentrated under reduced pressure.  The crude product was purified using flash 
column chromatography (SiO2, 1.5 x 25 cm, 4:1→2:1→1:2 hexanes:acetone) to afford β-
hydroxyketone 154i as a mixture of diastereomers (21.6 mg, 0.083 mmol, 89% yield over 
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2 steps, 2.8:1 dr) as a clear, colorless residue which solidified upon standing.  (For 
characterization data, see p. 165).  
 
HO
O
O
i-BuO
1. NaBH4, CeCl3•7H2O
    MeOH, 0 °C
2. 10% aq HCl, Et2O, 0 °C
     95% yield, 2 steps149m
OTBDPSOTBDPS
154m  
General Method C:  Luche Reduction / 10% Aq. HCl Hydrolysis 
β-Hydroxyketone 154m.  A 100 mL round-bottom flask with magnetic stir bar was 
charged with vinylogous ester 149m (65.6 mg, 0.134 mmol, 1.00 equiv) and anhydrous 
MeOH (8.3 mL).  The solution was cooled to 0 °C in an ice/water bath.  CeCl3·7H2O 
(78.2 mg, 0.21 mmol, 1.56 equiv) was added in one portion and the mixture was stirred 
for 5 min.  Addition of NaBH4 (23.8 mg, 0.63 mmol, 4.70 equiv) led to the evolution of 
gas and a turbid solution that became clear after several minutes.  The reaction was 
stirred at 0 °C.  After 15 min, the reaction was diluted with CH2Cl2 (20 mL) until turbid, 
filtered through a Celite plug (3 x 3 cm, CH2Cl2), and concentrated under reduced 
pressure.  The residue was taken up in CH2Cl2, filtered through a Celite plug (3 x 5 cm, 
CH2Cl2), and concentrated under reduced pressure a second time.  Rf = 0.33 (10:1 
hexanes:EtOAc). 
The crude hydroxy isobutyl enol ether was added to a 25 mL round-bottom flask with 
a magnetic stir bar and dissolved in Et2O (3.8 mL).  The vigorously stirred solution was 
cooled to 0 °C and aqueous HCl (384 µL, 10% w/w) was added dropwise via syringe.  
After 30 min, the reaction was allowed to warm to ambient temperature and extracted 
with Et2O (3 x 5 mL).  The combined organic phases were dried over Na2SO4, filtered, 
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and concentrated under reduced pressure.  The crude product was purified using flash 
column chromatography (SiO2, 1.5 x 25 cm, 6:1→4:1 hexanes:EtOAc) to afford β-
hydroxyketone 154m as a mixture of diastereomers (55.6 mg, 0.13 mmol, 95% yield over 
2 steps, 3.5:1 dr) as a colorless oil.  (For characterization data, see p. 168). 
 
HO
O
OHO
i-BuO
O 1. DIBAL, PhCH3, –78 °C
2. 10% HCl, Et2O, 0 °C
             38% yield
149n 154n
O
Ph
 
General Method D:  DIBAL Reduction / 10% Aq. HCl Hydrolysis 
β-Hydroxyketone 154n.  A 50 mL pear-shaped flask was charged with vinylogous ester 
149n (100 mg, 0.292 mmol, 1.00 equiv) and toluene (9.5 mL).  The solution was cooled 
to –78 °C using an acetone/CO2(s) bath.  A 1.0 M solution of DIBAL in toluene (963 µL, 
0.963 mmol, 1.00 equiv) was added dropwise and the mixture was stirred for 15 min.  
MeOH (1.0 mL), Na2SO4·10 H2O (6.0 g), and Celite (1.2 g) were added and the mixture 
was stirred vigorously and allowed to warm slowly to ambient temperature.  The mixture 
was filtered through a Celite plug (3 x 3 cm, EtOAc), and concentrated under reduced 
pressure.  Rf = 0.30 (2:1 hexanes:EtOAc). 
The crude hydroxy isobutyl enol ether was added to a 50 mL pear-shaped flask, 
dissolved in Et2O (10 mL), and cooled to 0 °C in an ice/water bath.  Aqueous HCl (0.835 
mL, 10% w/w) was added dropwise and the biphasic mixture was stirred vigorously at 0 
°C.  After 40 min or stirring, additional aqueous HCl (0.835 mL, 10% w/w) was added.  
After 1.5 h, the layers were separated and the aqueous layer was extracted with Et2O (5 x 
15 mL).  The combined organic layers were dried over Na2SO4, filtered, and concentrated 
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under reduced pressure.  The crude product was purified using flash column 
chromatography (SiO2, 1.5 x 25 cm, 10:1→6:1→4:1→2:1→1:1→1:2 hexanes:EtOAc) to 
afford β-hydroxyketone 154n as a mixture of diastereomers (20.3 mg, 0.110 mmol, 38% 
yield over 2 steps) as a clear, colorless oil.  (For characterization data, see p. 172). 
 
HO
O
154a
LiOH, TFE
THF, 60 °C
96% yield 135a
O
 
General Method E:  β-Hydroxyketone Ring Contraction 
Acylcyclopentene 135a.  Alcohol 154a (6.09 g, 33.4 mmol, 1.00 equiv) was dissolved in 
THF (334 mL) in a 500 mL round-bottom flask.  The solution was treated with 2,2,2-
trifluoroethanol (3.67 mL, 50.1 mmol, 1.50 equiv) and anhydrous LiOH (1.20 g, 50.1 
mmol, 1.50 equiv).  The flask was fitted with a condenser, purged with N2, and heated to 
60 °C using an oil bath.  After 18 h of stirring, the suspension was allowed to cool to 
ambient temperature, diluted with Et2O (150 mL), dried over Na2SO4 (30 min of stirring), 
filtered, and concentrated carefully under reduced pressure, allowing for a film of ice to 
form on the outside of the flask.  The crude product was purified using flash column 
chromatography (SiO2, 5 x 15 cm, 15:1 hexanes:Et2O) to afford acylcyclopentene 135a 
(5.29 g, 32.2 mmol, 96% yield) as a colorless fragrant oil.  (For characterization data, see 
p. 156). 
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O
137a  
Cycloheptenone 137a. 6Prepared using General Method A.  387 mg, 2.36 mmol, 6% 
yield.  Flash column chromatography (SiO2, 5 x 15 cm, 9:1→3:1 hexanes:EtOAc, dry-
loaded using Celite).  Rf = 0.54 (7:3 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 
6.04 (dd, J = 12.9, 0.7 Hz, 1H), 5.82 (d, J = 12.9 Hz, 1H), 5.75 (dddd, J = 17.1, 10.3, 7.8, 
7.1 Hz, 1H), 5.10 (dddd, J = 10.3, 1.2, 1.2, 1.2 Hz, 1H), 5.08–5.03 (m, 1H), 2.65–2.52 
(m, 2H), 2.19 (app dd, J = 13.7, 6.8 Hz, 1H), 2.11 (app dd, J = 13.7, 8.1 Hz, 1H), 1.84–
1.76 (m, 3H), 1.68–1.63 (m, 1H), 1.10 (s, 3H);  13C NMR (75 MHz, CDCl3) δ 204.7, 
152.5, 133.8, 128.6, 118.6, 47.2, 45.1, 42.7, 38.2, 27.1, 18.4;  IR (Neat Film NaCl) 3076, 
3011, 2962, 2934, 2870, 1659, 1454, 1402, 1373, 1349, 1335, 1278, 1208, 1172, 997, 
916, 874, 822, 772 cm–1;  HRMS (EI+) m/z calc'd for C11H16O [M]+•: 164.1201; found 
164.1209;  [α]D21.0 –9.55 (c 1.07, CHCl3, 88.0% ee). 
 
O
154a
HO
 
β-Hydroxyketone 154a  (Table 2.4, entry 1). 7Prepared using General Method A.  6.09 
g, 33.41 mmol, 87% yield, 1.3:1 dr.  Flash column chromatography (SiO2, 5 x 15 cm, 
9:1→3:1 hexanes:EtOAc, dry-loaded using Celite).  Rf =  0.23 (7:3 hexanes:EtOAc);  1H 
NMR (500 MHz, CDCl3) δ major epimer: 5.88 (dddd, J = 15.1, 9.0, 7.6, 7.6 Hz, 1H), 
5.12–5.08 (m, 2H), 3.70 (dd, J = 4.9, 3.9 Hz, 1H), 2.86 (dd, J = 15.6, 1.7 Hz, 1H), 2.65 
(dd, J = 15.6, 7.3 Hz, 1H), 2.54–2.43 (m, 2H), 2.24 (dd, J = 13.7, 7.8 Hz, 1H), 2.07 (dd, J 
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= 13.4, 7.3 Hz, 1H), 1.99 (dd, J = 15.9, 4.4 Hz, 1H), 1.82–1.69 (m, 2H), 1.45–1.41 (m, 
1H), 0.96 (s, 3H);  minor epimer: 5.83 (dddd, J = 14.9, 10.3, 7.6, 7.6 Hz, 1H), 5.12–5.06 
(m, 2H), 3.68 (dd, J = 4.1, 2.4 Hz, 1H) 2.80 (dd, J = 15.4, 2.4 Hz, 1H), 2.74 (dd, J = 15.4, 
8.1 Hz 1H), 2.46–2.38 (m, 2H), 2.18 (dd, J = 13.9, 7.3 Hz, 1H), 2.09 (dd, J = 12.9, 7.8 
Hz, 1H), 1.82–1.65 (m, 3H), 1.50–1.47 (m, 1H), 1.02 (s, 3H);  13C NMR (75 MHz, 
CDCl3) δ major epimer: 213.2, 135.0, 118.1, 72.9, 46.7, 44.9, 44.2, 41.0, 36.3, 21.9, 
18.9;  minor epimer: 212.6, 134.2, 118.3, 73.3, 47.2, 42.8, 41.0, 35.9, 22.6, 18.7;  IR 
(Neat Film NaCl) 3436, 3074, 2932, 1692, 1638, 1443, 1403, 1380, 1352, 1318, 1246, 
1168, 1106, 1069, 999, 913, 840 cm–1;  HRMS (EI+) m/z calc'd for C11H18O2 [M]+•: 
182.1313; found 182.1307;  [α]D22.8 –57.10 (c 2.56, CHCl3, 88.0% ee). 
 
O
135a  
Acylcyclopentene 135a (Table 2.4, entry 1). 8Prepared using General Method E.  5.29 g, 
32.2 mmol, 96% yield.  Flash column chromatography (SiO2, 5 x 15 cm, 15:1 
hexanes:Et2O).  Rf = 0.67 (8:2 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 6.45 (app 
t, J = 1.7 Hz, 1H), 5.76 (dddd, J = 16.4, 10.7, 7.3, 7.3 Hz, 1H), 5.07–5.03 (m, 2H), 2.59–
2.48 (m, 2H), 2.30 (s, 3H), 2.21–2.14 (m, 2H), 1.85 (ddd, J = 12.9, 8.3, 6.3 Hz, 1H), 1.64 
(ddd, J = 12.9, 8.5, 6.1 Hz, 1H), 1.11 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 197.5, 
151.9, 143.8, 134.9, 117.8, 50.0, 45.3, 36.0, 29.7, 26.8, 25.6;  IR (Neat Film NaCl) 3077, 
2956, 2863, 1668, 1635, 1616, 1454, 1435, 1372, 1366,  1309, 1265, 1213, 1177, 993, 
914, 862 cm–1;  HRMS (EI+) m/z calc'd for C11H17O [M+H]+•: 165.1279; found 165.1281;  
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[α]D21.4 +17.30 (c 0.955, CHCl3, 88.0% ee);  GC conditions: 80 °C isothermal, GTA 
column, tR (min): major = 54.7, minor = 60.2. 
 
154b
HO
O
 
β-Hydroxyketone 154b  (Table 2.4, entry 2).  Prepared using General Method A.  111.5 
mg, 0.57 mmol, 95% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 10:1→3:1 
hexanes:EtOAc).  Rf = 0.36 (2:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) mixture 
of two diastereomers, see Figure A1.133;  IR (Neat Film NaCl) 3448, 3073, 2965, 2933, 
1832, 1696, 1691, 1673, 1459, 1413, 1381, 1352, 1334, 1323, 1306, 1269, 1252, 1269, 
1252, 1172, 1138, 1111, 1084, 1071, 1050, 997, 955, 930, 912, 876, 825, 777, 737 cm–1;  
HRMS (EI+) m/z calc'd for C12H20O2 [M]+•: 196.1463; found 196.1480. 
 
O
135b  
Acylcyclopentene 135b  (Table 2.4, entry 2).  Prepared using General Method E.  21.8 
mg, 0.12 mmol, 95% yield.  Flash column chromatography (SiO2, 1 x 20 cm, 15:1 
hexanes:Et2O).  Rf = 0.73 (2:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 6.44 (dd, 
J = 1.8, 1.8 Hz, 1H), 5.80–5.64 (m, 1H), 5.08–5.04 (m, 1H), 5.03–5.00 (m, 1H), 2.55–
2.46 (m, 2H), 2.30 (s, 3H), 2.19–2.16 (m, 2H), 1.81–1.68 (m, 2H), 1.52–1.41 (m, 2H), 
0.85 (dd, J = 7.5, 7.5 Hz, 3H);  13C NMR (75 MHz, CDCl3) δ 197.4, 150.7, 144.6, 134.8, 
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117.7, 54.0, 43.1, 32.9, 31.3, 30.1, 26.9, 9.1;  IR (Neat Film NaCl) 3075, 2962, 2922, 
2878, 2855, 1669, 1639, 1617, 1459, 1437, 1372, 1319, 1266, 1207, 1052, 995, 913, 868, 
784 cm–1;  HRMS (EI+) m/z calc'd for C12H19O [M+H]+: 179.1436; found 179.1401; 
[α]D25.0 +7.06 (c 0.98, CHCl3, 91.6% ee). 
 
154c
HO
O
Ph
 
β-Hydroxyketone 154c  (Table 2.4, entry 3).  Prepared using General Method A.  109.9 
mg, 0.43 mmol, 89% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 10:1→3:1 
hexanes:EtOAc).  Rf = 0.11 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) mixture 
of two diastereomers, see Figure A1.135;  IR (Neat Film NaCl) 3443, 3072, 3028, 3003, 
2930, 2865, 1696, 1692, 1685, 1636, 1601, 1582, 1495, 1453, 1413, 1400, 1352, 1340, 
1255, 1182, 1163, 1118, 1058, 1031, 995, 970, 916, 885, 848, 809, 754 cm–1;  HRMS 
(EI+) m/z calc'd for C17H22O2 [M]+•: 258.1620; found 258.1642. 
 
O
Ph
135c  
Acylcyclopentene 135c  (Table 2.4, entry 3).  Prepared using General Method E.  22.7 
mg, 0.094 mmol, 97% yield.  Flash column chromatography (SiO2, 1 x 20 cm, 15:1 
hexanes:Et2O).  Rf = 0.54 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 7.30–7.18 
(m, 3H), 7.14–7.08 (m, 2H), 6.45 (dd, J = 1.8, 1.8 Hz, 1H), 5.78 (dddd, J = 16.3, 10.8, 
7.7, 7.0 Hz, 1H), 5.13–5.10 (m, 1H), 5.07 (dddd, J = 9.1, 2.2, 1.2, 1.2 Hz, 1H), 2.79 (d, J 
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= 13.3 Hz, 1H), 2.73 (d, J = 13.3 Hz, 1H), 2.43 (dddd, J = 16.5, 8.6, 5.7, 1.7 Hz, 1H), 
2.27–2.17 (m, 3H), 2.21 (s, 3H), 1.91–1.75 (m, 2H);  13C NMR (75 MHz, CDCl3) δ 
197.1, 150.1, 144.9, 138.2, 134.7, 130.4, 128.1, 126.4, 118.3, 54.6, 45.2, 43.3, 33.3, 30.0, 
26.9;  IR (Neat Film NaCl) 3061 3027, 3002, 2920, 2853, 1668, 1638. 1617, 1495, 1453, 
1442, 1371, 1314, 1264, 1197, 1089, 1030, 995, 914, 861, 734 cm–1;  HRMS (EI+) m/z 
calc'd for C17H20O [M]+•: 240.1514; found 240.1530;  [α]D25.0 –20.63 (c 0.83, CHCl3, 
86.3% ee). 
 
154d
HO
O
 
β-Hydroxyketone 154d  (Table 2.4, entry 4).  Prepared using General Method A.  117 
mg, 0.56 mmol, 98% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 10:1→3:1 
hexanes:EtOAc).  Rf = 0.35 (10:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) mixture 
of two diastereomers, see Figure A1.137;  IR (Neat Film NaCl) 3434, 3295, 3074, 3002, 
2932, 2114, 1690, 1684, 1637, 1447, 1354, 1252, 1166, 1124, 1064, 977, 917, 886, 838 
cm–1;  HRMS (EI+) m/z calc'd for C13H18O2 [M]+•: 206.1307; found 206.1311. 
 
O
135d  
Acylcyclopentene 135d  (Table 2.4, entry 4).  Prepared using General Method E.  22.5 
mg, 0.12 mmol, 97% yield.  Flash column chromatography (SiO2, 1 x 20 cm, 15:1 
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hexanes:Et2O).  Rf = 0.74 (2:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 6.51 (dd, 
J = 1.8, 1.8 Hz, 1H), 5.73 (dddd, J = 16.9, 10.2, 7.4, 7.4 Hz, 1H), 5.13 (dm, J = 10.2 Hz, 
1H), 5.10–5.07 (m, 1H), 2.66–2.46 (m, 2H), 2.34–2.33 (m, 1H), 2.33–2.32 (m, 1H), 2.32 
(s, 3H), 2.32–2.30 (m, 2H), 1.99 (dd, J = 2.7, 2.7 Hz, 1H), 1.93–1.75 (m, 2H);  13C NMR 
(75 MHz, CDCl3) 197.3, 148.6, 145.2, 133.9, 118.6, 81.4, 70.3, 53.2, 42.4, 33.4, 30.0, 
28.5, 26.9;  IR (Neat Film NaCl) 3298, 3075, 3001, 2924, 2857, 2116, 1669, 1639, 1617, 
1457, 1437, 1372, 1318, 1265, 1222, 1204, 996, 919, 867 cm–1;  HRMS (EI+) m/z calc'd 
for C13H16O [M]+•: 188.1201; found 188.1211;  [α]D25.0 –58.65 (c 0.71, CHCl3, 88.5% ee). 
 
154e
HO
O
 
β-Hydroxyketone 154e  (Table 2.4, entry 5).  Prepared using General Method A.  116.7 
mg, 0.52 mmol, 97% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 10:1→3:1 
hexanes:EtOAc).  Rf = 0.15 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) mixture 
of two diastereomers, see Figure A1.139;  IR (Neat Film NaCl) 3447, 3075, 3001, 2975, 
2931, 2866, 1827, 1693, 1639, 1456, 1415, 1352, 1336, 1250, 1169, 1116, 1073, 995, 
910, 855, 763, 714 cm–1;  HRMS (EI+) m/z calc'd for C18H28O2 [M]+•: 276.2089; found 
276.2060. 
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O
135e  
Acylcyclopentene 135e  (Table 2.4, entry 5).  Prepared using General Method E.  19.1 
mg, 0.093 mmol, 90% yield.  Flash column chromatography (SiO2, 1 x 20 cm, 15:1 
hexanes:Et2O).  Rf = 0.62 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 6.45 (dd, 
J = 1.8, 1.8 Hz, 1H), 5.79 (dddd, J = 16.8, 10.2, 6.5, 6.5 Hz, 1H), 5.72 (dddd, J = 16.8, 
9.5, 7.3, 7.3 Hz, 1H), 5.09–5.07 (m, 1H), 5.05–4.97 (m, 2H), 4.94 (dm, J = 10.2 Hz, 1H), 
2.56–2.49 (m, 2H), 2.30 (s, 3H), 2.23–2.17 (m, 2H), 2.15–1.91 (m, 2H), 1.85–1.70 (m, 
2H), 1.58–1.50 (m, 2H);  13C NMR (75 MHz, CDCl3) δ 197.3, 150.4, 144.6, 138.8, 134.6, 
117.9, 114.6, 53.5, 43.6, 38.1, 33.3, 30.1, 29.2, 26.9;  IR (Neat Film NaCl) 3076, 3001, 
2976, 2919, 2854, 1670, 1640, 1618, 1437, 1372, 1314, 1265, 1204, 995, 911, 865 cm–1;  
HRMS (EI+) m/z calc'd for C14H21O [M+H]+: 205.1592; found 205.1588;  [α]D25.0 –30.08 
(c 0.92, CHCl3, 86.9% ee). 
 
154f
HO
O
 
β-Hydroxyketone 154f  (Table 2.4, entry 6).  Prepared using General Method A.  117.5 
mg, 0.50 mmol, 96% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 10:1→3:1 
hexanes:EtOAc).  Rf = 0.19 (4:1 hexanes:EtOAc); 1H NMR (300 MHz, CDCl3) mixture 
of two diastereomers, see Figure A1.141;  IR (Neat Film NaCl) 3448, 3075, 3035, 3007, 
2972, 2929, 2865, 1700, 1696, 1691, 1685, 1648, 1637, 1600, 1449, 1415, 1352, 1333, 
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1245, 1171, 1120, 1068, 1052, 1005, 969, 954, 912, 855, 838, 817, 720 cm–1;  HRMS 
(FAB+) m/z calc'd for C15H23O2 [M+H]+: 235.1698; found 235.1697. 
 
O
135f  
Acylcyclopentene 135f  (Table 2.4, entry 6).  Prepared using General Method E.  25.2 
mg, 0.12 mmol, 95% yield.  Flash column chromatography (SiO2, 1 x 20 cm, 15:1 
hexanes:Et2O).  Rf = 0.65 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 6.45 (dd, 
J = 1.8, 1.8 Hz, 1H), 6.30 (ddd, J = 16.9, 10.2, 10.2 Hz, 1H), 6.08 (dd, J = 15.0, 10.4 Hz, 
1H), 5.73 (dddd, J = 16.4, 11.6, 8.9, 7.5 Hz, 1H), 5.63 (ddd, J = 15.0, 7.6, 7.6 Hz, 1H), 
5.14–5.09 (m, 2H), 5.06–5.02 (m, 1H), 5.00 (dm, J = 10.1 Hz, 1H), 2.54–2.46 (m, 2H), 
2.30 (s, 3H), 2.25–2.17 (m, 4H), 1.80–1.74 (m, 2H);  13C NMR (75 MHz, CDCl3) δ 
197.3, 150.0, 144.8, 137.0, 134.5, 134.3, 130.4, 118.1, 115.9, 54.0, 43.3, 42.0, 33.2, 30.0, 
26.9;  IR (Neat Film NaCl) 3079, 3006, 2929, 2857, 1735, 1670, 1640, 1617, 1439, 1371, 
1318, 1267, 1201, 1175, 1084, 1004, 952, 912 cm–1;  HRMS (FAB+) m/z calc'd for 
C15H21O [M+H]+: 217.1592; found 217.1568;  [α]D25.0 –32.14 (c 1.26, CHCl3, 89.6% ee). 
 
154g
HO
O
Cl
 
β-Hydroxyketone 154g  (Table 2.4, entry 7).  Prepared using General Method A.  114.9 
mg, 0.47 mmol, 93% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 10:1→3:1 
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hexanes:EtOAc).  Rf = 0.15 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) mixture 
of two diastereomers, see Figure A1.143;  IR (Neat Film NaCl) 3436, 3075, 2931, 2869, 
1695, 1627, 1452, 1414, 1352, 1297, 1251, 1222, 1151, 1064, 1021, 997, 974, 915, 887, 
839 cm–1;  HRMS (EI+) m/z calc'd for C13H19O2Cl [M]+•: 242.1074; found 242.1063. 
 
O
135g
Cl
 
Acylcyclopentene 135g  (Table 2.4, entry 7).  Prepared using General Method E.  23.8 
mg, 0.11 mmol, 99% yield.  Flash column chromatography (SiO2, 1 x 20 cm, 15:1 
hexanes:Et2O).  Rf = 0.55 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 6.61 (dd, 
J = 1.8, 1.8 Hz, 1H), 5.73 (dddd, J = 15.9, 11.1, 7.9, 7.3 Hz, 1H), 5.29 (d, J = 1.2 Hz, 
1H), 5.15–5.14 (m, 1H), 5.11–5.10 (m, 1H), 5.08–5.04 (m, 1H), 2.56–2.48 (m, 4H), 2.31 
(s, 3H), 2.28–2.25 (m, 2H), 1.93 (ddd, J = 13.3, 8.4, 6.6 Hz, 1H), 1.84 (ddd, J = 13.3, 8.1, 
6.4 Hz, 1H);  13C NMR (75 MHz, CDCl3) δ 197.3, 149.6, 144.4, 139.4, 134.0, 118.7, 
116.4, 53.4, 48.0, 43.4, 33.3, 29.8, 26.9;  IR (Neat Film NaCl) 3076, 2946, 2857, 1669, 
1629, 1434, 1372, 1320, 1266, 1230, 1206, 1167, 996, 917, 886 cm–1;  HRMS (EI+) m/z 
calc'd for C13H18OCl [M+H]+: 225.1046; found 225.1053;  [α]D25.0 +46.29 (c 1.06, CHCl3, 
85.7% ee). 
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154h
HO
O
CN
 
β-Hydroxyketone 154h  (Table 2.4, entry 8).  Prepared using General Method A.  72.4 
mg, 0.33 mmol, 90% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 
4:1→2:1→1:1 hexanes:EtOAc).  Rf = 0.40, broad (1:1 hexanes:EtOAc);  1H NMR (300 
MHz, CDCl3) mixture of two diastereomers, see Figure A1.145;  IR (Neat Film NaCl) 
3468, 3075, 2932, 2871, 2247, 1696, 1458, 1437, 1420, 1352, 1319, 1252, 1169, 1122, 
1070, 999, 921, 853, 754 cm–1;  HRMS (EI+) m/z calc'd for C13H19O2N [M]+•: 221.1416; 
found 221.1411.  
 
O
135h
CN
 
Acylcyclopentene 135h  (Table 2.4, entry 8).  Prepared using General Method E.  19.4 
mg, 0.095 mmol, 94% yield.  Flash column chromatography (SiO2, 1 x 20 cm, 
2:1→3:2→1:1 hexanes:Et2O).  Rf = 0.84, broad (1:1 hexanes:EtOAc);  1H NMR (300 
MHz, CDCl3) δ 6.42 (dd, J = 1.8, 1.8 Hz, 1H), 5.70 (dddd, J = 16.4, 10.6, 7.4, 7.4 Hz, 
1H), 5.15–5.12 (m, 1H), 5.15–5.06 (m, 1H), 2.60–2.52 (m, 2H), 2.37–2.22 (m, 2H), 2.32 
(s, 3H), 2.23–2.20 (m, 2H), 1.93–1.82 (m, 3H), 1.73 (ddd, J = 13.6, 8.2, 7.0 Hz, 1H);  13C 
NMR (75 MHz, CDCl3) δ 196.8, 147.2, 146.0, 133.3, 120.0, 119.0, 53.2, 43.5, 34.2, 32.7, 
30.2, 27.0, 13.1;  IR (Neat Film NaCl) 3074, 2923, 2857, 2245, 1667, 1640, 1618, 1423, 
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1373, 1308, 1264, 1202, 1090, 996, 918, 867 cm–1;  HRMS (EI+) m/z calc'd for C13H18NO 
[M+H]+: 204.1388; found 204.1385;  [α]D25.0 –31.11 (c 0.90, CHCl3, 87.4% ee). 
 
154i
HO
O
N
 
β-Hydroxyketone 154i  (Table 2.4, entry 9). 9Prepared using General Method B.  21.6 
mg, 0.083 mmol, 89% yield over 2 steps.  Flash column chromatography (SiO2, 1.5 x 25 
cm, 4:1→2:1→1:2 hexanes:acetone).  Rf = 0.10 (2:1 hexanes:acetone);  1H NMR (300 
MHz, CDCl3) mixture of two diastereomers, see Figure A1.147;  IR (Neat Film NaCl) 
3391, 3201, 3073, 2929, 2865, 1699, 1636, 1603, 1557, 1497, 1456, 1418, 1352, 1332, 
1297, 1258, 1222, 1187, 1161, 1113, 1069, 1005, 995, 972, 915, 886, 851, 802, 735 cm–1;  
HRMS (FAB+) m/z calc'd for C16H22O2N [M+H]+: 260.1650; found 260.1649. 
 
O
135i
N
 
Acylcyclopentene 135i  (Table 2.4, entry 9).  Prepared using General Method E.  15.7 
mg, 0.065 mmol, 90% yield.  Flash column chromatography (SiO2, 1.5 x 16 cm, 2:1→1:1 
hexanes:acetone).  Rf = 0.47 (2:1 hexanes:acetone);  1H NMR (300 MHz, CDCl3) δ 8.49 
(br d, J = 3.8 Hz, 2H), 7.04 (d, J = 5.7 Hz, 2H), 6.40 (dd, J = 1.7, 1.7 Hz, 1H), 5.75 
(dddd, J = 17.3, 10.3, 7.3, 7.3 Hz, 1H), 5.16–5.04 (m, 2H), 2.77 (d, J = 13.0 Hz, 1H), 
2.71 (d, J = 13.0 Hz, 1H), 2.52–2.39 (m, 1H), 2.33–2.35 (m, 1H), 2.28 (s, 3H), 2.24–2.20 
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(m, 2H), 1.85–1.80 (m, 2H);  13C NMR (75 MHz, CDCl3) δ 196.8, 149.6, 148.6, 147.3, 
145.4, 134.0, 125.7, 118.8, 54.2, 44.4, 43.3, 33.3, 30.0, 27.0;  IR (Neat Film NaCl) 3401, 
3071, 3025, 2922, 2856, 1668, 1640, 1618, 1600, 1557, 1495, 1441, 1415, 1373, 1318, 
1277, 1265, 1220, 1194, 1071, 994, 917, 874, 844, 810, 763 cm–1;  HRMS (EI+) m/z 
calc'd for C16H19ON [M]+•: 176.1467; found 176.1458;  [α]D25.0 –8.58 (c 0.77, CHCl3, 
84.6% ee). 
 
154j
HO
O
N Ts
 
β-Hydroxyketone 154j  (Table 2.4, entry 10).  Prepared using General Method A.  300.1 
mg, 0.67 mmol, 94% yield.  Flash column chromatography (SiO2, 3 x 25 cm, 
4:1→3:1→2:1→1:1 hexanes:EtOAc).  Rf = 0.20, 0.26 (two diastereomers) (2:1 
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) mixture of two diastereomers, see Figure 
A1.149;  IR (Neat Film NaCl) 3436, 3068, 2930, 2873, 1693, 1639, 1597, 1494, 1447, 
1365, 1402, 1365, 1279, 1211, 1188, 1172, 1133, 1121, 1095, 1063, 1020, 995, 975, 913, 
813, 778, 747 cm–1;  HRMS (FAB+) m/z calc'd for C26H30O4NS [M+H]+: 452.1896; found 
452.1896. 
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O
135j
N Ts
 
Acylcyclopentene 135j  (Table 2.4, entry 10).  Prepared using General Method E.  55.7 
mg, 0.10 mmol, 93% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 
10:1→8:1→6:1→4:1  hexanes:EtOAc).  Rf = 0.67 (2:1 hexanes:EtOAc);  1H NMR (300 
MHz, CDCl3) δ 7.98 (br d, J = 8.2 Hz, 1H), 7.63 (dm, J = 8.4 Hz, 2H), 7.40 (dd, J = 7.3, 
0.8 Hz, 1H), 7.33 (br s, 1H), 7.30 (ddd, J = 8.2, 8.2, 1.3 Hz, 1H), 7.21 (ddd, J = 7.5, 7.5, 
1.1 Hz, 1H), 7.17 (dm, J = 8.2 Hz, 2H), 6.35 (dd, J = 1.8, 1.8 Hz, 1H), 5.75 (dddd, J = 
16.9, 10.3, 7.7, 6.9 Hz, 1H), 5.13–5.10 (m, 1H), 5.10–5.04 (m, 1H), 2.82 (s, 3H), 2.44 
(dddd, J = 14.7, 8.8, 5.9, 1.7 Hz, 1H), 2.33 (br s, 2H), 2.31–2.18 (m, 3H), 2.16 (s, 3H), 
1.86 (ddd, J = 14.6, 8.6, 6.1 Hz, 1H), 1.79 (ddd, J = 14.8, 7.6, 5.8 Hz, 1H);  13C NMR (75 
MHz, CDCl3) δ 196.9, 149.9, 145.1, 144.9, 135.2, 135.1, 134.3, 131.9, 130.0, 126.7, 
124.8, 124.7, 123.2, 119.9, 119.4, 118.5, 113.9, 54.5, 43.5, 33.8, 33.4, 30.0, 26.8, 21.7;  
IR (Neat Film NaCl) 3316, 3129, 3101, 3068, 3001, 2974, 2922, 2855, 1667, 1639, 1618, 
1597, 1562, 1493, 1448, 1400, 1372, 1307, 1293, 1277, 1211, 1188, 1174, 1121, 1094, 
1020, 978, 916, 853, 813, 747 cm–1;  HRMS (EI+) m/z calc'd for C26H27O3NS [M]+•: 
433.1712; found 433.1694;  [α]D25.0 +0.35 (c 1.09, CHCl3, 82.9% ee). 
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154m
HO
O
OTBDPS
 
β-Hydroxyketone 154m  (Table 2.4, entry 11).10Prepared using General Method C.  
55.6 mg, 0.13 mmol, 95% yield over 2 steps.  Flash column chromatography (SiO2, 1.5 x 
25 cm, 6:1→4:1 hexanes:EtOAc).  Rf = 0.22, 0.28 (two diastereomers) (4:1 
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) mixture of two diastereomers, see Figure 
A1.151;  IR (Neat Film NaCl) 3468, 3072, 3050, 2999, 3013, 2931, 2895, 2858, 2248, 
1960, 1891, 1823, 1772, 1698, 1638, 1590, 1472, 1462, 1446, 1428, 1391, 1361, 1337, 
1260, 1222, 1186, 1172, 1158, 1113, 1088, 1030, 1006, 999, 976, 914, 841, 823, 810, 740 
cm–1;  HRMS (FAB+) m/z calc'd for C27H37O3Si [M+H]+: 437.2512; found 437.2517. 
 
O
OTBDPS
135m  
Acylcyclopentene 135m  (Table 2.4, entry 11).  Prepared using General Method E.  32.6 
mg, 0.078 mmol, 96% yield.  Flash column chromatography (SiO2, 1 x 20 cm, 15:1 
hexanes:Et2O).  Rf = 0.60 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 7.67–7.60 
(m, 4H), 7.47–7.34 (m, 6H), 6.50 (dd, J = 1.8, 1.8 Hz, 1H), 5.71 (dddd, J = 17.0, 10.1, 
7.8, 6.9 Hz, 1H), 5.12–5.08 (m, 1H), 5.06–5.02 (m, 1H), 3.57 (d, J = 9.8 Hz, 1H), 3.53 (d, 
J = 9.8 Hz, 1H), 2.54–2.48 (m, 2H), 2.38 (ddd, J = 13.8, 6.9, 1.1 Hz, 1H), 2.31–2.25 (m, 
1H), 2.29 (s, 3H), 1.81–1.72 (m, 2H), 1.07 (s, 9H);  13C NMR (75 MHz, CDCl3) δ 197.2, 
148.5, 145.7, 135.8, 135.7, 134.5, 133.6, 133.6, 129.9, 129.9, 127.8, 118.0, 69.1, 56.5, 
40.4, 30.7, 30.0, 27.0, 26.8, 19.5;  IR (Neat Film NaCl) 3072, 3050, 2999, 2956, 2931, 
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2896, 2857, 1671, 1639, 1618, 1472, 1463, 1427, 1367, 1320, 1266, 1232, 1188, 1112, 
998, 936, 915, 864, 824, 740 cm–1;  HRMS (EI+) m/z calc'd for C27H34O2Si [M]+•: 
433.1712; found 433.1694;  [α]D25.0 –17.58 (c 0.94, CHCl3, 51.4% ee). 
 
154o
HO
O
OTBDPS
 
β-Hydroxyketone 154o  (Table 2.4, entry 12).  Prepared using General Method C.  
110.6 mg, 0.24 mmol, 92% yield over 2 steps.  Flash column chromatography (SiO2, 2 x 
25 cm, 6:1→4:1 hexanes:EtOAc).  Rf = 0.15 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, 
CDCl3) mixture of two diastereomers, see Figure A1.153;  IR (Neat Film NaCl) 3436, 
3071, 3050, 3013, 2999, 2931, 2896, 2859, 1960, 1891, 1826, 1694, 1638, 1589, 1472, 
1461, 1428, 1390, 1360, 1325, 1307, 1251, 1218, 1188, 1168, 1111, 1092, 1007, 998, 
973, 934, 914, 823, 798, 740 cm–1;  HRMS (FAB+) m/z calc'd for C29H41O3Si [M+H]+: 
465.2825; found 465.2810. 
 
OTBDPS
O
135o  
Acylcyclopentene 135o  (Table 2.4, entry 12).  Prepared using General Method E.  92.2 
mg, 0.21 mmol, 92% yield.  Flash column chromatography (SiO2, 2 x 25 cm, 15:1 
hexanes:Et2O).  Rf = 0.64 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 7.71–7.64 
(m, 4H), 7.48–7.35 (m, 6H), 6.44 (dd, J = 1.7, 1.7 Hz, 1H), 5.81–5.65 (m, 1H), 5.10–5.07 
CHAPTER 2 – Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures  
 
170 
(m, 1H), 5.05–5.02 (m, 1H), 3.69–3.64 (m, 2H), 2.55–2.49 (m, 2H), 2.31 (s, 3H), 2.20–
2.18 (m, 2H), 1.84–1.67 (m, 2H), 1.53–1.48 (m, 4H), 1.07 (s, 9H);  13C NMR (75 MHz, 
CDCl3) δ 197.3, 150.7, 144.4, 135.7, 134.7, 134.0, 129.7, 127.7, 117.8, 64.3, 53.3, 43.5, 
34.8, 33.3, 30.0, 28.0, 27.0, 26.8, 19.3;  IR (Neat Film NaCl) 3071, 3050, 3013, 2999, 
2931, 2897, 2857, 1670, 638, 1618, 1589, 1472, 1461, 1448, 1428, 1388, 1372, 1316, 
1263, 1201, 1157, 1111, 1093, 1030, 1008, 998, 937, 915, 865, 823, 803, 741, 726 cm–1;  
HRMS (FAB+) m/z calc'd for C25H29O2Si [M–C4H9]+: 389.1968; found 389.1958;  [α]D25.0 
–14.19 (c 0.92, CHCl3, 78.4% ee). 
 
154p
HO
O
 
β-Hydroxyketone 154p  (Table 2.4, entry 13).  Prepared using General Method A.  
429.5 mg, 2.36 mmol, 87% yield.  Flash column chromatography (SiO2, 3 x 20 cm, 
9:1→3:1 hexanes:EtOAc).  Rf = 0.14 (4:1 hexanes:EtOAc);  1H NMR (400 MHz, CDCl3) 
mixture of two diastereomers, see Figure A1.155;  IR (Neat Film NaCl) 3449, 3027, 
2963, 2928, 2873, 1694, 1454, 1404, 1350, 1320, 1251, 1170, 1066, 969 cm–1;  HRMS 
(MM: ESI-APCI+) m/z calc'd for C11H19O2 [M+H]+: 165.1274; found 165.1278. 
 
O
135p  
Acylcyclopentene 135p  (Table 2.4, entry 13).  Prepared using General Method E.  Due 
to the volatility of acylcyclopentene 135p, the work-up solvent (Et2O) was removed using 
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ambient pressure distillation (50→80 °C).  323.8 mg, 1.97 mmol, 93% yield.  The crude 
oil was purified by automated flash column chromatography using a Teledyne Isco 
CombiFlash Rf (SiO2, 32 g loading cartridge, 80 g column, linear gradient, 0→30% Et2O 
in pentane [33 min]) and solvent was removed using ambient pressure distillation (60 
°C).  Rf = 0.55 (4:1 hexanes:EtOAc);  1H NMR (400 MHz, CDCl3) δ 6.41 (dd, J = 1.7, 1.7 
Hz, 1H), 5.50 (dq, J = 15.5, 1.3 Hz, 1H), 5.39 (dq, J = 15.6, 6.2 Hz, 1H), 2.58–2.52 (m, 
2H), 2.31–2.28 (m, 1H), 2.30 (s, 3H), 1.91 (ddd, J = 12.8, 7.4, 7.4 Hz, 1H), 1.74 (ddd, J = 
12.8, 7.2, 7.2 Hz, 1H), 1.68–1.64 (m, 2H), 1.19 (s, 3H);  13C NMR (100 MHz, CDCl3) δ 
197.5, 151.4, 143.8, 137.5, 122.3, 51.5, 38.1, 29.6, 26.8, 25.4, 18.2;  IR (Neat Film NaCl) 
3022, 2958, 2859, 1674, 1617, 1451, 1377, 1365, 1310, 1271, 1229, 1165, 967 cm–1;  
HRMS (MM: ESI-APCI+) m/z calc'd for C11H17O [M+H]+: 165.1279; found 165.1278;  
[α]D25.0 +89.82 (c 1.04, CHCl3, 88.0 % ee). 
 
154q
HO
O
 
β-Hydroxyketone 154q  (Table 2.4, entry 14).  Prepared using General Method A.  29.1 
mg, 0.150 mmol, 96% yield.  Flash column chromatography (SiO2, 2 x 20 cm, 9:1→3:1 
hexanes:EtOAc).  Rf = 0.09 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) mixture 
of two diastereomers, see Figure A1.157;  IR (Neat Film NaCl) 3436, 3021, 2922, 2873, 
2842, 2697, 1692, 1656, 1436, 1402, 1353, 1318, 1256, 1202, 1184, 1172, 1152, 1093, 
1071, 1050, 1000, 981, 970, 949, 932, 876, 850, 834, 798, 750 cm–1;  HRMS (EI+) m/z 
calc'd for C12H18O2 [M]+•: 194.1307; found 194.1315. 
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O
135q  
Acylcyclopentene 135q  (Table 2.4, entry 14).  Prepared using General Method E.  21.7 
mg, 0.123 mmol, 91% yield.  Flash column chromatography (SiO2, 1 x 20 cm, 15:1 
hexanes:Et2O).  Rf = 0.65 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 6.58 (dd, 
J = 1.8, 1.8 Hz, 1H), 5.72 (dm, J = 10.0 Hz, 1H), 5.65 (dm, J = 10.0 Hz, 1H), 2.59–2.52 
(m, 2H), 2.30 (s, 3H), 2.13–2.04 (m, 2H), 2.02–1.98 (m, 2H), 1.77–1.70 (m, 2H), 1.69 
(ddd, J = 12.8, 6.3, 6.3 Hz, 1H), 1.56 (ddd, J = 12.8, 6.5, 6.5 Hz, 1H);  13C NMR (75 
MHz, CDCl3) δ 197.8, 151.4, 143.9, 127.0, 125.5, 48.7, 35.8, 35.8, 32.5, 28.9, 26.8, 23.1;  
IR (Neat Film NaCl) 3320, 3023, 2918, 2856, 1704, 1669, 1616, 1436, 1371, 1436, 1371, 
1316, 1269, 1231, 11945, 1116, 1086, 1045, 1020, 980, 962, 935, 864, 763 cm–1;  HRMS 
(EI+) m/z calc'd for C12H16O [M]+•: 176.1201; found 176.1234;  [α]D25.0 –10.42 (c 1.08, 
CHCl3, 78.4% ee). 
 
HO
O
OH
154n  
β-Hydroxyketone 154n  (Table 2.4, entry 15).11Prepared using General Method D.  
20.3 mg, 0.110 mmol, 38% yield over 2 steps.  Flash column chromatography (SiO2, 1.5 
x 25 cm, 10:1→6:1→4:1→2:1→1:1→1:2 hexanes:EtOAc).  Rf = 0.19 (1:1 
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) mixture of two diastereomers, see Figure 
A1.159;  IR (Neat Film NaCl) 3369, 3077, 3011, 2947, 2924, 1688, 1641, 1469, 1439, 
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1343, 1268, 1216, 1193, 1128, 1108, 1079, 1052, 1032, 1019, 999, 966, 909, 889, 808, 
731 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C10H15O2 [M–OH]+: 167.1067; found 
167.1066. 
 
O
OH
135n  
Acylcyclopentene 135n  (Table 2.4, entry 15).  Prepared using General Method E.  12.2 
mg, 0.073 mmol, 67% yield.  Flash column chromatography (SiO2, 1.5 x 25 cm, 
10:1→4:1→2:1→1:1 hexanes:EtOAc);  Rf = 0.44 (1:1 hexanes:EtOAc);  1H NMR (500 
MHz, CDCl3) δ 6.48 (app t, J = 1.9 Hz, 1H), 5.91–5.77 (dddd, J = 16.5, 10.7, 7.4, 7.4  
Hz, 1H), 5.23–5.15 (m, 2H), 2.67 (dddd, J = 17.0, 8.9, 4.1, 1.7 Hz, 1H), 2.50–2.40 (m, 
3H), 2.33 (s, 3H), 2.14 (ddd, J = 13.7, 8.5, 4.1 Hz, 1H), 2.03 (br s, 1H), 1.91 (ddd, J = 
13.7, 9.0, 5.8 Hz, 1H);  13C NMR (125 MHz, CDCl3) δ 197.5, 145.9, 145.5, 132.9, 119.8, 
85.2, 44.9, 37.4, 29.1, 27.0;  IR (Neat Film NaCl) 3400, 3077, 3004, 2961, 2929, 2856, 
1841, 1668, 1622, 1428, 1372, 1295, 1267, 1228, 1205, 1173, 1070, 1057, 1016, 998, 
966, 935, 917, 862, 831, 776 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C10H13O 
[M–OH]+: 149.0961; found 149.0967;  [α]D25.0 –22.45 (c 1.22, CHCl3, 57.1% ee).  
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2.10.2.9 LARGE SCALE SYNTHESIS OF ACYLCYCLOPENTENE 135a 
O
i-BuO
149a
Pd2(pmdba)3 (1.25 mol %)
(S)-t-Bu-PHOX (13) (3.12 mol %)
PhCH3, 30 °C
94% yield, 88% ee
O
i-BuO
148a
O
O
 
Vinylogous Ester 149a.  Pd2(pmdba)3 (733.1 mg, 0.67 mmol, 0.0125) and (S)-t-Bu-
PHOX (647.0 mg, 1.67 mmol, 0.0312 equiv) were placed in a 500 mL round-bottom 
flask.  The flask was evacuated/backfilled with N2 (3 cycles, 10 min evacuation per 
cycle).  Toluene (222 mL, sparged with N2 for 1 h immediately before use) was added 
and the black suspension was immersed in an oil bath preheated to 30 °C.  After 30 min 
of stirring,  β-ketoester 148a (15.0 g, 53.5 mmol, 1.0 equiv) in toluene (46 mL, sparged 
with N2 immediately before use) was added using positive pressure cannulation.  The 
dark orange catalyst solution turned olive green immediately after the addition of β-
ketoester 148a.  The solution was stirred at 30 °C for 32 h, allowed to cool to ambient 
temperature, filtered through a silica gel plug (2 x 5.5 cm SiO2, Et2O), and concentrated 
under reduced pressure.  The crude oil was purified by flash column chromatography 
(SiO2, 8 x 12 cm, 19:1 hexanes:EtOAc, dry-loaded using SiO2) to afford vinylogous ester 
149a (11.83 g, 50.1 mmol, 94% yield, 88% ee) as a pale yellow oil.  (For characterization 
data, see p. 124). 
 
HO
O
O
i-BuO
LiAlH4, Et2O, 0 °C
then 10% HCl
81% yield149a 154a  
β-Hydroxyketone 154a.  A 500 mL round-bottom flask with magnetic stir bar was 
charged with Et2O (150 mL) and cooled to 0 °C.  LiAlH4 (1.04 g, 0.0275 mol, 0.55 equiv) 
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was added in one portion.  After 10 min, a solution of vinylogous ester 149a (11.83 g, 50 
mmol, 1.0 equiv) in Et2O (50 and 25 mL for quantitative transfer) was added dropwise 
using positive pressure cannulation.  The grey suspension was stirred for 60 min after 
which LiAlH4 (190 mg, 5.0 mmol, 0.1 equiv) was added in one portion.  After an 
additional 10 min of stirring at 0 °C, the reaction was quenched by slow addition of 
aqueous HCl (143 mL, 10% w/w).  The resulting biphasic system was allowed to warm 
to ambient temperature and stirred vigorously for 10 h.  The reaction was diluted with 
Et2O, the phases were separated and the aqueous phase was extracted with Et2O (3 x 150 
mL).  The combined organic phases were dried over Na2SO4, filtered, and concentrated 
under reduced pressure.  The crude product was azeotroped with toluene (50 mL) and 
purified using flash column chromatography (SiO2, 8 x 13 cm, 9:1→3:1 hexanes:EtOAc, 
dry-loaded using Celite) to afford β-hydroxyketone 154a (7.25 g, 39.8 mmol, 81% yield) 
as a colorless semi-solid.  (For characterization data, see p. 155). 
 
HO
O
154a
LiOH, TFE
THF, 60 °C
91% yield 135a
O
 
Acylcyclopentene 135a.  Alcohol 154a (7.25 g, 39.8 mmol, 1.0 equiv) was dissolved in 
THF (400 mL) in a 1 L round-bottom flask.  The solution was treated with 2,2,2-
trifluoroethanol (5.99 g, 4.36 mL, 59.7 mmol, 1.5 equiv) and LiOH (1.43 g, 59.7 mmol, 
1.5 equiv).  The flask was fitted with a reflux condenser, purged with N2, and heated to 
60 °C using an oil bath.  After 18 h of stirring, the suspension was allowed to cool to 
ambient temperature, diluted with Et2O (200 mL), stirred with Na2SO4 for 30 min, 
CHAPTER 2 – Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures  
 
176 
filtered, and concentrated carefully under reduced pressure, allowing for a film of ice to 
form on the outside of the flask.  The crude product was purified using flash column 
chromatography (SiO2, 8 x 12 cm, 15:1→9:1 pentane:Et2O) to afford acylcyclopentene 
135a (5.93 g, 36.1 mmol, 91% yield) as a colorless fragrant oil.  (For characterization 
data, see p. 156). 
 
2.10.2.10 INITIAL SYNTHETIC STUDIES ON THE ORGANOMETALLIC 
ADDITION/REARRANGEMENT OF 149a 
i-BuO
O
10% aq HCl
THF, 23 °C
90% yield
149a
O
O
162  
Cyclic Dione 162.  A 20 mL scintillation vial equipped with a stir bar was charged with 
vinylogous ester 149a (144.6 mg, 0.61 mmol, 1.00 equiv), THF (1 mL), and aqueous HCl 
(1 mL, 10% w/w, 2.87 mmol, 4.69 equiv).  After 4.5 h of vigorous stirring, the solution 
was diluted with H2O (5 mL) and transferred to a separatory funnel where the aqueous 
phase was extracted four times with Et2O.  The combined organics (70 mL) were dried 
over MgSO4, filtered, and concentrated.  The crude oil was purified by flash 
chromatography (SiO2, 27.5 x 2 cm, 100% hexanes→10% EtOAc in hexanes) to afford 
cyclic dione 162 (99.4 mg, 0.55 mmol, 90% yield) as a pale yellow oil;  Rf = 0.48 (30% 
EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) δ 5.69 (d, J = 14.0 Hz, 1H), 5.12–5.04 
(m, 2H), 3.72 (d, J = 14.0 Hz, 1H), 3.53 (d, J = 14.0 Hz, 1H), 2.48 (t, J = 6.6 Hz, 2H), 
2.40 (dddd, J = 13.9, 7.1, 1.2, 1.2 Hz, 1H), 2.22 (dddd, J = 13.9, 7.7, 1.1, 1.1 Hz, 1H), 
2.02–1.75 (m, 4H), 1.15 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 208.4, 203.7, 133.1, 
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119.1, 57.6, 50.9, 43.5, 42.9, 36.7, 21.9, 19.8;  IR (Neat Film NaCl) 3076, 2972, 2935, 
2871, 1719, 1695, 1639, 1463, 1417, 1378, 1337, 1210, 1160, 1112, 1059, 1026, 921  
cm–1;  HRMS (EI+) m/z calc’d for C11H16O2  [M]+•: 180.1150; found 180.1165;  [α]D25.0  
–19.38 (c 1.00, CHCl3, 88.0% ee). 
 
O
OHn-Bu
O
n-Bu
i-BuO
O CeCl3, n-BuMgCl
THF, 23 °C
then 10% aq HCl
+
149a
65% yield28% yield
137r 154r
 
Cycloheptenone 137r and β-Hydroxyketone 154r.  CeCl3·7H2O (419 mg, 1.13 mmol, 
2.55 equiv) in a 100 mL round-bottom flask was immersed in a preheated oil bath at 150 
°C and placed under vacuum for 4 h while stirring.  The flask was cooled to ambient 
temperature, backfilled with N2, and charged with THF (4 mL).  After 15 h of stirring, 
additional THF (4 mL) and n-butylmagnesium chloride solution (1.2 mL, 1.86 M in THF, 
2.23 mmol, 5.02 equiv) were added to the flask.  The resulting slurry was stirred for 4.25 
h before vinylogous ester 149a (105 mg, 0.444 mmol, 1.00 equiv) dissolved in THF (1 
mL) was added using positive pressure cannulation followed by two THF rinses (2 x 0.5 
mL).  After 45 min of stirring, the reaction was quenched by addition of 10% w/w HCl 
(10 mL).  The phases were separated and the aqueous layer was extracted with ethyl 
acetate (3 x 15 mL).  The combined organic phases were washed with brine, dried over 
Na2SO4, filtered, and concentrated under reduced pressure.  The residue was purified by 
flash column chromatography using a Teledyne Isco CombiFlash Rf system (SiO2, 25 g 
loading cartridge, 12 g column, multi-step gradient, hold 0% [1 min]→ramp to 10% [5 
min]→hold 10% [31 min]→100% EtOAc in hexanes [10 min]) to afford cycloheptenone 
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137r (28 mg, 0.13 mmol, 28% yield) and β-hydroxyketone 154r (69 mg, 0.29 mmol, 
65% yield) as pale yellow oils.   
 
Cycloheptenone 137r.12Rf = 0.68 (30% EtOAc in hexanes);  1H NMR (500 MHz, 
CDCl3) δ 5.89 (s, 1H), 5.63 (dddd, J = 16.9, 10.3, 7.9, 6.7 Hz, 1H), 5.10–4.98 (m, 2H), 
2.61–2.54 (m, 2H), 2.37 (dddd, J = 14.1, 6.7, 1.3, 1.3 Hz, 1H), 2.18–2.03 (m, 3H), 1.85–
1.72 (m, 3H), 1.66–1.56 (m, 1H), 1.53–1.43 (m, 2H), 1.37 (app. septuplet, J = 7.3 Hz, 
2H), 1.15 (s, 3H), 0.92 (t, J = 7.3 Hz, 3H);  13C NMR (125 MHz, CDCl3) δ 205.4, 163.0, 
134.2, 128.7, 118.1, 45.7, 45.3, 44.4, 38.8, 34.0, 32.4, 25.7, 23.0, 17.6, 14.1;  IR (Neat 
Film NaCl) 3076, 2957, 2933, 2872, 1652, 1611, 1467, 1414, 1379, 1342, 1263, 1218, 
1178, 1109, 1072, 996, 962, 914, 841, 780, 713 cm–1;  HRMS (MM: ESI-APCI+) m/z 
calc’d for C15H25O [M+H]+: 221.1900; found 221.1905;  [α]D25.0 –33.17 (c 1.17, CHCl3, 
88.0% ee). 
 
β-Hydroxyketone 154r.13Rf = 0.48 (30% EtOAc in hexanes);  1H NMR (500 MHz, 
CDCl3) mixture of two diastereomers, see Figure A1.212;  IR (Neat Film NaCl) 3502, 
3073, 2956, 2871, 1695, 1638, 1468, 1404, 1380, 1341, 1286, 1181, 1125, 1052, 1028, 
998, 913, 868, 796, 732 cm–1;  HRMS (MM: ESI-APCI+) m/z calc’d for C15H27O2 
[M+H]+: 239.2006; found 239.2013. 
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O
n-Bu
O
O
OHn-Bu
154r 156r
LiOH, CF3CH2OH
THF, 60 °C, 3 h
71% yield  
Linear Dione 156r.  A 50 mL round-bottom flask equipped with a magnetic stir and 
fitted with a water condenser was charged with β-hydroxyketone 154r (56.9 mg, 0.24 
mmol, 1.00 equiv), THF (3 mL), TFE (60 µL, 0.83 mmol, 3.50 equiv), and LiOH (17.3 
mg, 0.72 mmol, 3.03 equiv).  The flask was backfilled with argon and lowered into a 
preheated oil bath (60 °C).  After 3 h, the reaction was removed from the bath, allowed to 
cool to room temperature, dried over Na2SO4, filtered, and concentrated under reduced 
pressure.  The crude oil was purified by flash chromatography (SiO2, 3 x 21 cm, 
10%→20%→30% EtOAc in hexanes) to afford linear dione 156r (40.1 mg, 0.17 mmol, 
71% yield) as a pale yellow oil; Rf = 0.57 (30% EtOAc in hexanes);  1H NMR (500 MHz, 
CDCl3) δ 5.68–5.57 (m, 1H), 5.06–4.98 (m, 2H), 2.43 (t, J = 7.3 Hz, 2H), 2.39 (t, J = 6.4 
Hz, 2H), 2.31 (dddd, J = 14.0, 7.3, 1.2, 1.2 Hz, 1H), 2.18 (dddd, J = 14.0, 7.7, 1.2, 1.2 Hz, 
1H), 2.11 (s, 3H), 1.63–1.34 (m, 6H), 1.33–1.24 (m, 2H), 1.10 (s, 3H), 0.89 (t, J = 7.3 Hz, 
3H);  13C NMR (125 MHz, CDCl3) δ 214.9, 208.6, 133.9, 118.1, 50.9, 44.0, 42.6, 37.4, 
37.4, 30.1, 25.9, 22.6, 21.1, 18.7, 14.1;  IR (Neat Film NaCl) 3076, 2958, 2933, 2873, 
1718, 1701, 1639, 1465, 1409, 1378, 1360, 1256, 1230, 1174, 1142, 1120, 1029, 994, 
916, 766, 728 cm–1;  HRMS (MM: ESI-APCI+) m/z calc’d for C15H27O2 [M+H]+: 
239.2006; found 239.2005;  [α]D25.0 +5.57 (c 1.17, CHCl3, 88.0% ee). 
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n-Bu
O
O
OHn-Bu
154r 135r
KOt-Bu
THF, 60 °C, 22 h
65% yield  
Acylcyclopentene 135r.  A 25 mL round-bottom flask equipped with a stir bar and fitted 
with a water condenser was charged with β-hydroxyketone 154r (91.5 mg, 0.38 mmol, 
1.00 equiv), THF (4 mL), and KOt-Bu (66.5 mg, 0.59 mmol, 1.55 equiv).  The flask was 
lowered into a preheated oil bath (60 °C) and stirred overnight.  Additional THF (4 mL) 
was added after 19 h of heating.  After an additional 3 h, the reaction was removed from 
the bath, allowed to cool to room temperature, dried over Na2SO4, filtered through a silica 
gel plug, and concentrated under reduced pressure.  The crude oil was purified by flash 
chromatography (SiO2, 3 x 27 cm, 100% pentane→2%→5%→10% Et2O in pentane) to 
afford acylcyclopentene 135r (55.1 mg, 0.25 mmol, 65% yield) as a pale yellow oil;  Rf = 
0.81 (30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) δ 5.77–5.65 (m, 1H), 5.08–
5.00 (m, 2H), 2.60–2.49 (m, 2H), 2.45–2.37 (m, 1H), 2.24–2.17 (m, 4H), 2.15–2.10 (m, 
2H), 1.85 (ddd, J = 12.8, 7.7, 6.2 Hz, 1H), 1.60–1.51 (m, 1H), 1.47–1.34 (m, 4H), 1.06 (s, 
3H), 0.93 (t, J = 7.1 Hz, 3H);  13C NMR (125 MHz, CDCl3) δ 198.8, 164.2, 135.0, 134.7, 
117.6, 52.6, 43.8, 35.0, 32.1, 31.5, 30.4, 27.6, 24.7, 23.8, 14.0;  IR (Neat film NaCl) 
3075, 3002, 2957, 2930, 2870, 2859, 1677, 1653, 1639, 1602, 1456, 1432, 1373, 1355, 
1311, 1275, 1258, 1188, 1141, 1089, 995, 959, 913, 848, 801, 726 cm–1;  HRMS (MM: 
ESI-APCI+) m/z calc’d for C15H25O [M+H]+: 221.1900; found 221.1900;  [α]D25.0  –1.44 
(c 1.35, CHCl3, 88.0% ee). 
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n-Bu
O
O
OHn-Bu
154r 135r
KOt-Bu
THF, 85 °C, 5 min
µwaves
73% yield  
Acylcyclopentene 135r.  KOt-Bu (32 mg, 0.283 mmol, 1.62 equiv), THF (1.75 mL), and 
β-hydroxyketone mmol, 1.00 equiv) were added to a 0.5–2.0 mL microwave vial with a 
magnetic spin vane.  The pale yellow solution was subjected to microwave irradiation in 
a Biotage Initiator microwave reactor (temperature: 85 °C, sensitivity: normal).  After 5 
min of irradiation, the crimp cap was removed and Na2SO4 was added to the vial.  The 
contents were filtered through a silica gel plug with Et2O, concentrated under reduced 
pressure, and purified by flash column chromatography (5% Et2O in pentane) to yield 
acylcyclopentene 135 (31 mg, 0.14 mmol, 73% yield) as a pale yellow oil. 
 
2.10.2.11 PREPARATION OF ACYLCYCLOPENTENE DERIVATIVES 
O
135a 163
98% ee
N
H
N NH2
ONaOAc
H2O, 60 °C
recrystallize twice
63% yield
H2N
H
N NH2
O
HCl
 
Semicarbazone 163.  A 15 mL round-bottom flask was charged with sodium acetate 
(150 mg, 1.83 mmol, 1.20 equiv), semicarbazide hydrochloride (204 mg, 1.83 mmol, 
1.20 equiv), and a magnetic stir bar.  Purified water (1.7 mL) was added and the mixture 
was stirred until all the solids had dissolved.  Acylcyclopentene 135a (250 mg, 1.52 
mmol, 1.00 equiv) was added neat and the mixture was heated to 60 °C for 4 h.  The 
slurry was allowed to cool to ambient temperature while stirring and vacuum filtered 
CHAPTER 2 – Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures  
 
182 
(water aspirator).  The white solid was dried under reduced pressure to afford 
semicarbazone 15 (311 mg, 1.40 mmol, 92% yield).  The ee of the semicarbazone at this 
point was found to be 91% (measured by hydrolysis to ketone 135a, GC conditions: 80 
°C isothermal for 90 min, G-TA column, tR (min): acylcyclopentene 135a = 54.98).  
The semicarbazone 163 (300 mg, 1.36 mmol) was transferred to a round-bottom 
flask, the solids were suspended in toluene-hexanes (50:50), and the mixture was heated 
to 90 °C while stirring.  After a few min of stirring, the solids had dissolved completely 
to afford a clear, colorless solution.  Heating was discontinued and the stirring mixture 
was allowed to cool to ambient temperature while still immersed in the oil bath.  After 10 
h had elapsed, the slurry was vacuum filtered to afford 163 (246 mg, 1.11 mmol, 82% 
yield, 63% overall yield after recrystallizing twice).  The ee at this point was found to be 
94.5% (measured by hydrolysis to ketone 135a).  A second recrystallization following the 
above procedure employing 163 (241 mg, 1.09 mmol) afforded 163 (201 mg, 0.91 mmol, 
83% yield).  The ee at this point was found to be 97.9% (measured by hydrolysis to 
ketone 135a);  Rf = 0.30 (9:1 CHCl3-MeOH);  1H NMR (300 MHz, CDCl3) δ 8.52 (br s, 
1H), 6.06 (br s, 1H), 5.85 (app t, J = 1.6 Hz, 1H), 5.76 (dddd, J =  16.7, 9.3, 7.4, 7.4 Hz, 
1H), 5.47 (br s, 1H), 5.06–4.98 (m, 2H), 2.67–2.49 (m, 2H), 2.15–2.12 (m, 2H), 1.98 (s, 
3H), 1.82 (ddd, J = 12.8, 8.2, 6.9 Hz, 1H), 1.62 (ddd, J = 12.8, 8.5, 6.4 Hz, 1H), 1.07 (s, 
3H);  13C NMR (75 MHz, CDCl3) δ 158.1, 145.0, 141.7, 141.2, 135.6, 117.2, 49.2, 45.9, 
36.2, 30.8, 26.3, 12.8;  IR (Neat Film NaCl) 3473, 3266, 3189, 2946, 2858, 1698, 1579, 
1478, 1437, 1377, 1349, 1321, 1130, 1109, 993, 910, 845, 768 cm–1;  HRMS (ESI+) m/z 
calc'd for C12H20N3O [M+H]+: 222.1606; found 222.1610;  [α]D22.6 +39.80 (c 0.84, CHCl3, 
97.9% ee);  mp = 145–146 °C (1:1 toluene-hexanes). 
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O
135a163
N
H
N NH2
O 6 M aq HCl
THF, H2O, 23 °C
93% yield
 
Acylcyclopentene 135a.  A solution of semicarbazone 163 (191.8 mg, 0.867 mmol, 1.00 
equiv) in THF (1.92 mL) was treated with aqueous HCl (3.84 mL, 6.0 M, in H2O) was 
added.  The resulting biphasic mixture was stirred vigorously at ambient temperature for 
30 h.  The reaction was diluted with Et2O (10 mL), the phases were separated, and the 
aqueous phase was extracted with Et2O (2 x 10 mL).  The combined organics were dried 
over MgSO4, filtered, and concentrated carefully under reduced pressure, allowing for a 
film of ice to form on the outside of the flask.  The residue was filtered through a short 
silica gel plug (1 x 10 cm SiO2, 4:1 hexanes:Et2O) to afford acylcyclopentene 135a 
(132.6 mg, 0.81 mmol, 93% yield);  [α]D22.6 +39.80 (c 0.84, CHCl3, 97.9% ee).  (For 
characterization data, see p. 156). 
 
163
N
H
N NH2
O
N
H
N
H
N
O
I
164
m-xylene, 150 °C
89% yield
NH2
I
(X-ray)  
Iodoarene 164.  To a solution of semicarbazone 163 (50 mg, 0.23 mmol, 1.00 equiv) in 
m-xylene (2.2 mL) was added 4-iodo-benzylamine (63 mg, 0.27 mmol, 1.17 equiv).  The 
resulting pale yellow solution was immersed in an oil bath and heated to 150 °C.  After 9 
h of stirring at 150 °C, the reaction was allowed to cool to ambient temperature and 
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concentrated under reduced pressure to afford a pale yellow solid.  The crude solid was 
purified by flash column chromatography (1.0 x 15 cm SiO2, 9:1→7:3 hexanes:EtOAc) to 
afford iodoarene 164 (88 mg, 0.20 mmol, 89% yield) as a white solid.  X-ray quality 
crystals were obtained by slow vapor diffusion of pentane into a chloroform solution of 
164;  Rf = 0.52 (9:1 CHCl3-MeOH);  1H NMR (500 MHz, CDCl3) δ 7.88 (s, 1H), 7.66–
7.64 (m, 2H), 7.08 (d, J = 8.5 Hz, 2H), 6.50 (t, J = 6.1 Hz, 1H), 5.86 (app t, J = 1.5 Hz, 
1H), 5.76 (dddd, J = 16.9, 9.0, 7.6, 7.6 Hz, 1H), 5.04–5.01 (m, 2H), 4.46 (d, J = 6.3 Hz, 
2H), 2.60–2.49 (m, 2H), 2.18–2.10 (m, 2H); 1.95 (s, 3H), 1.82 (ddd, J = 12.9, 8.5, 6.3 Hz, 
1H), 1.62 (ddd, J = 12.9, 8.5, 6.1 Hz, 1H), 1.07 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 
156.3, 144.5, 141.5, 141.4, 139.2, 137.8, 135.6, 129.4, 117.2, 92.6, 49.3, 45.9, 43.2, 36.2, 
30.9, 26.3, 12.5;  IR (Neat Film NaCl) 3411, 3194, 3075, 2946, 2920, 2863, 1677, 1528, 
1486, 1401, 1323, 1259, 1142, 1114, 1057, 1000, 913, 845 cm–1;  HRMS (FAB+) m/z 
calc'd for C19H25N3OI [M+H]+: 438.1043; found 438.1036;  [α]D22.2 +31.43 (c 0.36, 
CHCl3, 91.0% ee);  mp = 123–124 °C (CHCl3-n-pentane). 
 
CeCl3, MeLi
THF, –78!23 °C
92% yield
O
135a 165
OH
 
Alcohol 165.  CeCl3 (187 mg, 0.759 mmol, 2.50 equiv) was weighed out in a glove box 
and placed in a 25 mL round-bottom flask.  The flask was sealed with a septum and 
removed from the glove box.  THF (3 mL) was added to the flask, the suspension was 
cooled to –78 °C using an acetone/CO2(s) bath, and MeLi (326 µL, 0.912 mmol, 2.80 M 
in DME, 3.00 equiv) was added in a dropwise manner.  The resulting pale brown 
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suspension was stirred at –78 °C for 30 min.  Acylcyclopentene 135a (50.0 mg, 0.304 
mmol, 1.00 equiv) was added neat to the reaction in a dropwise manner.  After 30 min of 
stirring at –78 °C, the reaction was quenched by dropwise addition of sat. aqueous NH4Cl 
(1.0 mL), the cooling bath was removed, and the reaction was allowed to warm to 
ambient temperature.  The reaction was diluted with Et2O (10 mL) and H2O (10 mL), and 
the phases were separated.  The aqueous phase was extracted with Et2O (3 x 15 mL), and 
the combined organic phases were washed with brine (10 mL), dried over MgSO4, 
filtered, and concentrated under reduced pressure.  The crude product was purified by 
automated flash column chromatography using a Teledyne Isco CombiFlash Rf (SiO2, 5 g 
loading cartridge, 12 g column, multi-step gradient, 5% [5 min]→10% Et2O in pentane) 
to afford alcohol 165 (50.4 mg, 0.280 mmol, 92% yield) as a pale yellow oil;  Rf = 0.31 
(4:1 hexanes:EtOAc);  1H NMR (400 MHz, CDCl3) δ 5.78 (dddd, J = 14.7, 11.8, 9.3, 7.4 
Hz, 1H), 5.34 (dd, J = 1.8, 1.8 Hz, 1H), 5.04–5.00 (m, 1H), 5.00–4.97 (m, 1H), 2.45–2.29 
(m, 2H), 2.18–2.00 (m, 2H), 1.81 (ddd, J = 12.7, 8.3, 6.0 Hz, 1H), 1.60 (ddd, J = 12.7, 
8.5, 6.1 Hz, 1H), 1.44 (br s, 1H), 1.34 (s, 6H), 1.02 (s, 3H);  13C NMR (100 MHz, CDCl3) 
δ 149.7, 136.21, 131.6, 116.7, 70.9, 48.2, 46.2, 36.9, 30.9, 29.3, 29.3, 26.5;  IR (Neat 
Film NaCl) 3370, 3077, 2973, 2943, 2859, 1637, 1454, 1412, 1367, 1328, 1254, 1212, 
1162, 1137, 997, 960, 940, 910, 853, 806 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for 
C12H19 [M-OH]+: 163.1481; found 163.1482;  [α]D25.0 +5.34 (c 1.16, CHCl3, 88.0 % ee). 
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O
135a 166
N
OH
H2NOH
3 M aq NaOH
MeOH
90% yield
 
Oxime 166.  A 1 dram vial with magnetic stir bar was charged with acylcyclopentene 
135a (40.0 mg, 0.24 mmol, 1.00 equiv), MeOH (0.24 mL), 50% wt aqueous 
hydroxylamine (47 µL, 0.76 mmol, 3.13 equiv), and 3 M aqueous NaOH (125 µL, 0.376 
mmol, 0.51 equiv).  After 9 d, the reaction was diluted with Et2O (10 mL) and H2O (2 
mL) and stirred vigorously for several minutes.  The layers were separated and the 
aqueous layer was extracted with Et2O (5 x 10 mL).  The combined organic layers were 
dried over MgSO4, filtered, and concentrated under reduced pressure.  The residue was 
taken up in CH2Cl2, filtered through a cotton plug, and concentrated under reduced 
pressure.  The residue was purified by flash column chromatography (SiO2, 1.5 x 20 cm, 
20:1→15:1 hexanes:EtOAc) to afford oxime 166 (39.3 mg, 0.21 mmol, 90% yield) as a 
clear oil;  Rf = 0.52 (4:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 9.73 (br s, 1H), 
5.90 (br t, J = 1.5 Hz, 1H), 5.85–5.66 (m, 1H), 5.02 (m, 2H), 2.70–2.45 (m, 2H), 2.14 (m, 
2H), 2.05 (s, 3H), 1.85 (ddd, J = 12.9, 8.1, 6.6 Hz, 1H), 1.65 (ddd, J = 12.8, 8.3, 6.3 Hz, 
1H), 1.08 (s, 3H);  13C NMR (75 MHz, CDCl3) δ 154.0, 141.8, 139.1, 135.6, 117.2, 48.9, 
45.9, 36.3, 30.6, 26.2, 11.3;  IR (Neat Film NaCl) 3272, 3233, 3075, 3003, 2952, 2925, 
2864, 1639, 1455, 1437, 1414, 1379, 1322, 1280, 1103, 1010, 995, 913, 850, 828, 756, 
715 cm–1;  HRMS (EI+) m/z calc'd for C8H12NO [M–C3H5]+: 138.0919; found 138.0960;  
[α]D25.0 +21.34 (c 1.57, CHCl3, 88.0% ee). 
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N
NHTs
CH3(CH2)15N(CH3)3Br
KOH, TsNHNH2
ClCH2CH2Cl
74% yield
 
Tosylhydrazone 167.  A 25 mL flask with magnetic stir bar was charged with 
acylcyclopentene 135a (40.0 mg, 0.24 mmol, 1.00 equiv), 1,2-dichloroethane (2.7 mL), 
cetyltrimethylammonium bromide (26.6 mg, 0.073 mmol, 0.30 equiv), KOH (136.7 mg, 
2.44 mmol, 10.0 equiv), and TsHNNH2 (271.9 mg, 1.46 mmol, 6.00 equiv), forming a 
thick white suspension.  After 43 h, the reaction was quenched by the addition of sat. 
aqueous NH4Cl (5 mL).  The mixture was extracted with CH2Cl2 (5 x 10 mL) and the 
combined organic layers were dried over Na2SO4, filtered, and concentrated under 
reduced pressure.  The residue was purified by flash column chromatography using a 
Teledyne Isco CombiFlash Rf system (SiO2, 3 x 25 cm, 4:1→3:1 hexanes:EtOAc) to 
afford tosylhydrazone 167 (196.7 mg, 0.94 mmol, 74% yield) as a clear oil;  Rf = 0.41 
(2:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 7.86 (d, J = 8.3 Hz, 2H), 7.54 (br s, 
1H), 7.31 (d, J = 8.0 Hz, 2H), 5.85 (app t, J = 1.6 Hz, 1H), 5.81–5.62 (m, 1H), 5.06–4.92 
(m, 2H), 2.58–2.48 (m, 2H), 2.43 (s, 3H), 2.19–2.00 (m, 2H), 1.89 (s, 3H), 1.85–1.71 (m, 
1H), 1.71–1.50 (m, 1H), 1.03 (s, 3H);  13C NMR (75 MHz, CDCl3) δ 151.5, 144.1, 142.4, 
141.6, 135.5, 135.4, 129.5, 128.3, 117.2, 49.3, 45.8, 36.2, 30.7, 26.1, 21.7, 12.9;  IR (Neat 
Film NaCl) 3217, 3072, 2953, 2924, 2864, 1706, 1639, 1618, 1598, 1495, 1454, 1401, 
1337, 1307, 1292, 1212, 1185, 1168, 1094, 1059, 1029, 996, 914, 870, 850, 830, 813, 706 
cm–1;  HRMS (EI+) m/z calc'd for C15H19O2N2S [M–C3H5]+: 291.1167; found 291.1181;  
[α]D25.0 +34.25 (c 1.05, CHCl3, 88.0% ee). 
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Grubbs–Hoveyda 2nd 
generation (68) (5 mol %)
methyl vinyl ketone
O
O
O
Rh(PPh3)3Cl (10 mol %)
CH2Cl2, H2 (1 atm)
93% yield
O
O135a 195 168
Ru
O
Cl
Cl
NN
PhCH3, 50 °C
99% yield
 
Bis-enone 195.  To an oven-dried reaction tube with magnetic stir bar was added 
acylcyclopentene 135a (50 mg, 0.304 mmol, 1.00 equiv).  The headspace was purged 
with N2 and dry degassed toluene (2.0 mL, sparged with N2 for 1 h immediately before 
use) was added, followed by methyl vinyl ketone (124 µL, 1.53 mmol, 5.03 equiv).  
Grubbs–Hoveyda 2nd generation catalyst (9.5 mg, 15.2 µmol, 5 mol %) was quickly 
added to the reaction, giving the solution an olive green color.  A reflux condenser was 
attached and the reaction was inserted into a 50 °C heating block.  The solution quickly 
developed a dark brown color.  After 2 h, the reaction was cooled to ambient temperature.  
The solution was filtered through a short silica gel plug (2 x 4 cm, Et2O).  The filtrate was 
concentrated under reduced pressure and the brown residue was purified by flash column 
chromatography (SiO2, 2 x 25 cm, 10:1→4:1→2:1→1:1 hexanes:EtOAc) to afford bis-
enone 195 (62.3 mg, 0.30 mmol, 99% yield) as a brown liquid;  Rf = 0.31 (2:1 
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 6.71 (ddd, J = 15.5, 7.6, 7.6 Hz, 1H), 
6.42 (s, 1H), 6.10 (d, J = 15.8 Hz, 1H), 2.68–2.40 (m, 2H), 2.33 (dd, J = 7.6, 0.9 Hz, 2H), 
2.28 (s, 3H), 2.22 (s, 3H), 1.84 (ddd, J = 14.7, 8.2, 6.6 Hz, 1H), 1.70 (ddd, J = 13.1, 8.4, 
6.1 Hz, 1H), 1.14 (s, 3H);  13C NMR (75 MHz, CDCl3) δ 198.1, 197.1, 150.2, 144.3, 
143.8, 133.8, 50.1, 43.7, 36.2, 29.8, 27.3, 26.8, 25.7;  IR (Neat Film NaCl) 3584, 3318, 
2956, 2866, 1697, 1669, 1626, 1454, 1429, 1365, 1308, 1254, 1182, 1098, 1021, 982, 
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937, 867 cm–1;  HRMS (EI+) m/z calc'd for C13H18O2 [M]+•: 206.1307; found 206.1303;  
[α]D25.0 +47.61 (c 1.02, CHCl3, 88.0% ee). 
 
Mono-enone 168.  An oven-dried 2-neck flask fitted with a magnetic stir bar, rubber 
septum, and glass T-joint with 14/20 adapter was charged with bis-enone 195 (50.0 mg, 
0.24 mmol, 1.00 equiv) and evacuated/backfilled with N2 in a glove box antechamber (3 
cycles, 5 min evacuation per cycle) before being transferred into the glove box.  CH2Cl2 
(2.5 mL) and Rh(PPh3)3Cl (22.4 mg, 0.024 mmol, 10 mol %) were added to the flask, 
giving a red solution.  The flask was sealed with a septum on one neck and T-joint (set to 
the closed position) on the other neck and carefully brought out of the glove box.  A H2 
balloon was attached to the T-joint and the flask was gently evacuated/backfilled with H2 
(3 cycles, 2 min evacuation per cycle).  After 10 h of stirring, the brown reaction mixture 
was filtered through a short silica gel plug (2 x 4 cm, Et2O) and concentrated under 
reduced pressure.  The residue was purified by flash column chromatography (SiO2, 2 x 
25 cm, 10:1→4:1→2:1 hexanes:Et2O) to afford enone 168 (46.8 mg, 0.23 mmol, 93% 
yield) as an orange liquid;  Rf = 0.40 (2:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) 
δ 6.43 (app t, J = 1.7 Hz, 1H), 2.65–2.46 (m, 2H), 2.40 (t, J = 7.1 Hz, 2H), 2.27 (s, 3H), 
2.11 (s, 3H), 1.88–1.72 (m, 1H), 1.71–1.46 (m, 3H), 1.46–1.29 (m, 2H), 1.08 (s, 3H);  13C 
NMR (75 MHz, CDCl3) δ 208.8, 197.5, 152.0, 143.6, 50.0, 44.2, 40.4, 36.1, 30.1, 29.7, 
26.8, 25.6, 19.4;  IR (Neat Film NaCl) 2998, 2953, 2866, 1716, 1667, 1616, 1456, 1427, 
1367, 1308, 1270, 1225, 1190, 1170, 1103, 1058, 1021, 841, 871, 726 cm–1;  HRMS 
(EI+) m/z calc'd for C13H20O2 [M]+•: 208.1463; found 208.1460;  [α]D25.0 +25.55 (c 1.46, 
CHCl3, 88.0% ee). 
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Grubbs–Hoveyda 2nd 
generation (68) (5 mol %)
crotonaldehyde
O
O H
O
Rh(PPh3)3Cl (10 mol %)
CH2Cl2, H2 (1 atm)
90% yield
O
O H135a 196 169
Ru
O
Cl
Cl
NN
PhH, 50 °C
90% yield
 
Bis-enone 196.  To a 2-neck round-bottomed flask with magnetic stir bar and attached 
reflux condenser was added acylcyclopentene 135a (100 mg, 0.608 mmol, 1.00 equiv).  
The flask was evacuated/backfilled with N2 (3 cycles, 30 s evacuation per cycle).  Dry 
degassed benzene (8.0 mL, sparged with N2 for 1 h immediately before use) was added, 
followed by crotonaldehyde (251 µL, 3.06 mmol, 5.03 equiv).  Grubbs–Hoveyda 2nd 
generation catalyst (19.0 mg, 30.4 µmol, 5 mol %) was quickly added to the reaction, 
giving the solution an olive green color.  The flask was immersed in a 50 °C oil bath.  
The solution quickly developed a dark brown color.  After 2 h, the reaction was cooled to 
ambient temperature.  Several drops of ethyl vinyl ether were added and the reaction 
mixture was stirred for 5 min.  The mixture was concentrated under reduced pressure and 
the brown residue was purified by flash column chromatography (SiO2, 2 x 25 cm, 
10:1→4:1→2:1 hexanes:EtOAc) to afford bis-enone 196 (105.4 mg, 0.55 mmol, 90% 
yield) as a brown oil;  Rf = 0.38 (2:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 
9.50 (d, J = 7.8 Hz, 1H), 6.76 (app dt, J = 15.4, 7.6 Hz, 1H), 6.42 (app t, J = 1.8 Hz, 1H), 
6.13 (app ddt, J = 15.5, 7.8, 1.3 Hz, 1H), 2.68–2.50 (m, 2H), 2.45 (dd, J = 7.6, 1.3 Hz, 
2H), 2.28 (s, 3H), 1.85 (ddd, J = 13.1, 8.4, 6.5 Hz, 1H), 1.72 (ddd, J = 13.1, 8.5, 6.0 Hz, 
1H), 1.16 (s, 3H);  13C NMR (75 MHz, CDCl3) δ 197.0, 193.5, 154.0, 149.7, 144.5, 135.6, 
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50.1, 43.9, 36.1, 29.8, 26.8, 25.8;  IR (Neat Film NaCl) 3359, 3317, 3041, 2957, 2928, 
2867, 2820, 2743, 2708, 1691, 1668, 1636, 1618, 1456, 1431, 1378, 1369, 1341, 1308, 
1269, 1203, 1162, 1149, 1109, 1093, 1036, 1013, 978, 936, 893, 868 cm–1;  HRMS 
(FAB+) m/z calc'd for C12H17O2 [M+H]+: 193.1229; found 193.1224;  [α]D25.0 +46.07 (c 
1.13, CHCl3, 88.0% ee). 
 
Mono-enone 169.  An oven-dried 2-neck flask fitted with a magnetic stir bar, rubber 
septum, and a glass T-joint with 14/20 adapter was charged with and bis-enone 196 (42.8 
mg, 0.22 mmol, 1.00 equiv) and evacuated/backfilled with N2 in a glove box antechamber 
(3 cycles, 5 min evacuation per cycle) before being transferred into the glove box.  
CH2Cl2 (2.5 mL) and Rh(PPh3)3Cl (10.3 mg, 0.011 mmol, 5 mol %) were added to the 
flask, giving a red solution.  The flask was sealed with a septum on one neck and T-joint 
(set to the closed position) on the other neck and carefully brought out of the glove box.  
A H2 balloon was attached to the T-joint and the flask was gently evacuated/backfilled 
with H2 (five cycles, 2 min evacuation per cycle).  After 20 h of stirring, an additional 
portion of Rh(PPh3)3Cl (10.3 mg, 0.011 mmol, 5 mol %) in CH2Cl2 (0.5 mL) was added 
to the reaction using positive pressure cannulation.  After 1.5 h of stirring, the reaction 
was diluted with Et2O, filtered through a short silica gel plug (2 x 4 cm, Et2O), and 
concentrated under reduced pressure.  The residue was purified by flash column 
chromatography (SiO2, 2 x 25 cm, 10:1→4:1 hexanes:Et2O) to afford enone 169 (39.2 
mg, 0.20 mmol, 90% yield) as an pale colorless oil;  Rf = 0.48 (2:1 hexanes:EtOAc);  1H 
NMR (300 MHz, CDCl3) δ 9.75 (t, J = 1.5 Hz, 1H), 6.44 (app t, J = 1.7 Hz, 1H), 2.59–
2.48 (m, 2H), 2.43 (td, J = 7.1, 1.4 Hz, 2H), 2.28 (s, 3H), 1.88–1.73 (m, 1H), 1.73–1.51 
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(m, 3H), 1.51–1.33 (m, 2H), 1.09 (s, 3H);  13C NMR (75 MHz, CDCl3) δ 202.3, 197.5, 
151.7, 143.8, 50.0, 44.5, 40.4, 36.1, 29.8, 26.8, 25.6, 17.8;  IR (Neat Film NaCl) 3427, 
3314, 3042, 2951, 2865, 2721, 1723, 1665, 1616, 1457, 1411, 1378, 1367, 1340, 1308, 
1269, 1193, 1156, 1105, 1060, 1034, 1020, 970, 942, 867, 801 cm–1;  HRMS (EI+) m/z 
calc'd for C12H18O2 [M]+•: 194.1307; found 194.1321;  [α]D25.0 +32.50 (c 0.69, CHCl3, 
88.0% ee). 
 
NaOH, I2, KI
H2O, p-dioxane
0!23 °C
O
OH
O
135a 197
N
O
O
171
CDI, CH2Cl2
then         
MeHNOMe•HCl
77% yield
2 steps  
Carboxylic acid 197.  A 50 mL round-bottom flask with magnetic stir bar was charged 
with acylcyclopentene 135a (200 mg, 1.22 mmol, 1.00 equiv) and p-dioxane (10 mL).  
The solution was cooled to 0 °C and 5 M aqueous NaOH (10 mL) was added dropwise.  
The white suspension was stirred for 5 min at 0 °C.  A dark brown solution of I2 (1.37 g, 
5.40 mmol, 4.40 equiv) and KI (2.09 g, 12.59 mmol, 10.50 equiv) in purified H2O (10 
mL) was added to the reaction dropwise, causing the reaction to become a yellow 
suspension.  After 6.5 h of stirring at 0 °C, an additional portion of I2 (343 mg, 1.35 
mmol, 1.11 equiv) in p-dioxane (2 mL) was added to the reaction.  After 30 min of 
stirring at 0 °C, the reaction was acidified to pH 2 using 2 M aqueous HCl.  The reaction 
was extracted with Et2O (3 x 30 mL) until the organic layer was clear.  The combined 
organic phases were washed with sat. aqueous K2S2O3 (2 x 10 mL), H2O (2 x 10 mL), and 
brine (2 x 10 mL).  The combined organic phases were dried over Na2SO4, filtered, and 
concentrated under reduced pressure to give a yellow semi-solid.  The residue was taken 
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up in EtOAc, filtered through a silica gel plug (3 x 3 cm, EtOAc), and concentrated to 
give carboxylic acid 197 as a pale yellow oil which was used directly in the next step;  Rf 
= 0.35, broad (2:1 hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 6.69 (app t, J = 1.9 
Hz, 1H), 5.89–5.62 (m, 1H), 5.11–4.99 (m, 2H), 2.68–2.47 (m, 2H), 2.26–2.09 (m, 2H), 
1.91 (ddd, J = 13.0, 8.2, 7.0 Hz, 1H), 1.69 (ddd, J = 13.0, 8.2, 6.2 Hz, 1H), 1.10 (s, 3H);  
13C NMR (75 MHz, CDCl3) δ 170.7, 154.3, 134.8, 133.9, 117.8, 49.8, 45.2, 36.3, 30.3, 
25.5;  IR (Neat Film NaCl) 3076, 3004, 2956, 2926, 2865, 2610, 1687, 1634, 1454, 1424, 
1374, 1348, 1306, 1280, 1216, 1180, 1083, 995, 915, 745, 720 cm–1;  HRMS (EI+) m/z 
calc'd for C7H9O2 [M–C3H5]+: 125.0603; found 125.0629;  [α]D25.0 +1.43 (c 0.80, CHCl3, 
88.0% ee). 
 
Amide 171.  A 50 mL flask with magnetic stir bar was charged with carboxylic acid 197 
(202.7 mg, 1.22 mmol, 1.00 equiv) and anhydrous CH2Cl2 (4.0 mL).  To the vigorously 
stirred reaction was added 1,1’-carbonyldiimidazole (217 mg, 1.34 mmol, 1.10 equiv) in 
a portionwise manner.  After 15 min, anhydrous N,O-dimethylhydroxylamine 
hydrochloride (143 mg, 1.46 mmol, 1.20 equiv) was added portionwise.  The reaction 
became turbid after several min.  After 21 h, an additional portion of N,O-
dimethylhydroxylamine hydrochloride (14.3 mg, 0.146 mmol, 0.12 equiv) was added.  At 
23.5 h, the reaction was transferred to a separatory funnel, washed with 0.25 M HCl (2 x 
2 mL), sat. aqueous NaHCO3, and brine.  The combined organic phases were dried over 
Na2SO4, filtered, and concentrated under reduced pressure.  The residue was purified by 
flash column chromatography (SiO2, 3 x 25 cm, 4:1→3:1 hexanes:EtOAc) to afford 
amide 171 as a clear oil (196.7 mg, 0.94 mmol, 77% yield over 2 steps);  Rf = 0.41 (2:1 
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hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 6.26 (app t, J = 1.9 Hz, 1H), 5.87–5.68 
(m, 1H), 5.09–4.97 (m, 2H), 3.63 (s, 3H), 3.23 (s, 3H), 2.77–2.55 (m, 2H), 2.21–2.11 (m, 
2H), 1.83 (ddd, J = 12.8, 8.3, 6.4 Hz, 1H), 1.62 (ddd, J = 12.7, 8.4, 6.0 Hz, 1H), 1.08 (s, 
3H);  13C NMR (75 MHz, CDCl3) δ 167.5, 147.0, 135.4, 135.3, 117.4, 61.2, 49.4, 45.4, 
35.9, 33.3, 32.9, 25.6;  IR (Neat Film NaCl) 3584, 3401, 3078, 2954, 2930, 2864, 1641, 
1609, 1454, 1441, 1414, 1378, 1329, 1198, 1177, 1152, 1105, 1043, 997, 969, 914, 812, 
723 cm–1;  HRMS (EI+) m/z calc'd for C12H20NO2 [M+H]+: 210.1494; found 210.1498;  
[α]D25.0 +1.41 (c 0.98, CHCl3, 88.0% ee). 
 
N
O
171 172
THF, –15 °C
45% yield
O
O
MgBr
 
Divinylketone 172.  A 25 mL round-bottomed flask with magnetic stir bar was charged 
with amide 171 (97.0 mg, 0.46 mmol, 1.00 equiv), evacuated/backfilled with N2 (3 
cycles, 5 min evacuation per cycle), dissolved in THF (3.0 mL), and cooled to –15 °C 
using an ethylene glycol/CO2(s) bath.  The yellow solution became cloudy.  
Vinylmagnesium bromide solution (1.38 mL, 1.0 M in THF, 1.38 mmol, 3.00 equiv) was 
added dropwise.  The solution was maintained at –15 °C for 20 min before the flask was 
allowed to warm to ambient temperature.  The reaction was quenched by addition into 
sat. aqueous NH4Cl (2.0 mL) using positive pressure cannulation.  The mixture was 
extracted with Et2O (3 x 10 mL), dried over Na2SO4, filtered, and concentrated under 
reduced pressure.  The residue was purified by flash column chromatography (SiO2, 2 x 
25 cm, 0%→1%→2%→3% Et2O in hexanes) to afford divinylketone 172 (36.2 mg, 0.21 
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mmol, 45% yield) as a pale yellow liquid;  Rf = 0.68 (4:1 hexanes:EtOAc);  1H NMR 
(300 MHz, CDCl3) δ 6.88 (dd, J = 17.1, 10.5 Hz, 1H), 6.53 (app t, J = 1.7 Hz, 1H), 6.28 
(dd, J = 17.1, 1.9 Hz, 1H), 5.85–5.65 (m, 1H), 5.69 (dd, J = 10.5, 1.9 Hz, 1H), 5.11–4.99 
(m, 2H), 2.76–2.50 (m, 2H), 2.29–2.09 (m, 2H), 1.87 (ddd, J = 12.9, 8.2, 6.8 Hz, 1H), 
1.67 (ddd, J = 12.9, 8.3, 6.3 Hz, 1H), 1.13 (s, 3H);  13C NMR (75 MHz, CDCl3) δ 188.9, 
152.1, 143.7, 134.8, 132.6, 127.7, 117.8, 50.3, 45.3, 35.8, 30.1, 25.5;  IR (Neat Film 
NaCl) 3584, 3400, 3078, 2955, 2927, 2866, 1622, 1606, 1453, 1440, 1408, 1374, 1348, 
1308, 1255, 1204, 1169, 1059, 981, 956, 915, 783 cm–1;  HRMS (EI+) m/z calc'd for 
C9H11O [M–C3H5]+: 135.0846; found 135.0810;  [α]D25.0 +0.84 (c 0.81, CHCl3, 88.0% ee). 
 
LiOH, H2O2
MeOH
96% yield
1:1.1 dr
O
135a 173
O
O
 
Epoxide 173.  A solution of acylcyclopentene 135a (100 mg, 0.609 mmol, 1.00 equiv) in 
MeOH (6.1 mL) in a 25 mL round-bottom flask was treated with LiOH (7.3 mg, 0.30 
mmol, 0.50 equiv) in one portion.  Aqueous H2O2 (75.0 µL, 83.3 mg, 2.00 equiv, 50% in 
H2O) was added dropwise.  After 12 h of stirring at ambient temperature additional 
aqueous H2O2 (75.0 µL, 83.3 mg, 2.00 equiv, 50% in H2O) was added.  The reaction was 
stirred for an additional 8 h, diluted with CH2Cl2 (10 mL), sat. aqueous NaHCO3 (1.0 
mL), and water (1.0 mL).  The phases were separated and the aqueous phase was 
extracted with CH2Cl2.  The combined organic phases were dried over Mg2SO4, filtered, 
and concentrated carefully under reduced pressure.  The crude product was purified by 
automated flash column chromatography using a Teledyne Isco CombiFlash Rf (SiO2, 12 
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g loading cartridge, 25 g column, linear gradient, 5%→30% Et2O in pentane [15 min]) to 
afford epoxide 173 (106 mg, 0.588 mmol, 96% yield) as a colorless fragrant oil and as a 
1.1:1 mixture of diastereomers;  Rf = 0.54 (4:1 hexanes:EtOAc);  1H NMR (400 MHz, 
CDCl3) δ 5.90–5.68 (m, 2H), 5.14–5.01 (m, 4H), 3.32 (s, 1H), 3.30 (s, 1H), 2.35–2.21 (m, 
4H), 2.07 (s, 3H), 2.07 (s, 3H), 2.05–1.99 (m, 2H), 1.96–1.85 (m, 2H), 1.54–1.49 (m, 
1H), 1.33–1.29 (m, 2H), 1.20–1.16 (m, 1H), 1.13 (s, 3H), 0.91 (s, 3H);  13C NMR (100 
MHz, CDCl3) δ 205.8, 205.6, 134.7, 133.6, 118.4, 117.8, 70.3, 70.2, 69.4, 69.3, 42.7, 
42.7, 42.4, 42.3, 41.3, 31.9, 31.4, 25.0, 24.8, 24.1, 21.7, 20.5;  IR (Neat Film NaCl) 3072, 
3002, 2958, 2878, 1706, 1642, 1459, 1444, 1419, 1397, 1360, 1325, 1286, 1261, 1115, 
922, 856, 831 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C11H17 [M+H]+: 181.1223; 
found 181.1226;  [α]D25.0 –6.94 (c 1.40, CHCl3, 88.0 % ee). 
 
Me3SI, NaH
DMSO, THF, –5 °C
O
LDA, THF
–78!23 °C
55% yield
2 steps
135a 175
O
OH
174  
Allylic alcohol 174.  NaH (36.5 mg, 0.91 mmol, 3.0 equiv, 60% w/w in mineral oil) was 
suspended in DMSO (1.2 mL) in a 25 mL round-bottom flask.  After 20 min of stirring at 
ambient temperature, THF (3.7 mL) was added and the resulting mixture was cooled to  
–5 °C using a water/NaCl/ice bath.  Me3SI (192.3 mg, 0.95 mmol, 3.1 equiv) was 
dissolved in DMSO (1.2 mL) and added dropwise to the stirred reaction.  After an 
additional 5 min of stirring, acylcyclopentene 135a (50 mg, 0.30 mmol, 1.0 equiv) was 
added neat dropwise.  After 1.5 h of stirring at –5 °C, the reaction was diluted with Et2O 
(15 mL) and quenched by pouring the reaction over 10 g of ice.  The phases were 
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separated and the aqueous layer was extracted with Et2O (2 x 10 mL).  The combined 
organic phases were washed with brine (10 mL), dried over MgSO4, filtered, and 
concentrated carefully under reduced pressure, allowing for a film of ice to form on the 
outside of the flask, to give the volatile crude epoxide 174 as a colorless oil;  Rf  = 0.60 
(4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) mixture of two diastereomers, see 
Figure A1.259; 13C NMR (100 MHz, CDCl3) mixture of two diastereomers, see Figure 
A1.260;  IR (Neat Film NaCl) 3072, 3037, 2953, 2923, 2864, 1637, 1451, 1437, 1385, 
1370, 1338, 1259, 1140, 1105, 1066, 994, 910, 856, 846, 806, 730 cm–1;  HRMS (APCI+) 
m/z calc’d for C12H19O [M+H]+: 179.1435; found 179.1430. 
To a solution of diisopropylamine (0.11 mL, 0.76 mmol, 2.5 equiv) in THF (2.0 mL) 
in a 10 mL round-bottom flask at 0 °C was added n-BuLi (370 µL, 0.76 mmol, 2.05 M in 
cyclohexane, 2.5 equiv) dropwise over 10 min.  After 15 min of stirring, the reaction was 
cooled to –78 °C using an acetone/CO2(s) bath and crude epoxide 174 in THF (1.0 mL) 
was added dropwise using positive pressure cannulation.  The cooling bath was allowed 
to warm to ambient temperature and the reaction was stirred for 18 h.  The reaction was 
diluted with Et2O (10 mL) and quenched by addition of a 50:50 (v/v) mixture of sat. 
aqueous NH4Cl and water (2.0 mL each).  The phases were separated and the aqueous 
phase was extracted with Et2O (2 x 10 mL).  The combined organic phases were washed 
with brine (10 mL), dried over MgSO4, filtered, and concentrated carefully under reduced 
pressure, allowing for a film of ice to form on the outside of the flask, to afford a pale 
yellow oil.  The residue was purified by flash column chromatography (SiO2, 1 x 22 cm, 
20% Et2O in pentane) to afford allylic alcohol 175 (29.9 mg, 0.17 mmol, 55% yield over 
2 steps) as a colorless oil;  Rf = 0.25 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) 
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δ 5.82–5.72 (m, 1H), 5.60 (dd, J = 1.7, 1.7 Hz, 1H), 5.22 (app q, J = 1.4 Hz, 1H), 5.05–
5.04 (m, 1H), 5.04–5.01 (m, 1H), 5.01–4.99 (m, 1H), 4.33 (br s, 2H), 2.58–2.45 (m, 2H), 
2.17–2.08 (m, 2H), 1.82 (ddd, J = 12.7, 8.8, 5.9 Hz, 1H), 1.62 (ddd, J = 12.7, 8.8, 5.8 Hz, 
1H), 1.51 (br s, 1H), 1.06 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 143.6, 139.1, 136.0, 
135.9, 116.9, 111.9, 64.3, 49.3, 46.2, 35.9, 32.0, 26.4;  IR (Neat Film NaCl) 3325, 3071, 
3032, 2948, 2859, 1639, 1600, 1451, 1437, 1414, 1370, 1320, 1226, 1194, 1078, 1029, 
994, 910, 848 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C12H17 [M–OH]+: 
161.1325; found 161.1324;  [α]D25.0 +17.59 (c 1.38, CHCl3, 88.0% ee). 
 
PhCl
250 °C, µwaves
90% yield
2:2:1:1 ratio of 
isomers
OO
135f 176  
Cyclohexene 176.  Acylcyclopentene 135f (25.2 mg, 0.12 mmol, 1.00 equiv) was added 
to a 2.0–5.0 mL microwave vial with magnetic stir bar and sealed with a septum-fitted 
crimp cap.  Chlorobenzene (5 mL) was added via syringe.  The clear, colorless solution 
was subjected to microwave irradiation in a Biotage Initiator microwave reactor 
(temperature: 250 °C, sensitivity: low).  After 2 h of irradiation, the vial was uncapped 
and the solvent was removed under reduced pressure.  The yellow residue was purified 
by flash column chromatography (SiO2, 1.5 x 15 cm, 15:1 hexanes:Et2O) to afford 
cyclohexene 176 as a yellow oil (22.5 mg, 0.104 mmol, 90% yield);  Rf = 0.65 (4:1 
hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) mixture of four diastereomers (2:2:1:1), 
see Figure A1.265;  13C NMR (125 MHz, CDCl3) mixture of four diastereomers, see 
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Figure A1.266;  IR (Neat Film NaCl) 3014, 2921, 2855, 1666, 1611, 1448, 1437, 1369, 
1339, 1303, 1268, 1190, 1093, 1075, 1051, 1037, 1024, 935, 868, 798, 733, 703 cm–1;  
HRMS (EI+) m/z calc'd for C15H20O [M]+•: 216.1514; found 216.1518;  [α]D25.0 –15.57 (c 
1.01, CHCl3, 88.0% ee). 
 
O
135g 177
O
Cl
Cl
Grubbs–Hoveyda 3rd 
generation (69) (25 mol %)
Ru
O
Cl
Cl
NN
PhH, 50 °C
59% yield
 
Spirocycle 177.  A 2-neck flask fitted with rubber septum and reflux condenser under N2 
was charged with Grubbs–Hoveyda 3rd generation catalyst (2.2 mg, 0.035 mmol, 6.1 mol 
%).  Dry degassed benzene (4 mL, sparged with N2 for 1 h immediately before use) was 
added to give a pale green solution.  The flask was evacuated/backfilled with N2 (3 
cycles, 5 min evacuation per cycle).  Acylcyclopentene 135g (14.2 mg, 0.063 mmol, 1.0 
equiv) in dry, degassed benzene (4 mL) under N2 was added to the catalyst solution using 
positive pressure cannulation.  The flask was rinsed with benzene  (2 mL) and washes 
were added into the catalyst solution.  The reaction was immersed in a preheated 50 °C 
oil bath and stirred for 44 h.  An additional portion of Grubbs–Hoveyda 3rd generation 
catalyst (4.4 mg, 0.070 mmol, 12.2 mol %) in degassed benzene (2 mL) was added into 
the reaction using positive pressure cannulation.  After stirring for an additional 15 h, a 
third portion of Grubbs–Hoveyda 3rd generation catalyst (2.2 mg, 0.035 mmol, 6.1 mol 
%) in degassed benzene (2 mL) was added into the reaction using positive pressure 
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cannulation.  After 31 h, the reaction was treated with several drops of ethyl vinyl ether 
and allowed to cool to ambient temperature.  The solution was diluted with Et2O (15 mL) 
and filtered through a short silica gel plug (2 x 10 cm, Et2O).  The orange filtrate was 
purified by flash column chromatography (SiO2, 2 x 25 cm, 1%→3%→5%→6.5% Et2O 
in hexanes) to give volatile spirocycle 177 (7.3 mg, 0.0376 mmol, 59% yield);  Rf = 0.49 
(4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 6.61 (app t, J = 1.7 Hz, 1H), 5.64 
(app p, J = 2.2 Hz, 1H), 2.66 (ddd, J = 16.2, 4.5, 2.1 Hz, 1H), 2.62–2.53 (m, 3H), 2.51 
(ddd, J = 16.2, 4.6, 2.4 Hz, 1H), 2.43 (ddd, J = 16.3, 4.6, 2.4 Hz, 1H), 2.31 (s, 3H), 2.09–
1.95 (m, 2H);  13C NMR (125 MHz, CDCl3) δ 197.3, 150.2, 144.2, 130.7, 125.2, 56.2, 
49.7, 44.3, 39.4, 29.6, 26.8;  IR (Neat Film NaCl) 2929, 2845, 1726, 1668, 1616, 1436, 
1370, 1340, 1314, 1276, 1193, 1079, 1052, 990, 966, 936, 905, 866, 822, 804 cm–1;  
HRMS (EI+) m/z calc'd for C11H13OCl [M]+•: 196.0655; found 196.0655;  [α]D25.0 –19.80 
(c 0.53, CHCl3, 88.0% ee). 
 
1) Et3N, TBSOTf 
    CH2Cl2, 0 °C
2) DMAD, PhCH3
    µwaves, 160 °C
O OTBS
CO2Me
CO2Me
1) DDQ, PhCH3
2) TBAF, THF
    57% yield
      4 steps
135a 179
OH
CO2Me
CO2Me
178
mixture of diastereomers  
Phenol 179.  A 15 mL flask with magnetic stir bar was charged with acylcyclopentene 
135a (50 mg, 0.274 mmol, 1.00 equiv) and anhydrous CH2Cl2 (3.0 mL).  The flask was 
cooled to 0 °C and Et3N (152.8 µL, 1.096 mmol, 4.00 equiv) was added, followed by 
dropwise addition of TBSOTf (125.8 µL, 0.548 mmol, 2.00 equiv).  The reaction became 
a pale yellow solution.  After 1 h of stirring at 0 °C, the reaction was quenched by the 
addition of sat. aqueous NaHCO3 and slowly allowed to warm to ambient temperature.  
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The mixture was extracted with CH2Cl2 (3 x 10 mL) and the combined organics were 
dried over Na2SO4, filtered, and concentrated under reduced pressure.  The residue was 
filtered through a silica gel plug (2 x 3 cm, 5:1 H:Et2O) and concentrated under reduced 
pressure to give crude silyl enol ether as a pale yellow oil.  Rf = 0.79 (10:1 
hexanes:EtOAc). 
The silyl enol ether was added to a 2.0–5.0 mL microwave vial with magnetic stir bar 
and sealed with a septum-fitted crimp cap.  Toluene (5 mL) was added, followed by 
dimethyl acetylenedicarboxylate (101 µL, 0.822 mmol, 3.00 equiv).  The clear, colorless 
solution was subjected to microwave irradiation in a Biotage Initiator microwave reactor 
(temperature: 160 °C, sensitivity: low).  After 2.5 h of irradiation, the vial was uncapped 
and solvent was removed under reduced pressure.  The yellow residue was purified by 
flash column chromatography (SiO2, 3 x 25 cm, 15:1→10:1→4:1→2:1 hexanes:EtOAc) 
to afford siloxydiene 178 as a mixture of diastereomers.  Rf = 0.31 (10:1 hexanes:EtOAc). 
A 20 mL scintillation vial with magnetic stir bar was charged with siloxydiene 178 
and toluene (3.0 mL).  DDQ (63.5 mg, 0.280 mmol, 1.02 equiv) was added portionwise.  
Upon complete addition, the solution became a turbid red suspension.  After 2 h, the 
reaction was diluted with CH2Cl2 and filtered through a Celite plug (2 x 3 cm, CH2Cl2).  
The clear yellow solution was concentrated under reduced pressure.  The residue was 
purified by flash column chromatography (SiO2, 2 x 25 cm, 20:1→15:1→10:1→4:1→2:1 
hexanes:EtOAc) to afford the intermediate silyl aryl ether.  Rf = 0.31 (10:1 
hexanes:EtOAc).  
A 20 mL scintillation vial with magnetic stir bar was charged with silyl aryl ether.  
The vial was evacuated, and backfilled with N2.  Anhydrous THF (3 mL) was added and 
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a TBAF solution (300 µL, 1.0 M in THF) was added dropwise, giving a bright red 
solution.  After 10 min, the reaction was quenched by the addition of sat. aqueous NH4Cl 
(600 µL) and H2O (600 µL).  The mixture was stirred vigorously for 20 min and 
extracted with Et2O (3 x 5 mL).  The combined organics were dried over Na2SO4, filtered, 
and concentrated under reduced pressure.  The residue was purified by flash column 
chromatography (SiO2, 2 x 25 cm, 5:1→4:1 hexanes:EtOAc) to afford phenol 179 as a 
pale yellow oil (52.6 mg, 0.173 mmol, 57% yield over 4 steps);  Rf = 0.11 (2:1 
hexanes:EtOAc);  1H NMR (300 MHz, CDCl3) δ 7.30 (s, 1H), 5.89 (br s, J = 1.9 Hz, 1H), 
5.66 (dddd, J = 17.3, 10.2, 7.9, 7.9 Hz, 1H), 5.09–4.91 (m, 2H), 3.88 (s, 3H), 3.83 (s, 
3H), 2.76 (t, J = 7.3 Hz, 2H), 2.47–2.26 (m, 2H), 2.24–2.08 (ddd, J = 12.0, 7.0, 7.0 Hz, 
1H), 1.85–1.70 (ddd, J = 12.7, 7.6, 7.6 Hz, 1H), 1.26 (s, 3H);  13C NMR (75 MHz, 
CDCl3) δ 170.4, 166.7, 152.5, 150.0, 135.8, 135.3, 128.3, 124.0, 117.7, 115.4, 52.7, 52.5, 
49.4, 44.1, 38.3, 26.1, 25.6;  IR (Neat Film NaCl) 3401, 3075, 2953, 2871, 1723, 1639, 
1588, 1435, 1418, 1376, 1330, 1311, 1258, 1192, 1175, 1142, 1047, 995, 964, 916, 884, 
857, 794, 769, 738, 719 cm–1;  HRMS (EI+) m/z calc'd for C17H20O5 [M]+•: 304.1311; 
found 304.1317;  [α]D25.0 –45.63 (c 0.91, CHCl3, 88.0% ee). 
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TBAI, Et3N, 2-iodophenol 
Pd(OAc)2 (2.5 mol %)
     
DMF, 100 °C
90% yield
O
135a
O 181
OTf
183
Herrmann–Beller 
catalyst (182) (10 mol %)
TBAA, DMA, 115 °C
77% yield
O
(E/Z)-180
HO
Rh(PPh3)3Cl (10 mol %)
PhCH3, H2 (1 atm)
95% yield
(Ar = o-CH3-C6H4)O
170
HO
Comins' reagent
DMAP, CH2Cl2
94% yield
N N
Tf
Tf
Cl
O
H
Pd
P
Pd
P
O O
O O
ArAr
Ar Ar
tricyclic core of 
Hamigerans C and D  
Phenol 180.  DMF (1.52 mL) was sparged with N2 in a 25 mL Schlenk flask for 1 h.  
Et3N (0.849 mL, 6.09 mmol, 5.0 equiv), TBAI (450 mg, 1.22 mmol, 1.0 equiv) and 2-
iodophenol (282.2 mg, 1.28 mmol, 1.05 equiv) were added, followed by Pd(OAc)2 (6.84 
mg, 0.030 mmol, 2.5 mol %).  The flask was carefully evacuated/backfilled with N2 (3 
cycles, 1 min evacuation per cycle) followed by addition of acylcyclopentene 135a (200 
mg, 1.22 mmol, 1.0 equiv).  The suspension was immersed in an oil bath at 100 °C.  The 
reaction turned orange within 15 min of stirring.  After 5 h of stirring, the reaction was 
allowed to cool to ambient temperature, diluted with EtOAc (10 mL), and poured into 
aqueous HCl (10 mL, 1.0 M).  The phases were separated and the aqueous phase was 
extracted with EtOAc (2 x 10 mL).  The combined organic phases were washed with 
brine (10 mL), dried over MgSO4, filtered, and concentrated under reduced pressure.  The 
crude oil was purified by flash column chromatography using a Teledyne Isco 
CombiFlash Rf system (SiO2, 12 g loading cartridge, 40 g column, linear gradient, 
5%→30% EtOAc in hexanes [25 min]) to afford styrenyl phenol 180 as a mixture of 
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olefin isomers (283.0 mg, 1.10 mmol, 90% yield) as a colorless oil.  Rf = 0.17 (4:1 
hexanes:EtOAc). 
Rh(PPh3)3Cl (22.2 mg, 0.024 mmol, 0.10 equiv) was weighed out in a glove box and 
added to a long reaction tube with magnetic stir bar.  Styrenyl phenol 180 (61.5 mg, 
0.240 mmol, 1.0 equiv) was dissolved in toluene (4.8 mL) and added to the reaction tube 
using positive pressure cannulation.  H2 was bubbled through the suspension for 5 min 
and the reaction tube was fitted with a balloon containing H2 (1 atm).  The reaction was 
stirred for an additional 6 h at which point TLC analysis indicated complete conversion 
of the starting material.  The resulting clear orange reaction mixture was adsorbed onto a 
12 g Isco loading cartridge and purified by flash column chromatography using a 
Teledyne Isco CombiFlash Rf system (SiO2, 12 g loading cartridge, 24 g column, linear 
gradient, 5%→50% Et2O in hexanes [40 min]) to afford phenol 170 (58.9 mg, 0.228 
mmol, 95% yield) as a pale yellow oil;  Rf = 0.18 (4:1 hexanes:EtOAc);  1H NMR (300 
MHz, CDCl3) δ 7.13–7.04 (m, 2H), 6.87 (t, J = 7.4 Hz, 1H), 6.75 (d, J = 7.9 Hz, 1H), 
6.46 (app t, J = 1.7 Hz, 1H), 4.82 (bs, 1H), 2.60 (t, J = 7.3 Hz, 2H), 2.56–2.50 (m, 2H), 
2.29 (s, 3H), 1.87–1.75 (m, 1H), 1.71–1.42 (m, 5H), 1.09 (s, 3H);  13C NMR (125 MHz, 
CDCl3) δ 197.9, 153.6, 152.8, 143.4, 130.4, 128.4, 127.3, 120.9, 115.3, 50.1, 40.8, 36.2, 
30.8, 29.7, 26.8, 25.8, 25.5;  IR (Neat Film NaCl) 3344, 3054, 3039, 2951, 2863, 1651, 
1610, 1592, 1507, 1455, 1377, 1365, 1313, 1272, 1238, 1179, 1155, 1127, 1106, 1042, 
907, 853, 752 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C17H23O2 [M+H]+: 
259.1693; found 259.1691;  [α]D25.0 +28.73 (c 0.74, CHCl3, 88.0% ee). 
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Triflate 181.  To a solution of phenol 170 (104.2 mg, 0.40 mmol, 1.00 equiv) in CH2Cl2 
(8.0 mL) in a 20 mL vial was added DMAP (97.8 mg, 0.80 mmol, 2.0 equiv) in one 
portion, followed by N,N-Bis(trifluoromethylsulfonyl)-5-chloro-2-pyridylamine (172.8 
mg, 0.44 mmol, 1.1 equiv).  After 15 min of stirring at ambient temperature, TLC 
revealed full conversion of phenol 170.  The reaction mixture was adsorbed onto a 12 g 
Isco loading cartridge and purified by flash column chromatography using a Teledyne 
Isco CombiFlash Rf system (SiO2, 12 g loading cartridge, 40 g column, linear gradient, 
5→20% EtOAc in hexanes [25 min]) to afford triflate 181 (146.2 mg, 0.374 mmol, 94% 
yield) as a clear, colorless oil;  Rf = 0.44.  (4:1 hexanes:EtOAc);  1H NMR (500 MHz, 
CDCl3) δ 7.32–7.30 (m, 2H), 7.28 (dd, J = 8.5, 4.0 Hz, 1H), 7.24 (dm, J = 7.8 Hz, 1H), 
6.44 (app t, J = 1.8 Hz, 1H), 2.69 (t, J = 7.7 Hz, 2H), 2.61–2.46 (m, 2H), 2.29 (s, 3H), 
1.80 (ddd, J = 13.0, 8.7, 6.5 Hz, 1H), 1.66 (ddd, J = 11.8, 8.0, 5.2 Hz, 1H), 1.64–1.45 (m, 
3H), 1.50 (ddd, J = 11.4, 7.5, 5.1 Hz, 1H), 1.10 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 
197.6, 152.0, 148.1, 143.7, 135.1, 131.3, 128.5, 128.0, 121.5, 118.7 (q, J = 320 Hz, 1C), 
50.0, 40.7, 36.1, 30.8, 29.8, 26.8, 25.8, 25.7;  IR (Neat Film NaCl) 3032, 2958, 2868, 
1671, 1617, 1486, 1454, 1420, 1365, 1303, 1251, 1217, 1140, 1100, 1073, 893, 814, 767 
cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C18H22F3O4S [M+H]+: 391.1188; found 
391.1193;  [α]D25.0 +22.00 (c 1.31, CHCl3, 88.0% ee). 
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O
183
Ha
Hb
Hb
Hb
NOE
 
Acylcyclopentene 183.  To a solution of triflate 181 (30.0 mg, 0.077 mmol, 1.0 equiv) in 
dry DMA (1.54 mL) in a 4 dram vial was added TBAA (57.9 mg, 0.19 mmol, 2.5 equiv, 
stored and weighed out in a glove box).  The resulting clear, colorless solution was 
degassed by bubbling Ar though the solution for 1 h.  Herrmann's catalyst57 (7.2 mg, 7.7 
µmol, 0.10 equiv) was placed in a reaction tube which was subsequently 
evacuated/backfilled with Ar (3 cycles, 1 min evacuation per cycle).  The solution 
containing triflate 181 was added to the catalyst using positive pressure cannulation.  The 
resulting pale green-yellow solution was immersed in an oil bath at ambient temperature 
and heated to 115 °C.  After 2 h of stirring, the reaction was allowed to cool to ambient 
temperature, diluted with EtOAc (10 mL), and poured into aqueous HCl (1.0 M, 5.0 mL).  
The phases were separated and the aqueous phase was extracted with EtOAc (10 mL).  
The combined organics were washed with brine (5.0 mL), dried over MgSO4, filtered, 
and concentrated under reduced pressure.  The crude product was purified by flash 
column chromatography using a Teledyne Isco CombiFlash Rf system (SiO2, 2.5 g 
loading cartridge, 4 g column, multi-step gradient, hold 5% [10 min]→hold 10% [4 
min]→hold 20% [3 min]→hold 60% EtOAc in hexanes [3 min]) to afford 
acylcyclopentene 183 (14.3 mg, 0.0595 mmol, 77% yield, 62% yield over 4 steps) as a 
pale yellow solid.  The relative stereochemistry was assigned based on strong NOE 
interaction between Ha and Hb;  Rf = 0.46 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, 
CDCl3) δ 7.17–7.06 (m, 3H), 6.95 (app t, J = 2.4 Hz, 1H), 6.63 (bd, J = 6.2 Hz, 1H), 3.86 
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(s, 1H), 2.92–2.84 (m, 1H), 2.66 (app dd, J = 13.5, 7.9 Hz, 1H), 2.41 (s, 3H), 2.32–2.18 
(m, 2H) 1.84 (app ddt, J = 13.5, 7.7, 5.6 Hz, 1H), 1.58–1.43 (m, 1H), 1.30 (ddd, J = 14.0, 
5.1, 2.3 Hz, 1H), 1.18 (s, 3H), 0.85 (app dt, J = 13.5, 5.6 Hz, 1H);  13C NMR (125 MHz, 
CDCl3) δ 196.7, 146.2, 144.6, 139.6, 139.2, 128.5, 126.7, 126.2, 125.0, 55.5, 48.4, 43.9, 
34.1, 30.6, 26.9, 25.9, 21.4;  IR (Neat Film NaCl) 3062, 3012, 2933, 2893, 2859, 1659, 
1617, 1476, 1456, 1446, 1370, 1278, 1266, 1244, 1199, 1123, 997, 935, 794, 757, 752, 
730 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C17H21O [M+H]+: 241.1587; found 
241.1591;  [α]D25.0 +3.88 (c 1.43, CHCl3, 88.0% ee). 
 
2.10.2.12 REVISED APPROACH TO THE REDUCTION/REARRANGEMENT 
AND ORGANOMETALLIC ADDITION/REARRANGEMENT OF 149a 
O
H
NaOAc•3H2O
Ac2O, 110 °C
80% yield
2 steps 137a
O
HHO
O
H
i-BuO
O
+
149a
LiAlH4
Et2O, 0 °C
then
10% aq HCl
137a
154a  
Cycloheptenone 137a.  A round-bottom flask charged with vinylogous ester 149a (367.0 
mg, 1.55 mmol, 1.00 equiv) and THF (5 mL, 0.3 M) was cooled in a 0 °C ice/water bath 
and LiAlH4 (34.0 mg, 0.90 mmol, 0.58 equiv) was added.  After 25 min of stirring, the 
reaction was quenched at 0 °C with the addition of aqueous HCl (10 mL, 10% w/w) and 
transferred to a separatory funnel where the aqueous phase was extracted with EtOAc (3 
x 10 mL).  The combined organics were dried over Na2SO4, filtered, and concentrated 
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under reduced pressure.  To the resulting crude oil was added Ac2O (3.8 mL) and 
NaOAc·3H2O (1.28 g, 9.43 mmol, 6.08 equiv) and the mixture was lowered into a 
preheated oil bath (110 °C).  After 15 h of heating, the reaction was allowed to cool to 
ambient temperature and quenched with K2CO3 (5.59 g, 40.5 mmol) and water (10 mL).  
After an addition 30 min of stirring, the solution was transferred to a separatory funnel 
where the aqueous phase was extracted with EtOAc (4 x 10 mL).  The combined organics 
were dried over Na2SO4, filtered, and concentrated under reduced pressure.  The crude oil 
was purified by flash chromatography (SiO2, 2 x 16 cm, 20:1 hexanes:EtOAc) to afford 
cycloheptenone 137a (203.9 mg, 1.24 mmol, 80% yield) as a pale yellow oil.  (For 
characterization data, see p. 155–155). 
 
+
O
HHO
O
H
i-BuO
O
149a
CeCl3•7H2O
NaBH4, MeOH, 0 °C
then 10% aq HCl
137a
82% yield
154a
1% yield  
Cycloheptenone 137a and β-Hydroxyketone 154a.  A 100 mL round-bottom flask with 
magnetic stir bar was charged with vinylogous ester 149a (186.8 mg, 0.79 mmol, 1.00 
equiv) and anhydrous MeOH (14 mL).  The solution was cooled to 0 °C (water/ice bath).  
CeCl3·7H2O (294.5 mg, 0.79 mmol, 1.00 equiv) was added in one portion and the mixture 
was stirred for 5 min.  Portionwise addition of NaBH4 (89.7 mg, 2.37 mmol, 3.00 equiv) 
at 0 °C led to the evolution of gas and a turbid solution that became clearer after several 
minutes.  TLC analysis indicated that no starting material remained after 2 min.  
Consequently, the reaction was quenched by dropwise addition of aqueous HCl (2 mL, 
10% w/w) at 0 °C.  After an additional 10 min of stirring, the reaction was diluted with 
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CH2Cl2 (60 mL) and H2O (2 mL).  The layers were separated.  The aqueous layer was 
extracted with CH2Cl2 (6 x 5 mL).  The combined organic layers were washed with sat. 
aqueous NaHCO3 (2 x 5 mL) and brine (2 x 5 mL), dried over Na2SO4, filtered, and 
evaporated to give a pale yellow oil.  The crude mixture was purified using flash 
chromatography (SiO2, 2 x 25 cm, 20:1→15:1→3:1 hexanes:EtOAc) to afford volatile 
enone 137a (106.9 mg, 0.645 mmol, 82% yield) as a pale yellow oil and β-
hydroxyketone 154a as a mixture of diastereomers (1.4 mg, 0.0077 mmol, 1% yield, 
3.5:1 dr) as a colorless oil.  (For characterization data of 137a and 154a, see p. 155–155). 
 
CeCl3, n-BuMgCl, THF, 23 °C
then 10% aq HCl, 60 °C
O
i-BuO
n-Bu
O O
+
149a
n-Pr
4% yield
137r 184
76% yield  
Cycloheptenone 137r and Cycloheptenone Isomer 184. An oven dried 15 mL round-
bottom flask equipped with a magnetic stir bar was cycled into a glove box. The flask 
was loaded with anhydrous cerium chloride (130.4 mg, 0.53 mmol, 2.49 equiv), fitted 
with a septum, removed from the glove box, and connected to an argon-filled Schlenk 
manifold.  A portion of THF (5.5 mL) was added, rinsing the cerium chloride to the 
bottom of the flask.  As the resulting thick white slurry was stirred, a solution of n-
butylmagnesium chloride (340 µL, 1.89 M in THF, 0.64 mmol, 3.03 equiv) was added 
and the mixture turned pale yellow.  After 45 min of stirring, neat vinylogous ester 149a 
(50.2 mg, 0.21 mmol, 1.00 equiv) was added to the flask.  The slurry maintained the 
yellow color with the addition.  TLC analysis indicated that no starting material remained 
after 5 min.  After an additional 10 min of stirring, the reaction was quenched with 
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aqueous HCl (1 mL, 10% w/w) and lowered into a preheated oil bath (60 °C).  After 17 h, 
the yellow suspension was removed from the bath, cooled to ambient temperature, and 
transferred to a separatory funnel where the aqueous phase was extracted four times with 
Et2O.  The combined organics (75 mL) were dried over MgSO4, filtered, and 
concentrated under reduced pressure.  The crude oil was purified by flash 
chromatography (SiO2, 1 x 27 cm, 100% hexanes→2%→10% EtOAc in hexanes) to 
afford moderately contaminated cycloheptenone 137r and pure alkene isomer 184 (35.4 
mg, 0.16 mmol, 76% yield) as an orange oil.  Additional purification by flash 
chromatography (SiO2, 1 x 27 cm, 100% hexanes→2%→5% EtOAc in hexanes) 
furnished cycloheptenone 137r (1.7 mg at 95% purity, 0.0076 mmol, 4% yield) as a 
yellow oil.  (For characterization data of 137r, see p. 178). 
 
O
n-Pr
184
Ha
 
Cycloheptenone Isomer 184.  Rf = 0.76 (30% EtOAc in hexanes); The relative alkene 
stereochemistry was assigned based on NOE interactions of Ha proton;  1H NMR (500 
MHz, CDCl3) δ 5.66 (dddd, J = 16.9, 10.6, 7.9, 6.6 Hz, 1H), 5.43 (t, J = 7.1 Hz, 1H), 
5.03–4.97 (m, 2H), 3.20 (d, J = 14.6 Hz, 1H), 3.13 (d, J = 14.6 Hz, 1H), 2.47–2.38 (m, 
1H), 2.36–2.26 (m, 2H), 2.15–1.95 (m, 3H), 1.82–1.69 (m, 2H), 1.66–1.58 (m, 1H), 1.58–
1.50 (m, 1H), 1.40–1.32 (m, 2H), 1.07 (s, 3H), 0.88 (t, J = 7.4 Hz, 3H);  13C NMR (125 
MHz, CDCl3) δ 210.0, 136.2, 135.1, 130.0, 117.2, 44.8, 43.3, 43.3, 41.8, 41.1, 30.2, 25.0, 
22.9, 19.6, 13.9;  IR (Neat Film NaCl) 3074, 3042, 2959, 2929, 2871, 1706, 1638, 1457, 
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1436, 1378, 1351, 1302, 1262, 1231, 1163, 1098, 1069, 996, 953, 912, 805, 776, 729  
cm–1;  HRMS (EI+) m/z calc’d for C15H24O2 [M]+•: 220.1827; found 220.1780;  [α]D25.0   
–10.92 (c 0.76, CHCl3, 88.0% ee). 
 
i-BuO
O
149a 137r
1. CeCl3, n-BuMgCl, THF, 23 °C
    then Na3PO4 buffer (pH 6.5)
2. 6 mM aq HCl, CH3CN O
n-Bu
84% yield  
Cycloheptenone 137r.  A 50 mL round-bottom flask equipped with a magnetic stir bar 
was cycled into a glove box.  The flask was loaded with anhydrous cerium chloride 
(260.8 mg, 1.06 mmol, 2.50 equiv), fitted with a septum, removed from the glove box, 
and connected to an argon-filled Schlenk manifold.  A portion of THF (8.5 mL) was 
added, rinsing the cerium chloride to the bottom of the flask. As the resulting thick white 
slurry was stirred, a solution of n-butylmagnesium bromide (680 µL, 1.87 M in THF, 
1.27 mmol, 3.00 equiv) was added and the mixture turned grey.  After 30 min of stirring, 
vinylogous ester 149a (100.0 mg, 0.42 mmol, 1.00 equiv) was added neat from a 
Hamilton syringe and the needle was rinsed with a small portion of THF (2 mL; total 
THF added = 10.5 mL, 0.04 M).  The color of the slurry initially transitioned to yellow 
with the vinylogous ester addition before turning back to grey.  TLC analysis indicated 
that no starting material remained after 15 min.  After an additional 10 min of stirring, the 
reaction was quenched with pH 6.5 Na3PO4 buffer (8 mL).  A thick grey emulsion 
formed.  The mixture was transferred to a separatory funnel where the aqueous phase was 
extracted four times with Et2O.  The combined organics (125 mL) were dried over 
MgSO4, filtered, and concentrated under reduced pressure.  The crude oil was transferred 
to a 20 mL scintillation vial and concentrated under reduced pressure.  A stir bar, CH3CN 
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(1.0 mL), and 6 mM aqueous HCl (1.0 mL) were added to the vial.  The resulting cloudy 
solution was stirred vigorously for 5 min before being transferred to a separatory funnel 
where the aqueous phase was extracted four times with Et2O.  The combined organics 
(100 mL) were dried over MgSO4, filtered, and concentrated under reduced pressure.  
The crude oil was purified by flash chromatography (SiO2, 3 x 30 cm, 100% 
hexanes→2%→5% EtOAc in hexanes) to afford cycloheptenone 137r (82.4 mg, 0.35 
mmol, 84% yield) as a pale yellow oil.  (For characterization data of 137r, see p. 178). 
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2.10.2.13 GRIGNARD AND ORGANOLITHIUM REAGENTSa 
Table 2.7.  Sources of Grignard and Organolithium Reagents 
reagent
MgBr
entry
6
MgBr1
MgBr
3
7 Ph Li
MgBr
4
MgBr5
MgCl
10
S
MgBr2
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
Li
9
O
8
MgBr
molarity (M)
0.25 M in THF
N/Ab
0.86 M in Et2O
0.39 M in THF
0.44 M in THF
0.41 M in THF
0.35 M in THF
obtained from
0.40 M in THF
0.44 M in THF
N/Ab
Br
Br
Cl
S
O
a Titrated using method of Love (see ref. 49). b Not titrated.
Ph
Br
Br
 
Grignard and Organolithium Reagents.  Reagents were purchased from Sigma-Aldrich 
or prepared according to procedures listed below.  Reagents were titrated according to the 
method of Love.49 
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MgBrBr
Mg(0), DIBAL (4 mol %)
THF
0.41 M in THF  
(3-Methylbut-3-enyl)magnesium bromide  (Table 2.7, entry 4).  A 250 mL Schlenk 
bomb (14/20 joint off of a 12 mm Kontes valve) equipped with a magnetic stir bar, fitted 
with a rubber septum, and connected to a Schlenk manifold was flame-dried three times, 
backfilling with argon after each drying cycle. Once cool, magnesium metal (2.04 g, 
83.79 mmol, 2.50 equiv) was added.  After three argon backfilling cycles, the flask was 
charged with THF (50 mL, 0.7 M) and neat DIBAL59 (150 µL, 1.29 mmol, 4 mol %) and 
stirring was initiated.  The stirring was stopped after 10 min and 4-bromo-2-methylbut-1-
ene60 (5.00 g, 33.57 mmol, 1.00 equiv) was added via syringe with the needle in the 
solution directly above the magnesium.  The mixture was heated to reflux, sealed by 
closing the Schlenk valve, and stirred vigorously.  The flask was occasionally heated 
back to reflux and then allowed to cool to room temperature (23 °C).  The reaction color 
became amber over time.  After 30 min, an aliquot was removed and titrated following 
the procedure of Love (0.41 M in THF).49  See p. 227 for use of this reagent. 
 
MgBrBr Mg(0), DIBAL (4 mol %)
THF
0.35 M in THF  
Pent-4-enylmagnesium bromide  (Table 2.7, entry 5).  A 250 mL Schlenk bomb (14/20 
joint off of a 12 mm Kontes valve) equipped with a magnetic stir bar, fitted with a rubber 
septum, and connected to a Schlenk manifold was flame-dried three times, backfilling 
with argon after each drying cycle.  Once cool, magnesium metal (614.4 mg, 25.27 
mmol, 2.53 equiv) was added.  After three argon backfilling cycles, the flask was charged 
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with THF (20 mL, 0.5 M) and neat DIBAL59 (50 µL, 0.43 mmol, 4 mol %) and stirring 
was initiated.  The stirring was stopped after 10 min and 5-bromopent-1-ene (1.18 mL, 
9.98 mmol, 1.00 equiv) was added via a syringe with the needle in the solution directly 
above the magnesium.  The mixture was heated to reflux, sealed by closing the Schlenk 
valve, and stirred vigorously.  The flask was occasionally heated back to reflux and then 
allowed to cool to room temperature (23 °C).  The reaction color became amber over 
time.  After 30 min, an aliquot was removed and titrated following the procedure of Love 
(0.35 M in THF).49  See p. 217 and p. 229 for use of this reagent. 
 
Ph
Br
Ph
Li
t-BuLi (1.7 M in pentane)
Et2O, –78 ! 23 °C  
(E)-Styryllithium  (Table 2.7, entry 7).  See p. 231 for the synthesis and use of this 
reagent. 
 
Br MgBrMg(0), DIBAL (18 mol %)
THF
0.40 M in THF  
(2-Vinylphenyl)magnesium bromide  (Table 2.7, entry 8).  A 250 mL Schlenk round-
bottom flask (14/20 joint off of a 12 mm Kontes valve) equipped with a magnetic stir bar, 
fitted with a rubber septum, and connected to a Schlenk manifold was flame-dried three 
times, backfilling with argon after each drying cycle.  Once cool, magnesium metal 
(491.3 mg, 20.21 mmol, 2.53 equiv) was added.  After three argon backfilling cycles, the 
flask was charged with THF (16 mL, 0.5 M) and neat DIBAL59 (170 µL, 1.46 mmol, 18 
mol %) and stirring was initiated.  The stirring was stopped after 10 min and o-
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bromostyrene (1.00 mL, 7.98 mmol, 1.00 equiv) was added with the needle in the 
solution directly above the magnesium.  The mixture was heated to reflux, sealed by 
closing the Schlenk valve, and stirred vigorously.  The flask was occasionally heated 
back to reflux and then allowed to cool to room temperature (23 °C).  The reaction 
became amber over time.  After 2 h, a small portion of the reaction was removed and 
titrated following the procedure of Love.49  See p. 234 for use of this reagent. 
 
Li
OO
n-BuLi
Et2O, –15 ! 23 °C  
Furan-2-yllithium  (Table 2.7, entry 9).  Prepared following a procedure similar to 
Sauers and Hagedorn.61  See p. 236 for the synthesis and use of this reagent. 
 
MgCl
S
Cl
S
Mg(0), DIBAL (4 mol %)
THF
0.44 M in THF  
Thiophen-2-ylmagnesium chloride  (Table 2.7, entry 10).  A two neck 50 mL round-
bottom flask equipped with a magnetic stir bar, fitted with a rubber septum on one neck 
and a water condenser on the other neck, and connected to a Schlenk manifold (through 
the condenser) was flame-dried three times, backfilling with argon after each drying 
cycle.  Once cool, magnesium metal (635.0 mg, 26.12 mmol, 2.60 equiv) was added.  
After two argon backfilling cycles, the flask was charged with THF (20 mL) and neat 
DIBAL59 (50 µL, 0.43 mmol, 4 mol %) and stirring was initiated.  The stirring was 
stopped after 10 min and 2-chlorothiophene (930 µL, 10.04 mmol, 1.00 equiv) was added 
via a syringe with the needle in the solution directly above the magnesium.  The mixture 
was heated to reflux.  A small piece of I2 (size of a spatula tip) dissolved in THF (1 mL) 
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was cannula-transferred into the mixture after 12 h and 13.5 h.  The flask was allowed to 
cool to room temperature (23 °C).  After 15 h, an aliquot was removed and titrated 
following the procedure of Love (0.44 M in THF).49  See p. 218 and p. 238 for use this 
reagent. 
 
2.10.2.14 CARBONYL TRANSPOSITION TO γ-QUATERNARY 
CYCLOHEPTENONES 
Representative procedures for General Methods F–H are described below. 
 
O
MgBr
O
i-BuO
1. CeCl3, THF, 23 °C
    then Na3PO4 buffer
    (pH 6.5)
2. 6 mM aq HCl, CH3CN
             92% yield149a 137w  
General Method F:   
Organometallic Addition / Na3PO4 Buffer Quench / Dilute HCl Workup 
Cycloheptenone 137w.14A 100 mL round-bottom flask equipped with a magnetic stir 
bar was cycled into a glove box.  The flask was loaded with anhydrous cerium chloride 
(616.2 mg, 2.50 mmol, 2.50 equiv), fitted with a septum, removed from the glove box, 
and connected to an argon-filled Schlenk manifold.  A portion of THF (13 mL) was 
added, rinsing the cerium chloride to the bottom of the flask.  As the resulting thick white 
slurry was stirred, a solution of pent-4-enylmagnesium bromide (8.6 mL, 0.35 M in THF, 
3.01 mmol, 3.01 equiv) was added and the mixture turned grey.  After 30 min of stirring, 
vinylogous ester 149a (236.3 mg, 1.00 mmol, 1.00 equiv) was cannula-transferred to the 
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slurry from a flame-dried 10 mL conical flask using several THF rinses (3 x 4 mL; total 
THF added = 25 mL, 0.04 M).  TLC analysis indicated that no starting material remained 
after 5 min.  After an additional 10 min of stirring, the reaction was quenched with pH 
6.5 Na3PO4 buffer (20 mL).  A thick grey emulsion formed. The mixture was transferred 
to a separatory funnel where the aqueous phase was extracted four times with Et2O.  The 
combined organic (150 mL) were dried over MgSO4, filtered, and concentrated under 
reduced pressure.  The crude oil was transferred to a 20 mL scintillation vial and 
concentrated under reduced pressure.  A stir bar, CH3CN (2.0 mL), and aqueous HCl (2.0 
mL, 6 mM) were added to the vial.  The resulting cloudy solution was stirred vigorously 
for 30 min before being transferred to a separatory funnel where the aqueous phase was 
extracted four times with Et2O.  The combined organics (75 mL) were dried over MgSO4, 
filtered, and concentrated under reduced pressure. The crude oil was purified by flash 
chromatography (SiO2, 3 x 30 cm, 100% hexanes→1%→2%→5% EtOAc in hexanes) to 
afford cycloheptenone 137w (214.2 mg, 0.92 mmol, 92% yield) as a clear colorless oil. 
 
O
MgCl
S
S
O
i-BuO
CeCl3, THF, 23 °C
then 10% aq HCl, 60 °C
84% yield149a 137ab  
General Method G:  Organometallic Addition / Aq. HCl Quench 
Cycloheptenone 137ab.15A 100 mL round-bottom flask equipped with a magnetic stir 
bar was cycled into a glove box.  The flask was loaded with anhydrous cerium chloride 
(616.2 mg, 2.50 mmol, 2.50 equiv), fitted with a septum, removed from the glove box, 
and connected to an argon-filled Schlenk manifold.  A portion of THF (13 mL) was 
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added, rinsing the cerium chloride to the bottom of the flask.  As the resulting thick white 
slurry was stirred, a solution of thiophen-2-ylmagnesium chloride (6.8 mL, 0.44 M in 
THF, 2.99 mmol, 2.99 equiv) was added and the mixture turned dark grey.  After 30 min 
of stirring, vinylogous ester 149a (236.4 mg, 1.00 mmol, 1.00 equiv) was cannula-
transferred to the slurry from a flame-dried 10 mL conical flask using several THF rinses 
(3 x 4 mL; total THF added = 25 mL, 0.04 M).  TLC analysis indicated that no starting 
material remained after 25 min.  After an additional 5 min of stirring, the reaction was 
quenched with aqueous HCl (5 mL, 10% w/w) and lowered into a preheated oil bath (60 
°C).  After 20 h, additional aqueous HCl (5 mL, 10% w/w) was added.  After 26 h, the 
yellow solution was removed from the bath, cooled to ambient temperature, treated with 
sat. aqueous NaHCO3 solution (25 mL), and transferred to a separatory funnel where the 
aqueous phase was extracted four times with Et2O.  The combined organics (150 mL) 
were rinsed once with sat. aqueous NaHCO3, dried over MgSO4, filtered, and 
concentrated under reduced pressure.  The crude oil was purified by flash 
chromatography (SiO2, 3 x 30 cm, 100% hexanes→2%→5% EtOAc in hexanes) to afford 
cycloheptenone 137ab (206.1 mg, 0.84 mmol, 84% yield) as a yellow/orange oil. 
 
O
MgBr
O
i-BuO
CeCl3, THF, 23 °C
then 2 M aq H2SO4, 60 °C
97% yield149a 137y  
General Method H:  Organometallic Addition / Aq. H2SO4 Quench 
Cycloheptenone 137y.16A 100 mL round-bottom flask equipped with a magnetic stir bar 
was cycled into a glove box.  The flask was loaded with anhydrous cerium chloride 
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(616.2 mg, 2.50 mmol, 2.50 equiv), fitted with a septum, removed from the glove box, 
and connected to an argon-filled Schlenk manifold.  A portion of THF (13 mL) was 
added, rinsing the cerium chloride to the bottom of the flask.  As the resulting thick white 
slurry was stirred, a solution of prop-1-ynylmagnesium bromide (12 mL, 0.25 M in THF, 
3.00 mmol, 3.00 equiv) was added and the mixture turned yellow.  After 30 min of 
stirring, vinylogous ester 149a (236.4 mg, 1.00 mmol, 1.00 equiv) was cannula-
transferred to the slurry from a flame-dried 10 mL conical flask using several THF rinses 
(3 x 4 mL; total THF added = 25 mL, 0.04 M).  The slurry maintained the yellow color 
with the addition.  TLC analysis indicated that no starting material remained after 5 min.  
After an additional 10 min of stirring, the reaction was quenched with 2 M H2SO4 (5 mL) 
and lowered into a preheated oil bath (60 °C).  A white precipitate formed within several 
minutes.  After 12 h, the yellow suspension was removed from the bath, cooled to 
ambient temperature, treated with sat. aqueous NaHCO3 solution (50 mL), and 
transferred to a separatory funnel where the aqueous phase was extracted four times with 
Et2O.  The combined organics (175 mL) were rinsed once with sat. aqueous NaHCO3, 
dried over MgSO4, filtered, and concentrated under reduced pressure.  The crude oil was 
purified by flash chromatography (SiO2, 3 x 30 cm, 100% hexanes→2%→5% EtOAc in 
hexanes) to afford cycloheptenone 137y (195.4 mg, 0.97 mmol, 97% yield) as a yellow 
oil.  
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O
O
i-BuO
1. CeCl3, THF, 23 °C
then pH 6.5 Na3PO4 buffer
2. 6 mM aq HCl, CH3CN
84% yield149a 137r
MgBr
 
Cycloheptenone 137r  (Table 2.5, entry 1).17Prepared using General Method F.  A 50 
mL round-bottom flask equipped with a magnetic stir bar, fitted with a rubber septum, 
and connected to a Schlenk manifold was flame-dried three times, backfilling with argon 
after each drying cycle.  The hot flask was placed into a glove box antechamber, which 
was evacuated/backfilled with N2 (3 cycles, 5 min evacuation per cycle) before the flask 
was brought into the glove box.  The flask was loaded with anhydrous cerium chloride 
(260.8 mg, 1.06 mmol, 2.50 equiv), refitted with the septum, removed from the glove 
box, and reconnected to the argon-filled Schlenk manifold.  A portion of THF (8.5 mL) 
was added, rinsing the cerium chloride to the bottom of the flask. As the resulting thick 
white slurry was stirred, a solution of n-butylmagnesium bromide (680 µL, 1.87 M in 
THF, 1.27 mmol, 3.00 equiv) was added and the mixture turned grey.  After 30 min of 
stirring, vinylogous ester 149a (100.0 mg, 0.42 mmol, 1.00 equiv) was added neat from a 
Hamilton syringe and the needle was rinsed with a small portion of THF (2 mL; total 
THF added = 10.5 mL, 0.04 M).  The color of the slurry initially transitioned to yellow 
with the vinylogous ester addition before turning back to grey. 
TLC analysis indicated that no starting material remained after 15 min.  After an 
additional 10 min of stirring, the reaction was quenched with pH 6.5 Na3PO4 buffer (8 
mL).  A thick grey emulsion formed.  The mixture was transferred to a separatory funnel 
where the aqueous phase was extracted four times with Et2O.  The combined organics 
(125 mL) were dried over MgSO4, filtered, and concentrated under reduced pressure.  
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The crude oil was transferred to a 20 mL scintillation vial and concentrated under 
reduced pressure.  A stir bar, CH3CN (1.0 mL), and 6 mM aqueous HCl (1.0 mL) were 
added to the vial.  The resulting cloudy solution was stirred vigorously for 5 min before 
being transferred to a separatory funnel where the aqueous phase was extracted four 
times with Et2O.  The combined organics (100 mL) were dried over MgSO4, filtered, and 
concentrated under reduced pressure.  The crude oil was purified by flash 
chromatography (SiO2, 3 x 30 cm, 100% hexanes→2%→5% EtOAc in hexanes) to afford 
cycloheptenone 137r (82.4 mg, 0.35 mmol, 84% yield) as a pale yellow oil. (For 
characterization data, see p. 178). 
 
MgBr
1. CeCl3, THF, 23 °C
then pH 6.5 Na3PO4 buffer
2. 6 mM aq HCl, CH3CN
73% yield
O
O
i-BuO
149a 137s  
Cycloheptenone 137s  (Table 2.5, entry 2).18Prepared using General Method F.  A 100 
mL round-bottom flask equipped with a magnetic stir bar, fitted with a rubber septum, 
and connected to a Schlenk manifold was flame-dried three times, backfilling with argon 
after each drying cycle.  The hot flask was placed into a glove box antechamber, which 
was evacuated/backfilled with N2 (3 cycles, 5 min evacuation per cycle) before the flask 
was brought into the glove box.  The flask was loaded with anhydrous cerium chloride 
(616.3 mg, 2.50 mmol, 2.50 equiv), refitted with the septum, removed from the glove 
box, and reconnected to the argon-filled Schlenk manifold.  A portion of THF (13 mL) 
was added, rinsing the cerium chloride to the bottom of the flask.  As the resulting thick 
white slurry was stirred, a solution of allylmagnesium bromide (3.49 mL, 0.86 M in Et2O, 
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3.00 mmol, 3.00 equiv) was added and the mixture turned initially orange and red over 
time.  After 30 min of stirring, vinylogous ester 149a (236.6 mg, 1.00 mmol, 1.00 equiv) 
was cannula-transferred to the slurry from a flame-dried 10 mL conical flask using 
several THF rinses (3 x 4 mL; total THF added = 25 mL, 0.04 M).  The mixture faded 
back to orange with the addition.  
TLC analysis indicated that no starting material remained after 5 min.  After an 
additional 10 min of stirring, the reaction was quenched with pH 6.5 Na3PO4 buffer (20 
mL).  A thick grey emulsion formed.  The mixture was transferred to a separatory funnel 
where the aqueous phase was extracted four times with Et2O.  The combined organics 
(250 mL) were dried over MgSO4, filtered, and concentrated under reduced pressure.  
The crude oil was transferred to a 20 mL scintillation vial and concentrated under 
reduced pressure.  A stir bar, CH3CN (2.0 mL), and 6 mM aqueous HCl (2.0 mL) were 
added to the vial.  The resulting cloudy solution was stirred vigorously for 30 min before 
being transferred to a separatory funnel where the aqueous phase was extracted four 
times with Et2O.  The combined organics (75 mL) were dried over MgSO4, filtered, and 
concentrated under reduced pressure.  The crude oil was purified by flash 
chromatography (SiO2, 3 x 30 cm, 100% hexanes→2%→5% EtOAc in hexanes) to afford 
cycloheptenone 137s (148.6 mg, 0.73 mmol, 73% yield) as a pale yellow oil;  Rf = 0.68 
(30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) δ 5.88 (s, 1H), 5.75 (dddd, J = 
16.9, 10.1, 6.8, 6.8 Hz, 1H), 5.64 (dddd, J = 17.0, 10.3, 7.8, 6.8 Hz, 1H), 5.14–5.00 (m, 
4H), 2.96–2.84 (m, 2H), 2.62–2.54 (m, 2H), 2.38 (dddd, J = 14.2, 6.8, 1.3, 1.3 Hz, 1H), 
2.10 (dddd, J = 14.2, 7.8, 1.1, 1.1 Hz, 1H), 1.84–1.76 (m, 3H), 1.67–1.57 (m, 1H), 1.17 
(s, 3H);  13C NMR (125 MHz, CDCl3) δ 205.2, 160.3, 136.0, 134.0, 130.0, 118.3, 117.9, 
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45.5, 45.2, 44.4, 38.8, 38.5, 25.7, 17.6;  IR (Neat Film NaCl) 3077, 2976, 2939, 2872, 
1654, 1612, 1458, 1412, 1380. 1342, 1290, 1250, 1217, 1177, 1106, 996, 916 cm-1;  
HRMS (MM: ESI-APCI+) m/z calc’d for C14H21O [M+H]+: 205.1587; found 205.1587; 
[α]D25.0 –34.64 (c 1.55, CHCl3, 88% ee). 
 
1. CeCl3, THF, 23 °C
then pH 6.5 Na3PO4 buffer
2. 6 mM aq HCl, CH3CN
93% yield
O
O
i-BuO
149a 137t
MgBr
 
Cycloheptenone 137t  (Table 2.5, entry 3).19Prepared using General Method F.  A 100 
mL round-bottom flask equipped with a magnetic stir bar, fitted with a rubber septum, 
and connected to a Schlenk manifold was flame-dried three times, backfilling with argon 
after each drying cycle.  The hot flask was placed into a glove box antechamber, which 
was evacuated/backfilled with N2 (3 cycles, 5 min evacuation per cycle) before the flask 
was brought into the glove box.  The flask was loaded with anhydrous cerium chloride 
(616.2 mg, 2.50 mmol, 2.50 equiv), refitted with the septum, removed from the glove 
box, and reconnected to the argon-filled Schlenk manifold.  A portion of THF (13 mL) 
was added, rinsing the cerium chloride to the bottom of the flask.  As the resulting thick 
white slurry was stirred, a solution of (2-methylallyl)magnesium bromide (7.7 mL, 0.39 
M in THF, 3.00 mmol, 3.00 equiv) was added and the mixture turned initially yellow and 
eventually orange with time.  After 30 min of stirring, vinylogous ester 149a (236.2 mg, 
1.00 mmol, 1.00 equiv) was cannula-transferred to the slurry from a flame-dried 10 mL 
conical flask using several THF rinses (3 x 4 mL; total THF added = 25 mL, 0.04 M). 
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TLC analysis indicated that no starting material remained after 5 min.  After an 
additional 15 min of stirring, the reaction was quenched with pH 6.5 Na3PO4 buffer (20 
mL).  A thick grey emulsion formed.  The mixture was transferred to a separatory funnel 
where the aqueous phase was extracted four times with Et2O.  The combined organics 
(150 mL) were dried over MgSO4, filtered, and concentrated under reduced pressure.  
The crude oil was transferred to a 20 mL scintillation vial and concentrated under 
reduced pressure.  A stir bar, CH3CN (2.0 mL), and 6 mM aqueous HCl (2.0 mL) were 
added to the vial.  The resulting cloudy solution was stirred vigorously for 30 min before 
being transferred to a separatory funnel where the aqueous phase was extracted four 
times with Et2O.  The combined organics (75 mL) were dried over MgSO4, filtered, and 
concentrated under reduced pressure.  The crude oil was purified by flash 
chromatography (SiO2, 3 x 30 cm, 100% hexanes→2%→5% EtOAc in hexanes) to afford 
cycloheptenone 137t (202.9 mg, 0.93 mmol, 93% yield) as a pale yellow oil;  Rf = 0.65 
(30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) δ 5.89 (s, 1H), 5.65 (dddd, J = 
16.9, 10.3, 7.8, 6.8 Hz, 1H), 5.09–5.01 (m, 2H), 4.94–4.91 (m, 1H), 4.78 (dd, J = 1.9, 0.9 
Hz, 1H), 2.85 (q, J = 16.2 Hz, 2H), 2.63–2.55 (m, 2H), 2.37 (dddd, J = 14.1, 6.8, 1.3, 1.3 
Hz, 1H), 2.10 (dddd, J = 14.2, 7.8, 1.1, 1.1 Hz, 1H), 1.85–1.75 (m, 3H), 1.68 (s, 3H), 
1.66–1.59 (m, 1H), 1.16 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 205.3, 159.1, 142.8, 
134.0, 129.5, 118.3, 115.2, 45.4, 45.0, 44.4, 42.7, 38.8, 25.6, 22.2, 17.6;  IR (Neat Film 
NaCl) 3075, 2970, 2939, 2872, 1661, 1652, 1612, 1455, 1376, 1342, 1309, 1249, 1218, 
996, 914, 893 cm-1;  HRMS (MM: ESI-APCI+) m/z calc’d for C15H23O [M+H]+: 
219.1743; found 219.1740;  [α]D25.0 –35.09 (c 0.95, CHCl3, 88% ee). 
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1. CeCl3, THF, 23 °C
then pH 6.5 Na3PO4 buffer
2. 6 mM aq HCl, CH3CN
90% yield
O
O
i-BuO
149a 137u
MgBr
 
Cycloheptenone 137u  (Table 2.5, entry 4).20Prepared using General Method F.  A 100 
mL round-bottom flask equipped with a magnetic stir bar, fitted with a rubber septum, 
and connected to a Schlenk manifold was flame-dried three times, backfilling with argon 
after each drying cycle.  The hot flask was placed into a glove box antechamber, which 
was evacuated/backfilled with N2 (3 cycles, 5 min evacuation per cycle) before the flask 
was brought into the glove box.  The flask was loaded with anhydrous cerium chloride 
(616.2 mg, 2.50 mmol, 2.50 equiv), refitted with the septum, removed from the glove 
box, and reconnected to the argon-filled Schlenk manifold.  A portion of THF (13 mL) 
was added, rinsing the cerium chloride to the bottom of the flask.  As the resulting white 
mixture was stirred, a solution of but-3-enylmagnesium bromide (6.82 mL, 0.44 M in 
THF, 3.00 mmol, 3.00 equiv) was added, generating a thick grey slurry.  After 30 min of 
stirring, vinylogous ester 149a (236.4 mg, 1.00 mmol, 1.00 equiv) was cannula-
transferred to the slurry from a flame-dried 10 mL conical flask using several THF rinses 
(3 x 4 mL; total THF added = 25 mL, 0.04 M). 
After 20 min, the reaction was quenched with pH 6.5 Na3PO4 buffer (20 mL).  A thick 
grey emulsion formed.  The mixture was transferred to a separatory funnel where the 
aqueous phase was extracted four times with Et2O.  The combined organic (150 mL) 
were dried over MgSO4, filtered, and concentrated under reduced pressure.  The crude oil 
was transferred to a 20 mL scintillation vial and concentrated under reduced pressure.  A 
stir bar, CH3CN (2.0 mL), and 6 mM aqueous HCl (2.0 mL) were added to the vial.  The 
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resulting cloudy solution was stirred vigorously for 5 min before being transferred to a 
separatory funnel where the aqueous phase was extracted four times with Et2O.  The 
combined organics (80 mL) were dried over MgSO4, filtered, and concentrated under 
reduced pressure.  The crude oil was purified by flash chromatography (SiO2, 3 x 30 cm, 
100% hexanes→2%→5%→10% EtOAc in hexanes) to afford cycloheptenone 137u 
(196.6 mg, 0.90 mmol, 90% yield) as a yellow oil;  Rf = 0.67 (30% EtOAc in hexanes);  
1H NMR (500 MHz, CDCl3) δ 5.88 (s, 1H), 5.86–5.77 (m, 1H), 5.63 (dddd, J = 16.9, 
10.3, 7.8, 6.8 Hz, 1H), 5.08–4.96 (m, 4H), 2.59–2.54 (m, 2H), 2.36 (dddd, J = 14.1, 6.7, 
1.3, 1.3 Hz, 1H), 2.28–2.17 (m, 4H), 2.08 (dddd, J = 14.1, 7.9, 2.1, 1.0 Hz, 1H), 1.83–
1.73 (m, 3H), 1.65–1.57 (m, 1H), 1.15 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 205.2, 
161.6, 137.7, 134.0, 128.9, 118.2, 115.4, 45.7, 45.2, 44.3, 38.7, 34.0, 33.4, 25.7, 17.6;  IR 
(Neat Film NaCl) 3076, 2975, 2938, 2872, 1652, 1611, 1465, 1452, 1415, 1379, 1342, 
1263, 1218, 1177, 1109, 1069, 996, 914, 877, 841, 764, 714 cm-1;  HRMS (MM: ESI-
APCI+) m/z calc’d for C15H23O [M+H]+: 219.1743; found 219.1742;  [α]D25.0 –34.11 (c 
1.21, CHCl3, 88% ee). 
 
1. CeCl3, THF, 23 °C
then pH 6.5 Na3PO4 buffer
2. 6 mM aq HCl, CH3CN
82% yield
O
O
i-BuO
149a 137v
MgBr
 
Cycloheptenone 137v  (Table 2.5, entry 5).21Prepared using General Method F.  A 100 
mL round-bottom flask equipped with a magnetic stir bar, fitted with a rubber septum, 
and connected to a Schlenk manifold was flame-dried three times, backfilling with argon 
after each drying cycle.  The hot flask was placed into a glove box antechamber, which 
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was evacuated/backfilled with N2 (3 cycles, 5 min evacuation per cycle) before the flask 
was brought into the glove box.  The flask was loaded with anhydrous cerium chloride 
(616.2 mg, 2.50 mmol, 2.50 equiv), refitted with the septum, removed from the glove 
box, and reconnected to the argon-filled Schlenk manifold.  A portion of THF (13 mL) 
was added, rinsing the cerium chloride to the bottom of the flask.  As the resulting thick 
white slurry was stirred, a solution of (3-methylbut-3-enyl)magnesium bromide (7.3 mL, 
0.41 M in THF, 2.99 mmol, 2.99 equiv) was added and the mixture turned yellow.  After 
30 min of stirring, vinylogous ester 149a (236.4 mg, 1.00 mmol, 1.00 equiv) was 
cannula-transferred to the slurry from a flame-dried 10 mL conical flask using several 
THF rinses (3 x 4 mL; total THF added = 25 mL, 0.04 M). 
TLC analysis indicated that no starting material remained after 5 min.  After an 
additional 10 min of stirring, the reaction was quenched with pH 6.5 Na3PO4 buffer (20 
mL).  A thick grey emulsion formed.  The mixture was transferred to a separatory funnel 
where the aqueous phase was extracted four times with Et2O.  The combined organic 
(150 mL) were dried over MgSO4, filtered, and concentrated under reduced pressure.  
The crude oil was transferred to a 20 mL scintillation vial and concentrated under 
reduced pressure.  A stir bar, CH3CN (2.0 mL), and 6 mM aqueous HCl (2.0 mL) were 
added to the vial.  The resulting cloudy solution was stirred vigorously for 5 min before 
being transferred to a separatory funnel where the aqueous phase was extracted four 
times with Et2O.  The combined organics (75 mL) were dried over MgSO4, filtered, and 
concentrated under reduced pressure.  The crude oil was purified by flash 
chromatography (SiO2, 3 x 30 cm, 100% hexanes→2%→5% EtOAc in hexanes) to afford 
cycloheptenone 137v (191.1 mg, 0.82 mmol, 82% yield) as a clear colorless oil;  Rf = 
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0.69 (30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) δ 5.89 (s, 1H), 5.64 (dddd, J 
= 16.9, 10.3, 7.8, 6.8 Hz, 1H), 5.09–4.99 (m, 2H), 4.77–4.73 (m, 1H), 4.72–4.69 (m, 1H), 
2.59–2.56 (m, 2H), 2.38 (dddd, J = 14.1, 6.7, 1.3, 1.3 Hz, 1H), 2.31–2.14 (m, 4H), 2.10 
(dddd, J = 14.1, 7.8, 1.1, 1.1 Hz, 1H), 1.83–1.75 (m, 3H), 1.75–1.74 (m, 3H), 1.66–1.57 
(m, 1H), 1.17 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 205.3, 162.1, 145.1, 134.0, 129.0, 
118.3, 110.6, 45.8, 45.3, 44.3, 38.8, 38.3, 32.5, 25.7, 22.7, 17.6;  IR (Neat Film NaCl) 
3075, 2968, 2938, 2873, 1652, 1611, 1455, 1415, 1377, 1342, 1262, 1218, 1181, 1109, 
1069, 996, 915, 887 cm-1;  HRMS (MM: ESI-APCI+) m/z calc’d for C16H25O [M+H]+: 
233.1900; found 233.1896;  [α]D25.0 –32.57 (c 1.32, CHCl3, 88% ee). 
 
1. CeCl3, THF, 23 °C
then pH 6.5 Na3PO4 buffer
2. 6 mM aq HCl, CH3CN
92% yield
O
O
i-BuO
149a 137w
MgBr
 
Cycloheptenone 137w  (Table 2.5, entry 6).22Prepared using General Method F.  A 100 
mL round-bottom flask equipped with a magnetic stir bar, fitted with a rubber septum, 
and connected to a Schlenk manifold was flame-dried three times, backfilling with argon 
after each drying cycle.  The hot flask was placed into a glove box antechamber, which 
was evacuated/backfilled with N2 (3 cycles, 5 min evacuation per cycle) before the flask 
was brought into the glove box.  The flask was loaded with anhydrous cerium chloride 
(616.2 mg, 2.50 mmol, 2.50 equiv), refitted with the septum, removed from the glove 
box, and reconnected to the argon-filled Schlenk manifold.  A portion of THF (13 mL) 
was added, rinsing the cerium chloride to the bottom of the flask.  As the resulting thick 
white slurry was stirred, a solution of pent-4-enylmagnesium bromide (8.6 mL, 0.35 M in 
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THF, 3.01 mmol, 3.01 equiv) was added and the mixture turned grey.  After 30 min of 
stirring, vinylogous ester 149a (236.3 mg, 1.00 mmol, 1.00 equiv) was cannula-
transferred to the slurry from a flame-dried 10 mL conical flask using several THF rinses 
(3 x 4 mL; total THF added = 25 mL, 0.04 M). 
TLC analysis indicated that no starting material remained after 5 min.  After an 
additional 10 min of stirring, the reaction was quenched with pH 6.5 Na3PO4 buffer (20 
mL).  A thick grey emulsion formed. The mixture was transferred to a separatory funnel 
where the aqueous phase was extracted four times with Et2O.  The combined organic 
(150 mL) were dried over MgSO4, filtered, and concentrated under reduced pressure.  
The crude oil was transferred to a 20 mL scintillation vial and concentrated under 
reduced pressure.  A stir bar, CH3CN (2.0 mL), and 6 mM aqueous HCl (2.0 mL) were 
added to the vial.  The resulting cloudy solution was stirred vigorously for 30 min before 
being transferred to a separatory funnel where the aqueous phase was extracted four 
times with Et2O.  The combined organics (75 mL) were dried over MgSO4, filtered, and 
concentrated under reduced pressure. The crude oil was purified by flash chromatography 
(SiO2, 3 x 30 cm, 100% hexanes→1%→2%→5% EtOAc in hexanes) to afford 
cycloheptenone 137w (214.2 mg, 0.92 mmol, 92% yield) as a clear colorless oil;  Rf = 
0.65 (30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) δ 5.88 (s, 1H), 5.79 (dddd, J 
= 16.9, 10.2, 6.7, 6.7 Hz, 1H), 5.67–5.57 (m, 1H), 5.07–4.96 (m, 4H), 2.60–2.53 (m, 2H), 
2.35 (dddd, J = 14.1, 6.7, 2.5, 1.2 Hz, 1H), 2.20–2.04 (m, 5H), 1.83–1.73 (m, 3H), 1.66–
1.53 (m, 3H), 1.14 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 205.3, 162.6, 138.2, 134.1, 
128.8, 118.2, 115.3, 45.7, 45.2, 44.3, 38.7, 33.8, 33.5, 29.3, 25.7, 17.6;  IR (Neat Film 
NaCl) 3076, 2975, 2937, 2870, 1652, 1611, 1456, 1415, 1380, 1343, 1257, 1218, 1179, 
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1110, 1071, 994, 913 cm-1;  HRMS (MM: ESI-APCI+) m/z calc’d for C16H25O [M+H]+: 
233.1900; found 233.1900;  [α]D25.0 –34.96 (c 1.46, CHCl3, 88% ee). 
 
O
Ph
Ph Br
O
i-BuO
1. t-BuLi, Et2O
    –78!23 °C
   then 149a
2. 10% aq HCl
    THF/H2O, 50 °C
84% yield149a 137x  
Cycloheptenone 137x  (Table 2.5, entry 7).23Prepared using General Method G.  A 
flame-dried round-bottom flask equipped with a magnetic stir bar and fitted with a rubber 
septum was connected to a Schlenk manifold.  The flask was charged with (E)-β-
bromostyrene (1.5 mL, 11.69 mmol, 1.98 equiv) and Et2O (13 mL) and lowered into a 
dry ice/acetone bath (–78 °C).  After dropwise addition of t-butyllithium (13.5 mL, 1.7 M 
in pentane, 22.95 mmol, 3.88 equiv), the solution was stirred for 2 hours (at –78 °C), 
warmed to room temperature (30 min stir at 23 °C), and placed back into the dry 
ice/acetone bath.  Vinylogous ester 149a (1.40 g, 5.92 mmol, 1.00 equiv) was transferred 
to the round-bottom flask by two Et2O rinses (2 x 3 mL, total Et2O added = 19 mL, 0.3 
M).  The flask was stirred at –78 °C for 25 min before being transferred to an ice/water 
bath (0 °C). 
TLC analysis indicated that no starting material remained after 2 h.  Consequently, 
the reaction was quenched with 10% w/w aqueous HCl (10 mL).  After 20 min of 
stirring, the mixture was transferred to a separatory funnel where the aqueous phase was 
extracted three times with Et2O.  The combined organics were dried over MgSO4, 
filtered, and concentrated under reduced pressure. A round-bottom flask was charged 
with the crude oil, THF (20 mL), and 10% w/w aqueous HCl (0.5 mL) and lowered into a 
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preheated oil bath (50 °C).  After 2 h, the reaction allowed to cool to room temperature, 
concentrated under reduced pressure, diluted with water (10 mL) and Et2O (20 mL), and 
transferred to a separatory funnel where the aqueous layer was extracted twice with Et2O 
(2 x 20 mL).  The combined organics were dried over MgSO4, filtered, and concentrated 
under reduced pressure.  The crude oil was purified by flash chromatography (SiO2, 3 x 
23 cm, 20:1→15:1→10:1 hexanes:EtOAc) to afford cycloheptenone 137x (1.33 g, 4.99 
mmol, 84% yield) as a yellow oil;  Rf = 0.67 (30% EtOAc in hexanes);  1H NMR (500 
MHz, CDCl3) δ 7.42 (d, J = 7.3 Hz, 2H), 7.35 (d, J = 7.4 Hz, 2H), 7.28 (d, J = 7.3 Hz, 
1H), 6.90 (s, 2H), 6.30 (s, 1H), 5.67 (dddd, J = 16.8, 10.3, 8.1, 6.5 Hz, 1H), 5.09–5.02 
(m, 2H), 2.71–2.57 (m, 2H), 2.46 (dddd, J = 14.1, 6.5, 1.3, 1.3 Hz, 1H), 2.14 (dddd, J = 
14.1, 8.1, 1.1, 1.1 Hz, 1H), 1.92–1.79 (m, 3H), 1.72–1.64 (m, 1H), 1.27 (s, 3H);  13C 
NMR (125 MHz, CDCl3) δ 204.7, 158.5, 136.7, 133.9, 133.3, 129.2, 128.9, 128.5, 127.1, 
127.1, 118.4, 46.2, 44.5, 44.4, 38.7, 26.8, 17.6;  IR (Neat Film NaCl) 3075, 3059, 3002, 
2966, 2936, 2869, 1640, 1581, 1573, 1495, 1449, 1414, 1379. 1343, 1303, 12.77, 1250, 
1217, 1178, 1109, 1082, 1028, 996, 963, 916, 839, 799, 752, 718 cm-1;  HRMS (MM: 
ESI-APCI+) m/z calc’d for C19H23O [M+H]+: 267.1743; found 267.1755;  [α]D25.0 –44.99 
(c 0.81, CHCl3, 88% ee). 
 
O
MgBr
O
i-BuO
CeCl3, THF, 23 °C
then
2 M aq H2SO4, 60 °C
97% yield149a 137y  
Cycloheptenone 137y  (Table 2.5, entry 8).24Prepared using General Method H.  A 100 
mL round-bottom flask equipped with a magnetic stir bar, fitted with a rubber septum, 
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and connected to a Schlenk manifold was flame-dried three times, backfilling with argon 
after each drying cycle.  The hot flask was placed into a glove box antechamber, which 
was evacuated/backfilled with N2 (3 cycles, 5 min evacuation per cycle) before the flask 
was brought into the glove box.  The flask was loaded with anhydrous cerium chloride 
(616.2 mg, 2.50 mmol, 2.50 equiv), refitted with the septum, removed from the glove 
box, and reconnected to the argon-filled Schlenk manifold.  A portion of THF (13 mL) 
was added, rinsing the cerium chloride to the bottom of the flask.  As the resulting thick 
white slurry was stirred, a solution of prop-1-ynylmagnesium bromide (12 mL, 0.25 M in 
THF, 3.00 mmol, 3.00 equiv) was added and the mixture turned yellow.  After 30 min of 
stirring, vinylogous ester 149a (236.4 mg, 1.00 mmol, 1.00 equiv) was cannula-
transferred to the slurry from a flame-dried 10 mL conical flask using several THF rinses 
(3 x 4 mL; total THF added = 25 mL, 0.04 M).  The slurry maintained the yellow color 
with the addition. 
TLC analysis indicated that no starting material remained after 5 min.  After an 
additional 10 min of stirring, the reaction was quenched with 2 M H2SO4 (5 mL) and 
lowered into a preheated oil bath (60 °C).  A white precipitate formed within several 
minutes.  After 12 h, the yellow suspension was removed from the bath, cooled to room 
temperature (23 °C), treated with sat. aqueous NaHCO3 solution (50 mL), and transferred 
to a separatory funnel where the aqueous phase was extracted four times with Et2O.  The 
combined organics (175 mL) were rinsed once with sat. aqueous NaHCO3, dried over 
MgSO4, filtered, and concentrated under reduced pressure.  The crude oil was purified by 
flash chromatography (SiO2, 3 x 30 cm, 100% hexanes→2%→5% EtOAc in hexanes) to 
afford cycloheptenone 137y (195.4 mg, 0.97 mmol, 97% yield) as a yellow oil;  Rf = 0.65 
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(30% EtoAc in hexanes);  1H NMR (500 MHz, CDCl3) δ 6.20 (s, 1H), 5.70 (dddd, J = 
16.8, 10.5, 8.2, 6.6 Hz, 1H), 5.10–5.01 (m, 2H), 2.65–2.49 (m, 3H), 2.16 (dddd, J = 13.8, 
8.2, 1.0, 1.0 Hz, 1H), 2.01 (s, 3H), 1.83–1.75 (m, 3H), 1.66–1.59 (m, 1H), 1.24 (s, 3H);  
13C NMR (125 MHz, CDCl3) δ 203.5, 145.6, 135.0, 134.3, 118.3, 92.9, 80.7, 46.5, 45.4, 
44.6, 37.3, 27.0, 17.6, 4.7;  IR (Neat Film NaCl) 3076, 2969, 2937, 2219, 1652, 1580, 
1455, 1415, 1377, 1346, 1255, 1225, 1184, 1110, 998, 916, 893, 866, 813, 784, 716 cm-1;  
HRMS (MM: ESI-APCI+) m/z calc’d for C14H19O [M+H]+: 203.1430; found 203.1428;  
[α]D25.0  –49.25 (c 1.21, CHCl3, 88% ee). 
 
O
O
i-BuO
CeCl3, THF, 23 °C
then
2 M aq H2SO4, 60 °C
66% yield149a 137z
MgBr
 
Cycloheptenone 137z  (Table 2.5, entry 9).25Prepared using General Method H.  A 100 
mL round-bottom flask equipped with a magnetic stir bar, fitted with a rubber septum, 
and connected to a Schlenk manifold was flame-dried three times, backfilling with argon 
after each drying cycle.  The hot flask was placed into a glove box antechamber, which 
was evacuated/backfilled with N2 (4 cycles, 1 min evacuation per cycle) before the flask 
was brought into the glove box.  The flask was loaded with anhydrous cerium chloride 
(616.4 mg, 2.50 mmol, 2.50 equiv), refitted with the septum, removed from the glove 
box, and reconnected to the argon-filled Schlenk manifold.  A portion of THF (13 mL) 
was added, rinsing the cerium chloride to the bottom of the flask.  As the resulting thick 
white slurry was stirred, a solution of (2-vinylphenyl)magnesium bromide (7.5 mL, 0.40 
M in THF, 3.00 mmol, 3.00 equiv) was added and the mixture turned yellow and green 
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over time.  After 30 min of stirring, vinylogous ester 149a (236.3 mg, 1.00 mmol, 1.00 
equiv) was cannula-transferred to the slurry from a flame-dried 10 mL conical flask using 
several THF rinses (3 x 4 mL; total THF added = 25 mL, 0.04 M).  The reaction color 
returned to yellow with addition of vinylogous ester 149a. 
TLC analysis indicated that no starting material remained after 40 min.  After an 
additional 30 min of stirring, the reaction was quenched with 2 M H2SO4 (5 mL) and 
lowered into a preheated oil bath (60 °C).  A grey precipitate formed within several 
minutes.  After 26 h, the yellow suspension was removed from the bath, cooled to room 
temperature (23 °C), treated with sat. aqueous NaHCO3 solution (50 mL), and transferred 
to a separatory funnel where the aqueous phase was extracted four times with Et2O.  The 
combined organics (175 mL) were rinsed once with sat. aqueous NaHCO3, dried over 
MgSO4, filtered, and concentrated under reduced pressure.  The crude oil was purified 
first by flash chromatography (SiO2, 3 x 30 cm, 100% hexanes→2%→5% EtOAc in 
hexanes) and then by flash chromatography using a Teledyne Isco CombiFlash Rf system 
(SiO2, 12 g loading cartridge, 40 g column, multi-step gradient, hold 0% [2 min]→ramp 
to 85% [17 min]→hold 85% CH2Cl2 in hexanes [2.5 min]→ramp to 100% [3 min]→hold 
100% CH2Cl2 [5 min]) to afford cycloheptenone 137z (176.7 mg, 0.66 mmol, 66% yield) 
as a pale yellow oil;  Rf = 0.74 (30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) 
and 13C NMR (125 MHz, CDCl3) mixture of two atropisomers isomers (1.9 : 1 ratio), see 
Figure A1.307 for 1H NMR (in CDCl3) and Figure A1.308 for variable temperature 1H 
NMR data (in DMSO-d6 at 25, 50, 75, and 100 °C);  IR (Neat Film NaCl) 3060, 3007, 
2973, 2936, 2936, 1669, 1626, 1604, 1594, 1476, 1464, 1443, 1413, 1379, 1356, 1338, 
1307, 1281, 1251, 1214, 1177, 1136, 1109, 1095, 1057, 1020, 996, 915, 864, 818, 769, 
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743 cm-1;  HRMS (MM: ESI-APCI+) m/z calc’d for C19H23O [M+H]+: 267.1743; found 
267.1751. 
 
Li
O
CeCl3, THF, 23 °C
then 
10% aq HCl, 60 °C
72% yield
O
O
i-BuO
149a 137aa
O
 
Cycloheptenone 137aa  (Table 2.5, entry 10).26Prepared using General Method G.  A 
100 and a 25 mL round-bottom flask each equipped with a magnetic stir bar, fitted with a 
rubber septum, and connected to a Schlenk manifold were flame-dried three times, 
backfilling with argon after each drying cycle.  The hot 100 mL flask was placed into a 
glove box antechamber, which was evacuated/backfilled with N2 (3 cycles, 5 min 
evacuation per cycle) before the flask was brought into the glove box.  The flask was 
loaded with anhydrous cerium chloride (616.2 mg, 2.50 mmol, 2.50 equiv), refitted with 
the septum, removed from the glove box, and reconnected to the argon-filled Schlenk 
manifold.  
Once cool, the 25 mL flask was charged with furan (230 µL, 3.16 mmol, 1.05 equiv) 
and Et2O (3 mL, 1 M) and lowered into an ethylene glycol/dry ice bath (–15 °C).  To the 
cooled solution was added n-BuLi (1.42 mL, 2.12 M in hexanes, 3.01 mmol, 1.00 equiv) 
dropwise and the flask was warmed to room temperature (23 °C).  The reaction became 
cloudy and white with time. After 1 h, a portion of THF (13 mL) was added to the 100 
mL flask before the contents of the 25 mL flask were cannula-transferred to the 100 mL 
flask.  After 30 min of stirring, vinylogous ester 149a (236.4 mg, 1.00 mmol, 1.00 equiv) 
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was cannula-transferred to the 100 mL flask from a flame-dried 10 mL conical flask 
using several THF rinses (3 x 4 mL; total THF added = 25 mL, 0.04 M). 
After 35 min, the reaction was quenched with 10% w/w aqueous HCl (5 mL) and 
lowered into a preheated oil bath (60 °C).  After 17 h, the solution was removed from the 
bath, cooled to room temperature (23 °C), treated with sat. aqueous NaHCO3 solution (50 
mL), and transferred to a separatory funnel where the aqueous phase was extracted four 
times with Et2O.  The combined organics (250 mL) were rinsed once with sat. aqueous 
NaHCO3, dried over MgSO4, filtered, and concentrated under reduced pressure.  The 
crude oil was purified by flash chromatography (SiO2, 3 x 30 cm, 100% 
hexanes→2%→5% EtOAc in hexanes) to afford cycloheptenone 137aa (164.7 mg, 0.72 
mmol, 72% yield) as a yellow oil;  Rf = 0.70 (30% EtOAc in hexanes);  1H NMR (500 
MHz, CDCl3) δ 7.45 (dd, J = 1.8, 0.6 Hz, 1H), 6.56 (dd, J = 3.4, 0.7 Hz, 1H), 6.43 (s, 
1H), 6.41 (dd, J = 3.4, 1.8 Hz, 1H), 5.65 (dddd, J = 16.9, 10.2, 8.1, 6.6 Hz, 1H), 5.01 
(dddd, J = 10.2, 2.0, 0.9, 0.9 Hz, 1H), 4.97 (dddd, J = 16.9, 2.3, 1.4, 1.4 Hz, 1H), 2.71–
2.60 (m, 3H), 2.24 (dddd, J = 14.1, 8.1, 1.1, 1.1 Hz, 1H), 1.97–1.81 (m, 3H), 1.72–1.64 
(m, 1H), 1.38 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 204.7, 155.3, 149.2, 142.9, 134.3, 
129.3, 118.1, 111.4, 111.2, 45.9, 44.7, 44.3, 39.8, 26.3, 17.4;  IR (Neat Film NaCl) 3118, 
3075, 2941, 2871, 1661, 1652, 1645, 1581, 1557, 1455, 1415, 1380, 1341, 1258, 1215, 
1173, 1152, 1106, 1080, 1029, 997, 956, 917, 898, 886, 858, 812, 742 cm-1;  HRMS 
(MM: ESI-APCI+) m/z calc’d for C15H19O2 [M+H]+: 231.1380; found 231.1374;  [α]D25.0 
–26.90 (c 1.18, CHCl3, 88% ee). 
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Li
S
CeCl3, THF, 23 °C
then 
10% aq HCl, 60 °C
84% yield
O
O
i-BuO
149a 137ab
S
 
Cycloheptenone 137ab  (Table 2.5, entry 11).27Prepared using General Method G.  A 
100 mL round-bottom flask equipped with a magnetic stir bar, fitted with a rubber 
septum, and connected to a Schlenk manifold was flame-dried three times, backfilling 
with argon after each drying cycle.  The hot flask was placed into a glove box 
antechamber, which was evacuated/backfilled with N2 (3 cycles, 5 min evacuation per 
cycle) before the flask was brought into the glove box.  The flask was loaded with 
anhydrous cerium chloride (616.2 mg, 2.50 mmol, 2.50 equiv), refitted with the septum, 
removed from the glove box, and reconnected to the argon-filled Schlenk manifold.  A 
portion of THF (13 mL) was added, rinsing the cerium chloride to the bottom of the flask.  
As the resulting thick white slurry was stirred, a solution of thiophen-2-ylmagnesium 
chloride (6.8 mL, 0.44 M in THF, 2.99 mmol, 2.99 equiv) was added and the mixture 
turned dark grey.  After 30 min of stirring, vinylogous ester 149a (236.4 mg, 1.00 mmol, 
1.00 equiv) was cannula-transferred to the slurry from a flame-dried 10 mL conical flask 
using several THF rinses (3 x 4 mL; total THF added = 25 mL, 0.04 M). 
TLC analysis indicated that no starting material remained after 25 min.  After an 
additional 5 min of stirring, the reaction was quenched with 10% w/w aqueous HCl (5 
mL) and lowered into a preheated oil bath (60 °C).  After 20 h, additional 10% w/w 
aqueous HCl (5 mL) was added.  After 26 h, the yellow solution was removed from the 
bath, cooled to room temperature (23 °C), treated with sat. aqueous NaHCO3 solution (25 
mL), and transferred to a separatory funnel where the aqueous phase was extracted four 
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times with Et2O.  The combined organics (150 mL) were rinsed once with sat. aqueous 
NaHCO3, dried over MgSO4, filtered, and concentrated under reduced pressure.  The 
crude oil was purified by flash chromatography (SiO2, 3 x 30 cm, 100% 
hexanes→2%→5% EtOAc in hexanes) to afford cycloheptenone 137ab (206.1 mg, 0.84 
mmol, 84% yield) as a yellow/orange oil;  Rf = 0.70 (30% EtOAc in hexanes);  1H NMR 
(500 MHz, CDCl3) δ 7.27 (dd, J = 5.0, 1.5 Hz, 1H), 7.00–6.95 (m, 2H), 6.17 (s, 1H), 5.69 
(dddd, J = 16.7, 10.2, 8.1, 6.4 Hz, 1H), 5.06 (dddd, J = 10.2, 2.0, 1.0, 1.0 Hz, 1H), 5.01 
(ddd, J = 16.9, 3.4, 1.5 Hz, 1H), 2.74–2.59 (m, 2H), 2.50 (dddd, J = 14.1, 6.4, 1.4, 1.4 Hz, 
1H), 2.12 (dddd, J = 14.1, 8.1, 1.1, 1.1 Hz, 1H), 1.96–1.84 (m, 3H), 1.77–1.68 (m, 1H), 
1.29 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 204.2, 154.6, 143.8, 134.0, 133.7, 127.0, 
126.7, 125.5, 118.5, 45.6, 45.1, 44.2, 38.8, 26.4, 17.7;  IR (Neat Film NaCl) 3103, 3075, 
2964, 2938, 2871, 1671, 1655, 1590, 1519, 1454, 1438, 1415, 1378, 1341, 1251, 1234, 
1218, 1178, 1134, 1107, 1077, 1045, 996, 917, 849, 836, 761, 708 cm-1;  HRMS (MM: 
ESI-APCI+) m/z calc’d for C15H19OS [M+H]+: 247.1151; found 247.1152;  [α]D25.0 –3.65 
(c 1.31, CHCl3, 88% ee).  
 
1. CeCl3, THF, 23 °C
then pH 6.5 Na3PO4 buffer
2. 6 mM aq HCl, CH3CN
79% yield
O
O
i-BuO
149p 198
MgBr
 
Cycloheptenone 198.28Prepared using General Method F.  A 100 mL round-bottom 
flask equipped with a magnetic stir bar, fitted with a rubber septum, and connected to a 
Schlenk manifold was flame-dried three times, backfilling with argon after each drying 
cycle.  The hot flask was placed into a glove box antechamber, which was 
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evacuated/backfilled with N2 (4 cycles, 1 min evacuation per cycle) before the flask was 
brought into the glove box.  The flask was loaded with anhydrous cerium chloride (591.6 
mg, 2.40 mmol, 2.50 equiv), refitted with the septum, removed from the glove box, and 
reconnected to the argon-filled Schlenk manifold.  A portion of THF (12 mL) was added, 
rinsing the cerium chloride to the bottom of the flask.  As the resulting thick white slurry 
was stirred, a solution of but-3-enylmagnesium bromide (6.55 mL, 0.44 M in THF, 2.88 
mmol, 3.00 equiv) was added and the mixture turned pale yellow.  After 40 min of 
stirring, vinylogous ester 149p (226.9 mg, 0.96 mmol, 1.00 equiv) was cannula-
transferred to the slurry from a 20 mL scintillation vial using several THF rinses (3 x 4 
mL; total THF added = 24 mL, 0.04 M). 
TLC analysis indicated that no starting material remained after 5 min.  After an 
additional 10 min, the reaction was quenched with pH 6.5 Na3PO4 buffer (20 mL).  A 
thick grey emulsion formed. The mixture was transferred to a separatory funnel where the 
aqueous phase was extracted four times with Et2O.  The combined organic (125 mL) 
were dried over MgSO4, filtered, and concentrated under reduced pressure.  The crude oil 
was transferred to a 20 mL scintillation vial and concentrated under reduced pressure.  A 
stir bar, CH3CN (2.0 mL), and 6 mM aqueous HCl (2.0 mL) were added to the vial.  The 
resulting cloudy solution was stirred vigorously for 5 min before being transferred to a 
separatory funnel where the aqueous phase was extracted four times with Et2O.  The 
combined organics (75 mL) were dried over MgSO4, filtered, and concentrated under 
reduced pressure. The crude oil was purified by flash chromatography (SiO2, 3 x 30.5 cm, 
100% hexanes→2%→5% EtOAc in hexanes) to afford cycloheptenone 198 (165.0 mg, 
0.76 mmol, 79% yield) as a pale yellow oil;  Rf = 0.74 (30% EtOAc in hexanes);  1H 
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NMR (500 MHz, CDCl3) δ 5.93 (s, 1H), 5.83–5.74 (m, 1H), 5.43–5.32 (m, 2H), 5.02 
(dm, J = 17.2 Hz, 1H), 4.97 (dm, J = 10.2 Hz, 1H), 2.66–2.50 (m, 2H), 2.27–2.12 (m, 
4H), 1.84–1.71 (m, 4H), 1.69 (dd, J = 4.8, 0.7 Hz, 3H), 1.22 (s, 3H);  13C NMR (125 
MHz, CDCl3) δ 204.8, 161.7, 137.8, 137.2, 129.3, 124.4, 115.2, 48.6, 44.1, 41.3, 34.8, 
34.1, 26.0, 18.2, 18.0;  IR (Neat Film NaCl) 3077, 2962, 2937, 2874, 2856, 1650, 1614, 
1451, 1414, 1378, 1342, 1273, 1251, 1224, 1198, 1126, 1069, 974, 911 cm-1;  HRMS 
(MM: ESI-APCI+) m/z calc’d for C15H23O [M+H]+: 219.1743; found 219.1741;  [α]D20.0 
+123.43 (c 1.10, CHCl3, 88% ee). 
 
2.10.2.15 PREPARATION OF POLYCYCLIC CYCLOHEPTENONE 
DERIVATIVES BY RING-CLOSING METATHESIS 
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (68) (5 mol %)
PhH, 50 °C
99% yield
O O
137w 185w  
General Method I:  Ring-Closing Metathesis 
Enone 185w.  A 100 mL round-bottom flask equipped with a magnetic stir bar, fitted 
with a water condenser, and connected to a Schlenk manifold (through the condenser) 
was flame-dried three times, backfilling with argon after each drying cycle.  Once cool, 
the flask was loaded with neat cycloheptenone 137w (50.0 mg, 0.22 mmol, 1.00 equiv) 
and backfilled with argon twice.  Benzene (1 h argon sparge before use, 43 mL, 0.005 M) 
was added to the flask, followed by Grubbs–Hoveyda 2nd generation catalyst (6.7 mg, 
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0.011 mmol, 5 mol %).  The solution color turned pale green with addition of catalyst.  
The flask was lowered into a preheated oil bath (50 °C).  The reaction was removed from 
the oil bath after 30 min, cooled to room temperature (23 °C), and quenched with ethyl 
vinyl ether (1 mL).  The reaction was filtered through a short silica gel plug rinsing with 
Et2O and concentrated under reduced pressure.  The crude oil was purified twice by flash 
chromatography (SiO2, both columns 2 x 28 cm, 100% hexanes→2%→5% EtOAc in 
hexanes) to afford cycloheptenone 185w (43.5 mg, 0.21 mmol, 99% yield) as a yellow 
oil. 
 
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (68) (0.2 mol %)
CH2Cl2, reflux
88% yield
O O
Ph
137x 185x  
Enone 185x  (Table 2.6, entry 1).  Prepared using General Method I.  A 100 mL round-
bottom flask equipped with a magnetic stir bar, fitted with a water condenser, and 
connected to a Schlenk manifold (through the condenser) was flame-dried three times, 
backfilling with argon after each drying cycle.  Once cool, the flask was loaded with neat 
cycloheptenone 137x (452.8 mg, 1.70 mmol, 1.00 equiv) and dichloromethane (60 mL, 
0.03 M) and the resulting solution was sparged with Ar.  After 30 min of degassing, 
Grubbs 2nd generation catalyst (3.4 mg, 0.0040 mmol, 0.2 mol %) was added to the 
flask.  The solution color turned pale red with addition of catalyst.  The flask was lowered 
into a preheated oil bath (50 °C). 
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The flask was removed from oil bath after 1 h, cooled to room temperature (23 °C), 
and charged with DMSO (50 µL) and silica gel (70 mg).  The resulting mixture was 
concentrated the reaction under reduced pressure and purified by flash chromatography 
(SiO2, 2 x 17 cm, 15:1 hexanes:EtOAc) to afford cycloheptenone 185x (242.9 mg, 1.50 
mmol, 88% yield) as a yellow oil;  Rf = 0.52 (30% EtOAc in hexanes);  1H NMR (500 
MHz, CDCl3) δ 6.35–6.32 (m, 1H), 6.14 (dddd, J = 5.6, 2.5, 1.7, 0.7 Hz, 1H), 5.87 (app s, 
1H), 2.70 (dddt, J = 15.1, 6.4, 3.5, 0.9 Hz, 1H), 2.59–2.51 (m, 2H), 2.41 (ddd, J = 17.9, 
2.9, 1.6 Hz, 1H), 2.11–2.02 (m, 1H), 2.00–1.82 (m, 3H), 1.23 (s, 3H);  13C NMR (125 
MHz, CDCl3) δ 204.8, 169.2, 142.7, 134.4, 121.7, 51.6, 46.7, 45.1, 37.9, 29.7, 21.2;  IR 
(Neat Film NaCl) 3056, 2930, 2867, 2841, 1651, 1615, 1580, 1449, 1372, 1352, 1293, 
1261, 1211, 1190, 1159, 1080, 968, 951, 862, 844, 801, 811, 723 cm-1;  HRMS (MM: 
ESI–APCI+) m/z calc’d for C11H15O [M+H]+: 163.1117; found 163.1120;  [α]D26.0 –48.88 
(c 1.83, CHCl3, 88% ee). 
 
O O
137y 185y
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (68) (5 mol %)
PhH, 50 °C
99% yield  
Enone 185y  (Table 2.6, entry 2).  Prepared using General Method I.  A two neck 100 
mL round-bottom flask equipped with a magnetic stir bar, fitted with rubber septa and a 
water condenser, and connected to a Schlenk manifold (through the condenser) was 
flame-dried three times, backfilling with argon after each drying cycle.  Once cool, the 
flask was loaded with neat cycloheptenone 137y (50.0 mg, 0.25 mmol, 1.00 equiv) and 
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backfilled with argon.  Benzene (1 h argon sparge before use, 39 mL) was added to the 
flask, followed by Grubbs–Hoveyda 2nd generation catalyst (7.8 mg, 0.012 mmol, 5 mol 
%).  The solution color turned pale green with addition of catalyst.  The flask was rinsed 
with more benzene (10 mL; total benzene added = 49 mL, 0.005 M) and lowered into a 
preheated oil bath (50 °C). 
TLC analysis indicated no starting material remained after 3 h.  Consequently, the 
reaction was removed from oil bath, cooled to room temperature (23 °C), and quenched 
with ethyl vinyl ether (1 mL).  The reaction was filtered through a short silica gel plug 
rinsing with Et2O and concentrated under reduced pressure.  The crude oil was purified 
by flash chromatography (SiO2, 2 x 28.5 cm, 100% hexanes→2%→5% EtOAc in 
hexanes) to afford cycloheptenone 185y (50 mg, 0.25 mmol, 99% yield) as a yellow oil;  
Rf = 0.64 (30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) δ 6.16 (t, J = 2.8 Hz, 
1H), 6.02 (s, 1H), 5.13–5.11 (m, 1H), 4.97 (s, 1H), 2.76 (ddd, J = 14.7, 6.7, 4.7 Hz, 1H), 
2.56 (ddd, J = 14.7, 9.8, 5.1 Hz, 1H), 2.48 (dd, J = 17.8, 2.0 Hz, 1H), 2.33 (dd, J = 17.8, 
3.1 Hz, 1H), 2.09–1.99 (m, 1H), 1.94 (dd, J = 9.9, 4.0 Hz, 2H), 1.91–1.89 (m, 3H), 1.89–
1.83 (m, 1H), 1.26 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 204.7, 167.2, 146.8, 138.4, 
137.5, 122.0, 115.9, 49.5, 48.3, 45.0, 38.2, 28.4, 23.1, 20.9;  IR (Neat Film NaCl) 3084, 
3052, 2918, 2868, 2845, 1652, 1607, 1450, 1374, 1352, 1311, 1290, 1259, 1210, 1190, 
1164, 1117, 1082, 1004, 982, 944, 898, 881, 848, 811, 771, 746 cm-1;  HRMS (MM: ESI–
APCI+) m/z calc’d for C14H19O [M+H]+: 203.1430; found 203.11428;  [α]D25.0 –55.41 (c 
1.61, CHCl3, 88% ee). 
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Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (68) (5 mol %)
1,4-benzoquinone (10 mol %)
PhH, 50 °C
91% yield
O O
137s 185s  
Enone 185s  (Table 2.6, entry 3).  Prepared using General Method I.  A 250 mL round-
bottom flask equipped with a magnetic stir bar, fitted with a water condenser, and 
connected to a Schlenk manifold (through the condenser) was flame-dried three times, 
backfilling with argon after each drying cycle.  Once cool, cycloheptenone 137s (174.6 
mg, 0.85 mmol, 1.00 equiv) was cannula-transferred from a 20 mL scintillation vial to the 
250 mL flask using several benzene rinses (1.5 h argon sparge before use, 5 x 4 mL).  
Additional benzene (141 mL) was added to the flask followed by 1,4-benzoquinone (9.2 
mg, 0.085 mmol, 10 mol %) and Grubbs–Hoveyda 2nd generation catalyst (26.8 mg, 
0.043 mmol, 5 mol %).  The solution color turned pale green with addition of catalyst.  
The flask was rinsed with more benzene (10 mL; total benzene added = 171 mL, 0.005 
M) and lowered into a preheated oil bath (50 °C). 
The reaction was removed from oil bath after 2.5 h, cooled to room temperature (23 
°C), and quenched with ethyl vinyl ether (2 mL).  The reaction color turned dark green 
with the ethyl vinyl ether addition.  The reaction was filtered through a short silica gel 
plug rinsing with Et2O and concentrated under reduced pressure.  The crude oil was 
purified by flash chromatography (SiO2, 3 x 25 cm, 100% hexanes→2%→5% EtOAc in 
hexanes) to afford cycloheptenone 185s (47.7 mg, 0.27 mmol, 91% yield) as a yellow oil;  
Rf = 0.58 (30% EtOAc in hexanes);  1H NMR (500 MHz, C6D6) δ 5.95 (d, J = 2.1 Hz, 
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1H), 5.46–5.41 (m, 1H), 5.34 (ddddd, J = 9.9, 4.4, 2.8, 2.8, 1.0 Hz, 1H), 2.72 (dm, J = 
20.2 Hz, 1H), 2.44–2.33 (m, 2H), 2.27 (dm, J = 20.2 Hz, 1H), 1.97 (dm, J = 17.6 Hz, 
1H), 1.44 (ddd, J = 17.5, 5.2, 0.9 Hz, 1H), 1.33–1.19 (m, 4H), 0.86 (s, 3H);  13C NMR 
(125 MHz, C6D6) δ 202.2, 156.0, 127.2, 125.1, 125.0, 44.3, 41.8, 41.4, 41.2, 36.3, 26.1, 
17.6;  IR (Neat Film NaCl) 3274, 3029, 2933, 2833, 1720, 1650, 1619, 1452, 1420, 1381, 
1345, 1306, 1264, 1239, 1219, 1185, 1125, 1105, 1082, 1004, 976, 952, 938, 924, 892, 
884, 871, 836, 775, 733 cm-1;  HRMS (MM: ESI–APCI+) m/z calc’d for C12H17O 
[M+H]+: 177.1274; found 177.1277;  [α]D25.0 –49.94 (c 0.86, CHCl3, 88% ee). 
 
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (68) (5 mol %)
1,4-benzoquinone (10 mol %)
PhH, 50 °C
90% yield
O O
137t 185t  
Enone 185t  (Table 2.6, entry 4).  Prepared using General Method I.  A three neck 100 
mL round-bottom flask equipped with a magnetic stir bar and fitted with rubber septa and 
a water condenser was connected to a Schlenk manifold (through the condenser).  The 
flask was flame-dried three times, backfilling with argon after each drying cycle.  Once 
cool, the flask was loaded with neat cycloheptenone 137t (50.0 mg, 0.23 mmol, 1.00 
equiv), benzene (1 h argon sparge before use, 46 mL, 0.005 M), 1,4-benzoquinone (2.5 
mg, 0.023 mmol, 10 mol %), and Grubbs–Hoveyda 2nd generation catalyst (7.2 mg, 
0.011 mmol, 5 mol %).  The solution color turned pale green with addition of catalyst.  
The flask was lowered into a preheated oil bath (50 °C). 
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The reaction was removed from oil bath after 1 h, cooled to room temperature (23 
°C), and quenched with ethyl vinyl ether (1.5 mL).  The reaction color turned dark green 
with the ethyl vinyl ether addition.  The reaction was filtered through a short silica gel 
plug rinsing with Et2O and concentrated under reduced pressure.  The crude oil was 
purified by flash chromatography (SiO2, 2 x 28 cm, 100% hexanes→2%→5% EtOAc in 
hexanes) to afford cycloheptenone 185t (39.0 mg, 0.21 mmol, 90% yield) as a yellow oil;  
Rf = 0.56 (30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) δ 5.87 (d, J = 2.0 Hz, 
1H), 5.38–5.34 (m, 1H), 3.06 (dm, J = 19.7 Hz, 1H), 2.63–2.49 (m, 3H), 2.28 (dm, J = 
17.2 Hz, 1H), 1.85 (dd, J = 17.2, 5.3 Hz, 1H), 1.81–1.75 (m, 2H), 1.74–1.65 (m, 2H), 
1.68 (s, 3H), 1.16 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 205.1, 159.4, 131.8, 126.3, 
119.5, 44.3, 41.6, 41.5, 41.3, 41.3, 26.6, 22.5, 17.6;  IR (Neat Film NaCl) 3273, 3017, 
2963, 2930, 1720, 1656, 1651, 1645, 1619, 1616, 1450, 1418, 1378, 1363, 1345, 1268, 
1239, 1220, 1191, 1151, 1134, 1104, 1072, 1038, 989, 972, 962, 944, 931, 897, 877, 854, 
827, 784, 732 cm-1;  HRMS (MM: ESI–APCI+) m/z calc’d for C13H19O [M+H]+: 
191.1430; found 191.1436;  [α]D25.0 +9.09 (c 0.86, CHCl3, 88% ee). 
 
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (68) (5 mol %)
PhH, 50 °C
90% yield
O
185u
O
137u  
Enone 185u  (Table 2.6, entry 5).  Prepared using General Method I.  A two neck 100 
mL round-bottom flask equipped with a magnetic stir bar, fitted with rubber septa and a 
water condenser, and connected to a Schlenk manifold (through the condenser) was 
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flame-dried three times, backfilling with argon after each drying cycle.  Once cool, the 
flask was loaded with neat cycloheptenone 137u (50.0 mg, 0.23 mmol, 1.00 equiv), 
Grubbs–Hoveyda 2nd generation catalyst (7.2 mg, 0.011 mmol, 5 mol %), benzene (1 h 
argon sparge before use, 46 mL, 0.005 M).  The solution color turned pale green with 
addition of catalyst.  The flask was lowered into a preheated oil bath (50 °C). 
TLC analysis indicated no starting material remained after 15 min.  Consequently, the 
reaction was removed from the oil bath, cooled to room temperature (23 °C), and 
quenched with ethyl vinyl ether (1 mL).  The reaction color turned amber with the ethyl 
vinyl ether addition.  The reaction was filtered through a short silica gel plug rinsing with 
Et2O and concentrated under reduced pressure.  The crude oil was purified by flash 
chromatography (SiO2, 2 x 27.5 cm, 100% hexanes→2%→5% EtOAc in hexanes) to 
afford cycloheptenone 185u (39.4 mg, 0.21 mmol, 90% yield) as a yellow oil;  Rf = 0.58 
(30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) δ 5.87 (s, 1H), 5.65–5.58 (m, 
1H), 5.54–5.49 (m, 1H), 2.81–2.74 (m, 1H), 2.66–2.59 (m, 2H), 2.56–2.46 (m, 2H), 2.24–
2.13 (m, 2H), 2.07 (ddd, J = 14.1, 11.1, 3.1 Hz, 1H), 1.93 (ddddd, J = 14.1, 11.0, 9.3, 4.8, 
2.9 Hz, 1H), 1.85–1.79 (m, 1H), 1.76 (dd, J = 14.9, 7.9 Hz, 1H), 1.66 (ddd, J = 14.0, 6.9, 
2.8 Hz, 1H), 1.16 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 204.8, 165.3, 129.9, 129.7, 
126.2, 47.8, 43.9, 40.7, 40.3, 34.5, 32.2, 27.8, 19.6;  IR (Neat Film NaCl) 3287, 3017, 
2930, 2833, 1652, 1616, 1481, 1450, 1380, 1352, 1342, 1291, 1279, 1262, 1243, 1224, 
1204, 1184, 1162, 1084, 1075, 1047, 1021, 984, 963, 921, 896, 877, 846, 834, 788, 755 
cm-1;  HRMS (MM: ESI–APCI+) m/z calc’d for C13H19O [M+H]+: 191.1430; found 
191.1430;  [α]D25.0 –92.01 (c 0.82, CHCl3, 88% ee). 
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Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (68) (5 mol %)
PhH, 50 °C
98% yield
O O
137v 185v  
Enone 185v  (Table 2.6, entry 6).  Prepared using General Method I.  A two neck 100 
mL round-bottom flask equipped with a magnetic stir bar, fitted with rubber septa and a 
water condenser, and connected to a Schlenk manifold (through the condenser) was 
flame-dried three times, backfilling with argon after each drying cycle.  Once cool, the 
flask was loaded with neat cycloheptenone 137v (50.0 mg, 0.22 mmol, 1.00 equiv) and 
backfilled with argon.  Benzene (1 h argon sparge before use, 33 mL) was added to the 
flask, followed by Grubbs–Hoveyda 2nd generation catalyst (6.7 mg, 0.011 mmol, 5 mol 
%).  The solution color turned pale green with addition of catalyst.  The flask was rinsed 
with more benzene (10 mL; total benzene added = 43 mL, 0.005 M) and lowered into a 
preheated oil bath (50 °C). 
TLC analysis indicated no starting material remained after 30 min.  After an 
additional 10 min of stirring, the reaction was removed from the oil bath, cooled to room 
temperature (23 °C), and quenched with ethyl vinyl ether (1 mL).  The reaction color 
turned dark brown with the ethyl vinyl ether addition.  The reaction was filtered through a 
short silica gel plug rinsing with Et2O and concentrated under reduced pressure.  The 
crude oil was purified by flash chromatography (SiO2, 2 x 28.5 cm, 100% 
hexanes→2%→5% EtOAc in hexanes) to afford cycloheptenone 185v (43.2 mg, 0.21 
mmol, 98% yield) as a clear colorless oil;  Rf = 0.63 (30% EtOAc in hexanes);  1H NMR 
(500 MHz, CDCl3) δ 5.87 (s, 1H), 5.41–5.34 (m, 1H), 2.79 (td, J = 12.3, 5.3 Hz, 1H), 
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2.66–2.55 (m, 2H), 2.54–2.42 (m, 2H), 2.19 (ddd, J = 12.5, 6.0, 3.3 Hz, 1H), 2.14–2.02 
(m, 2H), 1.98–1.88 (m, 1H), 1.85–1.76 (m, 1H), 1.71–1.63 (m, 2H), 1.62 (s, 3H), 1.13 (s, 
3H);  13C NMR (125 MHz, CDCl3) δ 204.9, 165.8, 136.9, 129.5, 120.7, 47.7, 43.9, 40.6, 
40.2, 36.9, 34.3, 27.5, 25.3, 19.7;  IR (Neat Film NaCl) 3300, 3014, 2928, 2828, 1657, 
1617, 1480, 1450, 1379, 1353, 1342, 1292, 1259, 1216, 1171, 1131, 1106, 1082, 1050, 
1009, 982, 962, 916, 897, 874, 833, 814, 795, 765 cm-1;  HRMS (MM: ESI–APCI+) m/z 
calc’d for C14H21O2 [M+H]+: 205.1587; found 205.1582;  [α]D25.0 –73.66 (c 0.95, CHCl3, 
88% ee). 
 
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (68) (5 mol %)
PhCH3, 50 °C
99% yield
O O
185z137z  
Enone 185z  (Table 2.6, entry 7).  Prepared using General Method I.  A three neck 100 
mL round-bottom flask equipped with a magnetic stir bar, fitted with rubber septa and a 
water condenser, and connected to a Schlenk manifold (through the condenser) was 
flame-dried three times, backfilling with argon after each drying cycle.  Once cool, 
cycloheptenone 137z (65.8 mg, 0.25 mmol, 1.00 equiv) was cannula-transferred from a 
20 mL scintillation vial to the 100 mL flask using several toluene rinses (1.5 h argon 
sparge before use, 5 x 4 mL).  Additional toluene (20 mL) was added to the flask 
followed by Grubbs–Hoveyda 2nd generation catalyst (7.7 mg, 0.012 mmol, 5 mol %).  
The solution color turned pale green with addition of catalyst.  The flask was rinsed with 
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more toluene (9 mL; total toluene added = 49 mL, 0.005 M) and lowered into a preheated 
oil bath (50 °C). 
The reaction was removed from the oil bath after 6.5 h, cooled to room temperature 
(23 °C), and quenched with ethyl vinyl ether (0.5 mL).  The reaction color turned dark 
brown with the ethyl vinyl ether addition.  The reaction was filtered through a short silica 
gel plug rinsing with EtOAc and concentrated under reduced pressure.  The crude oil was 
purified by flash chromatography (SiO2, 2 x 24.5 cm, 100% hexanes→2%→5% EtOAc 
in hexanes) to afford cycloheptenone 185z (56.7 mg, 0.23 mmol, 96% yield) as a yellow 
oil;  Rf = 0.64 (30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) δ 7.31–7.26 (m, 
1H), 7.22–7.19 (m, 2H), 7.10 (d, J = 7.4 Hz, 1H), 6.53 (dm, J = 11.1 Hz, 1H), 6.03 (dt, J 
= 11.2, 6.0 Hz, 1H), 5.82 (s, 1H), 2.71–2.60 (m, 2H), 2.30 (ddd, J = 15.6, 5.8, 0.8 Hz, 
1H), 2.21 (ddd, J = 15.6, 6.3, 1.8 Hz, 1H), 2.15 (ddd, J = 13.9, 7.5, 4.5 Hz, 1H), 2.01–
1.85 (m, 3H), 1.14 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 204.3, 162.5, 142.5, 135.5, 
132.0, 130.8, 130.0, 128.8, 128.8, 127.9, 127.3, 50.6, 44.2, 42.4, 40.1, 27.8, 19.3;  IR 
(Neat Film NaCl) 3057, 3017, 2933, 2870, 1718, 1665, 1601, 1481, 1445, 1417, 1383, 
1354, 1340, 1286, 1258, 1228, 1180, 1125, 996, 984, 936, 890, 828, 780, 757 cm-1;  
HRMS (MM: ESI–APCI+) m/z calc’d for C17H19O [M+H]+: 239.1430; found 239.1432;  
[α]D20.0 –86.75 (c 0.70, CHCl3, 88% ee). 
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Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (68) (5 mol %)
PhH, 50 °C
99% yield
O O
137w 185w  
Enone 185w  (Table 2.6, entry 8).  Prepared using General Method I.  A 100 mL round-
bottom flask equipped with a magnetic stir bar, fitted with a water condenser, and 
connected to a Schlenk manifold (through the condenser) was flame-dried three times, 
backfilling with argon after each drying cycle.  Once cool, the flask was loaded with neat 
cycloheptenone 137w (50.0 mg, 0.22 mmol, 1.00 equiv) and backfilled with argon twice.  
Benzene (1 h argon sparge before use, 43 mL, 0.005 M) was added to the flask, followed 
by Grubbs–Hoveyda 2nd generation catalyst (6.7 mg, 0.011 mmol, 5 mol %).  The 
solution color turned pale green with addition of catalyst.  The flask was lowered into a 
preheated oil bath (50 °C). 
The reaction was removed from the oil bath after 30 min, cooled to room temperature 
(23 °C), and quenched with ethyl vinyl ether (1 mL).  The reaction was filtered through a 
short silica gel plug rinsing with Et2O and concentrated under reduced pressure.  The 
crude oil was purified twice by flash chromatography (SiO2, both columns 2 x 28 cm, 
100% hexanes→2%→5% EtOAc in hexanes) to afford cycloheptenone 185w (43.5 mg, 
0.21 mmol, 99% yield) as a yellow oil;  Rf = 0.56 (30% EtOAc in hexanes);  1H NMR 
(500 MHz, CDCl3) δ 5.77–5.70 (m, 1H), 5.65 (tdt, J = 10.4, 6.4, 1.3 Hz, 1H), 2.68–2.55 
(m, 2H), 2.54–2.44 (m, 1H), 2.30–2.24 (m, 2H), 2.24–2.15 (m, 1H), 2.13–2.04 (m, 1H), 
1.94–1.69 (m, 7H), 1.52–1.41 (m, 1H), 1.22 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 
204.2, 165.6, 132.2, 131.9, 128.5, 49.0, 44.2, 39.8, 39.5, 35.5, 31.1, 27.0, 26.5, 17.8;  IR 
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(Neat Film NaCl) 3018, 2928, 2859, 1645, 1608, 1468, 1448, 1411, 1380, 1343, 1327, 
1279, 1253, 1214, 1178, 1131, 1102, 1088, 1051, 1015, 987, 965, 937, 920, 899, 880, 
845, 796, 777, 747 cm-1;  HRMS (MM: ESI–APCI+) m/z calc’d for C14H21O [M+H]+: 
205.1587; found 205.1587;  [α]D25.0 –141.99 (c 1.01, CHCl3, 88% ee). 
 
O O
198 186
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (68) (5 mol %)
PhH, 50 °C
99% yield  
Enone 186.  Prepared using General Method I.  A 100 mL round-bottom flask equipped 
with a magnetic stir bar, fitted with a water condenser, and connected to a Schlenk 
manifold (through the condenser) was flame-dried three times, backfilling with argon 
after each drying cycle.  Once cool, the flask was loaded with neat cycloheptenone 198 
(50.0 mg, 0.23 mmol, 1.00 equiv) and backfilled with argon twice.  Benzene (1 h argon 
sparge before use, 44 mL) was added to the flask, followed by Grubbs–Hoveyda 2nd 
generation catalyst (7.2 mg, 0.011 mmol, 5 mol %).  The flask was rinsed with more 
benzene (2 mL; total benzene added = 46 mL, 0.005 M) and lowered into a preheated oil 
bath (50 °C).  The solution color turned pale green with addition of catalyst and amber 
over time. 
The reaction was removed from the oil bath after 50 min, cooled to room temperature 
(23 °C), and quenched with ethyl vinyl ether (0.5 mL).  The reaction was filtered through 
a short silica gel plug rinsing with Et2O and concentrated under reduced pressure.  The 
crude oil was purified twice by flash chromatography (SiO2, both columns 2 x 27.5 cm, 
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100% hexanes→2%→5% EtOAc in hexanes) to afford cycloheptenone 186 (35.8 mg, 
0.23 mmol, 89% yield, 70% yield from vinylogous ester 149p) as a pale yellow oil;  Rf = 
0.62 (30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) δ 5.87 (s, 1H), 5.72–5.67 
(m, 1H), 5.28 (dd, J = 9.7, 2.4 Hz, 1H), 2.71–2.64 (m, 1H), 2.62–2.54 (m, 1H), 2.53–2.46 
(m, 1H), 2.31–2.11 (m, 3H), 1.92–1.74 (m, 3H), 1.70 (ddd, J = 14.0, 6.6, 2.4 Hz, 1H), 
1.27 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 204.5, 161.3, 137.8, 126.9, 125.3, 44.6, 
43.6, 40.6, 33.8, 28.1, 27.7, 18.6;  IR (Neat Film NaCl) 3019, 2934, 2866, 2845, 1665, 
1653, 1621, 1450, 1414, 1350, 1309, 1281, 1258, 1217, 1181, 1171, 1132, 1087, 1074, 
1024, 1013, 973, 938, 902, 881, 865, 783, 767, 716 cm-1;  HRMS (MM: ESI–APCI+) m/z 
calc’d for C12H17O [M+H]+: 177.1274; found 177.1274;  [α]D20.0 –188.35 (c 0.72, CHCl3, 
88% ee). 
 
2.10.2.16 PREPARATION OF POLYCYCLIC CYCLOHEPTENONE 
DERIVATIVES BY OTHER METHODS 
OO
DBU
CH3CN, 23 °C
73% yield
185s 187  
Diene 187.  A 20 mL scintillation vial containing enone 185s (31.5 mg, 0.18 mmol, 1.00 
equiv) was equipped with a stir bar and sealed with a screw cap containing a teflon 
septum.  The vial was connected to a Schlenk manifold and backfilled with argon three 
times.  Acetonitrile (1.8 mL, 0.1 M) was added to the vial followed by DBU (30 µL, 0.20 
mmol, 1.12 equiv).  The solution was stirred at room temperature (23 °C) until no starting 
material remained by TLC analysis (4 h).  The reaction was passed through a short silica 
CHAPTER 2 – Synthesis of Cyclopentanoid and Cycloheptanoid Core Structures  
 
255 
gel plug, rinsed with water, dried over MgSO4, filtered through another short silica gel 
plug, and concentrated under reduced pressure.  The resulting crude oil was purified by 
flash chromatography (SiO2, 1 x 28.5 cm, 100% hexanes→2%→5% EtOAc in hexanes) 
to afford diene 187 (23.1 mg, 0.13 mmol, 73% yield) as a pale yellow oil;  Rf = 0.63 
(30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) δ 5.86 (ddt, J = 9.0, 5.3, 1.7 Hz, 
1H), 5.79–5.73 (m, 2H), 3.27 (d, J = 16.3 Hz, 1H), 2.93 (d, J = 16.3 Hz, 1H), 2.73 (ddd, J 
= 12.4, 10.0, 4.7 Hz, 1H), 2.33–2.23 (m, 2H), 2.08–2.00 (m, 1H), 1.89–1.67 (m, 3H), 
1.49–1.41 (m, 1H), 0.99 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 212.0, 138.6, 125.4, 
123.9, 123.6, 49.5, 42.7, 37.6, 37.5, 36.5, 24.1, 20.9;  IR (Neat Film NaCl) 3039, 2929, 
2865, 2817, 1708, 1645, 1587, 1453, 1424, 1403, 1371, 1356, 1319, 1286, 1263, 1235, 
1211, 1143, 1105, 1082, 1039, 987, 969, 940, 925, 851, 817, 761, 704 cm-1;  HRMS (GC-
EI+) m/z calc’d for C12H16O [M+⋅]+: 176.1201; found 176.1219;  [α]D25.0 –205.54 (c 0.71, 
CHCl3, 88% ee). 
 
OO
DBU
CH3CN, 180 °C
µwaves
185s 188
59% yield
O
187
16% yield
+
 
Diene 187 and Diene 188.  A 2.0–5.0 mL µwave vial fitted with a stir bar and sealed 
with a screw cap containing a teflon septum was flame-dried three times, backfilling with 
argon after each drying cycle.  Once cool, diene 185s (66.7 mg, 0.38 mmol, 1.00 equiv) 
was cannula-transferred to the vial with several acetonitrile rinses (4 x 1 mL, 0.09 M) and 
the flask was charged with DBU (66 µL, 0.44 mmol, 1.17 equiv). The pale yellow 
solution was subjected to microwave irradiation in a Biotage Initiator microwave reactor 
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(temperature: 180 °C, sensitivity: normal).  After 5 h of irradiation, the crimp cap was 
removed and the reaction was filtered through a silica gel plug.  The resulting solution 
was concentrated under reduced pressure and purified by flash chromatography (SiO2, 2 x 
29 cm, 100% hexanes→10%→30%→50%→80% CH2Cl2 in hexanes) to yield diene 188 
(39.5 mg, 0.22 mmol, 59% yield) as a yellow oil and diene 187 (10.4 mg, 0.059 mmol, 
16% yield) as a pale yellow oil.   
 
Diene 187:  Characterization data are identical to the data described above.   
 
Diene 188:  Rf = 0.56 (30% EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) δ 6.13–
6.07 (m, 1H), 6.02 (dd, J = 9.9, 2.8 Hz, 1H), 5.76 (s, 1H), 2.75 (dddt, J = 15.6, 6.6, 5.0, 
0.9 Hz, 1H), 2.52 (ddd, J = 15.4, 9.5, 5.6 Hz, 1H), 2.38–2.27 (m, 1H), 2.19 (dtt, J = 19.3, 
5.6, 1.3 Hz, 1H), 2.05–1.93 (m, 1H), 1.87–1.77 (m, 2H), 1.74–1.62 (m, 2H), 1.44 (ddt, J 
= 13.2, 5.4, 1.5 Hz, 1H), 1.13 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 204.1, 156.2, 
135.1, 131.4, 129.1, 44.6, 42.2, 38.9, 37.6, 23.1, 22.9, 18.8;  IR (Neat Film NaCl) 3026, 
2967, 2922, 2868, 2849, 1650, 1621, 1583, 1449, 1428, 1383, 1353, 1338, 1284, 1244, 
1225, 1207, 1173, 1163, 1130, 1114, 1090, 1077, 1023, 978, 954, 935, 911, 881, 866, 
840, 777, 727 cm-1;  HRMS (MM: ESI-APCI+) m/z calc’d for C12H17O [M+H]+: 
177.1274; found 177.1278;  [α]D25.0 –298.04 (c 1.24, CHCl3, 88% ee). 
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137y
O
Co2(CO)8
THF, 23 °C
then DMSO, 60 °C
O
O
H
O
O
H
+
90% yield
3:1 dr 189a 189b  
Enones 189a and 189b.  A 20 mL scintillation vial containing cycloheptenone 137y 
(185.6 mg, 0.92 mmol, 1.00 equiv) was equipped with a stir bar and sealed with a screw 
cap containing a teflon septum.  The vial was connected to a Schlenk manifold and 
backfilled with argon three times.  The vial was charged with THF (5.0 mL, 0.2 M) and 
dicobalt octacarbonyl (388.5 mg, 1.14 mmol, 1.24 equiv), generating a dark brown 
solution.  After 12 h of stirring at room temperature (23 °C), DMSO (380 µL, 5.35 mmol, 
5.83 equiv) was added and the vial was lowered into a preheated oil bath (60 °C).  
Reaction turned dark red over time.  The vial was removed from the oil bath after 14 h 
and cooled to room temperature.  The reaction mixture was concentrated under reduced 
pressure and purified by flash chromatography using a Teledyne Isco CombiFlash Rf 
system (SiO2, 25 g loading cartridge, 40 g column, multi-step gradient, hold 0% [5 
min]→ramp to 5% [5 min]→hold 5% [50 min]→ramp to 10% [5 min]→hold 10% [15 
min]→ramp to 15% [1 min]→hold 15% [7 min]→ramp to 20% [1 min]→hold 20% 
EtOAc in hexanes [27 min]) to afford a 3:1 diastereomeric mixture of cycloheptenones 
189a:189b (190.2 mg, 0.83 mmol, 90% yield).  Analytically pure samples of 189a and 
189b could be obtained using the above column conditions. 
 
Major diastereomer (189a): yellow oil that solidified upon cooling;  Rf = 0.32 (30% 
EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) δ 6.38 (s, 1H), 3.21–3.12 (m, 1H), 
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2.81–2.75 (m, 1H), 2.75 (dd, J = 17.8, 6.3 Hz, 1H), 2.62 (ddd, J = 14.0, 11.4, 4.6 Hz, 
1H), 2.19–2.09 (m, 1H), 2.11 (dd, J = 17.8, 3.7 Hz, 1H), 2.01 (dd, J = 11.6, 6.9 Hz, 1H), 
1.99–1.90 (m, 2H), 1.89 (d, J = 2.6 Hz, 3H), 1.88–1.81 (m, 1H), 1.32 (s, 3H), 1.28 (t, J = 
11.8 Hz, 1H);  13C NMR (125 MHz, CDCl3) δ 209.5, 204.8, 172.4, 155.0, 135.6, 128.8, 
50.9, 47.2, 45.6, 42.3, 40.5, 39.5, 26.8, 20.9, 9.0;  For NOESY correlation data, see 
Figure A1.351;  IR (Neat Film NaCl) 2945, 2917, 2867, 1701, 1662, 1446, 1375, 1332, 
1304, 1258, 1219, 1196, 1148, 1099, 1054, 978, 945, 895, 869, 852, 830, 802, 706 cm-1;  
HRMS (GC-EI+) m/z calc’d for C15H19O2 [M+H]+: 231.1380; found 231.1381;  [α]D20.0 
+150.77 (c 1.01, CHCl3, 88% ee).  
 
Minor diastereomer (189b): orange oil that solidified upon cooling;  Rf = 0.25 (30% 
EtOAc in hexanes);  1H NMR (500 MHz, CDCl3) δ 6.27 (s, 1H), 3.09–2.98 (m, 1H), 2.70 
(dd, J = 18.1, 6.4 Hz, 1H), 2.71–2.64 (m, 1H), 2.63–2.56 (m, 1H), 2.16 (dd, J = 12.5, 8.5 
Hz, 1H), 2.11 (dd, J = 18.1, 3.3 Hz, 1H), 2.12–1.96 (m, 2H), 1.95–1.87 (m, 2H), 1.87 (d, 
J = 2.5 Hz, 3H), 1.28 (dd, J = 12.4, 11.6 Hz, 1H), 1.24 (s, 3H);  13C NMR (125 MHz, 
CDCl3) δ 209.7, 206.4, 173.0, 154.6, 133.7, 127.4, 48.9, 48.3, 42.4, 42.3, 41.3, 37.5, 31.9, 
22.2, 8.5;  For NOESY correlation data, see Figure A1.355;  IR (Neat Film NaCl) 2928, 
2867, 1703, 1668, 1453, 1410, 1377, 1305, 1285, 1236, 1208, 1157, 1094, 1054, 996, 
949, 891, 874, 859, 791, 720 cm-1;  HRMS (GC-EI+) m/z calc’d for C15H19O2 [M+H]+: 
231.1380; found 231.1372;  [α]D20.0 –407.06 (c 1.65, CHCl3, 88% ee). 
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2.10.2.17 DETERMINATION OF ENANTIOMERIC EXCESS 
Table 2.8.  Methods for the Determination of Enantiomeric Excess (Chiral HPLC and SFC) 
entry product compound assayed
assay 
conditions
retention time 
of major 
isomer (min)
retention time 
of minor 
isomer (min)
% ee
1
HPLC
Chiralcel OD-H
5% IPA in hexane
isocratic, 1.0 mL/min
5.80 6.53 86
2
O
i-BuO
O
i-BuO
HPLC
Chiralcel OD-H
1% IPA in hexane
isocratic, 1.0 mL/min
6.30 7.26 88
O
i-BuO
O
i-BuO
3
O
i-BuO
O
i-BuO
HPLC
Chiralcel AD
0.25% IPA in hexane
isocratic, 1.0 mL/min
18.08 16.23 92
151 151
149a 149a
149b 149b
4
O
i-BuO
O
i-BuO
HPLC
Chiralcel OD-H
0.5% IPA in hexane
isocratic, 1.0 mL/min
15.70 13.96 86
Ph Ph
149c 149c
5
O
i-BuO
O
i-BuO
HPLC
Chiralcel OD-H
0.5% IPA in hexane
isocratic, 1.0 mL/min
12.35 13.43 89
149d 149d
6
O
i-BuO
O
i-BuO
HPLC
Chiralcel AD
0.8% IPA in hexane
isocratic, 2.0 mL/min
5.03 6.06 87
149e 149e
7
O
i-BuO
O
i-BuO
SFC
Chiralcel AD-H
5% IPA in hexane
isocratic, 2.5 mL/min
6.99 6.31 90
149f 149f
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N
Cl
entry product compound assayed
assay 
conditions
retention time 
of major 
isomer (min)
retention time 
of minor 
isomer (min)
% ee
8
9
O
i-BuO
O
i-BuO
HPLC
Chiralcel OD-H
0.1% IPA in hexane
isocratic, 1.0 mL/min
27.22 24.19 86
149g 149g
Cl
CN
O
i-BuO
O
i-BuO
HPLC
Chiralcel OD-H
5% IPA in hexane
isocratic, 1.0 mL/min
10.67 14.66 87
149h 149h
CN
O
i-BuO
O
i-BuO
HPLC
Chiralcel AD
5% EtOH in hexane
isocratic, 1.0 mL/min
13.22 15.13 85
149i 149i
N N
O
i-BuO
O
i-BuO
HPLC
Chiralcel AD
5% EtOH in hexane
isocratic, 1.0 mL/min
11.11 16.64 83
149j 149j
N Ts Ts
O
i-BuO
O
i-BuO
HPLC
Chiralcel AD
0.8% IPA in hexane
isocratic, 2.0 mL/min
4.39 5.17 80
149k 149e
H O
O
i-BuO
O
i-BuO
HPLC
Chiralcel OD-H
0.2% IPA in hexane
isocratic, 1.0 mL/min
21.74 25.53 58
OTBDPS OTBDPS
149l 149l
O
i-BuO
F O
i-BuO
F HPLC
Chiralcel OD-H
1% IPA in hexane
isocratic, 1.0 mL/min
8.80 8.05 91
149l 149l
OO
i-BuO
O O
i-BuO
O HPLC
Chiralcel OD-H
1% IPA in hexane
isocratic, 1.0 mL/min
18.28 22.01 57
149n 149n
Ph
O
Ph
10
11
12
13
14
15
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Table 2.9.  Methods for the Determination of Enantiomeric Excess (Chiral GC) 
entry product compound assayed
assay 
conditions
retention time 
of major 
isomer (min)
retention time 
of minor 
isomer (min)
% ee
1
2
GC
G-TA
80 °C isotherm
54.98 61.35 88
GC
G-TA
80 °C isotherm
54.74 60.24 98
135a 135a
O O
O O
135a 135a  
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Ph2P N
O
192  
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(17) For a preparation of electron-deficient PHOX ligand 14 ((S)-p-(CF3)3-t-Bu-
PHOX), see:  (a) McDougal, N. T.; Streuff, J.; Mukherjee, H.; Virgil, S. C.; 
Stoltz, B. M. Tetrahedron Lett. 2010, 51, 5550–5554.  (b) Also see ref. 7b and 7f. 
(18) The reaction with silyl-protected alcohol 148m afforded alkylation product 149m 
and exocyclic enone 199 in 10% yield.  A related silyl-protected alcohol substrate 
did not display this type of elimination during an asymmetric decarboxylative 
alkylation reaction on a six-membered ring β-ketoester substrate.  See ref. 2b. 
O
i-BuO
149m
(S)-t-Bu-PHOX (13) (6.25 mol %)
Pd2(pmdba)3  (2.5 mol %)
PhCH3, 30 °C
148m
OTBDPS
66% yield
58% ee
O
i-BuO
199
10% yield
O
i-BuO
OTBDPS
O
O
+
 
(19) The reaction with benzoate ester 148n afforded alkylation product 149n and 
endocyclic enone 200 in 14% yield. 
O
i-BuO
O
149n
(S)-t-Bu-PHOX (13) (6.25 mol %)
Pd2(pmdba)3  (2.5 mol %)
PhCH3, 30 °C
O
i-BuO
O
148n
O
O
PhO
75% yield
57% ee
O
Ph
O
i-BuO
200
14% yield
+
 
(20) Stork, G.; Danheiser, R. L. J. Org. Chem. 1973, 38, 1775–1776. 
(21) Differences in ring conformational preferences can also be observed in the 1H 
NMR spectra of 1,3-cyclohexadione (exclusively ketoenol form) and 1,3-
cycloheptadione (exclusively diketo form).  See ref. 12c. 
(22) For selected examples of the two-carbon ring contraction of seven-membered 
carbocycles, see:  (a) Frankel, J. J.; Julia, S.; Richard-Neuville, C. Bull. Soc. 
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been fully explored.  See:  Rinderhagen, H.; Mattay, J. Chem. Eur. J. 2004, 10, 
851–874. 
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see:  Yang, Z.; Li, Y.; Pattenden, G. Tetrahedron 2010, 66, 6546–6549. 
(26) For examples of ring contractions of medium-sized ring heterocycles, see:   
(a) Nasveschuk, C. G.; Rovis, T. Angew. Chem. Int. Ed. 2005, 44, 3264–3267.   
(b) Nasveschuk, C. G.; Rovis, T. J. Org. Chem. 2008, 73, 612–617.   
(c) Nasveschuk, C. G.; Rovis, T. Org. Biomol. Chem. 2008, 6, 240–254.   
(d) Baktharaman, S.; Afagh, N.; Vandersteen, A.; Yudin A. K. Org. Lett. 2010, 
12, 240–243.  (e) Dubovyk, I.; Pichugin, D.; Yudin, A. K. Angew. Chem. Int. Ed. 
2011, 50, 5924–5926.  (f) Volchkov, I.; Park, S.; Lee, D. Org. Lett. 2011, 13, 
3530–3533.  (g) Dubinina, G. G.; Chain, W. J. Tetrahedron Lett. 2011, 52, 939–
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(27) For a discussion of the properties of fluorinated alcohols and their use, see:  
Begue, J.-P.; Bonnet-Delpon, D.; Crousse, B. Synlett 2004, 18–29. 
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(28) A lithium alkoxide species is presumably generated in situ based on the following 
pKa values:  (H2O = 15.7, TFE = 12.5, HFIP = 9.3 [water]; H2O = 31.2, TFE = 
23.5, HFIP = 18.2 [DMSO]);  Bordwell, F. G. Acc. Chem. Res. 1988, 21, 456–
463. 
(29) No reaction was observed with the following bases (with or without TFE 
additive):  DBU, TMG, Na2CO3, BaCO3, and CaH2. DBU = 1,8-
diazabicyclo[5.4.0]undec-7-ene, TMG = 1,1,3,3-tetramethylguanidine. 
(30) The two-carbon ring contraction strategy can potentially be extended to  β-
hydroxyketones of other medium sized rings to provide other useful cyclic enone 
products.  These possibilities are the subject of current investigations. 
O
O
H
R2
R1
O R2
R1
203
HO
O
R2R
1
202
O
RO
R2R
1
201  
(31) Fluorinated lithium alkoxides were recently used to promote Horner–Wadsworth–
Emmons olefinations of sensitive substrates, demonstrating their mild reactivity.  
See:  Blasdel, L. K.; Myers, A. G. Org. Lett. 2005, 7, 4281–4283. 
(32) Luche, J. L. J. Am. Chem. Soc. 1978, 100, 2226–2227. 
(33) Although we had success in preparing silyloxy acylcyclopentene 135p from 
vinylogous ester 149p, we wondered whether it would be possible to perform a 
ring contraction on aldehyde 149k.  Under our standard conditions, the 
intermediate ketodiol 154k can be obtained in 89% yield, however the subsequent 
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ring contraction proceeded in 62% yield to afford a complex mixture of pyran 
diastereomers 204 and uncyclized acylcyclopentene 135k. 
LiAlH4, Et2O, 0 °C
then 10% aq HCl
89% yield
O O
OH
O
1:1 dr
O
i-BuO
OH
149k
204 135k
OH
O
OH
154k
LiOH, TFE
THF, 60 °C
62% yield 
(5:1 ratio)  
(34) Analytically pure samples of dione 162 can be obtained from vinylogous ester 
149a by treatment with acid.  See Experimental Section (Section 2.10.2.10) for 
details. 
(35) The addition of cerium chloride to reactions with organolithium or Grignard 
reagents has been shown to increase reactivity and reduce side reactions with 
vinylogous ester systems, see:  Crimmins, M. T.; Dedopoulou, D. Synth. 
Commun. 1992, 22, 1953–1958. 
(36) The increase in enone formation with the organometallic addition relative to the 
hydride reduction is likely due to the higher stability of the tertiary carbocation 
(205) compared to the secondary carbocation (206) formed along the reduction 
pathway. 
vs.
H
i-BuO
R
i-BuO
206
2° carbocation
205
3° carbocation  
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(37) CCDC 686849 (164) contains the supplementary crystallographic data for this 
chapter.  These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.  The data 
can also be viewed in Appendix 2.  
(38) Comins, D. L.; Dehghani, A. Tetrahedron Lett. 1992, 33, 6299–6302. 
(39) Herrmann, W. A.; Brossmer, C.; Öfele, K.; Reisinger, C.-P.; Priermeier, T.; 
Beller, M.; Fischer, H. Angew. Chem. Int. Ed. Engl. 1995, 34, 1845–1848. 
(40) Preferential β-hydroxyketone formation is observed when the acidification of the 
intermediate isobutyl enol ether is performed in diethyl ether instead of methanol. 
See Table 2.4. 
(41) Attempts to purify the crude enol ether were challenging due to decomposition to 
enone 137r and β-hydroxyketone 154r. 
(42) The yield of cycloheptenone 137s is lower than many related enones due to the 
formation of several side products presumed to be non-conjugated alkene isomers. 
O
MgBrO
i-BuO then Na3PO4 buffer (pH 6.5)then HCl (6 mM), CH3CN
73% yield
149a 137s
+
CeCl3, THF, 23 °C mixture of 
olefin isomers
 
(43) Synthesis of the simple β-vinyl substituted enone proved challenging due to the 
formation of a complex product mixture. 
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isomeric peaks coalesce in a variable temperature 1H NMR study.  See Figure 
A1.308. 
(46) Jin, Z.; Fuchs, P. L. J. Am. Chem. Soc. 1994, 116, 5995–5996. 
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Figure A1.3.  13C NMR (125 MHz, CDCl3) of compound 147. 
Figure A1.2.  Infrared spectrum (thin film/NaCl) of compound 147. 
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Figure A1.6.  13C NMR (125 MHz, CDCl3) of compound 148a. 
 
Figure A1.5.  Infrared spectrum (thin film/NaCl) of compound 148a. 
 
APPENDIX 1 – Spectra Relevant to Chapter 2 278 
O
i-B
uO
OO
14
8b
 
 
Fi
gu
re
 A
1.
7.
  1
H
 N
M
R
 (3
00
 M
H
z,
 C
D
C
l 3
) o
f c
om
po
un
d 
14
8b
. 
APPENDIX 1 – Spectra Relevant to Chapter 2 279 
 
Figure A1.9.  13C NMR (75 MHz, CDCl3) of compound 148b. 
Figure A1.8.  Infrared spectrum (thin film/NaCl) of compound 148b. 
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Figure A1.12.  13C NMR (75 MHz, CDCl3) of compound 148c. 
Figure A1.11.  Infrared spectrum (thin film/NaCl) of compound 148c. 
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Figure A1.15.  13C NMR (75 MHz, CDCl3) of compound 148d. 
Figure A1.14.  Infrared spectrum (thin film/NaCl) of compound 148d. 
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Figure A1.18.  13C NMR (75 MHz, CDCl3) of compound 148e. 
Figure A1.17.  Infrared spectrum (thin film/NaCl) of compound 148e. 
APPENDIX 1 – Spectra Relevant to Chapter 2 286 
O
i-B
uO
OO
14
8f
 
Fi
gu
re
 A
1.
19
.  
1 H
 N
M
R
 (3
00
 M
H
z,
 C
D
C
l 3
) o
f c
om
po
un
d 
14
8f
. 
APPENDIX 1 – Spectra Relevant to Chapter 2 287 
 
Figure A1.21.  13C NMR (75 MHz, CDCl3) of compound 148f. 
Figure A1.20.  Infrared spectrum (thin film/NaCl) of compound 148f. 
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Figure A1.24.  13C NMR (75 MHz, CDCl3) of compound 148g. 
Figure A1.23.  Infrared spectrum (thin film/NaCl) of compound 148g. 
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Figure A1.27.  13C NMR (75 MHz, CDCl3) of compound 148h. 
Figure A1.26.  Infrared spectrum (thin film/NaCl) of compound 148h. 
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Figure A1.29.  Infrared spectrum (thin film/NaCl) of compound 148i. 
Figure A1.30.  13C NMR (75 MHz, CDCl3) of compound 148i. 
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Figure A1.33.  Infrared spectrum (thin film/NaCl) of compound 148ac. 
Figure A1.32. 13C NMR (75 MHz, CDCl3) of compound 148ac. 
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Figure A1.36.  13C NMR (75 MHz, CDCl3) of compound 148j. 
Figure A1.35.  Infrared spectrum (thin film/NaCl) of compound 148j. 
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Figure A1.39.  13C NMR (75 MHz, CDCl3) of compound 148k. 
Figure A1.38.  Infrared spectrum (thin film/NaCl) of compound 148k. 
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Figure A1.42.  13C NMR (75 MHz, CDCl3) of compound 148l. 
 
Figure A1.41.  Infrared spectrum (thin film/NaCl) of compound 148l. 
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Figure A1.45.  13C NMR (75 MHz, CDCl3) of compound 148ad. 
Figure A1.44.  Infrared spectrum (thin film/NaCl) of compound 148ad. 
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Figure A1.48.  13C NMR (75 MHz, CDCl3) of compound 148m. 
Figure A1.47.  Infrared spectrum (thin film/NaCl) of compound 148m. 
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Figure A1.51.  13C NMR (75 MHz, CDCl3) of compound 148n. 
 
Figure A1.50.  Infrared spectrum (thin film/NaCl) of compound 148n. 
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Figure A1.54.  13C NMR (125 MHz, CDCl3) of compound 191. 
Figure A1.53.  Infrared spectrum (thin film/NaCl) of compound 191. 
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Figure A1.57.  13C NMR (125 MHz, CDCl3) of compound 192. 
Figure A1.56.  Infrared spectrum (thin film/NaCl) of compound 192. 
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Figure A1.60.  13C NMR (75 MHz, CDCl3) of compound 193. 
Figure A1.59.  Infrared spectrum (thin film/NaCl) of compound 193. 
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Figure A1.63.  13C NMR (125 MHz, CDCl3) of compound 150. 
Figure A1.62.  Infrared spectrum (thin film/NaCl) of compound 150. 
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Figure A1.66.  13C NMR (125 MHz, CDCl3) of compound 149a. 
 
Figure A1.65.  Infrared spectrum (thin film/NaCl) of compound 149a. 
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Figure A1.69.  13C NMR (75 MHz, CDCl3) of compound 149b. 
Figure A1.68.  Infrared spectrum (thin film/NaCl) of compound 149b. 
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Figure A1.72.  13C NMR (75 MHz, CDCl3) of compound 149c. 
Figure A1.71.  Infrared spectrum (thin film/NaCl) of compound 149c. 
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Figure A1.75.  13C NMR (75 MHz, CDCl3) of compound 149d. 
Figure A1.74.  Infrared spectrum (thin film/NaCl) of compound 149d. 
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Figure A1.78.  13C NMR (75 MHz, CDCl3) of compound 149e. 
Figure A1.77.  Infrared spectrum (thin film/NaCl) of compound 149e. 
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Figure A1.81.  Infrared spectrum (thin film/NaCl) of compound 149f. 
Figure A1.80.  13C NMR (75 MHz, CDCl3) of compound 149f. 
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Figure A1.84.  13C NMR (75 MHz, CDCl3) of compound 149g. 
Figure A1.83.  Infrared spectrum (thin film/NaCl) of compound 149g. 
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Figure A1.87.  Infrared spectrum (thin film/NaCl) of compound 149h. 
Figure A1.86.  13C NMR (75 MHz, CDCl3) of compound 149h. 
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Figure A1.90.  13C NMR (75 MHz, CDCl3) of compound 149i. 
Figure A1.89.  Infrared spectrum (thin film/NaCl) of compound 149i. 
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Figure A1.93.  Infrared spectrum (thin film/NaCl) of compound 149j. 
Figure A1.92.  13C NMR (75 MHz, CDCl3) of compound 149j. 
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Figure A1.96.  13C NMR (75 MHz, CDCl3) of compound 149k. 
Figure A1.95.  Infrared spectrum (thin film/NaCl) of compound 149k. 
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Figure A1.99.  Infrared spectrum (thin film/NaCl) of compound 149l. 
Figure A1.98.  13C NMR (75 MHz, CDCl3) of compound 149l. 
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Figure A1.102.  13C NMR (75 MHz, CDCl3) of compound 149m. 
Figure A1.101.  Infrared spectrum (thin film/NaCl) of compound 149m. 
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Figure A1.105.  13C NMR (75 MHz, CDCl3) of compound 149n. 
Figure A1.104.  Infrared spectrum (thin film/NaCl) of compound 149n. 
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Figure A1.108.  13C NMR (75 MHz, CDCl3) of compound 149o. 
Figure A1.107.  Infrared spectrum (thin film/NaCl) of compound 149o. 
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Figure A1.111.  13C NMR (75 MHz, CDCl3) of compound 149p. 
Figure A1.110.  Infrared spectrum (thin film/NaCl) of compound 149p. 
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Figure A1.114.  13C NMR (75 MHz, CDCl3) of compound 149q. 
Figure A1.113.  Infrared spectrum (thin film/NaCl) of compound 149q. 
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Figure A1.117.  13C NMR (75 MHz, CDCl3) of compound 194. 
Figure A1.116.  Infrared spectrum (thin film/NaCl) of compound 194. 
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Figure A1.120.  13C NMR (75 MHz, CDCl3) of compound 151. 
Figure A1.119.  Infrared spectrum (thin film/NaCl) of compound 151. 
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Figure A1.123.  13C NMR (75 MHz, CDCl3) of compound 152. 
Figure A1.122.  Infrared spectrum (thin film/NaCl) of compound 152. 
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Figure A1.126.  13C NMR (125 MHz, CDCl3) of compound 160. 
Figure A1.125.  Infrared spectrum (thin film/NaCl) of compound 160. 
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Figure A1.129.  13C NMR (125 MHz, CDCl3) of compound 137a. 
Figure A1.128.  Infrared spectrum (thin film/NaCl) of compound 137a. 
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Figure A1.131.  Infrared spectrum (thin film/NaCl) of compound 154a. 
Figure A1.132.  13C NMR (125 MHz, CDCl3) of compound 154a. 
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Figure A1.134.  Infrared spectrum (thin film/NaCl) of compound 154b. 
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Figure A1.136.  Infrared spectrum (thin film/NaCl) of compound 154c. 
APPENDIX 1 – Spectra Relevant to Chapter 2 366 
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Figure A1.138.  Infrared spectrum (thin film/NaCl) of compound 154d. 
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Figure A1.140.  Infrared spectrum (thin film/NaCl) of compound 154e. 
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Figure A1.142.  Infrared spectrum (thin film/NaCl) of compound 154f. 
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Figure A1.144.  Infrared spectrum (thin film/NaCl) of compound 154g. 
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Figure A1.146.  Infrared spectrum (thin film/NaCl) of compound 154h. 
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Figure A1.148.  Infrared spectrum (thin film/NaCl) of compound 154i. 
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Figure A1.150.  Infrared spectrum (thin film/NaCl) of compound 154j. 
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Figure A1.152.  Infrared spectrum (thin film/NaCl) of compound 154m. 
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Figure A1.154.  Infrared spectrum (thin film/NaCl) of compound 154o. 
APPENDIX 1 – Spectra Relevant to Chapter 2 384 
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 Figure A1.156.  Infrared spectrum (thin film/NaCl) of compound 154p. 
APPENDIX 1 – Spectra Relevant to Chapter 2 386 
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Figure A1.158.  Infrared spectrum (thin film/NaCl) of compound 154q. 
APPENDIX 1 – Spectra Relevant to Chapter 2 388 
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Figure A1.160.  Infrared spectrum (thin film/NaCl) of compound 154n. 
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Figure A1.163.  13C NMR (125 MHz, CDCl3) of compound 135a. 
Figure A1.162.  Infrared spectrum (thin film/NaCl) of compound 135a. 
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Figure A1.166.  13C NMR (75 MHz, CDCl3) of compound 135b. 
Figure A1.165.  Infrared spectrum (thin film/NaCl) of compound 135b. 
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Figure A1.169.  13C NMR (75 MHz, CDCl3) of compound 135c. 
Figure A1.168.  Infrared spectrum (thin film/NaCl) of compound 135c. 
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Figure A1.172.  13C NMR (75 MHz, CDCl3) of compound 135d. 
Figure A1.171.  Infrared spectrum (thin film/NaCl) of compound 135d. 
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Figure A1.175.  13C NMR (75 MHz, CDCl3) of compound 135e. 
Figure A1.174.  Infrared spectrum (thin film/NaCl) of compound 135e. 
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Figure A1.178.  13C NMR (75 MHz, CDCl3) of compound 135f. 
Figure A1.177.  Infrared spectrum (thin film/NaCl) of compound 135f. 
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Figure A1.181.  13C NMR (75 MHz, CDCl3) of compound 135g. 
Figure A1.180.  Infrared spectrum (thin film/NaCl) of compound 135g. 
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Figure A1.184.  13C NMR (75 MHz, CDCl3) of compound 135h. 
Figure A1.183.  Infrared spectrum (thin film/NaCl) of compound 135h. 
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Figure A1.187.  13C NMR (75 MHz, CDCl3) of compound 135i. 
Figure A1.186.  Infrared spectrum (thin film/NaCl) of compound 135i. 
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Figure A1.190.  13C NMR (75 MHz, CDCl3) of compound 135j. 
Figure A1.189.  Infrared spectrum (thin film/NaCl) of compound 135j. 
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Figure A1.193.  13C NMR (75 MHz, CDCl3) of compound 135m. 
Figure A1.192.  Infrared spectrum (thin film/NaCl) of compound 135m. 
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Figure A1.196.  13C NMR (75 MHz, CDCl3) of compound 135n. 
Figure A1.195.  Infrared spectrum (thin film/NaCl) of compound 135n. 
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Figure A1.199.  13C NMR (100 MHz, CDCl3) of compound 135p. 
Figure A1.198.  Infrared spectrum (thin film/NaCl) of compound 135p. 
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Figure A1.202.  13C NMR (75 MHz, CDCl3) of compound 135q. 
Figure A1.201.  Infrared spectrum (thin film/NaCl) of compound 135q. 
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Figure A1.205.  13C NMR (125 MHz, CDCl3) of compound 135n. 
Figure A1.204.  Infrared spectrum (thin film/NaCl) of compound 135n. 
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Figure A1.208.  13C NMR (125 MHz, CDCl3) of compound 146. 
Figure A1.207.  Infrared spectrum (thin film/NaCl) of compound 146. 
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Figure A1.211.  13C NMR (125 MHz, CDCl3) of compound 137r. 
Figure A1.210.  Infrared spectrum (thin film/NaCl) of compound 137r. 
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Figure A1.213.  Infrared spectrum (thin film/NaCl) of compound 154r. 
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Figure A1.216.  13C NMR (125 MHz, CDCl3) of compound 156r. 
Figure A1.215.  Infrared spectrum (thin film/NaCl) of compound 156r. 
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Figure A1.219.  13C NMR (125 MHz, CDCl3) of compound 135r. 
Figure A1.218.  Infrared spectrum (thin film/NaCl) of compound 135r. 
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Figure A1.222.  13C NMR (75 MHz, CDCl3) of compound 163. 
Figure A1.221.  Infrared spectrum (thin film/NaCl) of compound 163. 
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Figure A1.225.  13C NMR (125 MHz, CDCl3) of compound 164. 
Figure A1.224.  Infrared spectrum (thin film/NaCl) of compound 164. 
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Figure A1.228.  13C NMR (100 MHz, CDCl3) of compound 165. 
Figure A1.227.  Infrared spectrum (thin film/NaCl) of compound 165. 
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Figure A1.231.  13C NMR (75 MHz, CDCl3) of compound 166. 
Figure A1.230.  Infrared spectrum (thin film/NaCl) of compound 166. 
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Figure A1.234.  13C NMR (75 MHz, CDCl3) of compound 167. 
Figure A1.233.  Infrared spectrum (thin film/NaCl) of compound 167. 
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Figure A1.237.  13C NMR (75 MHz, CDCl3) of compound 195. 
Figure A1.236.  Infrared spectrum (thin film/NaCl) of compound 195. 
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Figure A1.240.  13C NMR (75 MHz, CDCl3) of compound 168. 
Figure A1.239.  Infrared spectrum (thin film/NaCl) of compound 168. 
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Figure A1.243.  Infrared spectrum (thin film/NaCl) of compound 196. 
Figure A1.242.  13C NMR (75 MHz, CDCl3) of compound 196. 
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Figure A1.246.  13C NMR (75 MHz, CDCl3) of compound 169. 
Figure A1.245.  Infrared spectrum (thin film/NaCl) of compound 169. 
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Figure A1.249.  13C NMR (75 MHz, CDCl3) of compound 197. 
Figure A1.248.  Infrared spectrum (thin film/NaCl) of compound 197. 
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Figure A1.252.  13C NMR (75 MHz, CDCl3) of compound 171. 
Figure A1.251.  Infrared spectrum (thin film/NaCl) of compound 171. 
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Figure A1.255.  Infrared spectrum (thin film/NaCl) of compound 172. 
Figure A1.254.  13C NMR (75 MHz, CDCl3) of compound 172. 
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Figure A1.258.  13C NMR (100 MHz, CDCl3) of compound 173. 
Figure A1.257.  Infrared spectrum (thin film/NaCl) of compound 173. 
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Figure A1.261.  Infrared spectrum (thin film/NaCl) of compound 174. 
Figure A1.260.  13C NMR (125 MHz, CDCl3) of compound 174. 
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Figure A1.264.  13C NMR (125 MHz, CDCl3) of compound 175. 
Figure A1.263.  Infrared spectrum (thin film/NaCl) of compound 175. 
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Figure A1.267.  13C NMR (125 MHz, CDCl3) of compound 176. 
Figure A1.266.  Infrared spectrum (thin film/NaCl) of compound 176. 
APPENDIX 1 – Spectra Relevant to Chapter 2 462 
O 17
7
Cl
 
Fi
gu
re
 A
1.
26
8.
  1
H
 N
M
R
 (5
00
 M
H
z,
 C
D
C
l 3
) o
f c
om
po
un
d 
17
7.
 
APPENDIX 1 – Spectra Relevant to Chapter 2 463 
 
Figure A1.270.  13C NMR (125 MHz, CDCl3) of compound 177. 
Figure A1.269.  Infrared spectrum (thin film/NaCl) of compound 177. 
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Figure A1.273.  13C NMR (75 MHz, CDCl3) of compound 179. 
Figure A1.272.  Infrared spectrum (thin film/NaCl) of compound 179. 
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Figure A1.276.  13C NMR (125 MHz, CDCl3) of compound 170. 
Figure A1.275.  Infrared spectrum (thin film/NaCl) of compound 170. 
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Figure A1.279.  Infrared spectrum (thin film/NaCl) of compound 181. 
Figure A1.278.  13C NMR (125 MHz, CDCl3) of compound 181. 
APPENDIX 1 – Spectra Relevant to Chapter 2 470 
18
3
OH
 
Fi
gu
re
 A
1.
28
0.
  1
H
 N
M
R
 (5
00
 M
H
z,
 C
D
C
l 3
) o
f c
om
po
un
d 
18
3.
 
APPENDIX 1 – Spectra Relevant to Chapter 2 471 
 
Figure A1.282.  13C NMR (125 MHz, CDCl3) of compound 183. 
Figure A1.281.  Infrared spectrum (thin film/NaCl) of compound 183. 
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Figure A1.285.  13C NMR (125 MHz, CDCl3) of compound 184. 
Figure A1.284.  Infrared spectrum (thin film/NaCl) of compound 184. 
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Figure A1.287.  Infrared spectrum (thin film/NaCl) of compound 137s. 
Figure A1.288.  13C NMR (125 MHz, CDCl3) of compound 137s. 
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Figure A1.290.  Infrared spectrum (thin film/NaCl) of compound 137t. 
Figure A1.291.  13C NMR (125 MHz, CDCl3) of compound 137t. 
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Figure A1.293.  Infrared spectrum (thin film/NaCl) of compound 137u. 
Figure A1.294.  13C NMR (125 MHz, CDCl3) of compound 137u. 
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Figure A1.296.  Infrared spectrum (thin film/NaCl) of compound 137v. 
Figure A1.297.  13C NMR (125 MHz, CDCl3) of compound 137v. 
APPENDIX 1 – Spectra Relevant to Chapter 2 482 
O
13
7w
Fi
gu
re
 A
1.
29
8.
  1
H
 N
M
R
 (5
00
 M
H
z,
 C
D
C
l 3
) o
f c
om
po
un
d 
13
7w
. 
APPENDIX 1 – Spectra Relevant to Chapter 2 483 
 
 
Figure A1.299.  Infrared spectrum (thin film/NaCl) of compound 137w. 
Figure A1.300.  13C NMR (125 MHz, CDCl3) of compound 137w. 
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Figure A1.302.  Infrared spectrum (thin film/NaCl) of compound 137x. 
Figure A1.303.  13C NMR (125 MHz, CDCl3) of compound 137x. 
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Figure A1.305.  Infrared spectrum (thin film/NaCl) of compound 137y. 
Figure A1.306.  13C NMR (125 MHz, CDCl3) of compound 137y. 
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Figure A1.309.  Infrared spectrum (thin film/NaCl) of compound 137z. 
Figure A1.310.  13C NMR (125 MHz, CDCl3) of compound 137z. 
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Figure A1.312.  Infrared spectrum (thin film/NaCl) of compound 137aa. 
Figure A1.313.  13C NMR (125 MHz, CDCl3) of compound 137aa. 
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Figure A1.315.  Infrared spectrum (thin film/NaCl) of compound 137ab. 
Figure A1.316.  13C NMR (125 MHz, CDCl3) of compound 137ab. 
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Figure A1.318.  Infrared spectrum (thin film/NaCl) of compound 198. 
Figure A1.319.  13C NMR (125 MHz, CDCl3) of compound 198. 
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Figure A1.321.  Infrared spectrum (thin film/NaCl) of compound 185x. 
Figure A1.322.  13C NMR (125 MHz, CDCl3) of compound 185x. 
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Figure A1.324.  Infrared spectrum (thin film/NaCl) of compound 185y. 
Figure A1.325.  13C NMR (125 MHz, CDCl3) of compound 185y. 
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Figure A1.327.  Infrared spectrum (thin film/NaCl) of compound 185s. 
Figure A1.328.  13C NMR (125 MHz, C6D6) of compound 185s. 
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Figure A1.330.  Infrared spectrum (thin film/NaCl) of compound 185t. 
Figure A1.331.  13C NMR (125 MHz, CDCl3) of compound 185t. 
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Figure A1.333.  Infrared spectrum (thin film/NaCl) of compound 185u. 
Figure A1.334.  13C NMR (125 MHz, CDCl3) of compound 185u. 
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Figure A1.336.  Infrared spectrum (thin film/NaCl) of compound 185v. 
Figure A1.337.  13C NMR (125 MHz, CDCl3) of compound 185v. 
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Figure A1.339.  Infrared spectrum (thin film/NaCl) of compound 185z. 
Figure A1.340.  13C NMR (125 MHz, CDCl3) of compound 185z. 
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Figure A1.342.  Infrared spectrum (thin film/NaCl) of compound 185w. 
Figure A1.343.  13C NMR (125 MHz, CDCl3) of compound 185w. 
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Figure A1.345.  Infrared spectrum (thin film/NaCl) of compound 187. 
Figure A1.346.  13C NMR (125 MHz, CDCl3) of compound 187. 
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Figure A1.348.  Infrared spectrum (thin film/NaCl) of compound 188. 
Figure A1.349.  13C NMR (125 MHz, CDCl3) of compound 188. 
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Figure A1.352.  Infrared spectrum (thin film/NaCl) of compound 189a. 
Figure A1.353.  13C NMR (125 MHz, CDCl3) of compound 189a. 
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Figure A1.356.  Infrared spectrum (thin film/NaCl) of compound 189b. 
Figure A1.357.  13C NMR (125 MHz, CDCl3) of compound 189b. 
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A2.1 CRYSTAL STRUCTURE ANALYSIS OF 164 
H
H
OOH
 
Compound 353  
(AYH02) (CCDC 889570) 
 
Contents 
Table A2.1.  Crystal data 
Table A2.2.  Atomic coordinates 
Table A2.3.  Full bond distances and angles  
Table A2.4.  Anisotropic displacement parameters 
Table A2.5.  Hydrogen bond distances and angles 
 
Figure A2.1. Semicarbazone 164 is shown with 50% probability ellipsoids. 
 
CCDC 686849 (164) contains the supplementary crystallographic data for this appendix.  These 
data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
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Table A2.1.  Crystal data and structure refinement for semicarbazone 164 (CCDC 686849) 
Empirical formula  C19H24N3OI 
Formula weight  437.31 
Crystallization solvent  Dichloromethane/pentane 
Crystal habit  Needle 
Crystal size 0.28 x 0.11 x 0.07 mm3 
Crystal color  Colorless 
 
 Data Collection  
Type of diffractometer  Bruker KAPPA APEX II 
Wavelength  0.71073 Å MoKα  
Data collection temperature  100(2) K 
θ range for 9911 reflections used 
    in lattice determination  2.57 to 28.78° 
Unit cell dimensions a = 17.160(4) Å 
 b = 5.5921(14) Å β = 90.689(6)° 
 c = 19.984(5) Å 
Volume 1917.6(8) Å3 
Z 4 
Crystal system  Monoclinic 
Space group  P21 
Density (calculated) 1.515 Mg/m3 
F(000) 880 
Data collection program Bruker APEX2 v2.1-0 
θ range for data collection 1.55 to 29.84° 
Completeness to θ = 29.84° 88.9 %  
Index ranges –23 ≤ h ≤ 23, –7 ≤ k ≤ 7, –26 ≤ l ≤ 25 
Data collection scan type  ω scans; 16 settings 
Data reduction program  Bruker SAINT-Plus v7.34A 
Reflections collected 8962 
Independent reflections 8962 [Rint= 0.0000] 
Absorption coefficient 1.680 mm–1 
Absorption correction Semi-empirical from equivalents (TWNABS) 
Max. and min. transmission 0.7460 and 0.5010 
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Structure solution and Refinement 
Structure solution program  SHELXS-97 (Sheldrick, 2008) 
Primary solution method  Direct methods 
Secondary solution method  Difference Fourier map 
Hydrogen placement  Geometric positions 
Structure refinement program  SHELXL-97 (Sheldrick, 2008) 
Refinement method Full matrix least-squares on F2 
Data / restraints / parameters 8962 / 1 / 437 
Treatment of hydrogen atoms  Riding 
Goodness-of-fit on F2 1.609 
Final R indices [I>2σ(I), 7203 reflections] R1 = 0.0409, wR2 = 0.0481 
R indices (all data) R1 = 0.0619, wR2 = 0.0493 
Type of weighting scheme used Sigma 
Weighting scheme used w=1/σ2(Fo2) 
Max shift/error  0.002 
Average shift/error  0.000 
Absolute structure determination Anomalous differences 
Absolute structure parameter 0.003(11) 
Largest diff. peak and hole 0.807 and –0.967 e.Å–3 
 
Special Refinement Details 
 
The structure was refined as a single component, although the crystals were twins, using an HKLF4 
format reflection file prepared with TWINABS (see below). The two orientations were separated using 
CELL_NOW as follows. 
Rotated from first domain by 178.9 degrees about reciprocal axis –0.032  1.000  0.104  and real axis    
–0.001  1.000  0.007. Twin law to convert hkl from first to this domain (SHELXL TWIN matrix): 
 
-1.000  -0.065   0.016 
-0.003   0.998   0.014 
-0.022   0.207  -0.999 
 
From Saint integration; Twin Law, Sample 1 of 1 transforms h1.1(1)->h1.2(2) 
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-0.99897 -0.07583  0.01646 
-0.00750  0.99693  0.01538 
-0.02464  0.19596 -0.99910 
 
Twinabs; 
PART 1 - Refinement of parameters to model systematic errors 
 
18757 data ( 4443 unique ) involve domain  1 only,  mean I/sigma  13.7 
18551 data ( 4364 unique ) involve domain  2 only,  mean I/sigma   7.1 
10342 data ( 4106 unique ) involve   2 domains,  mean I/sigma  19.2 
 
HKLF 4 dataset constructed from all observations involving domains 1..2 
    8970 Corrected reflections written to file twin4.hkl 
 Reflections merged according to point-group 2 
 Minimum and maximum apparent transmission:  0.501007  0.745969 
 Additional spherical absorption correction applied with mu*r =  0.2000 
 
Crystals were mounted on a glass fiber using Paratone oil then placed on the diffractometer under a 
nitrogen stream at 100 K. 
Refinement of F2 against ALL reflections.  The weighted R-factor (wR) and goodness of fit (S) are 
based on F2, conventional R-factors (R) are based on F, with F set to zero for negative F2. The threshold 
expression of F2 > 2σ( F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of 
reflections for refinement.  R-factors based on F2 are statistically about twice as large as those based on F, 
and R-factors based on ALL data will be even larger. 
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix.  The cell esds are taken into account individually in the estimation of esds in distances, 
angles and torsion angles; correlations between esds in cell parameters are only used when they are defined 
by crystal symmetry.  An approximate (isotropic) treatment of cell esds is used for estimating esds 
involving l.s. planes. 
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Figure A2.2.  Semicarbazone 164 (CCDC 686849). 
 
 
Table A2.2.  Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 x 103) 
for semicarbazone 164 (CCDC 686849).  U(eq) is defined as the trace of the orthogonalized Uij 
tensor 
 
 x y z Ueq 
 
I(1) 9525(1) 8297(1) 6590(1) 36(1) 
O(1A) 7955(1) 941(3) 3051(1) 30(1) 
N(1A) 7500(2) 3872(4) 3727(1) 30(1) 
N(2A) 6670(2) 1070(4) 3270(1) 28(1) 
N(3A) 6059(2) 2296(4) 3562(1) 28(1) 
C(1A) 8489(2) 4383(5) 4938(2) 26(1) 
C(2A) 8786(2) 5006(6) 5555(2) 27(1) 
C(3A) 9158(2) 7186(5) 5637(2) 24(1) 
C(4A) 9240(2) 8700(6) 5094(2) 23(1) 
C(5A) 8934(2) 8049(6) 4481(2) 24(1) 
C(6A) 8541(2) 5886(5) 4389(2) 21(1) 
C(7A) 8214(2) 5251(6) 3716(2) 29(1) 
C(8A) 7411(2) 1915(5) 3335(2) 24(1) 
C(9A) 5356(2) 1676(5) 3411(2) 25(1) 
C(10A) 5153(2) -221(5) 2912(2) 34(1) 
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Table A2.2 (cont.) 
C(11A) 4738(2) 3016(6) 3736(2) 25(1) 
C(12A) 4902(2) 5012(5) 4229(2) 30(1) 
C(13A) 4096(2) 6199(5) 4302(2) 34(1) 
C(14A) 3501(2) 4222(5) 4130(2) 33(1) 
C(15A) 3985(2) 2625(5) 3693(2) 32(1) 
C(16A) 3271(2) 2838(6) 4771(2) 47(1) 
C(17A) 2751(2) 5160(6) 3793(2) 36(1) 
C(18A) 2864(2) 6198(6) 3116(2) 39(1) 
C(19A) 2612(2) 8233(8) 2900(2) 51(1) 
 
I(2) 5760(1) 351(1) -1541(1) 52(1) 
O(1B) 6661(1) 7118(3) 2275(1) 34(1) 
N(1B) 7173(2) 4167(4) 1625(1) 34(1) 
N(2B) 7955(2) 7040(4) 2098(1) 27(1) 
N(3B) 8578(2) 5882(4) 1807(1) 26(1) 
C(1B) 6496(2) 3858(5) 289(2) 33(1) 
C(2B) 6341(2) 3322(8) -374(2) 35(1) 
C(3B) 5958(2) 1240(6) -534(2) 29(1) 
C(4B) 5742(2) -303(6) -40(2) 31(1) 
C(5B) 5895(2) 235(6) 618(2) 28(1) 
C(6B) 6287(2) 2329(5) 795(2) 26(1) 
C(7B) 6454(2) 2863(6) 1519(2) 32(1) 
C(8B) 7233(2) 6143(5) 2016(2) 25(1) 
C(9B) 9266(2) 6619(5) 1925(2) 24(1) 
C(10B) 9471(2) 8670(6) 2382(2) 33(1) 
C(11B) 9892(2) 5325(6) 1586(2) 25(1) 
C(12B) 9704(2) 3469(7) 1051(2) 34(1) 
C(13B) 10499(2) 2401(6) 903(2) 54(1) 
C(14B) 11131(2) 4019(5) 1204(2) 33(1) 
C(15B) 10659(2) 5558(6) 1666(2) 30(1) 
C(16B) 11736(3) 2543(7) 1600(2) 67(2) 
C(17B) 11522(2) 5571(7) 690(2) 58(1) 
C(18B) 12017(3) 4302(6) 194(2) 52(1) 
C(19B) 11859(3) 3982(7) -416(2) 77(2) 
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Table A2.3.  Bond lengths [Å] and angles [°] for semicarbazone 164 (CCDC 686849) 
 
I(1)-C(3A)  2.092(3) 
O(1A)-C(8A)  1.226(4) 
N(1A)-C(8A)  1.354(4) 
N(1A)-C(7A)  1.449(4) 
N(2A)-C(8A)  1.361(4) 
N(2A)-N(3A)  1.388(3) 
N(3A)-C(9A)  1.289(4) 
C(1A)-C(2A)  1.375(5) 
C(1A)-C(6A)  1.386(4) 
C(2A)-C(3A)  1.385(4) 
C(3A)-C(4A)  1.384(4) 
C(4A)-C(5A)  1.376(4) 
C(5A)-C(6A)  1.397(5) 
C(6A)-C(7A)  1.494(4) 
C(9A)-C(11A)  1.457(4) 
C(9A)-C(10A)  1.494(4) 
C(11A)-C(15A)  1.312(4) 
C(11A)-C(12A)  1.514(5) 
C(12A)-C(13A)  1.542(4) 
C(13A)-C(14A)  1.542(5) 
C(14A)-C(15A)  1.505(4) 
C(14A)-C(17A)  1.538(5) 
C(14A)-C(16A)  1.552(5) 
C(17A)-C(18A)  1.487(5) 
C(18A)-C(19A)  1.290(5) 
I(2)-C(3B)  2.096(3) 
O(1B)-C(8B)  1.242(4) 
N(1B)-C(8B)  1.356(4) 
N(1B)-C(7B)  1.447(4) 
N(2B)-C(8B)  1.346(4) 
N(2B)-N(3B)  1.383(3) 
N(3B)-C(9B)  1.270(4) 
C(1B)-C(6B)  1.376(4) 
C(1B)-C(2B)  1.380(5) 
C(2B)-C(3B)  1.373(5) 
C(3B)-C(4B)  1.366(4) 
C(4B)-C(5B)  1.372(4) 
C(5B)-C(6B)  1.394(5) 
C(6B)-C(7B)  1.501(5) 
C(9B)-C(11B)  1.467(4) 
C(9B)-C(10B)  1.504(4) 
C(11B)-C(15B)  1.330(4) 
C(11B)-C(12B)  1.522(4) 
C(12B)-C(13B)  1.521(5) 
C(13B)-C(14B)  1.530(5) 
C(14B)-C(15B)  1.505(4) 
C(14B)-C(17B)  1.509(5) 
C(14B)-C(16B)  1.537(6) 
C(17B)-C(18B)  1.493(5) 
C(18B)-C(19B)  1.260(5) 
 
C(8A)-N(1A)-C(7A) 120.7(3) 
C(8A)-N(2A)-N(3A) 119.8(3) 
C(9A)-N(3A)-N(2A) 118.6(3) 
C(2A)-C(1A)-C(6A) 122.1(3) 
C(1A)-C(2A)-C(3A) 119.6(3) 
C(2A)-C(3A)-C(4A) 119.8(3) 
C(2A)-C(3A)-I(1) 120.1(2) 
C(4A)-C(3A)-I(1) 119.9(2) 
C(5A)-C(4A)-C(3A) 119.7(3) 
C(4A)-C(5A)-C(6A) 121.7(3) 
C(1A)-C(6A)-C(5A) 117.2(3) 
C(1A)-C(6A)-C(7A) 122.8(3) 
C(5A)-C(6A)-C(7A) 120.1(3) 
N(1A)-C(7A)-C(6A) 115.0(3) 
O(1A)-C(8A)-N(1A) 123.1(3) 
O(1A)-C(8A)-N(2A) 121.2(3) 
N(1A)-C(8A)-N(2A) 115.8(3) 
N(3A)-C(9A)-C(11A) 116.2(3) 
N(3A)-C(9A)-C(10A) 123.9(3) 
C(11A)-C(9A)-C(10A) 119.8(3) 
C(15A)-C(11A)-C(9A) 127.4(3) 
C(15A)-C(11A)-C(12A) 109.9(3) 
C(9A)-C(11A)-C(12A) 122.6(3) 
C(11A)-C(12A)-C(13A) 102.6(3) 
C(12A)-C(13A)-C(14A) 105.2(2) 
C(15A)-C(14A)-C(17A) 114.4(3) 
C(15A)-C(14A)-C(13A) 100.7(3) 
C(17A)-C(14A)-C(13A) 113.7(3) 
C(15A)-C(14A)-C(16A) 109.3(3) 
C(17A)-C(14A)-C(16A) 108.2(3) 
C(13A)-C(14A)-C(16A) 110.3(3) 
C(11A)-C(15A)-C(14A) 114.4(3) 
C(18A)-C(17A)-C(14A) 114.4(3) 
C(19A)-C(18A)-C(17A) 127.0(3) 
C(8B)-N(1B)-C(7B) 123.6(3) 
C(8B)-N(2B)-N(3B) 119.3(3) 
C(9B)-N(3B)-N(2B) 119.4(3) 
C(6B)-C(1B)-C(2B) 121.4(3) 
C(3B)-C(2B)-C(1B) 119.6(3) 
C(4B)-C(3B)-C(2B) 120.0(3) 
C(4B)-C(3B)-I(2) 120.1(3) 
C(2B)-C(3B)-I(2) 119.8(2) 
C(3B)-C(4B)-C(5B) 120.3(3) 
C(4B)-C(5B)-C(6B) 120.9(3) 
C(1B)-C(6B)-C(5B) 117.7(3) 
C(1B)-C(6B)-C(7B) 122.4(3) 
C(5B)-C(6B)-C(7B) 119.8(3) 
N(1B)-C(7B)-C(6B) 113.3(3) 
O(1B)-C(8B)-N(2B) 121.1(3) 
APPENDIX 2 — X-Ray Crystallography Reports Relevant to Chapter 2 531 
Table A2.3 (cont.) 
O(1B)-C(8B)-N(1B) 123.0(3) 
N(2B)-C(8B)-N(1B) 115.9(3) 
N(3B)-C(9B)-C(11B) 116.0(3) 
N(3B)-C(9B)-C(10B) 124.7(3) 
C(11B)-C(9B)-C(10B) 119.3(3) 
C(15B)-C(11B)-C(9B) 128.7(3) 
C(15B)-C(11B)-C(12B) 110.6(3) 
C(9B)-C(11B)-C(12B) 120.7(3) 
C(13B)-C(12B)-C(11B) 102.9(3) 
 
 
 
 
C(12B)-C(13B)-C(14B) 108.9(3) 
C(15B)-C(14B)-C(17B) 109.6(3) 
C(15B)-C(14B)-C(13B) 101.3(3) 
C(17B)-C(14B)-C(13B) 112.9(3) 
C(15B)-C(14B)-C(16B) 110.9(3) 
C(17B)-C(14B)-C(16B) 110.8(3) 
C(13B)-C(14B)-C(16B) 110.9(3) 
C(11B)-C(15B)-C(14B) 114.2(3) 
C(18B)-C(17B)-C(14B) 116.1(3) 
C(19B)-C(18B)-C(17B) 126.3(5)
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Table A2.4.  Anisotropic displacement parameters (Å2 x 104) for semicarbazone 164 (CCDC 
686849).  The anisotropic displacement factor exponent takes the form: –2π2[ h2a*2U11 + ... + 2 h k 
a* b* U12 ] 
 
 U11 U22 U33 U23 U13 U12 
 
I(1) 340(2)  433(1) 310(1)  1(1) -116(1)  -2(1) 
O(1A) 177(14)  294(13) 431(15)  -131(10) -15(11)  35(10) 
N(1A) 166(17)  377(19) 352(17)  -168(12) 3(13)  -6(12) 
N(2A) 150(17)  315(15) 378(18)  -133(12) -22(13)  22(12) 
N(3A) 186(19)  310(15) 328(18)  -35(12) -35(15)  38(13) 
C(1A) 190(20)  176(16) 420(20)  13(15) -22(18)  9(13) 
C(2A) 250(20)  237(18) 320(20)  88(15) -7(16)  -4(16) 
C(3A) 170(20)  261(17) 270(20)  -18(14) -7(16)  69(14) 
C(4A) 180(20)  200(20) 310(20)  -23(14) -29(15)  -13(14) 
C(5A) 240(20)  201(19) 275(19)  26(16) 5(15)  34(16) 
C(6A) 171(19)  195(18) 269(19)  -26(14) -8(15)  64(14) 
C(7A) 260(20)  280(18) 330(20)  -40(17) -16(16)  -38(18) 
C(8A) 200(20)  257(18) 260(20)  -33(14) -61(17)  19(16) 
C(9A) 200(20)  231(17) 330(20)  -9(14) -9(18)  -26(15) 
C(10A) 200(20)  410(20) 430(20)  -69(17) 3(18)  -44(17) 
C(11A) 190(20)  240(20) 330(20)  21(16) -31(15)  -26(17) 
C(12A) 250(20)  283(18) 360(20)  -23(16) -60(16)  -30(16) 
C(13A) 260(20)  305(19) 440(20)  -99(15) -50(18)  42(16) 
C(14A) 190(20)  305(19) 490(30)  -7(15) 9(19)  19(15) 
C(15A) 260(20)  240(20) 460(20)  -48(14) -26(19)  -18(15) 
C(16A) 360(30)  500(30) 540(30)  114(18) 30(20)  88(19) 
C(17A) 250(20)  390(20) 450(20)  -34(18) 9(18)  40(20) 
C(18A) 270(20)  480(20) 420(30)  -75(18) -70(20)  77(18) 
C(19A) 410(30)  600(20) 510(20)  40(20) -88(19)  120(30) 
 
I(2) 431(2)  791(2) 333(2)  -69(1) -57(1)  -30(2) 
O(1B) 227(16)  346(12) 447(16)  -105(10) 2(13)  9(11) 
N(1B) 220(19)  350(17) 440(20)  -151(12) -38(16)  9(12) 
N(2B) 230(20)  301(15) 272(17)  -106(12) -29(14)  3(13) 
N(3B) 208(18)  309(16) 277(16)  -57(12) -23(14)  26(14) 
C(1B) 340(30)  190(20) 470(30)  -9(15) -50(20)  -62(15) 
C(2B) 310(20)  404(19) 350(20)  130(20) -22(16)  20(20) 
C(3B) 190(20)  370(20) 310(20)  -17(16) -51(17)  17(16) 
C(4B) 200(20)  270(20) 450(30)  -58(16) -50(18)  -39(15) 
C(5B) 270(20)  236(18) 340(20)  71(16) -20(16)  -10(17) 
C(6B) 170(20)  246(18) 350(20)  8(15) -46(17)  -2(14) 
C(7B) 300(20)  310(20) 360(20)  -12(15) -23(17)  -59(16) 
C(8B) 200(20)  282(19) 270(20)  -34(14) -76(16)  -6(16) 
C(9B) 250(20)  257(18) 220(20)  11(14) 2(17)  11(16) 
C(10B) 260(20)  400(20) 330(20)  -104(16) 37(16)  -60(18) 
C(11B) 250(20)  241(17) 253(19)  -25(16) -45(15)  -52(18) 
C(12B) 340(20)  341(18) 330(20)  -105(19) -60(16)  10(20) 
C(13B) 450(30)  450(20) 730(30)  -310(20) 70(30)  -4(19) 
C(14B) 250(20)  350(20) 390(20)  -54(15) 20(19)  25(15) 
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Table A2.4 (cont.) 
C(15B) 340(20)  290(18) 266(19)  -75(16) -25(16)  33(18) 
C(16B) 720(40)  680(30) 610(30)  -170(20) -50(30)  380(30) 
C(17B) 840(30)  400(20) 510(30)  -150(20) 330(20)  -90(20) 
C(18B) 500(30)  540(30) 520(30)  -104(19) 110(30)  -49(19) 
C(19B) 1060(50)  830(40) 420(30)  40(20) 60(30)  500(30) 
 
 
Table A2.5.  Hydrogen bonds for semicarbazone 164 (CCDC 686849) [Å and °] 
 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
 
 N(2A)-H(2A)...O(1B)#1 0.88 2.13 2.972(3) 159.7 
 N(2B)-H(2B)...O(1A)#2 0.88 2.04 2.895(3) 163.1 
 
Symmetry transformations used to generate equivalent atoms:  
#1 x,y-1,z     
#2 x,y+1,z      
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CHAPTER 3 
The Catalytic Asymmetric Total Synthesis of  
Presilphiperfolanol Natural Products† 
 
3.1 INTRODUCTION AND BACKGROUND 
Presilphiperfolanols (or prebotrydials) constitute a family of biosynthetically 
important sesquiterpenes.  The natural products have been isolated from several species 
of plants and fungi and are distinguished by their unique tricyclic structures, which can 
rearrange to diverse sesquiterpenoid skeletons.  The intriguing structures and biosynthetic 
roles of these compounds provide compelling reasons for their synthesis. 
 
3.1.1 ISOLATION AND STRUCTURAL ELUCIDATION 
Currently, three presilphiperfolanols have been isolated and characterized:  
presilphiperfolan-8α-ol (221)1 presilphiperfolan-9α-ol  (222),2 and presilphiperfolan-1β-
                                                
† Portions of this work have been published.  For the initial communication, see:  Hong, A. Y.; Stoltz, B. M. 
Angew. Chem. Int. Ed. 2012, 51, 9674–9678.  For a review of the presilphiperfolanols, see: Hong, A. Y.; 
Stoltz, B. M. Angew. Chem. Int. Ed. 2014, 53, 5248–5260. 
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ol (223)3,4 (Figure 3.1).  Each of these natural products corresponds to the hydration 
product of a presilphiperfolanyl cation involved in terpene cyclization pathways.  To 
date, naturally occurring stereoisomers of structures 221–223 have not been reported.  
The structurally complex presilphiperfolanols are distinguished by their rare, compact 
tricyclo[5.3.1.04,11]undecane sesquiterpene skeleton, which bears five contiguous 
stereocenters, two all-carbon quaternary centers, and a tertiary alcohol.  In addition to 
these readily apparent structural features, considerable ring strain is present in the 
tricyclic system,5,6 allowing these compounds to undergo thermodynamically favorable 
skeletal rearrangements that lead to structurally diverse polycyclic sesquiterpenes.  
Computational studies have shown that the heat of formation (ΔHf) of the 
presilphiperfolane skeleton is at least 7.1 kcal/mol greater than those for several isomeric 
sesquiterpene skeletons formed later in the biosynthetic sequence.5 
 
Figure 3.1.  Presilphiperfolanol (Prebotrydial) Natural Products 
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Presilphiperfolan-8α-ol (221) was the first member of the family to be identified.1  
Bohlmann and co-workers isolated the compound from the flowering plants Eriophyllum 
staechadifolium and Flourensia heterolepis in 1981.  The tricyclic structure and 
stereochemistry were assigned based on detailed 1H NMR analysis employing chiral shift 
reagents.  Subsequent work by Coates provided an X-ray crystal structure of the p-
nitrobenzoate ester derivative.7 
Presilphiperfolan-9α-ol (222)2 was later discovered by Weyerstahl in the wormwood 
Artemisia lacinata in 1993, and subsequently by Marco in the related species Artemisia 
chamaemelifolia in 1996.  The structure of 222 was determined based on NMR 
spectroscopic analysis and additionally confirmed by the total synthesis of (±)-222.8 
In contrast to presilphiperfolanols 221 and 222, the structure of presilphiperfolan-1β-
ol (223)3,4 has been revised several times (Figure 3.2).  Alcohol 223 was initially isolated 
by König in small quantities from the liverwort Conocephalum conicum in 1999,3 but 
was incorrectly assigned structure 224 based on NMR data.  The same compound was 
isolated by Leitão from the fern Anemia tomentosa var. anthriscifolia and reported as a 
unique natural product with initial structure 225 from the analysis of NMR spectra.4a  
Subsequent collaborations between Leitão and Joseph-Nathan unambiguously determined 
that the isolated compound possessed revised structure 223 by X-ray crystallography.4b  
Recently, our research group proposed that the compounds isolated by König and Leitão 
are in fact the same natural product 223 based on synthetic studies, spectroscopic data, 
and analysis of the likely biosynthetic pathway (see Section 3.4.7). 
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Figure 3.2.  Structural Reassignments of Presilphiperfolan-1β-ol (223) 
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In addition to the parent presilphiperfolanols, natural products with dehydrated or 
oxidized tricyclic skeletons have also been reported (Figure 3.3).  Presiphiperfol-1(8)-ene 
(226)1,7 and presilphiperfol-7(8)-ene (227)9 presumably arise from the deprotonation of 
presilphiperfolanyl cation intermediates.  Natural products such as the britanlins (228–
230)10 display additional oxidation at primary carbons in the presilphiperfolane skeleton.  
Other isolated compounds, such as angelates 233 and 234, show oxidation at multiple 
secondary carbons in the tricyclic framework.11  Oxidative ring cleavage is also possible 
as evidenced by the structures of botrydial (231)12 and dihydrobotrydial (232).12  All of 
these natural products arise from structural modification of the presilphiperfolanols, 
which exhibit a low level of oxidation.  
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Figure 3.3.  Natural Products with Dehydrated or Oxidized Presilphiperfolanol Skeletons 
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3.1.2 BIOSYNTHESIS OF THE PRESILPHIPERFOLANOLS 
The co-isolation of the presilphiperfolanols with structurally related sesquiterpenes 
provided important clues for their biosynthetic origin.  Bohlmann and co-workers 
observed that presilphiperfolan-8α-ol (221) was often found with various triquinane 
natural products.1,13  Tricyclic alcohol 221 and β-caryophyllene (248) (Figure 3.4) were 
also isolated from the same natural sources in numerous reports.9,14  These findings 
suggested that three classes of polycyclic sesquiterpenes were connected in a common 
biosynthetic pathway.  In 1980, Bohlmann explained these results by proposing that 
farnesyl pyrophosphate (FPP) (235) undergoes enzymatic polycyclization to 
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caryophyllenyl cation 237 (Scheme 3.1A).13  Subsequent cyclobutane ring expansion and 
cation-alkene cyclization leads to the C(8)-presilphiperfolanyl cation (239).  From this 
common intermediate, rearrangement of the carbon skeleton by Wagner–Meerwein shifts 
can lead to the observed triquinanes.   
Concurrent studies by Hanson in 1981 helped to elucidate the presilphiperfolane 
biosynthetic pathway.15  In an effort to understand the biogenesis of the downstream 
metabolite dihydrobotrydial (232) from farnesyl pyrophosphate (235), his group 
performed NMR studies with isotopically labeled FPP (235).  Both 2H and 13C labels 
could be incorporated into these compounds, which were fed to the fungus Botryis 
cinerea.  Subsequent analysis of the cyclized and oxidized dihydrobotrydial (232) 
products provided the first evidence for an unusual 1,3-hydride shift linking the initially 
formed C(9)-presilphiperfolanyl cation (238) to the isomeric C(8)-cation (239) (Scheme 
3.1A).  From this intermediate, Hanson reasoned that hydration and enzymatic oxidative 
cleavage of the less-substituted cyclopentane ring would lead to botrydial (231) and 
dihydrobotrydial (232) (Scheme 3.1B). 
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Scheme 3.1.  Modified Bohlmann–Hanson Mechanism for Presilphiperfolane Biosynthesis 
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The Bohlmann–Hanson mechanism has been refined and expanded by numerous 
groups through biochemical, spectroscopic, and computational techniques in recent years.  
The groups of Collado, Cane, and Viaud worked together to identify the BcBOT gene 
cluster in B. cinerea responsible for the enzymatic conversion of FPP (235) to botrydial 
(231).16  In these studies, it was demonstrated that the BcBOT2 gene encoded an essential 
sesquiterpene cyclase while other genes in the cluster expressed cytochrome P450 
monooxygenases responsible for the oxidation of the presilphiperfolane skeleton to 
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botrydial (231) and related derivatives (Scheme 3.1B).  Subsequent work by Cane 
focused on FPP isotopic labeling with the isolated enzyme.  These experiments provided 
detailed NMR evidence for the stereochemistry of individual cyclization steps.17 
Concurrent work by Tantillo sought to understand the presilphiperfolanol 
biosynthetic pathway through computational means.18  Numerous theoretical terpene 
cyclization pathways were evaluated and a revised mechanism was proposed on the basis 
of these results (Scheme 3.1A).  The key findings were the conformer of caryophyllenyl 
cation 237 responsible for cyclization, the highly synchronous nature of the cation-alkene 
cyclizations leading from 237 to 238, and the feasibility of the 1,3-hydride shift leading 
from C(9)-cation 238 to C(8)-cation 239.  Barquera-Lozada identified a similar 
polycyclization pathway for the biosynthetic conversion of FPP (235) to α-terrecyclene 
(247) (Scheme 3.1B).19  
 
3.1.3 BROADER RELEVANCE OF THE PRESILPHIPERFOLANOLS 
The importance of the presilphiperfolanols in sesquiterpene biosynthesis has 
prompted more detailed investigations of the rearrangements leading to other related 
natural products.7,9  A report by Weyerstahl in 1998 described the constituents of the 
essential oil from the rhizome Echinops giganteus var. lelyi as containing a rich 
collection of biogenetically related sesquiterpenes (Figure 3.4).9  Along with β-
caryophyllene (248) and presilphiperfolan-8α-ol (221), 18 unique tricyclic natural 
products were discovered.  All of the tricyclic compounds could be traced to common 
presilphiperfolanyl cation intermediates through reasonable Wagner–Meerwein shifts.  
The co-occurrence of these compounds further supports the findings of Bohlmann.1,13 
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Figure 3.4.  Selected Co-isolated Sesquiterpenes from Rhizome Echinops giganteus var. lelyi 
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In conjunction with these natural product isolation studies, others have sought to 
understand the biosynthetic conversion of presilphiperfolane skeletons to those of other 
sesquiterpene natural products through chemical semi-synthesis.  Coates successfully 
performed the rearrangement of presilphiperfolan-8α-ol (221) with TFAA at 70 °C to 
obtain cameroonan-7-ol trifluoroacetate (249) in 11% yield, silphiperfol-6-ene (240) in 
40% yield, and presilphiperfol-1(8)-ene (226) in 20% yield (Scheme 3.2).5,7  Ionization of 
alcohol 221 with H2SO4·SiO2 in benzene at 70 °C provided silphiperfol-6-ene (240) in 
79% yield and α-terrecyclene (247) in 1% yield.  The different distribution of 
sesquiterpene products obtained under these reaction conditions highlights the strong 
influence of reaction parameters on competing rearrangement pathways.  
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Scheme 3.2.  Rearrangement of Presilphiperfolan-8α-ol to Other Sesquiterpene Skeletons 
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Currently, the presilphiperfolane skeleton is believed to serve as the precursor to 
silphiperfolane, silphinane, isocomane, modhephane, terrecyclane, prenopsane, nopsane, 
and cameroonane skeletons (Scheme 3.1B and Scheme 3.3).9  The structural diversity of 
polycyclic skeletons produced from the presilphiperfolane skeleton underscores their 
fundamental biosynthetic importance in sesquiterpene cyclase pathways.  
While past work has explored the formation of presilphiperfolan-9α-ol (222) and 
presilphiperfolan-8α-ol (221) in great detail, existing biosynthetic proposals have not 
accounted for the formation of presilphiperfolan-1β-ol (223), the newest discovered 
member of the family (Scheme 3.3).  The understanding of the mechanistic pathway 
leading to this natural product could additionally provide new insight into the formation 
of downstream rearranged sesquiterpene natural products. 
 
CHAPTER 3 – The Total Synthesis of Presilphiperfolanol Natural Products 549 
Scheme 3.3.  Rearrangement of Presilphiperfolanols to Other Sesquiterpene Natural Products 
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3.1.4 BIOLOGICAL ACTIVITY 
While the presilphiperfolanols have proven to be important biosynthetic precursors to 
a number of polycyclic sesquiterpenes, they also exhibit modest biological activity.  As a 
relatively nonpolar low molecular weight alcohol, presilphiperfolan-9α-ol (222) has 
pleasant olfactory properties and has attracted interest as a possible fragrance 
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compound.2,20  The natural product (–)-2222 has a pleasantly sweet and woody aroma with 
hints of coconut and celery.  Synthetic (±)-2228 possesses a slightly different olfactory 
profile with a strongly radiative, woody, resinous, and amber(gris) notes. 
González-Coloma and co-workers discovered the insect antifeedant properties of 
presilphiperfolan-9α-ol (222) while screening a collection of polycyclic 
sesquiterpenoids.21  The tricyclic alcohol displayed an EC50 of 19.5 nmol/cm2 against the 
Colorado potato beetle Leptinotarsa decemlineata and 47.5 nmol/cm2 against the aphid 
species Diuraphis noxia.  Direct injection or oral dosing of this compound with L. 
decemlineata beetles led to 47% mortality after 72 hours.  While the mode of action has 
not been fully elucidated, alcohol 222 is believed to be toxic to the insect’s peripheral and 
central nervous system. 
Leitão and co-workers have found that presilphiperfolan-1β-ol (223) possesses 
antimycobacterial properties.22  The natural product is active against Mycobacterium 
tuberculosis (H37Rv) and Mycobacterium smegmatis (mc2155) strains with minimal 
inhibitory concentrations (MICs) of 100 µg/mL and 200 µg/mL, respectively.  Currently, 
the basis for the observed antimycobaterial activity is unclear. 
Unnatural presilphiperfolane analogs have also been investigated for their biological 
properties.  Presilphiperfolane derivatives 224, 251–261 were investigated as novel 
antifungal agents by Collado (Figure 3.5).23  Of these compounds, alcohols 252 and 257 
showed the most promising inhibition in fungal growth assays with Botryis cinerea.  
Tertiary alcohol 252 showed complete suppression of fungal growth for four days with 
continued growth reduction after seven days.  Primary alcohol 257 effectively reduced 
the size of fungal colonies and triggered changes in fungal morphology.  For both of 
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these active tricyclic terpenoid compounds, the hydroxyl groups are believed to be 
essential for inhibition, as the evaluation of acetylated derivates such as 258 led to no 
observable activity. 
 
Figure 3.5. Natural and Unnatural Presilphiperfolanol Analogs Investigated for Antifungal Activity 
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3.2 PREVIOUS SYNTHETIC STUDIES TOWARD 
PRESILPHIPERFOLANOL NATURAL PRODUCTS 
Although the presilphiperfolanols are vitally important to the biosynthesis of 
numerous polycyclic sesquiterpenes, efforts to synthesize these natural products have 
been scarce.  A number of biomimetic synthetic approaches have aimed to convert 
advanced biosynthetic precursors to the tricyclic alcohols 221–223, but these approaches 
have not been successful.  More recently, research directed toward the total synthesis of 
the presilphiperfolanols has led to compounds that possess the tricyclic core of the 
targeted natural products.  
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3.2.1 BIOMIMETIC CATION-POLYENE CYCLIZATIONS OF 
CARYOPHYLLENE AND ISOCARYOPHYLLENE 
Based on the substantial evidence for the biosynthetic conversion of FPP (235) to 
caryophyllenyl cations en route to presilphiperfolanyl cations through cation-polyene 
cyclizations, many researchers have sought to achieve biomimetic syntheses of the 
presilphiperfolanols by rearrangement of β-caryophyllene (248) or isocaryophyllene 
(262) (Scheme 3.4).24  To date, however, these efforts have not resulted in the formation 
of any of the naturally occurring tricyclic alcohols 221–223.  
 
Scheme 3.4.  Strategy for the Rearrangement of Caryophyllenyl and Isocaryophyllenyl Skeletons 
presilphiperfolanyl
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!-caryophyllene
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Research by numerous groups has explored the rearrangement of β-caryophyllene 
under acidic conditions (Scheme 3.5A).25,26  These reactions typically have led to 
complex mixtures with product distributions that change over time.  In this context, 
numerous rearrangement products such as α-neoclovene (263), clovene (264), and β-
caryolanol (264) have been isolated and characterized.  A supporting computational study 
was also performed to help understand the complex nature of the diverse rearrangement 
pathways.26a  To date, however, presilphiperfolane structures have not been observed in 
any of these detailed studies. 
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More recently, Coates and co-workers studied the solvolytic rearrangement of β-
caryophyllene-derived structures with intriguing results (Scheme 3.5B).26b  The ionization 
and rearrangement β-caryophyllene-derived tosylate 266 in water and acetone at 75 °C 
provided 12-nor-8α-presilphiperfolan-9β-ol (267) and alcohol 268a.  Compound 267 
resembles presilphiperfolan-9α-ol (222), but notably lacks the C(4) methyl group present 
in the natural product.  Rearrangement reactions employing β-caryophyllenyl precursors 
with the requisite C(4)-methyl group were also investigated.  Subjection of the p-
nitrobenzoate ester 269 to similar solvolytic rearrangement conditions at slightly higher 
temperatures did not furnish presilphiperfolan-9α-ol (222), but instead led to 5,8-
cyclocaryophyllen-4α-ol (270), β-caryophyllene (248), and alcohol 268b.  The different 
product distributions under nearly identical reaction conditions suggests that the non-
enzymatic cyclization is sensitive to the substitution of the caryophyllenyl framework. 
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Scheme 3.5.  Reported Rearrangements of Caryophyllene Skeletons 
HH
H2O, acetone
75 °C
TsO
H
266
H H
H
H
OH
267
+
9% yield
HH
HO
H
268a
HH
H2O, acetone
125 °C
PNBO
269
+
70% yield
HH
248
10% yield
HH
268b
HO+
H H
H OH
3% yield
270
HH
H2SO4
AcOH or Et2O
H
!-caryophyllene
(248)
"-neoclovene
(263)
clovene
(264)
OHHH
!-caryolanol
(265)
H
+ +
additional rearrangement products+
(presilphiperfolane structures not observed)
A
B
4
9
61% yield
(X-ray)
 
 
The rearrangement of isocaryophyllene (262) to presilphiperfolane-type structures has 
also been investigated.23,27,28  Robertson and co-workers treated isocaryophyllene (262) 
with sulfuric acid in diethyl ether to obtain α-neoclovene (263) and tricyclic olefin 255, 
which resembles the tricyclic core of the presilphiperfolanols (Scheme 3.6A).  Since 
these early studies, Collado was able to favor the formation of olefin 255 by employing 
silica-supported FeCl3.23b  Further work by Khomenko and co-workers has produced 
alcohol-containing tricyclic structures that more closely resemble the 
presilphiperfolanols.28  Treatment of isocaryophyllene (262) with fluorosulfonic acid and 
sulfuryl fluorochloride at –100 °C followed by a careful quenching of the acidic solution 
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led to the formation of tricyclic alcohol 224 in 16% yield (Scheme 3.6B).  The structure 
was assigned based on 1H and 13C NMR studies and confirmed by single crystal X-ray 
diffraction.  Notably, this compound is the C(9)-epimer of presilphiperfolan-1β-ol (223) 
and the structure originally assigned by König as “presilphiperfolan-1-ol” (224). 
 
Scheme 3.6.  Reported Rearrangements of Isocaryophyllene (262) 
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3.2.2 WEYERSTAHL SYNTHESIS OF (±)-PRESILPHIPERFOLAN-9α-OL 
Driven by a keen interest in the biosynthetic importance, intriguing polycyclic 
structure, and olfactory properties of presilphiperfolan-9α-ol (222), Weyerstahl and co-
workers aimed to prepare the natural product by total synthesis.8 
  Beginning from isobutyric acid, enolization and alkylation with methallyl chloride 
provided functionalized pentenoic acid 271 (Scheme 3.7).  Subsequent carboxylate 
activation with oxalyl chloride and cyclization with AlCl3 provided cyclopentenone 272 
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in 69% yield.  The conjugate addition of organocuprate 273 with TMSCl as an activator 
followed by acidic deprotection and aldolization provided a mixture of β-hydroxyketones 
276a and 276b in 89% yield and 9:1 dr over two steps.  A subsequent Jones oxidation 
afforded diketone 277 in 96% yield.  Selective protection of the less hindered carbonyl 
proceeded smoothly with p-TsOH, ethylene glycol, and trimethyl orthoformate in CH2Cl2 
under reflux conditions.  Reduction of the remaining ketone in 278 with LiAlH4 followed 
by acidic workup provided β-hydroxyketones 279a and 279b in 92% yield and 2:1 dr.  
Dehydration was achieved by initial mesylation and elimination with DBU to give 
bicyclic enone 280 in 61% yield over two steps.  Alternatively, the elimination was 
achieved with Burgess’ reagent29 in 64% yield.  A subsequent diastereoselective Sakurai 
allylation30 afforded ketone 281 in 73% yield.  Regioselective radical hydrobromination 
of the terminal olefin followed by an intramolecular Wittig reaction completed the 
tricyclic core of the target tricyclic molecules (283) in 52% yield over two steps.   
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Scheme 3.7.  Synthesis of Key Tricyclic Olefin Intermediate 283 
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With key tricyclic olefin 283 in hand, a highly diastereoselective epoxidation with 
magnesium bis(monoperoxyphthalate) (MMPP)31 afforded epoxide 284 in 97% yield 
(Scheme 3.8).  The epoxidation could also be achieved with m-CPBA, but yields were 
typically lower.  A subsequent stereospecific epoxy-keto rearrangement catalyzed by 
ZnBr2 was effective, giving the expected ketone 285 with α-H stereochemistry at C(1) in 
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94% yield after 40 min.  While these reaction conditions proved successful, longer 
reaction times led to significant C(1)-epimerization to the undesired ketone epimer 286.  
The gradual conversion of tricyclic ketone 285 to its epimer 286 over time suggests that 
the desired ketone is thermodynamically unstable.  This hypothesis was also supported by 
epimerization studies on ketone 285 with NaHMDS, which provided a mixture of 285 
and 286 in a 1:7 ratio of diastereomers.   
With 14 of the 15 carbons of the target compound installed, it was anticipated that the 
addition of MeMgBr to 285 could give presilphiperfolan-9α-ol (222) in a direct and 
straightforward manner.  Unfortunately, this transformation predominantly led to the 
undesired C(9)-epimer with only trace amounts of the desired natural product 222.  The 
steric environment of the tricycle as well as the favorable Bürgi–Dunitz trajectory from 
the α-face of the molecule dictated the facial bias of nucleophilic additions into the 
ketone of 285.  In order to arrive at the natural product through alternative means, a 
Lombardo reaction was employed to give olefin 287 in 88% yield.  A subsequent 
epoxidation with m-CPBA gave a 2:3 ratio of diastereomers 288a and 288b in 87% yield.  
After chromatographic separation, LiAlH4 reduction of epoxide 288b finally provided 
(±)-presilphiperfolan-9α-ol (222) in 97% yield.  The total synthesis was completed in 17 
steps and 4.0% overall yield from commercial starting materials. 
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Scheme 3.8.  Weyerstahl’s Completion of (±)-Presilphiperfolan-9α-ol (222) 
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3.2.3 PIERS’ RADICAL CYCLIZATION STRATEGY AND SYNTHESIS OF 
(±)-EPI-9-NORPRESILPHIPERFOLAN-9-ONE 
Within a general program directed toward the construction of complex natural 
products, Piers aimed to complete a concise synthesis of (±)-presilphiperfolan-9α-ol 
(222) using a radical polycyclization strategy.32,33  The synthesis proceeded from 3-
methyl-2-cyclopentenone (289) (Scheme 3.9).  An initial Luche reduction34 provided 
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alcohol 290 in excellent yield.  By applying the method of Wilson,35 the allylic alcohol 
was converted to dianionic intermediate 291, which underwent a thermal Carroll 
rearrangement36 and decarboxylation to form functionalized cyclopentene 293 in 77% 
yield over two steps.  With the C(4) quaternary carbon installed, a Wittig homologation 
with ylide 29437 followed by methyl enol ether hydrolysis provided aldehyde 295 in 72% 
yield and 1:1 dr.  α-Alkylation with methyl iodide, alkyllithium addition with reagent 
296, and xanthate ester formation led to radical cyclization precursor 297.   
 
Scheme 3.9.  Synthesis of Radical Cyclization Precursor 297 
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The slow addition of Bu3SnH and AIBN to xanthate 297 in refluxing benzene 
provided a mixture of tricyclic olefins 300 and 301 (Scheme 3.10).  Oxidative alkene 
cleavage with RuCl3 and NaIO438 afforded (±)-epi-9-nor-presilphiperfolan-9-one (286)8 in 
40% yield over two steps.  The disubstituted alkyne was essential for efficient cyclization 
since precursor 298 only led to a complex mixture of volatile hydrocarbon products. 
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Scheme 3.10.  Radical Cyclization Cascades with Precursors 297 and 298 
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In order to proceed toward presilphiperfolan-9α-ol (222), epimerization of the C(1) 
methine hydrogen of ketone 286 was necessary (Scheme 3.11).  Thermodynamic 
equilibration according to Weyerstahl’s procedure (Scheme 3.8)8 failed, returning only 
starting material.  Other strong bases such as LDA, KOt-Bu, and NaOMe provided no 
trace of the desired ketone 285.  Due to the synthetic difficulties arising from the 
thermodynamic preferences of the tricyclic scaffold, the synthesis was not advanced 
further. 
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Scheme 3.11.  Attempted Epimerization of the C(1)-Methine Hydrogen of Ketone 285 
epimerization
conditions
NaHMDS, THF
LDA, THF
KOt-Bu, t-BuOH
NaOMe, MeOH
H
H
O
286
+ H
H
O
285
H H
H
H
O
286
H
3 steps
Weyerstahl
route
(ref. 8)
not observed
11
H
H
H
OH
9
presilphiperfolan-9!-ol
(222)  
 
3.2.4 SUMMARY OF PREVIOUS SYNTHETIC STUDIES 
The numerous syntheses directed toward the presilphiperfolanols have provided 
valuable insight into the challenges of achieving diastereoselective reactions due to the 
steric environment of the congested tricycle.  While several promising cation-alkene and 
radical cyclization approaches have been documented, Weyerstahl’s total synthesis of 
(±)-presilphiperfolan-9α-ol (222) was the only completed synthesis of any member of the 
important sesquiterpene family at the outset of our studies. 
 
3.3 ASYMMETRIC ALKYLATION/RING CONTRACTION APPROACH 
TO THE PRESILPHIPERFOLANOL NATURAL PRODUCTS 
Although the presilphiperfolanol natural products have garnered broad scientific 
interest in the natural products,9,10,11 biosynthesis,1,2,5,7,13,14,15,17,18,19  organic synthesis,8,33 
computation,18,19 and fragrance 2,8,20 literature since their discovery, they have proven to be 
challenging targets for total synthesis.39,40   To date, only 222 has been prepared in 
CHAPTER 3 – The Total Synthesis of Presilphiperfolanol Natural Products 563 
racemic form8 and no asymmetric routes toward any of the presilphiperfolanols have 
been reported.  The unique chemical structures and intriguing biosynthetic function of 
these natural products inspired us to devise an enantioselective total synthesis with an 
emphasis on asymmetric catalysis.41  In particular, the further development of our 
asymmetric alkylation and ring contraction methodology for the preparation of γ-
quaternary acylcyclopentenes (135)42 would provide valuable tools for addressing the 
long-standing synthetic challenges posed by the presilphiperfolanols.  Additionally, a 
successful synthetic route would enable further exploration of the biosynthetic 
relationships and biological activity of these important natural products. 
 
3.3.1 RETROSYNTHETIC ANALYSIS 
At the outset of our investigations, the aforementioned discrepancy of the structural 
assignments of “presilphiperfolan-1-ol” (224) and “9-epi-presilphiperfolan-1-ol” (223) 
was unknown (Figure 3.2).  Therefore, we sought a synthetic route that would not only 
allow access to presilphiperfolan-9α-ol 222, but also 1-hydroxy presilphiperfolanols 223 
and 224 as it was believed that each compound was a previously isolated natural product.  
Retrosynthetic analysis suggested that tricyclic presilphiperfolanols such as 222 and 
223 could be formed by late stage construction of the cyclohexane ring through an 
intramolecular Robinson annulation or an intramolecular Diels–Alder (IMDA) reaction 
(Scheme 3.12).  Further disconnections along the Robinson annulation route would lead 
to ketoaldehyde 303, which would arise from organometallic conjugate addition into 
enone-enal 304.  Alternatively, the IMDA route would lead to acylcyclopentene 
precursor 306, which could be traced to allyl electrophile 307 through an allylic 
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substitution reaction.  Both enone-enal 304 and allyl electrophile 307 could arise from the 
cross-metathesis of methyl/methallyl acylcyclopentene 308 with appropriate olefinic 
partners.  The strategic application of our newly developed methodology for the synthesis 
of γ-quaternary acylcyclopentenes (135) by means of Pd-catalyzed asymmetric alkylation 
and two-carbon ring contraction (see Chapter 2) would enable access to common 
intermediate 308.42  In proceeding forward with this route, it was important to recognize 
that our acylcyclopentene synthesis demonstrated broad scope for various R1 substituents, 
but provided no examples of the R2 substitution at the allyl fragment.  The pursuit of the 
presilphiperfolanol natural products would provide a valuable opportunity to expand our 
previously developed reaction methodology. 
 
Scheme 3.12.  Retrosynthetic Analysis of Presilphiperfolanol Natural Products 
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3.3.2 CONJUGATE ADDITION/ROBINSON ANNULATION STRATEGY  
Closer scrutiny of the Robinson annulation approach to the presilphiperfolanols 
suggested that the conjugate addition reaction could be coupled with cyclohexenone 
formation in an efficient synthetic approach (Scheme 3.13).  This sequence could proceed 
with the sterically controlled chemoselective conjugate addition into enone-enal 304 
using  Li2Cu3Me5 (Clive’s reagent).43  A second intramolecular conjugate addition would 
take place upon generation of enolate 309.  We envisioned that further treatment with 
base could afford enone 302 through a Robinson annulation reaction.  Olefin reduction 
could lead to ketone 285, which can be advanced to presilphiperfolan-9α-ol (222) using 
the route of Weyerstahl.8   
 
Scheme 3.13.  Conjugate Addition Cascade and Robinson Annulation Strategy  
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To evaluate the proposed polycyclization (309→302), we investigated a simple 
model cyclization with enone-aldehyde 169 based lacking the C(6) gem-dimethyl groups 
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(Scheme 3.14).  This compound was prepared by the straightforward application of our 
Pd-catalyzed asymmetric alkylation and ring contraction methodology42a for the 
formation of 135a. Subsequent olefin cross-metathesis with crotonaldehyde and 
chemoselective enal hydrogenation provided the model cyclization substrate  (see 
Chapter 2, Section 2.5).42c  Treatment of aldehyde 169 with K2CO3 in EtOH at 0 °C 
followed by slow warming to ambient temperature led to the formation of bicyclic 
ketoaldehyde with general structure 310b as a single diastereomer as observed by 1H 
NMR.44  The intermediate was heated in refluxing ethanol to promote formation of the 
remaining cyclohexane ring, but attempted cyclization failed as the reaction proceeded to 
decomposition products.  Simple molecular modeling studies revealed that the distance 
between the aldehyde carbon and the nucleophilic terminus of the methyl ketone is about 
3.7 Å, making the terminal intramolecular aldol cyclization challenging for this bicyclic 
system.45  On the basis of these findings, the conjugate addition cascade strategy was not 
pursued further.  Importantly, these results provided important experimental clues for the 
inherent ring strain of the tricyclic presilphiperfolane core.5,6 
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Scheme 3.14.  Evaluation of a Simple Model System Based on Acylcyclopentene 135a 
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3.3.3 INTRAMOLECULAR DIELS–ALDER STRATEGY 
As preliminary experiments began to cast doubt on the proposed Robinson annulation 
approach, we shifted our attention to the alternative IMDA strategy for the construction 
of the cyclohexane ring of the presilphiperfolanols.  To explore this route, we needed to 
modify our asymmetric alkylation and ring contraction methodology42 to prepare 
methyl/methallyl-substituted acylcyclopentene 308.  In previous studies, the acylation of 
parent vinylogous ester 147 was typically performed with allyl cyanoformate, which was 
prepared from commercial allyl chloroformate.46  For our synthesis, the use of methallyl 
cyanoformate was an option, however the absence of a commercial chloroformate 
precursor rendered large-scale synthesis inconvenient.   
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To remedy this situation, alternative reagents were explored for the construction of β-
ketoester 314.  Attempted acylations with commercial dimethallyl carbonate (311) 
according to reported procedures47b,c returned only starting material and trace quantities of 
desired product (Scheme 3.15).  The inefficiency of the reaction along with the high cost 
of carbonate 311 made it necessary to identify more practical reagents.  
Carbonylimidazole-based compounds were investigated next because of their 
straightforward preparation.48,49  Condensation of methallyl alcohol with CDI according 
to Sarpong’s protocol50 provided acylimidazole 312 (Scheme 3.15).  The addition of this 
compound to a solution of the lithium enolate of 14751 led to successful installation of the 
ester functionality.  Subsequent addition of methyl iodide to the reaction afforded β-
ketoester  313 in 82% yield in an efficient and improved tandem acylation/alkylation 
process.  In this manner, we prepared α,α-difunctionalized β-ketoester 313 on greater 
than 10 g scale. 
 
Scheme 3.15.  Improved Acylation and Alkylation of Vinylogous Ester 147 
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With a robust and expedient route to methallyl β-ketoester 313, the evaluation of the 
asymmetric alkylation and ring contraction reactions became the next focus (Scheme 
3.16).  Using our Pd-catalyzed asymmetric alkylation conditions42,47,52 with (S)-t-Bu-
PHOX (13)53,54 and Pd2(pmdba)355 in toluene at 30 °C, chiral vinylogous ester 314 could 
be obtained in 98% yield and 89% ee.56,57,58  LiAlH4 reduction proceeded smoothly to give 
β-hydroxyketone 315 in 96% yield.  Ring contraction with LiOH and TFE in THF at 60 
°C led to the desired methyl/methallyl acylcyclopentene 308 in 96% yield.  In this 
manner, multigram quantities of the essential chiral intermediate were readily obtained. 
 
Scheme 3.16.  Asymmetric Alkylation and Ring Contraction Sequence with β-Ketoester 313 
O
i-BuO
313
O
O
(S)-t-Bu-PHOX (13) (6.25 mol %)
Pd2(pmdba)3 (2.5 mol %)
PhCH3, 30 °C
98% yield, 89% ee
13 g scale
NPh2P
O
t-Bu
O
O
i-BuO
LiAlH4, Et2O, 0 °C
then 10% aq HCl
96% yield
2.4 g scale
314
315
OH
308
O
LiOH, TFE
THF, 60 °C
96% yield
1.8 g scale
 
 
To advance toward Diels–Alder precursor 306, we envisioned that we could perform 
olefin cross-metathesis with methyl/methallyl acylcyclopentene 308 and cis-1,4-
diacetoxy-2-butene ((Z)-316) or crotonaldehyde in a manner analogous to our previous 
studies (Scheme 3.14).  We expected that transformation would be challenging due to the 
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1,1-disubstituted olefin, but relevant examples have been documented59 and the simplicity 
and efficiency of the approach was attractive (Scheme 3.17).  Unfortunately, treatment of 
acylcyclopentene 308 with cis-1,4-diacetoxy-2-butene ((Z)-316) and Grubbs–Hoveyda 
2nd generation catalyst (68, 5–10 mol %) in CH2Cl2 or benzene provided no trace of the 
desired metathesis products.  Under similar reaction conditions with crotonaldehyde as 
the olefin partner, a mixture of enone-enal olefin isomers 304 and 319 could be obtained 
in 8% yield and 6.25:1 E:Z ratio.  The reaction mixture primarily consisted of starting 
material that could not be separated from overlapping impurities.  Employing CH2Cl2 as 
the reaction solvent led to a slight increase in reaction yield, but the efficiency of the 
transformation remained impractical for synthetic purposes.  
 
Scheme 3.17.  Examples of Attempted Cross-Metathesis Reactions with Acylcyclopentene 308 
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While additional ruthenium-based catalysts (321–323) were evaluated in the two cross 
metathesis reactions, none of these offered any improvement (Figure 3.6).  The 
investigation of carbonyl-protected substrates, alternative olefin partners, and additional 
solvents and temperatures provided similarly intractable results.  Given the difficulty of 
the desired cross-metathesis reactions with the key 1,1-disubstituted olefin, we refocused 
our efforts on more traditional olefination strategies to obtain IMDA precursor 306. 
 
Figure 3.6.  Summary of Attempted Cross-Metathesis Reactions 
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As an alternative approach, we envisioned that olefination reactions could be 
achieved through a suitable ketone derivative of methallyl acylcyclopentene 308 (Scheme 
3.18).  Efforts in this regard proceeded with ketalization of the carbonyl functionality 
with neopentyl glycol and PPTS in benzene under Dean–Stark conditions.  Subsequent 
ozonolysis of the methallyl group was possible, but the results varied with reaction scale 
and the desired product 324 could not be isolated in greater than 32% yield.  Better 
results were obtained with modified Lemieux–Johnson conditions60 for Os-catalyzed 
oxidative olefin cleavage.  Under these conditions, methyl ketone 324 could be obtained 
in 75% yield.   
 
Scheme 3.18.  Synthesis of Methyl Ketone 324 
HO OH
PPTS (10 mol %)
PhH, reflux
Dean–Stark
95% yield
308
O
conditions
324
O
OO
320
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O3, CH2Cl2, –78 °C
then PPh3, –78!23 °C 32% yield
75% yield  
 
With our desired ketone, we applied a variety of olefination reactions with the goal of 
obtaining compounds that could be advanced to target acylcyclopentene 306 (Scheme 
3.19).  The addition of Wittig reagent 325 in excesses of greater than 25 equivalents led 
to no observable consumption of starting material.  A variety of Horner–Wadsworth–
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Emmons conditions61 were also attempted, but the desired product could not be obtained.  
This lack of reactivity suggests that the highly congested steric environment or 
competitive deprotonation of methyl ketone in 324 hampers phosphorous ylide 
olefination reactions. 
An alternative organometallic addition strategy62 was explored to introduce the 
necessary carbon fragments for the planned IMDA reaction (Scheme 3.19).  Using 
vinylmagnesium bromide, tertiary allylic alcohol 327 was obtained in 96% yield and 1:1 
dr.  The installation of the remaining methyl group was needed to proceed toward desired 
acylcyclopentene 306.   
 
Scheme 3.19.  Various Attempts to Prepare Acylcyclopentene 306 
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A variety of redox-neutral and oxidative allylic transposition reactions were 
attempted to convert tertiary allylic alcohol 327 to acylcyclopentene 306 (Scheme 
3.19).63,64  The application of Re-catalyzed allylic alcohol isomerization conditions65 did 
not provide any trace of the isomeric primary allylic alcohol 330.  Cr-based oxidative 
transpositions66 with PCC or PDC also failed to give expected rearranged enal products, 
instead leading to eventual decomposition.67  Reported sulfur-mediated transformations68 
under Parikh–Doering oxidation conditions69 also provided no signs of the desired 
rearrangement.67  Attempted oxygen transposition by the action of oxoammonium salts70 
led to the formation of intractable side products.67 
To supplement our studies with allylic transposition reactions, we also explored the in 
situ activation of tertiary alcohol 327 followed by SN2' reactions with halide71 or 
carboxylate nucleophiles72 to arrive directly at allyl electrophiles such as 331–333 
(Scheme 3.19).  Activators such as oxalyl chloride, sulfonyl chloride, acetic anhydride, 
and trifluoroacetic anhydride were investigated in buffered and non-buffered reaction 
conditions, but these conditions proved to be incompatible with the sensitive ketal 
functionality.67 
Attempts to substitute the tertiary alcohol of 327 with a methyl group and directly 
obtain gem-dimethyl 334 also proved unsuccessful.  The application of reported 
methylations with TiCl2Me273 or AlMe374 only led to the destruction of starting material. 
 
3.3.4 SUMMARY AND OUTLOOK 
The cascade conjugate addition/Robinson annulation approach to the tricyclic core of 
the presilphiperfolanols was explored with a simple model system based on methyl/allyl 
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acylcyclopentene 135a.  Preliminary results suggested that the desired transformation 
would be challenging on the basis of unfavorable conformational restrictions.  An 
alternative intramolecular Diels–Alder strategy was also investigated.  The successful 
extension of our asymmetric alkylation/ring contraction methodology led to 
methyl/methallyl acylcyclopentene 308.  Numerous attempts to convert this compound to 
acylcyclopentene 306 proved unsuccessful.  In order to arrive at modified 
acylcyclopentene 306, a new approach was urgently needed to continue to the synthesis 
of the presilphiperfolanols.  
 
3.4 TOTAL SYNTHESIS OF (–)-PRESILPHIPERFOLAN-1β-OL AND 
RELATED ANALOGS 
While the application of our asymmetric alkylation and ring contraction strategy for 
the synthesis of γ-quaternary acylcyclopentenes (135)42 appeared to be a promising 
method for the preparation of the presilphiperfolanols, additional modification of our 
synthetic approach would be necessary to complete the polycyclic natural products.  
 
3.4.1 REVISED RETROSYNTHETIC ANALYSIS 
Our synthetic approach based on methyl/methallyl acylcyclopentene 308 proved to be 
scalable and efficient, but ultimately, attempts to install the necessary carbon fragments 
for our planned IMDA reaction were unsuccessful.  To overcome the obstacles in our 
previous synthetic route, we envisioned that methyl/isoprenyl acylcyclopentene 336 
could allow us to test the key [4+2] cycloaddition reaction through alternative means.  By 
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postponing the installation of the gem-dimethyl functionality to a later stage of the 
synthesis, we believed we could pursue simpler, less-substituted cyclization precursors 
such as acylcyclopentene 336.  The exploration of this modified strategy would require 
enantioenriched vinylogous ester 337, which would arise from the unprecedented 
asymmetric alkylation of a 2-vinyl π-allyl electrophile.75 
 
Scheme 3.20.  Retrosynthetic Analysis of Presilphiperfolanol Natural Products 
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3.4.2 ASYMMETRIC ALKYLATION AND RING CONTRACTION 
Our synthetic efforts began with the synthesis of a suitable isoprenol-containing 
acylating reagent (Scheme 3.21).  By adapting the method of Isobe, the selective mono-
epoxidation of isoprene and base-mediated isomerization to isoprenol was achieved on 10 
g scale.76  Trapping of the intermediate alcohol with CDI according to the method of 
Sarpong as before led to the novel acylimidazole 339.50 
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Scheme 3.21.  Synthesis of Isoprenol-Derived Acylimidazole 339 
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The successful preparation of isoprenol-derived carbamate 339 enabled us to proceed 
toward asymmetric alkylation substrate 338 (Scheme 3.22).  Commercial 3-
isobutoxycycloheptenone 14751 underwent acylation/alkylation with reagent 339 and 
methyl iodide under basic conditions to afford β-ketoester 338 in 84% yield.  With the 
functionalized allyl fragment in place, the asymmetric Pd-catalyzed decarboxylative 
alkylation42,47 of this novel substrate could be performed.  Although numerous allyl 
electrophiles have been employed in these types of reactions, the conjugated diene was 
recognized as a potential liability for detrimental side reactions under palladium 
catalysis.77  
Gratifyingly, treatment of β-ketoester 338 with catalytic Pd2(pmdba)355 and (S)-t-Bu-
PHOX53,54 in toluene afforded isoprenylated vinylogous ester 337 in 91% yield and 95% 
ee on 10 g scale.56,57  Subsequent LiAlH4 reduction afforded an intermediate β-
hydroxyketone, which underwent a base-mediated two-carbon ring contraction to provide 
acylcyclopentene 336 in 92% yield over two steps.42,78 
 
CHAPTER 3 – The Total Synthesis of Presilphiperfolanol Natural Products 578 
Scheme 3.22.  Asymmetric Alkylation and Ring Contraction Sequence with β-Ketoester 338 
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3.4.3 INTRAMOLECULAR DIELS–ALDER STUDIES 
With methyl/isoprenyl acylcyclopentene 336 in hand, straightforward conversion to 
the corresponding silyl dienol ether 335 enabled examination of our IMDA strategy79,80 
(Scheme 3.23).  We postulated that the reaction would presumably proceed through 
transition state TS-335 A to minimize steric interactions between the dienophile tether 
the cyclopentene ring.  While this was our desired outcome, we recognized that 
additional undesired IMDA cycloadducts could be formed due to the presence of two 
different dienes in the substrate.  When silyl dienol ether 335 was subjected to microwave 
irradiation in toluene at 150 °C, the IMDA reaction proceeded efficiently to give tricycle 
341 in 80% yield over two steps as a single diastereomer.  The bicyclization notably 
proceeded without the need for an activated dienophile.81  Subsequent NOESY 
experiments on cycloadduct 341 revealed the cis relationship of the C(7) and C(8) 
hydrogens.  Desilylation of silyl enol ether 341 provided ketone 342, which allowed 
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further stereochemical confirmation.  These results suggest that the IMDA primarily 
proceeds through TS-335B rather than the desired and expected TS-335A.82  Secondary 
orbital overlap in the IMDA transition state could be a possible reason for the outcome in 
this case.  Unfortunately, in order to advance toward the presilphiperfolanol natural 
products, a trans relationship was needed. 
 
Scheme 3.23.  IMDA Reaction on Substrate 335 
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3.4.4 ELABORATION OF METHYL/ISOPRENYL ACYLCYCLOPENTENE 
Although we succeeded in constructing the tricyclic framework of the 
presilphiperfolanols in six steps from commercial materials, we needed to modify our 
synthetic route to achieve the naturally occurring substitution and stereochemical 
configurations.  Our revised strategy aimed to install the gem-dimethyl group at an earlier 
stage and test our original synthetic approach with acylcyclopentene 306 (Scheme 3.12).  
Analysis of the possible IMDA transition states of silyl dienol ether 343 suggested that 
the desired trans product should be favored due to the increased steric interactions with 
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the C(6) gem-dimethyl groups (Scheme 3.24).83  In TS-343A, the steric elements would 
be oriented away from the bond-forming centers while cycloaddition through TS-343B 
could only proceed with severe steric clash between the cyclopentene ring and the gem-
dimethyl functionality.  Additionally, the sp3 hybridization at the C(6) position should 
decrease the C(5)-C(6)-C(7) bond angle while also providing greater conformational 
bias84 for the desired cyclization.  Furthermore, secondary orbital interactions that may be 
operative in TS-335B would no longer apply in the planned IMDA reaction.  With these 
motivating factors, we set out to test our modified IMDA strategy. 
 
Scheme 3.24.  Planned IMDA Reaction on Substrate 343 
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The synthesis of the requisite acylcyclopentene 306 proceeded with the ketalization 
of acylcyclopentene 336 under Dean–Stark conditions (Scheme 3.25).  A subsequent 
regioselective 1,4-hydroboration/oxidation of the sterically hindered substrate 345 was 
expected to provide desired allylic alcohol 346.  A survey of the chemical literature 
revealed that Pd,85 Fe,86a and Ni87 can promote transformation, but iron catalysis 
demonstrated the best selectivity for our substrate type with 2-substitution of the 1,3-
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diene.  A systematic screen of 1,4-hydroboration reactions with these three transition 
metals provided the results summarized in Table 3.1.88,89  To our surprise, the Ritter 
FeCl2(py-imine) catalyst system provided a disappointing 1.1:1 ratio of linear:branched 
products 346 and 347 (entries 1 and 2).86a  Investigation of Suzuki–Miyaura conditions 
with Pd(PPh3)4 and HBPin did not provide any reactivity (entries 3 and 4).85  Finally, we 
turned to Morken’s Ni(cod)2/PCy3 catalyst system.87  Gratifyingly, these conditions led to 
a more desirable 3:1 ratio of linear:branched products (entries 5 and 6).90  The 
investigation of other monodentate ligands such as P(NMe2)3 and Cy-JohnPhos led to 
similar product ratios but in lower combined yields (entries 7 and 8).  The bulkier ligand 
Pt-Bu3 was the only phosphine that provided improved results, products in a significantly 
improved 8.3:1 ratio (linear:branched).  This result can be rationalized based on the 
selective formation of the less sterically hindered Ni π-allyl intermediate.  Despite this 
increase in selectivity, the 57% combined yield for the reaction dimished the applicability 
of the transformation (entries 9 and 10).  Based on these results, we proceeded with the 
Ni(cod)2 and PCy3 conditions, which provided the highest quantity of desired allylic 
alcohol 346. 
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Table 3.1.  Metal-Catalyzed 1,4-Hydroboration/Oxidation Screen 
entry metal complex (mol %) ligand or additive (mol %) solvent yield (%)c
89
89
57
Ni(cod)2 (5%) PhCH3
60
Cy-Johnphos (348) (5%) 50
14
Ni(cod)2 (10%) PhCH3
–– 0
< 5
Pd(PPh3)4 (5%) PhH
Ni(cod)2 (10%)
Ni(cod)2 (5%)
Ni(cod)2 (5%)
Ni(cod)2 (5%)
Pd(Pt-Bu3)2 (5%) ––
PhCH3
PhCH3
PhCH3
PhCH3
PhH
a  Conditions: 1,3-Diene (1.0 equiv), pinacolborane (1.50 equiv), metal complex (x mol %), additive (2x mol %) in solvent 
(0.15 M) at indicated 23 °C in a N2-filled glove box. b Conditions: 1,3-Diene (1.0 equiv), pinacolborane (1.05 equiv),
metal complex (x mol %), ligand (x mol %) in solvent (0.1 M) at 23 °C in a N2-filled glove box. c Combined isolated yield
of 346 and 347. d Ratio of linear : branched allylic alcohols 346 and 347, determined by relative integration by 1H NMR.
5b
4b
6b
3b
9b
10b
7b
8b
time (h)
52
9.5
6.5
9.5
6.5
6.5
41
41
HBPin, metal complex
ligand, additive, solvent, 23 °C
then 3 M aq NaOH
H2O2, THF, 0!23 °C
OO OO
OH
OO
HO
+
345
l : bd
3.0 : 1
3.2 : 1
8.3 : 1
9.0 : 1
3.1 : 1
2.8 : 1
n.d.
n.d.
PCy3 (5%)
PCy3 (10%)
Pt-Bu3 (5%)
Pt-Bu3 (10%)
P(NMe2)3 (5%)
PCy2
Cy-Johnphos
(348)
NN
Fe
Cl Cl
CH2Cl2 •
Fe complex 349
350
N
Li
0Fe complex 349 (8%) Mg powder (16%) Et2O1a 42 n.d.
62Fe complex 349 (4%) aryllithium 350 (8%) Et2O2a 10 1.1 : 1
346
(linear)
347
(branched)
 
 
The preparative scale reaction of 1,3-diene 345 with Ni(cod)2/PCy3 (5 mol %) and 
HBPin followed by an oxidative workup provided the separable allylic alcohols 346 and 
34791 in 81% combined yield in a 3.5:1 ratio (linear:branched).  Doubling the catalyst 
loading led to a decrease in reaction time and a small improvement to 88% combined 
yield, supplying us with ample quantities of our compound 346.  To our knowledge, this 
is the first application of a regioselective metal-catalyzed 1,4-hydroboration in the 
context of total synthesis.  Subsequent phosphorylation and regioselective Cu-catalyzed 
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allylic substitution92,93 provided the requisite gem-dimethyl acylcyclopentene 306 in 80% 
yield over two steps after acidic workup. 
 
Scheme 3.25.  Modification of Acylcyclopentene 336 and Synthesis of Silyl Dienol Ether 343 
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3.4.5 FURTHER INTRAMOLECULAR DIELS–ALDER STUDIES 
With gem-dimethyl acylcyclopentene 306 in hand, silyl dienol ether formation94 and 
IMDA bicyclization proceeded smoothly under thermal or microwave-assisted conditions 
to provide a mixture of inseparable diastereomers 305 and 344. A highly 
diastereoselective Rubottom oxidation of these products with DMDO95 followed by the 
addition of TBAF96 provided α-hydroxyketones 352 and 353 in a 1:2 ratio as determined 
by 1H NMR spectroscopy.97,98  Chromatographic separation gave 352 in 27% yield and 
353 in 61% yield over three steps.  The structure of tricycle 353 was confirmed by single-
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crystal X-ray analysis (Figure 3.7).99  To our surprise, although trans-cis α-
hydroxyketone 352 was observed, the major product 353 was again derived from the 
more sterically congested IMDA transition state (TS-343B) (Scheme 3.24).  The results 
of both IMDA reactions indicate that the desired trans stereochemical configuration of 
the desired tricyclic IMDA cycloadducts could be thermodynamically unfavorable.  
Optimization of the IMDA/oxidation sequence was briefly investigated.100  Lower 
temperatures were investigated for the IMDA reaction.  At temperatures as low as 90 °C, 
the IMDA proceeded smoothly but longer reaction times were required and lower dr was 
typically observed.88  The use of m-CPBA as an alternative oxidant led to decreased 
overall yield in the Rubottom oxidation.88 
 
Scheme 3.26.  IMDA/Rubottom Oxidation with Silyl Dienol Ether 343 
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Concurrent with our thermal cyclization studies, we also tried to promote a more 
diastereoselective IMDA cyclization of silyl dienol ether substrate 343 using alternative 
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catalytic methods.  The investigation of transition metal-catalyzed cycloisomerization 
reactions, particularly those catalyzed by Rh101 and Ni,102 led to no reaction.  Additionally, 
the application of radical cation [4+2] cycloaddition protocols103 proved unsuccessful as 
only desilylation could be observed, returning acylcyclopentene 306 in 60% yield.  
 
3.4.6 COMPLETION OF (–)-PRESILPHIPERFOLAN-1β-OL AND 
UNNATURAL ANALOGS 
After obtaining α-hydroxyketones 352 and 353, we aimed to advance these 
intermediates to presilphiperfolanol natural products (Scheme 3.27).  Wittig 
methylenation of compound 353 proceeded smoothly in 94% yield.  After a brief survey 
of heterogeneous hydrogenation catalysts,104  PtO2 proved to be effective for the reduction 
of allyic alcohol 354,105 providing a mixture of diastereomers 355 and 356 in a 1.07:1 
ratio.  Chromatographic separation by flash column chromatography provided 355 in 
46% yield and 356 in 48% yield.  The structure of 356 was confirmed by single-crystal 
X-ray diffraction (Figure 3.7).99 
 
Scheme 3.27.  Wittig Methylenation and Hydrogenation of α-Hydroxyketone 353 
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Similar transformations enabled the conversion of α-hydroxyketone 352 to 
presilphiperfolanol structures.  Wittig methylenation proceeded efficiently to give allylic 
alcohol 357 in 90% yield (Scheme 3.28).  While PtO2-catalyzed hydrogenation of olefin 
357 afforded a HPLC-separable mixture of targets 223 and 224, a diastereoselective 
synthesis of both target molecules could also be achieved.  Tertiary alcohol-directed 
hydrogenation with Crabtree’s catalyst106,107 produced 9α-presilphiperfolan-1β-ol 224, the 
reported structure of “presilphiperfolan-1-ol,”3 in 92% yield.  The structure of 224 was 
verified by X-ray diffraction (Figure 3.7).99  Alternatively, efficient formation of 9β-
presilphiperfolan-1β-ol 223, the reported structure of “9-epi-presilphiperfolan-1-ol,”4 was 
accomplished in 88% yield over three steps by silylation108 of tertiary allylic alcohol 223 
followed by PtO2-catalyzed hydrogenation and desilylation with TBAF.  Upon 
completing tricyclic alcohols 223 and 224, we believed that had completed the total 
synthesis of the two reported presilphiperfolanol natural products, but careful inspection 
of the spectral data for the synthetic compounds provided evidence for a structural 
misassignment and the prompted the development of a new biosynthetic hypothesis. 
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Scheme 3.28.  Wittig Methylenation and Hydrogenation of α-Hydroxyketone 352 
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Figure 3.7.  X-ray Crystal Structures of Compounds 353, 356, and 224 
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3.4.7 STRUCTURAL REVISION AND PROPOSED BIOSYNTHESIS OF (–)-
PRESILPHIPERFOLAN-1β-OL  
Upon completing the syntheses of 355, 356, 223, and 224, we compared our spectral 
data to the reported data for the naturally isolated presilphiperfolanols88 (Figure 3.8).  
Natural “presilphiperfolan-1-ol”3,109 was assigned structure 224110 based on NMR data 
while natural “9-epi-presilphiperfolan-1-ol”4 was assigned structure 223 based on NMR 
and X-ray data.4b  The 1H and 13C NMR spectra of synthetic 223 were in excellent 
agreement with data for reported “9-epi-presilphiperfolan-1-ol” (223),4 but the spectra for 
synthetic 224 clearly did not match the data for isolated “presilphiperfolan-1-ol” (224).3  
In particular, the C(15) methyl hydrogens of synthetic 224 showed a 1H NMR resonance 
at 0.94 ppm compared to the corresponding resonance of reported 2443 at 0.89 ppm.  
Overall, the spectral data of isolated “presilphiperfolan-1-ol” (224) more closely matches 
synthetic 223 and isolated “9-epi-presilphiperfolan-1-ol” 2234a than synthetic 224 (Figure 
3.9).  The C(7) epimers 355 and 356 did not match the spectra for either of the reported 
natural compounds, thereby eliminating these stereochemical configurations as candidate 
structures for the isolated “presilphiperfolan-1-ol” (224) (Figure 3.9). 
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Figure 3.8.  Comparison of 1H NMR Spectra of Reported and Synthetic 223 and 224 
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Figure 3.9.  Summary of Spectral Comparisons (1H and 13C NMR)  
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Given the significant discrepancy between our data and König’s data for compound 
224, we sought to rationalize the formation of both 223 and 224 in the context of 
proposed mechanisms for presilphiperfolanol biosynthesis.1,2,5,7,13,14,15,17,18,19  While no 
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proposals for the biosynthesis of 223 and 224 have been published, it is reasonable that 
presilphiperfolanols 221–224 are commonly derived from caryophyllenyl cation 237 
(Scheme 3.1).  Upon rearrangement to C(1)-presilphiperfolanyl cation 238, a divergent 
pathway can be envisioned (Scheme 3.29).  A simple 1,2-syn hydride migration to 
tertiary C(1)-cation 250 followed by hydration leads to “9-epi-presilphiperfolan-1-ol” 
(223) with 9β-methyl (9S) stereochemistry without invoking the intermediacy of 
unfavorable secondary carbocations.2  In contrast to this pathway, the formation of 9α-
methyl-oriented “presilphiperfolan-1-ol” (224) seems unlikely since there is no obvious 
pathway from C(9)-cation 238 to C(1)-cation 358 with 9α-methyl (9R) stereochemistry.   
 
Scheme 3.29.  Proposed Biosynthesis of Presilphiperfolan-1β-ol (223) and Structural Revision of 
Reported “Presilphiperfolan-1-ol” (223)  
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Based on our NMR spectral data, X-ray crystal structure for 224, and new 
biosynthetic proposals, we believe the reported structure of natural “presilphiperfolan-1-
ol” (224) is misassigned at C(9) and most likely is not a natural product.  The nearly 
identical chemical shifts reported for 223 and 224 (Figure 3.9) suggest that the true 
structure of “presilphiperfolan-1-ol” (224) may actually be the same as “9-epi-
presilphiperfolan-1-ol” (223) with the 9β-methyl configuration (Scheme 3.29).  Since the 
reassignment can potentially lead to confusion, we suggest that the natural product 
structure represented by 223 be referred to as presilphiperfolan-1β-ol or the more 
descriptive names 9β-presilphiperfolan-1β-ol or (1S,4S,7R,8R,9S)-presilphiperfolan-1-ol 
in future discussions. 
 
3.4.8 SUMMARY AND OUTLOOK 
By taking advantage of the highly versatile nature of our asymmetric alkylation and 
ring contraction approach to  versatile γ-quaternary acylcyclopentenes (135),42 the total 
syntheses of 9β-presilphiperfolan-1β-ol (223) and three isomeric analogs 224, 355, and 
356 were completed.  Crucial to this synthetic effort was the application of a Ni-catalyzed 
1,4-hydroboration/oxidation reaction and a Cu-catalyzed allylic substitution reaction to 
provide acylcyclopentene 306.  A subsequent IMDA reaction and Rubottom oxidation 
secured the tricyclic skeleton of the presilphiperfolanol natural products.  Our synthetic 
efforts also prompted a clarification of reported structural assignments for the naturally 
isolated “presilphiperfolan-1-ol” (224) and “9-epi-presilphiperfolan-1-ol” (223).  With an 
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effective asymmetric synthetic route in place, we aimed to extend our strategy to access 
the remaining members of the presilphiperfolanol family. 
 
3.5 PLANNED SYNTHESIS OF (–)-PRESILPHIPERFOLAN-9α-OL 
With the synthesis of 9β-presilphiperfolan-1β-ol (223) completed, we aim to extend 
our synthetic approach to access the remaining members of the presilphiperfolanol 
family.  Presilphiperfolan-9α-ol (222) is an attractive target given its structural similarity 
to presilphiperfolan-1β-ol (223).  By diverting IMDA cycloadduct 305 and 
functionalizing the tricyclic core, the synthesis of alcohol 222 could potentially be 
achieved in a short and concise sequence. 
 
Scheme 3.30.  Divergent Strategy for the Preparation of Presilphiperfolan-9α-ol (222) 
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3.5.1 PROTONATION APPROACH 
Synthetic efforts toward this end began with the IMDA cyclization of silyl dienol 
ether 343 as before followed by desilylation of the intermediate tricycles 305 and 344 
with TBAF (Scheme 3.31).  Analysis of the crude reaction mixture containing 286 and 
359 by 1H NMR spectroscopy revealed a 1:2.09 ratio of diastereomers for the IMDA 
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reaction.  Following chromatographic separation, ketone 286 was isolated in 28% yield 
and ketone 359 was isolated in 64% yield.  Compound 286 was identical in all respects to 
the racemic compounds obtained by Weyerstahl8 and Piers.33  Thermodynamic 
equilibration of ketone 286 using NaHMDS in THF was performed according to 
Weyerstahl’s procedure.8  While the desired epimer 285 was expected to be the minor 
component, successful epimerization would provide isomeric ketone 285 for conversion 
to presilphiperfolan-9α-ol (222) in only three additional steps (see Section 3.2.2).  
Unfortunately, the reaction conditions failed to provide observable quantities of epimeric 
ketone 285, but additional epimerization conditions can be evaluated.  If epimerization 
proves unsuccessful with numerous bases, our results would be consistent with the 
observations of Piers33 (see Section 3.2.3).  If the ring strain of the presilphiperfolane 
tricyclic system disfavors stereochemical inversion at C(1), an alternative synthetic 
approach with a modified IMDA substrate may be needed to obtain the target compound.  
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Scheme 3.31.  Planned Formal Synthesis of Presilphiperfolan-9α-ol via IMDA Substrate 343 
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3.5.2 MODIFIED IMDA APPROACH 
After encountering obstacles in the late-stage modification of the tricycle 305, we 
considered a new approach in which the modified triene substrate 361 would be 
employed in the IMDA reaction (Scheme 3.32).  Synthetic studies along this route have 
been initiated.  Following a straightforward tosylhydrazone formation, the application of 
the Shapiro reaction111 provided the modified IMDA cyclization substrate 361 in an 
unoptimized 36% yield.  In future optimization efforts, Bamford–Stevens reaction 
conditions can also be evaluated.112  Application of typical IMDA reaction conditions 
with p-dioxane as solvent and heating at 170 °C in a sealed tube afforded a mixture of 
inseparable olefin diastereomers 283 and 362.  Epoxidation of the mixture of olefins with 
MMPP provided the corresponding epoxides 284 and 363 in 62% combined yield over 
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two steps and 1:6.29 dr.  While optimal conditions for the synthesis and separation of 284 
and 363 have not yet been identified, the 1H NMR and 13C NMR signals corresponding to 
epoxide 284 match those reported in the literature.8  In the optimization of this sequence, 
metal-catalyzed101,102 and radical cation103 cyclization methods can also be investigated 
since the reported methods are suitable for triene substrates such as 361.  Once tricyclic 
olefin 283 or epoxide 284 is obtained as a single isomer, we can intercept Weyerstahl’s 
racemic route (see Section 3.2.2)8 in a formal synthesis with only 4–5 steps remaining for 
the completion of an asymmetric total synthesis of presilphiperfolan-9α-ol (222).  Once 
this natural product is obtained, it can also be evaluated in biomimetic carbocationic 
rearrangement experiments. 
 
Scheme 3.32.  Planned Formal Synthesis of Presilphiperfolan-9α-ol via IMDA Substrate 361 
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3.6 PLANNED REARRANGEMENT OF PRESILPHIPERFOLANOLS TO 
OTHER SESQUITERPENE NATURAL PRODUCTS 
With a completed synthesis of presilphiperfolan-1β-ol (223) and promising routes for 
the preparation of presilphiperfol-9α-ol (221), we can begin to explore biosynthetic 
rearrangements leading to rearranged sesquiterpene natural products (Scheme 3.33).  
While these types of biomimetic transformations have been studied in detail for 
presilphiperfolan-8α-ol (221),5,7 little is known about the biosynthetic potential of 
presilphiperfolan-1β-ol (223).  By applying a variety of solvolytic or acidic conditions to 
promote carbocation formation, we can observe the evolution of the presilphiperfolane 
skeleton to other sesquiterpene frameworks, identifying and isolating the major 
rearrangement products.  Preliminary rearrangement experiments have been carried out 
with presilphiperfolan-1β-ol (223) in TFAA at 70 °C, but these conditions did not 
provide signs of promising rearrangement products on small scale.  In future experiments, 
additional conditions can be evaluated and the reaction can be performed on larger scale.  
The anticipated rearrangement compounds will be compared to reported natural products 
with the aim of elucidating new sesquiterpene biosynthetic pathways stemming from 
presilphiperfolan-1β-ol (223).  In this manner, we aim to learn more about the different 
skeletal rearrangements of presilphiperfolanyl cations (238, 239, and 250) and contribute 
to a more complete understanding of the biosynthetic role of the presilphiperfolanols 
(Scheme 3.3). 
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Scheme 3.33.  Planned Biomimetic Rearrangements of Synthetic Presilphiperfolanols 223 and 222 
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3.7 CONCLUSION 
In summary, we have described the first asymmetric total synthesis of 
presilphiperfolan-1β-ol (223) in 15 steps and 7.9% overall yield.  Central to our approach 
was the further development and application of our Pd-catalyzed allylic alkylation/ring 
contraction methodology for the preparation of acylcyclopentenes 135 and more highly 
functionalized variants 306 and 308.  Successful elaboration of acylcyclopentene 306 
enabled the construction of the tricyclic core of the presilphiperfolanols through an 
intramolecular Diels–Alder reaction.  Functionalization of cycloadducts 305 and 283 
completed the total synthesis of presilphiperfolan-1β-ol (223), as well as unnatural 
presilphiperfolanol analogs 224, 355, and 356.  Analysis of spectral data and evaluation 
of presilphiperfolanol biosynthetic pathways led us to reassign the structure of reported 
“presilphiperfolan-1-ol” (224) to revised structure 223. The synthesis of 
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presilphiperfolan-9α-ol (222) is in progress and optimization of key steps will be 
necessary to complete the synthesis.  The biomimetic rearrangement of the synthetic 
presilphiperfolanols to related sesquiterpene natural products has been initiated and will 
be explored in greater detail in future explorations.  Our general synthetic route enables 
further investigation of the biosynthesis and biological activity of the presilphiperfolanols 
and related analogs.   
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3.8 EXPERIMENTAL SECTION 
3.8.1 MATERIALS AND METHODS 
Unless otherwise stated, reactions were performed in flame-dried glassware under an 
argon or nitrogen atmosphere using dry, deoxygenated solvents.  Reaction progress was 
monitored by thin-layer chromatography (TLC).  THF, Et2O, CH2Cl2, toluene, benzene, 
CH3CN, CyCH3, and p-dioxane were dried by passage through an activated alumina 
column113 under argon.  1,2-DCE was distilled over CaH2 prior to use.  Triethylamine was 
distilled over CaH2 prior to use.  Purified water was obtained using a Barnstead 
NANOpure Infinity UV/UF system.  Brine solutions are saturated aqueous solutions of 
sodium chloride.  2-Methyl-2-propen-1-ol was purchased from TCI America or Sigma-
Aldrich.  Zn(CH3)2 (1.0 M in heptanes), vinylmagnesium bromide (1.0 M in THF), and 
TBAF (1.0 M in THF) were purchased from Sigma-Aldrich.  CDI was purchased from 
Sigma-Aldrich or Combi-blocks, Inc.  Adam’s catalyst (PtO2-hydrate) was purchased 
from Strem.  Anhydrous lithium hydroxide and P(NMe2)3 were purchased from Acros 
Organics.  LiHMDS, KHMDS, CH3Ph3PBr, pinacolborane, Pd(Pt-Bu3)2, and Crabtree’s 
catalyst ([Ir(cod)(PCy3)(py)]PF6)106 were purchased from Sigma-Aldrich and stored in a 
N2-filled glove box.  Ni(cod)2, CuCN, PCy3, Pt-Bu3, and Cy-Johnphos (CAS# [247940-
06-3]) were purchased from Strem and stored in a N2-filled glove box.  NBS from Sigma-
Aldrich was ground into a fine white powder with a mortar and pestle before use.  NaH 
(60% wt. dispersion in mineral oil) from Sigma-Aldrich was purified by trituration with 
hexanes under a N2 atmosphere and removal of residual solvent under vacuum.  
Isobutoxy-2-cyclohepten-1-one (#T271322) is commercially available from Sigma-
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Aldrich, but was prepared by a modified procedure42 of Ragan.114  2-Methyl-2-
vinyloxirane was purchased from Sigma-Aldrich or prepared by a modification of the 
procedure of Isobe.76  2-methylene-3-buten-1-ol (isoprenol) was prepared by the 
procedure of Isobe.76  Phosphinooxazoline (PHOX) ligands were prepared by methods 
described in our previous work.47a,53  Tris(4,4’-methoxydibenzylideneacetone) 
dipalladium(0) (Pd2(pmdba)3) was prepared according to the method of Ibers55a or 
Fairlamb.55b  Pd(PPh3)4 was prepared according to the procedure of Coulson.115  TBSOTf 
was prepared according to the procedure of Corey and stored under a N2 or Ar 
atmosphere in a –25 °C freezer.116  FeCl2(py-imine) complex 349 and [2-(N,N-
dimethylaminomethyl)phenyl]lithium (350) were prepared according the method of Ritter 
and stored in a N2-filled glove box.86a  DMDO was prepared according to the procedure 
of Singh.95  All other reagents were purchased from Sigma-Aldrich, Acros Organics, 
Strem, or Alfa Aesar and used as received unless otherwise stated.  Reaction 
temperatures were controlled by an IKAmag temperature modulator unless otherwise 
indicated.  Microwave-assisted reactions were performed in a Biotage Initiator 2.5 
microwave reactor.  Glove box manipulations were performed under a N2 atmosphere.  
TLC was performed using E. Merck silica gel 60 F254 precoated glass plates (0.25 mm) 
and visualized by UV fluorescence quenching, p-anisaldehyde, or KMnO4 staining.  
Silicycle SiliaFlash P60 Academic Silica gel (particle size 0.040–0.063 mm) was used 
for flash column chromatography.  Silica gel was deactivated by pre-stirring with 1% 
Et3N in hexanes for 30 min to 1 h before use for flash column chromatography.  Solutions 
of potentially volatile reaction products were concentrated under reduced pressure (25 
mm Hg) in a 0 °C ice/water bath using a rotary evaporator.  Ozonolysis reactions were 
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performed using an AZCO Industries HTU-500S Ozone Generator, and oxygen flow was 
controlled using an OzoneLab Instruments oxygen regulator with a CGA 540 fitting.  1H 
NMR spectra were recorded on a Varian Inova 500 MHz spectrometer and are reported 
relative to residual CHCl3 (δ 7.26 ppm), C6H6 (δ 7.16 ppm), or CH2Cl2 (δ 5.32 ppm).  13C 
NMR spectra are recorded on a Varian Inova 500 MHz spectrometer (125 MHz) and are 
reported relative to CHCl3 (δ 77.16 ppm) or C6H6 (δ 128.06 ppm).  Data for 1H NMR are 
reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), 
integration).  Multiplicities are reported as follows: s = singlet, d = doublet, t = triplet, q = 
quartet, p = pentet, sept = septuplet, m = multiplet, dm = double of multiplets, br s = 
broad singlet, br d = broad doublet, app = apparent.  Data for 13C are reported in terms of 
chemical shifts (δ ppm).  19F NMR spectra were recorded on a Varian Inova 500 (at 470 
MHz) instrument and are reported in terms of chemical shift (δ ppm) without the use of a 
reference peak. 31P NMR spectra were recorded on a Varian Inova 500 (at 202 MHz) 
instrument and are reported in terms of chemical shift (δ ppm) without the use of a 
reference peak.  IR spectra were obtained using a Perkin Elmer Spectrum BXII 
spectrometer using thin films deposited on NaCl plates and reported in frequency of 
absorption (cm–1).  Optical rotations were measured with a Jasco P-2000 polarimeter 
operating on the sodium D-line (589 nm) using a 100 mm path-length cell and are 
reported as: [α]DT (concentration in g/100 mL, solvent, ee).  Melting points were 
measured using a Büchi B-545 capillary melting point apparatus and the reported values 
are uncorrected.  Preparatory HPLC was performed with an Agilent 1100 Series HPLC 
utilizing an Agilent ZORBAX RX-SIL 5 µm column (9.4 x 250 mm), part number 
880975-201.  Analytical chiral HPLC was performed with an Agilent 1100 Series HPLC 
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utilizing a Chiralcel AD column (4.6 mm x 25 cm) obtained from Daicel Chemical 
Industries Ltd. with visualization at 254 nm.  Analytical UHPLC-LCMS was performed 
with an Agilent 1290 Infinity Series UHPLC/Agilent 6140 Quadrupole LCMS utilizing 
an Agilent Eclipse Plus C18 RRHD 1.8 µm column (2.1 x 50 mm), part number 959757-
902.  High-resolution mass spectra (HRMS) were obtained from the Caltech Mass 
Spectral Facility (EI+ or FAB+) or on an Agilent 6200 Series TOF with an Agilent 
G1978A Multimode source in electrospray ionization (ESI+), atmospheric pressure 
chemical ionization (APCI+), or mixed (MM: ESI-APCI+) ionization mode. 
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3.8.2 PREPARATIVE PROCEDURES 
3.8.2.1 METHALLYL/METHYL ACYLCYCLOPENTENE ROUTE 
CDI, CH2Cl2
0!23 °C
98% yield
N O
O
NHO
312  
Carbamate 312.  2-methyl-2-propen-1-ol was converted to carbamate 312 using the 
general procedure of Sarpong.50 
To a 1 L round-bottom flask with a magnetic stir bar were added CDI (29.19 g, 180.0 
mmol, 1.50 equiv) and CH2Cl2 (350 mL).  The suspension was cooled to 0 °C and 2-
methyl-2-propen-1-ol (10.1 mL, 120.0 mmol, 1.00 equiv) was added dropwise.  The flask 
was sealed with a rubber septum, connected to a N2 inlet, and allowed to warm to 23 °C.  
After 9 h of stirring, the reaction was quenched with H2O (100 mL).  The phases were 
separated and the organic phase was washed once more with H2O (100 mL), dried over 
Na2SO4, filtered, and concentrated under reduced pressure.  The crude oil was purified by 
flash column chromatography (SiO2, 8 x 15 cm, 2:1→1:1 hexanes:EtOAc) to afford 
carbamate 312 (18.07 g, 118.0 mmol, 98% yield) as a white solid.  (Note: The reagent is 
moisture sensitive.  Storage under Ar in a sealed vial in a –25 °C freezer is recommended 
for maintaining reagent quality, but the reagent is typically used shortly after generation.  
Storage in a dessicator led to partial decomposition and slow color change to an orange 
solid over several months.)  The spectral data match reported data. 48 
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β-Ketoester 313.  To a 1 L round-bottom flask with a magnetic stir bar was added 
LiHMDS (30.18 g, 164.6 mmol, 3.00 equiv) in a N2-filled glove box.  The flask was 
sealed with a rubber septum and removed from the glove box, connected to a N2 inlet, 
and cooled to –78 °C using an acetone/CO2(s) bath.  THF (390 mL) was added and the 
suspension was stirred vigorously for 5 min.  The cooling bath was removed and the flask 
was allowed to warm until the solids completely dissolved.  The pale orange solution was 
cooled to –78 °C.  A solution of vinylogous ester 14742 (10.00 g, 54.87 mmol, 1.00 equiv) 
in THF (80 mL) in a conical 100 mL flask was added to the reaction dropwise over 1 h 
using positive pressure cannulation.  The orange solution was stirred at –78 °C for 30 
min.  A solution of carbamate 312 (12.52 g, 82.30 mmol, 1.50 equiv) in THF (80 mL) in 
a conical 100 mL flask was added to the reaction dropwise over 1 h using positive 
pressure cannulation.  The orange solution was stirred at –78 °C for 2 h.  CH3I (34.1 mL, 
548.7 mmol, 10.00 equiv) was added dropwise.  The reaction was stirred at –78 °C for 6 
h and warmed to 0 °C using an ice/water bath.  After 11.5 h of stirring, the cooling bath 
was removed and the reaction was allowed to warm to 23 °C.  Additional CH3I (6.82 mL, 
109.73 mmol, 2.00 equiv) was added to the reaction after 2.5 h.  After an additional 9 h 
of stirring, the yellow solution became a yellow suspension.  The reaction was quenched 
with 50% sat. aqueous NH4Cl (200 mL) and Et3N (5 mL).  The biphasic mixture was 
stirred vigorously for 12 h.  The phases were separated and the organic phase was washed 
with brine (2 x 100 mL).  The combined aqueous phases were washed with EtOAc (2 x 
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150 mL).  The combined organic phases were dried over Na2SO4, filtered, and 
concentrated under reduced pressure.  The crude oil was purified by flash column 
chromatography (SiO2, 8 x 32 cm, 3%→5%→7%→10% EtOAc in hexanes) to afford β-
ketoester 313 (13.20 g, 44.80 mmol, 82% yield) as a pale yellow oil;  Rf = 0.55 (4:1 
hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 5.39 (s, 1H), 4.96–4.91 (m, 1H), 4.91–
4.85 (m, 1H), 4.52 (d, J = 13.2 Hz, 1H), 4.47 (d, J = 13.2 Hz, 1H), 3.54–3.40 (m, 2H), 
2.63–2.51 (ddd, J = 4.0, 9.9, 17.8 Hz, 1H), 2.47–2.29 (m, 2H), 2.04–1.90 (m, 2H), 1.86–
1.74 (m, 1H), 1.74–1.62 (m, 1H), 1.70 (s, 3H), 1.43 (s, 3H), 0.93 (dd, J = 6.7, 1.1 Hz, 
6H);  13C NMR (125 MHz, CDCl3) δ 199.0, 174.0, 173.5, 139.8, 113.2, 105.2, 74.8, 68.4, 
59.1, 34.4, 33.9, 27.9, 24.2, 21.4, 19.6, 19.2;  IR (Neat Film NaCl) 3082, 2959, 2936, 
2875, 1735, 1657, 1613, 1470, 1454, 1425, 1402, 1384, 1309, 1298, 1233, 1197, 1169, 
1114, 1084, 1035, 994, 969, 957, 904, 868, 821 cm–1;  HRMS (MM: ESI-APCI+) m/z 
calc'd for C17H27O4 [M+H]+: 295.1904; found 295.1908.  
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Pd2(pmdba)3 (2.5 mol %)
PhCH3, 30 °C
98–99% yield
88–89% ee
O
i-BuO
313
O
O
NPh2P
O
t-Bu
 
Vinylogous ester 314 (0.5 mmol scale).  A 20 mL scintillation vial was loaded with β-
ketoester 313 (170.3 mg, 0.58 mmol, 1.00 equiv).  A separate 20 mL scintillation vial 
was loaded with a magnetic stir bar, Pd2(pmdba)355 (15.8 mg, 0.015 mmol, 2.5 mol %), 
and (S)-t-Bu-PHOX53 (14.0 mg, 0.036 mmol, 6.25 mol %).  The two vials and a teflon-
lined hard cap were placed in a glove box antechamber, which was evacuated/backfilled 
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with N2 (3 cycles, 5 min evacuation per cycle) before the items were transferred into the 
glove box.  Toluene (5 mL) was added to the vial containing Pd2(pmdba)3 and (S)-t-Bu-
PHOX.  The vial was capped and the reaction was stirred for 30 min in a 30 °C heating 
block.  During this time, the reaction changed from a deep purple-black suspension to a 
deep red-orange color.  β-Ketoester 313 was dissolved in toluene (3 mL) and added to the 
catalyst solution dropwise, causing the solution to turn yellow.  The reaction was sealed 
with a teflon-lined hard cap and stirred at 30 °C.  After 9 h of stirring, the reaction 
became a deep red-orange color.  The capped vial was removed from the glove box and 
the reaction was concentrated under reduced pressure.  The crude oil was purified by 
flash column chromatography (SiO2, 2 x 25 cm, 20:1→15:1 hexanes:EtOAc) to afford 
vinylogous ester 314 (143.9 mg, 0.58 mmol, 99% yield, 88.9% ee) as a pale yellow oil.  
 
Vinylogous ester 314 (50 mmol scale).  To a 1 L round-bottom flask with a magnetic stir 
bar were added Pd2(pmdba)355 (1.23 g, 1.12 mmol, 2.5 mol %), (S)-t-Bu-PHOX53 (1.08 g, 
2.80 mmol, 6.25 mol %), and toluene (450 mL) in a N2-filled glove box.  The flask was 
sealed with a rubber septum, removed from the glove box, connected to a N2 inlet, and 
immersed in a 30 °C oil bath.  The deep purple-black suspension gradually became 
became a deep red-orange solution after 45 min of stirring.  β-Ketoester 313 (13.20 g, 
44.80 mmol, 1.00 equiv) in a 100 mL conical flask was freeze-pump-thawed using an 
acetone/CO2(s) bath (3 cycles, 5 min evacuation per cycle), dissolved in toluene (50 mL), 
and added to the reaction dropwise using positive pressure cannulation.  The solution 
became a deep green-brown solution.  After 31.5 h of stirring, the reaction was a deep 
red-orange solution.  The reaction was concentrated under reduced pressure and the crude 
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oil was purified by flash column chromatography (SiO2, 8 x 32 cm, 3%→5%→8% 
EtOAc in hexanes) to afford vinylogous ester 314 (10.96 g, 43.78 mmol, 98% yield, 
89.5% ee) as a pale tan oil;  Rf = 0.35 (10:1 hexanes:EtOAc);  1H NMR (500 MHz, 
CDCl3) δ 5.33 (s, 1H), 4.82–4.76 (m, 1H), 4.66–4.62 (m, 1H), 3.53–3.42 (m, 2H), 2.55 
(d, J = 13.3 Hz, 1H), 2.51–2.39 (m, 2H), 2.12 (d, J = 13.4, 1H), 1.97 (app. sept, J = 6.8 
Hz, 1H), 1.89–1.70 (m, 3H), 1.66 (s, 3H), 1.57 (dd, J = 13.6, 8.6 Hz, 1H), 1.15 (s, 3H), 
0.94 (d, J = 6.7 Hz, 6H);  13C NMR (125 MHz, CDCl3) δ 206.7, 171.2, 143.0, 114.8, 
105.4, 74.5, 51.2, 49.4, 36.2, 35.3, 28.0, 26.7, 24.6, 19.7, 19.3, 19.3;  IR (Neat Film 
NaCl) 3072, 2961, 2934, 2874, 1615, 1470, 1455, 1424, 1402, 1388, 1374, 1332, 1318, 
1284, 1223, 1188, 1174, 1121, 1085, 1027, 1012, 998, 969, 951, 887, 852, 745 cm–1;  
HRMS (MM: ESI-APCI+) m/z calc'd for C16H27O2 [M+H]+: 251.2006; found 251.2012;  
[α]D25.0 –137.73 (c 1.33, CHCl3, 88.9% ee);  HPLC conditions: 0.7% IPA in hexanes, 1.0 
mL/min, AD column, tR (min): major = 8.94, minor = 8.28. 
 
(Note: Pd2(pmdba)3 is preferable to Pd2(dba)3 in this reaction for ease of separation of 
pmdba from the reaction products during purification.  The non-enantioselective reaction 
was carried out with Pd(PPh3)4115 (5 mol %) in toluene (0.1 M) at 30 °C or with 
Pd2(dba)3·CHCl3 (2.5 mol %) and dppe (6.25 mol %) in toluene (0.1 M) at 30 °C.) 
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O O
+
O
i-BuO
LiAlH4, Et2O, 0 °C
then 10% aq HCl
96% yield 1% yield
314 364315
OH
 
β-Hydroxyketone 315 and Cycloheptenone 364.  A 500 mL round-bottom flask with a 
magnetic stir bar was charged with LiAlH4 (221 mg, 5.88 mmol, 0.60 equiv) and 
evacuated/backfilled with N2 (3 cycles, 5 min evacuation per cycle).  Et2O (150 mL) was 
added and the gray suspension was cooled to 0 °C using an ice/water bath.  A solution of 
vinylogous ester 314 (2.45 g, 9.80 mmol, 1.00 equiv) in Et2O (26 mL) in a conical 100 
mL flask was added to the reaction dropwise using positive pressure cannulation.  The 
flask was washed with THF (2 x 10 mL) and washes were added to the reaction.  The 
gray suspension was stirred at 0 °C.  After 40 min of stirring, the reaction was quenched 
by slow dropwise addition of 10% aqueous HCl (15.2 mL).  Gas evolution was observed.  
The reaction was allowed to warm to 23 °C and the phases were separated.  The aqueous 
phase was extracted with Et2O (3 x 30 mL).  Combined organic phases were dried over 
Na2SO4, filtered, and concentrated under reduced pressure.  The crude oil was purified by 
flash column chromatography (SiO2, 3 x 25 cm, 9:1→3:1 hexanes:EtOAc) to afford 
cycloheptenone 364 (22.9 mg, 0.128 mmol, 1% yield) as a pale yellow oil and β-
hydroxyketone 315 (1.85 g, 9.42 mmol, 96% yield, 1.91:1 dr) as a pale tan oil. 
 
β-Hydroxyketone 315.  Rf = 0.17 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) 
mixture of two overlapping diastereomers, see Figure A5.7;  13C NMR (125 MHz, 
CDCl3) δ major diastereomer: 213.5, 143.6, 115.4, 72.7, 48.1, 46.8, 44.1, 41.7, 36.7, 
25.7, 22.5, 19.2;  minor diastereomer: 212.9, 142.7, 115.6, 73.8, 47.4, 45.7, 44.0, 41.6, 
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36.1, 25.8, 22.9, 18.6;  IR (Neat Film NaCl) 3449, 3073, 2965, 2935, 1693, 1640, 1466, 
1452, 1401, 1376, 1352, 1319, 1253, 1237, 1168, 1115, 1099, 1072, 1039, 1013, 996, 
979, 963, 937, 892, 863, 809, 759, 734 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for 
C12H21O2 [M+H]+: 197.1536; found 197.1535;  [α]D25.0 –49.39 (c 0.98, CHCl3, 88.1% ee). 
 
Cycloheptenone 364.  Rf = 0.59 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 
6.11 (dd, J = 13.0, 1.1 Hz, 1H), 5.81 (d, J = 13.0 Hz, 1H), 4.91–4.86 (m, 1H), 4.72–4.67 
(m, 1H), 2.68–2.46 (m, 2H), 2.19 (d, J = 13.4 Hz, 1H), 2.12 (d, J = 13.3, 1H), 1.92–1.78 
(m, 3H), 1.74 (s, 3H), 1.69–1.60 (m, 1H), 1.13 (s, 3H);  1H NMR (125 MHz, CDCl3) δ 
204.7, 153.3, 142.1, 128.1, 115.6, 51.2, 45.2, 43.1, 38.4, 28.4, 25.0, 18.5;  IR (Neat Film 
NaCl) 3648, 3074, 2929, 2870, 1732, 1659, 1455, 1401, 1374, 1350, 1337, 1274, 1233, 
1203, 1160, 1120, 1089, 1075, 1025, 977, 928, 893, 877, 862, 850, 826, 810, 771, 694, 
668, 622 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C12H19O2 [M+H]+: 179.1430; 
found 179.1435;  [α]D25.0 –22.90 (c 0.24, CHCl3, 88.1% ee). 
 
308
O
HO
O
315
LiOH, TFE
THF, 60 °C
95–96% yield
 
Acylcyclopentene 308 (0.5 mmol scale).  β-Hydroxyketone 315 (102.4 mg, 0.522 mmol, 
1.00 equiv) was dissolved in THF (5.2 mL) in a 20 mL scintillation vial with a magnetic 
stir bar.  The solution was treated with 2,2,2-trifluoroethanol (57.1 µL, 0.783 mmol, 1.50 
equiv) and anhydrous LiOH (11.5 mg, 0.783 mmol, 1.50 equiv).  The headspace of the 
vial was purged with Ar.  The vial was sealed with a teflon-lined hard cap and inserted 
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into a 60 °C heating block.  After 14 h of stirring, the fine suspension was allowed to cool 
to ambient temperature, diluted with Et2O (5 mL), dried over Na2SO4 with stirring for 30 
min, filtered, and carefully concentrated under reduced pressure (25 mmHg) in a 0 °C 
ice/water bath.  The crude product was purified using flash column chromatography 
(SiO2, 2 x 25 cm, 15:1 hexanes:Et2O) to afford acylcyclopentene 308 (88.0 mg, 0.494 
mmol, 95% yield) as a fragrant pale tan oil. 
 
Acylcyclopentene 308 (10 mmol scale).  β-Hydroxyketone 315 (1.804 g, 9.19 mmol, 
1.00 equiv) was dissolved in THF (92 mL) in a 300 mL round-bottom flask with a 
magnetic stir bar.  The solution was treated with 2,2,2-trifluoroethanol (1.00 mL, 13.79 
mmol, 1.50 equiv) and anhydrous LiOH (331 mg, 13.79 mmol, 1.50 equiv).  The flask 
was fitted with a reflux condenser, purged with N2, and immersed in a 60 °C oil bath.  
After 33 h of stirring, the fine suspension was allowed to cool to ambient temperature, 
diluted with Et2O (100 mL), dried over Na2SO4 with stirring for 30 min, filtered, and 
carefully concentrated under reduced pressure (25 mmHg) in a 0 °C ice/water bath.  The 
crude product was purified using flash column chromatography (SiO2, 3 x 25 cm, 15:1 
hexanes:Et2O) to afford acylcyclopentene 308 (1.58 g, 8.85 mmol, 96% yield) as a 
fragrant pale tan oil.  
 
Acylcyclopentene 308: Rf = 0.61 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 
6.48 (app. t, J = 1.8 Hz, 1H), 4.84–4.78 (m, 1H), 4.66–4.63 (m, 1H), 2.50 (td, J = 7.8, 7.2, 
1.5 Hz, 2H), 2.25 (s, 3H), 2.15 (dd, J = 3.4 Hz, 2H), 1.90 (dt, J = 12.8, 7.7 Hz, 1H), 1.70 
(s, 3H), 1.72–1.58 (m, 1H), 1.07 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 197.3, 152.7, 
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143.1, 142.9, 114.6, 50.0, 48.7, 36.5, 29.5, 26.7, 26.0, 24.6;  IR (Neat Film NaCl) 3074, 
2956, 2923, 2865, 1670, 1616, 1454, 1376, 1366, 1340, 1320, 1305, 1271, 1228, 1200, 
1158, 1138, 1092, 1048, 1013, 976, 934, 891, 869 cm–1;  HRMS (APCI+) m/z calc'd for 
C12H19O2 [M+H]+: 179.1430; found 179.1430;  [α]D25.0 –41.19 (c 1.155, CHCl3, 88.1% 
ee). 
 
308
O
304
O
319
O
H
O O
H
+
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (68) (5 mol %)
crotonaldehyde
PhH, 23!50!80 °C
8% yield
6.25 : 1 (E : Z)
 
Enals 304 and 319.  To a 2-neck 50 mL round-bottom flask with stir bar and attached 
reflux condenser connected to a N2-inlet was added alkene 308 (76.7 mg, 0.43 mmol, 
1.00 equiv).  Dry degassed benzene (5.7 mL, sparged with Ar for 1 h immediately before 
use) was added.  Crotonaldehyde (175.7 µL, 2.15 mmol, 5.00 equiv) was added 
dropwise.  Grubbs–Hoveyda 2nd generation catalyst (13.5 mg, 0.0215 mmol, 5 mol %) 
was quickly added in one portion through the side neck.  The flask was sealed and the 
reaction was stirred at 23 °C.  After 3 h of stirring, the reaction was warmed to 50 °C, 
causing a color change to dark brown.  After 20.5 h of stirring, the reaction was warmed 
to 80 °C.  After an additional 4.5 h of stirring, ethyl vinyl ether (1 mL) was added and the 
reaction was diluted with hexanes and passed through a silica plug (2 x 8 cm), eluted with 
Et2O, and concentrated under reduced pressure.  The residue was purified by flash 
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column chromatography (SiO2, 2 x 15 cm, 15:1→10:1→1:1 hexanes:Et2O) to afford 
enals 304 and 319 (7.0 mg, 0.034 mmol, 8% yield, 6.25:1 E:Z ratio) as a brown oil. 
 
Enal 304 (E isomer):  Rf = 0.14 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 
9.99 (d, J = 7.9 Hz, 1H), 6.47 (app. t, J = 1.8 Hz, 1H), 5.87 (dm, J = 8.2 Hz, 1H), 2.66–
2.49 (m, 2H), 2.38 (s, 2H), 2.31 (s, 3H), 2.20 (d, J = 1.3 Hz, 3H), 1.92 (ddd, J = 13.0, 8.5, 
6.6 Hz, 1H), 1.75 (ddd, J = 13.0, 8.3, 5.7 Hz, 1H), 1.16 (s, 3H);  13C NMR (125 MHz, 
CDCl3) δ 197.2, 190.9, 160.5, 150.7, 144.0, 130.8, 51.5, 50.6, 36.9, 29.7, 26.9, 26.3, 19.9;  
IR (Neat Film NaCl) 3317, 2956, 2927, 2856, 2773, 2726, 1710, 1668, 1624, 1453, 1405, 
1379, 1367, 1340, 1304, 1269, 1197, 1135, 1113, 1048, 1022, 978, 935, 862, 836 cm–1;  
HRMS (EI+) m/z calc'd for C13H18O2 [M]+•: 206.1307; found 206.1307;  [α]D25.0 –19.87 (c 
0.86, CHCl3, 88.1% ee). 
 
Enal 319 (Z isomer):  Rf = 0.13 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 
9.87 (d, J = 8.0 Hz, 1H), 6.45 (app. t, J = 1.8 Hz, 1H), 6.02 (dm, J = 8.0 Hz, 1H), 2.93 (d, 
J = 13.1 Hz, 1H), 2.66–2.52 (m, 2H), 2.61 (d, J = 13.1 Hz, 1H), 2.30 (s, 3H), 2.01 (d, J = 
1.3 Hz, 3H), 1.94 (ddd, J = 12.9, 8.5, 6.3 Hz, 1H), 1.79 (ddd, J = 12.9, 8.5, 5.7 Hz, 1H), 
1.20 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 197.1, 190.8, 160.4, 150.4, 144.3, 131.0, 
50.5, 43.1, 37.3, 29.7, 27.8, 26.9, 26.5;  IR (Neat Film NaCl) 3317, 2957, 2928, 2866, 
2756, 1673, 1668, 1652, 1625, 1622, 1456, 1394, 1378, 1368, 1341, 1306, 1265, 1186, 
1151, 1135, 1093, 1048, 1018, 978, 937, 870, 855, 802, 747 cm–1;  HRMS (EI+) m/z 
calc'd for C13H18O2 [M]+•: 206.1307; found 206.1308;  [α]D25.0 –63.73 (c 0.25, CHCl3, 
88.1% ee). 
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308
O
304
O
319
O
H
O O
H
+
Ru
O
Cl
Cl
NN
Grubbs–Hoveyda 2nd 
generation (68) (5 mol %)
crotonaldehyde
CH2Cl2, 40 °C
21% yield
4.09 : 1 (E : Z)
 
Enals 304 and 319.  To a 1 dram vial with a magnetic stir bar was added Grubbs–
Hoveyda 2nd generation catalyst (17.6 mg, 0.028 mmol, 5 mol %).  The vial was sealed 
with a septum-fitted screw cap and electrical tape and covered with an inverted secondary 
rubber septum.  The vial was evacuated/backfilled with N2 (3 cycles, 5 min evacuation 
per cycle).  Dry degassed CH2Cl2 (0.56 mL, sparged with Ar for 1 h immediately before 
use) was added.  The sealed vial was heated at reflux for 15 min.  Alkene 308 (50 mg, 
0.280 mmol, 1.00 equiv) was added to the emerald green reaction and stirred at reflux for 
15 min.  Crotonaldehyde (34.6 µL, 0.421 mmol, 1.50 equiv) was added dropwise at 
reflux.  After 26 h of stirring, the reaction was a deep red-brown solution.  Ethyl vinyl 
ether (0.5 mL) was added and the reaction mixture was stirred for 30 min.  The reaction 
was concentrated under reduced pressure and purified by flash column chromatography 
(SiO2, 2 x 20 cm, 10:1→1:1 hexanes:Et2O) to afford enals 304 and 319 (12 mg, 0.058 
mmol, 21% yield, 4.09:1 E:Z ratio) as a brown oil. 
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PPTS (10 mol %)
PhH, reflux
Dean–Stark
95% yield
308
O
320
OO
HO OH
 
Ketal 320.  To a 25 mL round-bottom flask with a magnetic stir bar were added 
acylcyclopentene 308 (178.3 mg, 1.00 mmol, 1.00 equiv), benzene (10 mL), neopentyl 
glycol (624.9 mg, 6.00 mmol, 6.00 equiv), and PPTS (25.1 mg, 0.10 mmol, 0.10 equiv).  
A Dean–Stark trap and reflux condenser connected to a N2 inlet was attached and the 
flask was immersed in a 100 °C oil bath.  The suspension gradually became a clear, 
colorless solution.  After 4 h of stirring, the reaction was cooled to ambient temperature 
and poured into sat. aqueous NaHCO3 (3 mL) and the mixture was extracted with Et2O (3 
x 10 mL).  The combined organic phases were dried over Na2SO4, filtered, and 
concentrated under reduced pressure to give a white semisolid.  The crude product was 
purified using flash column chromatography (SiO2, 3 x 25 cm, 1%→2% EtOAc in 
hexanes) to afford ketal 320 (251.7 mg, 0.952 mmol, 95% yield) as a pale tan oil;  Rf = 
0.53 (10:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 5.59 (t, J = 1.9 Hz, 1H), 
4.83–4.80 (m, 1H), 4.70–4.67 (m, 1H), 3.56 (dd, J = 20.9, 10.9 Hz, 2H), 3.32 (dt, J = 
10.9, 2.3 Hz, 2H), 2.38–2.23 (m, 2H), 2.15 (s, 2H), 1.94 (ddd, J = 12.7, 8.6, 6.7 Hz, 1H), 
1.76 (s, 3H), 1.65 (ddd, J = 12.6, 8.2, 5.3 Hz, 1H), 1.41 (s, 3H), 1.17 (s, 3H), 1.07 (s, 3H), 
0.69 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 144.2, 140.6, 139.1, 113.9, 98.8, 71.8, 49.4, 
49.1, 37.1, 31.1, 29.8, 27.6, 27.3, 24.8, 22.9, 22.2;  IR (Neat Film NaCl) 3072, 3040, 
2980, 2952, 2868, 2852, 1642, 1471, 1453, 1395, 1369, 1352, 1319, 1298, 1253, 1239, 
1193, 1180, 1118, 1083, 1041, 1015, 950, 911, 889, 862, 808, 793, 674 cm–1;  HRMS 
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(EI+) m/z calc'd for C17H28O2 [M]+•: 264.2089; found 264.2086;  [α]D25.0 –5.47 (c 1.225, 
CHCl3, 88.1% ee). 
 
O3, CH2Cl2, –78 °C
then PPh3
–78!23 °C
32% yield
324
O
OO
320
OO
 
Methyl Ketone 324.117  To a 50 mL round-bottom flask with a magnetic stir bar was 
added a solution of alkene 320 (181.1 mg, 0.685 mmol, 1.00 equiv) in CH2Cl2 (12 mL).  
The flask was cooled to –78 °C using an acetone/CO2(s) bath.  O2 was bubbled through 
the reaction mixture for 2 min before ozone generation was turned initiated (O2 regulator 
setting: 1/4 L·min–1, ozonator setting: 1).  Ozonation was conducted for 5 min intervals 
and carefully monitored until starting material was completely consumed.  After 35 min 
of ozonation, the O2 was bubbled through the reaction for 15 min.  PPh3 (449 mg, 1.71 
mmol, 2.5 equiv) was added at –78 °C, the cooling bath was removed, and the flask was 
allowed to warm to 23 °C.  The reaction was concentrated under reduced pressure and the 
crude product was purified using flash column chromatography (SiO2, 3 x 25 cm, 
20:1→15:1→10:1→4:1 hexanes:EtOAc) to afford methyl ketone 324 (57.7 mg, 0.217 
mmol, 32% yield) as a pale yellow oil;  Rf = 0.43 (4:1 hexanes:EtOAc);  1H NMR (500 
MHz, CDCl3) δ 5.66 (t, J = 1.9 Hz, 1H), 3.53 (dd, J = 10.4, 7.7 Hz, 2H), 3.33 (d, J = 11.1 
Hz, 2H), 2.53 (s, 2H), 2.40–2.24 (m, 2H), 2.13 (s, 3H), 1.94 (ddd, J = 12.9, 8.5, 6.3 Hz, 
1H), 1.77 (ddd, J = 12.8, 8.4, 5.6 Hz, 1H), 1.41 (s, 3H), 1.16 (s, 3H), 1.15 (s, 3H), 0.71 (s, 
3H);  13C NMR (125 MHz, CDCl3) δ 208.3, 141.9, 137.5, 98.6, 71.8, 54.0, 47.8, 37.4, 
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32.1, 30.9, 29.8, 27.4, 26.7, 22.8, 22.3;  IR (Neat Film NaCl) 3400, 2952, 2868, 1718, 
1472, 1457, 1395, 1369, 1254, 1241, 1178, 1146, 1117, 1082, 1039, 1015, 949, 911, 862, 
809, 793 cm–1;  HRMS (EI+) m/z calc'd for C16H27O2 [M+H]+: 267.1955; found 267.1960;  
[α]D26.0 –10.89 (c 1.07, CHCl3, 88.1% ee). 
 
OsO4 (5 mol %)
NaIO4, 2,6-lutidine
p-dioxane:H2O (3:1)
75% yield
324
O
OO
320
OO
 
Methyl Ketone 324.  To a 50 mL round-bottom flask with a magnetic stir bar was added 
a solution of alkene 320 (288.4 mg, 1.09 mmol, 1.00 equiv) in a mixture of p-
dioxane:purified H2O (3:1, 10.9 mL).  The reaction was cooled to 0 °C using an ice/water 
bath.  2,6-Lutidine (254 µL, 2.18 mmol, 2.00 equiv) and OsO4 (13.9 mg, 0.055 mmol, 5 
mol %) were added to the reaction.  The thick white suspension was stirred vigorously 
and the cooling bath was allowed to expire.  The reaction was warmed to room 
temperature over several hours.  After 14 h of stirring, the reaction was passed through a 
plug of Celite (2 x 2 cm) and eluted with EtOAc.  The biphasic mixture was separated 
and the aqueous phase was extracted with EtOAc (3 x 20 mL).  The combined organic 
phases were dried over Na2SO4, filtered, and concentrated under reduced pressure to give 
a green-brown residue.  The crude product was purified using flash column 
chromatography (SiO2, 3 x 25 cm, 20:1→15:1→10:1 hexanes:EtOAc) to afford methyl 
ketone 324 (217.1 mg, 0.815 mmol, 75% yield) as a pale yellow oil.   
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THF, 0 °C
96% yield
1:1 dr
327
OO
324
O
OO BrMg
HO
 
Alcohol 327.  To a 50 mL round-bottom flask with a magnetic stir bar under N2 were 
added THF (6 mL) and vinylmagnesium bromide solution (1.0 M in THF, 585.6 µL, 
0.225 mmol, 3.00 equiv).  The reaction was cooled to 0 °C using an ice/water bath.  
Ketone 324 (52 mg, 0.195 mmol, 1.00 equiv) in THF (2 mL) was added dropwise by 
positive pressure cannulation.  After 30 min of stirring, the reaction was diluted with 
Et2O, quenched with H2O (2.0 mL) and sat. aqueous NH4Cl (2.0 mL).  The phases were 
separated and the aqueous phase was extracted with EtOAc (3 x 5 mL).  The aqueous 
phase was acidified to pH = 1 with the addition of aqueous KCl/HCl buffer.  The aqueous 
phase was extracted with EtOAc (3 x 5 mL).   The combined organic phases were dried 
over Na2SO4, filtered, and concentrated under reduced pressure.  The crude product was 
purified using flash column chromatography (SiO2, 3.0 x 12 cm, 6:1→4:1 
hexanes:EtOAc) to afford alcohol 327 (55.2 mg, 0.1876 mmol, 96% yield, 1:1 dr) as a 
pale yellow oil. .  (Note: The compound appears to be unstable to long-term storage for 
periods greater than 6 months.);  Rf = 0.41 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, 
CDCl3) mixture of two overlapping diastereomers, see Figure A5.28;  13C NMR (125 
MHz, CDCl3) mixture of two overlapping diastereomers, see Figure A5.30;  IR (Neat 
Film NaCl) 3480, 3084, 2951, 2868, 1642, 1472, 1457, 1453, 1395, 1369, 1353, 1320, 
1283, 1241, 1255, 1179, 1117, 1083, 1040, 1014, 949, 912, 862, 807, 793, 758 cm–1;  
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HRMS (EI+) m/z calc'd for C16H27O2 [M+H]+: 295.2268; found 295.2267;  [α]D25.0 –10.14 
(c 0.92, CHCl3, 88.1% ee). 
 
3.8.2.2 SYNTHESIS OF (–)-PRESILPHIPERFOLAN-1β-OL AND ANALOGS 
NBS, H2O, 0!10 °C
then 30% aq NaOH, 0 °C
62% yield
O
 
2-Methyl-2-vinyloxirane.76  To a 3-neck 1 L round-bottom flask with mechanical stirrer 
was added H2O (300 mL).  The flask was cooled to 0 °C using an ice/water bath and 
stirred for 10 min.  Isoprene (81 mL, 0.81 mol, 1.00 equiv) was added and glass stoppers 
were attached to the side necks.  The biphasic mixture was stirred vigorously for 5 min at 
0 °C.  Finely powdered NBS (140.52 g, 0.790 mol, 0.975 equiv) was added portionwise 
through a side neck over 35 min to give a pale tan suspension.  The glass stopper was 
reattached to the side neck and the reaction was stirred at 0 °C for 2.5 h.  Subsequent 
warming of the reaction to 10 °C led to clarification of the reaction mixture.  If stirring 
was halted, a clear, colorless upper aqueous phase and a clear, pale yellow lower organic 
phase could be observed.  The reaction was cooled to 0 °C and stirred for 9 h.  Chilled, 
ice-cold 10 M aqueous NaOH (160 mL) was added to the reaction over 15 min through 
an addition funnel to give a turbid white biphasic mixture.  Internal temperature was 
maintained below 5 °C during addition.  The reaction was stirred at 0 °C for 15 min.  If 
stirring was halted, a clear, colorless organic upper phase could be observed.  The phases 
were separated and the organic phase was washed with H2O (2 x 15 mL) and brine (2 x 
15 mL).  The organic phase was transferred to a 100 mL round-bottom flask and the 
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crude product was distilled (80 °C, 760 mmHg) to yield the first portion of 2-methyl-2-
vinyloxirane (34.66 g). 
A second portion of product was isolated by extraction of the aqueous phase with 
Et2O (3 x 40 mL).  The combined organic phases were washed with H2O (2 x 15 mL) and 
brine (2 x 15 mL), dried over MgSO4, filtered into a 200 mL pear-shaped flask.  The flask 
was fitted with a short-path distillation head and immersed in a 45 °C oil bath to remove 
Et2O by distillation.  Once Et2O was removed, the crude product was distilled (80 °C, 760 
mmHg) to yield the second portion of 2-methyl-2-vinyloxirane (7.24 g).  The portions of 
2-methyl-2-vinyloxirane (41.90 g, 0.498 mol, 62% yield) were combined to give a clear, 
colorless liquid.  The spectral data match data for commercially available material. 
 
O
1. LiHMDS, Et2O
     23 °C!reflux
2. CDI, CH2Cl2
     0!23 °C
      50% yield
      two steps
N O
O
N
339
 
Carbamate 339.  Isoprenol was prepared according to the method of Isobe76 and 
converted to carbamate 339 using the general procedure of Sarpong.50 
To a 500 mL 3-neck round-bottom flask equipped with a magnetic stir bar, rubber 
septum, and two glass stoppers was added LiHMDS (24.09 g, 143.97 mmol, 1.20 equiv) 
in a N2-filled glove box.  The flask was sealed with a rubber septum and removed from 
the glove box.  One of the glass stoppers was replaced with a reflux condenser connected 
to a N2 inlet.  The flask was cooled to –78 °C using an acetone/CO2(s) bath.  Et2O (160 
mL) was added and the suspension was stirred vigorously for 5 min.  The cooling bath 
was removed and the flask was allowed to warm to 23 °C, giving a white suspension.  A 
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solution of 2-methyl-2-vinyloxirane (10.0 g, 119.97 mmol, 1.00 equiv) in Et2O (50 mL) 
in a 100 mL conical flask was added to the reaction by positive pressure cannulation, 
leading to the formation of a turbid pale yellow solution.  The reaction was heated to 
reflux in a 45 °C oil bath.  After 22 h of stirring, the reaction was cooled to 0 °C and 
stirred for 10 min.  Chilled, ice-cold 2 M aqueous HCl (80 mL) was added and the 
reaction was stirred vigorously for 1 h.  The phases were separated and the aqueous phase 
was extracted with Et2O (3 x 20 mL).  The combined organic phases were dried over 
MgSO4, filtered, and concentrated under reduced pressure (150 mmHg) in a 0 °C 
ice/water bath to a volume of ca. 50 mL.  The solution of volatile isoprenol was used 
directly in the next step. 
To a 1 L round-bottom flask with a magnetic stir bar were added CDI (29.7 g, 179.96 
mmol, 1.50 equiv) and CH2Cl2 (400 mL).  An addition funnel was attached and the 
apparatus was connected to a N2 inlet.  The flask was cooled to 0 °C and stirred for 10 
min.  The solution of crude isoprenol in Et2O (50 mL) was transferred to the addition 
funnel and added dropwise with vigorous stirring at 0 °C.  The cooling bath was removed 
and the flask was allowed to warm to 23 °C.  After 1 h of stirring, the reaction was 
quickly washed with H2O (2 x 100 mL) and brine (2 x 100 mL).  The aqueous phases 
were extracted with CH2Cl2 (3 x 50 mL).  The combined organic phases were dried over 
MgSO4, filtered, and concentrated under reduced pressure.  The crude product was 
purified by flash column chromatography (SiO2, 8 x 15 cm, 20%→30%→50% EtOAc in 
hexanes) to afford carbamate 339 (10.74 g, 60.26 mmol, 50% yield over two steps) as a 
pale yellow oil which solidifies upon storage in a –25 °C freezer.  (Note: The reagent is 
moisture sensitive.  Storage under N2 in a sealed container in a –25 °C freezer is 
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recommended for maintaining reagent quality, but the reagent is typically used shortly 
after generation.);  Rf = 0.15 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 8.12 
(s, 1H), 7.45–7.37 (m, 1H), 7.09–7.02 (m, 1H), 6.40 (dd, J = 17.8, 11.1 Hz, 1H), 5.38–
5.34 (m, 1H), 5.34–5.31 (m, 1H), 5.30 (d, J = 17.9 Hz, 1H), 5.20 (d, J = 11.2 Hz, 1H), 
5.06 (s, 2H);  13C NMR (125 MHz, CDCl3) δ 148.5, 139.2, 137.1, 135.6, 130.8, 119.9, 
117.1, 115.4, 67.2;  IR (Neat Film NaCl) 3132, 3091, 3010, 2952, 2929, 2855, 1763, 
1599, 1526, 1472, 1403, 1390, 1318, 1290, 1281, 1240, 1172, 1095, 1058, 1007, 916, 
897, 835, 768, 746 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C9H11N2O2 [M+H]+: 
178.0815; found 178.0818. 
 
O
i-BuO
338
O
O
O
i-BuO
147
LiHMDS, THF, –78 °C
then CH3I, –78!23 °C
84% yield
N O
O
N 339
 
β-Ketoester 338.  To a 1 L round-bottom flask with a magnetic stir bar was added 
LiHMDS (25.83 g, 154.40 mmol, 3.00 equiv) in a N2-filled glove box.  The flask was 
sealed with a rubber septum and removed from the glove box, connected to a N2 inlet, 
and cooled to –78 °C using an acetone/CO2(s) bath.  THF (360 mL) was added and the 
suspension was stirred vigorously for 5 min.  The cooling bath was removed and the flask 
was allowed to warm until the solids completely dissolved.  The pale tan solution was 
cooled to –78 °C.  A solution of vinylogous ester 14742 (9.38 g, 51.47 mmol, 1.00 equiv) 
in THF (80 mL) in a 100 mL conical flask was added to the reaction dropwise over 1 h 
using positive pressure cannulation.  The orange solution was stirred at –78 °C for 30 
min.  A solution of carbamate 339 (11.46 g, 64.33 mmol, 1.25 equiv) in THF (25 mL) in 
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a 50 mL conical flask was added to the reaction dropwise over 15 min using positive 
pressure cannulation.  The orange solution was stirred at –78 °C for 2.5 h.  CH3I (38.4 
mL, 617.58 mmol, 12.00 equiv) was added dropwise.  The cooling bath was allowed to 
expire and the reaction warmed to 23 °C over 7 h.  After 13 h of stirring, the reaction was 
quenched with 50% sat. aqueous NH4Cl (190 mL) and Et3N (7.5 mL).  The biphasic 
mixture was stirred vigorously for 12 h.  The phases were separated and the organic 
phase was washed with brine (2 x 200 mL).  The combined aqueous phases were washed 
with EtOAc (3 x 150 mL).  The combined organic phases were dried over Na2SO4, 
filtered, and concentrated under reduced pressure.  The oil was taken up in Et2O, leading 
to the precipitation of solids.  The suspension was filtered through a silica gel plug (3 x 5 
cm), eluting with Et2O and concentrated under reduced pressure.  The crude oil was 
purified by flash column chromatography (SiO2, 8 x 32 cm, 3%→10%→20%→40% 
EtOAc in hexanes) to afford β-ketoester 338 (13.22 g, 43.15 mmol, 84% yield) as a pale 
yellow oil;  Rf = 0.54 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 6.29 (dd, J = 
17.7, 11.1 Hz, 1H), 5.37–5.31 (m, 1H), 5.22–5.18 (m, 1H), 5.16 (d, J = 18.2 Hz, 1H), 
5.16–5.12 (m, 1H), 5.06 (d, J = 11.1 Hz, 1H), 4.77 (d, J = 13.3 Hz, 1H), 4.69 (d, J = 13.3 
Hz, 1H), 3.44 (dd, J = 9.3, 6.6 Hz, 1H), 3.42 (dd, J = 9.3, 6.5 Hz, 1H), 2.53 (ddd, J = 
17.8, 9.9, 3.8 Hz, 1H), 2.43–2.28 (m, 2H), 2.00–1.87 (m, 2H), 1.81–1.68 (m, 1H), 1.65 
(ddd, J = 14.4, 7.3, 4.3 Hz, 1H), 1.39 (s, 3H), 0.90 (d, J = 6.7 Hz, 6H);  13C NMR (125 
MHz, CDCl3) δ 199.0, 173.9, 173.5, 140.4, 136.1, 118.4, 114.8, 105.1, 74.8, 64.3, 59.1, 
34.4, 33.9, 27.9, 24.2, 21.3, 19.3;  IR (Neat Film NaCl) 3090, 2859, 2935, 2874, 1735, 
1653, 1649, 1613, 1471, 1456, 1424, 1401, 1384, 1309, 1275, 1233, 1197, 1169, 1114, 
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1084, 1032, 994, 969, 910, 869, 768 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for 
C17H27O2 [M+H]+: 307.1904; found 307.1899. 
 
O
i-BuO
337
(S)-t-Bu-PHOX (13) (6.25 mol %)
Pd2(pmdba)3 (2.5 mol %)
PhCH3, 30 °C
90–91% yield
94–95% ee
O
i-BuO
338
O
O
NPh2P
O
t-Bu
 
Vinylogous ester 337 (2 mmol scale).  A 20 mL scintillation vial was loaded with β-
ketoester 338 (527 mg, 1.72 mmol, 1.00 equiv).  A separate 20 mL scintillation vial was 
loaded with a magnetic stir bar, Pd2(pmdba)355 (47.2 mg, 0.043 mmol, 2.5 mol %), and 
(S)-t-Bu-PHOX53 (41.7 mg, 0.108 mmol, 6.25 mol %).  The two vials and a teflon-lined 
hard cap were placed in a glove box antechamber, which was evacuated/backfilled with 
N2 (3 cycles, 5 min evacuation per cycle) before the items were transferred into the glove 
box.  Toluene (10 mL) was added to the vial containing Pd2(pmdba)3 and (S)-t-Bu-
PHOX.  The vial was capped and the reaction was stirred for 30 min in a 30 °C heating 
block.  During this time, the reaction changed from a deep purple-black suspension to a 
deep red-orange color.  β-Ketoester 338 was dissolved in toluene (7 mL) and added to the 
catalyst solution dropwise, causing the solution to turn olive green.  The reaction was 
sealed with a teflon-lined hard cap and stirred at 30 °C.  After 16.5 h of stirring, the 
reaction became a deep red-orange color.  The capped vial was removed from the glove 
box and the reaction was concentrated under reduced pressure.  The crude oil was 
purified by flash column chromatography (SiO2, 3 x 25 cm, 40:1→20:1→15:1 
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hexanes:EtOAc) to afford vinylogous ester 337 (143.9 mg, 1.57 mmol, 91% yield, 94.7% 
ee) as a pale yellow oil.  
 
Vinylogous ester 337 (40 mmol scale).  To a 1 L round-bottom flask with a magnetic stir 
bar were added Pd2(pmdba)355 (1.18 g, 1.08 mmol, 2.5 mol %), (S)-t-Bu-PHOX53 (1.04 g, 
2.70 mmol, 6.25 mol %), and toluene (430 mL) in a N2-filled glove box.  The flask was 
sealed with a rubber septum, removed from the glove box, connected to a N2 inlet, and 
immersed in a 30 °C oil bath.  The deep purple-black suspension gradually became 
became a deep red-orange solution after 50 min of stirring.  β-Ketoester 338 (13.22 g, 
43.14 mmol, 1.00 equiv) in a 100 mL conical flask was freeze-pump-thawed using an 
acetone/CO2(s) bath (3 cycles, 5 min evacuation per cycle), dissolved in toluene (30 mL), 
and added to the reaction dropwise using positive pressure cannulation.  The solution 
became a deep olive-green solution.  After 33 h of stirring, the reaction was a deep red-
orange solution.  The reaction was concentrated under reduced pressure and the crude oil 
was purified by flash column chromatography (SiO2, 8 x 32 cm, 3%→5%→10% EtOAc 
in hexanes) to afford vinylogous ester 337 (10.20 g, 38.87 mmol, 90% yield, 95.3% ee) 
as a pale tan oil.  
 
Vinylogous ester 337:  Rf = 0.35 (10:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 
6.32 (dd, J = 17.5, 10.9 Hz, 1H), 5.29 (s, 1H), 5.25 (d, J = 17.5 Hz, 1H), 5.17–5.11 (m, 
1H), 5.01 (d, J = 10.9 Hz, 1H), 4.93–4.87 (m, 1H), 3.48 (dd, J = 9.3, 6.6 Hz, 1H), 3.44 
(dd, J = 9.3, 6.4 Hz, 1H), 2.56 (d, J = 13.7 Hz, 1H), 2.50–2.35 (m, 2H), 2.42 (d, J = 13.8 
Hz, 1H), 1.96 (app. sept, J = 6.7 Hz, 1H), 1.88–1.74 (m, 2H), 1.74–1.61 (m, 1H), 1.54 
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(ddd, J = 14.5, 8.9, 1.3 Hz, 1H), 1.13 (s, 3H), 0.93 (d, J = 6.7 Hz, 6H);  13C NMR (125 
MHz, CDCl3) δ 207.0, 171.0, 143.1, 140.3, 119.2, 113.9, 105.4, 74.4, 52.2, 41.1, 36.2, 
35.1, 28.0, 26.3, 19.7, 19.3, 19.3;  IR (Neat Film NaCl) 3085, 2959, 2934, 2873, 1811, 
1722, 1699, 1614, 1470, 1464, 1455, 1423, 1402, 1387, 1373, 1317, 1260, 1212, 1187, 
1174, 1110, 1083, 1019, 992, 969, 951, 898, 887, 851, 822 cm–1;  HRMS (MM: ESI-
APCI+) m/z calc'd for C17H27O2 [M+H]+: 263.2006; found 263.2006;  [α]D26.0 –73.44 (c 
0.92, CHCl3, 94.7% ee);  HPLC conditions: 2.0% IPA in hexanes, 1.0 mL/min, OD-H 
column, tR (min): major = 6.41, minor = 7.53. 
 
(Note: Pd2(pmdba)3 is preferable to Pd2(dba)3 in this reaction for ease of separation of 
pmdba from the reaction products during purification.  The non-enantioselective reaction 
was carried out with Pd(PPh3)4115 (5 mol %) in toluene (0.1 M) at 30 °C or with 
Pd2(dba)3·CHCl3 (2.5 mol %) and dppe (6.25 mol %) in toluene (0.1 M) at 30 °C.) 
 
O O
+
O
i-BuO
LiAlH4, Et2O, 0 °C
then 10% aq HCl
96% yield 2% yield
337 365340
OH
 
β-Hydroxyketone 340 and Cycloheptenone 365.  A 1 L round-bottom flask with a 
magnetic stir bar was charged with LiAlH4 (862.6 mg, 22.97 mmol, 0.60 equiv) and 
evacuated/backfilled with N2 (3 cycles, 5 min evacuation per cycle).  Et2O (600 mL) was 
added and the gray suspension was cooled to 0 °C using an ice/water bath.  A solution of 
vinylogous ester 337 (10.05 g, 38.28 mmol, 1.00 equiv) in Et2O (80 mL) in a conical 100 
mL flask was added to the reaction dropwise over 20 min using positive pressure 
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cannulation.  The flask was washed with THF (2 x 10 mL) and washes were added to the 
reaction.  The gray suspension was stirred at 0 °C.  After 15 min of stirring, the reaction 
was quenched by slow dropwise addition of 10% aqueous HCl (59.4 mL).  Gas evolution 
was observed.  The reaction was stirred at 0 °C for 5 min and the phases were separated.  
The aqueous phase was extracted with Et2O (3 x 30 mL).  Combined organic phases were 
dried over Na2SO4, filtered, and concentrated under reduced pressure.  The crude oil was 
purified by flash column chromatography (SiO2, 3 x 25 cm, 10:1→3:1→2:1 
hexanes:EtOAc) to afford cycloheptenone 365 (174.9 mg, 0.919 mmol, 2% yield) as a 
pale yellow oil and β-hydroxyketone 340 (7.65 g, 36.73 mmol, 96% yield, 1.26:1 dr) as a 
pale tan oil.  (Note: Storage in a sealed container in a –25 °C freezer is recommended, but 
the compound is typically used shortly after generation.) 
 
β-Hydroxyketone 340:  Rf = 0.15 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) 
mixture of two overlapping diastereomers, see Figure A5.40;  13C NMR (125 MHz, 
CDCl3) mixture of two diastereomers: δ 214.0, 213.0, 143.4, 143.1, 140.7, 140.6, 119.5, 
119.3, 113.9, 113.9, 73.5, 72.1, 47.7, 46.8, 44.1, 43.9, 41.5, 41.4, 40.7, 38.8, 36.4, 36.0, 
22.1, 21.9, 19.2, 18.4;  IR (Neat Film NaCl) 3447, 3084, 2966, 2933, 2873, 1810, 1696, 
1628, 1590, 1465, 1457, 1400, 1351, 1321, 1252, 1166, 1113, 1064, 993, 899, 853, 802, 
759, 729 cm–1;  HRMS (APCI+) m/z calc'd for C13H18O [M–OH]+: 191.1430; found 
191.1426;  [α]D26.0 –30.27 (c 1.66, CHCl3, 94.7% ee). 
 
Cycloheptenone 365:  Rf = 0.60 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 
6.35 (ddd, J = 17.6, 10.9, 0.8 Hz, 1H), 6.05 (dd, J = 13.0, 1.0 Hz, 1H), 5.77 (d, J = 13.0 
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Hz, 1H), 5.23–5.20 (m, 1H), 5.20 (d, J = 17.5 Hz, 1H), 5.05 (dm, J = 10.9 Hz, 1H), 4.99–
4.94 (m, 1H), 2.66–2.49 (m, 2H), 2.38 (d, J = 13.6 Hz, 1H), 2.27 (dd, J = 13.6, 0.9 Hz, 
1H), 1.90–1.75 (m, 3H), 1.73–1.60 (m, 1H), 1.10 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 
204.8, 152.8, 142.3, 140.1, 128.0, 120.0, 114.3, 45.1, 43.3, 43.2, 39.0, 27.9, 18.4;  IR 
(Neat Film NaCl) 3087, 3008, 2962, 2930, 2869, 1811, 1707, 1658, 1591, 1457, 1400, 
1373, 1346, 1336, 1261, 1208, 1146, 1092, 1020, 900, 876, 801 cm–1;  HRMS (MM: ESI-
APCI+) m/z calc'd for C13H18O [M+H]+: 191.1430; found 191.1428;  [α]D25.0 –5.31 (c 
1.20, CHCl3, 94.7% ee). 
 
336
O
HO
O
340
LiOH, TFE
THF, 60 °C
95–96% yield
 
Acylcyclopentene 336 (0.4 mmol scale).  β-Hydroxyketone 340 (89.3 mg, 0.428 mmol, 
1.00 equiv) was dissolved in THF (4.3 mL) in a 20 mL scintillation vial with a magnetic 
stir bar.  The solution was treated with 2,2,2-trifluoroethanol (46.9 µL, 0.643 mmol, 1.50 
equiv) and anhydrous LiOH (15.4 mg, 0.643 mmol, 1.50 equiv).  The headspace of the 
vial was purged with Ar.  The vial was sealed with a teflon-lined hard cap and inserted 
into a 60 °C heating block.  After 14 h of stirring, the fine suspension was allowed to cool 
to ambient temperature, diluted with Et2O (4 mL), dried over Na2SO4 with stirring for 30 
min, filtered, and carefully concentrated under reduced pressure (25 mmHg) in a 0 °C 
ice/water bath.  The crude product was purified using flash column chromatography 
(SiO2, 2 x 25 cm, 15:1 hexanes:Et2O) to afford acylcyclopentene 336 (77.1 mg, 0.405 
mmol, 95% yield) as a fragrant pale tan oil. 
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Acylcyclopentene 336 (30 mmol scale).  β-Hydroxyketone 340 (6.46 g, 31.0 mmol, 1.00 
equiv) was dissolved in THF (310 mL) in a 1 L round-bottom flask with a magnetic stir 
bar.  The solution was treated with 2,2,2-trifluoroethanol (3.39 mL, 46.5 mmol, 1.50 
equiv) and anhydrous LiOH (1.116 g, 46.53 mmol, 1.50 equiv).  The flask was fitted with 
a reflux condenser, purged with N2, and immersed in a 60 °C oil bath.  After 34 h of 
stirring, the fine suspension was allowed to cool to ambient temperature, diluted with 
Et2O (300 mL), dried over Na2SO4 with stirring for 30 min, filtered, and carefully 
concentrated under reduced pressure (25 mmHg) in a 0 °C ice/water bath.  The crude 
product was purified using flash column chromatography (SiO2, 5 x 25 cm, 15:1 
hexanes:Et2O) to afford acylcyclopentene 336 (5.703 g, 29.97 mmol, 96% yield) as a 
fragrant pale tan oil. 
 
Rf = 0.61 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 6.45 (app. t, J = 1.8 Hz, 
1H), 6.35 (ddm, J = 17.6, 10.8 Hz, 1H), 5.16–5.12 (m, 1H), 5.16 (d, J = 17.8 Hz, 1H), 
5.04 (dm, J = 10.9 Hz, 1H), 4.97–4.91 (m, 1H), 2.55–2.43 (m, 2H), 2.38 (d, J = 13.5 Hz, 
1H), 2.32 (dd, J = 13.6, 0.9 Hz, 1H), 2.23 (s, 3H), 1.91 (ddd, J = 12.9, 7.6, 6.8 Hz, 1H), 
1.65 (ddd, J = 12.9, 7.8, 6.8 Hz, 1H), 1.10 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 197.5, 
152.7, 143.4, 142.9, 140.1, 119.3, 114.0, 50.3, 41.5, 37.0, 29.4, 26.7, 26.2;  1H NMR (500 
MHz, C6D6) δ 6.25 (ddd, J = 17.6, 10.8, 0.8 Hz, 1H), 6.07 (app. t, J = 1.8 Hz, 1H), 5.03 
(d, J = 17.3 Hz, 1H), 5.03–4.99 (m, 1H), 4.90 (dm, J = 10.9 Hz, 1H), 4.79–4.75 (m, 1H), 
2.65–2.52 (m, 2H), 2.17 (d, J = 13.5 Hz, 1H), 2.07 (dd, J = 13.5, 0.8 Hz, 1H), 1.98 (s, 
3H), 1.69 (ddd, J = 12.8, 7.9, 6.8 Hz, 1H), 1.41 (ddd, J = 12.9, 7.9, 6.6 Hz, 1H), 0.90 (s, 
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3H);  13C NMR (125 MHz, C6D6) δ 195.3, 150.9, 143.8, 143.4, 140.4, 119.3, 114.0, 50.2, 
41.6, 37.2, 30.0, 26.4, 26.1;  IR (Neat Film NaCl) 3084, 2954, 2927, 2864, 1807, 1669, 
1617, 1591, 1457, 1437, 1424, 1377, 1366, 1307, 1267, 1227, 1200, 1160, 1092, 1043, 
1019, 992, 934, 898, 867, 806 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C13H19O 
[M+H]+: 191.1430; found 191.1427;  [α]D26.0 –63.18 (c 1.02, CHCl3, 94.7% ee). 
 
TBSOTf, Et3N 
CH2Cl2, 0!23 °C
95% yield
OTBS
µwaves, PhCH3
150 °C, 6 h
84% yield
O
336 335
H
H
OTBS
341  
Silyl Dienol Ether 335.  A 20 mL scintillation vial with a magnetic stir bar was charged 
with acylcyclopentene 336 (41.7 mg, 0.219 mmol, 1.00 equiv), sealed with a septum-
fitted screw cap, and connected to a N2 inlet.  The headspace of the vial was gently 
purged with N2 through a venting needle for 1 min.  CH2Cl2 (2.2 mL) was added and the 
reaction was cooled to 0 °C using an ice/water bath.  After 5 min of stirring, Et3N (122 
µL, 0.877 mmol, 4.00 equiv) was added dropwise.  After 2 min of stirring, TBSOTf116 
(101 µL, 0.438 mmol, 2.00 equiv) was added dropwise.  The formation of vapor was 
observed.  The clear, colorless solution was stirred at 0 °C for 20 min.  The reaction was 
diluted with CH2Cl2 (2.2 mL) and quenched by addition of ice-cold sat. aqueous NaHCO3 
(1.5 mL) and stirred for 5 min at 0 °C.  The phases were separated and the aqueous phase 
was extracted with CH2Cl2 (3 x 2 mL).  The combined organic phases were dried over 
Na2SO4, filtered, and concentrated under reduced pressure.  The residue was purified by 
flash column chromatography with deactivated silica gel (SiO2, 3 x 12 cm, deactivated 
with 1% Et3N in hexanes, 1% Et3N in hexanes→20% Et2O in hexanes eluent) to afford 
CHAPTER 3 – The Total Synthesis of Presilphiperfolanol Natural Products 630 
silyl dienol ether 335 (63.1 mg, 0.207 mmol, 95% yield) as a colorless oil.  (Note: Silyl 
dienol ether 335 appears to be sensitive to moisture.  The compound was stored as a 
solidified benzene solution under N2 in a –25 °C freezer.);  Rf = 0.73 (10:1 
hexanes:EtOAc);  1H NMR (500 MHz, C6D6) δ 6.35 (ddd, J = 17.5, 10.8, 0.8 Hz, 1H), 
6.06 (app. t, J = 1.8 Hz, 1H), 5.20 (dm, J = 17.5 Hz, 1H), 5.11–5.08 (m, 1H), 4.98 (dm, J 
= 10.9 Hz, 1H), 4.94–4.91 (m, 1H), 4.37–4.35 (m, 1H), 4.36–4.34 (m, 1H), 2.49–2.36 (m, 
2H), 2.31 (d, J = 13.4 Hz, 1H), 2.24 (dd, J = 13.4, 0.9 Hz, 1H), 1.87 (ddd, J = 12.6, 8.2, 
6.9 Hz, 1H), 1.59 (ddd, J = 12.6, 8.0, 5.9 Hz, 1H), 1.05 (s, 3H), 1.02 (s, 9H), 0.18 (s, 3H), 
0.17 (s, 3H);  13C NMR (125 MHz, C6D6) δ 154.7, 144.5, 140.6, 139.1, 138.0, 118.8, 
114.0, 92.8, 49.3, 42.4, 38.2, 31.4, 26.9, 26.1, 18.5, –4.4, –4.5;  IR (Neat Film NaCl) 
3119, 3084, 2956, 2928, 2857, 1802, 1631, 1589, 1472, 1462, 1389, 1373, 1361, 1315, 
1284, 1256, 1225, 1210, 1164, 11121, 1092, 1063, 1016, 1005, 991, 939, 895, 865, 838, 
830, 812, 779 cm–1;  HRMS (FAB+) m/z calc'd for C19H33OSi [M+H]+: 305.2301; found 
305.2287;  [α]D25.0 –32.17 (c 1.02, CH2Cl2, 94.9% ee). 
 
Silyl Enol Ether 341.  To a 5 mL microwave vial with magnetic stir bar under N2 were 
added silyl dienol ether 335 (88.3 mg, 0.290 mmol, 1.00 equiv) and toluene (4 mL).  The 
reaction was sealed with a microwave crimp cap and subjected to microwave irradiation 
in a Biotage Initiator microwave reactor (temperature: 150 °C, sensitivity: low) with a 
gradual temperature increase over 10 min (10 °C increments).  After 6 h of stirring, the 
vial was cooled to ambient temperature and uncapped.  The reaction was concentrated 
under reduced pressure.  The residue was purified by flash column chromatography with 
deactivated silica gel (SiO2, 3 x 12 cm, deactivated with 1% Et3N in hexanes, 1% Et3N in 
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hexanes→20% Et2O in hexanes eluent) to afford silyl enol ether 341 (74.6 mg, 0.245 
mmol, 84% yield) as a colorless oil;  Rf = 0.60 (1% Et2O in hexanes);  1H NMR (500 
MHz, C6D6) δ 4.99–4.95 (m, 1H), 4.91–4.86 (m, 1H), 2.75–2.70 (m, 1H), 2.70–2.62 (m, 
1H), 2.32–2.09 (m, 4H), 2.01 (dm, J = 16.8 Hz, 1H), 1.97–1.83 (m, 2H), 1.83–1.71 (m, 
1H), 1.61 (ddd, J = 13.1, 9.2, 3.9 Hz, 1H), 1.48 (ddd, J = 12.9, 11.3, 6.7 Hz, 1H), 1.02 (s, 
3H), 1.01 (s, 9H), 0.14 (s, 3H), 0.11 (s, 3H);  13C NMR (125 MHz, C6D6) δ 154.4, 143.0, 
120.7, 106.1, 55.3, 47.2, 45.4, 40.3, 36.9, 26.1, 25.9, 25.9, 25.8, 24.1, 18.4, –3.5, –3.8;  
IR (Neat Film NaCl) 2928, 2859, 1696, 1653, 1472, 1461, 1378, 1356, 1285, 1257, 1215, 
1171, 1108, 1090, 1070, 1029, 1006, 978, 990, 959, 933, 890, 874, 834, 813, 777 cm–1;  
HRMS (EI+) m/z calc'd for C19H32OSi [M]+•: 304.2223; found 304.2209;  [α]D26.0 +114.41 
(c 1.06, CH2Cl2, 94.7% ee).  1H-NOESY-2D (500 MHz, C6D6) spectra were obtained for 
341 and selected NOE interactions are shown below. 
H
H
OTBS
341
NOE
 
 
TBAF, THF
96% yield
H
H
OTBS
341
H
H
O
342
H
 
Ketone 342.  To a 20 mL scintillation vial with magnetic stir bar and silyl enol ether 341 
(55.4 mg, 0.182 mmol, 1.00 equiv) was added THF (10 mL) to give a clear, colorless 
solution.  TBAF (1.0 M in THF, 364 µL, 0.364 mmol, 2.00 equiv) was added dropwise, 
leading to a pale tan solution.  After 20 min of stirring, the reaction was concentrated 
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under reduced pressure (25 mmHg) in a 0 °C ice/water bath.  The pale yellow residue 
was purified by flash column chromatography (SiO2, 3 x 12 cm, 2%→5%→10%→20% 
Et2O in hexanes) to afford ketone 342 (36.2 mg, 0.176 mmol, 96% yield) as a colorless 
oil;  Rf = 0.30 (10:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 4.93–4.89 (m, 1H), 
4.80–4.76 (m, 1H), 2.89–2.79 (m, 1H), 2.70 (ddd, J = 9.8, 9.8, 8.7 Hz, 1H), 2.51 (ddd, J = 
16.6, 7.8, 7.8 Hz, 1H), 2.43 (dd, J = 9.6, 9.6 Hz, 1H), 2.29 (ddd, J = 16.2, 2.9, 1.9 Hz, 
1H), 2.24 (ddd, J = 16.1, 1.7, 1.7 Hz, 1H), 2.14 (ddd, J = 16.8, 5.8, 5.8 Hz, 1H), 2.06 (dd, 
J = 5.6, 5.6 Hz, 1H), 2.04 (dd, J = 5.6, 5.6 Hz, 1H), 1.87 (dd, J = 8.5, 8.5 Hz, 1H), 1.86 
(dd, J = 8.5, 8.5 Hz, 1H), 1.63 (ddd, J = 12.6, 5.4, 5.4 Hz, 1H), 1.48 (ddd, J = 12.7, 8.5, 
8.5 Hz, 1H), 1.16 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 215.3, 154.7, 105.2, 55.6, 52.1, 
50.0, 47.8, 40.8, 40.8, 35.4, 30.5, 28.3, 24.9;  IR (Neat Film NaCl) 3071, 2925, 2861, 
1708, 1660, 1456, 1436, 1408, 1375, 1341, 1319, 1293, 1260, 1245, 1201, 1189, 1146, 
1096, 1074, 1042, 968, 882, 802 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C13H19O 
[M+H]+: 191.1430; found 191.1429;  [α]D25.0 +79.03 (c 1.01, CHCl3, 94.9% ee).  1H-
NOESY-2D (500 MHz, CDCl3) spectra were obtained for 342 and selected NOE 
interactions are shown below. 
H
H
O
342
H NOE
NOE
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PPTS (10 mol %)
PhH, reflux
Dean–Stark
94% yield
336
O
345
OO
HO OH
 
Ketal 345.  To a 250 mL round-bottom flask with a magnetic stir bar were added 
acylcyclopentene 336 (2.08 g, 11.0 mmol, 1.00 equiv), benzene (110 mL), neopentyl 
glycol (6.85 g, 65.74 mmol, 6.00 equiv), and PPTS (137.7 mg, 0.548 mmol, 0.05 equiv).  
A Dean–Stark trap and reflux condenser connected to a N2 inlet was attached and the 
flask was immersed in a 100 °C oil bath.  The suspension gradually became a clear, 
colorless solution.  After 4.5 h of stirring, the reaction was cooled to 0 °C using an 
ice/water bath and poured into 50% sat. aqueous NaHCO3 (25 mL) and stirred for 5 min.  
The phases were separated and the organic phase was washed with brine (3 x 40 mL).  
The combined aqueous phases were extracted with EtOAc (3 x 50 mL).  The combined 
organic phases were dried over Na2SO4, filtered, and concentrated under reduced pressure 
to give a white semisolid.  The crude product was purified using flash column 
chromatography (SiO2, 8 x 20 cm, 1%→2%→5% EtOAc in hexanes) to afford ketal 345 
(2.84 g, 10.3 mmol, 94% yield) as a pale tan oil;  Rf = 0.65 (10:1 hexanes:EtOAc);  1H 
NMR (500 MHz, CDCl3) δ 6.38 (dd, J = 17.4, 11.1 Hz, 1H), 5.54 (app. t, J = 1.9 Hz, 1H), 
5.24 (d, J = 17.5 Hz, 1H), 5.16–5.13 (m, 1H), 5.05 (d, J = 10.7 Hz, 1H), 5.00–4.93 (m, 
1H), 3.58 (d, J = 10.9 Hz, 1H), 3.50 (d, J = 11.0 Hz, 1H), 3.35–3.26 (m, 2H), 2.35 (d, J = 
13.5 Hz, 1H), 2.33 (d, J = 13.5 Hz, 1H), 2.31–2.19 (m, 2H), 1.95 (ddd, J = 12.7, 8.4, 6.6 
Hz, 1H), 1.65 (ddd, J = 12.7, 8.2, 5.6 Hz, 1H), 1.39 (s, 3H), 1.16 (s, 3H), 1.08 (s, 3H), 
0.68 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 144.3, 140.6, 140.4, 138.7, 118.7, 113.9, 
CHAPTER 3 – The Total Synthesis of Presilphiperfolanol Natural Products 634 
98.8, 71.8, 71.8, 49.5, 41.9, 37.2, 31.1, 29.8, 27.6, 27.6, 22.9, 22.2;  IR (Neat Film NaCl) 
3084, 2951, 2865, 1631, 1591, 1472, 1458, 1395, 1369, 1352, 1319, 1298, 1257, 1240, 
1180, 1117, 1083, 1040, 1014, 991, 949, 895, 862, 806, 793 cm–1;  HRMS (MM: ESI-
APCI+) m/z calc'd for C18H29O2 [M+H]+: 277.2162; found 277.2169;  [α]D25.0 –6.24 (c 
0.950, CHCl3, 94.9% ee). 
 
entry metal complex (mol %) ligand or additive (mol %) solvent yield (%)c
89
89
57
Ni(cod)2 (5%) PhCH3
60
Cy-Johnphos (348) (5%) 50
14
Ni(cod)2 (10%) PhCH3
–– 0
< 5
Pd(PPh3)4 (5%) PhH
Ni(cod)2 (10%)
Ni(cod)2 (5%)
Ni(cod)2 (5%)
Ni(cod)2 (5%)
Pd(Pt-Bu3)2 (5%) ––
PhCH3
PhCH3
PhCH3
PhCH3
PhH
a  Conditions: 1,3-Diene (1.0 equiv), pinacolborane (1.50 equiv), metal complex (x mol %), additive (2x mol %) in solvent 
(0.15 M) at indicated 23 °C in a N2-filled glove box. b Conditions: 1,3-Diene (1.0 equiv), pinacolborane (1.05 equiv),
metal complex (x mol %), ligand (x mol %) in solvent (0.1 M) at 23 °C in a N2-filled glove box. c Combined isolated yield
of 346 and 347. d Ratio of linear : branched allylic alcohols 346 and 347, determined by relative integration by 1H NMR.
5b
4b
6b
3b
9b
10b
7b
8b
time (h)
52
9.5
6.5
9.5
6.5
6.5
41
41
HBPin, metal complex
ligand, additive, solvent, 23 °C
then 3 M aq NaOH
H2O2, THF, 0!23 °C
OO OO
OH
OO
HO
+
345
l : bd
3.0 : 1
3.2 : 1
8.3 : 1
9.0 : 1
3.1 : 1
2.8 : 1
n.d.
n.d.
PCy3 (5%)
PCy3 (10%)
Pt-Bu3 (5%)
Pt-Bu3 (10%)
P(NMe2)3 (5%)
PCy2
Cy-Johnphos
(348)
NN
Fe
Cl Cl
CH2Cl2 •
Fe complex 349
350
N
Li
0Fe complex 349 (8%) Mg powder (16%) Et2O1a 42 n.d.
62Fe complex 349 (4%) aryllithium 350 (8%) Et2O2a 10 1.1 : 1
346
(linear)
347
(branched)
 
Ni- and Pd-catalyzed 1,4-Hydroboration Screening Procedure (0.1 mmol scale, Table 
3.1, entries 1–8).  To a 2 dram vial with magnetic stir bar were added metal source (20–
100 mM solution of Ni87 or Pd85 source in solvent, x mol %) and ligand (20–100 mM 
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solution of ligand in solvent, x mol %) in a N2-filled glove box.  Additional solvent was 
added to bring the reaction concentration to 0.10 M relative to substrate.  The reaction 
was stirred for 5 min at 23 °C.  Pinacolborane (13.8 µL, 0.0950 mmol, 1.05 equiv) was 
added and the reaction was stirred for an additional 5 min.  Diene substrate 345 (25.0 mg, 
0.0904 mmol, 1.00 equiv) was added and the reaction was capped with a teflon-lined 
hard cap.  Reaction progress was monitored by TLC.  Once the reaction was complete, 
the reaction was diluted with an equal volume of THF relative to reaction solvent.  The 
vial was capped, removed from the glove box, and cooled to 0 °C using an ice/water bath.  
The reaction was quenched by dropwise addition of 3 M aqueous NaOH (0.54 mL) and 
30% wt. aqueous H2O2 (0.43 mL), stirred at 0 °C for 5 min, and then warmed to 23 °C.  
Once the oxidation was complete, the reaction was cooled to 0 °C, treated with sat. 
aqueous Na2S2O3 (0.54 mL), stirred for 5 min at 0 °C, and then warmed to 23 °C.  The 
phases were separated and the aqueous phase was extracted with EtOAc (3 x 2 mL).  The 
combined organic phases were washed with brine, dried over Na2SO4, filtered, and 
concentrated under reduced pressure.  The residue was purified by flash column 
chromatography (SiO2, 2 x 25 cm, 6:1→4:1→2:1 hexanes:EtOAc) to afford branched 
allylic alcohol 347 and linear allylic alcohol 346.  The ratio of products was analyzed by 
1H NMR (300 or 500 MHz, C6D6) by comparing the relative integrations of the peaks 
corresponding to linear isomer 346 (δ 5.39 (t, J = 6.6 Hz, 1H)) and branched isomer 347 
(δ 5.29 (q, J = 6.9 Hz, 1H)).  Alternatively, the ratio of allylborane intermediates can be 
analyzed by 1H NMR (300 or 500 MHz, C6D6) by comparing the relative integrations of 
the peaks corresponding to the linear allylborane isomer (δ 5.53 (br t, J = 7.4 Hz, 1H)) 
and the branched allylborane isomer (δ 5.32 (br q, J = 6.4 Hz, 1H)). 
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Fe-catalyzed 1,4-Hydroboration Screening Procedure (0.1 mmol scale, Table 3.1, 
entries 9–10).  To a 2 dram vial with magnetic stir bar were added diene substrate 345 
(25.0 mg, 0.0904 mmol, 1.00 equiv) and FeCl2(py-imine) complex 34986 (x mol %).  Et2O 
(0.6 mL) was added, followed by additive (2x mol %) in a N2-filled glove box.  Finely 
divided Mg powder86a was added as a solid and aryllithium 35086b was added as a solution 
in THF (1.0 M).  The reaction was stirred for 5 min at 23 °C.  Pinacolborane (19.7 µL, 
0.136 mmol, 1.50 equiv) was added and the reaction was capped with a teflon-lined hard 
cap.  Reaction progress was monitored by TLC.  Once the reaction was complete, the 
reaction was diluted with an equal volume of THF relative to reaction solvent.  The vial 
was capped, removed from the glove box, and cooled to 0 °C using an ice/water bath.  
The reaction was quenched by dropwise addition of 3 M aqueous NaOH (0.54 mL) and 
30% wt. aqueous H2O2 (0.43 mL), stirred at 0 °C for 5 min, and then warmed to 23 °C.  
Once the oxidation was complete, the reaction was cooled to 0 °C, treated with sat. 
aqueous Na2S2O3 (0.54 mL), stirred for 5 min at 0 °C, and then warmed to 23 °C.  The 
phases were separated and the aqueous phase was extracted with EtOAc (3 x 2 mL).  The 
combined organic phases were washed with brine, dried over Na2SO4, filtered, and 
concentrated under reduced pressure.  The residue was purified by flash column 
chromatography (SiO2, 2 x 25 cm, 6:1→4:1→2:1 hexanes:EtOAc) to afford branched 
allylic alcohol 347 and linear allylic alcohol 346.  The ratio of products was analyzed by 
1H NMR (300 or 500 MHz, C6D6) by comparing the relative integrations of the peaks 
corresponding to linear isomer 346 (δ 5.39 (t, J = 6.6 Hz, 1H)) and branched isomer 347 
(δ 5.29 (q, J = 6.9 Hz, 1H)).  Alternatively, the ratio of allylborane intermediates can be 
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analyzed by 1H NMR (300 or 500 MHz, C6D6) by comparing the relative integrations of 
the peaks corresponding to the linear allylborane isomer (δ 5.53 (br t, J = 7.4 Hz, 1H)) 
and the branched allylborane isomer (δ 5.32 (br q, J = 6.4 Hz, 1H)). 
 
(Note: Control reactions were performed with isoprene as substrate.  With a 
Ni(cod)2/PCy3 catalyst system, a  1.26:1 linear:branched ratio was observed.  With a Fe 
complex 349 as the catalyst system, the reported 10:1 linear:branched ratio was 
observed.86a  The C(4) quaternary stereocenter is likely responsible for the differences in 
regioselectivity in our case.) 
 
HBPin
Ni(cod)2 (x mol %)
PCy3 (x mol %)
PhCH3, 23 °C
then 3 M aq NaOH
H2O2, THF, 0!23 °C
OO OO
OH
OO
HO
63% yield 18% yield
+
345
5 mol % catalyst loading
69% yield 19% yield10 mol % catalyst loading
346
(linear)
347
(branched)
 
Linear Allylic Alcohol 346 and Branched Allylic Alcohol 347 (5 mol % catalyst 
loading).87  To a 250 mL round-bottom flask with magnetic stir bar were added Ni(cod)2 
(113.9 mg, 0.414 mmol, 5 mol %), PCy3 (116.1 mg, 0.414 mmol, 5 mol %), and toluene 
(25 mL) in a N2-filled glove box.  The pale orange solution was stirred for 5 min.  
Pinacolborane (1.26 mL, 8.69 mmol, 1.05 equiv) was added dropwise, causing the 
reaction to become a dark orange solution.  Diene 345 (2.29 g, 8.28 mmol, 1.00 equiv) in 
toluene (8 mL) was added, causing further darkening of the reaction to a red-orange 
solution.  The reaction was sealed with a rubber septum and stirred at 23 °C in the glove 
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box.  After 96 h of stirring, the reaction reverted to an orange color.  The reaction was 
diluted with toluene (33 mL) and THF (33 mL), sealed with a rubber septum, removed 
from the glove box, and connected to a N2 inlet.  The reaction was cooled to 0 °C using 
an ice/water bath and 3 M aqueous NaOH (52.2 mL) was added dropwise over 5 min.  
Chilled, ice cold 30% wt. aqueous H2O2 (39.4 mL) was added dropwise over 20 min, 
giving a yellow biphasic mixture.  The reaction was stirred at 0 °C until the oxidation was 
complete by TLC (5 min).  At 0 °C, sat. aqueous Na2S2O3 (52.2 mL) was added dropwise 
over 20 min, causing the biphasic mixture to become colorless.  The reaction was stirred 
at 0 °C for 15 min, warmed to 23 °C, and stirred for 15 min.  The phases were separated 
and the organic phase was washed with H2O (2 x 20 mL) and brine (2 x 20 mL).  The 
combined aqueous phases were extracted with EtOAc (3 x 30 mL).  The combined 
organic phases were dried over Na2SO4, filtered, and concentrated under reduced 
pressure.  The residue was purified by flash column chromatography (SiO2, 8 x 35 cm, 
10:1→8:1→6:1→4:1→2:1 hexanes:EtOAc) to afford branched allylic alcohol 347 (427.2 
mg, 1.45 mmol, 18% yield) as a yellow oil and linear allylic alcohol 346 (1.535 g, 5.212 
mmol, 63% yield) as a yellow oil. 
 
Linear Allylic Alcohol 346 and Branched Allylic Alcohol 347 (10 mol % catalyst 
loading).87  To a 1 L round-bottom flask with magnetic stir bar were added Ni(cod)2 (660 
mg, 2.40 mmol, 10 mol %), PCy3 (674 mg, 2.40 mmol, 10 mol %), and toluene (65 mL) 
in a N2-filled glove box.  The pale orange solution was stirred for 5 min.  Pinacolborane 
(3.66 mL, 25.2 mmol, 1.05 equiv) was added dropwise, causing the reaction to become a 
dark orange solution.  Diene 345 (6.64 g, 24.0 mmol, 1.00 equiv) in toluene (30 mL) was 
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added, causing further darkening of the reaction to a red-orange solution.  The reaction 
was sealed with a rubber septum and stirred at 23 °C in the glove box.  After 48 h of 
stirring, the reaction reverted to an orange color.  The reaction was diluted with toluene 
(95 mL) and THF (95 mL), sealed with a rubber septum, removed from the glove box, 
and connected to a N2 inlet.  The reaction was cooled to 0 °C using an ice/water bath and 
3 M aqueous NaOH (153 mL) was added dropwise over 5 min.  Chilled, ice cold 30% wt. 
aqueous H2O2 (114 mL) was added dropwise over 45 min, giving a yellow biphasic 
mixture.  The reaction was stirred at 0 °C until the oxidation was complete by TLC (5 
min).  At 0 °C, sat. aqueous Na2S2O3 (153 mL) was added dropwise over 1 h, causing the 
biphasic mixture to become colorless.  The reaction was stirred at 0 °C for 15 min, 
warmed to 23 °C, and stirred for 15 min.  The phases were separated and the organic 
phase was washed with H2O (2 x 50 mL) and brine (2 x 50 mL).  The combined aqueous 
phases were extracted with EtOAc (3 x 60 mL).  The combined organic phases were 
dried over Na2SO4, filtered, and concentrated under reduced pressure.  The residue was 
purified by flash column chromatography (SiO2, 8 x 35 cm, 10:1→8:1→6:1→4:1→2:1 
hexanes:EtOAc) to afford branched allylic alcohol 347 (1.358 g, 4.6133 mmol, 19% 
yield) as a yellow oil and linear allylic alcohol 346 (4.876 g, 16.562 mmol, 69% yield) as 
a yellow oil. 
 
Linear Allylic Alcohol 346:  Rf = 0.15 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, C6D6) 
δ 5.63 (app. t, J = 1.9 Hz, 1H), 5.39 (br t, J = 6.6 Hz, 1H), 4.00 (d, J = 6.6 Hz, 2H), 3.51 
(d, J = 11.0 Hz, 1H), 3.49 (d, J = 11.0 Hz, 1H), 3.30 (dd, J = 6.9, 2.4 Hz, 1H), 3.28 (dd, J 
= 6.9, 2.4 Hz, 1H), 2.42–2.31 (m, 2H), 2.05 (s, 2H), 1.87 (ddd, J = 12.6, 8.1, 6.8 Hz, 1H), 
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1.63–1.51 (m, 1H), 1.59 (s, 3H), 1.55 (br s, 3H), 1.16 (s, 3H), 1.01 (s, 3H), 0.50 (s, 3H);  
13C NMR (125 MHz, C6D6) δ 141.9, 138.7, 136.3, 128.7, 98.9, 71.7, 59.4, 51.2, 49.4, 
37.4, 31.5, 29.7, 27.5, 22.9, 22.2, 18.6;  IR (Neat Film NaCl) 3413, 3039, 2951, 2866, 
2737, 2962, 1726, 1663, 1471, 1454, 1395, 1369, 1352, 1319, 1297, 1254, 1240, 1179, 
1116, 1082, 1040, 1013, 950, 929, 911, 861, 808, 7793, 755 cm–1;  HRMS (MM: ESI-
APCI+) m/z calc'd for C18H29O3 [M]+•: 277.2162; found 277.2155;  [α]D25.0 –0.82 (c 0.84, 
CHCl3, 94.9% ee). 
 
Branched Allylic Alcohol 347:  Rf = 0.21 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, 
C6D6) δ 5.71 (app. t, J = 1.9 Hz, 1H), 5.29 (br q, J = 6.9 Hz, 1H), 4.05 (s, 2H), 3.52 (d, J 
= 10.9 Hz, 1H), 3.49 (d, J = 10.9 Hz, 1H), 3.35–3.25 (m, 2H), 2.44–2.33 (m, 2H), 2.29 
(d, J = 13.4 Hz, 1H), 2.18 (d, J = 13.3 Hz, 1H), 1.95 (ddd, J = 12.6, 7.7, 7.7 Hz, 1H), 
1.64–1.56 (m, 1H), 1.58 (s, 3H), 1.55 (d, J = 6.8 Hz, 3H), 1.13 (s, 3H), 1.05 (s, 3H), 0.53 
(s, 3H);  13C NMR (125 MHz, C6D6) δ 142.1, 138.6, 138.6, 125.7, 99.0, 71.7, 60.7, 49.6, 
46.5, 37.0, 31.5, 29.8, 27.6, 27.2, 22.9, 22.2, 13.4;  IR (Neat Film NaCl) 3435, 3036, 
2950, 2866, 2739, 2693, 1877, 1723, 1649, 1471, 1455, 1395, 1369, 1353, 1297, 1282, 
1255, 1240, 1178, 1139, 1116, 1082, 1039, 1013, 950, 929, 911, 860, 808, 793, 739 cm–1;  
HRMS (MM: ESI-APCI+) m/z calc'd for C18H29O3 [M]+•: 277.2162; found 277.2155;  
[α]D25.0 –6.27 (c 1.08, CHCl3, 94.9% ee). 
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ClP(O)(OEt)2, Et3N
DMAP (20 mol %)
CH2Cl2, 0!23 °C
84% yield
OO
OH
Zn(CH3)2
CuCN (10 mol %)
THF, –78!23 °C
(acid workup)
94% yield
O
OO
O P
OEt
O
EtO
306351346  
Allylic Phosphate 351.118 To a 300 mL round-bottom flask with a magnetic stir bar 
containing linear allylic alcohol 346 (1.522 g, 5.17 mmol, 1.00 equiv) in CH2Cl2 (103 
mL) under N2 at 0 °C (ice/water bath) were added Et3N (1.08 mL, 7.76 mmol, 1.5 equiv) 
and DMAP (126.3 mg, 1.03 mmol, 0.2 equiv).  The pale tan solution was stirred for 5 
min.  Diethylchlorophosphate (1.12 mL, 7.76 mmol, 1.50 equiv) was added dropwise and 
the reaction was stirred for 5 min.  The cooling bath was removed and the reaction was 
allowed to warm to 23 °C.  After 3 h of stirring, the reaction was quenched with sat. 
aqueous NH4Cl (50 mL).  The reaction was stirred for 5 min and the phases were 
separated.  The organic phase was washed with brine (20 mL).  The combined aqueous 
phases were extracted with CH2Cl2 (3 x 50 mL).  The combined organic phases were 
dried over Na2SO4, filtered, and concentrated under reduced pressure.  The residue was 
purified by flash column chromatography (SiO2, 5 x 25 cm, 30%→40%→50% EtOAc in 
hexanes) to afford allyl phosphate 351 (1.86 g mg, 4.32 mmol, 84% yield) as a pale tan 
oil;  Rf = 0.20 (2:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 5.56 (app. t, J = 1.9 
Hz, 1H), 5.40 (br t, J = 7.0 Hz, 1H), 4.56 (dd, J = 7.5, 7.5 Hz, 2H), 4.10 (dq, J = 7.9, 7.1 
Hz, 4H), 3.52 (dd, J = 11.1, 3.5 Hz, 2H), 3.33 (ddd, J = 11.1, 3.9, 2.5 Hz, 2H), 2.38–2.21 
(m, 2H), 2.17 (s, 2H), 1.90 (ddd, J = 12.7, 8.6, 6.5 Hz, 1H), 1.73 (br s, 3H), 1.64 (ddd, J = 
12.6, 8.4, 5.4 Hz, 1H), 1.40 (s, 3H), 1.33 (td, J = 7.1, 1.0 Hz, 6H), 1.16 (s, 3H), 1.05 (s, 
3H), 0.70 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 141.0, 140.7, 138.7, 122.8 (JC–P = 5.7 
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Hz), 98.7, 71.8 (JC–P = 5.3 Hz), 64.1 (JC–P = 5.7 Hz), 63.7 (JC–P = 5.8 Hz), 51.0, 49.2, 37.2, 
31.1, 29.8, 27.4, 27.2, 22.8, 22.3, 18.8, 16.3 (JC–P = 6.8 Hz);  IR (Neat Film NaCl) 2980, 
2951, 2867, 1660, 1473, 1457, 1395, 1369, 1277, 1262, 1180, 1116, 1100, 1082, 1035, 
1000, 911, 862, 807, 746 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C22H39O6PNa 
[M+Na]+: 453.2376; found 453.2385;  [α]D25.0 –3.77 (c 0.85, CHCl3, 94.9% ee). 
 
(Note: A small amount of ketal deprotection of the phosphorylated product may be 
observed during work-up.  The resulting acylcyclopentene can also be converted to gem-
dimethyl acylcyclopentene 306 smoothly and chemoselectively using the Cu-catalyzed 
allylic substitution reaction conditions below.) 
 
Acylcyclopentene 306.92  To a 250 mL Schlenk flask with Kontes teflon valve and 14/20 
joint with rubber septum were added a magnetic stir bar and CuCN (101 mg, 1.129 
mmol, 10 mol %) in a N2-filled glove box.  The flask was sealed and removed from the 
glove box.  A solution of allyl phosphate 351 (4.86 g, 11.29 mmol, 1.00 equiv) in THF 
(120 mL) in a 100 mL conical flask was transferred to the Schlenk flask by positive 
pressure cannulation.  Additional THF (30 mL) was added to the Schlenk flask.  The 
reaction was a pale tan solution with insoluble pale green solids.  The reaction was cooled 
to –78 °C using an acetone/CO2(s) bath and stirred for 15 min.  Zn(CH3)2 (1.0 M in 
heptanes, 33.9 mL, 33.9 mmol, 3.00 equiv) was added dropwise by syringe over 15 min.  
The reaction became a darker tan-grey solution with insoluble pale green solids.  The 
flask was sealed and cooling bath was allowed to slowly expire and reach 23 °C over 16 
h.  After an additional 48 h of stirring, the reaction was a black suspension.  The reaction 
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was cooled to –78 °C and stirred for 10 min.  The reaction was diluted with Et2O (100 
mL) and stirred for 15 min.  The reaction was quenched by slow dropwise addition of 
10% aqueous HCl (47 mL).  The –78 °C acetone/CO2(s) cooling bath was exchanged for 
a 0 °C ice/water bath and the reaction was stirred for 30 min.  The ice/water cooling bath 
was removed and the reaction was allowed to warm to 23 °C.  After 2 h of stirring, the 
majority of the metal salts were dissolved and TLC analysis indicated that the 
intermediate ketal had been converted to the corresponding acylcyclopentene.  The 
phases were separated and the organic phase was washed with H2O (30 mL) and sat. 
aqueous NaHCO3 (30 mL).  The combined aqueous phases were extracted with Et2O (3 x 
30 mL).  The combined organic phases were dried over Na2SO4, filtered, and 
concentrated under reduced pressure (25 mmHg) in a 0 °C ice/water bath.  The residue 
was purified by flash column chromatography (SiO2, 5 x 25 cm, 15:1 hexanes:Et2O) to 
afford acylcyclopentene 306 (2.218 g, 10.750 mmol, 95% yield) as a fragrant pale tan oil;  
Rf = 0.41 (10:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 6.58 (app. t, J = 1.8 Hz, 
1H), 5.92–5.81 (m, 1H), 4.93–4.87 (m, 2H), 2.51 (dd, J = 7.1, 1.8 Hz, 1H), 2.49 (dd, J = 
7.1, 1.8 Hz, 1H), 2.27 (s, 3H), 1.94 (ddd, J = 12.9, 7.8, 7.8 Hz, 1H), 1.67 (d, J = 14.4 Hz, 
1H), 1.67–1.59 (m, 1H), 1.59 (d, J = 14.4 Hz, 1H), 1.11 (s, 3H), 1.07 (s, 3H), 1.04 (s, 
3H);  13C NMR (125 MHz, CDCl3) δ 197.7, 154.1, 149.7, 142.2, 110.0, 53.5, 50.7, 38.8, 
38.0, 29.7, 29.1, 28.7, 27.9, 26.8;  1H NMR (500 MHz, C6D6) δ 6.16 (app. t, J = 1.8 Hz, 
1H), 5.74–5.65 (m, 1H), 4.86–4.79 (m 2H), 2.61 (dd, J = 7.7, 1.8 Hz, 1H), 2.60 (dd, J = 
7.7, 1.8 Hz, 1H), 2.02 (s, 3H), 1.72 (ddd, J = 12.9, 7.7, 7.7 Hz, 1H), 1.45–1.36 (m, 1H), 
1.39 (d, J = 14.4 Hz, 1H), 1.29 (d, J = 14.4 Hz, 1H), 0.92 (s, 3H), 0.91 (s, 6H);  13C NMR 
(125 MHz, C6D6) δ 195.0, 151.7, 149.3, 142.2, 109.5, 53.0, 50.2, 38.4, 37.5, 29.3, 29.3, 
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28.1, 27.3, 26.1;  IR (Neat Film NaCl) 3080, 2956, 2926, 2872, 1730, 1711, 1668, 1636, 
1617, 1455, 1431, 1413, 1377, 1366, 1302, 1269, 1232, 1215, 1190, 1120, 1010, 971, 
934, 908, 861, 803 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C14H23O [M]+•: 
207.1743; found 207.1753;  [α]D25.0 –10.580 (c 1.12, CHCl3, 94.9% ee). 
 
TBSOTf, Et3N 
CH2Cl2, 0!23 °C
98% yield
OTBSO
306 343  
Silyl Dienol Ether 343.  A 100 mL pear-shaped flask with a magnetic stir bar under N2 
was charged with acylcyclopentene 306 (400 mg, 1.93 mmol, 1.00 equiv) and CH2Cl2 (40 
mL).  The colorless solution was cooled to 0 °C using an ice/water bath.  After 5 min of 
stirring, Et3N (1.08 mL, 7.75 mmol, 4.00 equiv) was added dropwise.  After 2 min of 
stirring, TBSOTf116 (891 µL, 3.88 mmol, 2.00 equiv) was added dropwise.  The 
formation of vapor was observed.  The clear, colorless solution was stirred at 0 °C for 15 
min.  The reaction was quenched by addition of ice-cold sat. aqueous NaHCO3 (12 mL) 
and stirred for 5 min at 0 °C.  The phases were separated and the aqueous phase was 
extracted with CH2Cl2 (3 x 15 mL).  The combined organic phases washed with brine, 
dried over Na2SO4, filtered, and concentrated under reduced pressure.  The residue was 
purified by flash column chromatography with deactivated silica gel (SiO2, 3 x 25 cm, 
deactivated with 1% Et3N in hexanes, 1% Et3N in hexanes→20% Et2O in hexanes eluent) 
to afford silyl dienol ether 343 (607.2 mg, 1.894 mmol, 98% yield) as a colorless oil.  
(Note: Silyl dienol ether 343 appears to be sensitive to moisture.  The compound was 
stored as a solidified benzene solution under N2 in a –25 °C freezer.);  Rf = 0.78 (10:1 
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hexanes:EtOAc, 1% Et3N in hexanes deactivated silica TLC plates);  1H NMR (500 MHz, 
C6D6) δ 6.17 (app. t, J = 1.8 Hz, 1H), 5.89 (dd, J = 17.5, 10.7 Hz, 1H), 4.94 (dd, J = 17.5, 
1.4 Hz, 1H), 4.92 (dd, J = 10.7, 1.4 Hz, 1H), 4.41–4.35 (m, 1H), 4.40–4.34 (m, 1H), 
2.50–2.35 (m, 2H), 1.88 (ddd, J = 12.7, 8.7, 7.0 Hz, 1H), 1.60 (ddd, J = 12.7, 8.3, 5.2 Hz, 
1H), 1.56 (d, J = 14.3 Hz, 1H), 1.47 (d, J = 14.3 Hz, 1H), 1.08 (s, 3H), 1.05–1.02 (m, 
12H), 1.03 (s, 3H), 0.19 (s, 3H), 0.18 (s, 3H);  13C NMR (125 MHz, C6D6) δ 154.8, 150.0, 
139.2, 138.3, 109.7, 92.7, 54.3, 49.8, 40.1, 38.0, 31.1, 29.9, 28.7, 28.3, 26.1, 18.5, -4.4, -
4.4;  IR (Neat Film NaCl) 3119, 3081, 2956, 2929, 2896, 2858, 1818, 1636, 1586, 1472, 
1463, 1412, 1389, 1373, 1361, 1330, 1309, 1283, 1256, 1201, 1129, 1090, 1060, 1016, 
1005, 939, 907, 838, 812, 779 cm–1;  HRMS (FAB+) m/z calc'd for C20H37OSi [M+H]+: 
321.2614; found 321.2607;  [α]D25.0 –7.57 (c 0.95, CH2Cl2, 94.9% ee). 
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Table 3.2.  Intramolecular Diels–Alder/Rubottom Oxidation Screening 
entrya temp (°C) solvent overall yield (%)b
78
83
79
PhCH3
58
170 92
90
PhCH3
200 95
93
p-dioxane
200
PhCH3
PhCH3
PhCH3
PhCH3
CyCH3
a Conditions: silyl dienol ether 343 (1.0 equiv), solvent (0.01 M) in a sealed tube at the indicated temperature for the
indicated time.  b Combined isolated yield over two steps for 352 and 353.  c Ratio of trans : cis !-hydroxyketones 352 
and 353, determined by relative integration by 1H NMR.
1
8
2
7
3
4
5
6
time (h)
96
24
6
2
3
1
1
1
352 : 353c
1 : 8.25
1 : 3.58
1 : 3.26
1 : 2.68
1 : 2.55
1 : 2.64
1 : 2.02
1 : 2.31
110
130
150
160
190
95200 PhCl9 1 1 : 3.26
DMDO
acetone, –78 °C 
then TBAF
–78"23 °C
H
H
OTBS
305
+ H
H
OTBS
344
H
H
O
352
+ H
H
O
353
OH OHOTBS
solvent
temp
sealed tube
343
heating method
sand bath
oil bath
oil bath
oil bath
oil bath
oil bath
oil bath
metal block
microwave irradiation
170 91
93
p-dioxane
170 CyCH311
10 2
2
1 : 2.03
1 : 2.07
94170 PhCl12 3 1 : 2.73
91170 CH3CN13 2 1 : 2.27
metal block
metal block
metal block
metal block
83170 1,2-DCE14 2 0 : 1.00metal block
 
Intramolecular Diels–Alder/Rubottom Oxidation Screening Procedure (0.05 mmol 
scale, Table 3.2, entries 1–14).  To a 5 mL microwave vial was added a solution of silyl 
dienol ether 343 in benzene (100 mg/mL, 20.0 mg, 0.0623 mmol, 1.00 equiv).  The 
solvent was removed under reduced pressure.  The vial, a magnetic stir bar, crimp cap, 
and crimper were placed in a glove box antechamber, which was evacuated/backfilled 
with N2 (3 cycles, 5 min evacuation per cycle) before the items were transferred into the 
glove box.  Solvent (6 mL) was added by syringe and the vial was sealed with a crimp 
cap.  The vial was removed from the glove box and heated according to the indicated 
conditions for the indicated time interval.  A blast shield was set up as a precaution.  The 
vial was uncapped and the reaction was concentrated under reduced pressure.  The crude 
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reaction mixture was analyzed by 1H NMR to confirm the complete consumption of 
starting material before use in the next step. 
The crude mixture of silyl enol ethers 305 and 344 was dissolved in acetone (3 mL) in 
a 20 mL scintillation vial with magnetic stir bar and sealed with a screw cap.  The vials 
were cooled to –78 °C and stirred for 5 min.  A solution of DMDO in acetone95 (0.103 M, 
607 µL, 0.0624 mmol, 1.00 equiv) was added dropwise over 5 min.  The reaction was 
stirred for 5 min, allowed to warm to 23 °C, and concentrated under reduced pressure.  
The residue was purified by flash column chromatography (SiO2, 3 x 12 cm, 10% EtOAc 
in hexanes) to afford mixture of α-hydroxyketones 352 and 353 as a pale yellow solid.  
The ratio of products was analyzed by 1H NMR (300 or 500 MHz, C6D6) by comparing 
the relative integrations of the peaks corresponding to trans isomer 352 (δ 0.64 (s, 3H)) 
and cis isomer 353 δ 0.68 (s, 3H)). 
 
(Note: Incomplete silyl transfer to the tertiary alcohol was observed during the Rubottom 
oxidation, so TBAF was added to simplify the reaction mixture.  The use of anhydrous 
acetone solvent and dry DMDO still did not lead to clean formation of the anticipated α-
silyloxyketone.  Attempts to install a silyl group on the alcohol of α-hydroxyketone 352 
led to a mixture of bis-, mono-, and unsilylated products.  Lower overall yields were 
observed with m-CPBA as the oxidant). 
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DMDO
acetone, –78 °C 
then TBAF
–78!23 °C
H
H
OTBS
305
+ H
H
OTBS
344
H
H
O
352
+ H
H
O
353
OH OHOTBS
p-dioxane
170 °C, 8 h
sealed tube
343
28% yield
2 steps
62% yield
2 steps
(X-ray)  
α-Hydroxyketones 352 and 353.  To a 20 mL microwave vial was added a solution of 
silyl dienol ether 343 in benzene (100 mg/mL, 98.1 mg, 0.306 mmol, 1.00 equiv).  The 
solvent was removed under reduced pressure.  The vial, a magnetic stir bar, crimp cap, 
and crimper were placed in a glove box antechamber, which was evacuated/backfilled 
with N2 (3 cycles, 5 min evacuation per cycle) before the items were transferred into the 
glove box.  p-Dioxane (12.5 mL) was added by syringe and the vial was sealed with a 
crimp cap.  The vial was removed from the glove box and immersed in a preheated 170 
°C heating mantle-supported sand bath regulated by a J-KEM Scientific Model 210 
Temperature Controller.  A blast shield was set up as a precaution.  The reaction was 
stirred for 8 h at 170 °C.  The reaction was allowed to cool to 23 °C and the vial was 
uncapped.  The reaction was diluted with hexanes (24 mL) and concentrated under 
reduced pressure to give a mixture of silyl enol ethers 305 and 344. 
To a 50 mL round-bottom flask with magnetic stir bar was added the mixture of silyl 
enol ethers 352 and 353.  The flask was evacuated and backfilled with N2 (3 cycles, 5 min 
evacuation per cycle).  Acetone (12.5 mL) was added and the reaction was cooled to –78 
°C.  After 15 min of stirring, a solution of DMDO in acetone95 (0.0734 M, 5.0 mL, 0.367 
mmol, 1.20 equiv) was added dropwise over 10 min.  After an additional 5 min of 
stirring, TBAF (1.0 M in THF, 367 µL, 0.367 mmol, 1.20 equiv).  The reaction was 
stirred at –78 °C for 5 min, the cooling bath was removed, and the reaction was allowed 
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to warm to 23 °C.  After 15 min of stirring at 23 °C, the reaction was concentrated under 
reduced pressure to give a pale orange residue, which was purified by flash column 
chromatography (SiO2, 5 x 30 cm, 2.5%→5%→10% EtOAc in hexanes) to afford α-
hydroxyketones 352 (19.2 mg, 0.0864 mmol, 28% yield over two steps) and 353 (42.3 
mg, 0.190 mmol, 62% yield over two steps) as a faint yellow solids.  X-ray quality 
crystals of alcohol 353 (colorless to pale yellow) were grown by slow evaporation from 
benzene. 
 
α-Hydroxyketone 352 (trans-isomer):  Rf = 0.18 (10:1 hexanes:EtOAc);  1H NMR (500 
MHz, CDCl3) δ 3.67 (br s, 1H), 2.62 (ddd, J = 16.2, 4.4, 1.8 Hz, 1H), 2.47 (ddd, J = 16.2, 
12.4, 6.8 Hz, 1H), 2.43–2.35 (m, 1H), 2.03–1.97 (m, 2H), 1.86 (dddd, J = 12.0, 6.9, 1.9, 
1.9 Hz, 1H), 1.86–1.74 (m, 2H), 1.77 (d, J = 13.4 Hz, 1H), 1.66 (d, J = 13.4 Hz, 1H), 
1.57 (ddd, J = 12.6, 12.6, 2.3 Hz, 1H), 1.48 (dddd, J = 12.3, 12.3, 12.3, 4.4 Hz, 1H), 1.28 
(s, 3H), 1.05 (s, 3H), 0.87 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 215.2, 87.9, 67.6, 59.8, 
54.2, 47.5, 42.0, 40.2, 39.1, 38.8, 31.0, 28.8, 24.0, 22.3;  1H NMR (500 MHz, C6D6) δ 
3.90 (br s, 1H), 2.33 (ddd, J = 15.9, 4.4, 1.8 Hz, 1H), 2.04–1.86 (m, 3H), 1.85 (br d, J = 
11.6 Hz, 1H), 1.68–1.53 (m, 2H), 1.56 (d, J = 13.2 Hz, 1H), 1.50 (d, J = 13.2 Hz, 1H), 
1.38 (s, 3H), 1.25 (dddd, J = 12.1, 6.7, 2.5, 1.8 Hz, 1H), 1.15 (ddd, J = 12.6, 12.6, 2.5 Hz, 
1H), 0.92 (dddd, J = 12.5, 12.5, 12.5, 4.4 Hz, 1H), 0.84 (s, 3H), 0.64 (s, 3H);  13C NMR 
(125 MHz, C6D6) δ 213.8, 87.7, 67.7, 59.9, 53.9, 47.5, 42.2, 40.0, 39.1, 38.5, 31.1, 28.6, 
23.8, 22.2;  IR (Neat Film NaCl) 3496, 2947, 2930, 2866, 1701, 1457, 1420, 1371, 1364, 
1349, 1319, 1303, 1267, 1243, 1221, 1211, 1196, 1179, 1148, 1114, 1074, 1056, 1040, 
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1012, 986, 974, 950, 932, 909, 878, 837, 816, 751 cm–1;  HRMS (EI+) m/z calc'd for 
C14H22O2 [M]+•: 222.1620; found 222.1625;  [α]D25.0 +2.96 (c 0.67, CHCl3, 94.9% ee). 
 
α-Hydroxyketone 353 (cis-isomer):  Rf = 0.14 (10:1 hexanes:EtOAc);  1H NMR (500 
MHz, CDCl3) δ 3.75 (br s, 1H), 2.60 (ddd, J = 19.8, 5.0, 2.2 Hz, 1H), 2.45 (dd, J = 8.7, 
2.0 Hz, 1H), 2.28 (ddd, J = 19.7, 11.6, 7.6 Hz, 1H), 2.05 (ddd, J = 13.3, 12.2, 8.5 Hz, 
1H), 1.88 (ddd, J = 12.4, 12.4, 7.5 Hz, 1H), 1.86–1.71 (m, 4H), 1.69 (d, J = 13.1 Hz, 1H), 
1.61 (dddd, J = 12.9, 7.1, 1.3, 1.3 Hz, 1H), 1.52 (d, J = 13.2 Hz, 1H), 1.39 (s, 3H), 1.10 
(s, 3H), 0.95 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 215.2, 86.1, 63.9, 54.0, 52.4, 48.6, 
43.9, 42.0, 40.3, 35.0, 32.1, 30.6, 25.3, 22.6;  1H NMR (500 MHz, C6D6) δ 4.04 (br s, 
1H), 2.34 (dd, J = 8.8, 1.4 Hz, 1H), 2.16–2.08 (m, 1H), 1.95 (ddd, J = 12.0, 12.0, 1.4 Hz, 
1H), 1.95–1.82 (m, 1H), 1.68–1.58 (m, 1H), 1.55 (dd, J = 12.0, 8.3 Hz, 1H), 1.50–1.43 
(m, 1H), 1.40 (s, 3H), 1.35 (d, J = 13.1 Hz, 1H), 1.33–1.22 (m, 1H), 1.26 (d, J = 13.1 Hz, 
1H), 1.17–1.05 (m, 2H), 0.88 (s, 3H), 0.68 (s, 3H);  13C NMR (125 MHz, C6D6) δ 213.7, 
85.8, 64.0, 53.9, 52.2, 48.3, 43.6, 42.1, 40.3, 34.8, 32.1, 30.5, 25.2, 22.6;  IR (Neat Film 
NaCl) 3415, 2970, 2948, 2866, 2759, 2717, 2658, 1708, 1485, 1467, 1456, 1443, 1399, 
1384, 1368, 1363, 1331,1304, 1254, 1242, 1223, 1211, 1180, 1167, 1153, 1137, 1114, 
1071, 1054, 1017, 997, 985, 961, 949, 937, 920, 903, 874, 861, 841, 799, 788, 735 cm–1;  
HRMS (FAB+) m/z calc'd for C14H23O2 [M+H]+: 224.1698; found 224.1693;  [α]D25.0 –
53.99 (c 0.98, CHCl3, 94.9% ee); mp = 51–52 °C (benzene). 
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9% yield 61% yield  
Silyl Enol Ethers 305 and 344.  To a 20 mL microwave vial with magnetic stir bar under 
N2 were added silyl dienol ether 343 (178.2 mg, 0.556 mmol, 1.00 equiv) and toluene (13 
mL).  The reaction was sealed with a microwave crimp cap and subjected to microwave 
irradiation in a Biotage Initiator microwave reactor (temperature: 150 °C, sensitivity: 
low) with a gradual temperature increase over 10 min (10 °C increments).  After 2 h of 
stirring, the vial was uncapped and the reaction was concentrated under reduced pressure.  
The residue was purified by flash column chromatography (SiO2, 3 x 25 cm, deactivated 
with 1% Et3N in hexanes, 1% Et3N in hexanes→20% Et2O in hexanes eluent) to afford a 
mixture of silyl enol ethers 305 and 344 (160.2 mg, 0.4997 mmol, 90% yield) as a 
colorless oil.  The mixture of silyl enol ethers was used directly in the next step. 
 
α-Hydroxyketones 352 and 353.119 To a 50 mL pear-shaped flask with a magnetic stir 
bar were added m-CPBA (168.1 mg, 0.750 mmol, 1.50 equiv) and EtOAc (10 mL).  The 
reaction was stirred until the solids dissolved.  NaHCO3 (125.9 mg, 1.499 mmol, 3.00 
equiv) was added in one portion and the reaction was stirred vigorously for 1 h before the 
addition of H2O (2 mL).  The reaction was cooled to 0 °C and stirred for 20 min.  The 
mixture of silyl enol ethers 305 and 344 (160.2 mg, 0.4997 mmol, 1.00 equiv) was 
dissolved in EtOAc (5 mL) and cooled to 0 °C before it was added dropwise to the 
biphasic mixture.  After 10 min of stirring, the reaction was quenched with sat. aqueous 
NaHSO4 and warmed to 23 °C.  The phases were separated and the aqueous phase was 
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extracted with EtOAc (3 x 10 mL).  The combined organic phases were dried over 
Na2SO4, filtered, and concentrated under reduced pressure.  The resulting mixture was 
taken up in THF (15 mL) and TBAF (1.0M in THF, 1 mL, 1.00 mmol, 2.00 equiv) was 
added.  The reaction was concentrated under reduced pressure and purified by flash 
column chromatography (SiO2, 4 x 25 cm, 2.5%→5%→10% EtOAc in hexanes) to 
afford α-hydroxyketones 352 (9.0 mg, 0.043 mmol, 9% yield over two steps) as a pale 
yellow solid and 353 (67.5 mg, 0.304 mmol, 61% yield over two steps) as a pale yellow 
solid. 
 
KHMDS, TBDPSCl
THF, –78!23 °C
81% yield
OTBDPSO
306 366  
Silyl Dienol Ether 366.  To a 100 mL pear-shaped flask with a magnetic stir bar was 
added KHMDS (154.7 mg, 0.775 mmol, 1.6 equiv) in a N2-filled glove box.  The flask 
was sealed with a rubber septum and removed from the glove box and connected to a N2-
inlet.  The flask was cooled to –78 °C using an acetone/CO2(s) bath.  After 10 min, THF 
(5 mL) was added and the suspension was stirred vigorously for 5 min.  The cooling bath 
was removed and the flask was allowed to warm until the solids completely dissolved.  
The solution was cooled to –78 °C.  Acylcyclopentene 306 (100 mg, 0.484 mmol, 1.00 
equiv) was added dropwise by syringe, leading to the formation of a pale tan-yellow 
mixture.  The reaction was stirred at –78 °C for 30 min.  TBDPSCl (151.2 µL, 0.581 
mmol, 1.2 equiv) was added dropwise.  The reaction was stirred at –78 °C for 5 min, the 
cooling bath was removed, and the reaction was allowed to warm to 23 °C over 30 min.  
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The turbid tan solution was stirred at 23 °C for 1 h.  The reaction was carefully 
concentrated under reduced pressure.  The yellow residue was diluted with hexanes, 
passed through a Celite pipet plug, and eluted with hexanes.  The filtrate was 
concentrated under reduced pressure and purified by flash column chromatography with 
deactivated silica gel (SiO2, 3 x 12 cm, deactivated with 1% Et3N in hexanes, 1% Et3N in 
hexanes→20% Et2O in hexanes eluent) to afford silyl dienol ether 366 (168 mg, 0.391 
mmol, 81% yield) as a colorless sap.  (Note: Silyl dienol ether 366 appears to be sensitive 
to moisture.  The compound was stored as a solidified benzene solution under N2 in a –25 
°C freezer.);  Rf = 0.63 (10:1 hexanes:EtOAc);  1H NMR (500 MHz, C6D6) δ 8.65–8.54 
(m, 4H), 7.99–7.86 (m, 6H), 7.16 (br s, 1H), 6.65 (dd, J = 17.5, 10.7 Hz, 1H), 5.69 (dd, J 
= 17.6, 1.2 Hz, 1H), 5.66 (dd, J = 10.7, 1.2 Hz, 1H), 4.97–4.92 (m, 1H), 4.91–4.87 (m, 
1H), 3.15–3.03 (m, 2H), 2.59 (ddd, J = 12.7, 8.7, 6.8 Hz, 1H), 2.33 (d, J = 14.0 Hz, 1H), 
2.31 (ddd, J = 12.7, 8.2, 5.4 Hz, 1H), 2.23 (d, J = 14.3 Hz, 1H), 1.91 (s, 9H), 1.84 (s, 3H), 
1.80 (s, 3H), 1.79 (s, 3H);  13C NMR (125 MHz, C6D6) δ 154.2, 149.9, 138.9, 138.1, 
135.9, 135.9, 133.4, 133.3, 130.1, 128.1, 128.1, 109.8, 94.2, 54.5, 49.8, 40.1, 38.1, 31.0, 
30.0, 28.8, 28.6, 26.9, 19.8;  IR (Neat Film NaCl) 3050, 3072, 2998, 2956, 2931, 2895, 
2858, 1956, 1886, 1819, 1776, 1724, 1634, 1588, 1472, 1462, 1429, 1413, 1389, 1373, 
1361, 1330, 1307, 1282, 1221, 1201, 1114, 1062, 1016, 939, 907, 822, 765, 742 cm–1;  
HRMS (FAB+) m/z calc'd for C30H41OSi [M+H]+: 445.2927; found 445.2912;  [α]D25.0 
+9.601 (c 1.29, CH2Cl2, 94.9% ee). 
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THF, 0!23 °C
glove box
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H
H
O
353
H
H
354
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Allylic Alcohol 354.120  To a 20 mL scintillation vial with magnetic stir bar was added 
Ph3PCH3Br (210.7 mg, 0.5898 mmol, 2.6 equiv) in a N2-filled glove box.  KOt-Bu (1.0 M 
in THF, 544.5 µL, 0.5445 mmol, 2.4 equiv) was added and the bright yellow suspension 
was diluted with THF (3 mL).  The mixture was stirred for 30 min.  α-Hydroxyketone 
353 (50.4 mg, 0.227 mmol, 1.00 equiv) was dissolved in THF (9 mL) and added to the 
reaction.  The reaction was capped with a teflon-lined hard cap and stirred in the glove 
box.  After 8.5 h, the reaction was removed from the glove box and quenched with sat. 
aqueous NH4Cl (1 mL) and H2O (1 mL).  The phases were separated and the aqueous 
phase was extracted with Et2O (3 x 5 mL).  The combined organic phases were dried over 
Na2SO4, filtered, and concentrated under reduced pressure (25 mmHg) in a 0 °C ice/water 
bath.  The residue was purified by flash column chromatography (SiO2, 3 x 25 cm, 
1%→3%→5% EtOAc in hexanes) to afford faintly fragrant allylic alcohol 354 (47.1 mg, 
0.214 mmol, 94% yield) as a white crystalline solid;  Rf = 0.34 (10:1 hexanes:EtOAc);  
1H NMR (500 MHz, CDCl3) δ 5.31 (t, J = 2.1 Hz, 1H), 4.90 (q, J = 2.0 Hz, 1H), 2.41 
(ddq, J = 17.0, 6.5, 2.0 Hz, 1H), 2.27–2.15 (m, 1H), 1.99–1.83 (m, 1H), 1.92 (td, J = 
12.1, 8.0 Hz, 1H), 1.74 (td, J = 12.7, 12.1, 8.1 Hz, 1H), 1.62 (ddd, J = 13.5, 7.9, 1.8 Hz, 
1H), 1.56 (dd, J = 12.4, 8.2 Hz, 1H), 1.54–1.46 (m, 1H), 1.45 (d, J = 13.1 Hz, 1H), 1.39 
(s, 3H), 1.31 (d, J = 13.0 Hz, 1H), 1.29–1.20 (m, 1H), 1.08 (tddd, J = 13.6, 11.9, 6.7, 1.3 
Hz, 1H), 0.97 (s, 3H), 0.80 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 151.2, 106.9, 84.1, 
65.4, 54.6, 51.2, 49.9, 43.4, 42.3, 42.1, 33.1, 30.8, 29.1, 25.4, 22.3;  IR (Neat Film NaCl) 
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3337, 3083, 2961, 2934, 2866, 2829, 1785, 1636, 1470, 1452, 1433, 1383, 1374, 1364, 
1318, 1300, 1241, 1228, 1213, 1177, 1163, 1133, 1110, 1062, 1047, 1019, 1007, 986, 
960, 953, 923, 891, 867, 778, 747 cm–1;  HRMS (EI+) m/z calc'd for C15H24O [M]+•: 
220.1827; found 220.1827;  [α]D25.0 –60.66 (c 0.45, CHCl3, 94.9% ee). 
 
PtO2 (5 mol %)
EtOAc, H2 (1 atm)
94% combined yield
1.05:1 dr
H
H
354
OH
+ H
H
OH
H
H
OH
355 356
9 9
46% yield 48% yield
(X-ray)  
Alcohol 355 and Alcohol 356.  To a 20 mL scintillation vial with magnetic stir bar 
containing allylic alcohol 354 (29.4 mg, 0.1335 mmol, 1.00 equiv) was added Adam’s 
catalyst (PtO2-hydrate, 1.5 mg, 0.024 mmol, 5 mol %).  The reaction was capped with a 
septum-fitted screw cap, evacuated for 5 min, and backfilled with an H2 (1 atm, balloon).  
EtOAc (2.0 mL) was added and the reaction was stirred vigorously.  After 5 min, the 
brown solids turned black.  After 4 h of stirring, the H2 balloon was removed.  The 
reaction was filtered through a Celite pipet plug (0.5 x 1 cm) and eluted with EtOAc.  
The residue was purified by flash column chromatography (SiO2, 3 x 25 cm, 
1%→2%→5% EtOAc in hexanes) to afford faintly fragrant alcohols 355 (13.5 mg, 
0.0608 mmol, 45% yield) as a clear, colorless solid and 356 (14.2 mg, 0.0639 mmol, 48% 
yield) as a clear, colorless oil which solidifies upon storage in a –25 °C freezer. X-ray 
quality crystals of alcohol 356 (colorless) were grown by slow evaporation from hexanes. 
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Alcohol (355) (9β-Me isomer):  Rf = 0.22 (10:1 hexanes:EtOAc);  1H NMR (500 MHz, 
C6D6) δ 2.18 (d, J = 8.9 Hz, 1H), 1.74 (ddd, J = 12.4, 6.5, 4.4 Hz, 1H), 1.71–1.54 (m, 
3H), 1.48–1.39 (m, 2H), 1.45 (d, J = 12.8 Hz, 1H), 1.39–1.28 (m, 2H), 1.31 (s, 3H), 1.25 
(dd, J = 12.8, 1.0 Hz, 1H), 1.17–1.06 (m, 1H), 1.01 (s, 3H), 0.97 (d, J = 6.9 Hz, 3H), 0.86 
(s, 3H), 0.84–0.70 (m, 1H);  13C NMR (125 MHz, C6D6) δ 82.5, 62.3, 53.8, 49.8, 47.9, 
45.6, 42.5, 42.0, 38.0, 32.7, 30.7, 28.6, 25.6, 25.4, 17.3;  IR (Neat Film NaCl) 3453, 
2928, 2867, 1722, 1463, 1383, 1364, 1375, 1310, 1285, 1236, 1204, 1217, 1181, 1163, 
1155, 1137, 1067, 1048, 998, 983, 972, 963, 949, 921, 897, 888, 880, 860, 850, 840, 801, 
782 cm–1;  HRMS (EI +) m/z calc'd for C15H26O [M]+•: 222.1984; found 222.1983;  [α]D25.0 
–35.22 (c 1.07, CHCl3, 94.9% ee). 
 
Alcohol (356) (9α-Me isomer):  Rf = 0.25 (10:1 hexanes:EtOAc);  1H NMR (500 MHz, 
C6D6) δ 1.94–1.82 (m, 2H), 1.72–1.44 (m, 6H), 150 (d, J = 13.0, 1H), 1.41 (s, 3H), 1.34 
(dd, J = 13.0, 0.9 Hz, 1H), 1.31–1.20 (m, 1H), 1.14–1.00 (m, 2H), 0.98 (s, 3H), 0.94 (d, J 
= 6.4 Hz, 3H), 0.82 (s, 3H);  13C NMR (125 MHz, C6D6) δ 85.7, 65.5, 55.5, 49.8, 48.6, 
43.4, 41.9, 36.1, 34.5, 33.7, 31.1, 28.7, 25.0, 21.6, 17.0;  IR (Neat Film NaCl) 3306, 
2974, 2959, 2978, 2936, 2863, 1454, 1382, 1370, 1362, 1331, 1302, 1289, 1261, 1282, 
1235, 1223, 1212, 1187, 1160, 1144, 1110, 1061, 1024, 1007, 999, 982, 962, 945, 926, 
893, 865, 830, 797, 761 cm–1;  HRMS (EI+) m/z calc'd for C15H26O [M]+•: 222.1984; 
found 222.1982;  [α]D25.0 –6.75 (c 1.33, CHCl3, 94.9% ee);  mp = 108–110 °C (hexanes). 
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Trimethylsilyl Ether 367.108  To a 20 mL scintillation vial with magnetic stir bar was 
added allylic alcohol 354 (10.8 mg, 0.0491 mmol, 1.00 equiv).  A septum-fitted screw 
cap was attached and the vial was evacuated/backfilled with N2 (3 cycles, 5 min 
evacuation per cycle).  CH2Cl2 (4 mL) was added.  HMDS (41.1 µL, 0.196 mmol, 4.00 
equiv) and TMSCl (12 µL, 0.098 mmol, 2.0 equiv) were added dropwise, followed by 
imidazole (6.5 mg, 0.098 mmol, 2.0 equiv) in one portion.  The clear, colorless solution 
turned into a turbid white solution several seconds after the addition of imidazole.  After 
24 h of stirring, the reaction was quenched by the addition of sat. aqueous NaHCO3 (2 
mL).  The phases were separated and the aqueous phase was extracted with CH2Cl2 (3 x 5 
mL).  The combined organic phases were dried over Na2SO4, filtered, and concentrated 
under reduced pressure.  The residue was purified by flash column chromatography 
(SiO2, 1.5 x 25 cm, 0%→1%→2% EtOAc in hexanes) to afford trimethylsilyl ether 367 
(13.8 mg, 0.0472 mmol, 96% yield) as a nearly colorless pale yellow oil;  Rf = 0.72 (10:1 
hexanes:EtOAc);  1H NMR (500 MHz, C6D6) δ 5.32 (q, J = 1.8 Hz, 1H), 4.91 (q, J = 1.9 
Hz, 1H), 2.45 (dd, J = 9.3, 1.7 Hz, 1H), 2.34 (dtd, J = 15.7, 3.2, 1.5 Hz, 1H), 2.20–2.08 
(m, 1H), 1.96–1.87 (m, 1H), 1.89–1.73 (m, 2H), 1.65 (dddd, J = 13.6, 9.3, 5.6, 1.2 Hz, 
1H), 1.50 (ddd, J = 10.4, 6.4, 2.6 Hz, 1H), 1.43 (s, 3H), 1.43 (dd, J = 13.1 Hz, 1H), 1.37–
1.25 (m, 1H), 1.29 (dd, J = 13.1, 1.4 Hz, 1H), 1.05–0.92 (m, 1H), 1.00 (s, 3H), 0.81 (s, 
3H), 0.25 (s, 9H);  13C NMR (125 MHz, C6D6) δ 151.8, 109.0, 86.8, 64.6, 54.3, 51.3, 
50.5, 44.6, 43.5, 41.8, 32.7, 31.2, 31.2, 25.6, 23.7, 2.7;  IR (Neat Film NaCl) 3083, 2952, 
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2868, 1731, 1638, 1459, 1383, 1373, 1364, 1315, 1300, 1259, 1249, 1214, 1187, 1162, 
1120, 1069, 1058, 1027, 1011, 985, 955, 943, 926, 911, 896, 882, 838, 808, 752 cm–1;  
HRMS (EI+) m/z calc'd for C18H32OSi [M]+•: 292.2223; found 292.2229;  [α]D25.0 –58.85 
(c 1.03, CH2Cl2, 94.9% ee). 
 
KOt-Bu
Ph3PCH3Br
THF, 0!23 °C
90% yield
H
H
O
352
H
H
357
OHOH
 
Allylic Alcohol 357.120 To a 20 mL scintillation vial with magnetic stir bar was added 
Ph3PCH3Br (138.8 mg, 0.3885 mmol, 2.6 equiv) in a N2-filled glove box.  KOt-Bu (1.0 M 
in THF, 358.7 µL, 0.3587 mmol, 2.4 equiv) was added and the bright yellow suspension 
was diluted with THF (2 mL).  The mixture was stirred for 30 min.  α-Hydroxyketone 
352 (33.2 mg, 0.149 mmol, 1.00 equiv) was dissolved in THF (6 mL) and added to the 
reaction.  The reaction was capped with a teflon-lined hard cap and stirred in the glove 
box.  After 8.5 h, the reaction was removed from the glove box and quenched with sat. 
aqueous NH4Cl (1 mL) and H2O (1 mL).  The phases were separated and the aqueous 
phase was extracted with Et2O (3 x 5 mL).  The combined organic phases were dried over 
Na2SO4, filtered, and concentrated under reduced pressure (25 mmHg) in a 0 °C ice/water 
bath.  The residue was purified by flash column chromatography (SiO2, 3 x 25 cm, 
1%→3%→5% EtOAc in hexanes) to afford faintly fragrant allylic alcohol 357 (29.8 mg, 
0.135 mmol, 90% yield) as a colorless crystalline solid;  Rf = 0.34 (10:1 hexanes:EtOAc);  
1H NMR (500 MHz, C6D6) δ 5.29–5.25 (m, 1H), 4.93–4.90 (m, 1H), 2.42 (dddd, J = 14.5, 
4.8, 3.0, 0.8 Hz, 1H), 2.11–1.97 (m, 3H), 1.83–1.75 (m, 1H), 1.65–1.57 (m, 1H), 1.53 (d, 
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J = 13.2 Hz, 1H), 1.51 (d, J = 13.1 Hz, 1H), 1.41 (dddd, J = 11.3, 5.8, 2.7, 2.7 Hz, 1H), 
1.34 (s, 3H), 1.31 (br d, J = 12.2 Hz, 1H), 1.04 (ddd, J = 12.2, 12.2, 2.5 Hz, 1H), 1.02–
0.93 (m, 1H), 0.92 (s, 3H), 0.77 (s, 3H);  13C NMR (125 MHz, C6D6) δ 153.6, 109.7, 85.0, 
67.6, 60.3, 55.5, 46.5, 42.8, 40.1, 38.1, 34.8, 32.3, 28.5, 25.2, 22.2;  IR (Neat Film NaCl) 
3351, 2950, 2944, 2923, 2856, 1816, 1730, 1636, 1457, 1452, 1377, 1370, 1363, 1344, 
1316, 1303, 1276, 1248, 1222, 1196, 1183, 1151, 1137, 1127, 1114, 1077, 1044, 1007, 
987, 979, 962, 942, 931, 908, 862, 836, 815, 756, 722 cm–1;  HRMS (FAB+) m/z calc'd 
for C15H25O [M+H]+: 221.1905; found 221.1898;  [α]D25.0 +2.96 (c 0.67, CHCl3, 94.9% 
ee). 
 
H
H
OH
synthetic 223
PtO2 (5 mol %)
EtOAc, H2 (1 atm)
95% combined yield
1.20 : 1 dr
H
H
357
OH
+
35% yield
(HPLC)
9
H
H
OH
synthetic 224
28% yield
(HPLC)
9
 
Alcohol 2234 and Alcohol 224.3  To a 20 mL scintillation vial with magnetic stir bar 
were added allylic alcohol 357 (6.8 mg, 0.031 mmol, 1.0 equiv), EtOAc (1.2 mL), and 
Adam’s catalyst (PtO2-hydrate, 0.35 mg, 0.0015 mmol, 5 mol %).  A brown suspension 
was obtained.  The reaction was capped with a septum-fitted screw cap and the solution 
was sparged with H2 (1 atm, balloon) through a long metal needle until a fine black 
suspension was formed.  After 45 min, the needle connected to the H2 balloon was raised 
above the surface of the reaction and the venting needle was removed.  After 1 h of 
stirring, the H2 balloon was removed and Celite (5 mg) was added.  The reaction was 
stirred briefly, filtered through a Celite pipet plug (0.5 x 1 cm), and eluted with EtOAc.  
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The clear filtrate was concentrated under reduced pressure (25 mmHg) in a 0 °C ice/water 
bath.  The residue was purified by flash column chromatography (SiO2, 3 x 12 cm, 15:1 
hexanes:Et2O) to afford a mixture of faintly fragrant alcohols 223 and 224 (6.5 mg, 0.029 
mmol, 95% combined yield, 1.20:1 dr.  (223:224)) as a white amorphous solid.  Alcohols 
223 and 224 can be separated by normal phase preparatory HPLC (SiO2, 10%→25% 
Et2O in pentane, 5.0 mL/min, ZORBAX RX-SIL column, 5 µm, 9.4 x 250 mm, manual 
collection every 0.2 min).  The purity of fractions was analyzed by UHPLC-MS (C18, 
33.5–36.0% CH3CN in H2O, 1.2 mL/min, Agilent Eclipse Plus C18, 1.8 µm, 2.1 x 50 
mm, tR (min): 223 = 7.22 (m/z = 205.2), 224 = 7.78 (m/z = 205.2).  X-ray quality crystals 
of alcohol 224 (colorless to pale yellow) were grown by slow evaporation from hexanes. 
 
The NMR spectra (C6D6) for synthetic compound 223 match spectral data for reported 
natural “9-epi-presilphiperfolan-1-ol” (assigned as 223),4 but the NMR spectra (C6D6) for 
synthetic compound 224 do not match spectral data for reported “presilphiperfolan-1-ol” 
(assigned as 224).3  The NMR spectra (CD2Cl2) for synthetic compound 224 match 
spectral data for reported synthetic 224.28 
 
Alcohol 223 (9β-Me isomer):  Rf = 0.32 (10:1 hexanes:EtOAc);  1H NMR (500 MHz, 
C6D6) δ 1.89–1.78 (m, 2H), 1.73–1.64 (m, 1H), 1.63–1.55 (m, 2H), 1.55 (br d, J = 12.3 
Hz, 1H), 1.50 (s, 2H), 1.48–1.38 (m, 1H), 1.36–1.25 (m, 2H), 1.33 (s, 3H), 1.19–1.05 (m, 
2H), 0.94 (s, 3H), 0.90 (d, J = 7.0 Hz, 3H), 0.80 (s, 3H), 0.58 (br s, 1H);  13C NMR (125 
MHz, C6D6) δ 84.5, 63.9, 59.4, 51.7, 46.2, 42.7, 40.5, 39.7, 36.9, 31.4, 29.9, 28.8, 22.3, 
20.3, 15.8;  IR (Neat Film NaCl) 3468, 2952, 2923, 2853, 1725, 1463, 1456, 1377, 1300, 
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1259, 1188, 1156, 1095, 1077, 104, 1008, 970, 945, 801, 720 cm–1;  HRMS (EI+) m/z 
calc'd for C15H26O [M]+•: 222.1984; found 222.1978;  [α]D25.0 –47.245 (c 0.63, CHCl3, 
94.9% ee). 
 
Alcohol 224 (9α-Me isomer):  Rf = 0.32 (10:1 hexanes:EtOAc);  1H NMR (500 MHz, 
C6D6) δ 1.96 (ddd, J = 13.3, 9.1, 9.1 Hz, 1H), 1.75 (ddd, J = 13.5, 10.1, 9.0 Hz, 1H), 
1.70–1.61 (m, 1H), 1.59 (ddd, J = 13.4, 10.2, 1.9 Hz, 1H), 1.53 (s, 2H), 1.52–1.34 (m, 
3H), 1.39 (s, 3H), 1.27 (br d, J = 11.9 Hz, 1H), 0.95 (s, 3H), 0.94 (d, J = 7.0 Hz, 3H), 
0.91–0.82 (m, 3H), 0.81 (s, 3H), 0.52 (br s, 1H);  13C NMR (125 MHz, C6D6) δ 85.7, 
66.2, 60.6, 56.2, 46.1, 42.2, 41.6, 40.4, 35.1, 32.5, 32.1, 28.7, 24.7, 22.3, 15.9;  1H NMR 
(500 MHz, CD2Cl2) δ 1.96 (ddd, J = 13.6, 9.8, 9.8 Hz, 1H), 1.84 (ddd, J = 13.6, 9.1, 9.1 
Hz, 1H), 1.82–1.76 (m, 1H), 1.65 (ddd, J = 13.5, 10.3, 1.9 Hz, 1H), 1.61–1.42 (m, 6H), 
1.25 (s, 3H), 1.14–1.11 (br s, 1H), 1.08–0.96 (m, 3H), 0.95 (s, 3H), 0.93 (d, J = 6.8 Hz, 
3H), 0.81 (s, 3H);  IR (Neat Film NaCl) 3325, 2949, 2921, 2853, 1734, 1460, 138, 1335, 
1304, 1283, 1276, 1258, 1250, 1218, 1189, 1181, 1145, 1126, 1069, 1053, 1030, 1002, 
995, 974, 964, 947, 926, 907, 859, 843, 801, 778, 743 cm–1;  HRMS (EI+) m/z calc'd for 
C15H26O [M]+•: 222.1984; found 222.1977;  [α]D25.0 –3.24 (c 0.19, CHCl3, 94.9% ee);  
[α]D22.0 –2.73 (c 0.68, CHCl3, 94.9% ee); mp = 113–116 °C (hexanes). 
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H
H
OH
synthetic 224
9
[Ir(cod)(py)(PCy3)]PF6
(10 mol %)
CH2Cl2, H2 (1 atm)
92% yield
H
H
357
OH
H
H
256
OH
 
Alcohol 224 (9α-Me isomer).  To a 20 mL scintillation vial with magnetic stir bar were 
added allylic alcohol 357 (6.8 mg, 0.034 mmol, 1.0 equiv) and [Ir(cod)(py)(PCy3)]PF6 
(2.9 mg, 0.0034 mmol, 10 mol %).  A septum-fitted screw cap was attached and the vial 
was evacuated for 5 min and backfilled with an H2 (1 atm, balloon).  CH2Cl2 (8 mL) was 
added, giving a golden yellow-orange solution.  The solution was freeze-pump-thawed 
using a N2(l) bath (3 cycles, 5 min evacuation per cycle), backfilling with H2 (1 atm, 
balloon) for each cycle.  The golden yellow-orange solution was stirred at 23 °C for 27 h.  
The reaction was filtered through a silica plug (0.5 x 2 cm), eluting with Et2O.  The 
filtrate was concentrated under reduced pressure (25 mmHg) in a 0 °C ice/water bath.  
The residue was purified by flash column chromatography (SiO2, 1.5 x 25 cm, 5%→10% 
EtOAc in hexanes) to afford faintly fragrant alcohol 224 (6.9 mg, 0.031 mmol, 92% 
combined yield) as a white amorphous solid.  
 
The NMR spectra (C6D6) for synthetic compound 224 do not match spectral data for 
reported “presilphiperfolan-1-ol” (assigned as 224).3  The NMR spectra (CD2Cl2) for 
synthetic compound 224 match spectral data for reported synthetic 224.28 
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(Note: Competitive olefin isomerization to a endocyclic trisubstituted alkene (256) is 
observed if the reaction is stopped at incomplete conversion, but with sufficient time, 
only reduced product 224 is observed.) 
 
1. PtO2 (5 mol %)
    EtOAc, H2 (1 atm)
2. TBAF, THF
    reflux
    92% yield
    two steps
H
H
368
TMSO
imidazole, HMDS
TMSCl, CH2Cl2
96% yield
H
H
357
OH
H
H
OH
synthetic 223
9
 
Trimethylsilyl Ether 368.108  To a 20 mL scintillation vial with magnetic stir bar was 
added allylic alcohol 357 (10.8 mg, 0.049 mmol, 1.00 equiv).  A septum-fitted screw cap 
was attached and the vial was evacuated/backfilled with N2 (3 cycles, 5 min evacuation 
per cycle).  CH2Cl2 (4 mL) was added.  HMDS (41.1 µL, 0.196 mmol, 4.00 equiv) and 
TMSCl (12 µL, 0.098 mmol, 2.0 equiv) were added dropwise, followed by imidazole (6.5 
mg, 0.098 mmol, 2.0 equiv) in one portion.  The clear, colorless solution turned into a 
turbid white solution several seconds after the addition of imidazole.  After 24 h of 
stirring, the reaction was quenched by the addition of sat. aqueous NaHCO3 (2 mL).  The 
phases were separated and the aqueous phase was extracted with CH2Cl2 (3 x 5 mL).  The 
combined organic phases were dried over Na2SO4, filtered, and concentrated under 
reduced pressure.  The residue was purified by flash column chromatography (SiO2, 1.5 x 
25 cm, 0%→1%→2% EtOAc in hexanes) to afford trimethylsilyl ether 368 (13.8 mg, 
0.04717 mmol, 96% yield) as a nearly colorless pale yellow oil;  Rf = 0.73 (10:1 
hexanes:EtOAc);  1H NMR (500 MHz, C6D6) δ 5.14–5.12 (m, 1H), 4.93–4.91 (m, 1H), 
2.55–2.42 (m, 1H), 2.12–2.01 (m, 3H), 1.98–1.83 (m, 2H), 1.66–1.55 (m, 1H), 1.53 (d, J 
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= 13.0 Hz, 1H), 1.47 (br d, J = 13.0 Hz, 1H), 1.48–1.40 (m, 1H), 1.36 (s, 3H), 1.29–1.17 
(m, 1H), 0.98 (ddd, J = 12.8, 12.8, 5.7 Hz, 1H), 0.88 (s, 3H), 0.81 (s, 3H), 0.23 (s, 9H);  
13C NMR (125 MHz, C6D6) δ 153.3, 113.1, 87.9, 67.0, 59.6, 52.3, 45.8, 42.6, 40.1, 38.5, 
32.0, 31.3, 28.4, 23.3, 22.2, 2.5;  IR (Neat Film NaCl) 3073, 2950, 2929, 2865, 1813, 
1730, 1648, 1458, 1440, 1412, 1384, 1368, 1335, 1300, 1248, 1202, 1186, 1142, 1115, 
1071, 1062, 1034, 1012, 997, 976, 950, 935, 921, 906, 889, 876, 838, 812, 751 cm–1;  
HRMS (EI+) m/z calc'd for C18H32OSi [M]+•: 292.2223; found 292.2211;  [α]D25.0 –94.32 
(c 0.98, CH2Cl2, 94.9% ee). 
 
Alcohol 223 (9β-Me isomer).  To a 20 mL scintillation vial with magnetic stir bar 
containing trimethylsilyl ether SI-8 (13.8 mg, 0.0472232 mmol, 1.00 equiv) was added 
Adam’s catalyst (PtO2-hydrate, 0.54 mg, 0.0024 mmol, 5 mol %).  The reaction was 
capped with a septum-fitted screw cap, evacuated for 5 min, and backfilled with an H2 (1 
atm, balloon).  EtOAc (2.5 mL) was added and the reaction was stirred vigorously.  After 
10 min, the brown solids turned black.  After 13.5 h of stirring, the H2 balloon was 
removed.  The reaction was filtered through a Celite pipet plug (0.5 x 1 cm) and eluted 
with EtOAc.  The clear filtrate was concentrated under reduced pressure.  The residue 
was taken up in THF (5 mL) and treated with TBAF (1.0 M in THF, 189 µL, 0.189 
mmol, 4.00 equiv).  The reaction was sealed with a teflon-lined hard cap and inserted into 
a 100 °C heating block.  After 10.5 h of stirring, the reaction was a tan solution.  The vial 
was cooled to 23 °C and an additional portion of TBAF (1.0 M in THF, 95 µL, 0.094 
mmol, 2.0 equiv) was added.  The vial was resealed and inserted into a 100 °C heating 
block.  After an additional 16 h of stirring, the vial was cooled to 23 °C and concentrated 
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under reduced pressure (25 mmHg) in a 0 °C ice/water bath.  The residue was purified by 
flash column chromatography (SiO2, 2 x 20 cm, 1%→3%→5% EtOAc in hexanes) to 
afford faintly fragrant alcohol 223 (9.6 mg, 0.043 mmol, 92% yield) as a clear, colorless, 
faintly fragrant oil which solidifies upon storage in a –25 °C freezer.   
 
The NMR spectra (C6D6) for synthetic compound 223 match spectral data for reported 
natural “9-epi-presilphiperfolan-1-ol” (assigned as 223).4 
 
3.8.2.3 PROGRESS TOWARD THE ASYMMETRIC SYNTHESIS OF  
(–)-PRESILPHIPERFOLAN-9α-OL 
then 
TBAF, THF
H
H
OTBS
305
+ H
H
OTBS
344
H
H
O
286
+ H
H
O
359
H HOTBS
p-dioxane
170 °C, 8.5 h
sealed tube
343
28% yield 64% yield  
Ketone 286 and Ketone 359.  To a 5 mL microwave vial was added a solution of silyl 
dienol ether 343 in benzene (100 mg/mL, 32.0 mg, 0.100 mmol, 1.00 equiv).  The solvent 
was removed under reduced pressure.  The vial, a magnetic stir bar, crimp cap, and 
crimper were placed in a glove box antechamber, which was evacuated/backfilled with 
N2 (3 cycles, 5 min evacuation per cycle) before the items were transferred into the glove 
box.  p-Dioxane (4.2 mL) was added by syringe and the vial was sealed with a crimp cap.  
The vial was removed from the glove box and immersed in a preheated 170 °C heating 
mantle-supported sand bath regulated by a J-KEM Scientific Model 210 Temperature 
Controller.  A blast shield was set up as a precaution.  The reaction was stirred for 8.5 h 
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at 170 °C.  The reaction was allowed to cool to 23 °C and TBAF (1.0 M in THF, 200 µL, 
0.200 mmol, 2.00 equiv) was added dropwise, leading to a color change from a clear, 
colorless solution to a yellow solution.  The vial was uncapped and the reaction was 
diluted with hexanes (5 mL) and concentrated under reduced pressure to give a crude 
mixture of tricyclic ketones.  The mixture was passed through a silica plug (2 x 8 cm), 
eluted with 9:1 hexanes:EtOAc, and concentrated under reduced pressure (25 mmHg) in 
a 0 °C ice/water bath.  Crude 1H NMR analysis indicates a 1:2.04 dr (305:344) for the 
reaction.  The mixture of tricyclic ketones was purified by flash column chromatography 
(SiO2, 3 x 25 cm, 1%→3%→5% Et2O in hexanes) and concentrated under reduced 
pressure (25 mmHg) in a 0 °C ice/water bath to afford ketone 286 (5.8 mg, 0.02811 
mmol, 28% yield) as a colorless oil and ketone 359 (13.2 mg, 0.06398 mmol, 64% yield) 
as a colorless oil. 
 
Ketone 286 (trans-isomer):  Rf = 0.34 (10:1 hexanes:EtOAc);  1H NMR (500 MHz, 
CDCl3) δ 2.81 (td, J = 9.0, 7.2 Hz, 1H), 2.48 (dddd, J = 16.5, 8.1, 3.3, 0.8 Hz, 1H), 2.32 
(dt, J = 16.5, 8.2 Hz, 1H), 2.19 (dd, J = 12.5, 7.0 Hz, 1H), 2.08–1.95 (m, 2H), 1.79 (ddt, J 
= 12.1, 8.4, 3.5 Hz, 1H), 1.69 ( d, J = 13.3 Hz, 1H), 1.67 (ddd, J = 13.3, 6.0 Hz, 1H), 1.59 
(d, J = 13.4 Hz, 1H), 1.59–1.48 (m, 2H), 1.40 (td, J = 12.7, 3.8 Hz, 1H), 1.07 (s, 3H), 
1.02 (s, 3H), 0.89 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 216.5, 59.3, 58.1, 52.8, 51.0, 
47.6, 42.1, 40.8, 38.5, 29.2, 29.0, 28.4, 22.8, 22.0;  IR (Neat Film NaCl) 2948, 2929, 
2864, 1702, 1458, 1385, 1372, 1364, 1316, 1260, 1233, 1209, 1164, 1115, 1102, 1072, 
1040, 120, 952, 917, 874, 807, 746 cm–1;  HRMS (EI+) m/z calc'd for C14H22O [M]+•: 
206.1671; found 206.1670;  [α]D25.0 –3.27 (c 0.56, CHCl3, 94.9% ee). 
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Ketone 359 (cis-isomer):  Rf = 0.28 (10:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) 
δ 2.67 (dd, J = 17.4, 9.1 Hz, 1H), 2.64 (dd, J = 16.8, 9.0 Hz, 1H), 2.46 (ddd, J = 18.0, 4.1, 
2.5 Hz, 1H), 2.05 (ddd, J = 18.2, 14.0, 5.0 Hz, 1H), 1.99–1.86 (m, 2H), 1.84–1.74 (m, 
1H), 1.63–1.50 (m, 3H), 1.60 (d, J = 13.2 Hz, 1H), 1.47 (d, J = 13.1 Hz, 1H), 1.40 (ddd, J 
= 12.7, 8.9, 7.2 Hz, 1H), 1.24 (s, 3H), 1.13 (s, 3H), 0.97 (s, 3H);  13C NMR (125 MHz, 
CDCl3) δ 215.7, 54.5, 53.7, 52.7, 52.4, 49.3, 44.5, 43.5, 38.4, 33.0, 31.3, 31.1, 25.8, 23.2;  
IR (Neat Film NaCl) 2951, 2930, 2867, 1707, 1462, 1405, 1384, 1375, 1364, 1332, 1308, 
1272, 1246, 1236, 1210, 1199, 1179, 1172, 1153, 1118, 1097, 996, 881, 892, 862, 842, 
800, 784 cm–1;  HRMS (EI+) m/z calc'd for C14H22O [M]+•: 206.1671; found 206.1719;  
[α]D25.0 –62.62 (c 0.56, CHCl3, 94.9% ee). 
 
TsHNNH2
MeOH, 40 °C
97% yield
N
n-BuLi, THF
–78!23 °C
36% yield
O
306 360
NHTs
361  
Tosylhydrazone 360.  A 20 mL scintillation vial with a magnetic stir bar was charged 
with acylcyclopentene 306 (50 mg, 0,423 mmol, 1.00 equiv) and MeOH (4 mL).  
TsHNNH2 (49.6 mg, 0.2666 mmol, 1.10 equiv) in MeOH (4 mL) was added. The vial 
was capped with a teflon-lined hard cap and inserted into a 40 °C heating block.  After 48 
h of stirring, the reaction was cooled to ambient temperature. The reaction was 
concentrated under reduced pressure, diluted with EtOAc (5 mL) and washed with H2O 
(2 x 1 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure.  The 
residue was purified by flash column chromatography (SiO2, 3 x 25 cm, 3:1 
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hexanes:EtOAc) to afford tosylhydrazone 360 (88.3 mg, 0.2358 mmol, 97% yield) as a 
pale white foam;  Rf = 0.29 (4:1 hexanes:EtOAc);  1H NMR (500 MHz, CDCl3) δ 7.86 (d, 
J = 8.0 Hz, 2H), 7.30 (d, J = 7.9 Hz, 2H), 5.99 (s, 1H), 5.84 (dd, J = 17.5, 10.7 Hz, 1H), 
4.91–4.79 (m, 2H), 2.49 (t, J = 7.3 Hz, 2H), 2.42 (s, 3H), 1.95–1.81 (m, 1H), 1.87 (s, 3H), 
1.65–1.56 (m, 1H), 1.59 (d, J = 14.3 Hz, 1H), 1.52 (d, J = 14.3 Hz, 1H), 1.04 (s, 3H), 
1.03 (s, 3H), 1.00 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 150.0, 144.2, 139.7, 135.3, 
129.5, 128.4, 109.6, 53.9, 50.1, 39.2, 37.9, 30.2, 29.7, 28.6, 28.1, 21.8, 12.9;  IR (Neat 
Film NaCl) 3214, 3078, 3042, 2954, 2925, 2870, 1710, 1636, 1597, 1491, 1452, 1400, 
1380, 1360, 1337, 1306, 1292, 1210, 1185, 1167, 1120, 1094, 1058, 1020, 1010, 971, 
910, 872, 829, 813, 706 cm–1;  HRMS (MM: ESI-APCI+) m/z calc'd for C21H30N2O2S 
[M+H]+: 375.2101; found 375.2117;  [α]D25.0 –17.83 (c 1.03, CHCl3, 95.3% ee). 
 
Triene 361.  To a 50 mL pear-shaped flask was added tosylhydrazone 360 (75 mg, 
0.2002 mmol, 1.00 equiv).  The flask was sealed with a rubber septum and 
evacuated/backfilled with N2 (3 cycles, 5 min evacuation per cycle).  The solids were 
dissolved in THF (8 mL) and cooled to –78 °C.  The solution was stirred at –78 °C for 20 
min.  A solution of n-BuLi (2.47 M in hexanes, 400 µL, 0.988 mmol, 4.94 equiv) was 
added until a consistent orange color was obtained.  During the n-BuLi addition, the 
reaction initially became yellow but turned orange as more n-BuLi was added.  The 
solution was stirred at –78 °C for 5 min.  The cooling bath was lowered and the reaction 
was allowed to warm to 23 °C over 1 h.  The solution became a deep orange color.  After 
2 h of stirring, the reaction was cooled to 0 °C and quenched with 4 mL sat. aqueous 
NH4Cl, warmed to 23 °C, and stirred for 5 min.  Petroleum ether was added and the 
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phases were separated.  The aqueous layer was extracted with petroleum ether (3 x 5 
mL).  The combined organics were dried over Na2SO4, filtered, and concentrated under 
reduced pressure (25 mmHg) in a 0 °C ice/water bath.  The residue was purified by flash 
column chromatography (SiO2, 2 x 25 cm, petroleum ether hexanes:EtOAc) and 
concentrated under reduced pressure (25 mmHg) in a 0 °C ice/water bath to afford triene 
361 (13.1 mg, 0.06883 mmol, 34% yield) as a clear, colorless oil;  Rf = 0.77 (hexanes);  
1H NMR (500 MHz, CDCl3) δ 6.50 (dd, J = 17.3, 10.6 Hz, 1H), 5.90 (dd, J = 17.5, 10.7 
Hz, 1H), 5.64–5.60 (m, 1H), 5.06–5.02 (m, 1H), 5.02–5.00 (m, 1H), 4.89 (dd, J = 17.5, 
1.4 Hz, 1H), 4.85 (dd, J = 10.7, 1.4 Hz, 1H), 2.46–2.34 (m, 2H), 1.91 (dt, J = 12.8, 7.5 
Hz, 1H), 1.64 (ddd, J = 13.1, 7.6, 6.4 Hz, 1H), 1.60 (d, J = 14.4 Hz, 1H), 1.52 (d, J = 14.3 
Hz, 1H), 1.05 (s, 3H), 1.05 (s, 3H), 1.03 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 150.1, 
141.8, 139.5, 134.2, 113.8, 109.4, 54.1, 49.5, 39.3, 38.0, 29.8, 29.5, 28.6, 28.2;  IR (Neat 
Film NaCl) 3083, 2955, 2929, 2898, 2871, 2849, 1802, 1653, 1636, 1591, 1473, 1457, 
1452, 1413, 1379, 1361, 1301, 1252, 1207, 1126, 1074, 1042, 1008, 987, 905, 898, 850 
cm–1;  HRMS (EI+) m/z calc'd for C14H22 [M]+•: 190.1721; found 190.1723;  [α]D25.0 –
15.56 (c 1.03, CHCl3, 95.3% ee). 
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3.8.3 METHODS FOR DETERMINATION OF ENANTIOMERIC EXCESS 
Table 3.3.  Methods for the Determination of Enantiomeric Excess (Chiral HPLC) 
entry product compound assayed
assay 
conditions
retention time 
of major 
isomer (min)
retention time 
of minor 
isomer (min)
% ee
O
i-BuO
O
i-BuO
HPLC
Chiralcel OD-H
1% IPA in hexane
isocratic, 1.0 mL/min
8.94 8.28 88
O
i-BuO
O
i-BuO
HPLC
Chiralcel OD-H
2.0% IPA in hexane
isocratic, 1.0 mL/min
6.41 7.53 95
314 314
337 337
O
i-BuO
O
i-BuO
HPLC
Chiralcel AD
1.0% IPA in hexane
isocratic, 1.0 mL/min
12.12 10.61 95
337 337
2
1
3
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3.8.4 COMPARISON OF SPECTRAL DATA FOR SYNTHETIC AND 
REPORTED PRESILPHIPERFOLANOLS 224 AND 223 
Spectral data for synthetic “presilphiperfolan-1-ol” (assigned as 224) and “9-epi-
presilphiperfolan-1-ol” (assigned as 223) (1H NMR, 13C NMR, [α]DT) were compared 
with reported spectral data for the natural samples.3,4  Tables comparing compound data 
are shown in Table 3.4–Table 3.7.  Superimposed NMR spectra are shown in Figures 
A5.122–A5.124.  Additionally, we compared the spectra of our synthetic 224 to a 
reported synthetic compound prepared from isocaryophyllene.28  The results are shown in 
Table 3.8–Table 3.9.  1H and 13C NMR spectra for naturally isolated “9-epi-
presilphiperfolan-1-ol” (assigned as 223)4 were generously provided by Prof. Suzana G. 
Leitão.  A 1H NMR spectrum of naturally isolated “presilphiperfolan-1-ol” (assigned as 
224) was published in a dissertation.3b  Unfortunately, attempts to obtain samples or 
spectra of naturally isolated “presilphiperfolan-1-ol” (assigned as 224) were unsuccessful.   
The NMR spectra (C6D6) for synthetic compound 223 match spectral data for 
reported natural “9-epi-presilphiperfolan-1-ol” (assigned as 223),4 but the NMR spectra 
(C6D6) for synthetic compound 224 do not match spectral data for reported 
“presilphiperfolan-1-ol” (assigned as 224).3  The NMR spectra (C6D6) of reported natural 
“presilphiperfolan-1-ol” (assigned as 224)3 appears to match spectral data for reported 
natural “9-epi-presilphiperfolan-1-ol” (assigned as 223).4  The NMR spectra (CD2Cl2) for 
synthetic compound 224 match spectral data for reported synthetic 224.28  Based on our 
analysis of spectral data, we believe that reported natural “presilphiperfolan-1-ol” 
(assigned as 224) is misassigned at C(9) and should have the same true structure as 
natural “9-epi-presilphiperfolan-1-ol” (assigned as 223) with a 9β-methyl configuration. 
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H
H
"presilphiperfolan-1-ol"
reported as structure 224
OH
H
H
"presilphiperfolan-1-ol"
reported as structure 223
OH
presilphiperfolan-1!-ol or 
9!-presilphiperfolan-1!-ol (223)
revised structure
structural
 revision 99
 
 
Table 3.4.  Comparison of Optical Rotation Data for Synthetic and Reported Natural3 
“Presilphiperfolan-1-ol” (224) and Reported Natural4 “9-epi-Presilphiperfolan-1-ol” (223) 
Compound Reported Natural 
Sample 
Synthetic Sample 
“Presilphiperfolan-1-ol” 
(224) 
[α]D
25 = –66.0 
(c 0.0015) 
[α]D
25 = –47.25 
(c 0.63, CHCl3, 94.9% ee) 
“9-epi-Presilphiperfolan-1-ol” 
(223) 
(not reported) [α]D25 = –2.73 
(c 0.68, CHCl3, 94.9% ee) 
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Table 3.5.  Comparison of 1H NMR Data for Synthetic and Reported Natural3 “Presilphiperfolan-1-
ol” (224)a 
H
OH
H
"presilphiperfolan-1-ol"
reported as structure 224
13 12
6
5
4
3
2
1
814
9
10
117
15
 
Assignment Synthetic 224 b 
(ppm) 
Multiplicity, J 
(Hz) 
Natural 224 c 
(ppm) 
Multiplicity, J 
(Hz) 
C1 –– –– –– –– 
C2 1.75 ddd, 13.5, 10.1, 
9.0 
1.92–1.77 m 
 1.52–1.34 m 1.72–1.62 m 
C3 1.96 ddd, 13.3, 9.1, 9.1 1.92–1.77 m 
 1.59 ddd, 13.4, 10.2, 
1.9 
1.62–1.53 m 
C4 –– –– –– –– 
C5 1.53 s 1.50 s 
C6 –– –– –– –– 
C7 0.91–0.82 m 1.17–1.08 m 
C8 1.27 br d, 11.9 1.62–1.53 m 
C9 1.52–1.34 m 1.62–1.53 m 
C10 1.70–1.61 m 1.45–1.39 m 
 0.91–0.82 m 1.33–1.20 m 
C11 1.52–1.34 m 1.33–1.20 m 
 0.91–0.82 m 1.17–1.08 m 
C12 0.81 s 0.80 s 
C13 0.95 s 0.94 s d 
C14 1.39 s 1.32 s 
C15 0.94 d, 7.0 0.89 d, 7 
a  For a comparison of 1H NMR spectra of synthetic and reported samples, see Figure 
A5.122. 
b  1H NMR spectra were obtained at 500 MHz in C6D6 and standardized relative to 
residual C6D6. 
c  1H NMR spectra were obtained at 500 MHz in C6D6 and standardized relative to TMS. 
d  Peak multiplicity was originally reported as (d, J = 7 Hz) in Ref. 3a, but corrected in 
Ref. 3b. 
 
 
CHAPTER 3 – The Total Synthesis of Presilphiperfolanol Natural Products 674 
Table 3.6.  Comparison of 1H NMR Data for Synthetic and Reported Natural4 “9-epi-
Presilphiperfolan-1-ol” (223)a 
H
OH
H
"9-epi-presilphiperfolan-1-ol"
reported as structure 223
13 12
6
5
4
3
2
1
814
9
10
117
15
 
Assignment Synthetic 223 b 
(ppm) 
Multiplicity, J 
(Hz) 
Reported 223 c 
(ppm) 
Multiplicity, J 
(Hz) 
C1 –– –– –– –– 
C2 1.87–1.78 m 1.87–1.79 m 
 1.73–1.64 m 1.72–1.61 m 
C3 1.89–1.81 m 1.87–1.79 m 
 1.63–1.55 m 1.61–1.54 m 
C4 –– –– –– –– 
C5 1.50 s 1.50 s 
C6 –– –– –– –– 
C7 1.15–1.05 m 1.16–1.09 m 
C8 1.55 br d, 12.3 1.61–1.54 m 
C9 1.63–1.55 m 1.61–1.54 m 
C10 1.48–1.38 m 1.45–1.39 m 
 1.36–1.27 m 1.34–1.24 m 
C11 1.33–1.25 m 1.34–1.24 m 
 1.19–1.09 m 1.16–1.09 m 
C12 0.80 s 0.80 s 
C13 0.94 s 0.93 s 
C14 1.33 s 1.32 s 
C15 0.90 d, 7.0 0.89 d, 7 
a  For a comparison of 1H NMR spectra of synthetic and reported samples, see Figure 
A5.124. 
b  1H NMR spectra were obtained at 500 MHz in C6D6 and standardized relative to 
residual C6D6. 
c  1H NMR spectra were obtained at 400 MHz in C6D6 and standardized relative to TMS. 
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Table 3.7.  Comparison of 13C NMR Data for Synthetic and Reported3 Natural “Presilphiperfolan-1-
ol” (224), Synthetic and Reported Natural4 “9-epi-Presilphiperfolan-1-ol” (223)a 
H
OH
H
"presilphiperfolan-1-ol"
reported as structure 224
13 12
6
5
4
3
2
1
814
9
10
117
15
H
OH
H
"9-epi-presilphiperfolan-1-ol"
reported as structure 223
13 12
6
5
4
3
2
1
814
9
10
117
15
 
Assignment Synthetic 224 b 
(ppm) 
Reported 224 c 
(ppm) 
Synthetic 223 b 
(ppm) 
Reported 223 d 
(ppm) 
C1 85.7 89.0 84.5 84.3 
C2 32.1 39.7 39.7 39.5 
C3 42.2 42.6 42.7 42.4 
C4 46.1 46.2 46.2 46.0 
C5 60.6 59.4 59.4 59.2 
C6 40.4 41.0 40.5 40.2 
C7 56.2 51.7 51.7 51.5 
C8 66.2 63.9 63.9 63.7 
C9 41.6 36.9 36.9 36.7 
C10  35.1 29.9 29.9 29.7 
C11 24.7 20.3 20.3 20.1 
C12 22.3 22.3 22.3 22.1 
C13 28.7 28.7 28.8 28.5 
C14 32.5 31.4 31.4 31.1 
C15 15.9 15.7 15.8 15.5 
a  For a comparison of 13C NMR spectra of synthetic and natural 223, see Figure A5.125. 
b  13C NMR spectra were obtained at 125 MHz in C6D6 and standardized relative to 
residual C6D6. 
c  13C NMR spectra were obtained at 125 MHz in C6D6 and standardized relative to TMS. 
d  13C NMR spectra were obtained at 100 MHz in C6D6 and standardized relative to TMS. 
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Table 3.8.  Comparison of 1H NMR Data for Synthetic and Reported Synthetic28 224 
H
OH
H
synthetic compound 224  
Synthetic 224 a 
(ppm) 
Multiplicity, J 
(Hz) 
Reported 224 b 
(ppm) 
Multiplicity, J 
(Hz) 
1.25 s 1.26 s 
0.95 s 0.95 s 
0.93 d, 6.8 0.94 d, 7 
0.81 s 0.82 s 
a  1H NMR spectra were obtained at 500 MHz in CD2Cl2 and 
standardized relative to residual CH2Cl2. 
b  1H NMR spectra were obtained at 100 or 200 MHz in CD2Cl2. 
 
Table 3.9.  Comparison of 13C NMR Data for Synthetic and Reported Synthetic28 224 
Synthetic 224 a 
(ppm) 
Reported 224 b 
(ppm) 
85.7 85.4 
66.2 65.8 
60.6 60.3 
56.2 55.8 
46.1 45.7 
42.2  41.5 
41.6 41.1 
40.4 40.1 
35.1 34.7 
32.5 32.1 
32.1 31.7 
28.7 28.5 
24.7 24.8 
22.3 22.0 
15.9 15.5 
a  13C NMR spectra were obtained at 125 MHz in 
C6D6 and standardized relative to residual C6D6. 
b  13C NMR spectra were obtained at 23 or 50 MHz 
in C6D6/CCl4 and standardized relative to CCl4.
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such as lithium methoxyacetylide or the corresponding Grignard reagents, we did 
not have the opportunity to carry out these transformations.  Following a 
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successful alkylation, an acid-promoted rearrangement could lead to enone-
acrylate ester 324.  
370
OO
324
O
OO
HO 371
O
O
OMe
Li
OMe
+
OMe
H3O+
 
(63) Two additional acylcyclopentenes were also targeted in alternative IMDA 
strategies.  We envisioned that the preparation of cyclopropyl acylcyclopentene 
373 could begin with the allylic oxidation of the methallyl group of ketal 320.  
Numerous conditions with catalytic or stoichiometric SeO2 were employed, but 
these reactions led to complex reaction mixtures.  We also believed that bis-enone 
374 could be productive for not only an IMDA reaction, but also an 
intramolecular Rauhut–Currier-type reaction.  We successfully prepared small 
quantities of compound 374, but it was prone to rapid decomposition. 
372
OO
320
OO SeO2
various
conditions
OH
Simmons–Smith
cyclopropanation
and 
additional steps
373
O
324
O
OO Eschenmosermethylenation 
and 
additional steps
374
O
O
(unstable)  
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(64) Ni and Pd-catalyzed hydrovinylation reactions for the direct conversion of 
methallyl acylcyclopentene 308 to gem-dimethyl acyclopentene 306 were briefly 
investigated, but none of these transformations led to the desired product. 
metal-catalyzed
hydrovinylation
C2H4
306
O
308
O
 
(65) (a) Bellemin-Laponnaz, S.; Gisie, H.; Le Ny, J.-P.; Osborn, J. A. Angew. Chem. 
Int. Ed. Engl. 1997, 36, 976–978.  (b) Morrill, C.; Grubbs, R. H. J. Am. Chem. 
Soc. 2005, 127, 2842–2843. 
(66) Dauben, W. G.; Michno, D. M. J. Org. Chem. 1977, 42, 682–685. 
(67) Several products corresponding to tertiary alcohol conjugate addition were 
isolated in the reaction mixtures. 
375
OO
O
376
O
O
H H
mixture of diastereomers mixture of diastereomers  
(68) Larson, K. K.; Sarpong, R. J. Am. Chem. Soc. 2009, 131, 13244–13245. 
(69) Parikh, J. R.; Doering, W. v. E. J. Am. Chem. Soc. 1967, 89, 5505–5507. 
(70) Shibuya, M.; Tomizawa, M.; Iwabuchi, Y. J. Org. Chem. 2008, 73, 4750–4752. 
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(71) For examples of SN2' halogenations, see:  (a) Jo, H.; Lee, J.; Kim, H.; Kim, S.; 
Kim, D. Tetrahedron Lett. 2003, 44, 7043–7044.  (b) Bakkestuen, A. K.; 
Gundersen, L.-L.; Petersen, D.; Utenova, B. T.; Vik, A. Org. Biomol. Chem. 
2005, 3, 1025–1033.  (c) Fuchter, M. J.; Levy, J.-N. Org. Lett. 2008, 10, 4919–
4922.  (d) Zhang, P.; Le, H.; Kyne, R. E.; Morken, J. P.  J. Am. Chem. Soc. 2011, 
133, 9716–9719. 
(72) For an example of SN2' trifluoroacetoxylation, see:  Ramharter, J.; Mulzer, J. Org. 
Lett. 2011, 13, 5310–5313. 
(73) (a) Reetz, M. T.; Westermann, J.; Steinbach, R. Angew. Chem. Int. Ed. Engl. 
1980, 19, 900–901.  (b) Reetz, M. T.; Westermann, J.; Kyung, S.-H. Chem. Ber. 
1985, 118, 1050–1057. 
(74) Salomon, R. G.; Kochi, J. K. J. Org. Chem. 1973, 38, 3715–3718. 
(75) Our group has previously investigated 2-alkyl, 2-aryl, and 2-halo π-allyl 
electrophiles in Pd-catalyzed asymmetric allylic alkylation reactions (see Refs. 
47, 52, and 56a,d), however, reactions with 2-vinyl π-allyl electrophiles have not 
been explored. 
(76) Satake, Y.; Nishikawa, T.; Hiramatsu, T.; Araki, H.; Isobe. M. Synthesis 2010, 
1992–1998. 
(77) Since Pd(0) is known to undergo cyclometallation with 1,3-dienes, it was believed 
that undesired side reactions could result from this reaction pathway.   
(78) The potentially incompatible electron-deficient olefin and diene functionalities in 
acylcyclopentene 336 did not appear to be a problem during the isolation and 
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storage of the compound.  The quaternary center likely deters undesired 
reactivity. 
(79) For selected IMDA reviews, see:  (a) Bear, B. R.; Sparks, S. M.; Shea, K. J. 
Angew. Chem. Int. Ed. 2001, 40, 820–849.  (b) Nicolaou, K. C.; Snyder, S. A.; 
Montagnon, T.; Vassilikogiannakis, G. Angew. Chem. Int. Ed. 2002, 41, 1668–
1698.  (c) Takao, K.-i.; Munakata, R.; Tadano, K.-i. Chem. Rev. 2005, 105, 4779–
4807.  (d) Juhl, M.; Tanner, D. Chem. Soc. Rev. 2009, 38, 2983–2992. 
(80) Our IMDA substrate does not fit neatly into the Type I or Type II IMDA 
classification, making prediction of the reaction outcome less straightforward. 
(81) A related IMDA cycloaddition for the construction of an analogous tricyclic 
system with an activated alkyne has been reported.  See:  Evanno, L.; Deville, A.; 
Bodo, B.; Nay, B. Tetrahedron Lett. 2007, 48, 4331–4333. 
(82) Although IMDA reactions with silyl dienol ether 335 provided product 341 with 
the undesired C(7) stereochemistry, we believed that we could enforce an endo 
transition state for the IMDA reaction with substrate 378.  Synthesis of the 
precursor 377 (E isomer) by olefin metathesis was successful, but attempted 
silylation and IMDA bicyclization did not afford the desired products.  
O
olefin
metathesis
336
O
377
O
OEt
silylation
379
H
H
OSiR3
7
CO2Et
O
OEt
OSiR3
378
O
OEt
IMDA
 
(83) Relevant IMDA studies performed by Jung and Corey demonstrated that the 
diastereoselectivity of normal-demand Type I IMDA reactions can be reversed by 
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substituting enone dienophiles with their corresponding sterically demanding 
cyclic ketal derivatives.  See:  (a) Jung, M. E; Halweg, K. M. Tetrahedron Lett. 
1981, 22, 3929–3932.  (b) Corey, E. J.; Magriotis, P. A. J. Am. Chem. Soc. 1987, 
109, 287–289. 
(84) Krenske, E. H.; Perry, E. W.; Jerome, S. V.; Maimone, T. J.; Baran, P. S.; Houk, 
K. N. Org. Lett. 2012, 14, 3016–3019. 
(85) Satoh, M.; Nomoto, Y.; Miyaura, N.; Suzuki, A. Tetrahedron Lett. 1989, 30, 
3789–3792. 
(86) (a) Wu, J. Y.; Moreau, B.; Ritter, T. J. Am. Chem. Soc. 2009, 131, 12915–12917. 
(b) Wu, J. Y.; Stanzl, B. N.; Ritter, T. J. Am. Chem. Soc. 2010, 132, 13214–
13216. 
(87) (a) Ely, R. J.; Morken, J. P. J. Am. Chem. Soc. 2010, 132, 2534–2535.  (b) Ely, R. 
J.; Morken, J. P. Org. Synth. 2011, 88, 342–352.  
(88) See Experimental Section for additional details, experimental procedures, reaction 
optimization tables, and comparisons of spectral data. 
(89) Control reactions were performed with isoprene as substrate.  With a 
Ni(cod)2/PCy3 catalyst system, a  1.26:1 linear:branched ratio was observed.  With 
Fe complex 349, the reported 10:1 linear:branched ratio was observed.  The C(4) 
quaternary stereocenter is likely responsible for the differences in regioselectivity 
in our case. 
(90) Attempts to perform the 1,4-hydroboration at an earlier stage of the synthesis 
were unsuccessful.  Treatment of chiral vinylogous ester 337 with Ni(cod)2, PCy3, 
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and HBpin led to a complex reaction mixture.  Treatment of the same compound 
with Mg(0), Fe complex 349, and HBPin also did not provide desired products. 
(91) We planned to transform undesired branched allylic alcohol 347 to 1,3-diene 345 
by an elimination route, but we did not have an opportunity to sufficiently explore 
this recovery route. 
1. alcohol activation
2. elimination
OO
347
OO
345HO  
(92) Luchaco-Cullis, C. A.; Mizutani, H.; Murphy, K. E.; Hoveyda, A. H. Angew. 
Chem. Int. Ed. 2001, 40, 1456–1460. 
(93) A small amount of ketal deprotection of the phosphorylated product 351 was 
sometimes observed in during work-up of the phosphorylation reaction.  The 
resulting acylcyclopentene 380 can also be converted to gem-dimethyl 
acylcyclopentene 306 smoothly and chemoselectively using the Cu-catalyzed 
allylic substitution reaction conditions employed for ketal 351. 
Zn(CH3)2
CuCN (10 mol %)
THF, –78!23 °C
(acid workup)
79% yield
O
O P
OEt
O
EtO
306380
O
 
(94) Our synthetic route makes use of TBS dienol ether 343, but TBDPS dienol ether 
366 was also investigated in the IMDA reaction.  Substrate 366 provided similar 
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yield and dr in the thermal cyclization reaction.  See Experimental Section for the 
preparation of this compound. 
OTBDPS
366  
(95) Murray, R. W.; Singh, M. Org. Synth. 1997, 74, 91–96. 
(96) Incomplete silyl transfer to the tertiary alcohol was observed during the Rubottom 
oxidation, so TBAF was added to simplify the reaction mixture.  The use of 
anhydrous acetone solvent and dry DMDO still did not lead to clean formation of 
the anticipated α-silyloxyketone.  Attempts to install a silyl group on the alcohol 
of α-hydroxyketone 352 led to a mixture of bis-, mono-, and unsilylated products.   
(97) We planned to evaluate IMDA reactions with silyl dienol ether 382 to enforce an 
endo transition state, but attempts to construct acylcyclopentene 381 by olefin 
metathesis were not productive.   
O
olefin
metathesis
306
O
381
O
OEt
silylation
383
H
H
OSiR3
7
CO2Et
O
OEt
OSiR3
382
O
OEt
IMDA
 
(98) We also planned to evaluate IMDA reactions with triene 384, but currently have 
have not had the opportunity to explore this route. 
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O
triflation
methylation
306 385
H
H
7
384
IMDA
 
(99) CCDC 889569 (224), CCDC 889570 (353), and CCDC 911859 (356) contain the 
supplementary crystallographic data for this chapter.  These data can be obtained 
free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif.   
(100) Other temperatures were also investigated for the IMDA reaction.  The reaction 
proceeds smoothly at temperatures as low as 90 °C, but longer reaction times are 
required.  Lower dr was observed at lower temperatures.  For a reaction screen of 
different solvents and temperatures, see Experimental Section for additional 
information (Table 3.2). 
(101) Jolly, R. S.; Luedtke, G.; Sheehan, D.; Livinghouse, T. J. Am. Chem. Soc. 1990, 
112, 4965–4966. 
(102) Wender, P. A.; Jenkins, T. E. J. Am. Chem. Soc. 1989, 111, 6432–6434. 
(103) Bellville, D. J.; Wirth, D. W.; Bauld, N. L. J. Am. Chem. Soc. 1981, 103, 718–
720. 
(104) Attempted hydrogenation of allylic alcohol 354 with Pd/C as catalyst in ethyl 
acetate at 23 °C led to rapid olefin isomerization to endocyclic olefin 386.  This 
compound underwent slow hydrogenation to alcohols 355 and 356.  Rapid initial 
olefin isomerization was also observed in reactions with Crabtree’s catalyst, but 
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with sufficient time, the reactions proceeded to the directed hydrogenation 
product 356.  
H
H
OH
isomerization
(fast)
H
H
354
OH
H
H
386
OH
hydrogenation
(slow)
355
H
H
OH
356
+
 
(105) The allylic alcohol 354 can be converted to trimethylsilyl ether 387.  See 
Experimental Section for the preparation of this compound. 
H
H
367
TMSO
 
(106) Crabtree, R. H.; Davis, M. W. J. Org. Chem. 1986, 51, 2655–2661. 
(107) Competitive olefin isomerization of allylic alcohol 357 to the endocyclic 
trisubstituted alkene 256 is similarly observed if the hydrogenation reaction with 
Crabtree’s catalyst is stopped at incomplete conversion, but if hydrogenation is 
allowed to go to completion, only reduced product 223 is observed. 
H
H
OH
synthetic
224
[Ir(cod)(py)(PCy3)]PF6
(10 mol %)
CH2Cl2, H2 (1 atm)
92% yield
H
H
357
OH
H
H
256
OH
 
(108) Kotoku, N.; Sumii, Y.; Kobayashi, M. Org. Lett. 2011, 13, 3514–3514. 
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(109) Unfortunately, attempts to obtain samples or spectra of naturally isolated 
“presilphiperfolan-1-ol” (224) were unsuccessful. 
(110) An X-ray crystal structure for a semi-synthetic compound with the same structure 
as our synthetic 224 (prepared from isocaryophyllene) was reported by 
Khomenko and co-workers (see ref. 28).  The NMR data for Khomenko’s 224 and 
König’s 224  were acquired in different solvents.  Our NMR data for synthetic 
224  matches the spectral data for Khomenko’s synthetic 224 but not the spectral 
data for König’s natural 224.  See Experimental Section. 
(111) (a) Shapiro, R. H.; Heath, M. J. J. Am. Chem. Soc. 1967, 89, 5734–5735.   
(b) Kaufman, G. M.; Cook, F. B.; Shechter, H.; Bayless, J. H.; Friedman, L. J. 
Am. Chem. Soc. 1967, 89, 5736–5737. 
(112) Bamford, W. R.; Stevens, T. S. M. J. Chem. Soc. 1952, 4735–4740. 
(113) Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. 
Organometallics 1996, 15, 1518–1520. 
(114) (a) Ragan, J. A.; Makowski, T. W.; am Ende, D. J.; Clifford, P. J.; Young, G. R.; 
Conrad, A. K.; Eisenbeis, S. A. Org. Process Res. Dev. 1998, 2, 379–381.   
(b) Ragan, J. A.; Murry, J. A.; Castaldi, M. J.; Conrad, A. K.; Jones, B. P.; Li, B.; 
Makowski, T. W.; McDermott, R.; Sitter, B. J.; White, T. D.; Young, G. R. Org. 
Process. Res. Dev. 2001, 5, 498–507.  (c) Do, N.; McDermott, R. E.; Ragan, J. A. 
Org. Synth. 2008, 85, 138–146. 
(115) Coulson, D. R.; Satek, L. C.; Grim, S. O. Inorg. Synth. 1972, 13, 121–124. 
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(116) Corey, E. J.; Cho, H.; Rücker, C.; Hua, D. H. Tetrahedron Lett. 1981, 22, 3455–
3458. 
(117) Pappo, R.; Allen, Jr., D. S.; Lemieux, R. U.; Johnson, W. S.  J. Org. Chem. 1956, 
21, 478–479. 
(118) Shintani, R.; Takatsu, K.; Takeda, M.; Hayashi, T. Angew. Chem. Int. Ed. 2011, 
50, 8656–8659. 
(119) Thompson, C. F.; Jamison, T. F.; Jacobsen, E. N.  J. Am. Chem. Soc. 2000, 122, 
10482 –10483. 
(120) Knapp, S.; Yu, Y. Org Lett. 2007, 9, 1359–1362. 
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Scheme A4.1.  Retrosynthetic Analysis of Presilphiperfolanol Natural Products 
TS-335
H
OTBS ‡
H
OH
H
presilphiperfolan-1!-ol
(223)
presilphiperfolan-9"-ol
(222)
H
H
H
OH
O
i-BuO
two-carbon
ring contraction
305
337
H
H
OTBS
O
i-BuO
338
asymmetric 
alkylation
O
O
O 336
[4+2]
cycloaddition
 
 
Scheme A4.2.  Synthesis of Isoprenyl Carbamate 339 
NBS, H2O, 0!10 °C
then 30% aq NaOH, 0 °C
62% yield
O
1. LiHMDS, Et2O
     23 °C!reflux
2. CDI, CH2Cl2
     0!23 °C
      50% yield
      two steps
N O
O
N
339
 
 
Scheme A4.3.  Synthesis of Vinylogous Ester 147 
O
i-BuO
147
O 1. TMSCl, Et3N, NaI
    CH3CN, 23 °C
2. Cl2CHCOCl, Et3N
    hexanes, 23 °C H
TMSO
Cl
Cl
O
3. Zn, AcOH, H2O
    i-PrOH, –10!23 °C
4. PPTS (1.5 mol %)
    i-BuOH, PhCH3
    reflux, Dean–Stark
    66% yield, 4 steps
190
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Scheme A4.4.  Asymmetric Alkylation/Ring Contraction Sequence to Methyl/Isoprenyl 
Acylcyclopentene 336 
(S)-t-Bu-PHOX (13) (6.25 mol %)
Pd2(pmdba)3 (2.5 mol %)
PhCH3, 30 °C
91% yield, 95% ee
10 g scale
O
O
i-BuO
acylimidazole 339
LiHMDS, THF, –78 °C
then CH3I, THF
–78!23 °C
N O
O
N
147
336
84% yield
12 g scale
Ph2P N
O
t-Bu
O
i-BuO
O
338
O
O
i-BuO
337
LiOH, TFE
THF, 60 °C
96% yield
6.5 g scale
LiAlH4, Et2O, 0 °C
then 10% aq HCl
96% yield
10 g scale
O
96% yield
340
OH
 
 
Scheme A4.5.  Synthesis of gem-Dimethyl Acylcyclopentene 306 
OO
PPTS (5 mol %)
PhH, reflux
Dean–Stark
94% yield
2 g scale 345336
O HBPin
Ni(cod)2 (x mol %)
PCy3 (x mol %)
PhCH3, 23 °C
then 3 M aq NaOH
H2O2, THF, 0!23 °C
OO
OH
OO
HO
63% yield 18% yield
+
5 mol % Ni (2 g scale)
69% yield 19% yield10 mol % Ni (5 g scale)
346
(linear)
347
(branched)
ClP(O)(OEt)2, Et3N
DMAP (20 mol %)
CH2Cl2, 0!23 °C
84% yield
OO
OH
O
306346
Zn(CH3)2
CuCN (10 mol %)
THF, –78!23 °C
(acid workup)
95% yield
HO OH
OO
O P
OEt
O
EtO
351  
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Scheme A4.6.  IMDA/Rubottom Sequence and Completion of Presilphiperfolan-1β-ol (223) 
DMDO
acetone
–78 °C
then TBAF
–78!23 °C
+
305 344
H
H
OTBS
H
H
OTBS
7
8
OTBS
343
5 7
6
p-dioxane
170 °C, 8 h
sealed tube
O
306
TBSOTf, Et3N
CH2Cl2, 0!23 °C
+H
H
O
H
H
OOH OH
352
27% yield
3 steps
353
62% yield
3 steps
(X-ray)  
 
Scheme A4.7.  Synthesis of Alcohols 355 and 356 
KOt-Bu
Ph3PCH3Br
THF
0!23 °C
94% yield
PtO2 (5 mol %)
EtOAc
H2 (1 atm)
95% combined yield
1.07:1 dr354
+H
H
OH
355
H
H
OH
356
H
H
OH
353
H
H
OOH
46% yield 48% yield
(X-ray)  
Scheme A4.8.  Synthesis of Presilphiperfolan-1β-ol (223) and Alcohol 224 
+
(X-ray)
1. HMDS, imidazole, TMSCl, CH2Cl2
2. PtO2 (5 mol %), EtOAc, H2 (1 atm)
3. TBAF, THF, reflux
          
                88% yield, 3 steps
[Ir(cod)(py)(PCy3)]PF6 (10 mol %), CH2Cl2,  H2 (1 atm)
92% yield
223
H
H
OH
224
H
H
OH
KOt-Bu
Ph3PCH3Br
THF
0!23 °C
90% yield
PtO2 (5 mol %)
EtOAc
H2 (1 atm)
95% combined yield
1.2:1 dr357
H
H
OH
352
H
H
OOH
1 9
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Scheme A4.9.  Planned Formal Synthesis of Presilphiperfolan-9α-ol (222) via IMDA Substrate 343 
OTBS
343
p-dioxane
170 °C, 8 h
sealed tube
NaHMDS, THF
H
H
O
286
+ H
H
O
285
H H
H
H
O
286
H
3 steps
Weyerstahl
route
H
H
H
OH
9
presilphiperfolan-9!-ol
(222)
not observedonly product
H
H
O
286
+ H
H
O
359
H H
then
TBAF
28% yield 64% yield
+
305 344
H
H
OTBS
H
H
OTBS
7
8
 
 
Scheme A4.10.  Planned Formal Synthesis of Presilphiperfolan-9α-ol (222) via IMDA Substrate 361 
TsHNNH2
MeOH, 40 °C
97% yield
N
n-BuLi, THF
–78!23 °C
36% yield
(unoptimized)
O
306 360
NHTs
361
H
H
283
5 steps
Weyerstahl
route
formal synthesis
H
H
362
+
presilphiperfolan-9"-ol
(222)
H
H
H
OH
MMPP
H2O, i-PrOH
62% combined yield
2 steps
1:6.29 dr
(unoptimized)
H
H
284
formal synthesis
H
H
363
+
O O
4 steps
Weyerstahl
route
p-dioxane
170 °C, 8 h
sealed tube
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Figure A5.3.  13C NMR (125 MHz, CDCl3) of compound 313. 
Figure A5.2.  Infrared spectrum (thin film/NaCl) of compound 313. 
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Figure A5.6.  13C NMR (125 MHz, CDCl3) of compound 314. 
Figure A5.5.  Infrared spectrum (thin film/NaCl) of compound 314. 
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Figure A5.9.  13C NMR (125 MHz, CDCl3) of compound 315. 
Figure A5.8.  Infrared spectrum (thin film/NaCl) of compound 315. 
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Figure A5.12.  13C NMR (125 MHz, CDCl3) of compound 364. 
Figure A5.11.  Infrared spectrum (thin film/NaCl) of compound 364. 
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Figure A5.15.  13C NMR (125 MHz, CDCl3) of compound 308. 
Figure A5.14.  Infrared spectrum (thin film/NaCl) of compound 308. 
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Figure A5.18.  13C NMR (125 MHz, CDCl3) of compound 304. 
Figure A5.17.  Infrared spectrum (thin film/NaCl) of compound 304. 
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Figure A5.21.  13C NMR (125 MHz, CDCl3) of compound 319. 
Figure A5.20.  Infrared spectrum (thin film/NaCl) of compound 319. 
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Figure A5.24.  13C NMR (125 MHz, CDCl3) of compound 320. 
Figure A5.23.  Infrared spectrum (thin film/NaCl) of compound 320. 
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Figure A5.27.  13C NMR (125 MHz, CDCl3) of compound 324. 
Figure A5.26.  Infrared spectrum (thin film/NaCl) of compound 324. 
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Figure A5.30.  13C NMR (125 MHz, CDCl3) of compound 327. 
Figure A5.29.  Infrared spectrum (thin film/NaCl) of compound 327. 
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Figure A5.33.  13C NMR (125 MHz, CDCl3) of compound 339. 
Figure A5.32.  Infrared spectrum (thin film/NaCl) of compound 339. 
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Figure A5.36.  13C NMR (125 MHz, CDCl3) of compound 338. 
Figure A5.35.  Infrared spectrum (thin film/NaCl) of compound 338. 
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Figure A5.39.  13C NMR (125 MHz, CDCl3) of compound 337. 
Figure A5.38.  Infrared spectrum (thin film/NaCl) of compound 337. 
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Figure A5.42.  Infrared spectrum (thin film/NaCl) of compound 340. 
Figure A5.41.  13C NMR (125 MHz, CDCl3) of compound 340. 
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Figure A5.45.  13C NMR (125 MHz, CDCl3) of compound 365. 
Figure A5.44.  Infrared spectrum (thin film/NaCl) of compound 365. 
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Figure A5.48.  13C NMR (125 MHz, CDCl3) of compound 336. 
Figure A5.47.  Infrared spectrum (thin film/NaCl) of compound 336. 
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Figure A5.50.  13C NMR (125 MHz, C6D6) of compound 336. 
APPENDIX 5 – Spectra Relevant to Chapter 3 738 
OT
BS
33
5
 
Fi
gu
re
 A
5.
51
.  1
H
 N
M
R
 (5
00
 M
H
z,
 C
6
D
6)
 o
f c
om
po
un
d 
33
5.
 
APPENDIX 5 – Spectra Relevant to Chapter 3 739 
 
Figure A5.53.  13C NMR (125 MHz, C6D6) of compound 335. 
Figure A5.52.  Infrared spectrum (thin film/NaCl) of compound 335. 
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Figure A5.56.  13C NMR (125 MHz, C6D6) of compound 341. 
Figure A5.55.  Infrared spectrum (thin film/NaCl) of compound 341. 
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Figure A5.59.  13C NMR (125 MHz, CDCl3) of compound 342. 
Figure A5.58.  Infrared spectrum (thin film/NaCl) of compound 342. 
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Figure A5.62.  13C NMR (125 MHz, CDCl3) of compound 345. 
Figure A5.61.  Infrared spectrum (thin film/NaCl) of compound 345. 
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Figure A5.65.  13C NMR (125 MHz, C6D6) of compound 346. 
Figure A5.64.  Infrared spectrum (thin film/NaCl) of compound 346. 
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Figure A5.68.  13C NMR (125 MHz, C6D6) of compound 347. 
Figure A5.67.  Infrared spectrum (thin film/NaCl) of compound 347. 
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Figure A5.71.  13C NMR (125 MHz, CDCl3) of compound 351. 
Figure A5.70.  Infrared spectrum (thin film/NaCl) of compound 351. 
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Figure A5.74.  13C NMR (125 MHz, CDCl3) of compound 306. 
Figure A5.73.  Infrared spectrum (thin film/NaCl) of compound 306. 
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Figure A5.76.  13C NMR (125 MHz, C6D6) of compound 306. 
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Figure A5.79.  13C NMR (125 MHz, C6D6) of compound 343. 
Figure A5.78.  Infrared spectrum (thin film/NaCl) of compound 343. 
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Figure A5.82.  13C NMR (125 MHz, C6D6) of compound 366. 
Figure A5.81.  Infrared spectrum (thin film/NaCl) of compound 366. 
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Figure A5.85.  13C NMR (125 MHz, CDCl3) of compound 352. 
Figure A5.84.  Infrared spectrum (thin film/NaCl) of compound 352. 
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Figure A5.87.  13C NMR (125 MHz, C6D6) of compound 352. 
APPENDIX 5 – Spectra Relevant to Chapter 3 764 
H H
O
35
3OH
 
Fi
gu
re
 A
5.
88
.  1
H
 N
M
R
 (5
00
 M
H
z,
 C
D
C
l 3
) o
f c
om
po
un
d 
35
3.
 
APPENDIX 5 – Spectra Relevant to Chapter 3 765 
 
Figure A5.90.  13C NMR (125 MHz, CDCl3) of compound 353. 
Figure A5.89.  Infrared spectrum (thin film/NaCl) of compound 353. 
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Figure A5.92.  13C NMR (125 MHz, C6D6) of compound 353. 
APPENDIX 5 – Spectra Relevant to Chapter 3 768 
H H
35
4OH
 
Fi
gu
re
 A
5.
93
.  1
H
 N
M
R
 (5
00
 M
H
z,
 C
6
D
6)
 o
f c
om
po
un
d 
35
4.
 
APPENDIX 5 – Spectra Relevant to Chapter 3 769 
 
Figure A5.95.  13C NMR (125 MHz, C6D6) of compound 354. 
Figure A5.94.  Infrared spectrum (thin film/NaCl) of compound 354. 
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Figure A5.98.  13C NMR (125 MHz, C6D6) of compound 367. 
Figure A5.97.  Infrared spectrum (thin film/NaCl) of compound 367. 
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Figure A5.101.  13C NMR (125 MHz, C6D6) of compound 355. 
Figure A5.100.  Infrared spectrum (thin film/NaCl) of compound 355. 
APPENDIX 5 – Spectra Relevant to Chapter 3 774 
H H
35
6OH
 
Fi
gu
re
 A
5.
10
2. 
 1 H
 N
M
R
 (5
00
 M
H
z,
 C
6D
6)
 o
f c
om
po
un
d 
35
6.
 
APPENDIX 5 – Spectra Relevant to Chapter 3 775 
 
Figure A5.104.  13C NMR (125 MHz, C6D6) of compound 356. 
Figure A5.103.  Infrared spectrum (thin film/NaCl) of compound 356. 
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Figure A5.107.  13C NMR (125 MHz, C6D6) of compound 357. 
Figure A5.106.  Infrared spectrum (thin film/NaCl) of compound 357. 
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Figure A5.110.  13C NMR (125 MHz, C6D6) of compound 368. 
Figure A5.109.  Infrared spectrum (thin film/NaCl) of compound 368. 
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Figure A5.113.  13C NMR (125 MHz, C6D6) of compound 223. 
Figure A5.112.  Infrared spectrum (thin film/NaCl) of compound 223. 
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Figure A5.116.  13C NMR (125 MHz, C6D6) of compound 224. 
Figure A5.115.  Infrared spectrum (thin film/NaCl) of compound 224. 
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Figure A5.124.  13C NMR (125 MHz, CDCl3) of compound 286. 
 
Figure A5.123.  Infrared spectrum (thin film/NaCl) of compound 286. 
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Figure A5.127.  13C NMR (125 MHz, CDCl3) of compound 359. 
Figure A5.126.  Infrared spectrum (thin film/NaCl) of compound 359. 
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Figure A5.130.  13C NMR (125 MHz, CDCl3) of compound 360. 
Figure A5.129.  Infrared spectrum (thin film/NaCl) of compound 360. 
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Figure A5.133.  13C NMR (125 MHz, CDCl3) of compound 361. 
Figure A5.132.  Infrared spectrum (thin film/NaCl) of compound 361. 
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A6.1 CRYSTAL STRUCTURE ANALYSIS OF 353 
H
H
OOH
 
Compound 353  
(AYH02) (CCDC 889570) 
 
Contents 
Table A6.1.  Crystal data 
Table A6.2.  Atomic coordinates 
Table A6.3.  Full bond distances and angles  
Table A6.4.  Anisotropic displacement parameters 
Table A6.5.  Hydrogen atomic coordinates 
Table A6.6.  Hydrogen bond distances and angles 
 
Figure A6.1.  α-Hydroxyketone 353 (CCDC 889570). 
 
CCDC 889569 contains the supplementary crystallographic data for this compound.  These data 
can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
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Table A6.1.  Crystal data and structure refinement for α-hydroxyketone 353 (CCDC 889570) 
Empirical formula  C14H22O2 
Formula weight  222.32 
Crystallization solvent  benzene, slow evaporation 
Crystal shape  irregular 
Crystal color  colorless  
Crystal size 0.05 x 0.10 x 0.44 mm 
 
 Data Collection  
Preliminary photograph(s)  rotation  
Type of diffractometer  Bruker KAPPA APEX II 
Wavelength  0.71073 Å  MoKα 
Data collection temperature  100 K 
Theta range for 4413 reflections used 
in lattice determination  2.77 to 31.42° 
Unit cell dimensions a = 5.8000(6) Å α = 90° 
 b = 7.3616(7) Å β = 90° 
 c = 29.454(3) Å γ = 90° 
Volume 1257.6(2) Å3 
Z 4 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1)   (# 19) 
Density (calculated) 1.174 g/cm3 
F(000) 488 
Theta range for data collection 2.8 to 35.1° 
Completeness to theta = 25.00° 99.9%  
Index ranges -9 ≤ h ≤ 8, -11 ≤ k ≤ 7, -46 ≤ l ≤ 46 
Data collection scan type  narrow omega and phi scans 
Reflections collected 19979 
Independent reflections 5133 [Rint= 0.0514] 
Reflections > 2σ(I) 4130  
Average σ(I)/(net I) 0.0579 
Absorption coefficient 0.08 mm–1 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9962 and 0.9672 
Reflections monitored for decay  0 
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Table A6.1 (cont.) 
Decay of standards  0% 
 
Structure Solution and Refinement 
Primary solution method  direct 
Secondary solution method  difmap 
Hydrogen placement  geom 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5133 / 0 / 233 
Treatment of hydrogen atoms  refall 
Goodness-of-fit on F2 1.56 
Final R indices [I>2σ(I), 4130 reflections] R1 = 0.0515, wR2 = 0.0685 
R indices (all data) R1 = 0.0713, wR2 = 0.0707 
Type of weighting scheme used calc 
Weighting scheme used calc w=1/[^2^(Fo^2^)+(0.0000P)^2^+0.0000P] where 
P=(Fo^2^+2Fc^2^)/3 
Max shift/error  0.000 
Average shift/error  0.000 
Absolute structure parameter -0.4(8) 
Largest diff. peak and hole 0.35 and -0.32 e.Å–3 
 
Programs Used 
Cell refinement   SAINT V8.18C (Bruker-AXS, 2007) 
Data collection   APEX2 2012.2-0 (Bruker-AXS, 2007) 
Data reduction   SAINT V8.18C (Bruker-AXS, 2007) 
Structure solution   SHELXS-97 (Sheldrick, 1990) 
Structure refinement   SHELXL-97 (Sheldrick, 1997) 
Graphics  DIAMOND 3 (Crystal Impact, 1999) 
 
References 
 
  Special Refinement Details  
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Figure A6.2.  α-Hydroxyketone 353 (CCDC 889570). 
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Table A6.2.  Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 x 103) 
for α-hydroxyketone 353 (CCDC 889570).  U(eq) is defined as the trace of the orthogonalized Uij 
tensor 
 x y z Ueq 
C(1) 3631(2) 7788(1) 1771(1) 15(1) 
C(2) 1527(2) 6527(2) 1808(1) 16(1) 
C(3) 1401(2) 5619(2) 1345(1) 18(1) 
C(4) 2282(2) 7021(1) 996(1) 15(1) 
C(5) 339(2) 8066(2) 754(1) 18(1) 
C(6) 1024(2) 10078(1) 743(1) 16(1) 
C(7) 2200(2) 10316(1) 1211(1) 14(1) 
C(8) 3529(2) 8518(1) 1283(1) 14(1) 
C(9) 3490(2) 9258(2) 2129(1) 18(1) 
C(10) 1817(2) 10785(2) 2050(1) 23(1) 
C(11) 531(2) 10713(2) 1601(1) 18(1) 
C(12) 2788(2) 10465(2) 368(1) 21(1) 
C(13) -1040(2) 11316(2) 665(1) 23(1) 
C(14) 3888(2) 6071(2) 660(1) 23(1) 
O(1) 5704(1) 6782(1) 1805(1) 20(1) 
O(2) 4656(2) 9193(1) 2472(1) 28(1) 
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Table A6.3.  Bond lengths [Å] and angles [°] for 353 (CCDC 889570) 
C(1)-O(1)  1.4155(13) 
C(1)-C(9)  1.5143(15) 
C(1)-C(8)  1.5351(14) 
C(1)-C(2)  1.5375(15) 
C(2)-C(3)  1.5225(15) 
C(2)-H(2A)  0.961(11) 
C(2)-H(2B)  0.993(11) 
C(3)-C(4)  1.5429(16) 
C(3)-H(3A)  0.958(12) 
C(3)-H(3B)  1.000(11) 
C(4)-C(14)  1.5291(15) 
C(4)-C(5)  1.5406(15) 
C(4)-C(8)  1.5654(15) 
C(5)-C(6)  1.5334(15) 
C(5)-H(5A)  0.980(12) 
C(5)-H(5B)  1.000(12) 
C(6)-C(13)  1.5227(16) 
C(6)-C(12)  1.5328(16) 
C(6)-C(7)  1.5483(14) 
C(7)-C(11)  1.5301(15) 
C(7)-C(8)  1.5462(15) 
C(7)-H(7)  0.982(10) 
C(8)-H(8)  0.956(10) 
C(9)-O(2)  1.2164(13) 
C(9)-C(10)  1.5036(16) 
C(10)-C(11)  1.5186(16) 
C(10)-H(10A)  1.000(13) 
C(10)-H(10B)  0.965(13) 
C(11)-H(11A)  0.997(11) 
C(11)-H(11B)  0.997(11) 
C(12)-H(12A)  0.968(12) 
C(12)-H(12B)  1.033(13) 
C(12)-H(12C)  0.981(12) 
C(13)-H(13A)  1.007(12) 
C(13)-H(13B)  1.020(13) 
C(13)-H(13C)  0.961(13) 
C(14)-H(14A)  0.980(12) 
C(14)-H(14B)  1.001(12) 
C(14)-H(14C)  0.977(13) 
O(1)-H(1)  0.804(14) 
 
O(1)-C(1)-C(9) 111.71(9) 
O(1)-C(1)-C(8) 106.39(8) 
C(9)-C(1)-C(8) 113.66(9) 
O(1)-C(1)-C(2) 110.67(8) 
C(9)-C(1)-C(2) 109.75(9) 
C(8)-C(1)-C(2) 104.39(9) 
C(3)-C(2)-C(1) 103.78(9) 
C(3)-C(2)-H(2A) 112.8(6) 
C(1)-C(2)-H(2A) 108.1(6) 
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Table A6.3 (cont.) 
C(3)-C(2)-H(2B) 110.7(6) 
C(1)-C(2)-H(2B) 112.1(6) 
H(2A)-C(2)-H(2B) 109.2(9) 
C(2)-C(3)-C(4) 106.72(9) 
C(2)-C(3)-H(3A) 113.5(7) 
C(4)-C(3)-H(3A) 110.2(7) 
C(2)-C(3)-H(3B) 108.2(6) 
C(4)-C(3)-H(3B) 108.7(6) 
H(3A)-C(3)-H(3B) 109.4(9) 
C(14)-C(4)-C(5) 111.95(9) 
C(14)-C(4)-C(3) 109.09(9) 
C(5)-C(4)-C(3) 113.61(9) 
C(14)-C(4)-C(8) 112.96(9) 
C(5)-C(4)-C(8) 103.68(9) 
C(3)-C(4)-C(8) 105.35(8) 
C(6)-C(5)-C(4) 107.57(9) 
C(6)-C(5)-H(5A) 114.9(7) 
C(4)-C(5)-H(5A) 110.4(7) 
C(6)-C(5)-H(5B) 109.9(7) 
C(4)-C(5)-H(5B) 109.3(7) 
H(5A)-C(5)-H(5B) 104.7(9) 
C(13)-C(6)-C(12) 107.76(9) 
C(13)-C(6)-C(5) 112.17(9) 
C(12)-C(6)-C(5) 111.53(9) 
C(13)-C(6)-C(7) 114.37(9) 
C(12)-C(6)-C(7) 109.10(9) 
C(5)-C(6)-C(7) 101.87(8) 
C(11)-C(7)-C(8) 112.14(9) 
C(11)-C(7)-C(6) 114.31(9) 
C(8)-C(7)-C(6) 104.12(8) 
C(11)-C(7)-H(7) 105.3(6) 
C(8)-C(7)-H(7) 111.3(6) 
C(6)-C(7)-H(7) 109.7(6) 
C(1)-C(8)-C(7) 116.49(9) 
C(1)-C(8)-C(4) 106.06(8) 
C(7)-C(8)-C(4) 107.38(9) 
C(1)-C(8)-H(8) 107.7(6) 
C(7)-C(8)-H(8) 110.1(6) 
C(4)-C(8)-H(8) 108.9(6) 
O(2)-C(9)-C(10) 121.13(10) 
O(2)-C(9)-C(1) 121.44(10) 
C(10)-C(9)-C(1) 117.42(9) 
C(9)-C(10)-C(11) 115.22(10) 
C(9)-C(10)-H(10A) 106.4(7) 
C(11)-C(10)-H(10A) 110.9(7) 
C(9)-C(10)-H(10B) 108.4(8) 
C(11)-C(10)-H(10B) 111.5(8) 
H(10A)-C(10)-H(10B) 103.6(10) 
C(10)-C(11)-C(7) 110.44(9) 
C(10)-C(11)-H(11A) 109.4(6) 
C(7)-C(11)-H(11A) 110.6(6) 
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Table A6.3 (cont.) 
C(10)-C(11)-H(11B) 111.1(6) 
C(7)-C(11)-H(11B) 110.9(6) 
H(11A)-C(11)-H(11B) 104.4(9) 
C(6)-C(12)-H(12A) 112.4(7) 
C(6)-C(12)-H(12B) 114.1(7) 
H(12A)-C(12)-H(12B) 105.9(9) 
C(6)-C(12)-H(12C) 110.5(7) 
H(12A)-C(12)-H(12C) 108.0(10) 
H(12B)-C(12)-H(12C) 105.5(10) 
C(6)-C(13)-H(13A) 112.8(7) 
C(6)-C(13)-H(13B) 113.7(7) 
H(13A)-C(13)-H(13B) 107.3(10) 
C(6)-C(13)-H(13C) 110.8(7) 
H(13A)-C(13)-H(13C) 107.9(9) 
H(13B)-C(13)-H(13C) 103.7(10) 
C(4)-C(14)-H(14A) 109.7(7) 
C(4)-C(14)-H(14B) 110.7(7) 
H(14A)-C(14)-H(14B) 105.5(9) 
C(4)-C(14)-H(14C) 113.0(7) 
H(14A)-C(14)-H(14C) 109.2(10) 
H(14B)-C(14)-H(14C) 108.4(10) 
C(1)-O(1)-H(1) 110.1(10) 
Symmetry transformations used to generate equivalent atoms: 
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Table A6.4.  Anisotropic displacement parameters (Å2 x 104) for α-hydroxyketone 353 (CCDC 
889570).  The anisotropic displacement factor exponent takes the form: –2π2[ h2a*2U11 + ... + 2 h k 
a* b* U12 ] 
  U11 U22  U33 U23 U13 U12 
 
C(1) 143(5)  177(5) 124(5)  12(4) -11(4)  17(5) 
C(2) 186(5)  177(5) 132(5)  40(5) 16(5)  -4(5) 
C(3) 231(6)  148(5) 171(6)  12(4) -4(5)  -26(5) 
C(4) 209(5)  144(5) 103(5)  -11(4) 0(4)  -24(5) 
C(5) 225(6)  196(6) 124(5)  -16(5) -29(5)  -36(5) 
C(6) 188(6)  170(5) 131(5)  7(4) -34(4)  -30(4) 
C(7) 146(5)  138(5) 127(5)  0(4) -11(4)  -28(4) 
C(8) 156(5)  163(5) 99(5)  0(4) 13(4)  -19(5) 
C(9) 219(5)  209(6) 112(5)  12(4) 15(4)  -39(5) 
C(10) 296(7)  266(7) 128(6)  -55(5) 0(5)  73(6) 
C(11) 204(5)  174(6) 148(5)  -3(5) 6(4)  27(5) 
C(12) 296(6)  218(6) 121(6)  25(5) -11(5)  -72(6) 
C(13) 254(7)  228(6) 198(6)  43(5) -84(5)  -21(5) 
C(14) 313(7)  207(6) 170(6)  -39(5) 32(5)  0(6) 
O(1) 186(4)  245(4) 176(4)  57(4) -14(3)  43(4) 
O(2) 389(5)  279(5) 174(4)  -32(4) -114(4)  21(4) 
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Table A6.5.  Hydrogen coordinates (x 103) and isotropic displacement parameters (Å2 x 103) for  
α-hydroxyketone 353 (CCDC 889570) 
 
 x  y  z  Uiso 
 
H(2A) 181(2) 568(1) 205(1) 11(3) 
H(2B) 8(2) 721(1) 187(1) 9(3) 
H(3A) -12(2) 522(2) 126(1) 17(3) 
H(3B) 247(2) 456(2) 134(1) 13(3) 
H(5A) 3(2) 753(2) 46(1) 24(3) 
H(5B) -113(2) 791(2) 93(1) 24(3) 
H(7) 325(2) 1136(1) 120(1) 4(2) 
H(8) 508(2) 864(1) 118(1) 7(3) 
H(10A) 272(2) 1194(2) 208(1) 39(4) 
H(10B) 77(2) 1084(2) 230(1) 40(4) 
H(11A) -28(2) 1189(2) 155(1) 15(3) 
H(11B) -73(2) 979(2) 161(1) 17(3) 
H(12A) 223(2) 1013(2) 7(1) 30(4) 
H(12B) 434(2) 979(2) 41(1) 27(3) 
H(12C) 318(2) 1176(2) 36(1) 32(4) 
H(13A) -63(2) 1264(2) 69(1) 25(3) 
H(13B) -237(2) 1109(2) 88(1) 30(4) 
H(13C) -171(2) 1110(2) 37(1) 30(3) 
H(14A) 307(2) 507(2) 51(1) 25(3) 
H(14B) 522(2) 550(2) 82(1) 26(3) 
H(14C) 450(2) 689(2) 43(1) 31(3) 
H(1) 568(2) 615(2) 203(1) 37(4) 
 
 
 
Table A6.6.  Hydrogen bonds for α-hydroxyketone 353 (CCDC 889570) [Å and °] 
 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
 
O(1)-H(1)...O(2)#1 0.804(14) 2.071(15) 2.8653(12) 169.7(13) 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,y-1/2,-z+1/2  
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A6.2 CRYSTAL STRUCTURE ANALYSIS OF 224 
H
H
OH
 
Compound 224 
(AYH01) (CCDC 889569) 
 
Contents 
Table A6.7.  Crystal data 
Table A6.8.  Atomic coordinates 
Table A6.9.  Full bond distances and angles  
Table A6.10.  Anisotropic displacement parameters 
Table A6.11.  Hydrogen atomic coordinates 
Table A6.12.  Hydrogen bond distances and angles 
 
Figure A6.3.  Tertiary alcohol 224 (CCDC 889569).  
 
CCDC 889569 contains the supplementary crystallographic data for this compound.  These data 
can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
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Table A6.7.  Crystal data and structure refinement for tertiary alcohol 224 (CCDC 889569) 
Empirical formula  C15H26O 
Formula weight  222.36 
Crystallization solvent  hexanes, slow evaporation  
Crystal shape  block 
Crystal color  colorless  
Crystal size 0.20 x 0.42 x 0.44 mm 
 
 Data Collection  
Preliminary photograph(s)  rotation  
Type of diffractometer  Bruker KAPPA APEX II 
Wavelength  0.71073 Å  MoKα 
Data collection temperature  100 K 
Theta range for 9919 reflections used 
in lattice determination  2.35 to 33.56° 
Unit cell dimensions a = 17.8200(13) Å α = 90° 
 b = 9.0182(4) Å β = 112.479(2)° 
 c = 18.7656(9) Å γ = 90° 
Volume 2786.6(3) Å3 
Z 8 
Crystal system  Monoclinic 
Space group  I2   (# 5) 
Density (calculated) 1.060 g/cm3 
F(000) 992 
Theta range for data collection 2.3 to 41.1° 
Completeness to theta = 25.00° 99.8%  
Index ranges -30 ≤ h ≤ 32, -16 ≤ k ≤ 16, -30 ≤ l ≤ 34 
Data collection scan type  narrow omega and phi scans 
Reflections collected 66426 
Independent reflections 17149 [Rint= 0.0390] 
Reflections > 2 s(I) 11947  
Average s(I)/(net I) 0.0568 
Absorption coefficient 0.06 mm–1 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9874 and 0.9726 
Reflections monitored for decay  0 
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Table A6.7 (cont.) 
Decay of standards  0% 
 
Structure Solution and Refinement 
Primary solution method  direct 
Secondary solution method  difmap 
Hydrogen placement  geom 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 17149 / 1 / 498 
Treatment of hydrogen atoms  refall 
Goodness-of-fit on F2 2.14 
Final R indices [I>2σ (I), 11947 reflections] R1 = 0.0566, wR2 = 0.0604 
R indices (all data) R1 = 0.0987, wR2 = 0.0618 
Type of weighting scheme used calc 
Weighting scheme used calc w=1/[^2^(Fo^2^)+(0.0000P)^2^+0.0000P] where 
P=(Fo^2^+2Fc^2^)/3 
Max shift/error  0.001 
Average shift/error  0.000 
Absolute structure parameter -0.4(5) 
Extinction coefficient 0.00083(11) 
Largest diff. peak and hole 0.62 and -0.30 e.Å–3 
 
Programs Used 
Cell refinement   SAINT V8.18C (Bruker-AXS, 2007) 
Data collection   APEX2 2012.2-0 (Bruker-AXS, 2007) 
Data reduction   SAINT V8.18C (Bruker-AXS, 2007) 
Structure solution   SHELXS-97 (Sheldrick, 1990) 
Structure refinement   SHELXL-97 (Sheldrick, 1997) 
Graphics  DIAMOND 3 (Crystal Impact, 1999) 
 
References 
 
  Special Refinement Details  
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Figure A6.4.  Tertiary alcohol 224, crystal form A (CCDC 889569). 
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Figure A6.5.  Tertiary alcohol 224, crystal form B (CCDC 889569). 
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Table A6.8.  Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 x 103) 
for tertiary alcohol 224 (CCDC 889569).  U(eq) is defined as the trace of the orthogonalized Uij 
tensor 
 x y z Ueq 
O(1A) 3956(1) 967(1) 101(1) 27(1) 
C(1A) 3287(1) 100(1) 135(1) 17(1) 
C(2A) 2590(1) 164(1) -659(1) 20(1) 
C(3A) 2207(1) 1716(1) -689(1) 22(1) 
C(4A) 2422(1) 2238(1) 158(1) 19(1) 
C(5A) 1685(1) 2307(1) 413(1) 26(1) 
C(6A) 1833(1) 1161(1) 1065(1) 25(1) 
C(7A) 2330(1) 16(1) 827(1) 19(1) 
C(8A) 2938(1) 944(1) 632(1) 16(1) 
C(9A) 3615(1) -1426(1) 480(1) 22(1) 
C(10A) 3068(1) -2264(1) 806(1) 27(1) 
C(11A) 2742(1) -1325(1) 1303(1) 28(1) 
C(12A) 2309(1) 1842(1) 1857(1) 37(1) 
C(13A) 1044(1) 514(1) 1063(1) 40(1) 
C(14A) 2882(1) 3712(1) 315(1) 27(1) 
C(15A) 3827(1) -2400(1) -80(1) 34(1) 
O(1B) 5561(1) 934(1) 1119(1) 28(1) 
C(1B) 5724(1) 1902(1) 1778(1) 18(1) 
C(2B) 6641(1) 1788(1) 2244(1) 24(1) 
C(3B) 6751(1) 344(1) 2714(1) 31(1) 
C(4B) 5919(1) -77(1) 2750(1) 23(1) 
C(5B) 5896(1) -2(1) 3573(1) 32(1) 
C(6B) 5334(1) 1292(1) 3590(1) 22(1) 
C(7B) 5432(1) 2293(1) 2970(1) 18(1) 
C(8B) 5373(1) 1228(1) 2320(1) 17(1) 
C(9B) 5359(1) 3445(1) 1494(1) 22(1) 
C(10B) 5299(1) 4442(1) 2131(1) 28(1) 
C(11B) 4935(1) 3678(1) 2654(1) 25(1) 
C(12B) 4460(1) 773(1) 3385(1) 33(1) 
C(13B) 5631(1) 2046(1) 4378(1) 32(1) 
C(14B) 5634(1) -1585(1) 2379(1) 36(1) 
C(15B) 5790(1) 4240(1) 1045(1) 32(1) 
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Table A6.9.  Bond lengths [Å] and angles [°] for tertiary alcohol 224 (CCDC 889569) 
O(1A)-C(1A)  1.4471(9) 
O(1A)-H(1A)  0.734(10) 
C(1A)-C(8A)  1.5110(10) 
C(1A)-C(2A)  1.5328(10) 
C(1A)-C(9A)  1.5385(11) 
C(2A)-C(3A)  1.5483(11) 
C(2A)-H(2A)  0.968(8) 
C(2A)-H(2B)  0.969(8) 
C(3A)-C(4A)  1.5590(11) 
C(3A)-H(3A)  0.999(8) 
C(3A)-H(3B)  0.996(8) 
C(4A)-C(14A)  1.5305(11) 
C(4A)-C(8A)  1.5400(11) 
C(4A)-C(5A)  1.5601(11) 
C(5A)-C(6A)  1.5450(12) 
C(5A)-H(5A)  1.001(8) 
C(5A)-H(5B)  0.974(9) 
C(6A)-C(13A)  1.5221(12) 
C(6A)-C(12A)  1.5305(12) 
C(6A)-C(7A)  1.5333(11) 
C(7A)-C(11A)  1.5158(12) 
C(7A)-C(8A)  1.5198(10) 
C(7A)-H(7A)  0.998(7) 
C(8A)-H(8A)  0.951(7) 
C(9A)-C(15A)  1.5236(12) 
C(9A)-C(10A)  1.5335(12) 
C(9A)-H(9A)  0.977(8) 
C(10A)-C(11A)  1.5288(13) 
C(10A)-H(10A)  0.998(8) 
C(10A)-H(10B)  1.018(9) 
C(11A)-H(11A)  0.972(9) 
C(11A)-H(11B)  0.999(9) 
C(12A)-H(12A)  0.995(10) 
C(12A)-H(12B)  0.992(9) 
C(12A)-H(12C)  0.999(10) 
C(13A)-H(13A)  0.977(11) 
C(13A)-H(13B)  0.970(10) 
C(13A)-H(13C)  0.942(11) 
C(14A)-H(14A)  0.976(9) 
C(14A)-H(14B)  0.983(9) 
C(14A)-H(14C)  0.989(9) 
C(15A)-H(15A)  0.979(10) 
C(15A)-H(15B)  1.024(10) 
C(15A)-H(15C)  0.987(10) 
O(1B)-C(1B)  1.4494(10) 
O(1B)-H(1B)  0.748(11) 
C(1B)-C(8B)  1.5103(10) 
C(1B)-C(2B)  1.5338(11) 
C(1B)-C(9B)  1.5419(11) 
C(2B)-C(3B)  1.5428(13) 
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Table A6.9 (cont.) 
C(2B)-H(2C)  0.977(8) 
C(2B)-H(2D)  1.005(9) 
C(3B)-C(4B)  1.5564(13) 
C(3B)-H(3C)  0.977(10) 
C(3B)-H(3D)  0.998(9) 
C(4B)-C(14B)  1.5232(12) 
C(4B)-C(8B)  1.5430(11) 
C(4B)-C(5B)  1.5621(12) 
C(5B)-C(6B)  1.5472(12) 
C(5B)-H(5C)  0.959(10) 
C(5B)-H(5D)  0.961(10) 
C(6B)-C(13B)  1.5264(11) 
C(6B)-C(12B)  1.5283(12) 
C(6B)-C(7B)  1.5340(11) 
C(7B)-C(11B)  1.5145(11) 
C(7B)-C(8B)  1.5238(10) 
C(7B)-H(7B)  0.984(7) 
C(8B)-H(8B)  0.984(8) 
C(9B)-C(15B)  1.5198(12) 
C(9B)-C(10B)  1.5316(12) 
C(9B)-H(9B)  0.967(7) 
C(10B)-C(11B)  1.5329(12) 
C(10B)-H(10C)  1.011(9) 
C(10B)-H(10D)  0.966(10) 
C(11B)-H(11C)  0.956(8) 
C(11B)-H(11D)  0.967(8) 
C(12B)-H(12D)  0.980(9) 
C(12B)-H(12E)  0.968(9) 
C(12B)-H(12F)  0.998(9) 
C(13B)-H(13D)  0.994(10) 
C(13B)-H(13E)  0.987(10) 
C(13B)-H(13F)  0.976(9) 
C(14B)-H(14D)  0.995(10) 
C(14B)-H(14E)  0.964(10) 
C(14B)-H(14F)  0.991(10) 
C(15B)-H(15D)  1.014(11) 
C(15B)-H(15E)  0.984(10) 
C(15B)-H(15F)  0.962(10) 
 
C(1A)-O(1A)-H(1A) 110.4(9) 
O(1A)-C(1A)-C(8A) 107.21(6) 
O(1A)-C(1A)-C(2A) 108.20(6) 
C(8A)-C(1A)-C(2A) 102.06(6) 
O(1A)-C(1A)-C(9A) 108.36(6) 
C(8A)-C(1A)-C(9A) 111.76(6) 
C(2A)-C(1A)-C(9A) 118.63(6) 
C(1A)-C(2A)-C(3A) 104.58(6) 
C(1A)-C(2A)-H(2A) 109.6(5) 
C(3A)-C(2A)-H(2A) 111.5(5) 
C(1A)-C(2A)-H(2B) 110.0(5) 
C(3A)-C(2A)-H(2B) 111.5(5) 
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H(2A)-C(2A)-H(2B) 109.5(6) 
C(2A)-C(3A)-C(4A) 107.62(6) 
C(2A)-C(3A)-H(3A) 111.5(5) 
C(4A)-C(3A)-H(3A) 111.5(4) 
C(2A)-C(3A)-H(3B) 111.2(5) 
C(4A)-C(3A)-H(3B) 109.2(5) 
H(3A)-C(3A)-H(3B) 105.9(7) 
C(14A)-C(4A)-C(8A) 112.91(6) 
C(14A)-C(4A)-C(3A) 111.26(7) 
C(8A)-C(4A)-C(3A) 102.70(6) 
C(14A)-C(4A)-C(5A) 110.99(7) 
C(8A)-C(4A)-C(5A) 103.88(6) 
C(3A)-C(4A)-C(5A) 114.65(7) 
C(6A)-C(5A)-C(4A) 107.85(6) 
C(6A)-C(5A)-H(5A) 112.3(5) 
C(4A)-C(5A)-H(5A) 111.2(5) 
C(6A)-C(5A)-H(5B) 109.3(5) 
C(4A)-C(5A)-H(5B) 110.6(5) 
H(5A)-C(5A)-H(5B) 105.5(7) 
C(13A)-C(6A)-C(12A) 108.90(8) 
C(13A)-C(6A)-C(7A) 112.14(8) 
C(12A)-C(6A)-C(7A) 112.71(7) 
C(13A)-C(6A)-C(5A) 112.13(8) 
C(12A)-C(6A)-C(5A) 111.38(8) 
C(7A)-C(6A)-C(5A) 99.39(6) 
C(11A)-C(7A)-C(8A) 110.62(7) 
C(11A)-C(7A)-C(6A) 124.72(7) 
C(8A)-C(7A)-C(6A) 104.02(6) 
C(11A)-C(7A)-H(7A) 105.1(4) 
C(8A)-C(7A)-H(7A) 105.6(4) 
C(6A)-C(7A)-H(7A) 105.3(4) 
C(1A)-C(8A)-C(7A) 111.77(6) 
C(1A)-C(8A)-C(4A) 108.72(6) 
C(7A)-C(8A)-C(4A) 103.50(6) 
C(1A)-C(8A)-H(8A) 109.4(4) 
C(7A)-C(8A)-H(8A) 108.5(4) 
C(4A)-C(8A)-H(8A) 114.8(4) 
C(15A)-C(9A)-C(10A) 110.76(7) 
C(15A)-C(9A)-C(1A) 112.32(7) 
C(10A)-C(9A)-C(1A) 114.30(7) 
C(15A)-C(9A)-H(9A) 106.5(4) 
C(10A)-C(9A)-H(9A) 107.2(4) 
C(1A)-C(9A)-H(9A) 105.1(5) 
C(11A)-C(10A)-C(9A) 114.74(7) 
C(11A)-C(10A)-H(10A) 108.7(5) 
C(9A)-C(10A)-H(10A) 110.0(5) 
C(11A)-C(10A)-H(10B) 110.1(5) 
C(9A)-C(10A)-H(10B) 108.3(5) 
H(10A)-C(10A)-H(10B) 104.6(7) 
C(7A)-C(11A)-C(10A) 107.07(7) 
C(7A)-C(11A)-H(11A) 108.1(5) 
APPENDIX 6 —X-Ray Crystallography Reports Relevant to Chapter 3 
 
817 
Table A6.9 (cont.) 
C(10A)-C(11A)-H(11A) 110.8(5) 
C(7A)-C(11A)-H(11B) 109.7(5) 
C(10A)-C(11A)-H(11B) 111.6(5) 
H(11A)-C(11A)-H(11B) 109.4(7) 
C(6A)-C(12A)-H(12A) 109.7(6) 
C(6A)-C(12A)-H(12B) 111.9(5) 
H(12A)-C(12A)-H(12B) 108.4(8) 
C(6A)-C(12A)-H(12C) 109.7(6) 
H(12A)-C(12A)-H(12C) 106.1(7) 
H(12B)-C(12A)-H(12C) 110.9(8) 
C(6A)-C(13A)-H(13A) 111.6(6) 
C(6A)-C(13A)-H(13B) 110.7(6) 
H(13A)-C(13A)-H(13B) 107.8(8) 
C(6A)-C(13A)-H(13C) 110.6(7) 
H(13A)-C(13A)-H(13C) 107.4(8) 
H(13B)-C(13A)-H(13C) 108.6(9) 
C(4A)-C(14A)-H(14A) 109.6(5) 
C(4A)-C(14A)-H(14B) 110.9(5) 
H(14A)-C(14A)-H(14B) 108.3(7) 
C(4A)-C(14A)-H(14C) 111.3(5) 
H(14A)-C(14A)-H(14C) 108.5(7) 
H(14B)-C(14A)-H(14C) 108.1(7) 
C(9A)-C(15A)-H(15A) 109.1(5) 
C(9A)-C(15A)-H(15B) 112.0(5) 
H(15A)-C(15A)-H(15B) 108.4(8) 
C(9A)-C(15A)-H(15C) 110.9(6) 
H(15A)-C(15A)-H(15C) 110.3(8) 
H(15B)-C(15A)-H(15C) 106.0(8) 
C(1B)-O(1B)-H(1B) 109.6(8) 
O(1B)-C(1B)-C(8B) 109.42(6) 
O(1B)-C(1B)-C(2B) 105.54(6) 
C(8B)-C(1B)-C(2B) 102.40(6) 
O(1B)-C(1B)-C(9B) 109.12(6) 
C(8B)-C(1B)-C(9B) 111.58(6) 
C(2B)-C(1B)-C(9B) 118.31(7) 
C(1B)-C(2B)-C(3B) 104.90(7) 
C(1B)-C(2B)-H(2C) 110.2(5) 
C(3B)-C(2B)-H(2C) 112.0(5) 
C(1B)-C(2B)-H(2D) 109.8(5) 
C(3B)-C(2B)-H(2D) 112.7(5) 
H(2C)-C(2B)-H(2D) 107.3(7) 
C(2B)-C(3B)-C(4B) 108.38(6) 
C(2B)-C(3B)-H(3C) 111.3(5) 
C(4B)-C(3B)-H(3C) 111.5(5) 
C(2B)-C(3B)-H(3D) 108.0(5) 
C(4B)-C(3B)-H(3D) 109.9(5) 
H(3C)-C(3B)-H(3D) 107.7(7) 
C(14B)-C(4B)-C(8B) 114.15(7) 
C(14B)-C(4B)-C(3B) 110.72(8) 
C(8B)-C(4B)-C(3B) 102.28(7) 
C(14B)-C(4B)-C(5B) 111.10(8) 
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C(8B)-C(4B)-C(5B) 103.54(7) 
C(3B)-C(4B)-C(5B) 114.67(7) 
C(6B)-C(5B)-C(4B) 108.32(7) 
C(6B)-C(5B)-H(5C) 110.3(6) 
C(4B)-C(5B)-H(5C) 112.0(6) 
C(6B)-C(5B)-H(5D) 107.5(6) 
C(4B)-C(5B)-H(5D) 111.5(6) 
H(5C)-C(5B)-H(5D) 107.2(8) 
C(13B)-C(6B)-C(12B) 108.80(7) 
C(13B)-C(6B)-C(7B) 112.00(7) 
C(12B)-C(6B)-C(7B) 113.00(7) 
C(13B)-C(6B)-C(5B) 111.61(7) 
C(12B)-C(6B)-C(5B) 111.70(8) 
C(7B)-C(6B)-C(5B) 99.55(6) 
C(11B)-C(7B)-C(8B) 110.85(7) 
C(11B)-C(7B)-C(6B) 124.21(7) 
C(8B)-C(7B)-C(6B) 104.03(6) 
C(11B)-C(7B)-H(7B) 105.4(4) 
C(8B)-C(7B)-H(7B) 105.6(4) 
C(6B)-C(7B)-H(7B) 105.3(4) 
C(1B)-C(8B)-C(7B) 111.41(6) 
C(1B)-C(8B)-C(4B) 108.52(6) 
C(7B)-C(8B)-C(4B) 103.07(6) 
C(1B)-C(8B)-H(8B) 110.3(4) 
C(7B)-C(8B)-H(8B) 110.5(4) 
C(4B)-C(8B)-H(8B) 112.9(4) 
C(15B)-C(9B)-C(10B) 110.84(7) 
C(15B)-C(9B)-C(1B) 112.46(7) 
C(10B)-C(9B)-C(1B) 113.92(7) 
C(15B)-C(9B)-H(9B) 109.4(4) 
C(10B)-C(9B)-H(9B) 105.7(4) 
C(1B)-C(9B)-H(9B) 104.0(4) 
C(9B)-C(10B)-C(11B) 114.14(7) 
C(9B)-C(10B)-H(10C) 108.9(5) 
C(11B)-C(10B)-H(10C) 106.1(5) 
C(9B)-C(10B)-H(10D) 110.2(5) 
C(11B)-C(10B)-H(10D) 108.0(5) 
H(10C)-C(10B)-H(10D) 109.3(7) 
C(7B)-C(11B)-C(10B) 107.05(7) 
C(7B)-C(11B)-H(11C) 110.3(5) 
C(10B)-C(11B)-H(11C) 110.8(5) 
C(7B)-C(11B)-H(11D) 111.4(5) 
C(10B)-C(11B)-H(11D) 111.1(5) 
H(11C)-C(11B)-H(11D) 106.2(6) 
C(6B)-C(12B)-H(12D) 110.6(5) 
C(6B)-C(12B)-H(12E) 111.3(5) 
H(12D)-C(12B)-H(12E) 107.6(7) 
C(6B)-C(12B)-H(12F) 111.6(5) 
H(12D)-C(12B)-H(12F) 107.9(7) 
H(12E)-C(12B)-H(12F) 107.7(8) 
C(6B)-C(13B)-H(13D) 110.8(6) 
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C(6B)-C(13B)-H(13E) 111.4(5) 
H(13D)-C(13B)-H(13E) 106.1(7) 
C(6B)-C(13B)-H(13F) 109.9(5) 
H(13D)-C(13B)-H(13F) 108.5(7) 
H(13E)-C(13B)-H(13F) 110.2(8) 
C(4B)-C(14B)-H(14D) 110.1(6) 
C(4B)-C(14B)-H(14E) 108.0(5) 
H(14D)-C(14B)-H(14E) 110.4(8) 
C(4B)-C(14B)-H(14F) 111.5(6) 
H(14D)-C(14B)-H(14F) 108.0(8) 
H(14E)-C(14B)-H(14F) 108.9(8) 
C(9B)-C(15B)-H(15D) 112.1(6) 
C(9B)-C(15B)-H(15E) 112.4(6) 
H(15D)-C(15B)-H(15E) 106.9(8) 
C(9B)-C(15B)-H(15F) 111.9(5) 
H(15D)-C(15B)-H(15F) 105.2(8) 
H(15E)-C(15B)-H(15F) 107.9(8) 
Symmetry transformations used to generate equivalent atoms: 
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Table A6.10.  Anisotropic displacement parameters (Å2 x 104) for tertiary alcohol 224 (CCDC 
889569).  The anisotropic displacement factor exponent takes the form: –2π2[ h2a*2U11 + ... + 2 h k 
a* b* U12 ] 
  U11 U22  U33 U23 U13 U12 
 
O(1A) 202(3)  283(3) 360(4)  20(3) 153(3)  -34(3) 
C(1A) 139(3)  171(4) 191(3)  2(3) 62(3)  -36(3) 
C(2A) 199(4)  235(4) 165(4)  12(3) 77(3)  -21(3) 
C(3A) 218(4)  256(4) 177(4)  52(3) 56(3)  15(3) 
C(4A) 163(3)  173(4) 208(4)  8(3) 55(3)  9(3) 
C(5A) 192(4)  306(5) 278(5)  -26(4) 82(4)  40(4) 
C(6A) 211(4)  343(5) 223(4)  -36(4) 115(3)  -30(4) 
C(7A) 185(4)  224(4) 164(3)  -10(3) 58(3)  -53(3) 
C(8A) 142(3)  168(4) 149(3)  2(3) 34(3)  -23(3) 
C(9A) 190(4)  185(4) 248(4)  1(3) 34(3)  4(3) 
C(10A) 286(5)  176(4) 292(5)  35(4) 40(4)  -28(4) 
C(11A) 307(5)  284(5) 227(4)  71(4) 90(4)  -87(4) 
C(12A) 356(5)  512(7) 248(5)  -87(5) 135(4)  16(5) 
C(13A) 317(5)  561(7) 409(6)  -19(6) 231(5)  -58(5) 
C(14A) 245(4)  167(4) 329(5)  26(4) 49(4)  1(3) 
C(15A) 344(5)  260(5) 414(6)  -46(5) 137(5)  61(4) 
O(1B) 319(4)  286(3) 183(3)  -61(3) 28(3)  61(3) 
C(1B) 170(3)  198(4) 173(3)  -45(3) 54(3)  7(3) 
C(2B) 166(4)  341(5) 223(4)  -81(4) 78(3)  20(3) 
C(3B) 218(4)  365(5) 289(5)  -25(4) 35(4)  131(4) 
C(4B) 268(4)  190(4) 170(4)  -6(3) 19(3)  64(3) 
C(5B) 371(5)  351(5) 194(4)  42(4) 51(4)  98(5) 
C(6B) 198(4)  276(4) 170(4)  -19(3) 49(3)  -12(3) 
C(7B) 142(3)  206(4) 204(4)  -53(3) 64(3)  -15(3) 
C(8B) 141(3)  165(4) 170(3)  -17(3) 21(3)  11(3) 
C(9B) 194(4)  193(4) 254(4)  12(3) 81(3)  -12(3) 
C(10B) 313(5)  171(4) 367(5)  -11(4) 151(4)  4(4) 
C(11B) 256(4)  217(4) 316(5)  -56(4) 158(4)  29(3) 
C(12B) 299(5)  406(6) 256(5)  24(5) 86(4)  -101(4) 
C(13B) 270(5)  468(6) 212(4)  -72(4) 94(4)  -45(5) 
C(14B) 500(6)  207(5) 255(5)  4(4) 1(4)  88(4) 
C(15B) 330(5)  310(5) 345(6)  45(5) 160(4)  -32(4) 
  
APPENDIX 6 —X-Ray Crystallography Reports Relevant to Chapter 3 
 
821 
 
Table A6.11.  Hydrogen coordinates (x 103) and isotropic displacement parameters (Å2 x 103) for 
tertiary alcohol 224 (CCDC 889569) 
 
 x  y  z  Uiso 
 
H(1A) 399(1) 87(1) -27(1) 38(4) 
H(2A) 220(1) -62(1) -70(1) 16(2) 
H(2B) 280(1) 5(1) -106(1) 19(2) 
H(3A) 161(1) 170(1) -98(1) 21(2) 
H(3B) 243(1) 244(1) -96(1) 21(2) 
H(5A) 161(1) 333(1) 57(1) 21(2) 
H(5B) 118(1) 206(1) -2(1) 29(2) 
H(7A) 195(1) -40(1) 33(1) 14(2) 
H(8A) 336(1) 123(1) 110(1) 9(2) 
H(9A) 413(1) -122(1) 91(1) 15(2) 
H(10A) 260(1) -271(1) 38(1) 22(2) 
H(10B) 338(1) -315(1) 112(1) 28(2) 
H(11A) 234(1) -187(1) 143(1) 31(2) 
H(11B) 319(1) -100(1) 179(1) 30(2) 
H(12A) 196(1) 258(1) 198(1) 45(3) 
H(12B) 281(1) 235(1) 187(1) 34(3) 
H(12C) 244(1) 106(1) 226(1) 42(3) 
H(13A) 114(1) -24(1) 146(1) 52(3) 
H(13B) 73(1) 6(1) 57(1) 45(3) 
H(13C) 72(1) 126(1) 116(1) 51(3) 
H(14A) 304(1) 398(1) 86(1) 29(2) 
H(14B) 254(1) 451(1) 0(1) 32(2) 
H(14C) 338(1) 364(1) 20(1) 29(2) 
H(15A) 412(1) -328(1) 19(1) 37(3) 
H(15B) 418(1) -186(1) -31(1) 46(3) 
H(15C) 333(1) -270(1) -52(1) 43(3) 
H(1B) 511(1) 90(1) 89(1) 44(3) 
H(2C) 683(1) 266(1) 258(1) 18(2) 
H(2D) 694(1) 177(1) 188(1) 30(2) 
H(3C) 717(1) 45(1) 323(1) 36(3) 
H(3D) 693(1) -45(1) 244(1) 35(3) 
H(5C) 571(1) -91(1) 371(1) 41(3) 
H(5D) 642(1) 20(1) 396(1) 40(3) 
H(7B) 600(1) 263(1) 319(1) 9(2) 
H(8B) 480(1) 93(1) 203(1) 15(2) 
H(9B) 480(1) 324(1) 116(1) 8(2) 
H(10C) 586(1) 476(1) 248(1) 26(2) 
H(10D) 497(1) 531(1) 191(1) 34(3) 
H(11C) 495(1) 432(1) 307(1) 22(2) 
H(11D) 437(1) 344(1) 237(1) 19(2) 
H(12D) 443(1) 9(1) 378(1) 33(3) 
H(12E) 426(1) 26(1) 289(1) 33(3) 
H(12F) 409(1) 162(1) 335(1) 39(3) 
H(13D) 527(1) 289(1) 438(1) 41(3) 
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Table A6.11 (cont.) 
H(13E) 618(1) 246(1) 451(1) 39(3) 
H(13F) 563(1) 134(1) 477(1) 31(3) 
H(14D) 509(1) -182(1) 238(1) 47(3) 
H(14E) 603(1) -231(1) 267(1) 40(3) 
H(14F) 559(1) -160(1) 184(1) 43(3) 
H(15D) 552(1) 521(1) 82(1) 57(3) 
H(15E) 581(1) 364(1) 61(1) 44(3) 
H(15F) 634(1) 450(1) 137(1) 40(3) 
 
 
 
Table A6.12.  Hydrogen bonds for tertiary alcohol 224 (CCDC 889569) [Å and °] 
 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
 
O(1A)-H(1A)...O(1B)#1 0.734(10) 2.033(10) 2.7380(9) 161.1(11) 
O(1B)-H(1B)...O(1A) 0.748(11) 2.028(11) 2.7658(9) 168.8(11) 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,y,-z  
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A6.3 CRYSTAL STRUCTURE ANALYSIS OF 356 
H
H
OH
 
Compound 356  
(AYH03) (CCDC 911859) 
 
Contents 
Table A6.13.  Crystal data 
Table A6.14.  Atomic coordinates 
Table A6.15.  Full bond distances and angles  
Table A6.16.  Anisotropic displacement parameters 
Table A6.17.  Hydrogen atomic coordinates 
Table A6.18.  Hydrogen bond distances and angles 
 
Figure A6.6.  Tertiary Alcohol 356 (CCDC 911859).  
 
CCDC 911859 contains the supplementary crystallographic data for this compound.  These data 
can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
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Table A6.13.  Crystal data and structure refinement for tertiary alcohol 356 (CCDC 911859) 
Empirical formula  C15H26O 
Formula weight  222.36 
Crystallization solvent  hexanes, slow evaporation  
Crystal shape  block 
Crystal color  colorless  
Crystal size 0.11 x 0.2 x 0.43 mm 
 
 Data Collection  
Preliminary photograph(s)  rotation  
Type of diffractometer  Bruker APEX-II CCD 
Wavelength  0.71073 Å  MoKα 
Data collection temperature  100 K 
Theta range for 9851 reflections used 
in lattice determination  2.25 to 35.10° 
Unit cell dimensions a = 20.8725(14) Å α = 90° 
 b = 9.2598(6) Å β = 119.717(3)° 
 c = 16.2667(11) Å γ = 90° 
Volume 2730.5(3) Å3 
Z 8 
Crystal system  monoclinic 
Space group  C 1 2 1   (# 5) 
Density (calculated) 1.082 g/cm3 
F(000) 992 
Theta range for data collection 2.2 to 38.1° 
Completeness to theta = 25.00° 99.9%  
Index ranges -35 ≤ h ≤ 35, -16 ≤ k ≤ 15, -27 ≤ l ≤ 27 
Data collection scan type  and scans 
Reflections collected 78345 
Independent reflections 13415 [Rint= 0.0435] 
Reflections > 2 s(I) 11403 
Average s(I)/(net I) 0.0343 
Absorption coefficient 0.06 mm–1 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.0000 and 0.9268 
APPENDIX 6 —X-Ray Crystallography Reports Relevant to Chapter 3 
 
825 
Table A6.13 (cont.) 
 
Structure Solution and Refinement 
Primary solution method  dual 
Secondary solution method  ? 
Hydrogen placement  geom 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 13415 / 1 / 299 
Treatment of hydrogen atoms  constr 
Goodness-of-fit on F2 1.51 
Final R indices [I>2σ (I), 11403 reflections] R1 = 0.0453, wR2 = 0.1039 
R indices (all data) R1 = 0.0591, wR2 = 0.1084 
Type of weighting scheme used calc 
Weighting scheme used  
Max shift/error  0.001 
Average shift/error  0.000 
Absolute structure parameter 0.5(3) 
Extinction coefficient 0.00083(11) 
Largest diff. peak and hole 0.39 and -0.26 e.Å–3 
 
Programs Used 
Cell refinement   SAINT V8.27B (Bruker-AXS, 2007) 
Data collection   APEX2 2012.4-3 (Bruker-AXS, 2007) 
Data reduction   SAINT V8.27B (Bruker-AXS, 2007) 
Structure solution   SHELXT (Sheldrick, 2012) 
Structure refinement   SHELXL-2012/6 (Sheldrick, 2012) 
Graphics  DIAMOND 3 (Crystal Impact, 1999) 
 
References 
 
  Special Refinement Details  
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Figure A6.7.  Tertiary alcohol 356, crystal form A (CCDC 889569). 
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Table A6.14.  Atomic coordinates (x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) for tertiary alcohol 356 (CCDC 911859).  U(eq) is defined as the trace of the 
orthogonalized Uij tensor 
 x y z Ueq 
O(1A) 6050(1) 724(1) 5532(1) 33(1) 
C(1A) 6702(1) 1621(1) 5956(1) 17(1) 
C(2A) 7062(1) 1474(1) 5338(1) 20(1) 
C(3A) 7417(1) -19(2) 5586(1) 26(1) 
C(4A) 7663(1) -279(1) 6640(1) 20(1) 
C(5A) 8483(1) 78(1) 7322(1) 23(1) 
C(6A) 8522(1) 929(1) 8156(1) 21(1) 
C(7A) 7823(1) 1887(1) 7662(1) 18(1) 
C(8A) 7242(1) 881(1) 6892(1) 16(1) 
C(9A) 6511(1) 3156(1) 6104(1) 20(1) 
C(10A) 7205(1) 4104(1) 6645(1) 24(1) 
C(11A) 7929(1) 3280(1) 7243(1) 20(1) 
C(12A) 9249(1) 1761(2) 8692(1) 31(1) 
C(13A) 8463(1) -68(2) 8869(1) 33(1) 
C(14A) 7478(1) -1839(1) 6763(1) 34(1) 
C(15A) 5955(1) 3889(2) 5180(1) 28(1) 
O(1B) 4896(1) 726(1) 3769(1) 34(1) 
C(1B) 4743(1) -64(1) 2928(1) 17(1) 
C(2B) 5437(1) 42(1) 2837(1) 20(1) 
C(3B) 5417(1) 1576(1) 2484(1) 23(1) 
C(4B) 4592(1) 1972(1) 1854(1) 19(1) 
C(5B) 4301(1) 1758(1) 787(1) 24(1) 
C(6B) 3549(1) 996(1) 372(1) 25(1) 
C(7B) 3672(1) -62(1) 1173(1) 20(1) 
C(8B) 4161(1) 815(1) 2089(1) 16(1) 
C(9B) 4481(1) -1590(1) 2961(1) 23(1) 
C(10B) 4232(1) -2424(1) 2031(1) 27(1) 
C(11B) 4026(1) -1488(1) 1156(1) 23(1) 
C(12B) 3338(1) 275(2) -573(1) 40(1) 
C(13B) 2927(1) 2037(2) 204(1) 35(1) 
C(14B) 4463(1) 3519(1) 2076(1) 32(1) 
C(15B) 5051(1) -2467(2) 3800(1) 39(1) 
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Table A6.15.  Bond lengths [Å] and angles [°] for tertiary alcohol 356 (CCDC 911859) 
O(1A)-H(1A)  0.8400 
O(1A)-C(1A)  1.4453(13) 
C(1A)-C(2A)  1.5308(14) 
C(1A)-C(8A)  1.5346(14) 
C(1A)-C(9A)  1.5270(15) 
C(2A)-H(2A1)  0.9900 
C(2A)-H(2A2)  0.9900 
C(2A)-C(3A)  1.5250(18) 
C(3A)-H(3A1)  0.9900 
C(3A)-H(3A2)  0.9900 
C(3A)-C(4A)  1.5463(17) 
C(4A)-C(5A)  1.5448(16) 
C(4A)-C(8A)  1.5658(14) 
C(4A)-C(14A)  1.5334(17) 
C(5A)-H(5A1)  0.9900 
C(5A)-H(5A2)  0.9900 
C(5A)-C(6A)  1.5364(17) 
C(6A)-C(7A)  1.5478(15) 
C(6A)-C(12A)  1.5318(17) 
C(6A)-C(13A)  1.5343(16) 
C(7A)-H(7A)  1.0000 
C(7A)-C(8A)  1.5493(15) 
C(7A)-C(11A)  1.5247(15) 
C(8A)-H(8A)  1.0000 
C(9A)-H(9A)  1.0000 
C(9A)-C(10A)  1.5426(17) 
C(9A)-C(15A)  1.5294(16) 
C(10A)-H(10A)  0.9900 
C(10A)-H(10B)  0.9900 
C(10A)-C(11A)  1.5338(16) 
C(11A)-H(11A)  0.9900 
C(11A)-H(11B)  0.9900 
C(12A)-H(12A)  0.9800 
C(12A)-H(12B)  0.9800 
C(12A)-H(12C)  0.9800 
C(13A)-H(13A)  0.9800 
C(13A)-H(13B)  0.9800 
C(13A)-H(13C)  0.9800 
C(14A)-H(14A)  0.9800 
C(14A)-H(14B)  0.9800 
C(14A)-H(14C)  0.9800 
C(15A)-H(15A)  0.9800 
C(15A)-H(15B)  0.9800 
C(15A)-H(15C)  0.9800 
O(1B)-H(1B)  0.8400 
O(1B)-C(1B)  1.4410(13) 
C(1B)-C(2B)  1.5298(14) 
C(1B)-C(8B)  1.5350(14) 
C(1B)-C(9B)  1.5261(16) 
C(2B)-H(2B1)  0.9900 
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Table A6.15 (cont.) 
C(2B)-H(2B2)  0.9900 
C(2B)-C(3B)  1.5243(17) 
C(3B)-H(3B1)  0.9900 
C(3B)-H(3B2)  0.9900 
C(3B)-C(4B)  1.5495(16) 
C(4B)-C(5B)  1.5417(16) 
C(4B)-C(8B)  1.5638(14) 
C(4B)-C(14B)  1.5336(17) 
C(5B)-H(5B1)  0.9900 
C(5B)-H(5B2)  0.9900 
C(5B)-C(6B)  1.5387(17) 
C(6B)-C(7B)  1.5469(16) 
C(6B)-C(12B)  1.5270(19) 
C(6B)-C(13B)  1.5282(18) 
C(7B)-H(7B)  1.0000 
C(7B)-C(8B)  1.5533(15) 
C(7B)-C(11B)  1.5211(16) 
C(8B)-H(8B)  1.0000 
C(9B)-H(9B)  1.0000 
C(9B)-C(10B)  1.5414(18) 
C(9B)-C(15B)  1.5258(18) 
C(10B)-H(10C)  0.9900 
C(10B)-H(10D)  0.9900 
C(10B)-C(11B)  1.5349(18) 
C(11B)-H(11C)  0.9900 
C(11B)-H(11D)  0.9900 
C(12B)-H(12D)  0.9800 
C(12B)-H(12E)  0.9800 
C(12B)-H(12F)  0.9800 
C(13B)-H(13D)  0.9800 
C(13B)-H(13E)  0.9800 
C(13B)-H(13F)  0.9800 
C(14B)-H(14D)  0.9800 
C(14B)-H(14E)  0.9800 
C(14B)-H(14F)  0.9800 
C(15B)-H(15D)  0.9800 
C(15B)-H(15E)  0.9800 
C(15B)-H(15F)  0.9800 
 
C(1A)-O(1A)-H(1A) 109.5 
O(1A)-C(1A)-C(2A) 106.76(9) 
O(1A)-C(1A)-C(8A) 105.75(9) 
O(1A)-C(1A)-C(9A) 110.62(8) 
C(2A)-C(1A)-C(8A) 104.70(8) 
C(9A)-C(1A)-C(2A) 115.98(9) 
C(9A)-C(1A)-C(8A) 112.33(9) 
C(1A)-C(2A)-H(2A1) 111.0 
C(1A)-C(2A)-H(2A2) 111.0 
H(2A1)-C(2A)-H(2A2) 109.0 
C(3A)-C(2A)-C(1A) 103.86(9) 
C(3A)-C(2A)-H(2A1) 111.0 
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Table A6.15 (cont.) 
C(3A)-C(2A)-H(2A2) 111.0 
C(2A)-C(3A)-H(3A1) 110.4 
C(2A)-C(3A)-H(3A2) 110.4 
C(2A)-C(3A)-C(4A) 106.57(9) 
H(3A1)-C(3A)-H(3A2) 108.6 
C(4A)-C(3A)-H(3A1) 110.4 
C(4A)-C(3A)-H(3A2) 110.4 
C(3A)-C(4A)-C(8A) 105.20(9) 
C(5A)-C(4A)-C(3A) 113.75(9) 
C(5A)-C(4A)-C(8A) 103.39(9) 
C(14A)-C(4A)-C(3A) 108.95(10) 
C(14A)-C(4A)-C(5A) 111.67(10) 
C(14A)-C(4A)-C(8A) 113.71(9) 
C(4A)-C(5A)-H(5A1) 110.3 
C(4A)-C(5A)-H(5A2) 110.3 
H(5A1)-C(5A)-H(5A2) 108.5 
C(6A)-C(5A)-C(4A) 107.31(8) 
C(6A)-C(5A)-H(5A1) 110.3 
C(6A)-C(5A)-H(5A2) 110.3 
C(5A)-C(6A)-C(7A) 102.26(8) 
C(12A)-C(6A)-C(5A) 111.37(9) 
C(12A)-C(6A)-C(7A) 114.86(11) 
C(12A)-C(6A)-C(13A) 107.42(10) 
C(13A)-C(6A)-C(5A) 111.73(11) 
C(13A)-C(6A)-C(7A) 109.24(9) 
C(6A)-C(7A)-H(7A) 109.0 
C(6A)-C(7A)-C(8A) 103.52(9) 
C(8A)-C(7A)-H(7A) 109.0 
C(11A)-C(7A)-C(6A) 114.14(8) 
C(11A)-C(7A)-H(7A) 109.0 
C(11A)-C(7A)-C(8A) 112.09(8) 
C(1A)-C(8A)-C(4A) 106.16(8) 
C(1A)-C(8A)-C(7A) 115.40(9) 
C(1A)-C(8A)-H(8A) 109.1 
C(4A)-C(8A)-H(8A) 109.1 
C(7A)-C(8A)-C(4A) 107.92(8) 
C(7A)-C(8A)-H(8A) 109.1 
C(1A)-C(9A)-H(9A) 107.0 
C(1A)-C(9A)-C(10A) 112.03(8) 
C(1A)-C(9A)-C(15A) 112.89(10) 
C(10A)-C(9A)-H(9A) 107.0 
C(15A)-C(9A)-H(9A) 107.0 
C(15A)-C(9A)-C(10A) 110.44(10) 
C(9A)-C(10A)-H(10A) 108.4 
C(9A)-C(10A)-H(10B) 108.4 
H(10A)-C(10A)-H(10B) 107.5 
C(11A)-C(10A)-C(9A) 115.42(9) 
C(11A)-C(10A)-H(10A) 108.4 
C(11A)-C(10A)-H(10B) 108.4 
C(7A)-C(11A)-C(10A) 112.92(9) 
C(7A)-C(11A)-H(11A) 109.0 
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Table A6.15 (cont.) 
C(7A)-C(11A)-H(11B) 109.0 
C(10A)-C(11A)-H(11A) 109.0 
C(10A)-C(11A)-H(11B) 109.0 
H(11A)-C(11A)-H(11B) 107.8 
C(6A)-C(12A)-H(12A) 109.5 
C(6A)-C(12A)-H(12B) 109.5 
C(6A)-C(12A)-H(12C) 109.5 
H(12A)-C(12A)-H(12B) 109.5 
H(12A)-C(12A)-H(12C) 109.5 
H(12B)-C(12A)-H(12C) 109.5 
C(6A)-C(13A)-H(13A) 109.5 
C(6A)-C(13A)-H(13B) 109.5 
C(6A)-C(13A)-H(13C) 109.5 
H(13A)-C(13A)-H(13B) 109.5 
H(13A)-C(13A)-H(13C) 109.5 
H(13B)-C(13A)-H(13C) 109.5 
C(4A)-C(14A)-H(14A) 109.5 
C(4A)-C(14A)-H(14B) 109.5 
C(4A)-C(14A)-H(14C) 109.5 
H(14A)-C(14A)-H(14B) 109.5 
H(14A)-C(14A)-H(14C) 109.5 
H(14B)-C(14A)-H(14C) 109.5 
C(9A)-C(15A)-H(15A) 109.5 
C(9A)-C(15A)-H(15B) 109.5 
C(9A)-C(15A)-H(15C) 109.5 
H(15A)-C(15A)-H(15B) 109.5 
H(15A)-C(15A)-H(15C) 109.5 
H(15B)-C(15A)-H(15C) 109.5 
C(1B)-O(1B)-H(1B) 109.5 
O(1B)-C(1B)-C(2B) 106.56(9) 
O(1B)-C(1B)-C(8B) 106.27(9) 
O(1B)-C(1B)-C(9B) 110.55(8) 
C(2B)-C(1B)-C(8B) 104.50(8) 
C(9B)-C(1B)-C(2B) 115.84(9) 
C(9B)-C(1B)-C(8B) 112.46(9) 
C(1B)-C(2B)-H(2B1) 110.9 
C(1B)-C(2B)-H(2B2) 110.9 
H(2B1)-C(2B)-H(2B2) 108.9 
C(3B)-C(2B)-C(1B) 104.21(9) 
C(3B)-C(2B)-H(2B1) 110.9 
C(3B)-C(2B)-H(2B2) 110.9 
C(2B)-C(3B)-H(3B1) 110.4 
C(2B)-C(3B)-H(3B2) 110.4 
C(2B)-C(3B)-C(4B) 106.49(8) 
H(3B1)-C(3B)-H(3B2) 108.6 
C(4B)-C(3B)-H(3B1) 110.4 
C(4B)-C(3B)-H(3B2) 110.4 
C(3B)-C(4B)-C(8B) 105.14(8) 
C(5B)-C(4B)-C(3B) 113.77(9) 
C(5B)-C(4B)-C(8B) 103.52(9) 
C(14B)-C(4B)-C(3B) 109.44(10) 
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Table A6.15 (cont.) 
C(14B)-C(4B)-C(5B) 111.62(10) 
C(14B)-C(4B)-C(8B) 113.13(9) 
C(4B)-C(5B)-H(5B1) 110.2 
C(4B)-C(5B)-H(5B2) 110.2 
H(5B1)-C(5B)-H(5B2) 108.5 
C(6B)-C(5B)-C(4B) 107.47(8) 
C(6B)-C(5B)-H(5B1) 110.2 
C(6B)-C(5B)-H(5B2) 110.2 
C(5B)-C(6B)-C(7B) 102.34(8) 
C(12B)-C(6B)-C(5B) 111.34(11) 
C(12B)-C(6B)-C(7B) 114.63(12) 
C(12B)-C(6B)-C(13B) 107.50(11) 
C(13B)-C(6B)-C(5B) 112.33(11) 
C(13B)-C(6B)-C(7B) 108.75(10) 
C(6B)-C(7B)-H(7B) 108.9 
C(6B)-C(7B)-C(8B) 103.49(9) 
C(8B)-C(7B)-H(7B) 108.9 
C(11B)-C(7B)-C(6B) 114.39(9) 
C(11B)-C(7B)-H(7B) 108.9 
C(11B)-C(7B)-C(8B) 112.13(9) 
C(1B)-C(8B)-C(4B) 106.41(8) 
C(1B)-C(8B)-C(7B) 115.49(9) 
C(1B)-C(8B)-H(8B) 108.9 
C(4B)-C(8B)-H(8B) 108.9 
C(7B)-C(8B)-C(4B) 107.94(8) 
C(7B)-C(8B)-H(8B) 108.9 
C(1B)-C(9B)-H(9B) 106.9 
C(1B)-C(9B)-C(10B) 112.45(9) 
C(10B)-C(9B)-H(9B) 106.9 
C(15B)-C(9B)-C(1B) 112.98(11) 
C(15B)-C(9B)-H(9B) 106.9 
C(15B)-C(9B)-C(10B) 110.18(11) 
C(9B)-C(10B)-H(10C) 108.4 
C(9B)-C(10B)-H(10D) 108.4 
H(10C)-C(10B)-H(10D) 107.5 
C(11B)-C(10B)-C(9B) 115.49(10) 
C(11B)-C(10B)-H(10C) 108.4 
C(11B)-C(10B)-H(10D) 108.4 
C(7B)-C(11B)-C(10B) 112.84(10) 
C(7B)-C(11B)-H(11C) 109.0 
C(7B)-C(11B)-H(11D) 109.0 
C(10B)-C(11B)-H(11C) 109.0 
C(10B)-C(11B)-H(11D) 109.0 
H(11C)-C(11B)-H(11D) 107.8 
C(6B)-C(12B)-H(12D) 109.5 
C(6B)-C(12B)-H(12E) 109.5 
C(6B)-C(12B)-H(12F) 109.5 
H(12D)-C(12B)-H(12E) 109.5 
H(12D)-C(12B)-H(12F) 109.5 
H(12E)-C(12B)-H(12F) 109.5 
C(6B)-C(13B)-H(13D) 109.5 
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Table A6.15 (cont.) 
C(6B)-C(13B)-H(13E) 109.5 
C(6B)-C(13B)-H(13F) 109.5 
H(13D)-C(13B)-H(13E) 109.5 
H(13D)-C(13B)-H(13F) 109.5 
H(13E)-C(13B)-H(13F) 109.5 
C(4B)-C(14B)-H(14D) 109.5 
C(4B)-C(14B)-H(14E) 109.5 
C(4B)-C(14B)-H(14F) 109.5 
H(14D)-C(14B)-H(14E) 109.5 
H(14D)-C(14B)-H(14F) 109.5 
H(14E)-C(14B)-H(14F) 109.5 
C(9B)-C(15B)-H(15D) 109.5 
C(9B)-C(15B)-H(15E) 109.5 
C(9B)-C(15B)-H(15F) 109.5 
H(15D)-C(15B)-H(15E) 109.5 
H(15D)-C(15B)-H(15F) 109.5 
H(15E)-C(15B)-H(15F) 109.5 
Symmetry transformations used to generate equivalent atoms: 
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Table A6.16.  Anisotropic displacement parameters (Å2 x 104) for tertiary alcohol 356 (CCDC 
911859).  The anisotropic displacement factor exponent takes the form: –2π2[ h2a*2U11 + ... + 2 h k 
a* b* U12 ] 
  U11 U22  U33 U23 U13 U12 
 
O(1A) 149(3)  246(4) 534(6)  -12(4) 133(4)  -50(3) 
C(1A) 134(4)  166(4) 209(4)  7(3) 94(3)  -15(3) 
C(2A) 187(4)  248(5) 187(4)  -31(4) 102(3)  -19(4) 
C(3A) 252(5)  263(6) 274(5)  -77(5) 146(4)  26(4) 
C(4A) 187(4)  148(5) 295(5)  -10(4) 136(4)  20(3) 
C(5A) 175(4)  233(5) 300(5)  31(4) 132(4)  43(4) 
C(6A) 186(4)  228(5) 204(4)  71(4) 84(4)  14(4) 
C(7A) 202(4)  176(4) 170(4)  30(3) 106(3)  14(4) 
C(8A) 163(4)  135(4) 228(4)  25(3) 129(3)  5(3) 
C(9A) 225(4)  179(5) 240(5)  52(4) 144(4)  54(4) 
C(10A) 310(5)  140(5) 235(5)  20(4) 117(4)  13(4) 
C(11A) 243(5)  158(5) 183(4)  3(4) 88(4)  -38(4) 
C(12A) 203(5)  375(7) 259(5)  52(5) 39(4)  -22(5) 
C(13A) 329(6)  355(7) 302(6)  179(5) 154(5)  67(5) 
C(14A) 324(6)  150(5) 531(8)  -3(5) 204(6)  4(5) 
C(15A) 216(5)  275(6) 324(6)  102(5) 120(4)  66(4) 
O(1B) 552(6)  301(5) 200(4)  -41(4) 224(4)  19(4) 
C(1B) 205(4)  163(4) 163(4)  -4(3) 108(3)  12(4) 
C(2B) 174(4)  214(5) 197(4)  -20(4) 88(3)  5(4) 
C(3B) 212(4)  218(5) 266(5)  -36(4) 122(4)  -66(4) 
C(4B) 236(4)  133(4) 246(4)  6(4) 151(4)  -7(4) 
C(5B) 270(5)  246(5) 232(5)  76(4) 157(4)  36(4) 
C(6B) 240(5)  275(6) 187(4)  51(4) 77(4)  45(4) 
C(7B) 178(4)  184(5) 208(4)  10(4) 82(3)  -7(4) 
C(8B) 183(4)  128(4) 191(4)  10(3) 113(3)  12(3) 
C(9B) 284(5)  184(5) 283(5)  83(4) 184(4)  46(4) 
C(10B) 312(6)  133(5) 351(6)  5(4) 159(5)  -20(4) 
C(11B) 234(5)  176(5) 242(5)  -55(4) 89(4)  -30(4) 
C(12B) 425(7)  498(9) 184(5)  16(6) 78(5)  39(7) 
C(13B) 256(5)  395(8) 358(6)  163(6) 124(5)  110(5) 
C(14B) 430(7)  135(5) 495(8)  -21(5) 294(6)  -18(5) 
C(15B) 546(9)  309(7) 331(7)  166(6) 231(7)  141(6) 
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Table A6.17.  Hydrogen coordinates (x 103) and isotropic displacement parameters (Å2 x 103) 
for tertiary alcohol 356 (CCDC 911859) 
 
 x  y  z  Uiso 
 
H(1A) 579 90 579 49 
H(2A1) 669 154 466 24 
H(2A2) 744 223 549 24 
H(3A1) 785 -6 548 31 
H(3A2) 706 -76 518 31 
H(5A1) 878 -82 755 28 
H(5A2) 868 66 699 28 
H(7A) 766 213 813 21 
H(8A) 696 38 715 19 
H(9A) 628 308 651 24 
H(10A) 726 471 618 28 
H(10B) 713 476 707 28 
H(11A) 815 305 684 24 
H(11B) 828 391 776 24 
H(12A) 925 232 920 47 
H(12B) 930 242 826 47 
H(12C) 966 108 896 47 
H(13A) 886 -80 909 50 
H(13B) 798 -55 856 50 
H(13C) 852 50 941 50 
H(14A) 772 -251 654 51 
H(14B) 694 -198 640 51 
H(14C) 765 -202 743 51 
H(15A) 617 400 477 42 
H(15B) 582 484 532 42 
H(15C) 551 329 486 42 
H(1B) 529 43 423 50 
H(2B1) 589 -12 346 24 
H(2B2) 542 -68 238 24 
H(3B1) 568 162 211 28 
H(3B2) 566 225 302 28 
H(5B1) 424 270 47 28 
H(5B2) 465 116 69 28 
H(7B) 319 -26 113 24 
H(8B) 384 132 229 19 
H(9B) 404 -149 304 28 
H(10C) 463 -309 212 32 
H(10D) 380 -302 190 32 
H(11C) 448 -129 112 28 
H(11D) 368 -203 58 28 
H(12D) 288 -26 -80 60 
H(12E) 373 -40 -49 60 
H(12F) 328 102 -104 60 
H(13D) 290 282 -22 52 
H(13E) 302 244 81 52 
H(13F) 246 152 -9 52 
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Table A6.17 (cont.) 
H(14D) 476 419 193 49 
H(14E) 461 359 275 49 
H(14F) 394 376 169 49 
H(15D) 548 -266 372 58 
H(15E) 483 -338 383 58 
H(15F) 521 -192 439 58 
 
 
 
 
Table A6.18.  Hydrogen bonds for tertiary alcohol 356 (CCDC 911859) [Å and °] 
 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
 
O(1A)-H(1A)...O(1B)#1 0.84 1.91 2.7228(13) 162.5 
O(1B)-H(1B)...O(1A) 0.84 1.94 2.6796(14) 146.9
Symmetry transformations used to generate equivalent atoms:  
#1                                        +1 
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APPENDIX 9 
Enantioselective Protonations† 
 
  
A9.1 INTRODUCTION AND BACKGROUND 
Enantioselective protonation is a common process in biosynthetic sequences.  The 
decarboxylase and esterase enzymes that effect this valuable transformation are able to 
control both the steric environment around the proton acceptor (typically an enolate) and 
the proton donor (typically a thiol).  Recently, several chemical methods to achieve 
enantioselective protonation have been developed by exploiting various means of 
enantiocontrol in different mechanisms.  These laboratory transformations have proven 
useful for the preparation of a number of valuable organic compounds. 
A fundamental method to generate a tertiary carbon stereocenter is to deliver a proton 
to a carbanion intermediate.  However, enantioselective transfer of a proton presents 
unusual challenges, specifically, manipulating a very small atom and avoiding product 
                                                
† This review was written in collaboration with J. T. Mohr.  A similar version has been published.  See:  
Mohr, J. T.; Hong, A. Y.; Stoltz, B. M. Nature Chem. 2009, 1, 359–369. 
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racemization at a particularly labile stereocenter.  As a result, the conditions for a 
successful enantioselective protonation protocol may be very specific to a certain 
substrate class.  Tertiary carbon stereocenters are extremely common in valuable 
biologically active natural products, and thus the need for synthetically useful 
enantioselective methods to form these stereocenters is vital.1 
In this chapter, several strategic approaches to enantioselective protonation are 
presented.  Emphasis has been placed on recently developed methods and their 
accompanying mechanisms in order to update the most recent prior reviews on this 
topic.2  Each method relies on particular stereochemical control elements based on the 
mechanism of the protonation transformation.  Appreciation of these controlling elements 
may lead to improved methods for preparing valuable chiral materials for a variety of 
synthetic applications. 
 
A9.2 IMPORTANT FACTORS IN ACHIEVING ENANTIOSELECTIVE 
PROTONATION 
Several of the most important practical features of enantioselective protonation were 
enumerated in Fehr’s 1996 review.2  Principal among these is the fact that 
enantioselective protonations are necessarily kinetic processes since under 
thermodynamic control racemate would be formed.  Accordingly, it is often necessary to 
match the pKa of the proton donor and the product to prevent racemization before product 
isolation.  It is unfortunate that the same anion stabilizing groups (e.g., ketones) that 
make protonations relatively easy to achieve also impart a degree of instability in the 
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product.  This has led some researchers to explore hydrogen atom transfer reactions in 
lieu of Brønsted acid-mediated protonations (see Section A9.4.4). 
In addition to the obvious challenges of product stability under the reaction 
conditions, the rapid rate of proton exchange in solution often leads to significant levels 
of background reaction without the intercession of the chiral control element.  As a result, 
typical proton donors are relatively weak acids that react with the proton acceptor in a 
slower and more controlled fashion. 
Since substrates for enantioselective protonation generally involve a prochiral sp2-
hybridized atom, the stereochemistry of the substrate is a concern.  In some cases, the 
ability to generate stereodefined proton acceptors (e.g., a pure E- or Z-enolate) is critical 
to the success of a protonation method.  In other cases, however, the two stereoisomers of 
enolate may in fact lead to the same enantiomer of product.2d  To obviate this concern 
many researchers choose to investigate cyclic substrates; in turn, this may lead to a 
limited substrate scope for a particular system.  The method to access the reactive proton 
acceptor is among the most important facets of each protonation system, and many 
strategies have been explored (e.g., conjugate addition, addition to ketenes, and 
decarboxylation from  β-ketoesters). 
Finally, the fine mechanistic details of enantioselective protonations are often not 
well understood.  Since typical proton acceptors are stabilized anions, there are multiple 
Lewis basic sites available for protonation.  It is likely that these sites protonate at 
kinetically different rates dependent on the specific reaction conditions.  Potentially, 
enantioselective protonations may be achieved either by direct protonation to generate the 
desired stereocenter, or by protonation at a different site followed by enantioselective 
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tautomerization.  In an important recent report, Fehr3 demonstrated that isolated enol 413 
(Scheme A9.1) could be transformed enantioselectively into ketone 416 (an immediate 
precursor to the rose-smelling fragrance compound (S)-(α)-damascone) via the proposed 
aggregate complex 415, and this mechanistic course seemed to be operative in the 
analogous protonation of a lithium enolate with the conjugate acid of alkoxide 414.  
Based on these findings, perhaps some protonation protocols are more accurately 
described as enantioselective tautomerization reactions.  Although ultimately 
inconsequential in terms of the products obtained, insights into the specific mechanistic 
course of the reaction are important in order to improve these systems.  However, only 
rarely have these levels of mechanistic understanding been realized. 
 
Scheme A9.1.  Enantioselective Tautomerization of an Isolated Enol 
OH
O
N Ph
OLi
414 Li
O
H
Ph
N
O
THF, PhCH3
–78 °C
413 415
H
416
2 equiv 414, 97% ee
0.5 equiv 414, 83% ee  
 
A9.3 ENANTIOSELECTIVE PROTONATION IN ENZYMATIC SYSTEMS 
A9.3.1 DECARBOXYLASE ENZYMES 
Nature has evolved several efficient enzymes that catalyze enantioselective 
protonation reactions on useful organic building blocks.  In recent reports, 
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decarboxylases and esterases have proven to be two popular classes of natural enzymes 
for the construction of α-stereocenters adjacent to ketones.  Esterases release latent 
enolates from prochiral substrates while decarboxylases generate enolates in situ from 
malonic acid derivatives (Scheme A9.2–Scheme A9.4). 
Ohta and co-workers4 isolated arylmalonate decarboxylase (AMDase) from Gram-
negative bacterium Alcaligenes bronchisepticus and found that it catalyzes the 
decarboxylative enantioselective protonation of α-aryl-α-methyl-malonates through the 
proposed mechanism in Scheme A9.2.  Yields and enantiomeric excesses were excellent 
for substrates with various α-aryl substitutents (up to 99% yield and 99% ee).  
Experiments have shown that the Cys188 residue is essential for activity, and this site is 
the putative proton donor that stabilizes the enolate intermediate.  A Hammett study5 of 
the reaction found a ρ value of +1.19, which is consistent with a negatively charged 
transition state.4  Recently, preliminary X-ray diffraction experiments and an X-ray 
crystal structure of AMDase were reported.6 
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Scheme A9.2.  Enzymatic Decarboxylative Protonation with Wild-Type and Mutant Decarboxylases 
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Accessing the opposite enantiomeric series of products required additional 
investigation.7  Analysis of the enzyme amino acid sequence was carried out to check for 
homology with known enzymes.  The Cys188 residue is conserved in several racemase 
enzymes from other microorganisms.  Glutamate racemase, found in the bacterium 
Lactobacillus fermenti, contains an active site similar to that of AMDase, but with 
cysteine residues (Cys188 and Cys74) on both sides of the substrate.  Presumably, one of 
the cysteine residues acts as a base and generates an enolate intermediate, which can then 
be protonated non-selectively from either cysteine residue to give rise to a racemic 
mixture.  When Ohta and co-workers prepared a G74C mutant of AMDase to mimic 
these racemase enzymes, they found that racemic α-thienylpropionic acid (418, Scheme 
A9.2) was formed in 37% yield from the malonic acid substrate (417).  Further 
explorations based on this homology hypothesis led to the preparation of a double mutant 
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of AMDase (G74C/C188S) that removed the native cysteine residue while maintaining 
the mutant residue on the opposite face of the substrate.  The opposite enantiomer of 
product was indeed obtained with this new enzyme in 94% enantiomeric excess, although 
yields decreased to 60% and the activity of this mutant was several orders of magnitude 
lower than the wild-type.  Some activity was rescued by performing random mutagenesis 
and identifying more active triple mutants.8 
Decarboxylase-type activity was also observed in the conversion of β-hydroxyacid 
424 to optically active α-arylpropionic acid (R)-428 by Gram-positive bacteria 
Rhodococcus sp. KU1314 (Scheme A9.3).9  In the proposed metabolic pathway, enzymes 
in the microorganism non-selectively oxidize hydroxyacid substrate 424 to aldehyde 425 
and then decarboxylate the corresponding acid to form enolate 425 that undergoes 
enantioselective protonation to generate aldehyde 427.  Subsequent non-selective 
oxidation affords enantioenriched α-arylpropionic acid 428.  Mechanistic experiments 
were consistent with this proposed enantioselective protonation mechanism rather than 
alternative possibilities such as enantioselective oxidation steps.  Enantioselectivity and 
yield varied considerably depending on the aryl and alkyl groups at the α-position in the 
substrate, but enantiomeric excesses up to 85% could be achieved.  Employing an 
electron poor aryl group appeared to give poor enantioselectivity due to increased acidity 
of the proton in the presumed aldehyde intermediate.  When the alkyl group was changed 
from methyl to ethyl, the reaction yield dropped, suggesting that the enzyme is sensitive 
to sterics. 
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Scheme A9.3.  Enzymatic Oxidation/Decarboxylation/Protonation/Oxidation Cascade 
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A9.3.2 ESTERASE ENZYMES 
Several researchers have employed esterases to obtain enantioenriched protonation 
products.  In 1990, Ohta and co-workers10 reported that live Pichia miso IAM 4682 yeast 
cells catalyze the conversion of enol acetates to enantioenriched ketones (e.g., 11 → 5, 
Scheme A9.4).  High levels of enantiomeric excess were attained with a variety of enol 
esters.  For larger ring systems, the reaction yield and absolute configuration varied 
unpredictably with ring size.  In an impressive application, this yeast-mediated reaction 
was used to generate an α-stereocenter in a 12-membered ring with 96% ee. 
 
Scheme A9.4.  Enzymatic Hydrolysis of Enol Acetates 
O
O
CH3
esterase
enzyme
O
CH3
H
11 (S)-5
Pichia miso IAM 4682, 99% ee
Marchantia polymorpha esterase I, 99% ee
Burkholderia cepacia lipase PS-C II, –77% ee
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Hirata and co-workers11 reported that liverwort Marchantia polymorpha esterase I 
also catalyzes the same reaction on a variety of substrates with differing alkyl side chains, 
but the facial preference for proton delivery varied for different enolate substitutions.  For 
example, the enzyme delivered (S)-2-methylcyclohexanone (5) and (R)-2-n-
propylcyclohexanone from their respective enol acetates in 99% conversion and 99% ee.  
Lipase PS-C II, originating from Gram-negative bacteria Burkholderia cepacia, may also 
be used for the hydrolysis of 1-acetoxy-2-methylcyclohexene (11).  Sakai and co-
workers12 discovered that the enantiomeric excess of the product ((R)-5) was largely 
dependent on the temperature and the proton source.  The best results were obtained by 
running the reaction at 0 °C with solid-supported enzyme PS-C II and ethanol as proton 
source (82% conversion, 77% ee). 
Among these enzymatic approaches, a general problem appears to be the difficulty of 
enzyme modification to give the unnatural antipode of product.  Another limitation is the 
need for buffers to help stabilize enzymes or cells.  Substrate scope is also limited due to 
the specificity of substrate recognition.  For these reasons, enzymatic reactions do not 
provide a general solution to the synthesis of enantioenriched protonation products.  
Laboratory means for enantioselective protonation may enable a more universal protocol 
due to the ability to tune the structural and electronic features of the catalyst.  These 
natural systems do, however, demonstrate many of the key controlling elements 
necessary for successful enantioselective protonation. 
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A9.4 STRATEGIC APPROACHES TO NONENZYMATIVE 
ENANTIOSELECTIVE PROTONATION 
A9.4.1 GENERAL CONSIDERATIONS 
Using enzymatic systems as a guide to the important factors in achieving 
enantioselective protonation, two distinct factors have been envisioned as opportunities 
for asymmetric induction: the use of a chiral Brønsted acid (see Section A9.4.2) and 
generation of a chiral proton acceptor intermediate (see Section A9.4.3).  Whereas the 
enzymatic systems exploit both of these control elements, many laboratory methods have 
sought to use only a single control element not only to minimize the amount of 
enantiopure material required for the transformation, but also to eliminate complicating 
diastereomeric interactions possible in systems with multiple chiral additives.  In 
practice, some of these systems seem to involve protonation through an aggregate 
complex of both proton acceptor and proton donor, typically in a metal complex (e.g., 
Fehr’s tautomerization depicted in Scheme A9.1). 
An additional factor important in improving efficiency of enantioselective 
protonation systems is achieving catalysis.  For example, catalytic generation of a chiral 
metal/enolate complex in situ minimizes the amount of chiral controller required.  
Alternatively, coupling of a catalytic chiral proton donor to a stoichiometric achiral 
proton source achieves a similarly efficient use of chiral information.  In the latter case, 
however, a specific order of thermodynamic acidity of the reaction components must be 
employed (necessarily in this order of decreasing Brønsted acidity: stoichiometric proton 
source, catalytic chiral protonating agent, and product).  An accompanying balance of 
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kinetic rates of proton transfer between all of these components must also be achieved to 
allow a reasonable rate of protonation through the catalyzed pathway while avoiding 
undesired background reaction between the prochiral proton acceptor and the 
stoichiometric achiral proton donor.  Vedejs and co-workers have disclosed a study of 
these factors that is representative of these important issues.13 
 
A9.4.2 ENANTIOSELECTIVE PROTONATION BY MEANS OF CHIRAL 
PROTON DONOR 
Perhaps the most fundamental means of achieving an enantioselective protonation is 
to employ a chiral proton donor.  The acidic proton often comes from an oxygen, 
nitrogen, or carbon atom in the proton donor.  Indeed, the earliest enantioselective 
protonation protocols employed this technique. 
Among the most popular substrates for enantioselective protonation are lithium 
enolates, which are often generated from ketones, enol acetates, or silyl enol ethers at low 
temperatures.  This method most closely resembles an esterase approach taken by Nature.  
Kim and co-workers14 have synthesized a family of hydroxyethers as chiral proton 
sources (e.g., 430, Scheme A9.5) capable of protonating lithium enolates of tetralones 
and indanones (prepared in situ from silyl enol ethers such as 429) in up to 97% yield and 
90% ee.  The acidity of the Brønsted acids had a strong correlation to enantioselectivity 
and salt-free conditions were important to selectivity.  A π–π-stacking interaction 
between the substrate and rigid proton source was proposed as the chiral controlling 
interaction during the protonation event.  Since cyclohexanone-derived enolates lack an 
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aryl group to participate in the stacking interaction, poor ee was observed for these 
substrates. 
 
Scheme A9.5.  Kim's Enolate Protonation 
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O
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then (R,R)-430
97% conversion (R,R)-430(R)-43190% ee429  
 
Eames and co-workers15 have developed several strategies for the asymmetric 
protonation of prochiral tetralone enolates based on structurally different chiral proton 
sources.  In one example, tris(sulfonamide) protonating agents with chiral backbones 
(e.g., 433, Scheme A9.6) provided yields of ketone products (e.g., 431) up to 70% and 
enantiomeric excesses of up to 77%.15c  In these systems, it is believed that the enolates 
and proton sources can form an organized transition state that is guided by lithium 
chelation and perhaps more closely resembles a chiral aggregate intermediate than a 
direct enolate protonation.  In some cases it was possible to access the opposite antipode 
of the product ketone by employing an external quench strategy.15 
 
Scheme A9.6.  Eames's Enolate Protonation 
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Enolate intermediates can also be accessed through decarboxylation.  Proton donors 
derived from Cinchona alkaloids (e.g., 435, Scheme A9.7) have proven to be especially 
useful reagents for this enantioselective protonation strategy.  Rouden and co-workers16 
have shown that cyclic and acyclic α-aminomalonate hemiester substrates (e.g., 434) can 
be protonated with high levels of enantioselectivity.  Enantiomeric excesses of product 
esters (e.g., 436) up to 93% could be achieved in cyclic cases and 89% in acyclic cases.  
Products in the opposite enantiomeric series could be generated in comparable ee using 
catalysts prepared from naturally occurring diastereomeric alkaloids.  The alkaloid 
derivatives are believed to serve as dual-purpose reagents: they deprotonate malonate 
hemiester substrates and promote a decarboxylation event.  The intermediate enolate can 
be protonated by the tertiary ammonium salt to give enantioenriched products.  This 
approach is biomimetic and resembles decarboxylase enzymes in Nature. 
 
Scheme A9.7.  Rouden’s Decarboxylative Protonation 
Ac
N
catalyst 435
acetone, 0 °C
90% yield
(S)-436
93% ee434
CO2H
CO2Et AcN
H
CO2Et
N
H
NH
N
OCH3
S
N
H
CF3
F3C
435  
 
Work done by Donohoe and co-workers17 has shown that it is possible to perform 
dissolving metal reductions of pyrrole esters and quench the resulting enolate 
intermediates with a chiral proton source.  Reduction of 2,5-disubstituted pyrroles (e.g., 
434, Scheme A9.8) led to a separable 1:1 mixture of trans- and meso-diasastereomers of 
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ester 439, but the asymmetric induction in the chiral trans-product was good when (–)-
ephedrine (438) was used as the chiral proton source.  Based on enantioselectivities of 
reactions with substituted ephedrine derivatives, it was proposed that the hydroxyl group 
provides the proton and that the ephedrine molecule needs to interact with the lithium 
cation in a bidentate fashion for optimal asymmetric induction.  Considering this 
proposal, this transformation may be more accurately described as protonation through a 
chiral aggregate of Brønsted acid and base.  A related transformation of pyrrole mono-
esters with oxazolidinone proton donors yielded reduced products in up to 68% ee and 
58% yield.  These partially reduced pyrroles could be elaborated to form uncommon 
dihydroxylated amino acids found in the marine mussel Mytilus edulis.17 
 
Scheme A9.8.  Donohoe's Partial Pyrrole Reduction 
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It is often possible to employ catalytic amounts of chiral protonating agents, provided 
that an appropriate stoichiometric proton source can be identified.  For this purpose, a 
number of chiral organic catalyts have been employed in various transformations.  In 
order to achieve a heterocycle reduction/protonation strategy analogous to that used by 
Donohoe and co-workers (Scheme A9.8), Rueping and co-workers18 were able reduce 
substituted quinolines enantioselectively (Scheme A9.9).  Initial hydride reduction of 
annulated quinoline 440 by a Hantzch dihydropyridine (445) to form enamine 441 was 
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followed by enantioselective protonation with a catalytic chiral BINOL-phosphoric acid 
(444).  Terminal hydride reduction of iminium ion 442 yielded optically active 
tetrahydroquinoline 443 as an 8:1 mixture of trans- and cis-diastereomers with the 
diastereomers formed in 94% and 99% enantiomeric excess, respectively.  Up to 84% 
yield and 85% enantiomeric excess could be obtained for mono-substituted quinolines 
using the optimal reaction conditions. 
 
Scheme A9.9.  Rueping's Quinoline Reduction/Protonation 
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In a mechanistically different approach, Cheon and Yamamoto19 used a related 
BINOL N-triflyl thiophosphoramide catalyst (448) to directly protonate cyclic silyl enol 
ethers (e.g., 446 → 447, Scheme A9.10).  Regeneration of the chiral proton source was 
made possible by using phenol as the achiral proton source.  With this system, yields up 
to 99% and enantiomeric excesses up to 90% were achieved.  The highest levels of 
enantioselectivity were obtained with substrates bearing an aryl substituent at the α-
position and 7-membered rings performed somewhat better than 6-membered rings.  
Comparable selectivity and yield could be obtained with catalyst loadings as low as 0.05 
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mol %.  In control experiments, the protonation reaction did not proceed without an 
achiral proton source, even with stoichiometric chiral Brønsted acid.  This observation 
led to a proposed mechanism that involves pre-association of the chiral and achiral proton 
sources to form an oxonium ion pair (449) that then protonates the silyl enol ether 
substrate. 
 
Scheme A9.10.  Yamamoto's Enol Silane Protonation 
(S)-447
88% ee446
448 (5 mol %)
PhOH, PhCH3
99% yield
O
O P NHTfi-Pr
i-Pr t-Bu
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proposed active
proton donor
OH2
PhOH
448
 
 
A common approach to enantioselective protonation employs a lithium enolate, 
catalytic chiral proton source, and stoichiometric achiral proton source.  These lithium 
enolates are often prepared from the corresponding enol silanes.  Reports of amino acids 
as catalytic proton sources have appeared in recent literature.  Yanagisawa and co-
workers20 employed commercially available dipeptide 450 (Scheme A9.11) for the 
protonation of lithium enolates of tetralones and cyclohexanones.  The catalytic proton 
source is regenerated through proton transfer from 2,6-di-t-butyl-4-methylphenol (BHT).  
The steric bulk of the phenol is important to suppressing background enolate protonation 
through a non-selective pathway.  The structure of the chiral proton donor is very specific 
to the success of the reaction because isomeric dipeptide aspartame afforded racemic 
product.  Enolates generated from deprotonation of racemic ketone 431 with lithium 
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diisopropylamide could also be protonated with comparable yield and enantioselectivity 
using this system. 
 
Scheme A9.11.  Yanagisawa's Lithium Enolate Protonation 
CH3
OTMS
CH3
O H1. n-BuLi, THF, –78 °C2. 450 (10 mol %), DMF
3. 2,6-di-t-Bu-4-Me-phenol
4. TMSCl
      
          71–79% yield
(S)-431
80% ee429
HO
O
NH2
N
H
O Ph
O
OCH3
450
 
 
In separate work from Yanagisawa and co-workers,21 enol silanes were found to react 
to form ketones in the presence of the complex of AgF and BINAP (Scheme A9.12) with 
methanol as a proton donor.  Excellent enantiomeric excesses were reported for a variety 
of cyclic ketones.  Cyclohexanone-derived enol silanes yielded significantly higher ee 
products than tetralone-derived enol ethers.  The highest levels of ee (up to 99%) were 
found for α-arylcyclohexanones.  Although the fine mechanistic details have not been 
elucidated, one possibility is that the chiral Lewis acidic Ag•BINAP complex binds 
methanol to generate a potent chiral Brønsted acid capable of protonating the latent 
enolate.  Taking the fluoride activation component into account, aggregate complex 452 
was proposed as a potential intermediate leading to the observed enantiomer of product 
ketone. 
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Scheme A9.12.  Yanagisawa's Enol Silane Protonation 
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Levacher and co-workers22 have reported that catalytic amounts of Cinchona alkaloid 
derivatives can be coupled to latent hydrogen fluoride sources to achieve enantioselective 
protonation of silyl enol ethers of 1-indanones and 1-tetralones (e.g., 454 → 456, Scheme 
A9.13).  The hydrogen fluoride, generated in situ from benzoyl fluoride and ethanol, is 
presumed to interact with the alkaloid-derived catalyst to form a cinchonium fluoride.  
The fluoride anion of this active catalyst then activates the silyl group to facilitate proton 
delivery from the ammonium cation (e.g., 455) through a proposed transition state 
reminiscent of the Ag•BINAP protonation protocol described above.  The optimal 
alkaloid catalyt was (DHQ)2(AQN), a common ligand for Sharpless’ enantioselective 
dihydroxylation reactions.23  Yields up to 86% and enantiomeric excesses up to 92% were 
reported.  Protonation of cyclohexanone-derived enol silanes gave moderate enantiomeric 
excess.  Later work revealed that carboxylic acids (e.g., citric acid) could be used directly 
with the alkaloid-derived catalysts to carry out the enol silane protonation.24 
Enantioselectivity for this variant of the reaction was moderately diminished, however 
(ee up to 75%).  The use of chiral carboxylic acids revealed a moderate, but measureable, 
influence of both the proton donor and the catalyst on enantioselection, with the catalyst 
influence apparently dominating. 
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Scheme A9.13.  Levacher’s Enol Silane Protonation 
N
*R R*
H R*
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SiMe3F
(DHQ)2AQN
(10 mol %)
PhCOF, EtOH
DMF
84% yield
OTMS O
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In a series of reports by Deng and co-workers,25 bifunctional Cinchona alkaloid-
derivatives (e.g., 435, 463–466, Scheme A9.14) were reported to catalyze tandem 
asymmetric conjugate addition/protonation reactions of cyclic and acyclic α-cyanoketone 
nucleophiles (e.g., 457 and 460) to 2-chloroacrylonitrile (458).  The Cinchona alkaloid 
derivative is proposed to serve two functions: activating the Michael acceptor for addition 
and serving as the chiral Brønsted acid for the protonation of the nitrile-stabilized 
carbanion intermediate.  The postulated stereochemical model involves a network of 
hydrogen bonding interactions, and it was found that modification of this network by 
masking the phenolic hydroxyl group and introducing a thiourea moiety led to 
preferential formation of the diastereomeric products in excellent ee.  By virtue of this 
discovery, all four stereoisomeric products of 459 could be prepared with high degrees of 
diastereo- and enantioselectivity.  This method was applied to an enantioselective formal 
synthesis of (–)-manzacidin A (462) via the intermediate thioester 461, prepared in 93% 
ee from α-cyanothioester 460 and 2-chloroacrylonitrile (458).  A very similar 
transformation was reported by Wu and co-workers26 for the conjugate addition of 
thiophenol to an α-substituted acrylamide with subsequent enantioselective protonation 
in up to 60% ee. 
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Scheme A9.14.  Deng's Conjugate Addition/Protonation 
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Organic catalysts other than Cinchona alkaloids have shown promise for catalytic 
asymmetric protonation as well.  Tan and co-workers27 used thiols and phosphine oxides 
as nucleophiles for 1,4-addition into various phthalimidoacrylates and itaconimides (e.g., 
467 → 469 Scheme A9.15).  Subsequent protonation of the intermediate enolates by the 
conjugate acid of chiral bicyclic guanidine catalyst 468 gave up to 99% yield and 94% 
enantiomeric excess.  Interestingly, the presence of water and relatively acidic 
thiophenols did not lead to appreciable amounts of non-selective enolate quenching.  
Kinetic isotope effects were explored with D2O and a primary kinetic isotope effect of 1.5 
was found, consistent with cleavage or formation of a bond containing H or D in the rate-
determining step. 
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Scheme A9.15.  Tan's Conjugate Addition/Protonation 
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An unusual technique to generate an enol in situ was reported by Hénin, Muzart and 
co-workers.28  In this work, a racemic α-quaternary ketone (e.g., 470, Scheme A9.16) was 
exposed to laser photolysis at 366 nm.  This irradiation caused a Norrish type II 
fragmentation (470 → 472) to occur with concomitant loss of isobutylene.  The enol 
(472) then undergoes enantioselective transformation to the corresponding ketone (431) 
in the presence of amino alcohol 473.  Although high ee was realized for this dealkylative 
protonation in some cases, yields were low largely due to undesired fragmentation 
reactions initiated by the photochemical irradiation and decomposition of the resulting 
radical intermediates.  This method represents one of the few enantioselective 
stereoablative transformations29 involving destruction of a quaternary stereocenter. 
 
Scheme A9.16.  Hénin/Muzart Norrish Type II Fragmentation/Protonation 
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A variety of transformations catalyzed by planar-chiral heterocycles involve 
protonation as the enantiodetermining step.  In one recent example from Fu and co-
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workers,30 catalyst 478 (Scheme A9.17) was found to promote the addition of HN3 to 
ketenes (e.g., 474).  The resulting acyl azides (e.g., 476) then underwent Curtius 
rearrangement at elevated temperatures.  The carbamate products (e.g., 479) were 
isolated with up to 97% ee, presumably from enantioselective protonation of the amide 
enolate intermediate (476).  Sterically large ketenes performed best since less 
encumbered ketenes suffered from rapid uncatalyzed background reaction even at 
cryogenic temperatures.  In control experiments, hydrazoic acid was found to be readily 
deprotonated by planar-chiral heterocycle catalyst 575.  Since the reaction also proceeded 
with higher selectivity at low substrate concentration, a mechanism involving an ion pair 
476 + 477 was proposed.  This behavior of the catalyst as a chiral Brønsted acid (i.e., 
477) rather than the more typical role of these catalysts as Lewis bases31 is somewhat 
unusual, but also serves as a testament to the privileged nature of these catalysts.32 
 
Scheme A9.17.  Fu's Addition of Hydrazoic Acid to Ketenes Followed by Curtius Rearrangement 
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Although the particular example in Scheme A9.17 is thought to occur through a 
protonated catalyst molecule as the proton donor, other similar transformations may 
proceed through a different mechanism (see section A9.4.3), however in both examples 
the lack of a nonlinear relationship33 between catalyst ee and product ee suggests that 
only one catalyst molecule is involved in the enantioselective step and therefore a hybrid 
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mechanism is unlikely.  Regardless of which of these two mechanistic hypotheses is 
operative, the transformation remains an enantioselective protonation process.  An 
understanding of the mechanistic details, however, is helpful in order to understand the 
stereochemical control elements important to the success of the transformation. 
 
A9.4.3 ENANTIOSELECTIVE PROTONATION BY MEANS OF CHIRAL 
BRØNSTED BASE 
The most common form of chiral Brønsted base employed in enantioselective 
protonations has been chiral metal enolates.  To circumvent the challenge of 
stereoselective generation of acyclic enolates, the majority of methods have focused on 
cyclic enolate precursors.  A variety of techniques for enolate generation have been 
employed including simple deprotonations, pericyclic reactions, decarboxylations, and 
dehalogenations.  The synthesis of the specific enolate precursor required for a 
protonation protocol (e.g., enol silane, acrylate, or β-ketoester) may determine how useful 
the method is for the preparation of specific target molecules.  Although several 
successful chiral Brønsted base protonation protocols have been developed, substrate 
scope remains a significant problem.  Especially lacking are general methods capable of 
protonation of acyclic enolates with high selectivity. 
Planar-chiral heterocycle catalysts have also been employed in the generation of 
chiral Brønsted base intermediates for enantioselective protonation.  Fu and co-workers34 
employed azaferrocene catalyst 481 (Scheme A9.18).  In the proposed reaction 
mechanism the heterocycle catalyst reacts with a ketene (e.g., 480) to form a zwitterionic 
chiral enolate intermediate (482).  Subsequent protonation of the enolate by methanol or 
APPENDIX 9 – Enantioselective Protonations 
 
876 
an achiral pyridinium cocatalyst then forms an acylferrocenium ion (e.g., 483) that goes 
on to form an enantioenriched ester (e.g., 484).  Evidence for this distinct reaction 
mechanism included the fact that catalyst 481 did not appreciably deprotonate methanol 
in solution.35  However, in the case above (Scheme A9.17) the catalyst 475 does readily 
deprotonate hydrazoic acid.  The remarkable ability of these Lewis base catalysts to 
achieve enantioselective protonation through two different mechanisms highlights the 
importance of understanding the details of the reaction pathways.  The preliminary 
mechanistic evidence does not always provide sufficient information to determine the 
operative mechanism, however.36 
 
Scheme A9.18.  Fu's Addition of Alcohols to Ketenes 
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Other organic molecules have been employed for the generation of chiral enolates as 
well.  For example, Rovis and co-workers37 found that treatment of α,α-
dichloroaldehydes such as 485 (Scheme A9.19) with enantiopure triazolium salt catalyst 
486 in the presence of a stoichiometric phenoxide base and phenol led to α-
chloroaldehydes with high enantiomeric excess.  The proposed path of the reaction 
involves addition of the carbene conjugate base of catalyst 486 to the aldehyde substrate.  
Subsequent elimination of HCl then generates a zwitterionic enolate intermediate (487) 
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that is subject to protonation to form enantioenriched aldehyde 488.  The precise structure 
of the putative enolate is a matter of conjecture since a number of different strain 
elements are likely in competition in this intermediate.  Nonetheless, this method 
represents a very valuable technique for the preparation of useful, but synthetically 
challenging, chiral synthons. 
 
Scheme A9.19.  Rovis' Protonation of Chloroenolates 
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In a separate application of carbene catalysis, Scheidt and co-workers38 found that 
homoenolate equivalents (e.g., 491, Scheme A9.20), generated in situ from enals such as 
489, could undergo enantioselective protonation when chiral triazolium catalyst 490 was 
employed.  Ester products (e.g., 482) were obtained in up to 58% yield and up to 59% ee, 
although competitive formation of overoxidized enoate byproduct 493 complicated the 
reaction.  Although the degree of enantioselectivity observed for this transformation was 
modest, this represents a significant advance in the type of proton acceptor that can be 
used for enantioselective protonation reactions since the site of protonation is relatively 
distant from the chiral control element. 
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Scheme A9.20.  Scheidt's Protonation of Homoenolate Equivalents 
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Metal-catalyzed 1,4-additions of organoboranes or organosilanes to enone systems 
have proven to be a popular strategy for generating chiral enolates for asymmetric 
protonation.  These reactions can employ neutral or cationic rhodium complexes.  
Arylboron, arylstannane, arylsilicon, or arylzinc (and in some cases, vinylboron) reagents 
can be used for coupling, but yields and enantioselectivities can depend on the type of 
organometallic reagent chosen.  Atropisomeric bis(phosphine) ligands such as BINAP 
and its analogues give excellent enantioselectivities for simple β-unsubstituted enone 
substrates.  Diverse proton sources have been used to enable the formation of α-
stereocenters.  The optimal proton source varies from system to system, but phenols and 
other low-pKa proton sources are common.  Recent examples have mainly explored 
simple β-unsubstituted systems, so issues of diastereoselectivity in the generation of 
multiple stereocenters have not been fully addressed. 
Frost and co-workers39 explored Rh-catalyzed additions of organotrifluoroborate salts 
to itaconate substrates with water as the stoichiometric proton donor (e.g., 494 → 495 → 
496, Scheme A9.21).  The metal-to-ligand ratio was found to be important in the 
selectivity of the reaction.  Equimolar amounts of metal and ligand gave racemic product 
in high yield, but 2.2 equivalents of ligand relative to metal gave product in 82% ee and 
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56% yield.  Interestingly, high reaction temperature was found to be an important factor 
in this reaction; racemic product was obtained when the reaction was carried out at 60 or 
80 °C instead of 110 °C.  In related work, Frost showed that organosiloxanes are also 
viable nucleophilic components for 1,4-addition, but such systems give poor yields and 
low enantioselectivity.40  In a separate system involving aryl boronic acid organometallic 
components in microwave reactors, Frost and co-workers41 examined whether a chiral 
proton source affected the stereochemical outcome of the reaction.  When (R)-, (S)-, or 
racemic-BINOL was used with a Rh•BINAP catalyst, the yields and enantioselectivities 
were comparable in each of the three scenarios.  This suggests that the chirality of the 
bis(phosphine) ligand is the dominant stereodetermining factor. 
 
Scheme A9.21.  Frost’s Rh-Catalyzed Conjugate Addition/Protonation 
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Sibi and co-workers42 also investigated rhodium-catalyzed conjugate addition-
protonation as a method for accessing β2-amino esters from enoates (e.g., 497 → 499, 
Scheme A9.22).  Reaction screening revealed that (S)-DifluorPhos ligand (498) and 
phthalimide proton donor provided the best enantioselectivity.  The best substrate 
provided 95% yield and 91% ee.  Notably, lower temperatures could be used to increase 
product ee. 
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Scheme A9.22.  Sibi’s Rh-Catalyzed Conjugate Addition/Protonation 
N
[Rh(acac)(C2H4)2] (2 mol %)
PhB(OH)2, phthalimide
p-dioxane, 50 °C
91% yield
Ot-Bu
OO
O
N Ot-Bu
OO
O
H Ph
(S)-499
88% ee497
O
O
O
O
F
F
F
F
PPh2
PPh2
498
(2 mol %)
 
 
Hayashi and co-workers43 reported a related conjugate addition/protonation sequence 
for an analogous diphenylphosphinylallene (e.g., 500) system with a cationic dimeric 
rhodium µ2-hydroxide  catalyst (Scheme A9.23).  Temperature did not appear to have an 
effect on enantioselectivities, but the choice of THF as solvent instead of dioxane 
improved product ee by more than 20%.  Minimal isomerization of the β,γ-unsaturated 
products (e.g., 501) was observed under the reaction conditions, and excellent yields (up 
to 97%) and enantiomeric excesses (up to 98%) were obtained.  In this case, the 
arylboronic acid appears to be acting as the proton source based on an NMR experiment. 
 
Scheme A9.23.  Hayashi’s Rh-Catalyzed Conjugate Addition/Protonation 
•
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Sodeoka and co-workers44 found that this conjugate addition/protonation sequence is 
viable with palladium complexes and heteroatom nucleophiles as well (502 → 503, 
Scheme A9.24).  A bimetallic palladium µ2-hydroxide complex effected the conjugate 
addition of aniline derivatives to acrylamides.  With BINAP as ligand, the enolate 
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intermediate was protonated enantioselectively to give product 502 in 80% yield and 94% 
ee.  Although this is a promising result, the substrate scope has not been fully 
investigated. 
 
Scheme A9.24.  Conjugate Addition/Protonation with a Nitrogen Nucleophile Catalyzed by 
Palladium 
H3C
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Genet, Darses, and co-workers45 sought to make α-amino esters using a similar 
conjugate addition/protonation strategy (e.g., 504 → 509, Scheme A9.25).  In this 
system, boronic esters, boronic acids, and organosilanes did not provide adequate 
conversion or enantioselectivity.  Organostannanes, however, were reactive under these 
conditions.  In the screening of various proton sources, phenol derivatives appeared to 
provide the best enantioselectivity.  Guaiacol (2-methoxyphenol) was determined to be 
the best proton donor, giving products with up to 91% yield and 88% ee.  Higher 
temperatures and optimized solvents (such as toluene or p-dioxane) increased conversion 
and enantioselectivity.  As in Frost’s work, the ratio of metal to ligand did have a notable 
effect on the enantioselectivity of the reaction, with 2.2 equivalents of chiral ligand 
relative to metal being optimal.  Chiral proton sources were also added to see if the chiral 
ligand or chiral proton source was the dominant selectivity factor.  Studies with (R)-
BINAP and both enantiomers of BINOL provided identical enatiomeric excesses, 
implying that the chirality of the enolate is dominant, as in the reports by Frost. 
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Scheme A9.25.  Divergent Pathway Consisting of β-Hydride Elimination, Hydride Transfer, and 
Protonation 
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Mechanistic studies showed that the hydrogen on the enamide was essential for 
reactivity.  Deuterium labeling studies showed that the reaction did not proceed via a 
direct protonation of the rhodium enolate (505); in a substrate with a labeled carbamate 
proton, deuterium incorporation at the α-carbon was high (41%).  Based on this 
observation, a mechanism involving sequential conjugate addition, β-hydride elimination 
from the carbamate (506 → 507), and intramolecular hydride transfer to the α-carbon 
(507 → 508) was proposed.  This proposed reaction pathway was supported by DFT 
calculations with the B3LYP/BII level of theory.45b  In light of these mechanistic insights, 
a more electron-poor bis(phophine) ligand was chosen to facilitate the postulated β-
hydride elimination step, and DifluorPhos (498) was experimentally shown to give higher 
enantiomeric excesses. 
A related conjugate addition/enantioselective protonation strategy consisted of a 
Friedel–Crafts-type addition of pyrroles to α-substituted acrylates (e.g., 510 → 513, 
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Scheme A9.26).46  Sibi and co-workers employed Zn(NTf2)2 complexed with chiral dbfox 
ligand 511 as a Lewis acid catalyst to achieve up to 98% yield and up to 98% ee.  The 
enolate intermediate (512) generated from the Friedel–Crafts reaction can be quenched 
by a proton from the pyrrole fragment to give a chiral product.  The isoxazolidinone 
auxiliary is believed to be critical for improving reactivity and providing greater enolate 
control during the course of the reaction. 
 
Scheme A9.26.  Friedel–Crafts-Type Conjugate Addition Followed by Enantioselective Protonation 
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A distinct method of accessing a chiral metal enolate is the use of a pericyclic 
reaction.  In the case of the Nazarov cyclization, the enantioselective reaction would not 
only generate a new stereocenter, but also a new five-membered ring.  However, until 
recently enantioselective variants of this classical reaction were unknown.  In studies 
directed toward the development of a general enantioselective Nazarov cyclization, 
Trauner and co-workers47 discovered that high ee cyclopentenone products could be 
synthesized from electronically activated substrates such as dienone 514 in the presence 
of Sc•PYBOX complex 515 (Scheme A9.27).  Interestingly, this enantioselective 
protonation protocol requires no external proton source.  Unfortunately, in cases where a 
second stereocenter would be generated at the β-carbon (i.e., 519 where R ≠ H), low 
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diastereoselectivity was observed.  This was interpreted as a result of low 
stereoselectivity in the electrocyclization step (518 → 517) followed by high selectivity 
in the protonation step (518 → 519). 
 
Scheme A9.27.  Trauner's Nazarov Cyclization/Enantioselective Protonation 
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A different strategy for accessing chiral metal enolates is decarboxylation of β-
ketoesters.  The nature of the ester is typically important to enable enolate formation.  In 
the case of palladium-catalyzed protonation reactions, benzyl and allyl esters have been 
the most common enolate precursors.  The first examples of these reactions, developed 
extensively by Hénin, Muzart, and co-workers,48 employed an initiation step such as Pd-
mediated hydrogenolysis to generate an achiral enol (or enolate)49 intermediate that was 
subsequently protonated with a chiral Brønsted acid (typically an amino alcohol).  The 
results of these studies showed a strong dependence on the specific reaction conditions 
(e.g., temperature and source of palladium on carbon).   
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More recently, this strategy has been refined to instead generate a chiral Pd-enolate 
intermediate from allyl β-ketoester substrates (e.g., 520 and 522, Scheme A9.28) in the 
hopes that chirality at the metal might impart improved stereocontrol in the protonation 
step and obviate the need for heterogeneous Pd catalysts.  Stoltz and co-workers50 found 
that the catalyst derived from Pd(OAc)2 and phosphinooxazoline (PHOX) ligand 13 was 
capable of achieving enantioselective protonation in the presence of formic acid and 
molecular sieves (MS).  High enantiomeric excesses were obtained for a range of cyclic 
ketone products including tetralone- and cyclohexanone-derived ketones (e.g., 520 and 
522).  Attempts to track the source of the proton incorporated in the product with 
isomeric mono-deuterated formic acids (DCO2H and HCO2D) led to inconclusive results: 
with DCO2H the formyl deuteron was not incorporated into the product, but with HCO2D 
only 35% D incorporation was observed in the product, suggesting that another 
unidentified proton donor is also participating in the reaction.   
 
Scheme A9.28.  Stoltz' Palladium-Catalyzed Decarboxylative Protonation Reactions 
H3CO
O
O
O
H3CO
O
CH3
H(S)-13(12.5 mol %)N
O
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4ÅMS, p-dioxane, 40 °C
91% yield
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95% ee(±)-520
O
Et
O
O O
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O O
O O
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The heterogeneous additive (MS) in the reaction is important to the selectivity for 
protonation in preference to the competitive allylation reaction also catalyzed by the 
Pd•PHOX complex,51 and the specific amount required varied somewhat depending on 
the substrate.  To address this issue, a related homogeneous protonation system was 
developed by Stoltz and co-workers52 employing Meldrum’s acid (523, Scheme A9.28) as 
the achiral proton donor and a Pd•PHOX catalyst.  Similar substrate scope and 
enantioselectivity was observed with this system, but without the need to optimize the 
amounts of additives to achieve optimal results.  Initial mechanistic studies found zero-
order kinetic dependence in substrate, which suggests a fast initial reaction between 
catalyst and substrate and a slow subsequent step, presumably either decarboxylation or 
protonation of the putative enolate intermediate common to both the protonation and 
allylic alkylation reactions with this catalyst system.53  However, in the protonation 
reaction opposite enolate facial preference was observed for tetralone- and 
cyclohexanone-derived enolates, whereas in the alkylation reaction consistent 
enantiofacial selectivity was observed.51  This unexpected result suggests a substantial 
difference in the bond-forming portion of the mechanism. 
Kanai, Shibasaki, and co-workers54 recently reported the use of a chiral gadolinium 
complex for the enantioselective protonation of Gd-enolates generated in situ (Scheme 
A9.29).  The Gd-enolates were accessed by two means: transmetallation from enol silane 
(e.g., 429) or conjugate addition of cyanide to N-acryloyl pyrroles (e.g., 526).  Based on 
optimization studies, a polymetallic enolate intermediate was proposed.  The optimal 
ligand-to-metal ratio is consistent with a 5:6 complex.  The lack of reactivity in the 
absence of ligand 525 was also interpreted as the necessity of polynuclear Gd complexes 
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for the success of the reaction.  Kinetic studies also suggested that the reaction proceeds 
via transmetallation from Si to Gd, and that this step is rate-limiting.  2,6-Dimethylphenol 
was the preferred proton source, providing indanone and tetralone products in up to 99% 
yield and up to 88% ee.  The same Gd•525 complex was also effective for the conjugate 
addition/protonation of cyanide to N-acryloyl pyrroles (e.g., 526 → 528).  In this case, 
hydrogen cyanide was the preferred proton source.  This transformation was capable of 
producing N-acyl pyrroles in up to 99% yield and up to 91% ee.  In the case of product 
528, recrystallization could be carried out to provide a 74% yield of material with >99% 
ee.  The versatility of this polynuclear Gd catalyst to effect protonation of considerably 
different enolate intermediates is important to the prospect of a general system for enolate 
protonation. 
 
Scheme A9.29.  Kanai and Shibasaki’s Gadolinium-Catalyzed Protonation Reactions 
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A9.4.4 ENANTIOSELECTIVE HYDROGEN ATOM TRANSFER 
An analogous strategy for arriving at protonation products is to exploit radical 
chemistry with a terminal H-atom abstraction step.  Although not explicitly an 
enantioselective protonation reaction, many of the same challenges apply when 
manipulating a hydrogen atom.  A recent example of this tactic by Sibi and co-
workers55,56 has led to new methods for synthesizing β-amino acid derivatives (Scheme 
A9.30).  By employing a Lewis acid complex formed from MgI2 and bis(oxazoline) 
ligand 530, tributyltin hydride, and triethylborane/O2, alkyl radicals (from alkyl halides) 
can undergo radical conjugate addition followed by enantioselective hydrogen atom 
transfer to afford optically active products (e.g., 529) in up to 95% yield and up to 98% 
ee.  The reaction is believed to proceed through a bidentate chelate of the substrate to the 
chiral magnesium complex.  The process can be made catalytic in Lewis acid without a 
significant effect on yield, but product ee suffered greatly in some cases due to a rapid 
uncatalyzed background reaction.  These reactions have the benefit of being essentially 
neutral as opposed to the acidic or basic conditions required for the transformations 
described above. 
 
Scheme A9.30.  Radical Conjugate Addition Followed by Enantioselective H-Atom Transfer 
N
MgI2, Et3B/O2
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A9.5 CONCLUSION 
From the enantioselective enzymatic protonation reactions of nature to the variety of 
techniques for achieving enantioselective protonation in laboratories, a great deal of 
energy has been dedicated to understanding this deceptively simple transformation.  
Despite the many systems reported to date, the search for a highly efficient system with a 
broad scope continues.  Moreover, although many of the key parameters needed to create 
a successful system have been enumerated here and elsewhere, the current level of 
mechanistic understanding in nearly all of the enantioselective protonation reactions 
reported to date remains relatively immature.  Nonetheless, these useful transformations 
allow the synthesis of valuable chiral materials including natural products like α- and β-
amino acids.  Given these preliminary successes and improved understanding of the 
underlying mechanisms, enantioselective protonation reactions should continue to rise to 
prominence as an important tool for synthetic organic chemistry. 
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